Entity Extraction Examples (3845)

check_circle_outline   F1 = 100.000
check_circle_outline   F1 >= 50.00
highlight_off   F1 < 50.00
  True Positive  
  False Positive  
  False Negative

Score Text
0.9992 DrugIsotretinoin teratogenicity.
0.9175 Isotretinoin Adverse-Effectteratogenicity .
Score Text
0.9966 DrugNiacin maculopathy.
0.9130 Niacin Adverse-Effectmaculopathy .
Score Text
0.9989 DrugAllopurinol hypersensitivity.
0.8684 Allopurinol Adverse-Effecthypersensitivity .
Score Text
0.9990 DrugTamoxifen retinopathy.
0.9154 Tamoxifen Adverse-Effectretinopathy .
Score Text
0.9990 DrugMetronidazole neuropathy.
0.8735 Metronidazole Adverse-Effectneuropathy .
Score Text
0.9986 DrugCyclophosphamide pneumonitis.
0.9015 Cyclophosphamide Adverse-Effectpneumonitis .
Score Text
0.9985 DrugGold nephropathy.
0.8537 Gold Adverse-Effectnephropathy .
Score Text
0.9995 Ocular Drugethambutol toxicity.
0.6846 Adverse-EffectOcular ethambutol toxicity .
Score Text
0.9995 DrugClozapine induced polyserositis.
0.9981 Clozapine induced Adverse-Effectpolyserositis .
Score Text
0.9981 DrugSulfadiazine crystalluria revisited.
0.8797 Sulfadiazine Adverse-Effectcrystalluria revisited.
Score Text
0.9951 Pulmonary Druggold toxicity.
0.8257 Adverse-EffectPulmonary gold toxicity .
Score Text
0.9996 Anaphylaxis to Drugcalcitonin .
0.9987 Adverse-EffectAnaphylaxis to calcitonin.
Score Text
0.9996 Dermatitis to Drugcaptopril .
0.9988 Adverse-EffectDermatitis to captopril.
Score Text
0.9986 Severe Drugdapsone hypersensitivity syndrome.
0.9151 Severe dapsone Adverse-Effecthypersensitivity syndrome .
Score Text
0.9996 Anisocoria from transdermal Drugscopolamine .
0.9987 Adverse-EffectAnisocoria from transdermal scopolamine.
Score Text
0.9996 Priapism associated with Drugolanzapine .
0.9986 Adverse-EffectPriapism associated with olanzapine.
Score Text
0.9995 Anaphylaxis to intrathecal Drugdiamorphine .
0.9987 Adverse-EffectAnaphylaxis to intrathecal diamorphine.
Score Text
0.9996 DrugDiclofenac - associated hepatitis.
0.9989 Diclofenac - associated Adverse-Effecthepatitis .
Score Text
0.9995 DrugCarbamazepine - induced hyperammonemia.
0.9972 Carbamazepine - induced Adverse-Effecthyperammonemia .
Score Text
0.9996 DrugImidazoline intoxication in children.
0.8091 Adverse-EffectImidazoline intoxication in children.
Score Text
0.9995 DrugGold - induced pneumonitis.
0.9989 Gold - induced Adverse-Effectpneumonitis .
Score Text
0.9995 DrugCarbamazepine - induced tics.
0.9986 Carbamazepine - induced Adverse-Effecttics .
Score Text
0.9996 Priapism associated with Drugzuclopenthixol .
0.9987 Adverse-EffectPriapism associated with zuclopenthixol.
Score Text
0.9994 Delayed hypersensitivity to Drugflurbiprofen .
0.9710 Adverse-EffectDelayed hypersensitivity to flurbiprofen.
Score Text
0.9996 Morphea after Drugbromocriptine therapy.
0.9988 Adverse-EffectMorphea after bromocriptine therapy.
Score Text
0.9996 DrugAmpicillin - associated seizures.
0.9988 Ampicillin - associated Adverse-Effectseizures .
Score Text
0.9996 DrugAtenolol - induced pseudolymphoma.
0.9979 Atenolol - induced Adverse-Effectpseudolymphoma .
Score Text
0.9995 DrugLosartan - induced angioedema.
0.9984 Losartan - induced Adverse-Effectangioedema .
Score Text
0.9996 DrugDisulfiram - induced hepatitis.
0.9990 Disulfiram - induced Adverse-Effecthepatitis .
Score Text
0.9996 DrugMetoclopramide - induced parkinsonism.
0.9985 Metoclopramide - induced Adverse-Effectparkinsonism .
Score Text
0.9993 DrugPhenylpropanolamine - induced psychosis.
0.9986 Phenylpropanolamine - induced Adverse-Effectpsychosis .
Score Text
0.9993 DrugClofazimine induced nail changes.
0.9910 Clofazimine induced Adverse-Effectnail changes .
Score Text
0.9993 DrugCiprofloxacin - induced psychosis.
0.9986 Ciprofloxacin - induced Adverse-Effectpsychosis .
Score Text
0.9995 Jaundice induced by Drugstreptokinase .
0.9988 Adverse-EffectJaundice induced by streptokinase.
Score Text
0.9996 Agranulocytosis during Drugclozapine therapy.
0.9981 Adverse-EffectAgranulocytosis during clozapine therapy.
Score Text
0.9993 DrugHeparin - induced hyperkalemia.
0.9983 Heparin - induced Adverse-Effecthyperkalemia .
Score Text
0.9996 Stupor from Druglamotrigine toxicity.
0.9991 Adverse-EffectStupor from lamotrigine toxicity.
Score Text
0.9996 DrugCimetidine - induced fever.
0.9964 Cimetidine - induced Adverse-Effectfever .
Score Text
0.9996 DrugVancomycin - induced vasculitis.
0.9987 Vancomycin - induced Adverse-Effectvasculitis .
Score Text
0.9997 Gigantomastia induced by Drugbucillamine .
0.9985 Adverse-EffectGigantomastia induced by bucillamine.
Score Text
0.9996 DrugIsoniazid - induced anaphylaxis.
0.9986 Isoniazid - induced Adverse-Effectanaphylaxis .
Score Text
0.9995 DrugVincristine induced cranial polyneuropathy.
0.9831 Vincristine induced Adverse-Effectcranial polyneuropathy .
Score Text
0.9994 DrugBromocriptine - induced schizophrenia.
0.9974 Bromocriptine - induced Adverse-Effectschizophrenia .
Score Text
0.9992 Hepatic reactions to Drugcyclofenil .
0.9916 Adverse-EffectHepatic reactions to cyclofenil.
Score Text
0.9996 DrugQuetiapine - induced myoclonus.
0.9989 Quetiapine - induced Adverse-Effectmyoclonus .
Score Text
0.9993 DrugEnalaprilat induced acute parotitis.
0.9859 Enalaprilat induced Adverse-Effectacute parotitis .
Score Text
0.9996 DrugTemsirolimus - induced glomerulopathy.
0.9973 Temsirolimus - induced Adverse-Effectglomerulopathy .
Score Text
0.9996 Rhabdomyolysis following Drugclarithromycin monotherapy.
0.9978 Adverse-EffectRhabdomyolysis following clarithromycin monotherapy.
Score Text
0.9996 DrugTaxane - induced glaucoma.
0.9988 Taxane - induced Adverse-Effectglaucoma .
Score Text
0.9996 DrugFurosemide - associated fever.
0.9961 Furosemide - associated Adverse-Effectfever .
Score Text
0.9993 DrugThalidomide neuropathy in childhood.
0.8830 Thalidomide Adverse-Effectneuropathy in childhood.
Score Text
0.9996 Hepatitis following Drugcimetidine administration.
0.9990 Adverse-EffectHepatitis following cimetidine administration.
Score Text
0.9994 DrugLansoprazole - induced thrombocytopenia.
0.9967 Lansoprazole - induced Adverse-Effectthrombocytopenia .
Score Text
0.9997 DrugColchicine - induced rhabdomyolysis.
0.9974 Colchicine - induced Adverse-Effectrhabdomyolysis .
Score Text
0.9995 Keratitis in Drugmethamphetamine abusers.
0.9990 Adverse-EffectKeratitis in methamphetamine abusers.
Score Text
0.9996 Localized purpura associated with Druglamotrigine .
0.9906 Adverse-EffectLocalized purpura associated with lamotrigine.
Score Text
0.9991 DrugCiprofloxacin - induced hemorrhagic vasculitis.
0.9880 Ciprofloxacin - induced Adverse-Effecthemorrhagic vasculitis .
Score Text
0.9992 DrugCodeine intoxication in the neonate.
0.8259 Adverse-EffectCodeine intoxication in the neonate.
Score Text
0.9996 Rosaceiform eruption induced by Drugerlotinib .
0.9916 Adverse-EffectRosaceiform eruption induced by erlotinib.
Score Text
0.9994 DrugMethyldopa - induced liver injury.
0.9917 Methyldopa - induced Adverse-Effectliver injury .
Score Text
0.9989 DrugAcetazolamide - accelerated anticonvulsant osteomalacia.
0.9946 Acetazolamide - accelerated anticonvulsant Adverse-Effectosteomalacia .
Score Text
0.9992 DrugCephalexin rash in infectious mononucleosis.
0.9128 Adverse-EffectCephalexin rash in infectious mononucleosis.
Score Text
0.9991 Adverse-EffectScleritis complicating zoledronic acid infusion.
0.9793 Scleritis complicating Drugzoledronic acid infusion.
Score Text
0.9996 Seizures associated with Drugfluoxetine therapy.
0.9992 Adverse-EffectSeizures associated with fluoxetine therapy.
Score Text
0.9996 Pulmonary fibrosis associated with Drugnabumetone .
0.9892 Adverse-EffectPulmonary fibrosis associated with nabumetone.
Score Text
0.9995 Metabolic acidosis induced by Drugacetazolamide .
0.9923 Adverse-EffectMetabolic acidosis induced by acetazolamide.
Score Text
0.9995 Probable Drugenoxaparin - induced hepatotoxicity.
0.9976 Probable enoxaparin - induced Adverse-Effecthepatotoxicity .
Score Text
0.9996 Pulmonary toxicity associated with Drugerlotinib .
0.9876 Adverse-EffectPulmonary toxicity associated with erlotinib.
Score Text
0.9994 Fixed drug eruption to Drugrofecoxib .
0.9724 Adverse-EffectFixed drug eruption to rofecoxib.
Score Text
0.9995 DrugEnoxaparin - induced generalized exanthem.
0.9856 Enoxaparin - induced Adverse-Effectgeneralized exanthem .
Score Text
0.9992 Biomicroscopy revealed Drugamiodarone corneal deposits.
0.8692 Biomicroscopy revealed amiodarone Adverse-Effectcorneal deposits .
Score Text
0.9995 DrugAlbendazole - induced pseudomembranous colitis.
0.9916 Albendazole - induced Adverse-Effectpseudomembranous colitis .
Score Text
0.9997 Catatonia associated with Drugdisulfiram therapy.
0.9988 Adverse-EffectCatatonia associated with disulfiram therapy.
Score Text
0.9993 DrugPropylthiouracil - induced cutaneous vasculitis.
0.9852 Propylthiouracil - induced Adverse-Effectcutaneous vasculitis .
Score Text
0.9996 Nodular scleritis following Drugalendronate therapy.
0.9897 Adverse-EffectNodular scleritis following alendronate therapy.
Score Text
0.9996 Acute dystonia induced by Druglamivudine .
0.9882 Adverse-EffectAcute dystonia induced by lamivudine.
Score Text
0.9991 Occult Drugquinine - induced thrombocytopenia.
0.9969 Occult quinine - induced Adverse-Effectthrombocytopenia .
Score Text
0.9979 DrugProtamine - induced fatal anaphylaxis.
0.9841 Protamine - induced Adverse-Effectfatal anaphylaxis .
Score Text
0.9992 DrugChlorpropamide - induced hemolytic anemia.
0.9916 Chlorpropamide - induced Adverse-Effecthemolytic anemia .
Score Text
0.9986 Adverse-EffectParaplegia following intrathecal cytosine arabinoside.
0.9755 Paraplegia following intrathecal Drugcytosine arabinoside .
Score Text
0.9993 Sarcoma complicating therapy with Drugcyclophosphamide .
0.9992 Adverse-EffectSarcoma complicating therapy with cyclophosphamide.
Score Text
0.9996 DrugQuinine - induced hearing loss.
0.9950 Quinine - induced Adverse-Effecthearing loss .
Score Text
0.9994 DrugGold - induced aplastic anemia.
0.9925 Gold - induced Adverse-Effectaplastic anemia .
Score Text
0.9995 Tardive dyskinesia induced by Drugsulpiride .
0.9903 Adverse-EffectTardive dyskinesia induced by sulpiride.
Score Text
0.9994 Intravenous Drugdiazepam exacerbated the seizures.
0.9970 Intravenous diazepam exacerbated the Adverse-Effectseizures .
Score Text
0.9996 DrugEzetimibe - induced acute pancreatitis.
0.9871 Ezetimibe - induced Adverse-Effectacute pancreatitis .
Score Text
0.9995 DrugCefuroxime - induced immune hemolysis.
0.9865 Cefuroxime - induced Adverse-Effectimmune hemolysis .
Score Text
0.9942 Lamotrigine toxicity secondary to Drugsertraline .
0.9941 DrugLamotrigine toxicity secondary to sertraline.
0.8827 Adverse-EffectLamotrigine toxicity secondary to sertraline.
Score Text
0.9991 DrugAzathioprine can cause severe myelosuppression.
0.9377 Azathioprine can cause severe Adverse-Effectmyelosuppression .
Score Text
0.9996 Acute leukaemia during Drugtamoxifen therapy.
0.9907 Adverse-EffectAcute leukaemia during tamoxifen therapy.
Score Text
0.9995 Vortex keratopathy associated with Drugatovaquone .
0.9866 Adverse-EffectVortex keratopathy associated with atovaquone.
Score Text
0.9995 Paradoxical seizures in Drugphenytoin toxicity.
0.9926 Paradoxical Adverse-Effectseizures in phenytoin toxicity.
Score Text
0.9994 Hepatic damage after Drugdanazol treatment.
0.9935 Adverse-EffectHepatic damage after danazol treatment.
Score Text
0.9994 DrugInsulin - induced cardiac failure.
0.9923 Insulin - induced Adverse-Effectcardiac failure .
Score Text
0.9994 Nail staining from Drughydroquinone cream.
0.9901 Adverse-EffectNail staining from hydroquinone cream.
Score Text
0.9996 Delusional parasitosis associated with Drugphenelzine .
0.9925 Adverse-EffectDelusional parasitosis associated with phenelzine.
Score Text
0.9995 DrugPiritrexim - induced pulmonary toxicity.
0.9886 Piritrexim - induced Adverse-Effectpulmonary toxicity .
Score Text
0.9991 DrugPropecia - associated bilateral cataract.
0.9873 Propecia - associated Adverse-Effectbilateral cataract .
Score Text
0.9996 DrugTerlipressin - induced ventricular arrhythmia.
0.9863 Terlipressin - induced Adverse-Effectventricular arrhythmia .
Score Text
0.9996 Asterixis induced by Drugcarbamazepine therapy.
0.9988 Adverse-EffectAsterixis induced by carbamazepine therapy.
Score Text
0.9993 Cardiorespiratory toxicity due to Drugmiconazole .
0.9885 Adverse-EffectCardiorespiratory toxicity due to miconazole.
Score Text
0.9995 DrugNabumetone - associated interstitial nephritis.
0.9875 Nabumetone - associated Adverse-Effectinterstitial nephritis .
Score Text
0.9976 Human insulin - induced Adverse-Effectlipoatrophy .
0.9902 DrugHuman insulin - induced lipoatrophy.
Score Text
0.9995 DrugSulfasalazine - induced lupus erythematosus.
0.9870 Sulfasalazine - induced Adverse-Effectlupus erythematosus .
Score Text
0.9994 Lichenoid drug eruption to Drugsalsalate .
0.9832 Adverse-EffectLichenoid drug eruption to salsalate.
Score Text
0.9995 Uncontrolled headache induced by Drugoxcarbazepine .
0.9938 Uncontrolled Adverse-Effectheadache induced by oxcarbazepine.
Score Text
0.9995 Intravenous Drugazithromycin - induced ototoxicity.
0.9983 Intravenous azithromycin - induced Adverse-Effectototoxicity .
Score Text
0.9996 Fulminant hepatitis associated with Drugdisulfiram .
0.9903 Adverse-EffectFulminant hepatitis associated with disulfiram.
Score Text
0.9996 Pulmonary toxicity secondary to Drugprocarbazine .
0.9881 Adverse-EffectPulmonary toxicity secondary to procarbazine.
Score Text
0.9995 DrugMesalamine - induced hypersensitivity pneumonitis.
0.9860 Mesalamine - induced Adverse-Effecthypersensitivity pneumonitis .
Score Text
0.9996 Psychotic disorder associated with Drugisoniazid .
0.9937 Adverse-EffectPsychotic disorder associated with isoniazid.
Score Text
0.9990 DrugMagnesium toxicosis in two horses.
0.8598 Adverse-EffectMagnesium toxicosis in two horses.
Score Text
0.9996 Seizures associated with Drugofloxacin therapy.
0.9992 Adverse-EffectSeizures associated with ofloxacin therapy.
Score Text
0.9995 Pemphigus foliaceus induced by Drugrifampicin .
0.9860 Adverse-EffectPemphigus foliaceus induced by rifampicin.
Score Text
0.9995 Anaphylactic reaction to Drugbacitracin ointment.
0.9886 Adverse-EffectAnaphylactic reaction to bacitracin ointment.
Score Text
0.9994 DrugRifampicin - induced renal failure.
0.9919 Rifampicin - induced Adverse-Effectrenal failure .
Score Text
0.9994 Intranasal Drugdesmopressin - induced hyponatremia.
0.9984 Intranasal desmopressin - induced Adverse-Effecthyponatremia .
Score Text
0.9995 DrugChloroquine - induced bilateral ptosis.
0.9925 Chloroquine - induced Adverse-Effectbilateral ptosis .
Score Text
0.9995 DrugDisopyramide - induced heart block.
0.9934 Disopyramide - induced Adverse-Effectheart block .
Score Text
0.9995 DrugCarbamazepine - induced Diabetes mellitus.
0.9899 Carbamazepine - induced Adverse-EffectDiabetes mellitus .
Score Text
0.9996 DrugEtoposide - related myocardial infarction.
0.9889 Etoposide - related Adverse-Effectmyocardial infarction .
Score Text
0.9995 Myoclonic spasms following intrathecal Drugmorphine .
0.9901 Adverse-EffectMyoclonic spasms following intrathecal morphine.
Score Text
0.9996 DrugMethotrexate - induced liver cirrhosis.
0.9889 Methotrexate - induced Adverse-Effectliver cirrhosis .
Score Text
0.9994 DrugCefoxitin - associated renal failure.
0.9914 Cefoxitin - associated Adverse-Effectrenal failure .
Score Text
0.9996 Acute psychosis associated with Druglevetiracetam .
0.9887 Adverse-EffectAcute psychosis associated with levetiracetam.
Score Text
0.9994 Metastatic osteomyelitis following DrugBCG vaccination.
0.9830 Adverse-EffectMetastatic osteomyelitis following BCG vaccination.
Score Text
0.9997 Atrial fibrillation after Drugvardenafil therapy.
0.9919 Adverse-EffectAtrial fibrillation after vardenafil therapy.
Score Text
0.9996 Visual hallucinations associated with Drugzonisamide .
0.9859 Adverse-EffectVisual hallucinations associated with zonisamide.
Score Text
0.9995 DrugGliclazide - induced acute hepatitis.
0.9901 Gliclazide - induced Adverse-Effectacute hepatitis .
Score Text
0.9995 DrugRisperidone - induced tardive dyskinesia.
0.9898 Risperidone - induced Adverse-Effecttardive dyskinesia .
Score Text
0.9728 Adverse-EffectAllergic contact dermatitis from 4 - chloro - 7 - nitrobenzofurazan.
0.9455 Allergic contact dermatitis from Drug4 - chloro - 7 - nitrobenzofurazan .
Score Text
0.9994 DrugNitrendipine - induced gingival hyperplasia.
0.9907 Nitrendipine - induced Adverse-Effectgingival hyperplasia .
Score Text
0.9996 DrugAdenosine - induced ventricular fibrillation.
0.9879 Adenosine - induced Adverse-Effectventricular fibrillation .
Score Text
0.9996 Edema associated with Drugibuprofen therapy.
0.9992 Adverse-EffectEdema associated with ibuprofen therapy.
Score Text
0.9996 DrugTegaserod - associated ischemic colitis.
0.9928 Tegaserod - associated Adverse-Effectischemic colitis .
Score Text
0.9992 Progressive hypokalemia developed during Drugphosphate treatment.
0.9885 Adverse-EffectProgressive hypokalemia developed during phosphate treatment.
Score Text
0.9995 Progressive pulmonary fibrosis complicating Drugcyclophosphamide therapy.
0.9841 Adverse-EffectProgressive pulmonary fibrosis complicating cyclophosphamide therapy.
Score Text
0.9994 Cardiopulmonary arrest following intravenous Drugphenytoin loading.
0.9930 Adverse-EffectCardiopulmonary arrest following intravenous phenytoin loading.
Score Text
0.9996 DrugQuetiapine - induced leucopenia and thrombocytopenia.
0.9980 Quetiapine - induced Adverse-Effectleucopenia and thrombocytopenia.
0.9971 Quetiapine - induced leucopenia and Adverse-Effectthrombocytopenia .
Score Text
0.9992 A paradoxical ocular effect of Drugbrimonidine .
0.9801 A Adverse-Effectparadoxical ocular effect of brimonidine.
Score Text
0.9994 Severe Drugvancomycin - induced anaphylactic reaction.
0.9913 Severe vancomycin - induced Adverse-Effectanaphylactic reaction .
Score Text
0.9996 Fulminant hepatic failure associated with Drugbicalutamide .
0.9851 Adverse-EffectFulminant hepatic failure associated with bicalutamide.
Score Text
0.9995 Tuberculous uveitis after treatment with Drugetanercept .
0.9885 Adverse-EffectTuberculous uveitis after treatment with etanercept.
Score Text
0.9995 Cardiac arrest following use of Drugsumatriptan .
0.9950 Adverse-EffectCardiac arrest following use of sumatriptan.
Score Text
0.9995 Early Drugritonavir - induced maculopapular eruption.
0.9920 Early ritonavir - induced Adverse-Effectmaculopapular eruption .
Score Text
0.9995 DrugCarbamazepine - induced systemic lupus erythematosus.
0.9776 Carbamazepine - induced Adverse-Effectsystemic lupus erythematosus .
Score Text
0.9994 DrugSalicylate - induced hepatotoxicity is reviewed.
0.9966 Salicylate - induced Adverse-Effecthepatotoxicity is reviewed.
Score Text
0.9979 An unusual case of DrugEcstasy poisoning.
0.9742 An unusual case of Adverse-EffectEcstasy poisoning .
Score Text
0.9994 Oculomotor disturbances associated with Drug5 - fluorouracil chemotherapy.
0.9888 Adverse-EffectOculomotor disturbances associated with 5 - fluorouracil chemotherapy.
Score Text
0.9986 Does Drugacyclovir increase serum lithium levels?
0.8128 Does acyclovir Adverse-Effectincrease serum lithium levels ?
Score Text
0.9995 Exacerbation of schizophrenia associated with Drugamantadine .
0.9844 Exacerbation of Adverse-Effectschizophrenia associated with amantadine.
Score Text
0.9994 Diagnosis : Drugpractolol induced sclerosing peritonitis.
0.9842 Diagnosis : practolol induced Adverse-Effectsclerosing peritonitis .
Score Text
0.9996 Erythema multiforme bullosum due to Drugrifampicin .
0.9834 Adverse-EffectErythema multiforme bullosum due to rifampicin.
Score Text
0.9993 Suspected Drugciprofloxacin - induced interstitial nephritis.
0.9870 Suspected ciprofloxacin - induced Adverse-Effectinterstitial nephritis .
Score Text
0.9996 Widespread cutaneous vasculitis associated with Drugdiltiazem .
0.9874 Widespread Adverse-Effectcutaneous vasculitis associated with diltiazem.
Score Text
0.9996 Acute interstitial nephritis due to Drugpantoprazole .
0.9783 Adverse-EffectAcute interstitial nephritis due to pantoprazole.
Score Text
0.9824 Allergic contact angioedema to Drugbenzoyl peroxide .
0.9651 Adverse-EffectAllergic contact angioedema to benzoyl peroxide.
Score Text
0.9881 DrugDapsone syndrome in cutaneous lupus erythematosus.
0.9275 Adverse-EffectDapsone syndrome in cutaneous lupus erythematosus.
Score Text
0.9997 Nonconvulsive status epilepticus due to Drugifosfamide .
0.9792 Adverse-EffectNonconvulsive status epilepticus due to ifosfamide.
Score Text
0.9994 Persisent ocular hypertension following intravitreal Drugranibizumab .
0.9847 Adverse-EffectPersisent ocular hypertension following intravitreal ranibizumab.
Score Text
0.9995 Trichiasis associated with Drugprostaglandin analog use.
0.9989 Adverse-EffectTrichiasis associated with prostaglandin analog use.
Score Text
0.9994 Persistent light reactivity from systemic Drugquinine .
0.9760 Adverse-EffectPersistent light reactivity from systemic quinine.
Score Text
0.9995 Interstitial granulomatous dermatitis associated with Drugdarifenacin .
0.9794 Adverse-EffectInterstitial granulomatous dermatitis associated with darifenacin.
Score Text
0.9995 DrugIfosfamide - induced nonconvulsive status epilepticus.
0.9824 Ifosfamide - induced Adverse-Effectnonconvulsive status epilepticus .
Score Text
0.9995 Nephrotic syndrome associated with Druglithium therapy.
0.9941 Adverse-EffectNephrotic syndrome associated with lithium therapy.
Score Text
0.9769 Aminophylline hypersensitivity apparently due to Drugethylenediamine .
0.9056 DrugAminophylline hypersensitivity apparently due to ethylenediamine.
0.7946 Aminophylline Adverse-Effecthypersensitivity apparently due to ethylenediamine.
Adverse-EffectAminophylline hypersensitivity apparently due to ethylenediamine.
Score Text
0.9993 The 3 - week Drugsulphasalazine syndrome strikes again.
0.8726 The 3 - week Adverse-Effectsulphasalazine syndrome strikes again.
Score Text
0.9994 DrugDoxycycline - induced photo - onycholysis.
0.9803 Doxycycline - induced Adverse-Effectphoto - onycholysis .
Score Text
0.9988 DrugBleomycin pneumonitis potentiated by oxygen administration.
0.8982 Bleomycin Adverse-Effectpneumonitis potentiated by oxygen administration.
Score Text
0.9992 Acute Drugvalproate ingestion induces symptomatic methemoglobinemia.
0.9824 Acute valproate ingestion induces Adverse-Effectsymptomatic methemoglobinemia .
Score Text
0.9994 DrugMethotrexate induced sprue - like syndrome.
0.9813 Methotrexate induced Adverse-Effectsprue - like syndrome .
Score Text
0.9994 Polymyositis after Drugpropylthiouracil treatment for hyperthyroidism.
0.9986 Adverse-EffectPolymyositis after propylthiouracil treatment for hyperthyroidism.
Score Text
0.9995 Atrial fibrillation following Drugmethylprednisolone pulse therapy.
0.9921 Adverse-EffectAtrial fibrillation following methylprednisolone pulse therapy.
Score Text
0.9893 Adverse-EffectOesophageal ulceration due to emepronium bromide.
0.9820 Oesophageal ulceration due to Drugemepronium bromide .
Score Text
0.9995 DrugTroglitazone - induced fulminant hepatic failure.
0.9852 Troglitazone - induced Adverse-Effectfulminant hepatic failure .
Score Text
0.9828 Adverse-EffectToxic epidermal necrolysis associated with interleukin - 2.
0.9764 Toxic epidermal necrolysis associated with Druginterleukin - 2 .
Score Text
0.9996 DrugCaptopril - associated " pseudocholangitis '.
0.9979 Captopril - associated " Adverse-Effectpseudocholangitis '.
Score Text
0.9996 Fulminant liver failure associated with Drugclarithromycin .
0.9855 Adverse-EffectFulminant liver failure associated with clarithromycin.
Score Text
0.9994 DrugCefuroxime - induced acute renal failure.
0.9829 Cefuroxime - induced Adverse-Effectacute renal failure .
Score Text
0.9995 Nail - changes induced by Drugpenicillamine .
0.9877 Adverse-EffectNail - changes induced by penicillamine.
Score Text
0.9987 Adverse-EffectPsoriasis induced by interferon - alpha.
0.9664 Psoriasis induced by Druginterferon - alpha .
Score Text
0.9995 DrugGentamicin - associated acute renal failure.
0.9826 Gentamicin - associated Adverse-Effectacute renal failure .
Score Text
0.9996 Radiation recall pneumonitis induced by Druggemcitabine .
0.9818 Adverse-EffectRadiation recall pneumonitis induced by gemcitabine.
Score Text
0.9960 Can magnesium sulfate therapy impact Adverse-Effectlactogenesis ?
0.9624 Can Drugmagnesium sulfate therapy impact lactogenesis?
Score Text
0.9982 DrugSalicylate hepato toxicity in rheumatic fever.
0.8475 Salicylate Adverse-Effecthepato toxicity in rheumatic fever.
Score Text
0.9995 Pemphigus vulgaris precipitated by Drugglibenclamide therapy.
0.9918 Adverse-EffectPemphigus vulgaris precipitated by glibenclamide therapy.
Score Text
0.9993 DrugFlurbiprofen - associated acute tubulointerstitial nephritis.
0.9814 Flurbiprofen - associated Adverse-Effectacute tubulointerstitial nephritis .
Score Text
0.9980 Fluorouracil for allergic reactions to Drugcapecitabine .
0.9645 Fluorouracil for Adverse-Effectallergic reactions to capecitabine.
Score Text
0.9987 Chronic Drugfentanyl application induces adrenocortical insufficiency.
0.9855 Chronic fentanyl application induces Adverse-Effectadrenocortical insufficiency .
Score Text
0.9996 Agranulocytosis and granulocytopenia associated with Drugquetiapine .
0.9969 Adverse-EffectAgranulocytosis and granulocytopenia associated with quetiapine.
0.9964 Agranulocytosis and Adverse-Effectgranulocytopenia associated with quetiapine.
Score Text
0.9840 Treatment of Druglithium tremor with metoprolol.
0.9713 Treatment of lithium Adverse-Effecttremor with metoprolol.
Score Text
0.9995 DrugBarbiturate - induced submassive hepatic necrosis.
0.9841 Barbiturate - induced Adverse-Effectsubmassive hepatic necrosis .
Score Text
0.9996 Ulcerating enteritis associated with Drugflucytosine therapy.
0.9907 Adverse-EffectUlcerating enteritis associated with flucytosine therapy.
Score Text
0.9872 Adverse-EffectExfoliative dermatitis secondary to tobramycin sulfate.
0.9790 Exfoliative dermatitis secondary to Drugtobramycin sulfate .
Score Text
0.9995 Protease inhibitor - induced Drugcarbamazepine toxicity.
0.8233 Protease inhibitor - induced Adverse-Effectcarbamazepine toxicity .
Score Text
0.9745 Severe hepatitis caused by Drugcyproterone acetate .
0.9737 Adverse-EffectSevere hepatitis caused by cyproterone acetate.
Score Text
0.9993 DrugGabapentin withdrawal presenting as status epilepticus.
0.9867 Gabapentin withdrawal presenting as Adverse-Effectstatus epilepticus .
Score Text
0.9990 DrugSuxamethonium apnoea terminated with commercial serumcholinesterase.
0.9394 Suxamethonium Adverse-Effectapnoea terminated with commercial serumcholinesterase.
Score Text
0.9996 Transient hemiparesis caused by Drugphenytoin toxicity.
0.9512 Adverse-EffectTransient hemiparesis caused by phenytoin toxicity.
Score Text
0.9992 Systemic corticosteroids in the Drugphenytoin hypersensitivity syndrome.
Systemic corticosteroids in the Adverse-Effectphenytoin hypersensitivity syndrome .
Score Text
0.9959 Adverse-EffectNeurotoxicity of intrathecal administration of amphotericin B.
0.9796 Neurotoxicity of intrathecal administration of Drugamphotericin B .
Score Text
0.9996 Sustained monomorphic ventricular tachycardia after Drugadenosine infusion.
0.9678 Adverse-EffectSustained monomorphic ventricular tachycardia after adenosine infusion.
Score Text
0.9777 Severe hepatocellular dysfunction following Drugcyproterone acetate therapy.
0.9478 Adverse-EffectSevere hepatocellular dysfunction following cyproterone acetate therapy.
Score Text
0.9994 DrugBleomycin induced hyperpigmentation with yolk sac tumor.
0.9927 Bleomycin induced Adverse-Effecthyperpigmentation with yolk sac tumor.
Score Text
0.9995 Atypical neuroleptic malignant syndrome associated with Drugolanzapine .
0.9410 Atypical Adverse-Effectneuroleptic malignant syndrome associated with olanzapine.
Score Text
0.9996 Focal renal cortical necrosis associated with Drugzomepirac .
0.9770 Adverse-EffectFocal renal cortical necrosis associated with zomepirac.
Score Text
0.9990 DrugCapecitabine - induced headache responding to diltiazem.
0.9990 Capecitabine - induced Adverse-Effectheadache responding to diltiazem.
Score Text
0.9996 Acute coronary syndrome induced by Drugcapecitabine therapy.
0.9886 Adverse-EffectAcute coronary syndrome induced by capecitabine therapy.
Score Text
0.9989 Acute Drugisoniazid neurotoxicity in an urban hospital.
0.8502 Acute isoniazid Adverse-Effectneurotoxicity in an urban hospital.
Score Text
0.9826 Adverse-EffectInappropriate antidiuretic hormone following adenine arabinoside administration.
0.9727 Inappropriate antidiuretic hormone following Drugadenine arabinoside administration.
Score Text
0.9996 Skin rash and splinter hemorrhages from Drugganciclovir .
0.9876 Adverse-EffectSkin rash and splinter hemorrhages from ganciclovir.
0.9826 Skin rash and Adverse-Effectsplinter hemorrhages from ganciclovir.
Score Text
0.9996 Priapism as a complication of Drugheparin therapy.
0.9991 Adverse-EffectPriapism as a complication of heparin therapy.
Score Text
0.9985 Thrombocytosis under Drugciprofloxacin and tazobactam / piperacillin.
0.9983 Thrombocytosis under ciprofloxacin and Drugtazobactam / piperacillin.
0.9982 Thrombocytosis under ciprofloxacin and tazobactam / Drugpiperacillin .
0.9970 Adverse-EffectThrombocytosis under ciprofloxacin and tazobactam / piperacillin.
Score Text
0.9996 Nonoliguric acute renal failure after Drugcaptopril therapy.
0.9785 Adverse-EffectNonoliguric acute renal failure after captopril therapy.
Score Text
0.9996 DrugCaptopril - induced acute reversible renal failure.
0.9809 Captopril - induced Adverse-Effectacute reversible renal failure .
Score Text
0.9996 Gastro - oesophageal reflux associated with Drugnifedipine .
0.9846 Adverse-EffectGastro - oesophageal reflux associated with nifedipine.
Score Text
0.9994 DrugIsoniazid associated, painful, bilateral gynaecomastia.
0.9794 Isoniazid associated, painful, Adverse-Effectbilateral gynaecomastia .
Score Text
0.9983 Adverse-EffectPiloerection induced by replacing fluvoxamine with milnacipran.
0.9973 Piloerection induced by replacing fluvoxamine with Drugmilnacipran .
0.9965 Piloerection induced by replacing Drugfluvoxamine with milnacipran.
Score Text
0.9995 Allergic and irritant contact dermatitis to Drugcalcipotriol .
0.9707 Allergic and Adverse-Effectirritant contact dermatitis to calcipotriol.
Score Text
0.9994 Case studies in Drugheparin - induced thrombocytopenia.
0.9967 Case studies in heparin - induced Adverse-Effectthrombocytopenia .
Score Text
0.9981 The bleeding resolved on discontinuation of DrugAPV .
0.9886 The Adverse-Effectbleeding resolved on discontinuation of APV.
Score Text
0.9968 DIAGNOSIS : Interferon alpha - 2b - induced Adverse-Effectcardiomyopathy .
0.9665 DIAGNOSIS : DrugInterferon alpha - 2b - induced cardiomyopathy.
Score Text
0.9991 Case study : adverse response to Drugclonidine .
0.9725 Case study : Adverse-Effectadverse response to clonidine.
Score Text
0.9994 Syncope induced by Drugpropranolol in hypertrophic cardiomyopathy.
0.9990 Adverse-EffectSyncope induced by propranolol in hypertrophic cardiomyopathy.
Score Text
0.9992 Prolonged severe cholestasis induced by Drugoxacillin derivatives.
0.8619 Prolonged Adverse-Effectsevere cholestasis induced by oxacillin derivatives.
Score Text
0.9996 DrugLithium - induced Creutzfeldt - Jakob syndrome.
0.9842 Lithium - induced Adverse-EffectCreutzfeldt - Jakob syndrome .
Score Text
0.9989 Adverse-EffectEctropion secondary to bolus injection of 5 - fluorouracil.
0.9981 Ectropion secondary to bolus injection of Drug5 - fluorouracil .
Score Text
0.9996 DrugCarbamazepine - related hyponatremia following cardiopulmonary bypass.
0.9973 Carbamazepine - related Adverse-Effecthyponatremia following cardiopulmonary bypass.
Score Text
0.9982 Clinical and morphological features of Druggold neuropathy.
0.8720 Clinical and morphological features of gold Adverse-Effectneuropathy .
Score Text
0.9996 Sporadic rippling muscle disease unmasked by Drugsimvastatin .
0.9816 Adverse-EffectSporadic rippling muscle disease unmasked by simvastatin.
Score Text
0.9994 Refractory hypoglycemia from ciprofloxacin and Drugglyburide interaction.
0.9994 Refractory hypoglycemia from Drugciprofloxacin and glyburide interaction.
0.9810 Adverse-EffectRefractory hypoglycemia from ciprofloxacin and glyburide interaction.
Score Text
0.9995 Two patients had Drugampicillin - associated seizures.
0.9985 Two patients had ampicillin - associated Adverse-Effectseizures .
Score Text
0.9994 Angioimmunoblastic lymphadenopathy with dysproteinemia following Drugdoxycycline administration.
0.9740 Adverse-EffectAngioimmunoblastic lymphadenopathy with dysproteinemia following doxycycline administration.
Score Text
0.9996 DrugMethadone - induced myoclonus in advanced cancer.
0.9987 Methadone - induced Adverse-Effectmyoclonus in advanced cancer.
Score Text
0.9996 Paradoxical cerebral cortical hyperexcitability following Drugflupirtine overdose.
0.9732 Adverse-EffectParadoxical cerebral cortical hyperexcitability following flupirtine overdose.
Score Text
0.9951 Torsade de pointes during loading with Drugamiodarone .
0.9876 Adverse-EffectTorsade de pointes during loading with amiodarone.
Score Text
0.9993 Severe abdominal pain in low dosage Drugclofazimine .
0.6184 Severe Adverse-Effectabdominal pain in low dosage clofazimine.
0.6162 Adverse-EffectSevere abdominal pain in low dosage clofazimine.
Score Text
0.9995 Ischaemic colitis in a patient taking Drugmeloxicam .
0.9926 Adverse-EffectIschaemic colitis in a patient taking meloxicam.
Score Text
0.9995 Probable Drugpropafenone - induced transient global amnesia.
0.9839 Probable propafenone - induced Adverse-Effecttransient global amnesia .
Score Text
0.9995 Acute myocardial necrosis during administration of Drugamsacrine .
0.9817 Adverse-EffectAcute myocardial necrosis during administration of amsacrine.
Score Text
0.9991 Generalized argyria after habitual use of DrugAgNO3 .
0.9893 Adverse-EffectGeneralized argyria after habitual use of AgNO3.
Score Text
0.9995 Corneal endothelial dysfunction associated with Drugamantadine toxicity.
0.9768 Adverse-EffectCorneal endothelial dysfunction associated with amantadine toxicity.
Score Text
0.9996 Reversible nonthrombocytopenic palpable purpura associated with Drugmetoclopramide .
0.9076 Reversible Adverse-Effectnonthrombocytopenic palpable purpura associated with metoclopramide.
Score Text
0.9974 Methylphenidate and Drugdextroamphetamine - induced peripheral vasculopathy.
0.9947 DrugMethylphenidate and dextroamphetamine - induced peripheral vasculopathy.
0.9866 Methylphenidate and dextroamphetamine - induced Adverse-Effectperipheral vasculopathy .
Score Text
0.9996 Pure red cell aplasia associated with Drugfenoprofen .
0.9780 Adverse-EffectPure red cell aplasia associated with fenoprofen.
Score Text
0.9995 Cicatricial entropion associated with chronic Drugdipivefrin application.
0.9903 Adverse-EffectCicatricial entropion associated with chronic dipivefrin application.
Score Text
0.9995 DrugLeflunomide - associated infections in rheumatoid arthritis.
0.9958 Leflunomide - associated Adverse-Effectinfections in rheumatoid arthritis.
Score Text
0.9994 A possible case of Drugcarbamazepine induced pancreatitis.
0.9981 A possible case of carbamazepine induced Adverse-Effectpancreatitis .
Score Text
0.9993 Lichen planus and acne provoked by Druggold .
0.9982 Lichen planus and Adverse-Effectacne provoked by gold.
0.9891 Adverse-EffectLichen planus and acne provoked by gold.
Score Text
0.9995 Cutaneous mycobacterial infection post intravesical DrugBCG installation.
0.9821 Adverse-EffectCutaneous mycobacterial infection post intravesical BCG installation.
Score Text
0.9989 An Drugamiodarone optic neuropathy has been described.
0.9163 An amiodarone Adverse-Effectoptic neuropathy has been described.
Score Text
0.9992 Regression of thyrotoxic ophthalmopathy following Druglithium withdrawal.
0.9597 Regression of Adverse-Effectthyrotoxic ophthalmopathy following lithium withdrawal.
Score Text
0.9876 Acute leukopenia associated with Drugsilver sulfadiazine therapy.
0.9757 Adverse-EffectAcute leukopenia associated with silver sulfadiazine therapy.
Score Text
0.9926 Trimethoprim - sulfamethoxazole - induced Adverse-Effectaseptic meningitis .
0.8475 DrugTrimethoprim - sulfamethoxazole - induced aseptic meningitis.
Score Text
0.9991 Unique behavioral change with Drugcinepazide in parkinsonism.
0.9752 Unique Adverse-Effectbehavioral change with cinepazide in parkinsonism.
Score Text
0.9995 DrugIsoniazid induced gynaecomastia : a case report.
0.9977 Isoniazid induced Adverse-Effectgynaecomastia : a case report.
Score Text
0.9995 Rapidly developing hyperglycemia during treatment with Drugolanzapine .
0.9982 Rapidly developing Adverse-Effecthyperglycemia during treatment with olanzapine.
Score Text
0.9978 The disease predisposes to severe Drugvincristine neurotoxicity.
0.8487 The disease predisposes to severe vincristine Adverse-Effectneurotoxicity .
The disease predisposes to severe Adverse-Effectvincristine neurotoxicity .
Score Text
0.9995 Intrahepatic cholestasis and sicca complex after Drugthiabendazole .
0.9854 Intrahepatic cholestasis and Adverse-Effectsicca complex after thiabendazole.
0.9843 Adverse-EffectIntrahepatic cholestasis and sicca complex after thiabendazole.
Score Text
0.9995 DrugNaproxen - associated sudden sensorineural hearing loss.
0.9809 Naproxen - associated Adverse-Effectsudden sensorineural hearing loss .
Score Text
0.9992 Neonatal mydriasis : intravenous Druglidocaine adverse reaction.
0.9740 Neonatal Adverse-Effectmydriasis : intravenous lidocaine adverse reaction.
Score Text
0.9995 Linear IgA bullous dermatosis occurring after Drugcarbamazepine .
0.9775 Adverse-EffectLinear IgA bullous dermatosis occurring after carbamazepine.
Score Text
0.9852 Adverse-EffectBilateral anterior uveitis associated with clomiphene citrate.
0.9764 Bilateral anterior uveitis associated with Drugclomiphene citrate .
Score Text
0.9993 DrugEthambutol toxicity manifesting as acute onset psychosis.
0.9700 Ethambutol toxicity manifesting as Adverse-Effectacute onset psychosis .
Score Text
0.9987 A drug interaction between zafirlukast and Drugtheophylline .
0.9987 A drug interaction between Drugzafirlukast and theophylline.
0.9765 A Adverse-Effectdrug interaction between zafirlukast and theophylline.
Score Text
0.9995 Recurrent hyponatremia associated with Drugcitalopram and mirtazapine.
0.9995 Recurrent hyponatremia associated with citalopram and Drugmirtazapine .
0.9757 Adverse-EffectRecurrent hyponatremia associated with citalopram and mirtazapine.
Score Text
0.9996 Seizures associated with Drugfluoxetine therapy are uncommon.
0.9992 Adverse-EffectSeizures associated with fluoxetine therapy are uncommon.
Score Text
0.9995 Spontaneous splenic infarction associated with Drugsumatriptan use.
0.9859 Adverse-EffectSpontaneous splenic infarction associated with sumatriptan use.
Score Text
0.9853 Nicotinic acid - induced Adverse-Effectfulminant hepatic failure .
0.9723 DrugNicotinic acid - induced fulminant hepatic failure.
Score Text
0.9996 DrugTriazolam - induced nocturnal bingeing with amnesia.
0.9954 Triazolam - induced nocturnal bingeing with Adverse-Effectamnesia .
0.9835 Triazolam - induced Adverse-Effectnocturnal bingeing with amnesia.
Score Text
0.9989 Asthma and Adverse-Effecturticaria during disodium cromoglycate treatment.
0.9988 Adverse-EffectAsthma and urticaria during disodium cromoglycate treatment.
0.9763 Asthma and urticaria during Drugdisodium cromoglycate treatment.
Score Text
0.9996 Cerebral and ocular toxicity induced by Drugdesferrioxamine .
0.9707 Adverse-EffectCerebral and ocular toxicity induced by desferrioxamine.
Score Text
0.9996 Acute drug induced hepatitis due to Drugerlotinib .
0.9988 Acute drug induced Adverse-Effecthepatitis due to erlotinib.
Score Text
0.9995 Panic anxiety after abrupt discontinuation of Drugmianserin .
0.9894 Adverse-EffectPanic anxiety after abrupt discontinuation of mianserin.
Score Text
0.9995 One patient on Drugouabain also developed cardiomyopathy.
0.9978 One patient on ouabain also developed Adverse-Effectcardiomyopathy .
Score Text
0.9996 DrugSotalol - induced bradycardia reversed by glucagon.
0.9986 Sotalol - induced Adverse-Effectbradycardia reversed by glucagon.
Score Text
0.9995 DrugPilocarpine toxicity and the treatment of xerostomia.
0.8849 Adverse-EffectPilocarpine toxicity and the treatment of xerostomia.
Score Text
0.9990 Probable early acute hepatitis with parenteral Drugamiodarone .
0.9694 Probable early Adverse-Effectacute hepatitis with parenteral amiodarone.
Score Text
0.9995 Acute respiratory distress syndrome after Drugrituximab infusion.
0.9731 Adverse-EffectAcute respiratory distress syndrome after rituximab infusion.
Score Text
0.9895 Adverse-EffectBromide intoxication secondary to pyridostigmine bromide therapy.
0.9758 Bromide intoxication secondary to Drugpyridostigmine bromide therapy.
Score Text
0.9993 Acute generalized exanthematous pustulosis induced by Drugnimesulide .
0.9739 Adverse-EffectAcute generalized exanthematous pustulosis induced by nimesulide.
Score Text
0.9983 DrugPhenytoin toxicity due to concomitant antituberculosis therapy.
0.8911 Adverse-EffectPhenytoin toxicity due to concomitant antituberculosis therapy.
Score Text
0.9993 Unusual pigmentary changes associated with Drug5 - fluorouracil therapy.
0.9824 Unusual Adverse-Effectpigmentary changes associated with 5 - fluorouracil therapy.
Score Text
0.9818 Juvenile absence epilepsy exacerbated by Drugvalproic acid .
0.9745 Adverse-EffectJuvenile absence epilepsy exacerbated by valproic acid.
Score Text
0.9989 Interstitial pneumopathy and low - dosage Drugamiodarone .
0.9831 Adverse-EffectInterstitial pneumopathy and low - dosage amiodarone.
Score Text
0.9993 DrugLevofloxacin - induced delirium with psychotic features.
0.9098 Levofloxacin - induced Adverse-Effectdelirium with psychotic features .
Score Text
0.9996 Multifocal inflammatory leukoencephalopathy associated with Druglevamisole therapy.
0.9686 Adverse-EffectMultifocal inflammatory leukoencephalopathy associated with levamisole therapy.
Score Text
0.9985 Prothipendylhydrochloride - induced Adverse-Effectpriapism : case report.
0.9809 DrugProthipendylhydrochloride - induced priapism : case report.
Score Text
0.9992 DrugPravastatin is associated with myotonia in animals.
0.9978 Pravastatin is associated with Adverse-Effectmyotonia in animals.
Score Text
0.9995 Hemodynamic collapse following Druglabetalol administration in preeclampsia.
0.9935 Adverse-EffectHemodynamic collapse following labetalol administration in preeclampsia.
Score Text
0.9995 Severe serotonin syndrome induced by Drugmirtazapine monotherapy.
0.8577 Severe Adverse-Effectserotonin syndrome induced by mirtazapine monotherapy.
0.7611 Adverse-EffectSevere serotonin syndrome induced by mirtazapine monotherapy.
Score Text
0.9995 DrugGemcitabine - induced rectus abdominus radiation recall.
0.9668 Gemcitabine - induced Adverse-Effectrectus abdominus radiation recall .
Score Text
0.9997 Life - threatening hyponatremia caused by Drugvinblastine .
0.9977 Life - threatening Adverse-Effecthyponatremia caused by vinblastine.
Score Text
0.9884 Long lasting Adverse-Effectrespiratory depression induced by morphine - 6 - glucuronide?
0.9693 Long lasting respiratory depression induced by Drugmorphine - 6 - glucuronide ?
Score Text
0.9992 Glaucoma secondary to epithelial downgrowth and Drug5 - fluorouracil .
0.9985 Adverse-EffectGlaucoma secondary to epithelial downgrowth and 5 - fluorouracil.
Score Text
0.9996 Drug - induced fever due to Drugdiltiazem .
0.9944 Drug - induced Adverse-Effectfever due to diltiazem.
Score Text
0.9996 A case of mania associated with Drugfluoxetine .
0.9985 A case of Adverse-Effectmania associated with fluoxetine.
Score Text
0.9996 DrugColchicine - induced myopathy in renal failure.
0.9981 Colchicine - induced Adverse-Effectmyopathy in renal failure.
Score Text
0.9995 Life - threatening hyperkalemia induced by Drugarginine .
0.9973 Life - threatening Adverse-Effecthyperkalemia induced by arginine.
Score Text
0.9994 Depressive symptoms disappeared after Druginterferon therapy was stopped.
0.9877 Adverse-EffectDepressive symptoms disappeared after interferon therapy was stopped.
Score Text
0.9994 Eruptive epidermoid cysts resulting from treatment with Drugimiquimod .
0.9812 Adverse-EffectEruptive epidermoid cysts resulting from treatment with imiquimod.
Score Text
0.9996 Deepening of lid sulcus from topical Drugbimatoprost therapy.
0.9760 Adverse-EffectDeepening of lid sulcus from topical bimatoprost therapy.
Score Text
0.9992 We diagnosed this case as Drugdanazol induced thrombocytopenia.
0.9971 We diagnosed this case as danazol induced Adverse-Effectthrombocytopenia .
Score Text
0.9996 DrugAliskiren - associated acute renal failure with hyperkalemia.
0.9827 Aliskiren - associated Adverse-Effectacute renal failure with hyperkalemia.
Score Text
0.9991 DrugCiprofloxacin - induced renal insufficiency in cystic fibrosis.
0.9897 Ciprofloxacin - induced Adverse-Effectrenal insufficiency in cystic fibrosis.
Score Text
0.9996 Fixed drug eruption in hands caused by Drugomeprazole .
0.8925 Fixed drug Adverse-Effecteruption in hands caused by omeprazole.
Score Text
0.9830 Reversible cardiomyopathy caused by administration of Druginterferon alpha .
0.9752 Adverse-EffectReversible cardiomyopathy caused by administration of interferon alpha.
Score Text
0.9996 DrugAlprazolam - induced mania : two clinical cases.
0.9984 Alprazolam - induced Adverse-Effectmania : two clinical cases.
Score Text
0.9995 Fulminant hepatitis and lymphocyte sensitization due to Drugpropylthiouracil .
0.9872 Adverse-EffectFulminant hepatitis and lymphocyte sensitization due to propylthiouracil.
0.7565 Fulminant hepatitis and Adverse-Effectlymphocyte sensitization due to propylthiouracil.
Score Text
0.9815 Theophylline intoxication following Drugviloxazine induced decrease in clearance.
0.8728 Adverse-EffectTheophylline intoxication following viloxazine induced decrease in clearance.
0.7972 DrugTheophylline intoxication following viloxazine induced decrease in clearance.
Theophylline intoxication following viloxazine induced Adverse-Effectdecrease in clearance .
Score Text
0.9975 Mycophenolate mofetil - induced Adverse-Effectneutropenia in liver transplantation.
0.9544 DrugMycophenolate mofetil - induced neutropenia in liver transplantation.
Score Text
0.9995 Allergic contact dermatitis to compound tincture of Drugbenzoin .
0.9645 Adverse-EffectAllergic contact dermatitis to compound tincture of benzoin.
Score Text
0.9996 Pulmonary infiltrates and skin pigmentation associated with Drugsulfasalazine .
0.9772 Pulmonary infiltrates and Adverse-Effectskin pigmentation associated with sulfasalazine.
0.9641 Adverse-EffectPulmonary infiltrates and skin pigmentation associated with sulfasalazine.
Score Text
0.9994 Spindle coma in Drugbenzodiazepine toxicity : case report.
0.9931 Adverse-EffectSpindle coma in benzodiazepine toxicity : case report.
Score Text
0.9990 DrugTiclopidine - induced marrow aplasia treated with cyclosporine.
0.9920 Ticlopidine - induced Adverse-Effectmarrow aplasia treated with cyclosporine.
Score Text
0.9996 Priapism associated with Drugtrazodone therapy : case report.
0.9988 Adverse-EffectPriapism associated with trazodone therapy : case report.
Score Text
0.9995 MR findings in Drugmethotrexate - induced CNS abnormalities.
0.9890 MR findings in methotrexate - induced Adverse-EffectCNS abnormalities .
Score Text
0.9987 Reversible findings of restricted diffusion in Drug5 - fluorouracil neurotoxicity.
0.9230 Reversible findings of restricted diffusion in 5 - fluorouracil Adverse-Effectneurotoxicity .
Score Text
0.9992 RESULTS : DrugBudesonide use can cause contact dermatitis.
0.9891 RESULTS : Budesonide use can cause Adverse-Effectcontact dermatitis .
Score Text
0.9888 Adverse-EffectRestless legs syndrome due to interferon - alpha.
0.9639 Restless legs syndrome due to Druginterferon - alpha .
Score Text
0.9994 A lethal complication of peripheral vein Drugvasopressin infusion.
0.9872 A Adverse-Effectlethal complication of peripheral vein vasopressin infusion.
Score Text
0.9993 Allergic reaction to Druggemfibrozil manifesting as eosinophilic gastroenteritis.
0.9847 Allergic reaction to gemfibrozil manifesting as Adverse-Effecteosinophilic gastroenteritis .
Score Text
0.9995 Progressive interstitial lung disease from prolonged Drugmethotrexate therapy.
0.9816 Adverse-EffectProgressive interstitial lung disease from prolonged methotrexate therapy.
Score Text
0.9996 Angioedema and maculopapular eruptions associated with Drugcarbamazepine administration.
0.9964 Adverse-EffectAngioedema and maculopapular eruptions associated with carbamazepine administration.
0.9894 Angioedema and Adverse-Effectmaculopapular eruptions associated with carbamazepine administration.
Score Text
0.9996 Fatal toxic epidermal necrolysis related to Druglamotrigine administration.
0.9805 Adverse-EffectFatal toxic epidermal necrolysis related to lamotrigine administration.
Score Text
0.9993 DrugNitrofurantoin - induced acute liver damage in pregnancy.
0.9877 Nitrofurantoin - induced Adverse-Effectacute liver damage in pregnancy.
Score Text
0.9985 DrugCyclophosphamide can rarely cause interstitial pneumonitis and fibrosis.
0.9959 Cyclophosphamide can rarely cause interstitial pneumonitis and Adverse-Effectfibrosis .
0.9829 Cyclophosphamide can rarely cause Adverse-Effectinterstitial pneumonitis and fibrosis.
Score Text
0.9995 Acute bilateral phrenic neuropathy following treatment with Drugadalimumab .
0.9380 Adverse-EffectAcute bilateral phrenic neuropathy following treatment with adalimumab.
Score Text
0.9992 DrugAmpicillin may aggravate clinical and experimental myasthenia gravis.
0.9860 Ampicillin may aggravate clinical and experimental Adverse-Effectmyasthenia gravis .
Score Text
0.9994 The increased libido disappeared after Drugfluvoxamine was discontinued.
0.9902 The Adverse-Effectincreased libido disappeared after fluvoxamine was discontinued.
Score Text
0.9990 DrugAmiodarone was discontinued, and thyrotoxicosis gradually abated.
0.9948 Amiodarone was discontinued, and Adverse-Effectthyrotoxicosis gradually abated.
Score Text
0.9996 Visceral herpesvirus infections in leukemic patients receiving Drugcytarabine .
0.9781 Adverse-EffectVisceral herpesvirus infections in leukemic patients receiving cytarabine.
Score Text
0.9903 Adverse-EffectBowel perforation associated with intraperitoneal chromic phosphate instillation.
0.9821 Bowel perforation associated with intraperitoneal Drugchromic phosphate instillation.
Score Text
0.9456 DrugCo - trimoxazole red cell aplasia in leukaemia.
0.8858 Co - trimoxazole Adverse-Effectred cell aplasia in leukaemia.
Score Text
0.9995 Recurrent hypotension immediately after seizures in Drugnortriptyline overdose.
0.9845 Recurrent hypotension immediately after Adverse-Effectseizures in nortriptyline overdose.
0.9844 Adverse-EffectRecurrent hypotension immediately after seizures in nortriptyline overdose.
Score Text
0.9997 Nephropathy caused by Drugmethicillin therapy for staphylococcal septicemia.
0.9981 Adverse-EffectNephropathy caused by methicillin therapy for staphylococcal septicemia.
Score Text
0.9995 DrugDapsone - induced erythroderma with Beau's lines.
0.9979 Dapsone - induced Adverse-Effecterythroderma with Beau's lines.
Score Text
0.9994 Esophageal spasm following Drugpropranolol overdose relieved by glucagon.
0.9897 Adverse-EffectEsophageal spasm following propranolol overdose relieved by glucagon.
Score Text
0.9995 DrugMetformin - associated lactic acidosis precipitated by diarrhea.
0.9911 Metformin - associated Adverse-Effectlactic acidosis precipitated by diarrhea.
Score Text
0.9996 DrugAmoxapine - induced cognitive impairment in two patients.
0.9885 Amoxapine - induced Adverse-Effectcognitive impairment in two patients.
Score Text
0.9996 First case of Drugivermectin - induced severe hepatitis.
0.9902 First case of ivermectin - induced Adverse-Effectsevere hepatitis .
Score Text
0.9994 Acute sensorineural hearing loss following intravenous Drugketoralac administration.
0.9819 Adverse-EffectAcute sensorineural hearing loss following intravenous ketoralac administration.
Score Text
0.9993 Leishmania infantum leishmaniasis in Drugcorticosteroid - - treated patients.
0.9740 Adverse-EffectLeishmania infantum leishmaniasis in corticosteroid - - treated patients.
Score Text
0.9991 Methemoglobinemia : an occupational hazard of Drugphenylpropanolamine production.
0.9976 Adverse-EffectMethemoglobinemia : an occupational hazard of phenylpropanolamine production.
Score Text
0.9995 DrugPentazocine - induced fibrous myopathy and localized neuropathy.
0.9953 Pentazocine - induced fibrous myopathy and localized Adverse-Effectneuropathy .
0.9812 Pentazocine - induced Adverse-Effectfibrous myopathy and localized neuropathy.
Score Text
0.9995 Anaphylactoid reaction to 50 % solution of Drugdextrose .
0.9899 Adverse-EffectAnaphylactoid reaction to 50 % solution of dextrose.
Score Text
0.9995 DrugLeflunomide - associated weight loss in rheumatoid arthritis.
0.9934 Leflunomide - associated Adverse-Effectweight loss in rheumatoid arthritis.
Score Text
0.9848 Anterior ischemic optic neuropathy secondary to Druginterferon alfa .
0.9740 Adverse-EffectAnterior ischemic optic neuropathy secondary to interferon alfa.
Score Text
0.9990 DrugPhenobarbital hepatotoxicity in an 8 - month - old infant.
0.8816 Phenobarbital Adverse-Effecthepatotoxicity in an 8 - month - old infant.
Score Text
0.9990 We conclude peripheral neuropathy with Drug5 - FU is rare.
0.9826 We conclude Adverse-Effectperipheral neuropathy with 5 - FU is rare.
Score Text
0.9996 PET scintigraphy of Drugetoposide - induced pulmonary toxicity.
0.9901 PET scintigraphy of etoposide - induced Adverse-Effectpulmonary toxicity .
Score Text
0.9995 He had priapism following the use of Drugolanzapine .
0.9982 He had Adverse-Effectpriapism following the use of olanzapine.
Score Text
0.9989 Anaphylaxis to Drugcisplatin following nine previous uncomplicated cycles.
0.9985 Adverse-EffectAnaphylaxis to cisplatin following nine previous uncomplicated cycles.
Score Text
0.9990 BACKGROUND : Hypersensitivity reactions to Drugcyclosporine are rare.
0.9737 BACKGROUND : Adverse-EffectHypersensitivity reactions to cyclosporine are rare.
Score Text
0.9994 Pulmonary oedema after Drughexoprenaline administration in preterm labour.
0.9928 Adverse-EffectPulmonary oedema after hexoprenaline administration in preterm labour.
Score Text
0.9941 After abstinence from oolong tea his Adverse-Effectdelirium resolved.
0.9630 After abstinence from Drugoolong tea his delirium resolved.
Score Text
0.9995 DrugQuinine induced coagulopathy - - a near fatal experience.
0.9981 Quinine induced Adverse-Effectcoagulopathy - - a near fatal experience.
Score Text
0.9996 The pulmonary toxicity is probably induced by Drugpiritrexim .
0.9859 The Adverse-Effectpulmonary toxicity is probably induced by piritrexim.
Score Text
0.9995 MR findings in Drugmethotrexate - induced CNS abnormalities.
0.9890 MR findings in methotrexate - induced Adverse-EffectCNS abnormalities .
Score Text
0.9996 Osteomyelitis occurring during Druginfliximab treatment of severe psoriasis.
0.9984 Adverse-EffectOsteomyelitis occurring during infliximab treatment of severe psoriasis.
Score Text
0.9993 She was thus diagnosed as having DrugAZ intoxication.
0.9337 She was thus diagnosed as having Adverse-EffectAZ intoxication .
Score Text
0.9989 Renal failure associated with the use of Drugdextran - 40 .
0.9947 Adverse-EffectRenal failure associated with the use of dextran - 40.
Score Text
0.9995 DrugAripiprazole - induced hiccups : a case report.
0.9988 Aripiprazole - induced Adverse-Effecthiccups : a case report.
Score Text
0.9996 Rhabdomyolysis associated with the use of intravenous Drugvasopressin .
0.9981 Adverse-EffectRhabdomyolysis associated with the use of intravenous vasopressin.
Score Text
0.9995 Other upper tract neoplasms after Drugcyclophosphamide are reviewed.
0.9829 Other Adverse-Effectupper tract neoplasms after cyclophosphamide are reviewed.
Score Text
0.9994 DrugBisphosphonate - related osteonecrosis of the skull base.
0.9795 Bisphosphonate - related Adverse-Effectosteonecrosis of the skull base .
Score Text
0.9996 Acute asthma associated with sustained - release Drugverapamil .
0.9914 Adverse-EffectAcute asthma associated with sustained - release verapamil.
Score Text
0.9995 Erosion of psoriatic plaques after chronic Drugmethotrexate administration.
0.9847 Adverse-EffectErosion of psoriatic plaques after chronic methotrexate administration.
Score Text
0.9855 We suspect that Drugnefazodone inhibits metabolism of tacrolimus.
0.9470 We suspect that nefazodone inhibits metabolism of Drugtacrolimus .
We suspect that nefazodone Adverse-Effectinhibits metabolism of tacrolimus .
Score Text
0.9995 Hyponatraemia developed after rechallenge with controlled release Drugcarbamazepine .
0.9985 Adverse-EffectHyponatraemia developed after rechallenge with controlled release carbamazepine.
Score Text
0.9994 DrugTriiodothyronine - induced thyrotoxicosis in ophthalmic Graves disease.
0.9972 Triiodothyronine - induced Adverse-Effectthyrotoxicosis in ophthalmic Graves disease.
Score Text
0.9992 DrugInsulin - induced lipoatrophy in type I diabetes.
0.9975 Insulin - induced Adverse-Effectlipoatrophy in type I diabetes.
Score Text
0.9995 Optic neuropathy in Drugethambutol - treated renal tuberculosis.
0.9873 Adverse-EffectOptic neuropathy in ethambutol - treated renal tuberculosis.
Score Text
0.9996 Localized dyskeratotic plaque with milia associated with Drugsorafenib .
0.9953 Localized dyskeratotic plaque with Adverse-Effectmilia associated with sorafenib.
0.9754 Adverse-EffectLocalized dyskeratotic plaque with milia associated with sorafenib.
Score Text
0.9903 Adverse-EffectChoroidal hemorrhage associated with systemic tissue plasminogen activator.
0.9452 Choroidal hemorrhage associated with systemic Drugtissue plasminogen activator .
Score Text
0.9992 Severe acute encephalopathy following inadvertent intrathecal Drugdoxorubicin administration.
0.9346 Adverse-EffectSevere acute encephalopathy following inadvertent intrathecal doxorubicin administration.
Score Text
0.9996 Pulmonary lymphohistiocytic reactions temporally related to Drugetanercept therapy.
0.9856 Adverse-EffectPulmonary lymphohistiocytic reactions temporally related to etanercept therapy.
Score Text
0.9995 A case of SIADH induced by Drugmizoribin administration.
0.9977 A case of Adverse-EffectSIADH induced by mizoribin administration.
Score Text
0.9993 Photo - onycholysis caused by Drugolanzapine and aripiprazole.
0.9993 Photo - onycholysis caused by olanzapine and Drugaripiprazole .
0.9798 Adverse-EffectPhoto - onycholysis caused by olanzapine and aripiprazole.
Score Text
0.9995 A woman developed delusional parasitosis when taking Drugphenelzine .
0.9930 A woman developed Adverse-Effectdelusional parasitosis when taking phenelzine.
Score Text
0.9907 Adverse-EffectEosinophilic cystitis after bladder instillation with dimethyl sulfoxide.
0.9676 Eosinophilic cystitis after bladder instillation with Drugdimethyl sulfoxide .
Score Text
0.9990 Transient asymptomatic bradycardia in patients on infusional Drug5 - fluorouracil .
0.9631 Adverse-EffectTransient asymptomatic bradycardia in patients on infusional 5 - fluorouracil.
Score Text
0.9997 Easily reversible hypoxemia and hypotension induced by Drugnimodipine .
0.9975 Easily reversible hypoxemia and Adverse-Effecthypotension induced by nimodipine.
0.9961 Easily reversible Adverse-Effecthypoxemia and hypotension induced by nimodipine.
Score Text
0.9993 DrugGelofusine allergy - - the need for identification jewellery.
0.8328 Adverse-EffectGelofusine allergy - - the need for identification jewellery.
Score Text
0.9995 Disseminated salmonellosis in a patient treated with Drugtemozolomide .
0.9887 Adverse-EffectDisseminated salmonellosis in a patient treated with temozolomide.
Score Text
0.9990 DrugEpoprostenol may be associated rarely with severe erythroderma.
0.9769 Epoprostenol may be associated rarely with severe Adverse-Effecterythroderma .
Score Text
0.9996 Chromosome abnormalities after Drugchlorambucil therapy of polycythaemia vera.
0.9875 Adverse-EffectChromosome abnormalities after chlorambucil therapy of polycythaemia vera.
Score Text
0.9996 Acute acoustic nerve palsy associated with Drugvincristine therapy.
0.9828 Adverse-EffectAcute acoustic nerve palsy associated with vincristine therapy.
Score Text
0.9996 Case report of withdrawal dyskinesia associated with Drugamoxapine .
0.9978 Case report of withdrawal Adverse-Effectdyskinesia associated with amoxapine.
Score Text
0.9996 Insulin - dependent diabetes mellitus associated with Drugdanazol .
0.9686 Adverse-EffectInsulin - dependent diabetes mellitus associated with danazol.
Score Text
0.9990 Acute dystonic reaction with low - dose Drugpimozide .
0.9858 Adverse-EffectAcute dystonic reaction with low - dose pimozide.
Score Text
0.9995 Falling backward in two elderly patients taking Drugbupropion .
0.9889 Adverse-EffectFalling backward in two elderly patients taking bupropion.
Score Text
0.9994 Reversible Drugsirolimus - associated pneumonitis after heart transplantation.
0.9977 Reversible sirolimus - associated Adverse-Effectpneumonitis after heart transplantation.
Score Text
0.9990 DrugRifampin - associated thrombocytopenia secondary to poor compliance.
0.9959 Rifampin - associated Adverse-Effectthrombocytopenia secondary to poor compliance.
Score Text
0.9995 Inappropriate antidiuretic hormone secretion after high dose Drugvinblastine .
0.9771 Adverse-EffectInappropriate antidiuretic hormone secretion after high dose vinblastine.
Score Text
0.9996 DrugClozapine - induced akathisia in children with schizophrenia.
0.9983 Clozapine - induced Adverse-Effectakathisia in children with schizophrenia.
Score Text
0.9995 A fatal case of pancytopenia due to Druglevomepromazine .
0.8997 A Adverse-Effectfatal case of pancytopenia due to levomepromazine.
Score Text
0.9994 Near fatal acute Drugcolchicine intoxication in a child.
0.9802 Adverse-EffectNear fatal acute colchicine intoxication in a child.
0.5398 Near fatal acute Adverse-Effectcolchicine intoxication in a child.
Score Text
0.9993 DrugAtenolol induced memory impairment : a case report.
0.9871 Atenolol induced Adverse-Effectmemory impairment : a case report.
Score Text
0.9988 After discontinuation of Drugdanazol the diabetes completely resolved.
0.9892 After discontinuation of danazol the Adverse-Effectdiabetes completely resolved.
Score Text
0.9993 DrugMethotrexate pneumonitis in nonsurgical treatment of ectopic pregnancy.
0.9225 Methotrexate Adverse-Effectpneumonitis in nonsurgical treatment of ectopic pregnancy.
Score Text
0.9995 Tardive dyskinesia in 2 patients treated with Drugziprasidone .
0.9909 Adverse-EffectTardive dyskinesia in 2 patients treated with ziprasidone.
Score Text
0.9994 Encephalopathy and seizures induced by intravesical Drugalum irrigations.
0.9986 Encephalopathy and Adverse-Effectseizures induced by intravesical alum irrigations.
0.9973 Adverse-EffectEncephalopathy and seizures induced by intravesical alum irrigations.
Score Text
0.9994 Life - threatening cranial dystonia following Drugtrihexyphenidyl withdrawal.
0.9855 Life - threatening Adverse-Effectcranial dystonia following trihexyphenidyl withdrawal.
Score Text
0.9994 Flaccid quadriparesis was noted after discontinuation of Drugvecuronium .
0.9789 Adverse-EffectFlaccid quadriparesis was noted after discontinuation of vecuronium.
Score Text
0.9995 DrugTheophylline intoxication mimicking diabetic ketoacidosis in a child.
0.8871 Adverse-EffectTheophylline intoxication mimicking diabetic ketoacidosis in a child.
Score Text
0.9995 Intraventricular Drugnafcillin - induced seizures in a neonate.
0.9987 Intraventricular nafcillin - induced Adverse-Effectseizures in a neonate.
Score Text
0.9996 Linear immunoglobulin A bullous dermatosis induced by Druggemcitabine .
0.9745 Adverse-EffectLinear immunoglobulin A bullous dermatosis induced by gemcitabine.
Score Text
0.9994 Renal failure associated with Drugacetazolamide therapy for glaucoma.
0.9927 Adverse-EffectRenal failure associated with acetazolamide therapy for glaucoma.
Score Text
0.9994 Gangrene of the fingertips after Drugbleomycin and methotrexate.
0.9994 Gangrene of the fingertips after bleomycin and Drugmethotrexate .
0.9989 Adverse-EffectGangrene of the fingertips after bleomycin and methotrexate.
Score Text
0.9991 DrugFlucloxacillin - induced aplastic anaemia and liver failure.
0.9920 Flucloxacillin - induced Adverse-Effectaplastic anaemia and liver failure.
0.9897 Flucloxacillin - induced aplastic anaemia and Adverse-Effectliver failure .
Score Text
0.9990 The course of delirium due to Druglithium intoxication.
0.9959 The course of Adverse-Effectdelirium due to lithium intoxication.
Score Text
0.9656 Severe neurotoxicity with Drugmethyl G : CALGB experience.
0.8321 Adverse-EffectSevere neurotoxicity with methyl G : CALGB experience.
Score Text
0.9996 Spontaneous bacterial peritonitis induced by intraarterial Drugvasopressin therapy.
0.9790 Spontaneous Adverse-Effectbacterial peritonitis induced by intraarterial vasopressin therapy.
0.9815 Adverse-EffectSpontaneous bacterial peritonitis induced by intraarterial vasopressin therapy.
Score Text
0.9989 Their parkinsonism improved on discontinuation of Drugmetoclopramide therapy.
0.9769 Their Adverse-Effectparkinsonism improved on discontinuation of metoclopramide therapy.
Score Text
0.9975 DrugLinezolid - induced dyserythropoiesis : chloramphenicol toxicity revisited.
0.9959 Linezolid - induced Adverse-Effectdyserythropoiesis : chloramphenicol toxicity revisited.
Score Text
0.9995 DrugRifampin - induced hypothyroidism without underlying thyroid disease.
0.9965 Rifampin - induced Adverse-Effecthypothyroidism without underlying thyroid disease.
Score Text
0.9994 Severe acidosis from Drugacetazolamide in a diabetic patient.
0.9899 Adverse-EffectSevere acidosis from acetazolamide in a diabetic patient.
Score Text
0.9993 Acute pancreatitis associated with Drugdanazol treatment for endometriosis.
0.9826 Adverse-EffectAcute pancreatitis associated with danazol treatment for endometriosis.
Score Text
0.9996 DrugSirolimus - associated hepatotoxicity in the kidney graft recipient.
0.9960 Sirolimus - associated Adverse-Effecthepatotoxicity in the kidney graft recipient.
Score Text
0.9991 Transient Drugphenytoin induced IgA deficiency and permanent IgE increase.
0.9898 Transient phenytoin induced IgA deficiency and permanent Adverse-EffectIgE increase .
0.9881 Transient phenytoin induced Adverse-EffectIgA deficiency and permanent IgE increase.
Score Text
0.9993 DrugMefloquine - associated hypoglycaemia in a cachectic AIDS patient.
0.9966 Mefloquine - associated Adverse-Effecthypoglycaemia in a cachectic AIDS patient.
Score Text
0.9993 DrugLansoprazole - associated collagenous colitis : a case report.
0.9902 Lansoprazole - associated Adverse-Effectcollagenous colitis : a case report.
Score Text
0.9996 DrugEnalapril - induced anemia in two kidney transplant recipients.
0.9988 Enalapril - induced Adverse-Effectanemia in two kidney transplant recipients.
Score Text
0.9909 Transient leucopenia and Adverse-Effectthrombocytopenia associated with sodium nitroprusside infusion.
0.9905 Transient leucopenia and thrombocytopenia associated with Drugsodium nitroprusside infusion.
0.6227 Transient Adverse-Effectleucopenia and thrombocytopenia associated with sodium nitroprusside infusion.
Score Text
0.9996 A case of Drugcolchicine - induced rhabdomyolysis is reported.
0.9977 A case of colchicine - induced Adverse-Effectrhabdomyolysis is reported.
Score Text
0.9996 A diagnosis of Drugtrastuzumab - induced pneumonitis was made.
0.9988 A diagnosis of trastuzumab - induced Adverse-Effectpneumonitis was made.
Score Text
0.9983 DrugAlprazolam withdrawal delirium unresponsive to diazepam : case report.
0.9980 Alprazolam withdrawal Adverse-Effectdelirium unresponsive to diazepam : case report.
Score Text
0.9996 Abnormal retinal function associated with Drugisotretinoin therapy for acne.
0.9829 Adverse-EffectAbnormal retinal function associated with isotretinoin therapy for acne.
Score Text
0.9995 Rupture of a cerebral aneurysm associated with Drugnifedipine treatment.
0.9725 Adverse-EffectRupture of a cerebral aneurysm associated with nifedipine treatment.
Score Text
0.9995 Phantom limb pain as a manifestation of Drugpaclitaxel neurotoxicity.
0.9787 Adverse-EffectPhantom limb pain as a manifestation of paclitaxel neurotoxicity.
0.8510 Phantom limb pain as a manifestation of paclitaxel Adverse-Effectneurotoxicity .
Score Text
0.9993 Papillary necrosis associated with the HIV protease inhibitor Drugindinavir .
0.9890 Adverse-EffectPapillary necrosis associated with the HIV protease inhibitor indinavir.
Score Text
0.9995 DrugAmpicillin - induced interstitial nephritis with generalised exfoliative dermatitis.
0.9876 Ampicillin - induced Adverse-Effectinterstitial nephritis with generalised exfoliative dermatitis.
0.9830 Ampicillin - induced interstitial nephritis with Adverse-Effectgeneralised exfoliative dermatitis .
Score Text
0.9962 Traumatic late flap dehiscence and Enterobacter keratitis following DrugLASIK .
0.9853 Traumatic late flap dehiscence and Adverse-EffectEnterobacter keratitis following LASIK.
0.9695 Adverse-EffectTraumatic late flap dehiscence and Enterobacter keratitis following LASIK.
Score Text
0.9991 DrugOfloxacin : a probable cause of toxic epidermal necrolysis.
0.9819 Ofloxacin : a probable cause of Adverse-Effecttoxic epidermal necrolysis .
Score Text
0.9989 DrugBisphosphonate induced osteochemonecrosis of the jaw mimicking a tumour.
0.9786 Bisphosphonate induced Adverse-Effectosteochemonecrosis of the jaw mimicking a tumour.
Score Text
0.9991 This case report illustrates the neurotoxicity unique to DrugHDARAC .
0.9963 This case report illustrates the Adverse-Effectneurotoxicity unique to HDARAC.
Score Text
0.9995 Three cases of Druggold - related neuropathy are reported.
0.9980 Three cases of gold - related Adverse-Effectneuropathy are reported.
Score Text
0.9983 DrugPropranolol - induced hypertension in treatment of cocaine intoxication.
0.9965 Propranolol - induced Adverse-Effecthypertension in treatment of cocaine intoxication.
Score Text
0.9994 Serotonin syndrome caused by interaction between Drugcitalopram and fentanyl.
0.9993 Serotonin syndrome caused by interaction between citalopram and Drugfentanyl .
0.9936 Adverse-EffectSerotonin syndrome caused by interaction between citalopram and fentanyl.
Score Text
0.9994 Hepatotoxicity after high - dose Drugmethylprednisolone for demyelinating disease.
0.9975 Adverse-EffectHepatotoxicity after high - dose methylprednisolone for demyelinating disease.
Score Text
0.9996 Accelerated nodulosis during Drugmethotrexate therapy for juvenile rheumatoid arthritis.
0.9853 Adverse-EffectAccelerated nodulosis during methotrexate therapy for juvenile rheumatoid arthritis.
Score Text
0.9995 Thrombotic thrombocytopenic purpura during Drugpenicillamine therapy in rheumatoid arthritis.
0.9800 Adverse-EffectThrombotic thrombocytopenic purpura during penicillamine therapy in rheumatoid arthritis.
Score Text
0.9995 Acute respiratory depression as a complication of nebulised Drugmorphine .
0.9754 Adverse-EffectAcute respiratory depression as a complication of nebulised morphine.
Score Text
0.9992 DrugCeftriaxone - induced fixed drug eruption : first report.
0.9701 Ceftriaxone - induced Adverse-Effectfixed drug eruption : first report.
Score Text
0.9896 Adverse-EffectComeoscleral perforation after pterygium excision and intraoperative mitomycin C.
0.9851 Comeoscleral perforation after pterygium excision and intraoperative Drugmitomycin C .
Score Text
0.9995 DrugIfosfamide is a known nephrotoxic drug with demonstrated tubulopathies.
0.9983 Ifosfamide is a known nephrotoxic drug with demonstrated Adverse-Effecttubulopathies .
Score Text
0.9991 Hepatotoxicity associated with Drug6 - thioguanine therapy for Crohn's disease.
0.9977 Adverse-EffectHepatotoxicity associated with 6 - thioguanine therapy for Crohn's disease.
Score Text
0.9989 Hepatotoxicity of Drughycanthone in patients with metastatic breast cancer.
0.9955 Adverse-EffectHepatotoxicity of hycanthone in patients with metastatic breast cancer.
Score Text
0.9992 DrugDisulfiram encephalopathy as a cause of the catatonia syndrome.
0.9913 Disulfiram encephalopathy as a cause of the Adverse-Effectcatatonia syndrome .
0.6384 Disulfiram Adverse-Effectencephalopathy as a cause of the catatonia syndrome.
Score Text
0.9845 Adverse-EffectSensorimotor polyneuropathy with 5 - aminosalicylic acid : a case report.
0.9755 Sensorimotor polyneuropathy with Drug5 - aminosalicylic acid : a case report.
Score Text
0.9784 Delayed neurotoxicity of intraventricular Druginterleukin - 2 : a case report.
0.8860 Delayed Adverse-Effectneurotoxicity of intraventricular interleukin - 2 : a case report.
Score Text
0.9898 Unusual hypersensitivity to Drugwarfarin in a critically ill patient.
0.9097 Unusual Adverse-Effecthypersensitivity to warfarin in a critically ill patient.
Score Text
0.9918 Adverse-EffectVasomotor reactions after gold sodium thiomalate are well recognized.
0.9659 Vasomotor reactions after Druggold sodium thiomalate are well recognized.
Score Text
0.9996 Intrahepatic cholestasis and cutaneous bullae associated with Drugglibenclamide therapy.
0.9895 Intrahepatic cholestasis and Adverse-Effectcutaneous bullae associated with glibenclamide therapy.
0.9864 Adverse-EffectIntrahepatic cholestasis and cutaneous bullae associated with glibenclamide therapy.
Score Text
0.9995 DrugTrazodone - induced transient hypomanic symptoms and their management.
0.9824 Trazodone - induced Adverse-Effecttransient hypomanic symptoms and their management.
Score Text
0.9992 Some patients develop hypersensitivity rash in response to DrugHCQ .
0.9915 Some patients develop Adverse-Effecthypersensitivity rash in response to HCQ.
Score Text
0.9991 Possible recurrence of Drugamiodarone pulmonary toxicity following corticosteroid therapy.
0.8646 Possible recurrence of amiodarone Adverse-Effectpulmonary toxicity following corticosteroid therapy.
Score Text
0.9996 Hepatotoxicity related to Drugitraconazole : report of three cases.
0.9976 Adverse-EffectHepatotoxicity related to itraconazole : report of three cases.
Score Text
0.9994 Septic knee arthritis after intra - articular Drughyaluronate injection.
0.9805 Adverse-EffectSeptic knee arthritis after intra - articular hyaluronate injection.
Score Text
0.9786 Adverse-EffectMultiple sclerosis - like disease secondary to alpha interferon.
0.9148 Multiple sclerosis - like disease secondary to Drugalpha interferon .
Score Text
0.9992 The literature of Drugvincristine optic nerve toxicity is reviewed.
0.8603 The literature of vincristine Adverse-Effectoptic nerve toxicity is reviewed.
Score Text
0.9994 An intertrigo - like eruption from pegylated liposomal Drugdoxorubicin .
0.9816 An Adverse-Effectintertrigo - like eruption from pegylated liposomal doxorubicin.
Score Text
0.9994 Hypotension and sinus arrest with Drugnifedipine in pulmonary hypertension.
0.9973 Adverse-EffectHypotension and sinus arrest with nifedipine in pulmonary hypertension.
0.9882 Hypotension and Adverse-Effectsinus arrest with nifedipine in pulmonary hypertension.
Score Text
0.9995 Liver transplantation for fulminant hepatitis related to Drugnevirapine therapy.
0.9734 Liver transplantation for Adverse-Effectfulminant hepatitis related to nevirapine therapy.
Score Text
0.9995 Diabetes Mellitus was observed in a patient given Drugcarbamazepine .
0.9892 Adverse-EffectDiabetes Mellitus was observed in a patient given carbamazepine.
Score Text
0.9995 DrugMethotrexate - induced papular eruption following treatment of psoriasis.
0.9915 Methotrexate - induced Adverse-Effectpapular eruption following treatment of psoriasis.
Score Text
0.9995 Pulmonary hypertension during Druglithium therapy : clinical case study.
0.9905 Adverse-EffectPulmonary hypertension during lithium therapy : clinical case study.
Score Text
0.9992 DrugClofazimine enteropathy in a pediatric bone marrow transplant recipient.
0.9288 Clofazimine Adverse-Effectenteropathy in a pediatric bone marrow transplant recipient.
Score Text
0.9994 Cardiac arrest associated with Drugsulprostone use during caesarean section.
0.9947 Adverse-EffectCardiac arrest associated with sulprostone use during caesarean section.
Score Text
0.9996 DrugPropafenone - induced ataxia : report of three cases.
0.9987 Propafenone - induced Adverse-Effectataxia : report of three cases.
Score Text
0.9995 Disseminated muscular cysticercosis with myositis induced by Drugpraziquantel therapy.
0.9793 Disseminated muscular cysticercosis with Adverse-Effectmyositis induced by praziquantel therapy.
Score Text
0.9997 We report a case of myoclonus induced by Drugquetiapine .
0.9988 We report a case of Adverse-Effectmyoclonus induced by quetiapine.
Score Text
0.9992 Hepatopathy subsided after the cessation of Drugcarbamazepine and lynestrenol.
0.9992 Hepatopathy subsided after the cessation of carbamazepine and Druglynestrenol .
0.9984 Adverse-EffectHepatopathy subsided after the cessation of carbamazepine and lynestrenol.
Score Text
0.9992 Large dose of Drugmethylphenidate may cause cataract and glaucoma.
0.9987 Large dose of methylphenidate may cause cataract and Adverse-Effectglaucoma .
0.9986 Large dose of methylphenidate may cause Adverse-Effectcataract and glaucoma.
Score Text
0.9995 Syndrome of inappropriate antidiuretic hormone associated with Drugvinorelbine therapy.
0.9441 Adverse-EffectSyndrome of inappropriate antidiuretic hormone associated with vinorelbine therapy.
Score Text
0.9869 Adverse-EffectAcute pancreatitis after long - term 5 - aminosalicylic acid therapy.
0.9790 Acute pancreatitis after long - term Drug5 - aminosalicylic acid therapy.
Score Text
0.9996 DrugFoscarnet - induced severe hypomagnesemia and other electrolyte disorders.
0.9925 Foscarnet - induced severe hypomagnesemia and other Adverse-Effectelectrolyte disorders .
0.9839 Foscarnet - induced Adverse-Effectsevere hypomagnesemia and other electrolyte disorders.
Score Text
0.9992 Anaphylactoid reaction to Drugmethylprednisolone pulsed therapy for multiple sclerosis.
0.9899 Adverse-EffectAnaphylactoid reaction to methylprednisolone pulsed therapy for multiple sclerosis.
Score Text
0.9973 Simvastatin - induced Adverse-Effectrhabdomyolysis following cyclosporine treatment for uveitis.
0.9880 DrugSimvastatin - induced rhabdomyolysis following cyclosporine treatment for uveitis.
0.9488 Simvastatin - induced rhabdomyolysis following Drugcyclosporine treatment for uveitis.
Score Text
0.9991 The spectrum of Drugnitrofurantoin lung injury continues to widen.
0.8908 The spectrum of nitrofurantoin Adverse-Effectlung injury continues to widen.
Score Text
0.9995 Paradoxical ventricular tachycardia and fibrillation after intravenous Drugbretylium therapy.
0.9943 Paradoxical ventricular tachycardia and Adverse-Effectfibrillation after intravenous bretylium therapy.
0.9754 Adverse-EffectParadoxical ventricular tachycardia and fibrillation after intravenous bretylium therapy.
Score Text
0.9995 The patient developed grade 3 Drugcapecitabine - induced headache.
0.9990 The patient developed grade 3 capecitabine - induced Adverse-Effectheadache .
Score Text
0.9762 Adverse-EffectEmbolia cutis medicamentosa following subcutaneous injection of glatiramer acetate.
0.9726 Embolia cutis medicamentosa following subcutaneous injection of Drugglatiramer acetate .
Score Text
0.9989 These results indicate that Druglithium may cause biochemical hyperparathyroidism.
0.9849 These results indicate that lithium may cause Adverse-Effectbiochemical hyperparathyroidism .
Score Text
0.9995 A new type of Drugminocycline - induced cutaneous hyperpigmentation.
0.9897 A new type of minocycline - induced Adverse-Effectcutaneous hyperpigmentation .
Score Text
0.9991 Reversible corneal keratinization following trabeculectomy and treatment with Drug5 - fluorouracil .
0.9826 Adverse-EffectReversible corneal keratinization following trabeculectomy and treatment with 5 - fluorouracil.
Score Text
0.9993 Acute endophthalmitis following intravitreal Drugbevacizumab ( Avastin ) injection.
0.9991 Acute endophthalmitis following intravitreal bevacizumab ( DrugAvastin ) injection.
0.9840 Adverse-EffectAcute endophthalmitis following intravitreal bevacizumab ( Avastin ) injection.
Score Text
0.9984 Adverse-EffectCamptocormia , a new side effect of sodium valproate.
0.9826 Camptocormia, a new side effect of Drugsodium valproate .
Score Text
0.9991 Histopathology of the thyroid in Drugamiodarone - induced hypothyroidism.
0.9969 Histopathology of the thyroid in amiodarone - induced Adverse-Effecthypothyroidism .
Score Text
0.9996 Multiple seizures after Drugbupropion overdose in a small child.
0.9896 Adverse-EffectMultiple seizures after bupropion overdose in a small child.
Score Text
0.9982 Successful challenge with Drugclozapine in a history of eosinophilia.
0.9588 Successful challenge with clozapine in a history of Adverse-Effecteosinophilia .
Score Text
0.9989 A case of Drugpyridoxine - dependent seizures is reported.
0.9942 A case of pyridoxine - dependent Adverse-Effectseizures is reported.
Score Text
0.9996 Systemic lupus erythematosus during Drugpenicillamine therapy for rheumatoid arthritis.
0.9785 Adverse-EffectSystemic lupus erythematosus during penicillamine therapy for rheumatoid arthritis.
Score Text
0.9994 Two fatal cases of poisoning by Drugparacetamol are described.
0.8953 Two Adverse-Effectfatal cases of poisoning by paracetamol are described.
Score Text
0.9995 Nephrotic range pseudoproteinuria in a Drugtolmetin - treated patient.
0.9758 Adverse-EffectNephrotic range pseudoproteinuria in a tolmetin - treated patient.
Score Text
0.9997 DrugCaptopril - related ( and - induced? ) asthma.
0.9950 Captopril - related ( and - induced? ) Adverse-Effectasthma .
Score Text
0.9828 A case of noncardiogenic pulmonary edema by Drugethanolamine oleate .
0.9818 A case of Adverse-Effectnoncardiogenic pulmonary edema by ethanolamine oleate.
Score Text
0.9981 Adverse-EffectHypercalcemia in an AIDS patient treated with growth hormone.
0.9689 Hypercalcemia in an AIDS patient treated with Druggrowth hormone .
Score Text
0.9995 Systemic vasculitis complicating hairy cell leukaemia treatment with Drugcladribine .
0.9909 Adverse-EffectSystemic vasculitis complicating hairy cell leukaemia treatment with cladribine.
Score Text
0.9990 DrugCephalosporins are most likely associated with Vitamin K deficiency.
0.9862 Cephalosporins are most likely associated with Adverse-EffectVitamin K deficiency .
Score Text
0.9995 Reversible cholestasis with bile duct injury following Drugazathioprine therapy.
0.9784 Reversible cholestasis with Adverse-Effectbile duct injury following azathioprine therapy.
0.8685 Reversible Adverse-Effectcholestasis with bile duct injury following azathioprine therapy.
Score Text
0.9996 Uveitis associated with Drugrifabutin therapy : a clinical alert.
0.9987 Adverse-EffectUveitis associated with rifabutin therapy : a clinical alert.
Score Text
0.9996 DrugAmiodarone - induced thyrotoxicosis associated with thyrotropin receptor antibody.
0.9972 Amiodarone - induced Adverse-Effectthyrotoxicosis associated with thyrotropin receptor antibody.
0.9799 Amiodarone - induced thyrotoxicosis associated with Adverse-Effectthyrotropin receptor antibody .
Score Text
0.9996 Peripheral neuropathy and cerebellar syndrome associated with Drugamiodarone therapy.
0.9885 Peripheral neuropathy and Adverse-Effectcerebellar syndrome associated with amiodarone therapy.
0.9860 Adverse-EffectPeripheral neuropathy and cerebellar syndrome associated with amiodarone therapy.
Score Text
0.9996 A case of priapism associated with Drugtrazodone is described.
0.9986 A case of Adverse-Effectpriapism associated with trazodone is described.
Score Text
0.9995 DISCUSSION : Electrolyte disorders associated with Drugfoscarnet are reviewed.
0.9914 DISCUSSION : Adverse-EffectElectrolyte disorders associated with foscarnet are reviewed.
Score Text
0.9995 Myocardial ischemia associated with high - dose Drugcarmustine infusion.
0.9901 Adverse-EffectMyocardial ischemia associated with high - dose carmustine infusion.
Score Text
0.9990 DrugMethylphenidate - associated enuresis in attention deficit hyperactivity disorder.
0.9975 Methylphenidate - associated Adverse-Effectenuresis in attention deficit hyperactivity disorder.
Score Text
0.9991 Development of porphyria cutanea tarda after treatment with Drugcyclophosphamide .
0.9860 Development of Adverse-Effectporphyria cutanea tarda after treatment with cyclophosphamide.
Score Text
0.9996 Acute reversible ataxo - myoclonic encephalopathy with Drugflecainide therapy.
0.9269 Adverse-EffectAcute reversible ataxo - myoclonic encephalopathy with flecainide therapy.
Score Text
0.9937 Thus Drugcabergoline may cause similar pleuropulmonary abnormalities to bromocriptine.
0.9864 Thus cabergoline may cause similar pleuropulmonary abnormalities to Drugbromocriptine .
0.9745 Thus cabergoline may cause similar Adverse-Effectpleuropulmonary abnormalities to bromocriptine.
Score Text
0.9995 High - grade atrioventricular block during Drugdipyridamole stress testing.
0.9779 Adverse-EffectHigh - grade atrioventricular block during dipyridamole stress testing.
Score Text
0.9992 Disulfiram - like reactions with newer cephalosporins : Drugcefmenoxime .
0.9832 Adverse-EffectDisulfiram - like reactions with newer cephalosporins : cefmenoxime.
Score Text
0.9992 We suggest discontinuing Druggemcitabine if radiation recall is observed.
0.9891 We suggest discontinuing gemcitabine if Adverse-Effectradiation recall is observed.
Score Text
0.9996 DrugFluoxetine - induced akathisia : clinical and theoretical implications.
0.9985 Fluoxetine - induced Adverse-Effectakathisia : clinical and theoretical implications.
Score Text
0.9875 The Adverse-Effectharlequin color change and association with prostaglandin E1.
0.9821 The harlequin color change and association with Drugprostaglandin E1 .
Score Text
0.9994 Management and successful desensitization in Drugmethotrexate - induced anaphylaxis.
0.9985 Management and successful desensitization in methotrexate - induced Adverse-Effectanaphylaxis .
Score Text
0.9995 Response of a Drugpromethazine - induced coma to flumazenil.
0.9968 Response of a promethazine - induced Adverse-Effectcoma to flumazenil.
Score Text
0.9994 Multifocal electroretinographic abnormalities in Drugethambutol - induced visual loss.
0.9950 Multifocal electroretinographic abnormalities in ethambutol - induced Adverse-Effectvisual loss .
Score Text
0.9995 Acute renal failure in a child associated with Drugacyclovir .
0.9692 Adverse-EffectAcute renal failure in a child associated with acyclovir.
Score Text
0.9994 Withdrawal of DrugDepakote resulted in resolution of the effusion.
0.9986 Withdrawal of Depakote resulted in resolution of the Adverse-Effecteffusion .
Score Text
0.9995 DrugDipyrone - induced granulocytopenia : a case for awareness.
0.9969 Dipyrone - induced Adverse-Effectgranulocytopenia : a case for awareness.
Score Text
0.9996 The second patient exhibited sudden PLMS following Drugolanzapine injection.
0.9943 The second patient exhibited sudden Adverse-EffectPLMS following olanzapine injection.
Score Text
0.9994 Fixed drug eruption of the scrotum due to Drugmethylphenidate .
0.8606 Adverse-EffectFixed drug eruption of the scrotum due to methylphenidate.
Score Text
0.9989 Hepatotoxic effects in a child receiving valproate and Drugcarnitine .
0.9989 Hepatotoxic effects in a child receiving Drugvalproate and carnitine.
0.9823 Adverse-EffectHepatotoxic effects in a child receiving valproate and carnitine.
Score Text
0.9990 Isoniazid and Drugethambutol as a cause of optic neuropathy.
0.9990 DrugIsoniazid and ethambutol as a cause of optic neuropathy.
0.9857 Isoniazid and ethambutol as a cause of Adverse-Effectoptic neuropathy .
Score Text
0.9660 DrugAmphotericin B nephrotoxicity in humans decreased by salt repletion.
0.6606 Amphotericin B Adverse-Effectnephrotoxicity in humans decreased by salt repletion.
Score Text
0.9994 DrugLevofloxacin induced polymorphic ventricular tachycardia with normal QT interval.
0.9828 Levofloxacin induced Adverse-Effectpolymorphic ventricular tachycardia with normal QT interval.
Score Text
0.9994 Pulmonary edema as a delayed complication of Drugritodrine therapy.
0.9918 Adverse-EffectPulmonary edema as a delayed complication of ritodrine therapy.
Score Text
0.9995 Toxicity related to Drugchloroquine treatment of resistant vivax malaria.
0.9980 Adverse-EffectToxicity related to chloroquine treatment of resistant vivax malaria.
Score Text
0.9974 Carbamazepine toxicity induced by Drugclarithromycin coadministration in psychiatric patients.
0.9955 DrugCarbamazepine toxicity induced by clarithromycin coadministration in psychiatric patients.
0.8913 Adverse-EffectCarbamazepine toxicity induced by clarithromycin coadministration in psychiatric patients.
Score Text
0.9987 Circulating anticoagulant in the Drugprocainamide - induced lupus syndrome.
0.9937 Circulating anticoagulant in the procainamide - induced Adverse-Effectlupus syndrome .
Score Text
0.9996 Myotonia associated with sarcoidosis : marked exacerbation with Drugpravastatin .
0.9987 Adverse-EffectMyotonia associated with sarcoidosis : marked exacerbation with pravastatin.
Score Text
0.9551 Gold nephropathy due to auranofin obscured by Drugtolmetin pseudoproteinuria.
0.9245 DrugGold nephropathy due to auranofin obscured by tolmetin pseudoproteinuria.
0.8911 Gold nephropathy due to Drugauranofin obscured by tolmetin pseudoproteinuria.
0.7560 Gold Adverse-Effectnephropathy due to auranofin obscured by tolmetin pseudoproteinuria.
Adverse-EffectGold nephropathy due to auranofin obscured by tolmetin pseudoproteinuria.
Gold nephropathy due to auranofin obscured by tolmetin Adverse-Effectpseudoproteinuria .
Score Text
0.9994 DrugDoxycycline - induced hypoglycemia in a nondiabetic young man.
0.9975 Doxycycline - induced Adverse-Effecthypoglycemia in a nondiabetic young man.
Score Text
0.9996 Tetany in a child with AIDS receiving intravenous Drugtobramycin .
0.9991 Adverse-EffectTetany in a child with AIDS receiving intravenous tobramycin.
Score Text
0.9987 Case report : acute renal failure after administering intravenous Drugimmunoglobulin .
0.9838 Case report : Adverse-Effectacute renal failure after administering intravenous immunoglobulin.
Score Text
0.9983 Adverse-EffectDyspnea possibly associated with controlled - release morphine sulfate tablets.
0.9837 Dyspnea possibly associated with controlled - release Drugmorphine sulfate tablets.
Score Text
0.9996 Acute kidney injury caused by Drugzonisamide - induced hypersensitivity syndrome.
0.9859 Acute kidney injury caused by zonisamide - induced Adverse-Effecthypersensitivity syndrome .
0.9661 Adverse-EffectAcute kidney injury caused by zonisamide - induced hypersensitivity syndrome.
Score Text
0.9995 The renal consequences of Drugindinavir - associated nephrotoxicity are uncertain.
0.9951 The renal consequences of indinavir - associated Adverse-Effectnephrotoxicity are uncertain.
Score Text
0.9993 Occurrence of IDDM during Druginterferon therapy for chronic viral hepatitis.
0.9975 Occurrence of Adverse-EffectIDDM during interferon therapy for chronic viral hepatitis.
Score Text
0.9992 A further case of anaphylactoid reaction to Drugmethylprednisolone is reported.
0.9878 A further case of Adverse-Effectanaphylactoid reaction to methylprednisolone is reported.
Score Text
0.9996 Bull's - eye maculopathy associated with Drugquinacrine therapy for malaria.
0.9631 Adverse-EffectBull's - eye maculopathy associated with quinacrine therapy for malaria.
Score Text
0.9989 Can Drugpropofol precipitate pancreatitis in patients with Cushing's syndrome?
0.9952 Can propofol precipitate Adverse-Effectpancreatitis in patients with Cushing's syndrome?
Score Text
0.9996 DrugClonidine - induced bradycardia in patients with spinal cord injury.
0.9983 Clonidine - induced Adverse-Effectbradycardia in patients with spinal cord injury.
Score Text
0.9996 Lymphoma developing in a patient with rheumatoid arthritis taking Drugmethotrexate .
0.9984 Adverse-EffectLymphoma developing in a patient with rheumatoid arthritis taking methotrexate.
Score Text
0.9942 Amphotericin B overdose in pediatric patients with associated Adverse-Effectcardiac arrest .
0.9713 DrugAmphotericin B overdose in pediatric patients with associated cardiac arrest.
Score Text
0.9991 DrugIsoniazid causing breast tissue enlargement has been very rarely reported.
0.9769 Isoniazid causing Adverse-Effectbreast tissue enlargement has been very rarely reported.
Score Text
0.9994 Paradoxical pulmonary vasoconstriction induced by Drugnitroglycerin in idiopathic pulmonary hypertension.
0.9409 Adverse-EffectParadoxical pulmonary vasoconstriction induced by nitroglycerin in idiopathic pulmonary hypertension.
Score Text
0.9996 However, recurrent staphylococcus aureus sepsis developed during DrugCyA therapy.
0.9827 However, recurrent Adverse-Effectstaphylococcus aureus sepsis developed during CyA therapy.
Score Text
0.9835 Adverse-EffectNoncardiogenic pulmonary edema during intrabiliary infusion of mono - octanoin.
0.9344 Noncardiogenic pulmonary edema during intrabiliary infusion of Drugmono - octanoin .
Score Text
0.9990 DrugMoxalactam is more likely to be associated with platelet dysfunction.
0.9887 Moxalactam is more likely to be associated with Adverse-Effectplatelet dysfunction .
Score Text
0.9995 Severe Raynaud's phenomenon with Drugyohimbine therapy for erectile dysfunction.
0.9648 Adverse-EffectSevere Raynaud's phenomenon with yohimbine therapy for erectile dysfunction.
Score Text
0.9992 Severe systemic hypersensitivity reaction to Drugibuprofen occurring after prolonged therapy.
0.9765 Adverse-EffectSevere systemic hypersensitivity reaction to ibuprofen occurring after prolonged therapy.
Score Text
0.9993 Fatal Druggemcitabine - induced pulmonary toxicity in metastatic gallbladder adenocarcinoma.
0.9891 Fatal gemcitabine - induced Adverse-Effectpulmonary toxicity in metastatic gallbladder adenocarcinoma.
Score Text
0.9992 Massive plasmocytosis due to Drugmethimazole - induced bone marrow toxicity.
0.9815 Massive plasmocytosis due to methimazole - induced Adverse-Effectbone marrow toxicity .
0.9609 Adverse-EffectMassive plasmocytosis due to methimazole - induced bone marrow toxicity.
Score Text
0.9947 Ketanserin in the treatment of Drugprotamine - induced pulmonary hypertension.
0.9897 Ketanserin in the treatment of protamine - induced Adverse-Effectpulmonary hypertension .
Score Text
0.9969 Adverse-EffectBradycardia and congestive heart failure associated with ocular timolol maleate.
0.9864 Bradycardia and Adverse-Effectcongestive heart failure associated with ocular timolol maleate.
0.9779 Bradycardia and congestive heart failure associated with ocular Drugtimolol maleate .
Score Text
0.9996 Ulcerative proctitis in juvenile systemic lupus erythematosus after Drugibuprofen treatment.
0.9889 Adverse-EffectUlcerative proctitis in juvenile systemic lupus erythematosus after ibuprofen treatment.
Score Text
0.9994 A patient developed cholestatic hepatitis while being treated with Drugnitrofurantoin .
0.9907 A patient developed Adverse-Effectcholestatic hepatitis while being treated with nitrofurantoin.
Score Text
0.9995 DrugDorzolamide - induced choroidal detachment in a surgically untreated eye.
0.9922 Dorzolamide - induced Adverse-Effectchoroidal detachment in a surgically untreated eye.
Score Text
0.9860 Mitomycin C - related Adverse-Effecthemolytic uremic syndrome in cancer patients.
0.9835 DrugMitomycin C - related hemolytic uremic syndrome in cancer patients.
Score Text
0.9928 Possible Adverse-Effectserotonin syndrome associated with clomipramine after withdrawal of clozapine.
0.9877 Possible serotonin syndrome associated with Drugclomipramine after withdrawal of clozapine.
0.9055 Possible serotonin syndrome associated with clomipramine after withdrawal of Drugclozapine .
Score Text
0.9996 A case of recall pneumonitis induced by Druggemcitabine is reported.
0.9871 A case of Adverse-Effectrecall pneumonitis induced by gemcitabine is reported.
Score Text
0.9996 Myoglobinuria and acute renal failure associated with intravenous Drugvasopressin infusion.
0.9972 Adverse-EffectMyoglobinuria and acute renal failure associated with intravenous vasopressin infusion.
0.9841 Myoglobinuria and Adverse-Effectacute renal failure associated with intravenous vasopressin infusion.
Score Text
0.9985 Amphotericin B - induced Adverse-Effectseizures in a patient with AIDS.
0.9723 DrugAmphotericin B - induced seizures in a patient with AIDS.
Score Text
0.9988 The Drugallopurinol hypersensitivity syndrome is a rare adverse drug reaction.
0.9321 The allopurinol Adverse-Effecthypersensitivity syndrome is a rare adverse drug reaction.
Score Text
0.9992 PURPOSE : We report an unusual paradoxical effect of Drugbrimonidine .
0.9482 PURPOSE : We report an unusual Adverse-Effectparadoxical effect of brimonidine.
Score Text
0.9995 The most likely cause of such hyponatremic episode is Drugvinblastine .
0.9857 The most likely cause of such Adverse-Effecthyponatremic episode is vinblastine.
Score Text
0.9993 DrugCefoxitin therapy for Mycobacterium fortuitum bacteremia with associated granulomatous hepatitis.
0.9893 Cefoxitin therapy for Mycobacterium fortuitum bacteremia with associated Adverse-Effectgranulomatous hepatitis .
Score Text
0.9993 Acceleration of ventricular response to atrial flutter after intravenous Drugadenosine .
0.9782 Adverse-EffectAcceleration of ventricular response to atrial flutter after intravenous adenosine.
Score Text
0.9996 We present a case of hypereosinophilia related to Drugzafirlukast therapy.
0.9961 We present a case of Adverse-Effecthypereosinophilia related to zafirlukast therapy.
Score Text
0.9943 Adverse-EffectRenal damage associated with long term use of lithium carbonate.
0.9844 Renal damage associated with long term use of Druglithium carbonate .
Score Text
0.9980 Reversible valproic acid - induced Adverse-Effectdementia : a case report.
0.9766 Reversible Drugvalproic acid - induced dementia : a case report.
Score Text
0.9994 Severe hypo - alpha - lipoproteinemia during treatment with Drugrosiglitazone .
0.8798 Adverse-EffectSevere hypo - alpha - lipoproteinemia during treatment with rosiglitazone.
Score Text
0.9995 Excluding other causes, DrugPentasa - associated pancytopenia was considered.
0.9978 Excluding other causes, Pentasa - associated Adverse-Effectpancytopenia was considered.
Score Text
0.9995 Thrombo - embolic complication after Drugstreptokinase therapy of pulmonary emboli.
0.9832 Adverse-EffectThrombo - embolic complication after streptokinase therapy of pulmonary emboli.
Score Text
0.9995 Development of persistent late onset asthma following treatment with Drugcaptopril .
0.9309 Development of Adverse-Effectpersistent late onset asthma following treatment with captopril.
Score Text
0.9838 Amphotericin B - induced Adverse-Effectcutaneous leucocytoclastic vasculitis : case report.
0.9727 DrugAmphotericin B - induced cutaneous leucocytoclastic vasculitis : case report.
Score Text
0.9995 DrugPropranolol - related bronchospasm in patients without history of asthma.
0.9978 Propranolol - related Adverse-Effectbronchospasm in patients without history of asthma.
Score Text
0.9972 Trimethoprim - sulfamethoxazole - induced Adverse-Effecthepatotoxicity in a pediatric patient.
0.8622 DrugTrimethoprim - sulfamethoxazole - induced hepatotoxicity in a pediatric patient.
Score Text
0.9993 Bronchiolitis obliterans organising pneumonia associated with the use of Drugnitrofurantoin .
0.9792 Adverse-EffectBronchiolitis obliterans organising pneumonia associated with the use of nitrofurantoin.
Score Text
0.9996 Cerebral edema associated with DrugGliadel wafers : two case studies.
0.9937 Adverse-EffectCerebral edema associated with Gliadel wafers : two case studies.
Score Text
0.9995 Agranulocytosis induced by Drugvancomycin in an ESRD patient on CAPD.
0.9976 Adverse-EffectAgranulocytosis induced by vancomycin in an ESRD patient on CAPD.
Score Text
0.9994 DrugZidovudine induced pure red cell aplasia : a case report.
0.9758 Zidovudine induced Adverse-Effectpure red cell aplasia : a case report.
Score Text
0.9996 Various case reports concerning Drugdapsone - induced agranulocytosis are reviewed.
0.9983 Various case reports concerning dapsone - induced Adverse-Effectagranulocytosis are reviewed.
Score Text
0.9993 Neurotoxicity of Drugvalacyclovir in peritoneal dialysis : a pharmacokinetic study.
0.9947 Adverse-EffectNeurotoxicity of valacyclovir in peritoneal dialysis : a pharmacokinetic study.
Score Text
0.9995 Recently, CD20 - negative tumors have been described after DrugRituximab therapy.
0.9807 Recently, Adverse-EffectCD20 - negative tumors have been described after Rituximab therapy.
Score Text
0.9994 Cutaneous ulceration : an unusual complication of intravenous Drugpentamidine therapy.
0.9920 Adverse-EffectCutaneous ulceration : an unusual complication of intravenous pentamidine therapy.
Score Text
0.9995 Aplastic anemia and agranulocytosis in patients using Drugmethazolamide for glaucoma.
0.9968 Aplastic anemia and Adverse-Effectagranulocytosis in patients using methazolamide for glaucoma.
0.9914 Adverse-EffectAplastic anemia and agranulocytosis in patients using methazolamide for glaucoma.
Score Text
0.9993 Lethargy in a newborn : Druglithium toxicity or lab error?
0.9979 Adverse-EffectLethargy in a newborn : lithium toxicity or lab error?
Lethargy in a newborn : Adverse-Effectlithium toxicity or lab error?
Score Text
0.9994 DrugLevofloxacin - induced toxic epidermal necrolysis in an elderly patient.
0.9844 Levofloxacin - induced Adverse-Effecttoxic epidermal necrolysis in an elderly patient.
Score Text
0.9807 Adverse-EffectMental nerve neuropathy as a result of hepatitis B vaccination.
0.9671 Mental nerve neuropathy as a result of Drughepatitis B vaccination .
Score Text
0.9995 DrugMuzolimine - induced severe neuromyeloencephalopathy : report of seven cases.
0.9630 Muzolimine - induced Adverse-Effectsevere neuromyeloencephalopathy : report of seven cases.
Score Text
0.9982 After Drug5 - ASA was discontinued, the polyneuropathy symptoms recovered gradually.
0.9953 After 5 - ASA was discontinued, the Adverse-Effectpolyneuropathy symptoms recovered gradually.
Score Text
0.9994 DrugCimetidine is a rare cause of drug - induced fever.
0.9967 Cimetidine is a rare cause of drug - induced Adverse-Effectfever .
Score Text
0.9969 He was later skin tested to confirm allergy to DrugMTX .
0.9865 He was later skin tested to confirm Adverse-Effectallergy to MTX.
Score Text
0.9996 Secondary acute myeloid leukemia after Drugetoposide therapy for haemophagocytic lymphohistiocytosis.
0.9425 Secondary Adverse-Effectacute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.
Score Text
0.9990 DrugMinocycline as a cause of drug - induced autoimmune hepatitis.
0.9875 Minocycline as a cause of drug - induced Adverse-Effectautoimmune hepatitis .
Score Text
0.9993 Macular infarction after endophthalmitis treated with vitrectomy and intravitreal Druggentamicin .
0.9915 Adverse-EffectMacular infarction after endophthalmitis treated with vitrectomy and intravitreal gentamicin.
Score Text
0.9994 A 57 - year - old man developed morphea while taking Drugbromocriptine .
0.9980 A 57 - year - old man developed Adverse-Effectmorphea while taking bromocriptine.
Score Text
0.9994 DrugMethotrexate is an effective but potentially toxic treatment for psoriasis.
Methotrexate is an effective but Adverse-Effectpotentially toxic treatment for psoriasis.
Score Text
0.9913 Isonicotinic acid hydrazide induced anagen effluvium and associated Adverse-Effectlichenoid eruption .
0.9856 Isonicotinic acid hydrazide induced Adverse-Effectanagen effluvium and associated lichenoid eruption.
0.9583 DrugIsonicotinic acid hydrazide induced anagen effluvium and associated lichenoid eruption.
Score Text
0.9972 Lovastatin - induced Adverse-Effectrhabdomyolysis possibly associated with clarithromycin and azithromycin.
0.9945 DrugLovastatin - induced rhabdomyolysis possibly associated with clarithromycin and azithromycin.
0.9851 Lovastatin - induced rhabdomyolysis possibly associated with clarithromycin and Drugazithromycin .
0.9763 Lovastatin - induced rhabdomyolysis possibly associated with Drugclarithromycin and azithromycin.
Score Text
0.9995 The occurrence of acute hepatitis is best known for Drugketoconazole .
0.9202 The occurrence of Adverse-Effectacute hepatitis is best known for ketoconazole.
The occurrence of acute Adverse-Effecthepatitis is best known for ketoconazole.
Score Text
0.9995 Our experience supports hemodialysis for ESRF patients with Drugatenolol toxicity.
0.9105 Our experience supports hemodialysis for ESRF patients with Adverse-Effectatenolol toxicity .
Score Text
0.9995 Stevens - Johnson syndrome caused by the antiretroviral drug Drugnevirapine .
0.9839 Adverse-EffectStevens - Johnson syndrome caused by the antiretroviral drug nevirapine.
Score Text
0.9996 DrugDasatinib - induced pleural effusions : a lymphatic network disorder?
0.9869 Dasatinib - induced Adverse-Effectpleural effusions : a lymphatic network disorder?
Score Text
0.9994 Increasing the Drugolanzapine dosage severely aggravated the symptoms of RLS.
0.9976 Increasing the olanzapine dosage severely aggravated the symptoms of Adverse-EffectRLS .
Score Text
0.9990 Hemodialysis was also shown to reverse Drugifosfamide - related neurotoxicity.
0.9966 Hemodialysis was also shown to reverse ifosfamide - related Adverse-Effectneurotoxicity .
Score Text
0.9994 Neurologic toxicity associated with hepatic artery infusion HAI of DrugFUdR .
0.9871 Adverse-EffectNeurologic toxicity associated with hepatic artery infusion HAI of FUdR.
Score Text
0.9971 Adverse-EffectPapilledema without peripheral neuropathy in a patient taking perhexiline maleate.
0.9827 Papilledema without peripheral neuropathy in a patient taking Drugperhexiline maleate .
Score Text
0.9994 Sudden cardiac death due to hypersensitivity myocarditis during Drugclozapine treatment.
0.9832 Adverse-EffectSudden cardiac death due to hypersensitivity myocarditis during clozapine treatment.
0.9737 Sudden cardiac death due to Adverse-Effecthypersensitivity myocarditis during clozapine treatment.
Score Text
0.9996 Marked elevation of serum creatine kinase associated with Drugolanzapine therapy.
0.9775 Marked Adverse-Effectelevation of serum creatine kinase associated with olanzapine therapy.
Score Text
0.9986 DrugDoxorubicin cardiotoxicity : possible role of digoxin in its prevention.
0.8813 Doxorubicin Adverse-Effectcardiotoxicity : possible role of digoxin in its prevention.
Score Text
0.9992 Paroxysmal supraventricular tachycardia during treatment with cisplatin and Drugetoposide combination.
0.9992 Paroxysmal supraventricular tachycardia during treatment with Drugcisplatin and etoposide combination.
0.9742 Adverse-EffectParoxysmal supraventricular tachycardia during treatment with cisplatin and etoposide combination.
Score Text
0.9996 Fatal acute encephalomyelitis after a single dose of intrathecal Drugmethotrexate .
0.9782 Adverse-EffectFatal acute encephalomyelitis after a single dose of intrathecal methotrexate.
Score Text
0.9907 Oxygen potentiation of bleomycin - induced Adverse-Effectpulmonary toxicity is discussed.
0.9860 Oxygen potentiation of Drugbleomycin - induced pulmonary toxicity is discussed.
0.8774 DrugOxygen potentiation of bleomycin - induced pulmonary toxicity is discussed.
Score Text
0.9986 Allergy to Drugcloxacillin with normal tolerance to amoxicillin and cefuroxime.
0.9731 Adverse-EffectAllergy to cloxacillin with normal tolerance to amoxicillin and cefuroxime.
Score Text
0.9988 DrugMagnesium tocolysis as the cause of urinary calculus during pregnancy.
0.9923 Magnesium tocolysis as the cause of Adverse-Effecturinary calculus during pregnancy.
Score Text
0.9992 Hemorrhagic cystitis is a significant toxic effect of Drugcyclophosphamide therapy.
0.9881 Adverse-EffectHemorrhagic cystitis is a significant toxic effect of cyclophosphamide therapy.
Score Text
0.9992 Hypokalemia after normal doses of neubulized Drugalbuterol ( salbutamol ).
0.9991 Hypokalemia after normal doses of neubulized albuterol ( Drugsalbutamol ).
0.9989 Adverse-EffectHypokalemia after normal doses of neubulized albuterol ( salbutamol ).
Score Text
0.9996 Toxic hepatitis induced by Drugdisulfiram in a non - alcoholic.
0.9895 Adverse-EffectToxic hepatitis induced by disulfiram in a non - alcoholic.
Score Text
0.9987 Acute renal failure during lisinopril and Druglosartan therapy for proteinuria.
0.9985 Acute renal failure during Druglisinopril and losartan therapy for proteinuria.
0.9777 Adverse-EffectAcute renal failure during lisinopril and losartan therapy for proteinuria.
Score Text
0.9995 Hair loss associated with Drugparoxetine treatment : a case report.
0.9939 Adverse-EffectHair loss associated with paroxetine treatment : a case report.
Score Text
0.9994 Severe diffuse interstitial pneumonitis induced by Drugcarmustine ( BCNU ).
0.9994 Severe diffuse interstitial pneumonitis induced by carmustine ( DrugBCNU ).
0.9251 Adverse-EffectSevere diffuse interstitial pneumonitis induced by carmustine ( BCNU ).
Score Text
0.9996 The cough continued for the duration of therapy with Drugquinapril .
0.9979 The Adverse-Effectcough continued for the duration of therapy with quinapril.
Score Text
0.9827 Adverse-EffectMulticentric hepatocellular carcinoma following phosphate diethylstilbestrol therapy for prostatic cancer.
0.9597 Multicentric hepatocellular carcinoma following Drugphosphate diethylstilbestrol therapy for prostatic cancer.
Score Text
0.9990 Adverse-EffectCough induced by quinapril with resolution after changing to fosinopril.
0.9990 Cough induced by Drugquinapril with resolution after changing to fosinopril.
Score Text
0.9902 Lipoid pneumonia : a silent complication of Drugmineral oil aspiration.
0.9887 Adverse-EffectLipoid pneumonia : a silent complication of mineral oil aspiration.
Score Text
0.9993 Corneal edema recurred when the administration of Drugamantadine was resumed.
0.9912 Adverse-EffectCorneal edema recurred when the administration of amantadine was resumed.
Score Text
0.9994 DrugFluphenazine - induced neuroleptic malignant syndrome in a schizophrenic patient.
0.9858 Fluphenazine - induced Adverse-Effectneuroleptic malignant syndrome in a schizophrenic patient.
Score Text
0.9988 After stopping Drugindapamide , glucose tolerance impairing may be reversed.
0.9777 After stopping indapamide, Adverse-Effectglucose tolerance impairing may be reversed.
Score Text
0.9994 Transient acute myopia resulting from Drugisotretinoin ( accutane ) therapy.
0.9993 Transient acute myopia resulting from isotretinoin ( Drugaccutane ) therapy.
0.9625 Adverse-EffectTransient acute myopia resulting from isotretinoin ( accutane ) therapy.
Score Text
0.9996 Cardiac decompensation following Drugverapamil therapy in infants with supraventricular tachycardia.
0.9912 Adverse-EffectCardiac decompensation following verapamil therapy in infants with supraventricular tachycardia.
Score Text
0.9995 Three patients developed proteinuria following Druggold therapy for rheumatoid arthritis.
0.9990 Three patients developed Adverse-Effectproteinuria following gold therapy for rheumatoid arthritis.
Score Text
0.9996 Nephrotic syndrome related to systemic lupus erythematosus after Druggriseofulvin therapy.
0.9912 Adverse-EffectNephrotic syndrome related to systemic lupus erythematosus after griseofulvin therapy.
0.9589 Nephrotic syndrome related to Adverse-Effectsystemic lupus erythematosus after griseofulvin therapy.
Score Text
0.9996 Colitis as a manifestation of Druginfliximab - associated disseminated cryptococcosis.
0.9982 Adverse-EffectColitis as a manifestation of infliximab - associated disseminated cryptococcosis.
0.9842 Colitis as a manifestation of infliximab - associated Adverse-Effectdisseminated cryptococcosis .
Score Text
0.9995 DrugGabapentin - induced mood changes with hypomanic features in adults.
0.9893 Gabapentin - induced mood changes with Adverse-Effecthypomanic features in adults.
0.9868 Gabapentin - induced Adverse-Effectmood changes with hypomanic features in adults.
Score Text
0.9994 Discontinuation of the Drugitraconazole caused resolution of the drug eruption.
0.9891 Discontinuation of the itraconazole caused resolution of the Adverse-Effectdrug eruption .
Score Text
0.9984 DrugTacrolimus ( FK506 ) - induced mutism after liver transplant.
0.9983 Tacrolimus ( FK506 ) - induced Adverse-Effectmutism after liver transplant.
0.9977 Tacrolimus ( DrugFK506 ) - induced mutism after liver transplant.
Score Text
0.9993 DrugCarbamazepine induced right bundle branch block in a Greenlandic patient.
0.9827 Carbamazepine induced Adverse-Effectright bundle branch block in a Greenlandic patient.
Score Text
0.9996 Angioedema and dysphagia caused by contact allergy to inhaled Drugbudesonide .
0.9985 Angioedema and Adverse-Effectdysphagia caused by contact allergy to inhaled budesonide.
0.9983 Adverse-EffectAngioedema and dysphagia caused by contact allergy to inhaled budesonide.
Score Text
0.9944 Apparent Drugcyclophosphamide ( cytoxan ) embryopathy : a distinct phenotype?
0.9623 Apparent cyclophosphamide ( cytoxan ) Adverse-Effectembryopathy : a distinct phenotype?
Score Text
0.9990 One patient had MRI T2 abnormalities compatible with Drugcyclosporin neurotoxicity.
0.9608 One patient had Adverse-EffectMRI T2 abnormalities compatible with cyclosporin neurotoxicity.
0.9078 One patient had MRI T2 abnormalities compatible with cyclosporin Adverse-Effectneurotoxicity .
Score Text
0.9995 Acute renal failure in a patient receiving treatment with Drugsuramin .
0.9686 Adverse-EffectAcute renal failure in a patient receiving treatment with suramin.
Score Text
0.9990 DrugCarboplatin hypersensitivity presenting as coronary vasospasm - a case report.
0.9870 Carboplatin hypersensitivity presenting as Adverse-Effectcoronary vasospasm - a case report.
Score Text
0.9995 Severe symptomatic hyponatremia during Drugsibutramine therapy : a case report.
0.9573 Adverse-EffectSevere symptomatic hyponatremia during sibutramine therapy : a case report.
Score Text
0.9994 DrugPhenytoin toxicity : an easily missed cause of cerebellar syndrome.
0.9915 Phenytoin toxicity : an easily missed cause of Adverse-Effectcerebellar syndrome .
Score Text
0.9995 This pattern is suggestive of renal toxicity due to Drugtobramycin .
0.9868 This pattern is suggestive of Adverse-Effectrenal toxicity due to tobramycin.
Score Text
0.9995 Delay of corneal wound healing in patients treated with Drugcolchicine .
0.9521 Adverse-EffectDelay of corneal wound healing in patients treated with colchicine.
Score Text
0.9994 DrugWarfarin - associated thoracic aortic dissection in an elderly woman.
0.9854 Warfarin - associated Adverse-Effectthoracic aortic dissection in an elderly woman.
Score Text
0.9992 Hypersensitivity to Drugzonisamide was confirmed by the skin patch test.
0.9875 Adverse-EffectHypersensitivity to zonisamide was confirmed by the skin patch test.
Score Text
0.9994 DrugPseudoephedrine - induced hemorrhage associated with a cerebral vascular malformation.
0.9983 Pseudoephedrine - induced Adverse-Effecthemorrhage associated with a cerebral vascular malformation.
0.9821 Pseudoephedrine - induced hemorrhage associated with a Adverse-Effectcerebral vascular malformation .
Score Text
0.9996 A case of acute cardiomyopathy and pericarditis associated with Drugmethylphenidate .
0.9972 A case of acute cardiomyopathy and Adverse-Effectpericarditis associated with methylphenidate.
0.9837 A case of Adverse-Effectacute cardiomyopathy and pericarditis associated with methylphenidate.
Score Text
0.9993 Syncope in a 65 - year - old woman after Drugnitrate ingestion.
0.9985 Adverse-EffectSyncope in a 65 - year - old woman after nitrate ingestion.
Score Text
0.9994 DIAGNOSIS : Sustained ventricular tachycardia possibly owing to Drugthalidomide treatment.
0.9783 DIAGNOSIS : Adverse-EffectSustained ventricular tachycardia possibly owing to thalidomide treatment.
Score Text
0.9991 Acute lung injury associated with 5 - fluorouracil and Drugoxaliplatinum combined chemotherapy.
0.9990 Acute lung injury associated with Drug5 - fluorouracil and oxaliplatinum combined chemotherapy.
0.9876 Adverse-EffectAcute lung injury associated with 5 - fluorouracil and oxaliplatinum combined chemotherapy.
Score Text
0.9995 Cardiac toxicity related to DrugBCNU has not been described well.
0.9910 Adverse-EffectCardiac toxicity related to BCNU has not been described well.
Score Text
0.9992 DrugCiprofloxacin - induced hemorrhagic vasculitis is a rare side effect.
0.9887 Ciprofloxacin - induced Adverse-Effecthemorrhagic vasculitis is a rare side effect.
Score Text
0.9992 An immediate hemolytic reaction induced by repeated administration of Drugoxaliplatin .
0.9915 An immediate Adverse-Effecthemolytic reaction induced by repeated administration of oxaliplatin.
Score Text
0.9993 DrugAcyclovir neurotoxicity : clinical experience and review of the literature.
0.8794 Acyclovir Adverse-Effectneurotoxicity : clinical experience and review of the literature.
Score Text
0.9703 Adverse-EffectAcute syphilitic posterior placoid chorioretinitis following intravitreal triamcinolone acetonide injection.
0.9693 Acute syphilitic posterior placoid chorioretinitis following intravitreal Drugtriamcinolone acetonide injection.
Score Text
0.9995 DrugRisperidone - induced obsessive - compulsive symptoms in two children.
0.9853 Risperidone - induced Adverse-Effectobsessive - compulsive symptoms in two children.
Score Text
0.9993 Fibrosis of corpus cavernosum after intracavernous injection of Drugphentolamine / papaverine.
0.9993 Fibrosis of corpus cavernosum after intracavernous injection of phentolamine / Drugpapaverine .
0.9451 Adverse-EffectFibrosis of corpus cavernosum after intracavernous injection of phentolamine / papaverine.
Score Text
0.9954 This eruption appears to be a distinct cutaneous toxicity of DrugPLD .
0.9939 This Adverse-Effecteruption appears to be a distinct cutaneous toxicity of PLD.
Score Text
0.9996 Erosion of psoriatic plaques : an early sign of Drugmethotrexate toxicity.
0.9824 Adverse-EffectErosion of psoriatic plaques : an early sign of methotrexate toxicity.
Erosion of psoriatic plaques : an early sign of Adverse-Effectmethotrexate toxicity .
Score Text
0.9992 After nine previous uncomplicated cycles she developed severe anaphylaxis to Drugcisplatin .
0.9859 After nine previous uncomplicated cycles she developed severe Adverse-Effectanaphylaxis to cisplatin.
Score Text
0.9996 DrugColchicine - induced myopathy in a teenager with familial Mediterranean fever.
0.9987 Colchicine - induced Adverse-Effectmyopathy in a teenager with familial Mediterranean fever.
Score Text
0.9995 DrugIbopamine - induced reversible leukopenia during treatment for congestive heart failure.
0.9642 Ibopamine - induced reversible Adverse-Effectleukopenia during treatment for congestive heart failure.
Score Text
0.9994 We also describe a case of Drugtimolol - induced ocular pemphigoid.
0.9725 We also describe a case of timolol - induced Adverse-Effectocular pemphigoid .
Score Text
0.9991 Acute aluminum toxicity after continuous intravesical Drugalum irrigation for hemorrhagic cystitis.
0.9436 Adverse-EffectAcute aluminum toxicity after continuous intravesical alum irrigation for hemorrhagic cystitis.
Acute Adverse-Effectaluminum toxicity after continuous intravesical alum irrigation for hemorrhagic cystitis.
Score Text
0.9996 Only a few reports of overt jaundice are associated with Drugstreptokinase .
0.9970 Only a few reports of overt Adverse-Effectjaundice are associated with streptokinase.
Score Text
0.9996 Sensory neuropathy revealing necrotizing vasculitis during Druginfliximab therapy for rheumatoid arthritis.
0.9866 Adverse-EffectSensory neuropathy revealing necrotizing vasculitis during infliximab therapy for rheumatoid arthritis.
0.9122 Sensory neuropathy revealing Adverse-Effectnecrotizing vasculitis during infliximab therapy for rheumatoid arthritis.
Score Text
0.9996 Electrical proarrhythmia with Drugprocainamide : a new ICD - drug interaction.
0.9820 Adverse-EffectElectrical proarrhythmia with procainamide : a new ICD - drug interaction.
Score Text
0.9884 Adverse-EffectLivedo reticularis associated with interferon alpha therapy in two melanoma patients.
0.9867 Livedo reticularis associated with Druginterferon alpha therapy in two melanoma patients.
Score Text
0.9991 The association of Drugphenothiazine overdose and respiratory distress syndrome merits consideration.
0.9842 The association of phenothiazine overdose and Adverse-Effectrespiratory distress syndrome merits consideration.
Score Text
0.9976 Adverse-EffectMethemoglobinemia associated with dermal application of benzocaine cream in a cat.
0.9962 Methemoglobinemia associated with dermal application of Drugbenzocaine cream in a cat.
Score Text
0.9990 When the Drugtrazodone was reduced, the involuntary movements promptly ceased.
0.9883 When the trazodone was reduced, the Adverse-Effectinvoluntary movements promptly ceased.
Score Text
0.9995 DrugAnastrozole - associated sclerosing glomerulonephritis in a patient with breast cancer.
0.9840 Anastrozole - associated Adverse-Effectsclerosing glomerulonephritis in a patient with breast cancer.
Score Text
0.9993 Transfusion haemosiderosis inspite of regular use of Drugdesferrioxamine : case report.
0.9823 Adverse-EffectTransfusion haemosiderosis inspite of regular use of desferrioxamine : case report.
Score Text
0.9993 This concerns 2 male patients who experienced incontinence while taking Drugvenlafaxine .
0.9982 This concerns 2 male patients who experienced Adverse-Effectincontinence while taking venlafaxine.
Score Text
0.9802 One patient had severe temporary weakness after an Drugampicillin sodium challenge.
0.9713 One patient had Adverse-Effectsevere temporary weakness after an ampicillin sodium challenge.
Score Text
0.9992 Arterial hypertension associated with topical ocular use of Drugphenylephrine in dogs.
0.9919 Adverse-EffectArterial hypertension associated with topical ocular use of phenylephrine in dogs.
Score Text
0.9996 DrugTigecycline - induced acute pancreatitis : case report and literature review.
0.9879 Tigecycline - induced Adverse-Effectacute pancreatitis : case report and literature review.
Score Text
0.9995 Antineutrophil cytoplasmic antibody - positive crescentic glomerulonephritis associated with Drugpropylthiouracil therapy.
0.9729 Adverse-EffectAntineutrophil cytoplasmic antibody - positive crescentic glomerulonephritis associated with propylthiouracil therapy.
Score Text
0.9984 Chronic Drughydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia.
0.9822 Chronic hydroxychloroquine use associated with Adverse-EffectQT prolongation and refractory ventricular arrhythmia.
0.9790 Chronic hydroxychloroquine use associated with QT prolongation and Adverse-Effectrefractory ventricular arrhythmia .
Score Text
0.9996 We report here a rare case of pleuropericarditis due to Drugmethotrexate .
0.9963 We report here a rare case of Adverse-Effectpleuropericarditis due to methotrexate.
Score Text
0.9992 Inadvertent and accidental Drugepinephrine overdose might result in potentially lethal complications.
0.9799 Inadvertent and accidental epinephrine overdose might result in potentially Adverse-Effectlethal complications .
Score Text
0.9996 Reversible heart failure in a patient receiving Drugetanercept for ankylosing spondylitis.
0.9762 Adverse-EffectReversible heart failure in a patient receiving etanercept for ankylosing spondylitis.
Score Text
0.9995 Extensive forearm deep venous thrombosis following a severe Druginfliximab infusion reaction.
0.9711 Adverse-EffectExtensive forearm deep venous thrombosis following a severe infliximab infusion reaction.
Score Text
0.9996 We report the first case of tuberculous uveitis due to Drugetanercept .
0.9875 We report the first case of Adverse-Effecttuberculous uveitis due to etanercept.
Score Text
0.9995 Five months after initiating Drugmirtazapine therapy, she developed symptomatic hyponatremia.
0.9874 Five months after initiating mirtazapine therapy, she developed Adverse-Effectsymptomatic hyponatremia .
Score Text
0.9995 PURPOSE : A case of Drugcarbamazepine - induced hyperammonemia is presented.
0.9976 PURPOSE : A case of carbamazepine - induced Adverse-Effecthyperammonemia is presented.
Score Text
0.9997 Pneumonitis with pleural and pericardial effusion and neuropathy during Drugamiodarone therapy.
0.9968 Adverse-EffectPneumonitis with pleural and pericardial effusion and neuropathy during amiodarone therapy.
0.9955 Pneumonitis with pleural and pericardial effusion and Adverse-Effectneuropathy during amiodarone therapy.
0.9429 Pneumonitis with Adverse-Effectpleural and pericardial effusion and neuropathy during amiodarone therapy.
Score Text
0.9995 Fatal hepatitis after long - term pulse Drugitraconazole treatment for onychomycosis.
0.9900 Adverse-EffectFatal hepatitis after long - term pulse itraconazole treatment for onychomycosis.
Score Text
0.9994 This is a rare case of ARDS associated with Druglithium intoxication.
0.9977 This is a rare case of Adverse-EffectARDS associated with lithium intoxication.
Score Text
0.9993 Hypersensitivity reactions due to Drugchloramphenicol are rarely reported in the literature.
0.9887 Adverse-EffectHypersensitivity reactions due to chloramphenicol are rarely reported in the literature.
Score Text
0.9992 Ischaemia following selfadministered intra - arterial injection of Drugmethylphenidate and diamorphine.
0.9992 Ischaemia following selfadministered intra - arterial injection of methylphenidate and Drugdiamorphine .
0.9991 Adverse-EffectIschaemia following selfadministered intra - arterial injection of methylphenidate and diamorphine.
Score Text
0.9986 Unaccountable severe hypercalcemia in a patient treated for hypoparathyroidism with Drugdihydrotachysterol .
0.9667 Unaccountable severe Adverse-Effecthypercalcemia in a patient treated for hypoparathyroidism with dihydrotachysterol.
Score Text
0.9995 DrugAllopurinol - associated hand and foot deformities in chronic tophaceous gout.
0.9822 Allopurinol - associated Adverse-Effecthand and foot deformities in chronic tophaceous gout.
Score Text
0.9997 We report a case of DrugRitalin - associated cataract and glaucoma.
0.9990 We report a case of Ritalin - associated cataract and Adverse-Effectglaucoma .
0.9987 We report a case of Ritalin - associated Adverse-Effectcataract and glaucoma.
Score Text
0.9996 Nephrogenic diabetes insipidus and renal tubular acidosis secondary to Drugfoscarnet therapy.
0.9777 Adverse-EffectNephrogenic diabetes insipidus and renal tubular acidosis secondary to foscarnet therapy.
0.9766 Nephrogenic diabetes insipidus and Adverse-Effectrenal tubular acidosis secondary to foscarnet therapy.
Score Text
0.9995 We report here a case of TEN after administration of Drugciprofloxacin .
0.9987 We report here a case of Adverse-EffectTEN after administration of ciprofloxacin.
Score Text
0.9991 DISCUSSION : Anaphylactoid reactions have been described previously with Drugcisplatin administration.
0.9908 DISCUSSION : Adverse-EffectAnaphylactoid reactions have been described previously with cisplatin administration.
Score Text
0.9994 Central nervous system toxicity associated with Drugmeperidine use in hepatic disease.
0.9841 Adverse-EffectCentral nervous system toxicity associated with meperidine use in hepatic disease.
Score Text
0.9994 Drug - induced agranulocytosis during treatment with Druginfliximab in enteropathic spondyloarthropathy.
0.9976 Drug - induced Adverse-Effectagranulocytosis during treatment with infliximab in enteropathic spondyloarthropathy.
Score Text
0.9991 One other patient on Drugdigoxin stopped taking it and developed cardiomyopathy.
0.9975 One other patient on digoxin stopped taking it and developed Adverse-Effectcardiomyopathy .
Score Text
0.9962 DrugAdrenaline dacryolith : detection by ultrasound examination of the nasolacrimal duct.
0.8982 Adrenaline Adverse-Effectdacryolith : detection by ultrasound examination of the nasolacrimal duct.
Score Text
0.9993 DrugGabapentin toxicity in renal failure : the importance of dose adjustment.
0.9805 Gabapentin toxicity in Adverse-Effectrenal failure : the importance of dose adjustment.
Score Text
0.9983 Severe steroid - induced Adverse-Effectglaucoma following intravitreal injection of triamcinolone acetonide.
0.9392 Severe steroid - induced glaucoma following intravitreal injection of Drugtriamcinolone acetonide .
0.9075 Severe Drugsteroid - induced glaucoma following intravitreal injection of triamcinolone acetonide.
Score Text
0.9996 A short review on Drugimatinib - related hepatotoxicity is also presented.
0.9969 A short review on imatinib - related Adverse-Effecthepatotoxicity is also presented.
Score Text
0.9989 Interaction between tacrolimus and Drugnefazodone in a stable renal transplant recipient.
0.9989 Interaction between Drugtacrolimus and nefazodone in a stable renal transplant recipient.
0.9899 Adverse-EffectInteraction between tacrolimus and nefazodone in a stable renal transplant recipient.
Score Text
0.9992 Severe apnea in an infant exposed to Druglamotrigine in breast milk.
0.9812 Adverse-EffectSevere apnea in an infant exposed to lamotrigine in breast milk.
Score Text
0.9968 DrugHalothane hepatitis and prompt resolution with methionine therapy : case report.
0.9319 Halothane Adverse-Effecthepatitis and prompt resolution with methionine therapy : case report.
Score Text
0.9994 The elicitation of a movement disorder by Drugtrazodone : case report.
0.9839 The elicitation of a Adverse-Effectmovement disorder by trazodone : case report.
Score Text
0.9995 Primary central nervous system lymphoma in a patient treated with Drugnatalizumab .
0.9800 Adverse-EffectPrimary central nervous system lymphoma in a patient treated with natalizumab.
Score Text
0.9994 We report three cases of Drugamiodarone - induced torsades de pointe.
0.9752 We report three cases of amiodarone - induced Adverse-Effecttorsades de pointe .
Score Text
0.9993 Prominent positive U waves appearing with high - dose intravenous Drugphenylephrine .
0.9577 Prominent Adverse-Effectpositive U waves appearing with high - dose intravenous phenylephrine.
Score Text
0.9994 Central nervous system manifestations of an Drugibuprofen overdose reversed by naloxone.
0.9826 Adverse-EffectCentral nervous system manifestations of an ibuprofen overdose reversed by naloxone.
Score Text
0.9995 Development of Peyronie's disease during long - term Drugcolchicine treatment.
0.9841 Development of Adverse-EffectPeyronie's disease during long - term colchicine treatment.
Score Text
0.9993 Acne provoked by Druggold seems not to have been described elsewhere.
0.9983 Adverse-EffectAcne provoked by gold seems not to have been described elsewhere.
Score Text
0.9991 Severe Drugsulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis.
0.8716 Severe sulfadiazine Adverse-Effecthypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis.
Score Text
0.9995 Sustained - release Drugprocainamide - induced reversible granulocytopenia after myocardial infarction.
0.9656 Sustained - release procainamide - induced Adverse-Effectreversible granulocytopenia after myocardial infarction.
Score Text
0.9939 Carbamyl phosphate synthetase - 1 deficiency discovered after valproic acid - induced Adverse-Effectcoma .
0.9850 Carbamyl phosphate synthetase - 1 deficiency discovered after Drugvalproic acid - induced coma.
Score Text
0.9994 Hepatobiliary disorders associated with orally administered Drugterbinafine have rarely been reported.
0.9934 Adverse-EffectHepatobiliary disorders associated with orally administered terbinafine have rarely been reported.
Score Text
0.9993 Diffusion - weighted MRI correlates of subacute Drugmethotrexate - related neurotoxicity.
0.9944 Diffusion - weighted MRI correlates of subacute methotrexate - related Adverse-Effectneurotoxicity .
Score Text
0.9994 Withdrawal emergent syndrome in an infant associated with maternal Drughaloperidol therapy.
0.9839 Adverse-EffectWithdrawal emergent syndrome in an infant associated with maternal haloperidol therapy.
Score Text
0.9994 The patient suffered a life - threatening anaphylactoid reaction to Drugamifostine .
0.9508 The patient suffered a Adverse-Effectlife - threatening anaphylactoid reaction to amifostine.
Score Text
0.9864 Three senile patients developed fatal acute encephalopathy while receiving Drugcalcium hopantenate .
0.9775 Three senile patients developed Adverse-Effectfatal acute encephalopathy while receiving calcium hopantenate.
Score Text
0.9909 Adverse-EffectHepatocellular damage following therapeutic intravenous iron sucrose infusion in a child.
0.9863 Hepatocellular damage following therapeutic intravenous Drugiron sucrose infusion in a child.
Score Text
0.9770 This paper reports a case of fatal Drugperhexiline maleate liver injury.
0.7778 This paper reports a case of Adverse-Effectfatal perhexiline maleate liver injury .
0.8681 This paper reports a case of fatal perhexiline Drugmaleate liver injury.
0.6049 This paper reports a case of fatal Adverse-Effectperhexiline maleate liver injury .
Score Text
0.9995 Proton MRS examination demonstrated a persistent lactate elevation during Drugmetronidazole treatment.
0.9711 Proton MRS examination demonstrated a persistent Adverse-Effectlactate elevation during metronidazole treatment.
Score Text
0.9984 A typical case of Drugdextran - 40 associated acute renal failure is presented.
0.9673 A typical case of dextran - 40 associated Adverse-Effectacute renal failure is presented.
Score Text
0.9990 Mycobacterium marinum infection complicating Crohn's disease, treated with Druginfliximab .
0.9842 Adverse-EffectMycobacterium marinum infection complicating Crohn's disease, treated with infliximab.
Score Text
0.9894 CONCLUSION : Acetic acid is corrosive and may cause Adverse-Effectvagina bleeding .
0.9778 CONCLUSION : DrugAcetic acid is corrosive and may cause vagina bleeding.
Score Text
0.9941 We describe a patient who became Adverse-Effecthypothyroid while taking ferrous sulfate.
0.9799 We describe a patient who became hypothyroid while taking Drugferrous sulfate .
Score Text
0.9996 DrugCaptopril - induced lichen planus pemphigoides with pemphigus - like features.
0.9785 Captopril - induced Adverse-Effectlichen planus pemphigoides with pemphigus - like features.
Score Text
0.9996 Thrombocytosis associated with Drugenoxaparin : A very rare cause in newborns.
0.9980 Adverse-EffectThrombocytosis associated with enoxaparin : A very rare cause in newborns.
Score Text
0.9992 Hypersensitivity reaction following Drugchloramphenicol administration in a patient with typhoid fever.
0.9871 Adverse-EffectHypersensitivity reaction following chloramphenicol administration in a patient with typhoid fever.
Score Text
0.9886 Adverse-EffectAnaphylactic reaction to recombinant insulin - like growth factor - I.
0.9045 Anaphylactic reaction to Drugrecombinant insulin - like growth factor - I .
Score Text
0.9993 Two reports of spindle coma are noted with alcohol and Drugimipramine .
0.9913 Two reports of Adverse-Effectspindle coma are noted with alcohol and imipramine.
Score Text
0.9993 This therapy was also complicated by DrugWarfarin - induced skin necrosis.
0.9917 This therapy was also complicated by Warfarin - induced Adverse-Effectskin necrosis .
Score Text
0.9990 DrugMetipranolol associated granulomatous anterior uveitis : not so uncommon as thought.
0.9825 Metipranolol associated Adverse-Effectgranulomatous anterior uveitis : not so uncommon as thought.
Score Text
0.9992 Choanal atresia and athelia : Drugmethimazole teratogenicity or a new syndrome?
0.9958 Choanal atresia and Adverse-Effectathelia : methimazole teratogenicity or a new syndrome?
0.9785 Adverse-EffectChoanal atresia and athelia : methimazole teratogenicity or a new syndrome?
0.9274 Choanal atresia and athelia : methimazole Adverse-Effectteratogenicity or a new syndrome?
Score Text
0.9991 Erythropoietin is beneficial in Drugmitomycin - induced hemolytic - uremic syndrome.
0.9873 Erythropoietin is beneficial in mitomycin - induced Adverse-Effecthemolytic - uremic syndrome .
Score Text
0.9994 We report four cases of severe corneal ulceration in Drugmethamphetamine abusers.
0.9804 We report four cases of Adverse-Effectsevere corneal ulceration in methamphetamine abusers.
Score Text
0.9995 Pneumocystis carinii pneumonia as a complication of Drugmethotrexate treatment of asthma.
0.9820 Adverse-EffectPneumocystis carinii pneumonia as a complication of methotrexate treatment of asthma.
Score Text
0.9989 DrugClofazimine enteropathy caused by crystal deposition can be life - threatening.
0.9569 Clofazimine enteropathy caused by crystal deposition can be Adverse-Effectlife - threatening .
0.8181 Clofazimine Adverse-Effectenteropathy caused by crystal deposition can be life - threatening.
Score Text
0.9996 Interference with the cortisol axis by the microtubule antagonist, DrugCPH82 .
0.9623 Adverse-EffectInterference with the cortisol axis by the microtubule antagonist, CPH82.
Score Text
0.9995 DrugDisulfiram - induced fulminant hepatic failure in an active duty soldier.
0.9870 Disulfiram - induced Adverse-Effectfulminant hepatic failure in an active duty soldier.
Score Text
0.9979 High - dose phosphate treatment leads to Adverse-Effecthypokalemia in hypophosphatemic osteomalacia.
0.9935 High - dose Drugphosphate treatment leads to hypokalemia in hypophosphatemic osteomalacia.
Score Text
0.9980 Possible mechanisms for damage to the urothelium by Drugketamine are suggested.
0.9605 Possible mechanisms for Adverse-Effectdamage to the urothelium by ketamine are suggested.
Score Text
0.9976 Adverse-EffectHepatotoxicity induced by cyproterone acetate : a report of three cases.
0.9742 Hepatotoxicity induced by Drugcyproterone acetate : a report of three cases.
Score Text
0.9873 Caution with use of Drugcimetidine in tolazoline induced upper gastrointestinal bleeding.
0.9857 Caution with use of cimetidine in tolazoline induced Adverse-Effectupper gastrointestinal bleeding .
0.9807 Caution with use of cimetidine in Drugtolazoline induced upper gastrointestinal bleeding.
Score Text
0.9993 Hypersensitivity pneumonitis - like syndrome associated with the use of Druglenalidomide .
0.9755 Adverse-EffectHypersensitivity pneumonitis - like syndrome associated with the use of lenalidomide.
Score Text
0.9996 The medical examiner's report indicated death caused by Drugfluoxetine toxicity.
0.9837 The medical examiner's report indicated Adverse-Effectdeath caused by fluoxetine toxicity.
0.6587 The medical examiner's report indicated death caused by Adverse-Effectfluoxetine toxicity .
Score Text
0.9995 In all the patients, pellagra symptoms appeared during Drugisoniazid therapy.
In all the patients, Adverse-Effectpellagra symptoms appeared during isoniazid therapy.
Score Text
0.9994 We hypothesize that Drugcapecitabine - induced headache is vascular in nature.
0.9988 We hypothesize that capecitabine - induced Adverse-Effectheadache is vascular in nature.
Score Text
0.9994 DrugDesipramine - associated SIADH in an elderly woman : case report.
0.9983 Desipramine - associated Adverse-EffectSIADH in an elderly woman : case report.
Score Text
0.9858 Mitomycin - C induced Adverse-Effecthemolytic uremic syndrome : a case report.
0.9635 DrugMitomycin - C induced hemolytic uremic syndrome : a case report.
Score Text
0.9996 Esophageal candidiasis following Drugomeprazole therapy : a report of two cases.
0.9895 Adverse-EffectEsophageal candidiasis following omeprazole therapy : a report of two cases.
Score Text
0.9988 The syndrome of irreversible Druglithium - effectuated neurotoxicity ( SILENT ).
0.9957 The syndrome of irreversible lithium - effectuated Adverse-Effectneurotoxicity ( SILENT ).
Score Text
0.9995 Thrombotic microangiopathy with renal failure in two patients undergoing Druggemcitabine chemotherapy.
0.9877 Thrombotic microangiopathy with Adverse-Effectrenal failure in two patients undergoing gemcitabine chemotherapy.
0.9869 Adverse-EffectThrombotic microangiopathy with renal failure in two patients undergoing gemcitabine chemotherapy.
Score Text
0.9970 Severe heparin associated Adverse-Effectthrombocytopenia is a rare complication of heparin therapy.
0.9961 Severe heparin associated thrombocytopenia is a rare complication of Drugheparin therapy.
0.9938 Severe Drugheparin associated thrombocytopenia is a rare complication of heparin therapy.
Score Text
0.9914 Adverse-EffectMammary gigantism is a rare complication of D - penicillamine treatment.
0.9639 Mammary gigantism is a rare complication of DrugD - penicillamine treatment.
Score Text
0.9970 Zolpidem tissue concentrations in a multiple drug related death involving DrugAmbien .
0.9877 Zolpidem tissue concentrations in a multiple drug related Adverse-Effectdeath involving Ambien.
DrugZolpidem tissue concentrations in a multiple drug related death involving Ambien.
Score Text
0.9991 Patient 1 presented bilateral ballism 1 week after intravenous Drugheroin injection.
0.9929 Patient 1 presented Adverse-Effectbilateral ballism 1 week after intravenous heroin injection.
Score Text
0.9994 It occasionally accompanies the Drugheparin - associated thrombocytopenia and thrombosis syndrome.
0.9950 It occasionally accompanies the heparin - associated Adverse-Effectthrombocytopenia and thrombosis syndrome.
0.9934 It occasionally accompanies the heparin - associated thrombocytopenia and Adverse-Effectthrombosis syndrome .
Score Text
0.9988 Selective estrogen receptor modulator Drugraloxifene - associated aggravation of nonalcoholic steatohepatitis.
0.9574 Selective estrogen receptor modulator raloxifene - associated Adverse-Effectaggravation of nonalcoholic steatohepatitis .
Score Text
0.9991 Hemolytic uremic syndrome following the infusion of Drugoxaliplatin : case report.
0.9871 Adverse-EffectHemolytic uremic syndrome following the infusion of oxaliplatin : case report.
Score Text
0.9995 Dose - dependent Drugolanzapine - associated leukopenia : three case reports.
0.9982 Dose - dependent olanzapine - associated Adverse-Effectleukopenia : three case reports.
Score Text
0.9995 Pellagra encephalopathy among tuberculous patients : its relation to Drugisoniazid therapy.
0.9695 Adverse-EffectPellagra encephalopathy among tuberculous patients : its relation to isoniazid therapy.
Score Text
0.9996 We report the first case of IHA associated with Drugcefuroxime administration.
0.9985 We report the first case of Adverse-EffectIHA associated with cefuroxime administration.
Score Text
0.9993 The HIV protease inhibitor Drugindinavir may cause nephrolithiasis and interstitial nephritis.
0.9977 The HIV protease inhibitor indinavir may cause Adverse-Effectnephrolithiasis and interstitial nephritis.
0.9870 The HIV protease inhibitor indinavir may cause nephrolithiasis and Adverse-Effectinterstitial nephritis .
Score Text
0.9993 Physicians should be aware that Drugindinavir nephrolithiasis may cause papillary necrosis.
0.9847 Physicians should be aware that indinavir nephrolithiasis may cause Adverse-Effectpapillary necrosis .
0.8685 Physicians should be aware that indinavir Adverse-Effectnephrolithiasis may cause papillary necrosis.
Score Text
0.9994 DrugTenofovir - associated nephrotoxicity in two HIV - infected adolescent males.
0.9911 Tenofovir - associated Adverse-Effectnephrotoxicity in two HIV - infected adolescent males.
Score Text
0.9974 DrugCarbamazepine toxicity following Oxybutynin and Dantrolene administration : a case report.
0.9971 Carbamazepine toxicity following Oxybutynin and DrugDantrolene administration : a case report.
0.9964 Carbamazepine toxicity following DrugOxybutynin and Dantrolene administration : a case report.
0.8584 Adverse-EffectCarbamazepine toxicity following Oxybutynin and Dantrolene administration : a case report.
Score Text
0.9816 When co - trimoxazole was stopped the Adverse-Effectred cell aplasia resolved.
0.9576 When Drugco - trimoxazole was stopped the red cell aplasia resolved.
Score Text
0.9996 DrugGemcitabine - induced pericardial effusion and tamponade after unblocked cardiac irradiation.
0.9947 Gemcitabine - induced pericardial effusion and Adverse-Effecttamponade after unblocked cardiac irradiation.
0.9875 Gemcitabine - induced Adverse-Effectpericardial effusion and tamponade after unblocked cardiac irradiation.
Score Text
0.9995 DrugCytarabine - induced cerebellar syndrome : case report and literature review.
0.9931 Cytarabine - induced Adverse-Effectcerebellar syndrome : case report and literature review.
Score Text
0.9996 DrugGemcitabine - related radiation recall preferentially involves internal tissue and organs.
0.9917 Gemcitabine - related Adverse-Effectradiation recall preferentially involves internal tissue and organs.
Score Text
0.9988 Can Drugroxithromycin and betamethasone induce acute pancreatitis? A case report.
0.9987 Can roxithromycin and Drugbetamethasone induce acute pancreatitis? A case report.
0.9871 Can roxithromycin and betamethasone induce Adverse-Effectacute pancreatitis ? A case report.
Score Text
0.9996 We report a patient who developed acute pancreatitis during Drugamiodarone therapy.
0.9798 We report a patient who developed Adverse-Effectacute pancreatitis during amiodarone therapy.
Score Text
0.9996 This report describes a case of bilateral ptosis induced by Drugchloroquine .
0.9926 This report describes a case of Adverse-Effectbilateral ptosis induced by chloroquine.
Score Text
0.9995 DrugSorafenib induced tumor lysis syndrome in an advanced hepatocellular carcinoma patient.
0.9849 Sorafenib induced Adverse-Effecttumor lysis syndrome in an advanced hepatocellular carcinoma patient.
Score Text
0.9995 Toxic optic neuropathy associated with Drugethambutol : implications for current therapy.
0.9784 Adverse-EffectToxic optic neuropathy associated with ethambutol : implications for current therapy.
Score Text
0.9855 Adverse-EffectLeukaemoid monocytosis in M4 AML following chemotherapy and G - CSF.
0.9637 Leukaemoid monocytosis in M4 AML following chemotherapy and DrugG - CSF .
Score Text
0.9987 Heparin - dependent antibodies and thrombosis without Drugheparin - induced thrombocytopenia.
0.9972 Heparin - dependent antibodies and thrombosis without heparin - induced Adverse-Effectthrombocytopenia .
Score Text
0.9994 However, an association of DrugRitalin with glaucoma has been reported.
0.9941 However, an association of Ritalin with Adverse-Effectglaucoma has been reported.
Score Text
0.9994 Nonconvulsive status epilepticus : the role of Drugmorphine and its antagonist.
0.9779 Adverse-EffectNonconvulsive status epilepticus : the role of morphine and its antagonist.
Score Text
0.9994 A patient with severe cholestatic jaundice induced by Drugcaptopril is presented.
0.8981 A patient with Adverse-Effectsevere cholestatic jaundice induced by captopril is presented.
Score Text
0.9996 Interstitial pneumonitis associated with Drugsirolimus : a dilemma for lung transplantation.
0.9859 Adverse-EffectInterstitial pneumonitis associated with sirolimus : a dilemma for lung transplantation.
Score Text
0.9993 Complete remission of the nephrosis occurred after discontinuation of Drughydroxychloroquine therapy.
0.9965 Complete remission of the Adverse-Effectnephrosis occurred after discontinuation of hydroxychloroquine therapy.
Score Text
0.9980 DrugGold nephropathy : tissue analysis by X - ray fluorescent spectroscopy.
0.8440 Gold Adverse-Effectnephropathy : tissue analysis by X - ray fluorescent spectroscopy.
Score Text
0.9992 The role of DrugAdriamycin in the production of cardiotoxicity is reviewed.
0.9935 The role of Adriamycin in the production of Adverse-Effectcardiotoxicity is reviewed.
Score Text
0.9996 Hyponatremia in patients treated with Druglorcainide , a new antiarrhythmic drug.
0.9983 Adverse-EffectHyponatremia in patients treated with lorcainide, a new antiarrhythmic drug.
Score Text
0.9992 Spontaneous hemothorax following anticoagulation with low - molecular - weight Drugheparin .
0.9902 Adverse-EffectSpontaneous hemothorax following anticoagulation with low - molecular - weight heparin.
Score Text
0.9993 The psychotic behavior resolved completely soon after the discontinuation of Druglevetiracetam .
0.9901 The Adverse-Effectpsychotic behavior resolved completely soon after the discontinuation of levetiracetam.
Score Text
0.9779 DrugRetinoic acid may increase the risk of bone marrow transplant nephropathy.
0.9696 Retinoic acid may increase the risk of Adverse-Effectbone marrow transplant nephropathy .
Score Text
0.9993 The relationship between Druginfliximab treatment and lymphoma in Crohn's disease.
0.9960 The relationship between infliximab treatment and Adverse-Effectlymphoma in Crohn's disease.
Score Text
0.9992 Therefore, Drugamantadine was permanently discontinued and the cornea cleared again.
0.9978 Therefore, amantadine was permanently discontinued and the Adverse-Effectcornea cleared again.
Score Text
0.9996 This is the first reported case of hepatolithiasis during Drugoctreotide therapy.
0.9980 This is the first reported case of Adverse-Effecthepatolithiasis during octreotide therapy.
Score Text
0.9993 The literature search revealed 22 cases of hypersensitivity reaction to Drugcyclosporine .
0.9798 The literature search revealed 22 cases of Adverse-Effecthypersensitivity reaction to cyclosporine.
Score Text
0.9996 Seizure with hyponatremia in a child prescribed Drugdesmopressin for nocturnal enuresis.
0.9982 Adverse-EffectSeizure with hyponatremia in a child prescribed desmopressin for nocturnal enuresis.
0.9969 Seizure with Adverse-Effecthyponatremia in a child prescribed desmopressin for nocturnal enuresis.
Score Text
0.9959 Rebound hyperglycemia following overdosing of Druginsulin in cats with diabetes mellitus.
0.8976 Rebound Adverse-Effecthyperglycemia following overdosing of insulin in cats with diabetes mellitus.
Score Text
0.9994 Vocal cord paralysis as a consequence of peritonsillar infiltration with Drugbupivacaine .
0.9828 Adverse-EffectVocal cord paralysis as a consequence of peritonsillar infiltration with bupivacaine.
Score Text
0.9996 DrugGemcitabine - related radiation recall in a patient with pancreatic cancer.
0.9918 Gemcitabine - related Adverse-Effectradiation recall in a patient with pancreatic cancer.
Score Text
0.9993 DrugPropylthiouracil - induced sensorineural hearing loss associated with antineutrophil cytoplasmic antibodies.
0.9867 Propylthiouracil - induced Adverse-Effectsensorineural hearing loss associated with antineutrophil cytoplasmic antibodies.
0.9822 Propylthiouracil - induced sensorineural hearing loss associated with Adverse-Effectantineutrophil cytoplasmic antibodies .
Score Text
0.9981 Adverse-EffectHepatotoxicity associated with use of D - penicillamine in rheumatoid arthritis.
0.9623 Hepatotoxicity associated with use of DrugD - penicillamine in rheumatoid arthritis.
Score Text
0.9993 DrugMesalamine may cause hypersensitivity pneumonitis in patients with Crohn's disease.
0.9830 Mesalamine may cause Adverse-Effecthypersensitivity pneumonitis in patients with Crohn's disease.
Score Text
0.9991 However, Drugcyclosporine dependency is associated with the risk of nephrotoxicity.
0.9915 However, cyclosporine dependency is associated with the risk of Adverse-Effectnephrotoxicity .
Score Text
0.9996 DrugCapecitabine - induced multifocal leukoencephalopathy : a report of five cases.
0.9840 Capecitabine - induced Adverse-Effectmultifocal leukoencephalopathy : a report of five cases.
Score Text
0.9996 In the third child, the tics ceased after DrugCBZ discontinuation.
0.9983 In the third child, the Adverse-Effecttics ceased after CBZ discontinuation.
Score Text
0.9988 Can Drugketamine prescribed for pain cause damage to the urinary tract?
0.9651 Can ketamine prescribed for pain cause Adverse-Effectdamage to the urinary tract ?
Score Text
0.9996 There have been only two reports of Drugcimetidine - induced hepatitis.
0.9989 There have been only two reports of cimetidine - induced Adverse-Effecthepatitis .
Score Text
0.9816 Lower extremity arterial insufficiency after long - term Drugmethysergide maleate therapy.
Lower extremity Adverse-Effectarterial insufficiency after long - term methysergide maleate therapy.
Score Text
0.9926 Elevated serum triglycerides with Drugclozapine resolved with risperidone in four patients.
0.9643 Adverse-EffectElevated serum triglycerides with clozapine resolved with risperidone in four patients.
Score Text
0.9991 Ulcer became worse after Drugtobramycin and gentamycin treatment for 2 days.
0.9991 Ulcer became worse after tobramycin and Druggentamycin treatment for 2 days.
0.9794 Adverse-EffectUlcer became worse after tobramycin and gentamycin treatment for 2 days.
Score Text
0.9993 In some cases this seems to happen because Drugspironolactone causes diarrhoea.
0.9979 In some cases this seems to happen because spironolactone causes Adverse-Effectdiarrhoea .
Score Text
0.9985 Secondary hyperparathyroidism in certain patients with Druglithium nephrotoxicity is also possible.
0.8866 Secondary hyperparathyroidism in certain patients with lithium Adverse-Effectnephrotoxicity is also possible.
0.7906 Adverse-EffectSecondary hyperparathyroidism in certain patients with lithium nephrotoxicity is also possible.
Score Text
0.9996 There have been several reported cases of Drugomeprazole - induced AIN.
0.9976 There have been several reported cases of omeprazole - induced Adverse-EffectAIN .
Score Text
0.9816 Stroke - like syndrome after gold sodium thiomalate induced Adverse-Effectvasomotor reaction .
0.9798 Adverse-EffectStroke - like syndrome after gold sodium thiomalate induced vasomotor reaction.
0.9636 Stroke - like syndrome after Druggold sodium thiomalate induced vasomotor reaction.
Score Text
0.9993 Torsade de pointes represents a potential complication of chronic Drugamiodarone therapy.
0.9866 Adverse-EffectTorsade de pointes represents a potential complication of chronic amiodarone therapy.
Score Text
0.9995 Intraventricular Drugvancomycin - induced cerebrospinal fluid eosinophilia : report of two patients.
0.9819 Intraventricular vancomycin - induced Adverse-Effectcerebrospinal fluid eosinophilia : report of two patients.
Score Text
0.9983 The Drugampicillin rash occurring in cases of infectious mononucleosis is well documented.
0.9764 The Adverse-Effectampicillin rash occurring in cases of infectious mononucleosis is well documented.
Score Text
0.9989 We report an unusual pattern of supravenous hyperpigmentation occurring after DrugCHOP chemotherapy.
0.9854 We report an unusual pattern of Adverse-Effectsupravenous hyperpigmentation occurring after CHOP chemotherapy.
Score Text
0.9990 DrugHydroxyurea - induced acute interstitial pneumonitis in a patient with essential thrombocythemia.
0.9824 Hydroxyurea - induced Adverse-Effectacute interstitial pneumonitis in a patient with essential thrombocythemia.
Score Text
0.9995 Graft versus host - like illness in a child with Drugphenobarbital hypersensitivity.
0.9725 Adverse-EffectGraft versus host - like illness in a child with phenobarbital hypersensitivity.
0.8109 Graft versus host - like illness in a child with phenobarbital Adverse-Effecthypersensitivity .
Score Text
0.9988 Neutropenia and agranulocytosis are risks known to occur with Drugphenothiazines and clozapine.
0.9987 Neutropenia and agranulocytosis are risks known to occur with phenothiazines and Drugclozapine .
0.9975 Neutropenia and Adverse-Effectagranulocytosis are risks known to occur with phenothiazines and clozapine.
0.9971 Adverse-EffectNeutropenia and agranulocytosis are risks known to occur with phenothiazines and clozapine.
Score Text
0.9857 Adverse-EffectMilk - alkali syndrome induced by 1, 25 ( OH ) 2D in a patient with hypoparathyroidism.
0.9750 Milk - alkali syndrome induced by Drug1, 25 ( OH ) 2D in a patient with hypoparathyroidism.
Score Text
0.9996 DrugPregabalin - induced cortical negative myoclonus in a patient with neuropathic pain.
0.9841 Pregabalin - induced Adverse-Effectcortical negative myoclonus in a patient with neuropathic pain.
Score Text
0.9977 Arthritis and Adverse-Effectbursitis in multiple sclerosis patients treated with interferon - beta.
0.9923 Adverse-EffectArthritis and bursitis in multiple sclerosis patients treated with interferon - beta.
0.9682 Arthritis and bursitis in multiple sclerosis patients treated with Druginterferon - beta .
Score Text
0.9995 A 53 - year - old man developed NMS without rigidity while taking Drugolanzapine .
0.9981 A 53 - year - old man developed Adverse-EffectNMS without rigidity while taking olanzapine.
Score Text
0.9995 Accordingly, camptocormia is a dose - dependent side effect of Drugvalproate .
0.9982 Accordingly, Adverse-Effectcamptocormia is a dose - dependent side effect of valproate.
Score Text
0.9995 We report a patient who experienced LABD shortly after starting Drugcarbamazepine therapy.
0.9982 We report a patient who experienced Adverse-EffectLABD shortly after starting carbamazepine therapy.
Score Text
0.9995 DrugTiclopidine - induced aplastic anemia ( TIAA ) is considered very uncommon.
0.9918 Ticlopidine - induced Adverse-Effectaplastic anemia ( TIAA ) is considered very uncommon.
0.9889 Ticlopidine - induced aplastic anemia ( Adverse-EffectTIAA ) is considered very uncommon.
Score Text
0.9996 Dystonia associated with Drugcarbamazepine administration : experience in brain - damaged children.
0.9991 Adverse-EffectDystonia associated with carbamazepine administration : experience in brain - damaged children.
Score Text
0.9994 We report on a patient who developed acute rhabdomyolysis after taking Drugcerivastatin .
0.9745 We report on a patient who developed Adverse-Effectacute rhabdomyolysis after taking cerivastatin.
Score Text
0.9995 One patient with systemic lupus erythematosus developed erythema multiforme after taking Druggriseofulvin .
0.9920 One patient with systemic lupus erythematosus developed Adverse-Effecterythema multiforme after taking griseofulvin.
Score Text
0.9997 Listeria brain abscess, Pneumocystis pneumonia and Kaposi's sarcoma after Drugtemozolomide .
0.9836 Listeria brain abscess, Adverse-EffectPneumocystis pneumonia and Kaposi's sarcoma after temozolomide.
0.9797 Adverse-EffectListeria brain abscess , Pneumocystis pneumonia and Kaposi's sarcoma after temozolomide.
0.9777 Listeria brain abscess, Pneumocystis pneumonia and Adverse-EffectKaposi's sarcoma after temozolomide.
Score Text
0.9994 In these patients, long - acting Drugoctreotide may trigger serious hypoglycemia.
0.9868 In these patients, long - acting octreotide may trigger Adverse-Effectserious hypoglycemia .
Score Text
0.9994 DrugAlbuterol - induced hypokalemia and its potential cardiac toxicity are discussed briefly.
0.9978 Albuterol - induced Adverse-Effecthypokalemia and its potential cardiac toxicity are discussed briefly.
0.9842 Albuterol - induced hypokalemia and its potential Adverse-Effectcardiac toxicity are discussed briefly.
Score Text
0.9993 CONCLUSIONS : Infectious endophthalmitis is a potential complication of intravitreal Drugbevacizumab injection.
0.9784 CONCLUSIONS : Adverse-EffectInfectious endophthalmitis is a potential complication of intravitreal bevacizumab injection.
Score Text
0.9995 Heat stroke in schizophrenia during Drugclozapine treatment : rapid recognition and management.
0.9936 Adverse-EffectHeat stroke in schizophrenia during clozapine treatment : rapid recognition and management.
Score Text
0.9979 Cutaneous reactions to propylthiouracil and Drugmethimazole occur in 3 % - 5 % of adults.
0.9974 Cutaneous reactions to Drugpropylthiouracil and methimazole occur in 3 % - 5 % of adults.
0.9919 Adverse-EffectCutaneous reactions to propylthiouracil and methimazole occur in 3 % - 5 % of adults.
Score Text
0.9995 This report describes a probable case of Druginfliximab - induced membranous nephropathy.
0.9867 This report describes a probable case of infliximab - induced Adverse-Effectmembranous nephropathy .
Score Text
0.9995 DrugTemozolomide - induced desquamative skin rash in a patient with metastatic melanoma.
0.9873 Temozolomide - induced Adverse-Effectdesquamative skin rash in a patient with metastatic melanoma.
Score Text
0.9997 This represents the first report of nonconvulsive status epilepticus induced by Drugifosfamide .
0.9810 This represents the first report of Adverse-Effectnonconvulsive status epilepticus induced by ifosfamide.
Score Text
0.9996 We present a case of Drugsotalol - induced bradycardia reversed by glucagon.
0.9986 We present a case of sotalol - induced Adverse-Effectbradycardia reversed by glucagon.
Score Text
0.9993 Eye movement disorders in bone marrow transplant patients on cyclosporin and Drugganciclovir .
0.9992 Eye movement disorders in bone marrow transplant patients on Drugcyclosporin and ganciclovir.
0.9916 Adverse-EffectEye movement disorders in bone marrow transplant patients on cyclosporin and ganciclovir.
Score Text
0.9991 The photosensitivity is still present 3 years after the withdrawal of Drugquinine .
0.9969 The Adverse-Effectphotosensitivity is still present 3 years after the withdrawal of quinine.
Score Text
0.9960 The clinical picture was identical to that of Drugchloroquine and hydroxychloroquine maculopathy.
0.9959 The clinical picture was identical to that of chloroquine and Drughydroxychloroquine maculopathy.
0.9339 The clinical picture was identical to that of chloroquine and hydroxychloroquine Adverse-Effectmaculopathy .
Score Text
0.9994 Life - threatening interstitial lung disease associated with Drugtrastuzumab : case report.
0.9818 Life - threatening Adverse-Effectinterstitial lung disease associated with trastuzumab : case report.
Score Text
0.9992 Combining Drugmethylephedrine and Chinese herbal drugs might carry a risk of stroke.
0.9967 Combining methylephedrine and Chinese herbal drugs might carry a risk of Adverse-Effectstroke .
Score Text
0.9994 Physicians should be aware of the potentially lethal side effects of Drugdapsone .
0.9447 Physicians should be aware of the potentially Adverse-Effectlethal side effects of dapsone.
Score Text
0.9890 The use of pamidronate for hypercalcemia secondary to acute Drugvitamin D intoxication.
0.9001 The use of pamidronate for hypercalcemia secondary to acute Adverse-Effectvitamin D intoxication .
0.7411 The use of Drugpamidronate for hypercalcemia secondary to acute vitamin D intoxication.
0.6067 The use of pamidronate for Adverse-Effecthypercalcemia secondary to acute vitamin D intoxication.
Score Text
0.9986 Both patients suddenly became hypotensive after injection of Drugchymopapain into a disk.
0.9962 Both patients suddenly became Adverse-Effecthypotensive after injection of chymopapain into a disk.
Score Text
0.9995 PURPOSE : A case of probable Drugenoxaparin - induced hepatotoxicity is described.
0.9972 PURPOSE : A case of probable enoxaparin - induced Adverse-Effecthepatotoxicity is described.
Score Text
0.9994 DrugLithium - associated transient thyrotoxicosis in 4 Chinese women with autoimmune thyroiditis.
0.9711 Lithium - associated Adverse-Effecttransient thyrotoxicosis in 4 Chinese women with autoimmune thyroiditis.
Score Text
0.9995 The literature search found 12 cases of radiation recall caused by Druggemcitabine .
0.9910 The literature search found 12 cases of Adverse-Effectradiation recall caused by gemcitabine.
Score Text
0.9992 Two patients on long - term Druglithium therapy developed the nephrotic syndrome.
0.9946 Two patients on long - term lithium therapy developed the Adverse-Effectnephrotic syndrome .
Score Text
0.9994 Fulminant hepatic failure is a rare complication of Drugdisulfiram treatment for alcoholism.
0.9857 Adverse-EffectFulminant hepatic failure is a rare complication of disulfiram treatment for alcoholism.
Score Text
0.9992 Incidence of seizures in pediatric cancer patients treated with imipenem / Drugcilastatin .
0.9992 Incidence of seizures in pediatric cancer patients treated with Drugimipenem / cilastatin.
0.9986 Incidence of Adverse-Effectseizures in pediatric cancer patients treated with imipenem / cilastatin.
Score Text
0.9995 Incomplete posterior hyaloid detachment after intravitreal Drugpegaptanib injection in diabetic macular edema.
0.9669 Adverse-EffectIncomplete posterior hyaloid detachment after intravitreal pegaptanib injection in diabetic macular edema.
Score Text
0.9993 Severe corneal toxicity after topical Drugfluoroquinolone therapy : report of two cases.
0.9748 Adverse-EffectSevere corneal toxicity after topical fluoroquinolone therapy : report of two cases.
Score Text
0.9993 Tardive oculogyric crisis during treatment with Drugclozapine : report of three cases.
0.9869 Adverse-EffectTardive oculogyric crisis during treatment with clozapine : report of three cases.
Score Text
0.9990 Intravenous Drugvalproate associated with significant hypotension in the treatment of status epilepticus.
0.9978 Intravenous valproate associated with significant Adverse-Effecthypotension in the treatment of status epilepticus.
Score Text
0.9995 Anterior spinal artery syndrome - - a complication of cervical intrathecal Drugphenol injection.
0.9859 Adverse-EffectAnterior spinal artery syndrome - - a complication of cervical intrathecal phenol injection.
Score Text
0.9863 Adverse-EffectPericardial hemorrhage due to acetylsalicylic acid in a patient with essential thrombocythemia.
0.9811 Pericardial hemorrhage due to Drugacetylsalicylic acid in a patient with essential thrombocythemia.
Score Text
0.9994 He developed a late secondary infection in some sites treated with Drugimiquimod .
0.9837 He developed a late Adverse-Effectsecondary infection in some sites treated with imiquimod.
Score Text
0.9875 PURPOSE : To report a case of Adverse-Effectnodular scleritis following alendronate sodium.
0.9862 PURPOSE : To report a case of nodular scleritis following Drugalendronate sodium .
Score Text
0.9990 Toxic hepatitis due to combination therapy with methotrexate and Drugetretinate in psoriasis.
0.9989 Toxic hepatitis due to combination therapy with Drugmethotrexate and etretinate in psoriasis.
0.9899 Adverse-EffectToxic hepatitis due to combination therapy with methotrexate and etretinate in psoriasis.
Score Text
0.9994 DrugSuccinylcholine - induced hyperkalemia in a patient with mucositis secondary to chemotherapy.
0.9978 Succinylcholine - induced Adverse-Effecthyperkalemia in a patient with mucositis secondary to chemotherapy.
Score Text
0.9996 Nonsustained polymorphous ventricular tachycardia during Drugamiodarone therapy for atrial fibrillation complicating cardiomyopathy.
0.9637 Adverse-EffectNonsustained polymorphous ventricular tachycardia during amiodarone therapy for atrial fibrillation complicating cardiomyopathy.
Score Text
0.9870 CONCLUSIONS : Amphotericin B overdose can be Adverse-Effectfatal in children and infants.
0.9828 CONCLUSIONS : DrugAmphotericin B overdose can be fatal in children and infants.
Score Text
0.9993 Stupor and fast activity on electroencephalography in a child treated with Drugvalproate .
0.9990 Adverse-EffectStupor and fast activity on electroencephalography in a child treated with valproate.
Score Text
0.9991 Neurological side effects in two patients receiving Druggold injections for rheumatoid arthritis.
0.9784 Adverse-EffectNeurological side effects in two patients receiving gold injections for rheumatoid arthritis.
Score Text
0.9993 Increased libido in a woman treated with Drugfluvoxamine : a case report.
0.9887 Adverse-EffectIncreased libido in a woman treated with fluvoxamine : a case report.
Score Text
0.9994 Marked sinus tachycardia resulting from the synergistic effects of marijuana and Drugnortriptyline .
0.9818 Marked Adverse-Effectsinus tachycardia resulting from the synergistic effects of marijuana and nortriptyline.
Score Text
0.9987 The exophthalmos improved dramatically within 72 hours of the withdrawal of Druglithium .
0.9948 The Adverse-Effectexophthalmos improved dramatically within 72 hours of the withdrawal of lithium.
Score Text
0.9993 Hyperglycemia and diabetic coma : possible relationship to diuretic - Drugpropranolol therapy.
0.9970 Adverse-EffectHyperglycemia and diabetic coma : possible relationship to diuretic - propranolol therapy.
0.9882 Hyperglycemia and Adverse-Effectdiabetic coma : possible relationship to diuretic - propranolol therapy.
Score Text
0.9995 Disseminated cellulitic cryptococcosis in the setting of Drugprednisone monotherapy for pemphigus vulgaris.
0.9809 Adverse-EffectDisseminated cellulitic cryptococcosis in the setting of prednisone monotherapy for pemphigus vulgaris.
Score Text
0.9994 We describe a case of prolonged Drugterbinafine - induced cholestatic liver disease.
0.9877 We describe a case of prolonged terbinafine - induced Adverse-Effectcholestatic liver disease .
Score Text
0.9994 However, 1 eye had vitreous hemorrhage after repeated injections of DrugtPA .
0.9858 However, 1 eye had Adverse-Effectvitreous hemorrhage after repeated injections of tPA.
Score Text
0.9993 Stuttering priapism complicating Drugwarfarin therapy in a patient with protein C deficiency.
0.9897 Adverse-EffectStuttering priapism complicating warfarin therapy in a patient with protein C deficiency.
Score Text
0.9770 Delayed bowel injury is an infrequently observed complication of Drugchromic phosphate administration.
0.8997 Delayed Adverse-Effectbowel injury is an infrequently observed complication of chromic phosphate administration.
Score Text
0.9994 Malignant mixed mullerian tumor of the uterus in a patient taking Drugraloxifene .
0.9640 Adverse-EffectMalignant mixed mullerian tumor of the uterus in a patient taking raloxifene.
Score Text
0.9982 Drug5 - Fluorouracil cardiotoxicity complicating treatment of stage IIB cervical cancer - - case report.
0.9274 5 - Fluorouracil Adverse-Effectcardiotoxicity complicating treatment of stage IIB cervical cancer - - case report.
Score Text
0.9994 Physicians should be aware that PLP can occur after initiation of Drugpaclitaxel .
0.9975 Physicians should be aware that Adverse-EffectPLP can occur after initiation of paclitaxel.
Score Text
0.9996 Gynaecomastia is a rarely reported adverse drug reaction due to Drugisoniazid therapy.
0.9979 Adverse-EffectGynaecomastia is a rarely reported adverse drug reaction due to isoniazid therapy.
Score Text
0.9944 Autopsy findings were consistent with Drugbleomycin and oxygen - induced pulmonary damage.
0.9930 Autopsy findings were consistent with bleomycin and oxygen - induced Adverse-Effectpulmonary damage .
0.9535 Autopsy findings were consistent with bleomycin and Drugoxygen - induced pulmonary damage.
Score Text
0.9838 Adverse-EffectPolymyoclonus seizure resulting from accidental injection of tranexamic acid in spinal anesthesia.
0.9789 Polymyoclonus seizure resulting from accidental injection of Drugtranexamic acid in spinal anesthesia.
Score Text
0.9993 Pediatric Drugheparin - induced thrombocytopenia : management with Danaparoid ( orgaran ).
0.9967 Pediatric heparin - induced Adverse-Effectthrombocytopenia : management with Danaparoid ( orgaran ).
Score Text
0.9996 We report a case of sustained hypotension after administration of parenteral Drugverapamil .
0.9818 We report a case of Adverse-Effectsustained hypotension after administration of parenteral verapamil.
Score Text
0.9996 The clinical course suggests that the interstitial pneumonitis was induced by Drughydroxyurea .
0.9874 The clinical course suggests that the Adverse-Effectinterstitial pneumonitis was induced by hydroxyurea.
Score Text
0.9980 Drug5 - fluorouracil ( 5 - FU ) - associated peripheral neuropathy is an uncommon event.
0.9977 5 - fluorouracil ( Drug5 - FU ) - associated peripheral neuropathy is an uncommon event.
0.9893 5 - fluorouracil ( 5 - FU ) - associated Adverse-Effectperipheral neuropathy is an uncommon event.
Score Text
0.9965 Abdominal wall ulceration and Adverse-Effectmucinosis secondary to recombinant human interferon - beta - 1b.
0.9790 Adverse-EffectAbdominal wall ulceration and mucinosis secondary to recombinant human interferon - beta - 1b.
0.9426 Abdominal wall ulceration and mucinosis secondary to Drugrecombinant human interferon - beta - 1b .
Score Text
0.9847 Adverse-EffectToxic epidermal necrolysis after the use of high - dose cytosine arabinoside.
0.9708 Toxic epidermal necrolysis after the use of high - dose Drugcytosine arabinoside .
Score Text
0.9952 Symptomatic hypoglycemia secondary to a glipizide - trimethoprim / Drugsulfamethoxazole drug interaction.
0.9947 Symptomatic hypoglycemia secondary to a glipizide - Drugtrimethoprim / sulfamethoxazole drug interaction.
0.9944 Symptomatic hypoglycemia secondary to a Drugglipizide - trimethoprim / sulfamethoxazole drug interaction.
0.9795 Adverse-EffectSymptomatic hypoglycemia secondary to a glipizide - trimethoprim / sulfamethoxazole drug interaction.
Score Text
0.9995 Angio - oedema as an unusual tolerable side effect of Drugvoriconazole therapy.
0.9900 Adverse-EffectAngio - oedema as an unusual tolerable side effect of voriconazole therapy.
Score Text
0.9989 Life - threatening acute hyponatraemia induced by low dose cyclophosphamide and Drugindomethacin .
0.9988 Life - threatening acute hyponatraemia induced by low dose Drugcyclophosphamide and indomethacin.
0.9858 Life - threatening Adverse-Effectacute hyponatraemia induced by low dose cyclophosphamide and indomethacin.
Score Text
0.9995 The authors report five additional cases of Drugcapecitabine - induced multifocal leukoencephalopathy.
0.9860 The authors report five additional cases of capecitabine - induced Adverse-Effectmultifocal leukoencephalopathy .
Score Text
0.9663 Chlormadinone acetate Adverse-Effectwithdrawal syndrome under combined androgen blockade for advanced prostate cancer.
0.8715 DrugChlormadinone acetate withdrawal syndrome under combined androgen blockade for advanced prostate cancer.
Score Text
0.9996 Pulmonary fibrosis subsequent to high doses of DrugCCNU for chronic myeloid leukemia.
0.9913 Adverse-EffectPulmonary fibrosis subsequent to high doses of CCNU for chronic myeloid leukemia.
Score Text
0.9996 Three distinct types of Drugminocycline - induced cutaneous pigmentation have been described.
0.9916 Three distinct types of minocycline - induced Adverse-Effectcutaneous pigmentation have been described.
Score Text
0.9996 DrugDocetaxel - induced Meibomian duct inflammation and blockage leading to chalazion formation.
0.9954 Docetaxel - induced Meibomian duct inflammation and blockage leading to Adverse-Effectchalazion formation.
0.9589 Docetaxel - induced Adverse-EffectMeibomian duct inflammation and blockage leading to chalazion formation.
Score Text
0.9996 DrugAmikacin - induced type 5 Bartter - like syndrome with severe hypocalcemia.
0.9685 Amikacin - induced type 5 Bartter - like syndrome with Adverse-Effectsevere hypocalcemia .
0.9535 Amikacin - induced Adverse-Effecttype 5 Bartter - like syndrome with severe hypocalcemia.
Score Text
0.9992 Fatal outcome of intravesical Drugformalin instillation, with changes mimicking renal tuberculosis.
0.9784 Adverse-EffectFatal outcome of intravesical formalin instillation, with changes mimicking renal tuberculosis.
Score Text
0.9991 The use of Drugrituximab has been uncommonly associated with delayed pulmonary toxicity.
0.9724 The use of rituximab has been uncommonly associated with Adverse-Effectdelayed pulmonary toxicity .
Score Text
0.9975 Neuroleptic malignant syndrome in an adolescent receiving Drugolanzapine - lithium combination therapy.
0.9961 Neuroleptic malignant syndrome in an adolescent receiving olanzapine - Druglithium combination therapy.
0.9865 Adverse-EffectNeuroleptic malignant syndrome in an adolescent receiving olanzapine - lithium combination therapy.
Score Text
0.9995 CONCLUSION : Therapy with Drugindapamide may induce diabetes in essential hypertension patients.
0.9944 CONCLUSION : Therapy with indapamide may induce Adverse-Effectdiabetes in essential hypertension patients.
Score Text
0.9962 Adriamycin - induced Adverse-Effectcardiomyopathy aggravated by cis - platinum nephrotoxicity requiring dialysis.
0.8813 DrugAdriamycin - induced cardiomyopathy aggravated by cis - platinum nephrotoxicity requiring dialysis.
Adriamycin - induced cardiomyopathy aggravated by Drugcis - platinum nephrotoxicity requiring dialysis.
Adriamycin - induced cardiomyopathy aggravated by cis - platinum Adverse-Effectnephrotoxicity requiring dialysis.
Score Text
0.9994 Reversible MR imaging and MR spectroscopy abnormalities in association with Drugmetronidazole therapy.
0.9564 Adverse-EffectReversible MR imaging and MR spectroscopy abnormalities in association with metronidazole therapy.
Score Text
0.9993 CONCLUSIONS : DrugCefazolin was a probable cause of this patient's leukopenia.
0.9977 CONCLUSIONS : Cefazolin was a probable cause of this patient's Adverse-Effectleukopenia .
Score Text
0.9988 Evaluation revealed elevated serum DrugLTG levels and no other etiology for encephalopathy.
0.7162 Evaluation revealed Adverse-Effectelevated serum LTG levels and no other etiology for encephalopathy.
Score Text
0.9994 Three diabetic cases of acute dizziness due to initial administration of Drugvoglibose .
0.9865 Three diabetic cases of Adverse-Effectacute dizziness due to initial administration of voglibose.
Score Text
0.9992 Hemodialysis should be performed for rapid reversal of Drugmannitol - induced ARF.
0.9983 Hemodialysis should be performed for rapid reversal of mannitol - induced Adverse-EffectARF .
Score Text
0.9978 A 54 - year - old man, treated with Drugamiodarone , developed thyrotoxicosis.
0.9976 A 54 - year - old man, treated with amiodarone, developed Adverse-Effectthyrotoxicosis .
Score Text
0.9993 CONCLUSIONS : DrugMetoclopramide may cause reversible nonthrombocytopenic vascular - type palpable purpura.
0.9593 CONCLUSIONS : Metoclopramide may cause reversible Adverse-Effectnonthrombocytopenic vascular - type palpable purpura .
Score Text
0.9944 Fatal pulmonary fibrosis following 1, 3 - bis ( 2 - chloroethyl ) - 1 - nitrosourea ( DrugBCNU ) therapy.
0.9869 Adverse-EffectFatal pulmonary fibrosis following 1, 3 - bis ( 2 - chloroethyl ) - 1 - nitrosourea ( BCNU ) therapy.
Fatal pulmonary fibrosis following Drug1, 3 - bis ( 2 - chloroethyl ) - 1 - nitrosourea ( BCNU ) therapy.
Score Text
0.9995 This report presents a potential case of Drugrisperidone - induced tardive dyskinesia.
0.9907 This report presents a potential case of risperidone - induced Adverse-Effecttardive dyskinesia .
Score Text
0.9996 OBJECTIVE : To report a case of angioedema associated with Druglosartan administration.
0.9983 OBJECTIVE : To report a case of Adverse-Effectangioedema associated with losartan administration.
Score Text
0.9990 A patient developed optic neuropathy while being treated with isoniazid and Drugethambutol .
0.9989 A patient developed optic neuropathy while being treated with Drugisoniazid and ethambutol.
0.9898 A patient developed Adverse-Effectoptic neuropathy while being treated with isoniazid and ethambutol.
Score Text
0.9803 Adverse-EffectPeripheral nervous system disturbances caused by cytosine arabinoside have rarely been reported.
0.9779 Peripheral nervous system disturbances caused by Drugcytosine arabinoside have rarely been reported.
Score Text
0.9994 These cases demonstrate that DrugCBZ can induce simple motor tics in children.
0.9761 These cases demonstrate that CBZ can induce simple Adverse-Effectmotor tics in children.
Score Text
0.9824 CONCLUSION : Anterior ischemic optic neuropathy may complicate treatment with Druginterferon alfa .
0.9772 CONCLUSION : Adverse-EffectAnterior ischemic optic neuropathy may complicate treatment with interferon alfa.
Score Text
0.9995 Optic neuropathy associated with Drugpenicillamine therapy in a patient with rheumatoid arthritis.
0.9887 Adverse-EffectOptic neuropathy associated with penicillamine therapy in a patient with rheumatoid arthritis.
Score Text
0.9996 Diffuse alveolar hemorrhage after Drugleflunomide therapy in a patient with rheumatoid arthritis.
0.9820 Adverse-EffectDiffuse alveolar hemorrhage after leflunomide therapy in a patient with rheumatoid arthritis.
Score Text
0.9995 This is the first reported case of suspected DIAN due to Drugcefuroxime .
0.9961 This is the first reported case of suspected Adverse-EffectDIAN due to cefuroxime.
Score Text
0.9824 Generalized lichen nitidus with involvement of the palms following Druginterferon alpha treatment.
0.9820 Adverse-EffectGeneralized lichen nitidus with involvement of the palms following interferon alpha treatment.
Score Text
0.9996 High - grade endometrial stromal sarcoma after Drugtamoxifen therapy for breast cancer.
0.9635 Adverse-EffectHigh - grade endometrial stromal sarcoma after tamoxifen therapy for breast cancer.
Score Text
0.9812 Correction of serum electrolyte imbalance prevents cardiac arrhythmia during Drugamphotericin B administration.
0.9809 Correction of serum electrolyte imbalance prevents Adverse-Effectcardiac arrhythmia during amphotericin B administration.
Score Text
0.9991 Ophthalmologic and neurologic findings in two children exposed to Drugvigabatrin in utero.
0.9698 Adverse-EffectOphthalmologic and neurologic findings in two children exposed to vigabatrin in utero.
Score Text
0.9992 The exact mechanism of DrugIVIG - associated acute renal failure remains unclear.
0.9845 The exact mechanism of IVIG - associated Adverse-Effectacute renal failure remains unclear.
Score Text
0.9994 Due to the severity of the rash, Drugtemozolomide was permanently discontinued.
0.9967 Due to the severity of the Adverse-Effectrash , temozolomide was permanently discontinued.
Score Text
0.9956 Possible interaction between lopinavir / Drugritonavir and valproic Acid exacerbates bipolar disorder.
0.9923 Possible interaction between Druglopinavir / ritonavir and valproic Acid exacerbates bipolar disorder.
0.9823 Possible interaction between lopinavir / ritonavir and valproic Acid exacerbates Adverse-Effectbipolar disorder .
0.9792 Possible interaction between lopinavir / ritonavir and Drugvalproic Acid exacerbates bipolar disorder.
Score Text
0.9995 Retinal dysfunction and anterior segment deposits in a patient treated with Drugrifabutin .
0.9870 Adverse-EffectRetinal dysfunction and anterior segment deposits in a patient treated with rifabutin.
0.9821 Retinal dysfunction and Adverse-Effectanterior segment deposits in a patient treated with rifabutin.
Score Text
0.9995 We describe a case of EGE manifested as an allergy to Druggemfibrozil .
0.9978 We describe a case of Adverse-EffectEGE manifested as an allergy to gemfibrozil.
Score Text
0.9995 Myasthenic patients receiving Drugampicillin should be closely monitored for possible acute exacerbations.
0.9773 Myasthenic patients receiving ampicillin should be closely monitored for possible Adverse-Effectacute exacerbations .
Score Text
0.9971 Adverse-EffectHyperpigmentation during interferon - alpha therapy for chronic hepatitis C virus infection.
0.9692 Hyperpigmentation during Druginterferon - alpha therapy for chronic hepatitis C virus infection.
Score Text
0.9995 Primary cutaneous coccidioidomycosis and subsequent drug eruption to Drugitraconazole in a dog.
0.9883 Primary cutaneous coccidioidomycosis and subsequent Adverse-Effectdrug eruption to itraconazole in a dog.
0.9749 Adverse-EffectPrimary cutaneous coccidioidomycosis and subsequent drug eruption to itraconazole in a dog.
Score Text
0.9973 Adverse-EffectOtotoxicity as a result of cis - platinum administration is well documented.
0.9726 Ototoxicity as a result of Drugcis - platinum administration is well documented.
Score Text
0.9993 We report a case of pediatric Drugbupropion ingestion resulting in multiple seizures.
0.9872 We report a case of pediatric bupropion ingestion resulting in Adverse-Effectmultiple seizures .
Score Text
0.9929 Adverse-EffectNephrotic syndrome in a multiple sclerosis patient treated with interferon beta 1a.
0.9674 Nephrotic syndrome in a multiple sclerosis patient treated with Druginterferon beta 1a .
Score Text
0.9996 DrugAmifostine - induced fever : case report and review of the literature.
0.9958 Amifostine - induced Adverse-Effectfever : case report and review of the literature.
Score Text
0.9996 Fatal intravascular autoimmune hemolytic anemia after Drugfludarabine treatment for chronic lymphocytic leukemia.
0.9806 Adverse-EffectFatal intravascular autoimmune hemolytic anemia after fludarabine treatment for chronic lymphocytic leukemia.
Score Text
0.9996 We report three cases of patients who developed leukopenia during Drugolanzapine treatment.
0.9982 We report three cases of patients who developed Adverse-Effectleukopenia during olanzapine treatment.
Score Text
0.9982 He became hyperkalemic on rechallenge with Drugtimolol and normokalemic following its withdrawal.
0.9947 He became Adverse-Effecthyperkalemic on rechallenge with timolol and normokalemic following its withdrawal.
Score Text
0.9993 Serious adverse events experienced by patients with chronic heart failure taking Drugspironolactone .
0.9737 Adverse-EffectSerious adverse events experienced by patients with chronic heart failure taking spironolactone.
Score Text
0.9990 DrugAminoglutethimide was discontinued until completion of radiotherapy, and the rash resolved.
0.9961 Aminoglutethimide was discontinued until completion of radiotherapy, and the Adverse-Effectrash resolved.
Score Text
0.9995 DrugLeflunomide - induced toxic epidermal necrolysis in a patient with rheumatoid arthritis.
0.9860 Leflunomide - induced Adverse-Effecttoxic epidermal necrolysis in a patient with rheumatoid arthritis.
Score Text
0.9994 Abnormalities of the pupil and visual - evoked potential in Drugquinine amblyopia.
0.9622 Adverse-EffectAbnormalities of the pupil and visual - evoked potential in quinine amblyopia.
0.8662 Abnormalities of the pupil and visual - evoked potential in quinine Adverse-Effectamblyopia .
Score Text
0.9985 Acute myocardial ischemia following accidental intravenous administration of Drugepinephrine in high concentration.
0.9792 Adverse-EffectAcute myocardial ischemia following accidental intravenous administration of epinephrine in high concentration.
Score Text
0.9984 Hepato - biliary abnormalities secondary to Drugceftriaxone use : a case report.
0.9830 Adverse-EffectHepato - biliary abnormalities secondary to ceftriaxone use : a case report.
Score Text
0.9949 Metabolic acidosis induced by Drugcetrimide - chlorhexidine solution in hydatid cyst surgery.
0.9925 Metabolic acidosis induced by cetrimide - Drugchlorhexidine solution in hydatid cyst surgery.
0.9912 Adverse-EffectMetabolic acidosis induced by cetrimide - chlorhexidine solution in hydatid cyst surgery.
Score Text
0.9864 Adverse-EffectBone formation induced in an infant by systemic prostaglandin - E2 administration.
0.9588 Bone formation induced in an infant by systemic Drugprostaglandin - E2 administration.
Score Text
0.9996 DrugInfliximab - induced lupus in Crohn's disease : a case report.
0.9986 Infliximab - induced Adverse-Effectlupus in Crohn's disease : a case report.
Score Text
0.9980 Protamine allergy as a complication of Druginsulin hypersensitivity : A case report.
0.9916 Adverse-EffectProtamine allergy as a complication of insulin hypersensitivity : A case report.
Score Text
0.9992 Additionally, Drugdanazol produces hepatocellular damage in approximately 10 % of women.
0.9906 Additionally, danazol produces Adverse-Effecthepatocellular damage in approximately 10 % of women.
Score Text
0.9996 Thymic enlargement in a patient with juvenile idiopathic arthritis during Drugetanercept therapy.
0.9907 Adverse-EffectThymic enlargement in a patient with juvenile idiopathic arthritis during etanercept therapy.
Score Text
0.9996 Esophageal candidiasis was diagnosed at endoscopy in two patients receiving Drugomeprazole therapy.
0.9871 Adverse-EffectEsophageal candidiasis was diagnosed at endoscopy in two patients receiving omeprazole therapy.
Score Text
0.9995 Symptoms and endoscopic lesions quickly regressed within 1 week of Drugmeloxicam withdrawal.
0.9918 Symptoms and Adverse-Effectendoscopic lesions quickly regressed within 1 week of meloxicam withdrawal.
Score Text
0.9996 A 61 year - old male patient developed gynecomastia after starting Drugtheophylline .
0.9984 A 61 year - old male patient developed Adverse-Effectgynecomastia after starting theophylline.
Score Text
0.9972 Adverse-EffectPapilloedema and hepatic dysfunction apparently induced by perhexiline maleate ( Pexid ).
0.9963 Papilloedema and hepatic dysfunction apparently induced by perhexiline maleate ( DrugPexid ).
0.9888 Papilloedema and Adverse-Effecthepatic dysfunction apparently induced by perhexiline maleate ( Pexid ).
0.9852 Papilloedema and hepatic dysfunction apparently induced by Drugperhexiline maleate ( Pexid ).
Score Text
0.9994 Managing cardiovascular collapse in severe Drugflecainide overdose without recourse to extracorporeal therapy.
0.9861 Managing Adverse-Effectcardiovascular collapse in severe flecainide overdose without recourse to extracorporeal therapy.
Score Text
0.9990 These nail changes gradually disappeared when the dose of Drugclofazimine was reduced.
0.9882 These Adverse-Effectnail changes gradually disappeared when the dose of clofazimine was reduced.
Score Text
0.9995 Reflex sympathetic dystrophy syndrome in renal transplanted patients under immunosuppression with Drugtacrolimus .
0.9811 Adverse-EffectReflex sympathetic dystrophy syndrome in renal transplanted patients under immunosuppression with tacrolimus.
Score Text
0.9995 CONCLUSION : Severe and sustained ocular hypertension may occur after intravitreal Drugranibizumab .
0.9706 CONCLUSION : Severe and Adverse-Effectsustained ocular hypertension may occur after intravitreal ranibizumab.
Score Text
0.9992 DrugOxcarbazepine - induced Drug Reaction with Eosinophilia and Systemic Symptoms ( DRESS ).
0.9904 Oxcarbazepine - induced Drug Reaction with Eosinophilia and Systemic Symptoms ( Adverse-EffectDRESS ).
0.8632 Oxcarbazepine - induced Adverse-EffectDrug Reaction with Eosinophilia and Systemic Symptoms ( DRESS ).
Oxcarbazepine - induced Adverse-EffectDrug Reaction with Eosinophilia and Systemic Symptoms ( DRESS ).
Score Text
0.9979 Serotonin syndrome induced by transitioning from Drugphenelzine to venlafaxine : four patient reports.
0.9979 Serotonin syndrome induced by transitioning from phenelzine to Drugvenlafaxine : four patient reports.
0.9943 Adverse-EffectSerotonin syndrome induced by transitioning from phenelzine to venlafaxine : four patient reports.
Score Text
0.9995 Radiation recall related to Druggemcitabine has been reported in lung and breast cancer.
0.9908 Adverse-EffectRadiation recall related to gemcitabine has been reported in lung and breast cancer.
Score Text
0.9993 DrugHeparin - induced thrombocytopenia is a rare and serious complication of anticoagulation therapy.
0.9968 Heparin - induced Adverse-Effectthrombocytopenia is a rare and serious complication of anticoagulation therapy.
Score Text
0.9974 A patient developed Adverse-Effectpapilloedema and hepatic dysfunction while being treated with perhexiline maleate.
0.9883 A patient developed papilloedema and Adverse-Effecthepatic dysfunction while being treated with perhexiline maleate.
0.9815 A patient developed papilloedema and hepatic dysfunction while being treated with Drugperhexiline maleate .
Score Text
0.9866 Adverse-EffectRestless legs syndrome may thus be an adverse effect of IFN alpha treatment.
0.9825 Restless legs syndrome may thus be an adverse effect of DrugIFN alpha treatment.
Score Text
0.9991 The responsibility of DrugCCNU in the pathogenesis of pulmonary fibrosis seems very likely.
0.9539 The responsibility of CCNU in the pathogenesis of Adverse-Effectpulmonary fibrosis seems very likely.
Score Text
0.9705 Indolent aspergillus arthritis complicating Drugfludarabine - based non - myeloablative stem cell transplantation.
0.8868 Indolent Adverse-Effectaspergillus arthritis complicating fludarabine - based non - myeloablative stem cell transplantation.
Score Text
0.9990 This report suggests that Drugbleomycin lung toxicity may be reversible if treated aggressively.
0.9037 This report suggests that bleomycin Adverse-Effectlung toxicity may be reversible if treated aggressively.
Score Text
0.9988 Three days after intravitreal injection of Drugbevacizumab , acute ocular ischemic syndrome occurred.
0.9856 Three days after intravitreal injection of bevacizumab, Adverse-Effectacute ocular ischemic syndrome occurred.
Score Text
0.9995 PURPOSE : To report two cases of acute endophthalmitis following intravitreal Drugbevacizumab injection.
0.9798 PURPOSE : To report two cases of Adverse-Effectacute endophthalmitis following intravitreal bevacizumab injection.
Score Text
0.9984 CONCLUSIONS : Amphotericin B seems to be the probable cause of the Adverse-Effectseizures .
0.9789 CONCLUSIONS : DrugAmphotericin B seems to be the probable cause of the seizures.
Score Text
0.9810 Adverse-EffectAcute myocardial infarction due to coronary spasm associated with L - thyroxine therapy.
0.9728 Acute myocardial infarction due to Adverse-Effectcoronary spasm associated with L - thyroxine therapy.
0.9665 Acute myocardial infarction due to coronary spasm associated with DrugL - thyroxine therapy.
Score Text
0.9962 Adverse-EffectHepatotoxicity of paracetamol enhanced by ingestion of alcohol : report of two cases.
0.9957 Hepatotoxicity of Drugparacetamol enhanced by ingestion of alcohol : report of two cases.
Score Text
0.9976 Early overanticoagulation with Drugacenocoumarol due to a genetic polymorphism of cytochrome P450 CYP2C9.
0.9695 Early Adverse-Effectoveranticoagulation with acenocoumarol due to a genetic polymorphism of cytochrome P450 CYP2C9.
Score Text
0.9994 Acute pancreatitis is a known, although rare, complication of Drugmesalamine treatment.
0.9247 Adverse-EffectAcute pancreatitis is a known, although rare, complication of mesalamine treatment.
Score Text
0.9996 DISCUSSION : The occurrence of priapism in our patient was related to Drugzuclopenthixol .
0.9978 DISCUSSION : The occurrence of Adverse-Effectpriapism in our patient was related to zuclopenthixol.
Score Text
0.9824 Neurointensive care management of raised intracranial pressure caused by severe Drugvalproic acid intoxication.
0.9816 Neurointensive care management of Adverse-Effectraised intracranial pressure caused by severe valproic acid intoxication.
Score Text
0.9992 A case of normotensive scleroderma renal crisis after high - dose Drugmethylprednisolone treatment.
0.9752 A case of Adverse-Effectnormotensive scleroderma renal crisis after high - dose methylprednisolone treatment.
Score Text
0.9976 Adverse-EffectRhabdomyolysis has been recognized as a complication of tocolytic therapy with ritodrine hydrochloride.
0.9769 Rhabdomyolysis has been recognized as a complication of tocolytic therapy with Drugritodrine hydrochloride .
Score Text
0.9995 DrugIbuprofen - induced meningitis : detection of intrathecal IgG synthesis and immune complexes.
0.9989 Ibuprofen - induced Adverse-Effectmeningitis : detection of intrathecal IgG synthesis and immune complexes.
Score Text
0.9995 Transtentorial herniation caused by an intracranial mass lesion following high - dose Drugmethotrexate .
0.9864 Adverse-EffectTranstentorial herniation caused by an intracranial mass lesion following high - dose methotrexate.
0.9818 Transtentorial herniation caused by an Adverse-Effectintracranial mass lesion following high - dose methotrexate.
Score Text
0.9993 Neuroleptic malignant syndrome due to Drugrisperidone treatment in a child with Joubert syndrome.
0.9856 Adverse-EffectNeuroleptic malignant syndrome due to risperidone treatment in a child with Joubert syndrome.
Score Text
0.9900 Adverse-EffectSkin necrosis after extravasation of low - dose vasopressin administered for septic shock.
0.8688 Skin necrosis after extravasation of low - dose Drugvasopressin administered for septic shock.
Score Text
0.9993 Histological examination of the dacryolith suggested its derivation from breakdown products of Drugadrenaline .
0.9945 Histological examination of the Adverse-Effectdacryolith suggested its derivation from breakdown products of adrenaline.
Score Text
0.9626 DrugItraconazole - related increased vincristine neurotoxicity : case report and review of literature.
0.8687 Itraconazole - related increased Drugvincristine neurotoxicity : case report and review of literature.
0.8702 Itraconazole - related increased vincristine Adverse-Effectneurotoxicity : case report and review of literature.
Itraconazole - related increased Adverse-Effectvincristine neurotoxicity : case report and review of literature.
Score Text
0.9979 Para - aminosalicylic acid - induced Adverse-Effecthypoglycaemia in a patient with diabetic nephropathy.
0.9576 DrugPara - aminosalicylic acid - induced hypoglycaemia in a patient with diabetic nephropathy.
Score Text
0.9979 Prolonged severe Drug5 - fluorouracil - associated neurotoxicity in a patient with dihydropyrimidine dehydrogenase deficiency.
0.9963 Prolonged severe 5 - fluorouracil - associated Adverse-Effectneurotoxicity in a patient with dihydropyrimidine dehydrogenase deficiency.
Score Text
0.9995 BACKGROUND : reports on delated cutaneous reactions to Drugcaptopril have been seldom reported.
0.9817 BACKGROUND : reports on Adverse-Effectdelated cutaneous reactions to captopril have been seldom reported.
Score Text
0.9993 Severe leukopenia associated with mild hepatotoxicity in an HIV carrier treated with Drugnevirapine .
0.9527 Severe leukopenia associated with Adverse-Effectmild hepatotoxicity in an HIV carrier treated with nevirapine.
0.9097 Adverse-EffectSevere leukopenia associated with mild hepatotoxicity in an HIV carrier treated with nevirapine.
Score Text
0.9986 Adverse reaction in a patient with Drugaspirin - induced asthma treated with zafirlukast.
0.9953 Adverse reaction in a patient with aspirin - induced Adverse-Effectasthma treated with zafirlukast.
Score Text
0.9992 Fatal complication of intravesical Drugformalin during control of intractable hemorrhage from radiation cystitis.
0.9836 Adverse-EffectFatal complication of intravesical formalin during control of intractable hemorrhage from radiation cystitis.
Score Text
0.9993 Cerebral infarcts in a pediatric patient secondary to Drugphenylpropanolamine , a recalled medication.
0.9908 Adverse-EffectCerebral infarcts in a pediatric patient secondary to phenylpropanolamine, a recalled medication.
Score Text
0.9995 A 45 - year - old woman with thyrotoxicosis developed agranulocytosis after treatment with Drugpropylthiouracil .
0.9984 A 45 - year - old woman with thyrotoxicosis developed Adverse-Effectagranulocytosis after treatment with propylthiouracil.
Score Text
0.9995 Fatal interstitial lung disease after Drugerlotinib administration in a patient with radiation fibrosis.
0.9839 Adverse-EffectFatal interstitial lung disease after erlotinib administration in a patient with radiation fibrosis.
Score Text
0.9941 Acute renal failure following intravenous Drugimmunoglobulin therapy in a HIV - infected patient.
0.9768 Adverse-EffectAcute renal failure following intravenous immunoglobulin therapy in a HIV - infected patient.
Score Text
0.9995 Restless legs syndrome and periodic limb movements during sleep probably associated with Drugolanzapine .
0.9892 Adverse-EffectRestless legs syndrome and periodic limb movements during sleep probably associated with olanzapine.
0.9815 Restless legs syndrome and Adverse-Effectperiodic limb movements during sleep probably associated with olanzapine.
Score Text
0.9983 Adverse-EffectPancytopenia associated with 5 - aminosalicylic acid use in a patient with Crohn's disease.
0.9754 Pancytopenia associated with Drug5 - aminosalicylic acid use in a patient with Crohn's disease.
Score Text
0.9995 The authors report the first case of Drugbucillamine - induced giant mammary hyperplasia.
0.9832 The authors report the first case of bucillamine - induced Adverse-Effectgiant mammary hyperplasia .
Score Text
0.9995 Acute myeloid leukemia evolving from essential thrombocythemia in two patients treated with Drughydroxyurea .
0.9790 Adverse-EffectAcute myeloid leukemia evolving from essential thrombocythemia in two patients treated with hydroxyurea.
Score Text
0.9995 There is no consensus on the treatment of Drugticlopidine - induced marrow aplasia.
0.9942 There is no consensus on the treatment of ticlopidine - induced Adverse-Effectmarrow aplasia .
Score Text
0.9996 DrugRisperidone - induced psychosis and depression in a child with a mitochondrial disorder.
0.9989 Risperidone - induced Adverse-Effectpsychosis and depression in a child with a mitochondrial disorder.
0.9819 Risperidone - induced psychosis and Adverse-Effectdepression in a child with a mitochondrial disorder.
Score Text
0.9996 Stevens - Johnson syndrome in a boy with nephrotic syndrome during Drugprednisolone therapy.
0.9855 Adverse-EffectStevens - Johnson syndrome in a boy with nephrotic syndrome during prednisolone therapy.
Score Text
0.9961 Acyclovir - induced Adverse-Effectneurotoxicity : concentration - side effect relationship in acyclovir overdose.
0.9915 DrugAcyclovir - induced neurotoxicity : concentration - side effect relationship in acyclovir overdose.
Score Text
0.9992 CONCLUSION : DrugAlendronate led to nodular scleritis and rechallenge caused recurrence of scleritis.
0.9935 CONCLUSION : Alendronate led to nodular scleritis and rechallenge caused recurrence of Adverse-Effectscleritis .
0.9839 CONCLUSION : Alendronate led to Adverse-Effectnodular scleritis and rechallenge caused recurrence of scleritis.
Score Text
0.9990 Deposits of plasma proteins in the skin during treatment with Drugcarbamazepine and diphenylhydantoin.
0.9989 Deposits of plasma proteins in the skin during treatment with carbamazepine and Drugdiphenylhydantoin .
0.9728 Adverse-EffectDeposits of plasma proteins in the skin during treatment with carbamazepine and diphenylhydantoin.
Score Text
0.9968 L - asparaginase - provoked Adverse-Effectseizures as singular expression of central nervous toxicity.
0.9772 L - asparaginase - provoked seizures as singular expression of Adverse-Effectcentral nervous toxicity .
0.9667 DrugL - asparaginase - provoked seizures as singular expression of central nervous toxicity.
Score Text
0.9994 Provocation of non - convulsive status epilepticus by Drugtiagabine in three adolescent patients.
0.9728 Provocation of Adverse-Effectnon - convulsive status epilepticus by tiagabine in three adolescent patients.
Score Text
0.9995 Nineteen cases of allergic contact dermatitis to compound tincture of Drugbenzoin are described.
0.9797 Nineteen cases of Adverse-Effectallergic contact dermatitis to compound tincture of benzoin are described.
Score Text
0.9993 This case extends the spectrum of Drugfludarabine pulmonary toxicity to include pulmonary nodules.
0.9856 This case extends the spectrum of fludarabine pulmonary toxicity to include Adverse-Effectpulmonary nodules .
0.6529 This case extends the spectrum of fludarabine Adverse-Effectpulmonary toxicity to include pulmonary nodules.
Score Text
0.9995 A case of oculogyric crisis induced by Drugmetoclopramide is described in this paper.
0.9915 A case of Adverse-Effectoculogyric crisis induced by metoclopramide is described in this paper.
Score Text
0.9736 Clostridium difficile toxin - induced colitis after use of Drugclindamycin phosphate vaginal cream.
0.5032 Adverse-EffectClostridium difficile toxin - induced colitis after use of clindamycin phosphate vaginal cream.
0.6029 Clostridium difficile toxin - induced Adverse-Effectcolitis after use of clindamycin phosphate vaginal cream.
Score Text
0.9994 CASE SUMMARIES : Two patients who received Drugifosfamide - containing chemotherapy developed NCSE.
0.9987 CASE SUMMARIES : Two patients who received ifosfamide - containing chemotherapy developed Adverse-EffectNCSE .
Score Text
0.9996 The authors describe a case of the catatonia syndrome associated with Drugdisulfiram therapy.
0.9944 The authors describe a case of the Adverse-Effectcatatonia syndrome associated with disulfiram therapy.
Score Text
0.9992 Prolonged prostate - specific antigen response in Drugflutamide withdrawal syndrome despite disease progression.
0.9072 Adverse-EffectProlonged prostate - specific antigen response in flutamide withdrawal syndrome despite disease progression.
Prolonged prostate - specific antigen response in Adverse-Effectflutamide withdrawal syndrome despite disease progression.
Score Text
0.9859 Anticonvulsant hypersensitivity syndrome associated with DrugBellamine S , a therapy for menopausal symptoms.
0.9813 Adverse-EffectAnticonvulsant hypersensitivity syndrome associated with Bellamine S, a therapy for menopausal symptoms.
Score Text
0.9964 Two weeks following rechallenge with alendronate sodium resulted in recurrence of his Adverse-Effectscleritis .
0.9857 Two weeks following rechallenge with Drugalendronate sodium resulted in recurrence of his scleritis.
Score Text
0.9995 One patient developed large intramural esophageal hematoma as a complication of Drugheparin therapy.
0.9790 One patient developed Adverse-Effectlarge intramural esophageal hematoma as a complication of heparin therapy.
Score Text
0.9987 The patient was diagnosed with Drugcarbamazepine toxicity related to the introduction of ritonavir.
0.9987 The patient was diagnosed with carbamazepine toxicity related to the introduction of Drugritonavir .
0.8788 The patient was diagnosed with Adverse-Effectcarbamazepine toxicity related to the introduction of ritonavir.
Score Text
0.9833 L - asparaginase - induced Adverse-Effectsevere necrotizing pancreatitis successfully treated with percutaneous drainage.
0.9687 DrugL - asparaginase - induced severe necrotizing pancreatitis successfully treated with percutaneous drainage.
Score Text
0.9995 We present a case of a sustained monomorphic ventricular tachycardia following Drugadenosine infusion.
0.9826 We present a case of a Adverse-Effectsustained monomorphic ventricular tachycardia following adenosine infusion.
Score Text
0.9996 Tremor : a newly described adverse event with long - term Drugitraconazole therapy.
0.9991 Adverse-EffectTremor : a newly described adverse event with long - term itraconazole therapy.
Score Text
0.9899 We report 2 patients who developed Adverse-Effectpolyarteritis nodosa following vaccination against hepatitis B.
0.9580 We report 2 patients who developed polyarteritis nodosa following Drugvaccination against hepatitis B .
Score Text
0.9985 Three patients receiving Druggold salt treatment for rheumatoid arthritis developed severe aplastic anemia.
0.9692 Three patients receiving gold salt treatment for rheumatoid arthritis developed severe Adverse-Effectaplastic anemia .
Score Text
0.9993 Hemorrhage from a falx meningioma after internal use of low - dose Drugaspirin .
0.9985 Adverse-EffectHemorrhage from a falx meningioma after internal use of low - dose aspirin.
Score Text
0.9994 DrugTemozolomide was restarted 2 months later ; the patient again developed a fever.
0.9979 Temozolomide was restarted 2 months later ; the patient again developed a Adverse-Effectfever .
Score Text
0.9994 Renal injury due to Druganastrozole has not been published in the English literature.
0.9938 Adverse-EffectRenal injury due to anastrozole has not been published in the English literature.
Score Text
0.9996 Mechanism of Drugtopiramate - induced acute - onset myopia and angle closure glaucoma.
0.9799 Mechanism of topiramate - induced acute - onset myopia and Adverse-Effectangle closure glaucoma .
0.9686 Mechanism of topiramate - induced Adverse-Effectacute - onset myopia and angle closure glaucoma.
Score Text
0.9991 There is a putative role of Drugliothyronine administration in precipitating or activating hyperthyroidism.
0.9928 There is a putative role of liothyronine administration in precipitating or activating Adverse-Effecthyperthyroidism .
Score Text
0.9991 She was treated with Drugacyclovir and subsequently developed VZV antigen - positive zoster.
0.9838 She was treated with acyclovir and subsequently developed Adverse-EffectVZV antigen - positive zoster .
Score Text
0.9993 Clostridium difficile colitis associated with Drugcisplatin - based chemotherapy in ovarian cancer patients.
0.9839 Adverse-EffectClostridium difficile colitis associated with cisplatin - based chemotherapy in ovarian cancer patients.
Score Text
0.9995 Polysomnographic and pharmacokinetic findings in Druglevodopa - induced augmentation of restless legs syndrome.
0.9077 Polysomnographic and pharmacokinetic findings in levodopa - induced augmentation of Adverse-Effectrestless legs syndrome .
Score Text
0.9995 Pemphigus foliaceus was seen in a patient with pulmonary tuberculosis during Drugrifampicin therapy.
0.9849 Adverse-EffectPemphigus foliaceus was seen in a patient with pulmonary tuberculosis during rifampicin therapy.
Score Text
0.9988 CONCLUSIONS : Intrathecal Drugbaclofen can impair sexual function and ejaculation in some patients.
0.9588 CONCLUSIONS : Intrathecal baclofen can Adverse-Effectimpair sexual function and ejaculation in some patients.
Score Text
0.9994 Acute renal failure should be recognized as a potential complication of Drugsuramin treatment.
0.9517 Acute Adverse-Effectrenal failure should be recognized as a potential complication of suramin treatment.
Score Text
0.9996 Lower extremity arterial thrombosis following sonographically guided Drugthrombin injection of a femoral pseudoaneurysm.
Lower extremity Adverse-Effectarterial thrombosis following sonographically guided thrombin injection of a femoral pseudoaneurysm.
Score Text
0.9995 EEG abnormalities were observed in two of the nine children during Drugchlorambucil therapy.
0.9901 Adverse-EffectEEG abnormalities were observed in two of the nine children during chlorambucil therapy.
Score Text
0.9993 Schneiderian first - rank symptoms associated with Drugfluvoxamine treatment : a case report.
0.9782 Adverse-EffectSchneiderian first - rank symptoms associated with fluvoxamine treatment : a case report.
Score Text
0.9813 Progression of chronic myeloid leukemia to Adverse-Effectblast crisis during treatment with imatinib mesylate.
0.9654 Progression of chronic myeloid leukemia to blast crisis during treatment with Drugimatinib mesylate .
Score Text
0.9996 Anaphylaxis from Drugisoniazid is a possible side effect to this commonly prescribed antibiotic.
0.9987 Adverse-EffectAnaphylaxis from isoniazid is a possible side effect to this commonly prescribed antibiotic.
Score Text
0.9985 Differential diagnoses included ocular rosacea with cicatrizing conjunctivitis and Drug5 - FU - induced ectropion.
0.9980 Differential diagnoses included ocular rosacea with cicatrizing conjunctivitis and 5 - FU - induced Adverse-Effectectropion .
Score Text
0.9956 We report a case of Drugbaclofen withdrawal syndrome resulting from oral baclofen underdosing.
0.9930 We report a case of baclofen withdrawal syndrome resulting from oral Drugbaclofen underdosing.
0.9734 We report a case of baclofen Adverse-Effectwithdrawal syndrome resulting from oral baclofen underdosing.
Score Text
0.9994 Reversible posterior leukoencephalopathy syndrome in systemic lupus erythematosus with thrombocytopenia treated with Drugcyclosporine .
0.9727 Adverse-EffectReversible posterior leukoencephalopathy syndrome in systemic lupus erythematosus with thrombocytopenia treated with cyclosporine.
Score Text
0.9992 A MEDLINE search identified all the reported cases of hypersensitivity reactions to Drugcyclosporine .
0.9809 A MEDLINE search identified all the reported cases of Adverse-Effecthypersensitivity reactions to cyclosporine.
Score Text
0.9995 The mechanism of RTA induced by DrugFK506 has not yet been clearly elucidated.
0.9951 The mechanism of Adverse-EffectRTA induced by FK506 has not yet been clearly elucidated.
Score Text
0.9995 DrugMethysergide - induced retroperitoneal fibrosis : successful outcome and two new laboratory features.
0.9888 Methysergide - induced Adverse-Effectretroperitoneal fibrosis : successful outcome and two new laboratory features.
Score Text
0.9995 Two renal transplant patients developed anemia during treatment of hypertension with Drugenalapril medication.
0.9976 Two renal transplant patients developed Adverse-Effectanemia during treatment of hypertension with enalapril medication.
Score Text
0.9994 Thus, the eosinophilia myalgia syndrome can be associated with parenteral Drugtryptophan administration.
0.9868 Thus, the Adverse-Effecteosinophilia myalgia syndrome can be associated with parenteral tryptophan administration.
Score Text
0.9923 When measured, the serum lithium level had increased 4 - fold during Drugacyclovir therapy.
0.8116 When measured, the serum Druglithium level had increased 4 - fold during acyclovir therapy.
When measured, the Adverse-Effectserum lithium level had increased 4 - fold during acyclovir therapy.
Score Text
0.9996 We report a case of papillary necrosis in a patient treated with Drugindinavir .
0.9905 We report a case of Adverse-Effectpapillary necrosis in a patient treated with indinavir.
Score Text
0.9995 DrugFluoxetine - related death in a child with cytochrome P - 450 2D6 genetic deficiency.
0.9897 Fluoxetine - related Adverse-Effectdeath in a child with cytochrome P - 450 2D6 genetic deficiency.
Score Text
0.9995 Visual loss after a single small dose of Drugvincristine has never been reported.
0.9953 Adverse-EffectVisual loss after a single small dose of vincristine has never been reported.
Score Text
0.9989 Laryngeal dyspnea in relation to an interaction between Drugacenocoumarol and topical econazole lotion.
0.9988 Laryngeal dyspnea in relation to an interaction between acenocoumarol and topical Drugeconazole lotion.
0.9901 Adverse-EffectLaryngeal dyspnea in relation to an interaction between acenocoumarol and topical econazole lotion.
Score Text
0.9992 PURPOSE : To report that acute Druglamotrigine poisoning may result in severe encephalopathy.
0.6888 PURPOSE : To report that acute lamotrigine poisoning may result in severe Adverse-Effectencephalopathy .
Score Text
0.9995 RESULTS : Extensive squamous metaplasia was found in endometrial glands following Drugprogestin therapy.
0.9392 RESULTS : Extensive Adverse-Effectsquamous metaplasia was found in endometrial glands following progestin therapy.
Score Text
0.9967 They continued to rise for five more days before Drugsalicylate hepatotoxicity was suspected.
0.9201 They continued to rise for five more days before salicylate Adverse-Effecthepatotoxicity was suspected.
Score Text
0.9996 OBJECTIVE : To describe a patient with Drugifosfamide - induced nonconvulsive status epilepticus.
0.9861 OBJECTIVE : To describe a patient with ifosfamide - induced Adverse-Effectnonconvulsive status epilepticus .
Score Text
0.9986 After four months, while receiving DrugRH , he developed painful bilateral gynaecomastia.
0.9737 After four months, while receiving RH, he developed painful Adverse-Effectbilateral gynaecomastia .
Score Text
0.9995 Five cases of Drugclindamycin - associated pseudomembranous colitis in leukaemic patients are reported.
0.9915 Five cases of clindamycin - associated Adverse-Effectpseudomembranous colitis in leukaemic patients are reported.
Score Text
0.9909 Trimethoprim - sulfamethoxazole - induced Adverse-Effecthypersensitivity syndrome associated with reactivation of human herpesvirus - 6.
0.8872 DrugTrimethoprim - sulfamethoxazole - induced hypersensitivity syndrome associated with reactivation of human herpesvirus - 6.
Score Text
0.9994 However, several case reports have suggested that Drugclozapine could also cause TD.
0.9962 However, several case reports have suggested that clozapine could also cause Adverse-EffectTD .
Score Text
0.9974 Atrial fibrillation occurring in a patient taking etanercept plus Drugmethotrexate for rheumatoid arthritis.
0.9965 Atrial fibrillation occurring in a patient taking Drugetanercept plus methotrexate for rheumatoid arthritis.
0.9923 Adverse-EffectAtrial fibrillation occurring in a patient taking etanercept plus methotrexate for rheumatoid arthritis.
Score Text
0.9994 RESULTS : All cases developed corneal endothelial deposits after previous use of Drugrifabutin .
0.9873 RESULTS : All cases developed Adverse-Effectcorneal endothelial deposits after previous use of rifabutin.
Score Text
0.9995 We report a case of RTA secondary to DrugFK506 administration in liver transplantation.
0.9982 We report a case of Adverse-EffectRTA secondary to FK506 administration in liver transplantation.
Score Text
0.9986 An adverse reaction to IFN was strongly suspected as the cause of Adverse-EffectCHF .
0.9947 An adverse reaction to DrugIFN was strongly suspected as the cause of CHF.
Score Text
0.9973 Both PAN and Drugmethotrexate have been independently demonstrated to cause sensorineural hearing loss.
0.9904 Both PAN and methotrexate have been independently demonstrated to cause Adverse-Effectsensorineural hearing loss .
0.9758 Both DrugPAN and methotrexate have been independently demonstrated to cause sensorineural hearing loss.
Score Text
0.9994 CONCLUSIONS : DrugAnastrozole may be the causative factor in patients with sclerosing glomerulonephritis.
0.8516 CONCLUSIONS : Anastrozole may be the causative factor in patients with Adverse-Effectsclerosing glomerulonephritis .
Score Text
0.9824 Adverse-EffectThrombotic thrombocytopenic purpura induced by trimethoprim - sulfamethoxazole in a Jehovah's Witness.
0.9625 Thrombotic thrombocytopenic purpura induced by Drugtrimethoprim - sulfamethoxazole in a Jehovah's Witness.
0.9102 Thrombotic thrombocytopenic purpura induced by trimethoprim - Drugsulfamethoxazole in a Jehovah's Witness.
Score Text
0.9995 Subacute cholestatic hepatitis likely related to the use of Drugsenna for chronic constipation.
0.9728 Adverse-EffectSubacute cholestatic hepatitis likely related to the use of senna for chronic constipation.
Score Text
0.9995 Acute myocardial infarction during high - dose Drugmethylprednisolone therapy for Graves'ophthalmopathy.
0.9830 Adverse-EffectAcute myocardial infarction during high - dose methylprednisolone therapy for Graves'ophthalmopathy.
Score Text
0.9996 Only 3 cases of Drugimatinib - induced tumor lysis syndrome have been reported.
0.9866 Only 3 cases of imatinib - induced Adverse-Effecttumor lysis syndrome have been reported.
Score Text
0.9992 DrugCiprofloxacin - induced toxic epidermal necrolysis in a patient with systemic lupus erythematosus.
0.9847 Ciprofloxacin - induced Adverse-Effecttoxic epidermal necrolysis in a patient with systemic lupus erythematosus.
Score Text
0.9995 OBJECTIVE : To report two cases of fixed drug eruption induced by Drugmethylphenidate .
0.9535 OBJECTIVE : To report two cases of Adverse-Effectfixed drug eruption induced by methylphenidate.
Score Text
0.9971 Concomitant administration of lithium with olanzapine may place patients at risk for Adverse-EffectNMS .
0.9846 Concomitant administration of lithium with Drugolanzapine may place patients at risk for NMS.
0.9774 Concomitant administration of Druglithium with olanzapine may place patients at risk for NMS.
Score Text
0.9993 METHODS : Three patients with apparent Drugitraconazole - induced liver injury were studied.
0.9939 METHODS : Three patients with apparent itraconazole - induced Adverse-Effectliver injury were studied.
Score Text
0.9995 Clinical profile of Drugoxcarbazepine - related angioneurotic edema : case report and review.
0.9922 Clinical profile of oxcarbazepine - related Adverse-Effectangioneurotic edema : case report and review.
Score Text
0.9994 Our series of 3 patients supports a causal connection between Drugbleomycin and scleroderma.
0.9944 Our series of 3 patients supports a causal connection between bleomycin and Adverse-Effectscleroderma .
Score Text
0.9995 It is concluded that SIADH is an important side effect of Druglorcainide therapy.
0.9978 It is concluded that Adverse-EffectSIADH is an important side effect of lorcainide therapy.
Score Text
0.9994 Treatment - related myelodysplastic syndrome after Drugtemozolomide for recurrent high - grade glioma.
0.9903 Treatment - related Adverse-Effectmyelodysplastic syndrome after temozolomide for recurrent high - grade glioma.
Score Text
0.9806 Adverse-EffectSustained hypothyroidism induced by recombinant alpha interferon in patients with chronic hepatitis C.
0.9626 Sustained hypothyroidism induced by Drugrecombinant alpha interferon in patients with chronic hepatitis C.
Score Text
0.9995 Leukopenia due to parvovirus B19 in a Crohn's disease patient using Drugazathioprine .
0.9988 Adverse-EffectLeukopenia due to parvovirus B19 in a Crohn's disease patient using azathioprine.
Score Text
0.9988 DrugBleomycin and cyclophosphamide toxicity simulating metastatic nodules to the lungs in childhood cancer.
0.9986 Bleomycin and Drugcyclophosphamide toxicity simulating metastatic nodules to the lungs in childhood cancer.
0.9760 Bleomycin and cyclophosphamide toxicity simulating Adverse-Effectmetastatic nodules to the lungs in childhood cancer.
Score Text
0.9994 DrugVerapamil in effort - induced angina pectoris in patients with normal coronary arteries.
0.9914 Verapamil in effort - induced Adverse-Effectangina pectoris in patients with normal coronary arteries.
Score Text
0.9959 This is the first report of DrugUFT - induced scleroderma - like reaction.
0.9812 This is the first report of UFT - induced Adverse-Effectscleroderma - like reaction .
This is the first report of Adverse-EffectUFT - induced scleroderma - like reaction .
Score Text
0.9989 Self - limited edema is a well - recognized complication of Druginsulin therapy.
0.9831 Adverse-EffectSelf - limited edema is a well - recognized complication of insulin therapy.
Score Text
0.9953 Celiac disease onset after pegylated interferon and Drugribavirin treatment of chronic hepatitis C.
0.9932 Adverse-EffectCeliac disease onset after pegylated interferon and ribavirin treatment of chronic hepatitis C.
0.9777 Celiac disease onset after Drugpegylated interferon and ribavirin treatment of chronic hepatitis C.
Score Text
0.9996 Sexual dysfunction associated with intrathecal Drugbaclofen use : a report of two cases.
0.9899 Adverse-EffectSexual dysfunction associated with intrathecal baclofen use : a report of two cases.
Score Text
0.9972 Adverse-EffectScleromyxedema in a patient with multiple sclerosis and monoclonal gammopathy on interferon beta - 1a.
0.9755 Scleromyxedema in a patient with multiple sclerosis and monoclonal gammopathy on Druginterferon beta - 1a .
Score Text
0.9996 The cases of DrugCBZ - induced SLE reported in the literature were reviewed.
0.9988 The cases of CBZ - induced Adverse-EffectSLE reported in the literature were reviewed.
Score Text
0.9995 Treatment of Drugcarbimazole - induced agranulocytosis and sepsis with granulocyte colony stimulating factor.
0.9976 Treatment of carbimazole - induced Adverse-Effectagranulocytosis and sepsis with granulocyte colony stimulating factor.
0.9962 Treatment of carbimazole - induced agranulocytosis and Adverse-Effectsepsis with granulocyte colony stimulating factor.
Score Text
0.9989 Early peritoneal dialysis has not previously been reported for Druglisinopril induced multiorgan failure.
0.9910 Early peritoneal dialysis has not previously been reported for lisinopril induced Adverse-Effectmultiorgan failure .
Score Text
0.9995 DrugCyclosporine - induced pain syndrome in a child undergoing hematopoietic stem cell transplant.
0.9923 Cyclosporine - induced Adverse-Effectpain syndrome in a child undergoing hematopoietic stem cell transplant.
Score Text
0.9994 DrugBaclofen withdrawal : a cause of prolonged fever in the intensive care unit.
0.9891 Baclofen withdrawal : a cause of prolonged Adverse-Effectfever in the intensive care unit.
Score Text
0.9996 Generalised cutaneous rash associated with Drugganciclovir therapy has rarely been reported in literature.
0.9843 Adverse-EffectGeneralised cutaneous rash associated with ganciclovir therapy has rarely been reported in literature.
Score Text
0.9994 DrugValproate embryopathy in three sets of siblings : further proof of hereditary susceptibility.
0.8735 Valproate Adverse-Effectembryopathy in three sets of siblings : further proof of hereditary susceptibility.
Adverse-EffectValproate embryopathy in three sets of siblings : further proof of hereditary susceptibility.
Score Text
0.9996 Granulocytopenia and agranulocytosis are considered among the most dangerous adverse effects of Drugclozapine .
0.9979 Granulocytopenia and Adverse-Effectagranulocytosis are considered among the most dangerous adverse effects of clozapine.
0.9977 Adverse-EffectGranulocytopenia and agranulocytosis are considered among the most dangerous adverse effects of clozapine.
Score Text
0.9995 The observations suggest that testicular swelling and pain are side effects of Drugdesipramine .
0.9899 The observations suggest that Adverse-Effecttesticular swelling and pain are side effects of desipramine.
0.9877 The observations suggest that testicular swelling and Adverse-Effectpain are side effects of desipramine.
Score Text
0.9896 Adverse-EffectNeurologic degeneration associated with nitrous oxide anesthesia in patients with vitamin B12 deficiency.
0.9895 Neurologic degeneration associated with Drugnitrous oxide anesthesia in patients with vitamin B12 deficiency.
Score Text
0.9994 This is the first report of a disulfiram - like reaction with Drugcefmenoxime .
0.9820 This is the first report of a Adverse-Effectdisulfiram - like reaction with cefmenoxime.
Score Text
0.9995 METHODS : We report two cases of pseudoporphyria caused by Drugnaproxen and oxaprozin.
0.9994 METHODS : We report two cases of pseudoporphyria caused by naproxen and Drugoxaprozin .
0.9978 METHODS : We report two cases of Adverse-Effectpseudoporphyria caused by naproxen and oxaprozin.
Score Text
0.9885 A case of Adverse-Effectcontact dermatitis due to sodium bisulfite in an ophthalmic solution.
0.9870 A case of contact dermatitis due to Drugsodium bisulfite in an ophthalmic solution.
Score Text
0.9920 The authors report 2 cases of Adverse-Effectrenal damage associated with lithium carbonate treatment.
0.9847 The authors report 2 cases of renal damage associated with Druglithium carbonate treatment.
Score Text
0.9993 Cutaneous rashes and eruptions can be caused by many medications, including Drugcarbamazepine .
0.9979 Cutaneous rashes and Adverse-Effecteruptions can be caused by many medications, including carbamazepine.
0.9925 Adverse-EffectCutaneous rashes and eruptions can be caused by many medications, including carbamazepine.
Score Text
0.9991 Acute generalized exanthematous pustulosis induced by Drugsalazosulfapyridine in a patient with ulcerative colitis.
0.9722 Adverse-EffectAcute generalized exanthematous pustulosis induced by salazosulfapyridine in a patient with ulcerative colitis.
Score Text
0.9993 Possible linkage of Drugamprenavir with intracranial bleeding in an HIV - infected hemophiliac.
0.9783 Possible linkage of amprenavir with Adverse-Effectintracranial bleeding in an HIV - infected hemophiliac.
Score Text
0.9995 DrugTamoxifen is suggested to be carcinogenic both through direct genotoxic and epigenetic mechanisms.
0.9955 Tamoxifen is suggested to be Adverse-Effectcarcinogenic both through direct genotoxic and epigenetic mechanisms.
Score Text
0.9976 Clearance rates of cerivastatin metabolites in a patient with cerivastatin - induced Adverse-Effectrhabdomyolysis .
0.9794 Clearance rates of cerivastatin metabolites in a patient with Drugcerivastatin - induced rhabdomyolysis.
Score Text
0.9996 Two cases of Drugsirolimus - associated pneumonitis have been reported after cardiac transplantation.
0.9982 Two cases of sirolimus - associated Adverse-Effectpneumonitis have been reported after cardiac transplantation.
Score Text
0.9995 Seizures and transient blindness following intravenous pulse Drugmethylprednisolone in children with primary glomerulonephritis.
0.9983 Adverse-EffectSeizures and transient blindness following intravenous pulse methylprednisolone in children with primary glomerulonephritis.
0.9906 Seizures and Adverse-Effecttransient blindness following intravenous pulse methylprednisolone in children with primary glomerulonephritis.
Score Text
0.9993 We conclude that MB is an effective treatment for Drugifosfamide - induced encephalopathy.
0.9968 We conclude that MB is an effective treatment for ifosfamide - induced Adverse-Effectencephalopathy .
We conclude that MB is an effective treatment for Adverse-Effectifosfamide - induced encephalopathy .
Score Text
0.9995 Possible heart failure exacerbation associated with Drugrosiglitazone : case report and literature review.
0.9810 Possible Adverse-Effectheart failure exacerbation associated with rosiglitazone : case report and literature review.
Score Text
0.9962 Acute interstitial pneumonia induced by ONO - 1078 ( Drugpranlukast ), a leukotriene receptor antagonist.
0.9812 Acute interstitial pneumonia induced by DrugONO - 1078 ( pranlukast ), a leukotriene receptor antagonist.
0.9551 Adverse-EffectAcute interstitial pneumonia induced by ONO - 1078 ( pranlukast ), a leukotriene receptor antagonist.
Acute Adverse-Effectinterstitial pneumonia induced by ONO - 1078 ( pranlukast ), a leukotriene receptor antagonist.
Score Text
0.9994 A 48 - year - old woman who was treated for thyrotoxicosis with Drugmethimazole developed agranulocytosis.
0.9980 A 48 - year - old woman who was treated for thyrotoxicosis with methimazole developed Adverse-Effectagranulocytosis .
Score Text
0.9978 Rapid resolution of topiramate - induced angle - closure glaucoma with Drugmethylprednisolone and mannitol.
0.9977 Rapid resolution of topiramate - induced angle - closure glaucoma with methylprednisolone and Drugmannitol .
0.9964 Rapid resolution of Drugtopiramate - induced angle - closure glaucoma with methylprednisolone and mannitol.
0.9840 Rapid resolution of topiramate - induced Adverse-Effectangle - closure glaucoma with methylprednisolone and mannitol.
Score Text
0.9974 Adverse-EffectRetinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin.
0.9934 Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and Drugribavirin .
0.9782 Retinopathy in hepatitis C patients due to combination therapy with Drugpegylated interferon and ribavirin.
Score Text
0.9985 However, DrugEO - induced noncardiogenic pulmonary edema has not been reported in human.
0.9868 However, EO - induced Adverse-Effectnoncardiogenic pulmonary edema has not been reported in human.
Score Text
0.9995 A case is reported of a child with fatal pulmonary fibrosis following DrugBCNU therapy.
0.9795 A case is reported of a child with Adverse-Effectfatal pulmonary fibrosis following BCNU therapy.
Score Text
0.9996 Fatal interstitial pneumonitis following high - dose intermittent Drugchlorambucil therapy for chronic lymphocyte leukemia.
0.9845 Adverse-EffectFatal interstitial pneumonitis following high - dose intermittent chlorambucil therapy for chronic lymphocyte leukemia.
Score Text
0.9993 Anaphylactic reaction to oral Drugprednisone : a case report and review of the literature.
0.9899 Adverse-EffectAnaphylactic reaction to oral prednisone : a case report and review of the literature.
Score Text
0.9995 The following is a report of 2 cases of Drugrifampicin - induced renal insufficiency.
0.9912 The following is a report of 2 cases of rifampicin - induced Adverse-Effectrenal insufficiency .
Score Text
0.9991 High - dose Drugmethotrexate - associated acute renal failure may be an avoidable complication.
0.9846 High - dose methotrexate - associated Adverse-Effectacute renal failure may be an avoidable complication.
Score Text
0.9993 CONCLUSIONS : Fixed drug rash induced by Drugmethylphenidate is a possible but rare phenomenon.
0.9638 CONCLUSIONS : Adverse-EffectFixed drug rash induced by methylphenidate is a possible but rare phenomenon.
Score Text
0.9996 Here, we report a case of angio - oedema associated with DrugVRC therapy.
0.9870 Here, we report a case of Adverse-Effectangio - oedema associated with VRC therapy.
Score Text
0.9995 DrugMethotrexate - induced hepatic necrosis requiring liver transplantation in a patient with rheumatoid arthritis.
0.9920 Methotrexate - induced Adverse-Effecthepatic necrosis requiring liver transplantation in a patient with rheumatoid arthritis.
Score Text
0.9995 Scleroderma in association with the use of Drugbleomycin : a report of 3 cases.
0.9980 Adverse-EffectScleroderma in association with the use of bleomycin : a report of 3 cases.
Score Text
0.9989 DrugVoriconazole ( VRC ) has not previously been reported to cause angio - oedema.
0.9984 Voriconazole ( DrugVRC ) has not previously been reported to cause angio - oedema.
0.9867 Voriconazole ( VRC ) has not previously been reported to cause Adverse-Effectangio - oedema .
Score Text
0.9994 Five days after the fourth dose of Drugvincristine , she presented with bilateral ptosis.
0.9947 Five days after the fourth dose of vincristine, she presented with Adverse-Effectbilateral ptosis .
Score Text
0.9986 However, repeated intracameral DrugtPA injections may cause unwanted complications such as vitreous hemorrhage.
0.9910 However, repeated intracameral tPA injections may cause unwanted complications such as Adverse-Effectvitreous hemorrhage .
Score Text
0.9815 Oral 25 - hydroxyvitain D3 in treatment of osteomalacia associated with Adverse-Effectileal resection and cholestyramine therapy.
0.9635 Oral Drug25 - hydroxyvitain D3 in treatment of osteomalacia associated with ileal resection and cholestyramine therapy.
Score Text
0.9987 Sideroblastic anemia due to Druglinezolid in a patient with a left ventricular assist device.
0.9914 Adverse-EffectSideroblastic anemia due to linezolid in a patient with a left ventricular assist device.
Score Text
0.9993 Idiosyncratic pulmonary reactions to Drugnitrofurantoin are not unusual, often presenting as eosinophilic pneumonia.
0.9796 Adverse-EffectIdiosyncratic pulmonary reactions to nitrofurantoin are not unusual, often presenting as eosinophilic pneumonia.
0.9693 Idiosyncratic pulmonary reactions to nitrofurantoin are not unusual, often presenting as Adverse-Effecteosinophilic pneumonia .
Score Text
0.9994 Hepatotoxicity resolved once Drugerlotinib was discontinued and serum transaminases returned to baseline normal values.
0.9975 Adverse-EffectHepatotoxicity resolved once erlotinib was discontinued and serum transaminases returned to baseline normal values.
Score Text
0.9995 A patient with acute changes suggesting acute hepatitis after parenteral Drugamiodarone administration is described.
0.9881 A patient with acute changes suggesting Adverse-Effectacute hepatitis after parenteral amiodarone administration is described.
Score Text
0.9977 Adverse-EffectCardiomyopathy after widely separated courses of adriamycin exacerbated by actinomycin - D and mithramycin.
0.9518 Cardiomyopathy after widely separated courses of Drugadriamycin exacerbated by actinomycin - D and mithramycin.
0.9309 Cardiomyopathy after widely separated courses of adriamycin exacerbated by actinomycin - D and Drugmithramycin .
0.9296 Cardiomyopathy after widely separated courses of adriamycin exacerbated by Drugactinomycin - D and mithramycin.
Score Text
0.9904 Because Adverse-Effectnephrotic syndrome may be induced by IFN therapy, the IFN was stopped.
0.9561 Because nephrotic syndrome may be induced by IFN therapy, the DrugIFN was stopped.
0.9559 Because nephrotic syndrome may be induced by DrugIFN therapy, the IFN was stopped.
Score Text
0.9995 Decreased plasma cortisol level during Drugalprazolam treatment of panic disorder : a case report.
0.9715 Adverse-EffectDecreased plasma cortisol level during alprazolam treatment of panic disorder : a case report.
Score Text
0.9992 Neurological improvement and rehabilitation potential following toxic myelopathy due to intrathecal injection of Drugdoxorubicin .
0.9825 Neurological improvement and rehabilitation potential following Adverse-Effecttoxic myelopathy due to intrathecal injection of doxorubicin.
Score Text
0.9994 Persistent hypoglycemia in a patient with diabetes taking Drugetanercept for the treatment of psoriasis.
0.9807 Adverse-EffectPersistent hypoglycemia in a patient with diabetes taking etanercept for the treatment of psoriasis.
Score Text
0.9986 An unusual cause of burn injury : unsupervised use of drugs that contain Adverse-Effectpsoralens .
0.8276 An unusual cause of Adverse-Effectburn injury : unsupervised use of drugs that contain psoralens.
An unusual cause of Drugburn injury : unsupervised use of drugs that contain psoralens.
Score Text
0.9990 Intravenous Drughaloperidol is generally well tolerated, but multiform ventricular tachycardia has been reported.
0.9661 Intravenous haloperidol is generally well tolerated, but Adverse-Effectmultiform ventricular tachycardia has been reported.
Score Text
0.9992 When DrugDSCG was withdrawn, urticaria vanished and the child remained symptom - free.
0.9975 When DSCG was withdrawn, Adverse-Effecturticaria vanished and the child remained symptom - free.
Score Text
0.9700 Growth and adrenal suppression in asthmatic children treated with high - dose Drugfluticasone propionate .
0.9397 Adverse-EffectGrowth and adrenal suppression in asthmatic children treated with high - dose fluticasone propionate.
Score Text
0.9991 Development of Crohn's disease in a patient with multiple sclerosis treated with Drugcopaxone .
0.9826 Development of Adverse-EffectCrohn's disease in a patient with multiple sclerosis treated with copaxone.
Score Text
0.9985 A young woman developed Adverse-Effectgalactorrhea during treatment with a new dibenzoxazepine antidepressant, amoxapine.
0.9941 A young woman developed galactorrhea during treatment with a new dibenzoxazepine antidepressant, Drugamoxapine .
0.9679 A young woman developed galactorrhea during treatment with a new Drugdibenzoxazepine antidepressant, amoxapine.
Score Text
0.9991 Central pontine myelinolysis manifested by temporary blindness : a possible complication of Druglithium toxicity.
0.9853 Central pontine myelinolysis manifested by Adverse-Effecttemporary blindness : a possible complication of lithium toxicity.
Adverse-EffectCentral pontine myelinolysis manifested by temporary blindness : a possible complication of lithium toxicity.
Score Text
0.9995 Skin manifestations of a case of Drugphenylbutazone - induced serum sickness - like reactions.
0.9821 Adverse-EffectSkin manifestations of a case of phenylbutazone - induced serum sickness - like reactions.
0.9785 Skin manifestations of a case of phenylbutazone - induced Adverse-Effectserum sickness - like reactions .
Score Text
0.9996 Cardiac arrest after Drugesmolol administration : a review of acute beta - blocker toxicity.
0.9946 Adverse-EffectCardiac arrest after esmolol administration : a review of acute beta - blocker toxicity.
Score Text
0.9985 The nephrotic syndrome developed in a patient receiving therapy with Druggold for rheumatoid arthritis.
0.9949 The Adverse-Effectnephrotic syndrome developed in a patient receiving therapy with gold for rheumatoid arthritis.
Score Text
0.9989 Adverse-EffectVitiligo associated with alpha - interferon in a patient with chronic active hepatitis C.
0.9533 Vitiligo associated with Drugalpha - interferon in a patient with chronic active hepatitis C.
Score Text
0.9982 All - trans retinoic acid - induced focal myositis, synovitis, and Adverse-Effectmononeuritis .
0.9973 All - trans retinoic acid - induced focal myositis, Adverse-Effectsynovitis , and mononeuritis.
0.9898 All - trans retinoic acid - induced Adverse-Effectfocal myositis , synovitis, and mononeuritis.
0.9563 DrugAll - trans retinoic acid - induced focal myositis, synovitis, and mononeuritis.
Score Text
0.9866 Subcutaneous DrugIL - 2 is safe and well tolerated, with a mortality rate < 3 %.
Subcutaneous IL - 2 is safe and well tolerated, with a Adverse-Effectmortality rate < 3 %.
Score Text
0.9995 We report a case of IDDM which occurred during Druginterferon therapy for chronic hepatitis.
0.9988 We report a case of Adverse-EffectIDDM which occurred during interferon therapy for chronic hepatitis.
Score Text
0.9996 Severe autoimmune hemolytic anemia following Drugrituximab therapy in a patient with a lymphoproliferative disorder.
0.8827 Adverse-EffectSevere autoimmune hemolytic anemia following rituximab therapy in a patient with a lymphoproliferative disorder.
Severe Adverse-Effectautoimmune hemolytic anemia following rituximab therapy in a patient with a lymphoproliferative disorder.
Score Text
0.9988 CCBs should be considered in the treatment of 5 - FU or capecitabine - induced Adverse-Effectheadaches .
0.9951 CCBs should be considered in the treatment of 5 - FU or Drugcapecitabine - induced headaches.
0.9899 CCBs should be considered in the treatment of Drug5 - FU or capecitabine - induced headaches.
Score Text
0.9995 She developed a severe urticarial rash 3 weeks following initiation of therapy with DrugEnoxaparin .
0.9855 She developed a Adverse-Effectsevere urticarial rash 3 weeks following initiation of therapy with Enoxaparin.
Score Text
0.9995 Three months after starting Drugcitalopram , she experienced episodes of chest tightness and dizziness.
0.9980 Three months after starting citalopram, she experienced episodes of chest tightness and Adverse-Effectdizziness .
0.9936 Three months after starting citalopram, she experienced episodes of Adverse-Effectchest tightness and dizziness.
Score Text
0.9996 Interstitial pneumonia probably associated with Drugsorafenib treatment : An alert of an adverse event.
0.9880 Adverse-EffectInterstitial pneumonia probably associated with sorafenib treatment : An alert of an adverse event.
Score Text
0.9991 Detection of activated eosinophils in nasal polyps of an Drugaspirin - induced asthma patient.
0.9976 Detection of activated eosinophils in nasal polyps of an aspirin - induced Adverse-Effectasthma patient.
Score Text
0.9885 Toxic epidermal necrolysis resulted after 19 days of treatment with Drug5 - fluorocytosine and amphotericin B.
0.9863 Adverse-EffectToxic epidermal necrolysis resulted after 19 days of treatment with 5 - fluorocytosine and amphotericin B.
0.9826 Toxic epidermal necrolysis resulted after 19 days of treatment with 5 - fluorocytosine and Drugamphotericin B .
Score Text
0.9995 A case of severe aplastic anemia secondary to treatment with Druglenalidomide for multiple myeloma.
0.9766 A case of Adverse-Effectsevere aplastic anemia secondary to treatment with lenalidomide for multiple myeloma.
Score Text
0.9996 Hepatic angiosarcoma occurring after Drugcyclophosphamide therapy : case report and review of the literature.
0.9867 Adverse-EffectHepatic angiosarcoma occurring after cyclophosphamide therapy : case report and review of the literature.
Score Text
0.9994 We report three cases of severe hepatotoxicity related to Drugbenzarone , a benzofuran derivative.
0.9520 We report three cases of Adverse-Effectsevere hepatotoxicity related to benzarone, a benzofuran derivative.
Score Text
0.9990 Two infants developed hyperkalemia shortly after cessation of prolonged DrugACTH therapy for infantile spasms.
0.9986 Two infants developed Adverse-Effecthyperkalemia shortly after cessation of prolonged ACTH therapy for infantile spasms.
Score Text
0.9995 However, acute cardiomyopathy and pericarditis secondary to Drugmethylphenidate use has been rarely reported.
0.9975 However, acute cardiomyopathy and Adverse-Effectpericarditis secondary to methylphenidate use has been rarely reported.
0.9859 However, Adverse-Effectacute cardiomyopathy and pericarditis secondary to methylphenidate use has been rarely reported.
Score Text
0.9995 We now present four cases of RSDS in kidney transplant recipients treated with Drugtacrolimus .
0.9980 We now present four cases of Adverse-EffectRSDS in kidney transplant recipients treated with tacrolimus.
Score Text
0.9991 This sulfonamide like nephropathy should be differentiated from Drugacetazolamide - related calcium phosphate nephrolithiasis.
0.9475 This sulfonamide like nephropathy should be differentiated from acetazolamide - related Adverse-Effectcalcium phosphate nephrolithiasis .
Score Text
0.9992 Alveolar - interstitial pneumopathy after Druggold - salts compounds administration, requiring mechanical ventilation.
0.9684 Adverse-EffectAlveolar - interstitial pneumopathy after gold - salts compounds administration, requiring mechanical ventilation.
Score Text
0.9990 The epivodes of NMS occured under treatment with clozapine, risperidone, and Drugamisulpride .
0.9987 The epivodes of NMS occured under treatment with clozapine, Drugrisperidone , and amisulpride.
0.9987 The epivodes of NMS occured under treatment with Drugclozapine , risperidone, and amisulpride.
0.9944 The epivodes of Adverse-EffectNMS occured under treatment with clozapine, risperidone, and amisulpride.
Score Text
0.9993 Cardiac hypersensitivity and myopericarditis have been reported during long - term treatment with Drugmesalazine .
0.9966 Cardiac hypersensitivity and Adverse-Effectmyopericarditis have been reported during long - term treatment with mesalazine.
0.9872 Adverse-EffectCardiac hypersensitivity and myopericarditis have been reported during long - term treatment with mesalazine.
Score Text
0.9995 Interstitial fibrosis of the lung is a potential complication of Drugmethotrexate therapy for psoriasis.
0.9807 Adverse-EffectInterstitial fibrosis of the lung is a potential complication of methotrexate therapy for psoriasis.
Score Text
0.9994 The events of non - convulsive status epilepticus subsided following reduction in Drugtiagabine dosages.
0.9760 The events of Adverse-Effectnon - convulsive status epilepticus subsided following reduction in tiagabine dosages.
Score Text
0.9992 CONCLUSION : This case illustrates a potential link between dermatologic and ocular Drug5 - FU toxicities.
0.6309 CONCLUSION : This case illustrates a potential link between Adverse-Effectdermatologic and ocular 5 - FU toxicities .
Score Text
0.9974 Visual hallucinations after intravitreal injection of Drugbevacizumab in vascular age - related macular degeneration.
0.9877 Adverse-EffectVisual hallucinations after intravitreal injection of bevacizumab in vascular age - related macular degeneration.
Score Text
0.9990 CONCLUSIONS : Symptoms and pathologic changes of colitis are associated with exposure to Drugrofecoxib .
0.9920 CONCLUSIONS : Symptoms and pathologic changes of Adverse-Effectcolitis are associated with exposure to rofecoxib.
Score Text
0.9850 Adverse-EffectReye - like syndrome following treatment with the pantothenic acid antagonist, calcium hopantenate.
0.9833 Reye - like syndrome following treatment with the pantothenic acid antagonist, Drugcalcium hopantenate .
Score Text
0.9994 Presented is a case of acute renal failure induced by Drugacetazolamide therapy for glaucoma.
0.9799 Presented is a case of Adverse-Effectacute renal failure induced by acetazolamide therapy for glaucoma.
Score Text
0.9994 Such anagen effluvium with lichenoid eruption following DrugINH therapy has not been observed previously.
0.9911 Such anagen effluvium with Adverse-Effectlichenoid eruption following INH therapy has not been observed previously.
0.9841 Such Adverse-Effectanagen effluvium with lichenoid eruption following INH therapy has not been observed previously.
Score Text
0.9989 The mean time from starting DrugMMF to the development of neutropenia was 4 months.
0.9970 The mean time from starting MMF to the development of Adverse-Effectneutropenia was 4 months.
Score Text
0.9995 Psoriasis - like skin reaction in a patient with rheumatoid arthritis after Drugsulphasalazine therapy.
0.9817 Adverse-EffectPsoriasis - like skin reaction in a patient with rheumatoid arthritis after sulphasalazine therapy.
Score Text
0.9596 Severe rhabdomyolysis following massive ingestion of Drugoolong tea : caffeine intoxication with coexisting hyponatremia.
0.9505 Severe rhabdomyolysis following massive ingestion of oolong tea : Drugcaffeine intoxication with coexisting hyponatremia.
0.5731 Severe rhabdomyolysis following massive ingestion of oolong tea : Adverse-Effectcaffeine intoxication with coexisting hyponatremia.
0.6836 Adverse-EffectSevere rhabdomyolysis following massive ingestion of oolong tea : caffeine intoxication with coexisting hyponatremia.
Severe Adverse-Effectrhabdomyolysis following massive ingestion of oolong tea : caffeine intoxication with coexisting hyponatremia.
Score Text
0.9993 DrugIbuprofen overdose is usually characterized by GI upset, dizziness, and mild sedation.
0.9916 Ibuprofen overdose is usually characterized by Adverse-EffectGI upset , dizziness, and mild sedation.
0.9913 Ibuprofen overdose is usually characterized by GI upset, Adverse-Effectdizziness , and mild sedation.
0.9864 Ibuprofen overdose is usually characterized by GI upset, dizziness, and Adverse-Effectmild sedation .
Score Text
0.9288 Administration of cisplatin in three patients with Drugcarboplatin hypersensitivity : is skin testing useful?
0.9113 Administration of cisplatin in three patients with carboplatin Adverse-Effecthypersensitivity : is skin testing useful?
Score Text
0.9992 Severe hepatotoxicity related to Drugbenzarone : a report of three cases with two fatalities.
0.9508 Adverse-EffectSevere hepatotoxicity related to benzarone : a report of three cases with two fatalities.
Score Text
0.9996 OBJECTIVE : To report a case of reversible nonthrombocytopenic palpable purpura associated with Drugmetoclopramide .
0.9468 OBJECTIVE : To report a case of reversible Adverse-Effectnonthrombocytopenic palpable purpura associated with metoclopramide.
Score Text
0.9814 DrugActinomycin D associated hepatic veno - occlusive disease - - a report of 2 cases.
0.9736 Actinomycin D associated Adverse-Effecthepatic veno - occlusive disease - - a report of 2 cases.
Score Text
0.9897 A patient developed typical Adverse-EffectECM after subcutaneous selfinjection of glatiramer acetate for multiple sclerosis.
0.9815 A patient developed typical ECM after subcutaneous selfinjection of Drugglatiramer acetate for multiple sclerosis.
Score Text
0.9995 Two patients are described who developed testicular swelling and pain during treatment with Drugdesipramine .
0.9930 Two patients are described who developed Adverse-Effecttesticular swelling and pain during treatment with desipramine.
0.9873 Two patients are described who developed testicular swelling and Adverse-Effectpain during treatment with desipramine.
Score Text
0.9908 Putaminal infarct in Drugmethanol intoxication : case report and role of brain imaging studies.
0.9314 Adverse-EffectPutaminal infarct in methanol intoxication : case report and role of brain imaging studies.
0.7082 Putaminal infarct in Adverse-Effectmethanol intoxication : case report and role of brain imaging studies.
Score Text
0.9994 Worsening of neurologic syndrome in patients with Wilson's disease with initial Drugpenicillamine therapy.
0.9699 Adverse-EffectWorsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy.
Score Text
0.9989 This is the first histologically confirmed case of NASH that was aggravated by Drugraloxifene .
0.9983 This is the first histologically confirmed case of Adverse-EffectNASH that was aggravated by raloxifene.
Score Text
0.9991 This was accepted as evidence for Drugpropranolol being the cause of this conduction disorder.
0.9614 This was accepted as evidence for propranolol being the cause of this Adverse-Effectconduction disorder .
Score Text
0.9844 Adverse-EffectPeripheral nerve dysfunction is a potentially serious complication of high - dose cytosine arabinoside.
0.9706 Peripheral nerve dysfunction is a potentially serious complication of high - dose Drugcytosine arabinoside .
Score Text
0.9994 Torsade de pointes associated with Drugmoxifloxacin : a rare but potentially fatal adverse event.
0.9879 Adverse-EffectTorsade de pointes associated with moxifloxacin : a rare but potentially fatal adverse event.
Score Text
0.9973 Hyperammonemia secondary to valproic acid as a cause of Adverse-Effectlethargy in a postictal patient.
0.9972 Adverse-EffectHyperammonemia secondary to valproic acid as a cause of lethargy in a postictal patient.
0.9801 Hyperammonemia secondary to Drugvalproic acid as a cause of lethargy in a postictal patient.
Score Text
0.9994 A small number of Drugoxaliplatin - related hemolytic and / or thrombocytopenic reactions have been reported.
0.9810 A small number of oxaliplatin - related Adverse-Effecthemolytic and / or thrombocytopenic reactions have been reported.
Score Text
0.9964 Clinical signs of Adverse-Effecthypermagnesemia are an uncommon complication following oral administration of magnesium sulfate.
0.9761 Clinical signs of hypermagnesemia are an uncommon complication following oral administration of Drugmagnesium sulfate .
Score Text
0.9996 Acute hemorrhagic gastritis associated with Drugacetazolamide intoxication in a patient with chronic renal failure.
0.9832 Adverse-EffectAcute hemorrhagic gastritis associated with acetazolamide intoxication in a patient with chronic renal failure.
Acute hemorrhagic gastritis associated with Adverse-Effectacetazolamide intoxication in a patient with chronic renal failure.
Score Text
0.9938 Adverse-EffectMyasthenia gravis during low - dose IFN - alpha therapy for chronic hepatitis C.
0.9716 Myasthenia gravis during low - dose DrugIFN - alpha therapy for chronic hepatitis C.
Score Text
0.9990 His fever resolved, but he developed symptoms consistent with those of Drugchloroquine toxicity.
0.9497 His fever resolved, but he developed symptoms consistent with those of Adverse-Effectchloroquine toxicity .
Score Text
0.9866 Adverse-EffectLupus - like syndrome caused by 5 - aminosalicylic acid in patients with inflammatory bowel disease.
0.9748 Lupus - like syndrome caused by Drug5 - aminosalicylic acid in patients with inflammatory bowel disease.
Score Text
0.9996 Intensive high - flux hemodiafiltration is often used in the management of Drugvancomycin toxicity.
0.8261 Intensive high - flux hemodiafiltration is often used in the management of Adverse-Effectvancomycin toxicity .
Score Text
0.9995 She developed neurotoxicity with an adjustment dosage of Drugvalacyclovir for a cutaneous zoster infection.
0.9972 She developed Adverse-Effectneurotoxicity with an adjustment dosage of valacyclovir for a cutaneous zoster infection.
Score Text
0.9991 DrugThalidomide was withdrawn from world markets in 1961 following recognition of its teratogenic effects.
0.9723 Thalidomide was withdrawn from world markets in 1961 following recognition of its Adverse-Effectteratogenic effects .
Score Text
0.9993 Itch and skin rash from chocolate during Drugfluoxetine and sertraline treatment : case report.
0.9993 Itch and skin rash from chocolate during fluoxetine and Drugsertraline treatment : case report.
0.9979 Adverse-EffectItch and skin rash from chocolate during fluoxetine and sertraline treatment : case report.
0.9938 Itch and Adverse-Effectskin rash from chocolate during fluoxetine and sertraline treatment : case report.
Score Text
0.9994 OBJECTIVE : To describe a case of thrombocytopenia associated with the administration of Druglansoprazole .
0.9959 OBJECTIVE : To describe a case of Adverse-Effectthrombocytopenia associated with the administration of lansoprazole.
Score Text
0.9994 Special care should be taken when pulmonary symptoms appear in association with Drugticlopidine treatment.
0.9832 Special care should be taken when Adverse-Effectpulmonary symptoms appear in association with ticlopidine treatment.
Score Text
0.9990 It is well - recognized that Drugflucloxacillin may occasionally result in fatal hepatic injury.
0.9850 It is well - recognized that flucloxacillin may occasionally result in Adverse-Effectfatal hepatic injury .
Score Text
0.9994 It is the first case of Drugciprofloxacin - induced VBDS successfully treated with tacrolimus.
0.9986 It is the first case of ciprofloxacin - induced Adverse-EffectVBDS successfully treated with tacrolimus.
Score Text
0.9995 We attribute the clinical and radiographic findings to cytotoxic edema secondary to intrathecal Drugmethotrexate .
0.9916 We attribute the clinical and radiographic findings to Adverse-Effectcytotoxic edema secondary to intrathecal methotrexate.
Score Text
0.9996 DrugBenzocaine - induced methemoglobinemia has been reported in man, dogs, and cats.
0.9976 Benzocaine - induced Adverse-Effectmethemoglobinemia has been reported in man, dogs, and cats.
Score Text
0.9992 Squamous - cell carcinoma arising in a basal - cell epithelioma treated with Drug5 - fluorouracil .
0.9758 Adverse-EffectSquamous - cell carcinoma arising in a basal - cell epithelioma treated with 5 - fluorouracil.
Score Text
0.9995 DrugRisperidone withdrawal - related respiratory dyskinesia : a case diagnosed by spirography and fibroscopy.
0.9911 Risperidone withdrawal - related Adverse-Effectrespiratory dyskinesia : a case diagnosed by spirography and fibroscopy.
Score Text
0.9840 Induction of Adverse-Effectrapid mood cycling during L - dopa treatment in a bipolar patient.
0.9673 Induction of rapid mood cycling during DrugL - dopa treatment in a bipolar patient.
Score Text
0.9985 Drug induced Adverse-Effectpolymyositis secondary to leuprolide acetate ( Lupron ) therapy for prostate carcinoma.
0.9969 Drug induced polymyositis secondary to leuprolide acetate ( DrugLupron ) therapy for prostate carcinoma.
0.9830 Drug induced polymyositis secondary to Drugleuprolide acetate ( Lupron ) therapy for prostate carcinoma.
Score Text
0.9984 Adverse-EffectAnaphylaxis to intravenous cyclosporine and tolerance to oral cyclosporine : case report and review.
0.9746 Anaphylaxis to intravenous Drugcyclosporine and tolerance to oral cyclosporine : case report and review.
Score Text
0.9977 Acute renal failure in a patient treated by continuous Drugpovidone - iodine mediastinal irrigation.
0.9968 Acute renal failure in a patient treated by continuous povidone - Drugiodine mediastinal irrigation.
0.9643 Adverse-EffectAcute renal failure in a patient treated by continuous povidone - iodine mediastinal irrigation.
Score Text
0.9995 We describe the first case of disseminated salmonellosis in a patient treated with Drugtemozolomide .
0.9876 We describe the first case of Adverse-Effectdisseminated salmonellosis in a patient treated with temozolomide.
Score Text
0.9994 New onset of Crohn's disease during treatment of active ankylosing spondylitis with Drugetanercept .
0.9645 New onset of Adverse-EffectCrohn's disease during treatment of active ankylosing spondylitis with etanercept.
Score Text
0.9992 CONCLUSIONS : Topical Drugbrimonidine may be associated with central nervous system depression in infants.
0.9867 CONCLUSIONS : Topical brimonidine may be associated with Adverse-Effectcentral nervous system depression in infants.
Score Text
0.9957 Pseudomembranous colitis readily occurs in at least certain population groups receiving trimethoprim - Drugsulfamethoxazole .
0.9933 Pseudomembranous colitis readily occurs in at least certain population groups receiving Drugtrimethoprim - sulfamethoxazole.
0.9902 Adverse-EffectPseudomembranous colitis readily occurs in at least certain population groups receiving trimethoprim - sulfamethoxazole.
Score Text
0.9995 We believe that the acute renal failure in our patient was associated with Druganastrozole .
0.9828 We believe that the Adverse-Effectacute renal failure in our patient was associated with anastrozole.
Score Text
0.9978 Adverse-EffectMyoclonus was induced and enhanced by L - dopa, developing into generalized seizures.
0.9772 Myoclonus was induced and enhanced by L - dopa, developing into Adverse-Effectgeneralized seizures .
0.9669 Myoclonus was induced and enhanced by DrugL - dopa , developing into generalized seizures.
Score Text
0.9589 Intravenous administration of levodopa ameliorated a refractory akathisia case induced by Druginterferon - alpha .
0.9556 Intravenous administration of levodopa ameliorated a refractory Adverse-Effectakathisia case induced by interferon - alpha.
Score Text
0.9907 Adverse-EffectCutaneous seeding after ultrasound - guided percutaneous ethanol injection for treatment of hepatocellular carcinoma.
0.9730 Cutaneous seeding after ultrasound - guided percutaneous Drugethanol injection for treatment of hepatocellular carcinoma.
Cutaneous seeding after ultrasound - guided percutaneous Drugethanol injection for treatment of hepatocellular carcinoma.
Score Text
0.9990 A patient presented with dilated cardiomyopathy after many years of overusing an Drugadrenaline inhaler.
0.9865 A patient presented with Adverse-Effectdilated cardiomyopathy after many years of overusing an adrenaline inhaler.
Score Text
0.9995 Are nasal decongestants safer than rhinitis? A case of Drugoxymetazoline - induced syncope.
0.9986 Are nasal decongestants safer than rhinitis? A case of oxymetazoline - induced Adverse-Effectsyncope .
Score Text
0.9996 Sixteen of 33 patients developed significant hyponatremia and hypoosmolality during oral treatment with Druglorcainide .
0.9982 Sixteen of 33 patients developed significant Adverse-Effecthyponatremia and hypoosmolality during oral treatment with lorcainide.
0.9979 Sixteen of 33 patients developed significant hyponatremia and Adverse-Effecthypoosmolality during oral treatment with lorcainide.
Score Text
0.9990 Serious Drugphenytoin hypersensitivity reactions may appear as dermatologic, lymphoid, or hepatic syndromes.
0.9426 Serious phenytoin hypersensitivity reactions may appear as Adverse-Effectdermatologic, lymphoid, or hepatic syndromes .
0.8640 Serious phenytoin Adverse-Effecthypersensitivity reactions may appear as dermatologic, lymphoid, or hepatic syndromes.
Score Text
0.9992 DrugGemcitabine should be added to the list of drugs known to cause radiation recall.
0.9930 Gemcitabine should be added to the list of drugs known to cause Adverse-Effectradiation recall .
Score Text
0.9993 Symptomatic hypocalcaemia and renal impairment associated with Drugbisphosphonate treatment in patients with multiple myeloma.
0.9875 Symptomatic hypocalcaemia and Adverse-Effectrenal impairment associated with bisphosphonate treatment in patients with multiple myeloma.
0.9842 Adverse-EffectSymptomatic hypocalcaemia and renal impairment associated with bisphosphonate treatment in patients with multiple myeloma.
Score Text
0.9994 In one case, Drugdisulfiram was the only potential teratogen exposed to the fetus.
0.9976 In one case, disulfiram was the only potential Adverse-Effectteratogen exposed to the fetus.
Score Text
0.9991 Conventional and diffusion - weighted MRI findings of Drugmethotrexate related sub - acute neurotoxicity.
0.9627 Conventional and diffusion - weighted MRI findings of methotrexate related Adverse-Effectsub - acute neurotoxicity .
Score Text
0.9993 METHOD : We describe three case - reports concerning haematological adverse effects of Drugquetiapine .
0.9671 METHOD : We describe three case - reports concerning Adverse-Effecthaematological adverse effects of quetiapine.
Score Text
0.9993 Oral intake and Drugacarbose were withheld and the ileus spontaneously resolved after 2 days.
0.9960 Oral intake and acarbose were withheld and the Adverse-Effectileus spontaneously resolved after 2 days.
Score Text
0.9839 Adverse-EffectKaposi's sarcoma in a patient treated with imatinib mesylate for chronic myeloid leukemia.
0.9805 Kaposi's sarcoma in a patient treated with Drugimatinib mesylate for chronic myeloid leukemia.
Score Text
0.9975 Drug2 - CdA induces lymphocytopenia, which may explain the improvement in this patient's psoriasis.
0.9962 2 - CdA induces Adverse-Effectlymphocytopenia , which may explain the improvement in this patient's psoriasis.
Score Text
0.9996 Development of tics in a thirteen - year - old male following Drugatomoxetine use.
0.9987 Development of Adverse-Effecttics in a thirteen - year - old male following atomoxetine use.
Score Text
0.9986 Gynecomastia in epileptics treated with Drugphenobarbital , phenytoin and fluoresone : two case reports.
0.9985 Gynecomastia in epileptics treated with phenobarbital, phenytoin and Drugfluoresone : two case reports.
0.9985 Gynecomastia in epileptics treated with phenobarbital, Drugphenytoin and fluoresone : two case reports.
0.9984 Adverse-EffectGynecomastia in epileptics treated with phenobarbital, phenytoin and fluoresone : two case reports.
Score Text
0.9992 The two middle aged women presented with respiratory symptoms after prolonged treatment with Drugnitrofurantoin .
0.9901 The two middle aged women presented with Adverse-Effectrespiratory symptoms after prolonged treatment with nitrofurantoin.
Score Text
0.9797 Visual system side effects caused by Adverse-Effectparasympathetic dysfunction after botulinum toxin type B injections.
0.9661 Adverse-EffectVisual system side effects caused by parasympathetic dysfunction after botulinum toxin type B injections.
0.9609 Visual system side effects caused by parasympathetic dysfunction after Drugbotulinum toxin type B injections.
Score Text
0.9994 Neutropenic colitis during standard dose combination chemotherapy with Drugnedaplatin and irinotecan for testicular cancer.
0.9993 Neutropenic colitis during standard dose combination chemotherapy with nedaplatin and Drugirinotecan for testicular cancer.
0.9922 Adverse-EffectNeutropenic colitis during standard dose combination chemotherapy with nedaplatin and irinotecan for testicular cancer.
Score Text
0.9984 Pharmacokinetic determinants of Drug6 - mercaptopurine myelotoxicity and therapeutic failure in children with acute lymphoblastic leukemia.
0.9299 Pharmacokinetic determinants of 6 - mercaptopurine Adverse-Effectmyelotoxicity and therapeutic failure in children with acute lymphoblastic leukemia.
Score Text
0.9992 This supports the well - reported potential of Drugbleomycin to trigger acral vascular toxicity.
0.9853 This supports the well - reported potential of bleomycin to trigger Adverse-Effectacral vascular toxicity .
Score Text
0.9995 We discuss a variety of bronchopulmonary complications of IBD and their association with Drugsulfasalazine .
0.9695 We discuss a variety of bronchopulmonary complications of Adverse-EffectIBD and their association with sulfasalazine.
Score Text
0.9996 DrugMethotrexate - induced papular eruption following treatment of psoriasis has not been previously reported.
0.9918 Methotrexate - induced Adverse-Effectpapular eruption following treatment of psoriasis has not been previously reported.
Score Text
0.9996 Acute erythroid leukemia after Drugcyclophosphamide therapy for multiple myeloma : report of two cases.
0.9689 Adverse-EffectAcute erythroid leukemia after cyclophosphamide therapy for multiple myeloma : report of two cases.
Score Text
0.9995 We report a case of Drugibuprofen - induced meningitis in an otherwise healthy individual.
0.9989 We report a case of ibuprofen - induced Adverse-Effectmeningitis in an otherwise healthy individual.
Score Text
0.9953 Fatal Drugdigoxin poisoning : an unsuccessful resuscitation with use of digoxin - immune Fab.
0.8115 Adverse-EffectFatal digoxin poisoning : an unsuccessful resuscitation with use of digoxin - immune Fab.
Score Text
0.9994 BACKGROUND : Headaches have been reported as a potential side effect of Drugcapecitabine therapy.
0.9975 BACKGROUND : Adverse-EffectHeadaches have been reported as a potential side effect of capecitabine therapy.
Score Text
0.9993 Transient cardiac arrhythmias related to Druglopinavir / ritonavir in two patients with HIV infection.
0.9992 Transient cardiac arrhythmias related to lopinavir / Drugritonavir in two patients with HIV infection.
0.9640 Adverse-EffectTransient cardiac arrhythmias related to lopinavir / ritonavir in two patients with HIV infection.
Score Text
0.9995 DrugChlorambucil - induced chromosome damage to human lymphocytes is dose - dependent and cumulative.
0.9918 Chlorambucil - induced Adverse-Effectchromosome damage to human lymphocytes is dose - dependent and cumulative.
Score Text
0.9996 A complex pattern of melanonychia and onycholysis after treatment with Drugpemetrexed for lung cancer.
0.9979 A complex pattern of Adverse-Effectmelanonychia and onycholysis after treatment with pemetrexed for lung cancer.
0.9962 A complex pattern of melanonychia and Adverse-Effectonycholysis after treatment with pemetrexed for lung cancer.
Score Text
0.9879 Niflumic acid - induced Adverse-Effectskeletal fluorosis : iatrogenic disease or therapeutic perspective for osteoporosis?
0.9752 DrugNiflumic acid - induced skeletal fluorosis : iatrogenic disease or therapeutic perspective for osteoporosis?
Score Text
0.9996 Bone marrow aplasia and severe skin rash after a single low dose of Drugmethotrexate .
0.9882 Bone marrow aplasia and Adverse-Effectsevere skin rash after a single low dose of methotrexate.
0.9821 Adverse-EffectBone marrow aplasia and severe skin rash after a single low dose of methotrexate.
Score Text
0.9638 Delayed pseudocyst of the pancreas can be a complication of intramuscular DrugL - asparaginase .
0.8995 Adverse-EffectDelayed pseudocyst of the pancreas can be a complication of intramuscular L - asparaginase.
Score Text
0.9993 Drug rash with eosinophilia and systemic symptoms after Drugchlorambucil treatment in chronic lymphocytic leukaemia.
Adverse-EffectDrug rash with eosinophilia and systemic symptoms after chlorambucil treatment in chronic lymphocytic leukaemia.
Score Text
0.9979 The patient was initially treated with hydration and Drugfurosemide but developed congestive heart failure.
0.9876 The patient was initially treated with hydration and furosemide but developed Adverse-Effectcongestive heart failure .
Score Text
0.9987 There are now reports of liver failure following treatment of childhood cancers with DrugAMD .
0.9944 There are now reports of Adverse-Effectliver failure following treatment of childhood cancers with AMD.
Score Text
0.9962 Adverse-EffectCalcification and ossification of the spinal arachnoid after intrathecal administration of Depo - Medrol.
0.9777 Calcification and Adverse-Effectossification of the spinal arachnoid after intrathecal administration of Depo - Medrol.
0.9650 Calcification and ossification of the spinal arachnoid after intrathecal administration of DrugDepo - Medrol .
Score Text
0.9992 The association of central diabetes insipidus ( CDI ) with Druglithium use is rare.
0.9921 The association of central diabetes insipidus ( Adverse-EffectCDI ) with lithium use is rare.
0.9816 The association of Adverse-Effectcentral diabetes insipidus ( CDI ) with lithium use is rare.
Score Text
0.9996 DrugProcainamide - induced incessant supraventricular tachycardia in the Wolff - Parkinson - White syndrome.
0.9709 Procainamide - induced Adverse-Effectincessant supraventricular tachycardia in the Wolff - Parkinson - White syndrome.
Score Text
0.9995 Upper tract urothelial malignancy after Drugcyclophosphamide therapy : a case report and literature review.
0.9741 Adverse-EffectUpper tract urothelial malignancy after cyclophosphamide therapy : a case report and literature review.
Score Text
0.9995 A case of severe visual loss following a single dose of Drugvincristine is described.
0.9828 A case of Adverse-Effectsevere visual loss following a single dose of vincristine is described.
Score Text
0.9995 Graves'hyperthyroidism following transient thyrotoxicosis during Druginterferon therapy for chronic hepatitis type C.
0.9755 Adverse-EffectGraves'hyperthyroidism following transient thyrotoxicosis during interferon therapy for chronic hepatitis type C.
0.9537 Graves'hyperthyroidism following Adverse-Effecttransient thyrotoxicosis during interferon therapy for chronic hepatitis type C.
Score Text
0.9982 After 5 weeks of therapy, she stopped taking Drugpantoprazole due to general malaise.
0.9571 After 5 weeks of therapy, she stopped taking pantoprazole due to Adverse-Effectgeneral malaise .
Score Text
0.9995 Acute severe intoxication with Drugcarbamazepine is associated with seizures, coma and respiratory depression.
0.9985 Acute severe intoxication with carbamazepine is associated with Adverse-Effectseizures , coma and respiratory depression.
0.9940 Acute severe intoxication with carbamazepine is associated with seizures, coma and Adverse-Effectrespiratory depression .
0.9876 Acute severe intoxication with carbamazepine is associated with seizures, Adverse-Effectcoma and respiratory depression.
Score Text
0.9996 OBJECTIVE : To describe a probable case of transient global amnesia caused by Drugpropafenone .
0.9795 OBJECTIVE : To describe a probable case of Adverse-Effecttransient global amnesia caused by propafenone.
Score Text
0.9994 This clinical course suggests that the sensorimotor polyneuropathy may have been caused by Drug5 - ASA .
0.9887 This clinical course suggests that the Adverse-Effectsensorimotor polyneuropathy may have been caused by 5 - ASA.
Score Text
0.9990 Vanishing bile duct and Stevens - Johnson syndrome associated with Drugciprofloxacin treated with tacrolimus.
0.9806 Adverse-EffectVanishing bile duct and Stevens - Johnson syndrome associated with ciprofloxacin treated with tacrolimus.
0.9802 Vanishing bile duct and Adverse-EffectStevens - Johnson syndrome associated with ciprofloxacin treated with tacrolimus.
Score Text
0.9914 Paradoxical precipitation of tonic seizures by Druglorazepam in a child with atypical absence seizures.
0.8368 Adverse-EffectParadoxical precipitation of tonic seizures by lorazepam in a child with atypical absence seizures.
Score Text
0.9996 DrugCaptopril - induced pulmonary infiltrates with eosinophilia in an infant with congenital heart disease.
0.8863 Captopril - induced Adverse-Effectpulmonary infiltrates with eosinophilia in an infant with congenital heart disease.
Score Text
0.9990 Reduction of Drugmethylprednisolone dosage rather than insulin therapy resulted in better control of glycemia.
0.9950 Reduction of methylprednisolone dosage rather than insulin therapy resulted in better control of Adverse-Effectglycemia .
Score Text
0.9837 We report a case of chronic use of HCQ associated with Adverse-Effecttorsade de pointes .
0.9771 We report a case of chronic use of DrugHCQ associated with torsade de pointes.
Score Text
0.9997 Hepatolithiasis ( intrahepatic stone ) during Drugoctreotide therapy for acromegaly : a case report.
0.9981 Adverse-EffectHepatolithiasis ( intrahepatic stone ) during octreotide therapy for acromegaly : a case report.
Score Text
0.9996 We report a case of glaucoma induced by Drugdoxetaxel therapy for metastatic breast cancer.
0.9984 We report a case of Adverse-Effectglaucoma induced by doxetaxel therapy for metastatic breast cancer.
Score Text
0.9988 DrugLithium therapy was discontinued because of poor compliance to the medication and intolerable polyuria.
0.9237 Lithium therapy was discontinued because of poor compliance to the medication and intolerable Adverse-Effectpolyuria .
Score Text
0.9863 Horner's syndrome and Adverse-Effectdemyelinating peripheral neuropathy caused by high - dose cytosine arabinoside.
0.9818 Adverse-EffectHorner's syndrome and demyelinating peripheral neuropathy caused by high - dose cytosine arabinoside.
0.9716 Horner's syndrome and demyelinating peripheral neuropathy caused by high - dose Drugcytosine arabinoside .
Score Text
0.9996 Leiomyosarcoma in urinary bladder after Drugcyclophosphamide therapy for retinoblastoma and review of bladder sarcomas.
0.9965 Adverse-EffectLeiomyosarcoma in urinary bladder after cyclophosphamide therapy for retinoblastoma and review of bladder sarcomas.
Score Text
0.9990 The authors caution that treatment with Drugalprazolam may be complicated by the induction of mania.
0.9963 The authors caution that treatment with alprazolam may be complicated by the induction of Adverse-Effectmania .
Score Text
0.9867 To treat hepatitis B, Druginterferon alpha was administered until the proximal muscle weakness developed.
0.9380 To treat hepatitis B, interferon alpha was administered until the proximal Adverse-Effectmuscle weakness developed.
Score Text
0.9995 Aggressive endometrial carcinoma in a breast cancer patient treated with Drugtamoxifen with normal transvaginal ultrasonography.
0.9794 Adverse-EffectAggressive endometrial carcinoma in a breast cancer patient treated with tamoxifen with normal transvaginal ultrasonography.
Score Text
0.9993 Two children with rheumatic fever developed anicteric hepatitis while on high - dose Drugaspirin therapy.
0.9923 Two children with rheumatic fever developed Adverse-Effectanicteric hepatitis while on high - dose aspirin therapy.
Score Text
0.9996 Myoclonus associated with continuous Drugdobutamine infusion in a patient with end - stage renal disease.
0.9990 Adverse-EffectMyoclonus associated with continuous dobutamine infusion in a patient with end - stage renal disease.
Score Text
0.9803 Induction of Adverse-Effectsystemic lupus erythematosus by interferon - gamma in a patient with rheumatoid arthritis.
0.9638 Induction of systemic lupus erythematosus by Druginterferon - gamma in a patient with rheumatoid arthritis.
Score Text
0.9971 We describe the case of acute hepatitis induced by Druggliclazide , a second generation sulfonylurea.
0.9840 We describe the case of Adverse-Effectacute hepatitis induced by gliclazide, a second generation sulfonylurea.
Score Text
0.9994 DrugAcyclovir produces neurologic symptoms that resemble extension of viral infection into the central nervous system.
0.9892 Acyclovir produces Adverse-Effectneurologic symptoms that resemble extension of viral infection into the central nervous system.
Score Text
0.9981 OBJECTIVE : To report the occurrence of anaphylactoid reactions to intraperitoneal Drugcisplatin in 3 patients.
0.9904 OBJECTIVE : To report the occurrence of Adverse-Effectanaphylactoid reactions to intraperitoneal cisplatin in 3 patients.
Score Text
0.9965 A case of Adverse-Effectpolymyositis with dilated cardiomyopathy associated with interferon alpha treatment for hepatitis B.
0.9850 A case of polymyositis with dilated cardiomyopathy associated with Druginterferon alpha treatment for hepatitis B.
0.9803 A case of polymyositis with Adverse-Effectdilated cardiomyopathy associated with interferon alpha treatment for hepatitis B.
Score Text
0.9995 Focal glomerulonephritis and interstitial nephritis in Drugmethicillin - treated, heroin - related infective endocarditis.
0.9793 Adverse-EffectFocal glomerulonephritis and interstitial nephritis in methicillin - treated, heroin - related infective endocarditis.
0.9793 Focal glomerulonephritis and Adverse-Effectinterstitial nephritis in methicillin - treated, heroin - related infective endocarditis.
Score Text
0.9996 We describe two women who developed HUS after DrugMMC therapy and presented massive pulmonary bleeding.
0.9984 We describe two women who developed Adverse-EffectHUS after MMC therapy and presented massive pulmonary bleeding.
0.9829 We describe two women who developed HUS after MMC therapy and presented Adverse-Effectmassive pulmonary bleeding .
Score Text
0.9996 Basilar invagination and mid - line skeletal abnormalities due to in utero exposure to Drugphenytoin .
0.9877 Adverse-EffectBasilar invagination and mid - line skeletal abnormalities due to in utero exposure to phenytoin.
0.9745 Basilar invagination and Adverse-Effectmid - line skeletal abnormalities due to in utero exposure to phenytoin.
Score Text
0.9996 CONCLUSIONS : There is very little published information regarding Drugofloxacin - induced toxic epidermal necrolysis.
0.9853 CONCLUSIONS : There is very little published information regarding ofloxacin - induced Adverse-Effecttoxic epidermal necrolysis .
Score Text
0.9991 While undergoing treatment with Drugalbendazole , he developed worsening diarrhea with abdominal pain and fever.
0.9889 While undergoing treatment with albendazole, he developed worsening diarrhea with Adverse-Effectabdominal pain and fever.
0.9815 While undergoing treatment with albendazole, he developed worsening diarrhea with abdominal pain and Adverse-Effectfever .
0.9757 While undergoing treatment with albendazole, he developed Adverse-Effectworsening diarrhea with abdominal pain and fever.
Score Text
0.9994 This is the first report of pulmonary hypertension in an adult patient during Druglithium therapy.
0.9881 This is the first report of Adverse-Effectpulmonary hypertension in an adult patient during lithium therapy.
Score Text
0.9977 Cystoid macular edema in a low - risk patient after switching from Druglatanoprost to bimatoprost.
0.9974 Cystoid macular edema in a low - risk patient after switching from latanoprost to Drugbimatoprost .
0.9864 Adverse-EffectCystoid macular edema in a low - risk patient after switching from latanoprost to bimatoprost.
Score Text
0.9993 The patient's arthritis flared after the second infusion of Druginfliximab , which was discontinued.
0.9857 The patient's Adverse-Effectarthritis flared after the second infusion of infliximab, which was discontinued.
Score Text
0.9993 Therefore, parenteral Drugamiodarone was implicated as the cause of acute hepatitis in this patient.
0.9864 Therefore, parenteral amiodarone was implicated as the cause of Adverse-Effectacute hepatitis in this patient.
Score Text
0.9991 The other patient developed transient intraoperative hypertension immediately after inadvertent submucosal injection of concentrated Drugepinephrine .
0.9773 The other patient developed Adverse-Effecttransient intraoperative hypertension immediately after inadvertent submucosal injection of concentrated epinephrine.
Score Text
0.9995 Sustained ventricular tachycardia in a Drugthalidomide - treated patient with primary plasma - cell leukemia.
0.9747 Adverse-EffectSustained ventricular tachycardia in a thalidomide - treated patient with primary plasma - cell leukemia.
Score Text
0.9839 Vogt - Koyanagi - Harada disease occurring during Druginterferon alpha therapy for chronic hepatitis C.
0.9770 Adverse-EffectVogt - Koyanagi - Harada disease occurring during interferon alpha therapy for chronic hepatitis C.
Score Text
0.9990 Following discontinuation of Drugclozapine , she was rechallenged and again was observed to have seizures.
0.9989 Following discontinuation of clozapine, she was rechallenged and again was observed to have Adverse-Effectseizures .
Score Text
0.9985 Discontinuation of simvastatin and Drugcyclosporine resulted in resolution of rhabdomyolysis and normalization of renal function.
0.9983 Discontinuation of Drugsimvastatin and cyclosporine resulted in resolution of rhabdomyolysis and normalization of renal function.
0.9976 Discontinuation of simvastatin and cyclosporine resulted in resolution of Adverse-Effectrhabdomyolysis and normalization of renal function.
Score Text
0.9994 DrugClozapine is speculated to cause rhabdomyolysis in patients with defective calcium - activated K + channels.
0.9974 Clozapine is speculated to cause Adverse-Effectrhabdomyolysis in patients with defective calcium - activated K + channels.
Score Text
0.9994 Recurrent palmar - plantar erythrodysaesthesia following high - dose Drugcytarabine treatment for acute lymphoblastic leukemia.
0.9052 Adverse-EffectRecurrent palmar - plantar erythrodysaesthesia following high - dose cytarabine treatment for acute lymphoblastic leukemia.
Recurrent Adverse-Effectpalmar - plantar erythrodysaesthesia following high - dose cytarabine treatment for acute lymphoblastic leukemia.
Score Text
0.9994 Renal tubular acidosis secondary to DrugFK506 in living donor liver transplantation : a case report.
0.9861 Adverse-EffectRenal tubular acidosis secondary to FK506 in living donor liver transplantation : a case report.
Score Text
0.9986 A 58 - year - old man with rheumatoid arthritis developed lichen planus during treatment with Druggold .
0.9934 A 58 - year - old man with rheumatoid arthritis developed Adverse-Effectlichen planus during treatment with gold.
Score Text
0.9988 We present an AIDS patient with severe and prolonged lactic acidosis on stavudine and Druglamivudine .
0.9987 We present an AIDS patient with severe and prolonged lactic acidosis on Drugstavudine and lamivudine.
0.9600 We present an AIDS patient with severe and prolonged Adverse-Effectlactic acidosis on stavudine and lamivudine.
Score Text
0.9988 DrugDiphenylhydantoin apparently adversely affected both the clinical and biochemical parameters of the acute intermittent porphyria.
0.9773 Diphenylhydantoin apparently adversely affected both the clinical and biochemical parameters of the Adverse-Effectacute intermittent porphyria .
Score Text
0.9994 Two patients who were receiving DrugTolazoline by infusion developed duodenal ulceration and subsequent intestinal perforation.
0.9909 Two patients who were receiving Tolazoline by infusion developed Adverse-Effectduodenal ulceration and subsequent intestinal perforation.
0.9894 Two patients who were receiving Tolazoline by infusion developed duodenal ulceration and subsequent Adverse-Effectintestinal perforation .
Score Text
0.9992 Here, we report a case of DrugRFP - induced hypothyroidism without underlying thyroid disease.
0.9971 Here, we report a case of RFP - induced Adverse-Effecthypothyroidism without underlying thyroid disease.
Score Text
0.9996 Generalized maculopapular and papular purpuric eruptions are perhaps the most common Drugthionamide - induced reactions.
0.9323 Adverse-EffectGeneralized maculopapular and papular purpuric eruptions are perhaps the most common thionamide - induced reactions.
Score Text
0.9995 This case illustrates the potential decoupling of PSA response from disease status in Drugflutamide withdrawal.
0.9770 This case illustrates the potential Adverse-Effectdecoupling of PSA response from disease status in flutamide withdrawal.
Score Text
0.9993 Intracranial haemorrhage from a meningioma in a patient receiving Drugaspirin prophylaxis : a case report.
0.9884 Adverse-EffectIntracranial haemorrhage from a meningioma in a patient receiving aspirin prophylaxis : a case report.
Score Text
0.9988 It is likely that DrugRA contributed to the deterioration in renal function in these patients.
0.9645 It is likely that RA contributed to the Adverse-Effectdeterioration in renal function in these patients.
Score Text
0.9990 We report the case of a 21 - year - old female patient with Drugdapsone hypersensitivity syndrome.
0.9269 We report the case of a 21 - year - old female patient with dapsone Adverse-Effecthypersensitivity syndrome .
Score Text
0.9993 DrugNitrofurantoin - induced lung disease : two cases demonstrating resolution of apparently irreversible CT abnormalities.
0.9920 Nitrofurantoin - induced Adverse-Effectlung disease : two cases demonstrating resolution of apparently irreversible CT abnormalities.
Score Text
0.9984 Severe hemolytic uremic syndrome in an advanced ovarian cancer patient treated with carboplatin and Druggemcitabine .
0.9981 Severe hemolytic uremic syndrome in an advanced ovarian cancer patient treated with Drugcarboplatin and gemcitabine.
0.9562 Adverse-EffectSevere hemolytic uremic syndrome in an advanced ovarian cancer patient treated with carboplatin and gemcitabine.
Score Text
0.9987 Adverse-EffectPolyarthritis , hepatitis and anti - native DNA antibodies after treatment with ethambutol and rifampicin.
0.9986 Polyarthritis, hepatitis and anti - native DNA antibodies after treatment with ethambutol and Drugrifampicin .
0.9984 Polyarthritis, hepatitis and anti - native DNA antibodies after treatment with Drugethambutol and rifampicin.
0.9981 Polyarthritis, Adverse-Effecthepatitis and anti - native DNA antibodies after treatment with ethambutol and rifampicin.
0.9686 Polyarthritis, hepatitis and Adverse-Effectanti - native DNA antibodies after treatment with ethambutol and rifampicin.
Score Text
0.9987 There was a clear relationship between restarting the DrugAccutane and recurrence of the transient myopia.
0.9865 There was a clear relationship between restarting the Accutane and recurrence of the Adverse-Effecttransient myopia .
Score Text
0.9873 To our knowledge, this is the first Adverse-Effectgranulomatous reaction described after calcium hydroxylapatite injection.
0.9873 To our knowledge, this is the first granulomatous reaction described after Drugcalcium hydroxylapatite injection.
Score Text
0.9976 Myelodysplasia terminating in acute myeloid leukemia in a hairy cell leukemia patient treated with Drug2 - deoxycoformycin .
0.9966 Adverse-EffectMyelodysplasia terminating in acute myeloid leukemia in a hairy cell leukemia patient treated with 2 - deoxycoformycin.
0.9580 Myelodysplasia terminating in Adverse-Effectacute myeloid leukemia in a hairy cell leukemia patient treated with 2 - deoxycoformycin.
Score Text
0.9979 Proconvulsive tendency of Drugimipenem / cilastatin is one of its well - known side effects.
0.9978 Proconvulsive tendency of imipenem / Drugcilastatin is one of its well - known side effects.
Adverse-EffectProconvulsive tendency of imipenem / cilastatin is one of its well - known side effects.
Score Text
0.9975 Thoracoscopic biopsy to confirm metastasis revealed instead fibrotic lesions apparently attributable to bleomycin or Drugcyclophosphamide .
0.9974 Thoracoscopic biopsy to confirm metastasis revealed instead fibrotic lesions apparently attributable to Drugbleomycin or cyclophosphamide.
0.9883 Thoracoscopic biopsy to confirm metastasis revealed instead Adverse-Effectfibrotic lesions apparently attributable to bleomycin or cyclophosphamide.
Score Text
0.9996 DrugFlecainide - associated pneumonitis with acute respiratory failure in a patient with the LEOPARD syndrome.
0.9979 Flecainide - associated Adverse-Effectpneumonitis with acute respiratory failure in a patient with the LEOPARD syndrome.
0.9854 Flecainide - associated pneumonitis with Adverse-Effectacute respiratory failure in a patient with the LEOPARD syndrome.
Score Text
0.9879 We report a case of contact dermatitis due to Drugsodium bisulfite in Tathion eye drops.
0.9844 We report a case of Adverse-Effectcontact dermatitis due to sodium bisulfite in Tathion eye drops.
Score Text
0.9992 Neutrophilic eccrine hidradenitis mimicking cutaneous vasculitis in a lupus patient : a complication of Drugcyclophosphamide .
0.9763 Adverse-EffectNeutrophilic eccrine hidradenitis mimicking cutaneous vasculitis in a lupus patient : a complication of cyclophosphamide.
Score Text
0.9807 Epsilon - aminocaproic acid and Adverse-Effectrenal complications : case report and review of the literature.
0.9390 DrugEpsilon - aminocaproic acid and renal complications : case report and review of the literature.
Score Text
0.9842 The use of beclomethasone diproprionate inhaler complicated by the development of an Adverse-Effecteosinophilic pneumonia reaction .
0.9629 The use of Drugbeclomethasone diproprionate inhaler complicated by the development of an eosinophilic pneumonia reaction.
Score Text
0.9990 De novo absence status of late onset following withdrawal of Druglorazepam : a case report.
0.9511 Adverse-EffectDe novo absence status of late onset following withdrawal of lorazepam : a case report.
Score Text
0.9816 Two elderly women suffered an acute deterioration of renal function after treatment with Drugcefoxitin sodium .
0.9739 Two elderly women suffered an Adverse-Effectacute deterioration of renal function after treatment with cefoxitin sodium.
Score Text
0.9970 Case study : a modified topical treatment regimen for sodium Drugwarfarin - induced necrotizing fasciitis.
0.9900 Case study : a modified topical treatment regimen for sodium warfarin - induced Adverse-Effectnecrotizing fasciitis .
Score Text
0.9902 Adverse-EffectThyroid dysfunction has been reported in patients with malignant disease treated with recombinant alpha interferon.
0.9518 Thyroid dysfunction has been reported in patients with malignant disease treated with Drugrecombinant alpha interferon .
Score Text
0.9947 BACKGROUND : DrugAccutane a teratogenic prescription drug licensed to treat severe, recalcitrant nodular acne.
0.9707 BACKGROUND : Accutane a Adverse-Effectteratogenic prescription drug licensed to treat severe, recalcitrant nodular acne.
Score Text
0.9994 The use of Drugcyclosporin has been associated with the development of cholelithiasis in transplant recipients.
0.9985 The use of cyclosporin has been associated with the development of Adverse-Effectcholelithiasis in transplant recipients.
Score Text
0.9990 CONCLUSION : These cases suggest that Drugmoxifloxacin may interfere with the healing of corneal ulcers.
0.9724 CONCLUSION : These cases suggest that moxifloxacin may interfere with the healing of Adverse-Effectcorneal ulcers .
Score Text
0.9995 The literature on Drugthiabendazole - induced cholestasis and its association with sicca complex is reviewed.
0.9972 The literature on thiabendazole - induced Adverse-Effectcholestasis and its association with sicca complex is reviewed.
0.9935 The literature on thiabendazole - induced cholestasis and its association with Adverse-Effectsicca complex is reviewed.
Score Text
0.9882 Patients with vitamin B12 deficiency are exceedingly sensitive to neurologic deterioration following Drugnitrous oxide anesthesia.
0.9721 Patients with vitamin B12 deficiency are exceedingly sensitive to Adverse-Effectneurologic deterioration following nitrous oxide anesthesia.
Score Text
0.9993 Clinicians should include Drugphenolphthalein in their list of possible causes of drug - induced TEN.
0.9989 Clinicians should include phenolphthalein in their list of possible causes of drug - induced Adverse-EffectTEN .
Score Text
0.9992 DrugStatin - associated myasthenia gravis : report of 4 cases and review of the literature.
0.9911 Statin - associated Adverse-Effectmyasthenia gravis : report of 4 cases and review of the literature.
Score Text
0.9996 Fever, pulmonary infiltrates, and pleural effusion following Drugacyclovir therapy for herpes zoster ophthalmicus.
0.9872 Fever, pulmonary infiltrates, and Adverse-Effectpleural effusion following acyclovir therapy for herpes zoster ophthalmicus.
0.9860 Adverse-EffectFever , pulmonary infiltrates, and pleural effusion following acyclovir therapy for herpes zoster ophthalmicus.
0.9771 Fever, Adverse-Effectpulmonary infiltrates , and pleural effusion following acyclovir therapy for herpes zoster ophthalmicus.
Score Text
0.9980 However, other factors or drugs ( e. g. Drugcresol ) are thought to induce MH.
0.9961 However, other factors or drugs ( e. g. cresol ) are thought to induce Adverse-EffectMH .
Score Text
0.9989 We report two cases of neutropenia following Drugcaptopril use in cardiac patients with trisomy 21.
0.9972 We report two cases of Adverse-Effectneutropenia following captopril use in cardiac patients with trisomy 21.
Score Text
0.9991 Life - threatening alterations in heart rate after the use of Drugadenosine in atrial flutter.
0.9775 Life - threatening Adverse-Effectalterations in heart rate after the use of adenosine in atrial flutter.
Score Text
0.9993 A case of liver damage following treatment with DrugDanazol for fibrocystic breast disease is reported.
0.9932 A case of Adverse-Effectliver damage following treatment with Danazol for fibrocystic breast disease is reported.
Score Text
0.9993 Alopecia, nausea, and vomiting were attributed to the Drugcyclophosphamide component of the therapy.
0.9990 Adverse-EffectAlopecia , nausea, and vomiting were attributed to the cyclophosphamide component of the therapy.
0.9989 Alopecia, nausea, and Adverse-Effectvomiting were attributed to the cyclophosphamide component of the therapy.
0.9988 Alopecia, Adverse-Effectnausea , and vomiting were attributed to the cyclophosphamide component of the therapy.
Score Text
0.9978 In one case, the readministration of riluzole was followed by the relapse of Adverse-Effecthepatitis .
0.9952 In one case, the readministration of Drugriluzole was followed by the relapse of hepatitis.
Score Text
0.9993 Subfulminant hepatitis B after Druginfliximab in Crohn's disease : need for HBV - screening?
0.9516 Adverse-EffectSubfulminant hepatitis B after infliximab in Crohn's disease : need for HBV - screening?
Score Text
0.9809 Adverse-EffectSystemic capillary leak syndrome after granulocyte colony - stimulating factor ( G - CSF ).
0.9559 Systemic capillary leak syndrome after Druggranulocyte colony - stimulating factor ( G - CSF ).
0.9443 Systemic capillary leak syndrome after granulocyte colony - stimulating factor ( DrugG - CSF ).
Score Text
0.9990 Markedly increased pigmementation of skin immediately overlying veins used for multiple Drug5 - fluorouracil infusions was noted.
0.9745 Markedly Adverse-Effectincreased pigmementation of skin immediately overlying veins used for multiple 5 - fluorouracil infusions was noted.
Score Text
0.9993 Severe hyperkalemia as a complication of Drugtimolol , a topically applied beta - adrenergic antagonist.
0.9419 Adverse-EffectSevere hyperkalemia as a complication of timolol, a topically applied beta - adrenergic antagonist.
Score Text
0.9991 This is the second report of lactic acidosis in a patient on stavudine and Druglamivudine .
0.9990 This is the second report of lactic acidosis in a patient on Drugstavudine and lamivudine.
0.9918 This is the second report of Adverse-Effectlactic acidosis in a patient on stavudine and lamivudine.
Score Text
0.9995 Drug - induced eosinophilia is a non - dose - dependent side effect of Drugclozapine .
0.9984 Drug - induced Adverse-Effecteosinophilia is a non - dose - dependent side effect of clozapine.
Score Text
0.9991 A review of the literature showed no previous description of this pattern in Drugbenzodiazepine coma.
0.9896 A review of the literature showed no previous description of this pattern in benzodiazepine Adverse-Effectcoma .
0.4425 A review of the literature showed no previous description of this pattern in Adverse-Effectbenzodiazepine coma .
Score Text
0.9993 We report a case of intrathecal Drugmethotrexate neurotoxicity manifesting as left arm weakness and aphasia.
0.9962 We report a case of intrathecal methotrexate neurotoxicity manifesting as left arm weakness and Adverse-Effectaphasia .
0.9739 We report a case of intrathecal methotrexate neurotoxicity manifesting as Adverse-Effectleft arm weakness and aphasia.
0.9493 We report a case of intrathecal methotrexate Adverse-Effectneurotoxicity manifesting as left arm weakness and aphasia.
Score Text
0.9985 Prior neurologic illness and the syndrome of irreversible Druglithium - effectuated neurotoxicity ( SILENT ).
0.9949 Prior neurologic illness and the syndrome of irreversible lithium - effectuated Adverse-Effectneurotoxicity ( SILENT ).
Score Text
0.9995 Herein we report four patients who underwent liver transplantation and developed neutropenia while receiving DrugMMF .
0.9681 Herein we report four patients who underwent liver transplantation and developed Adverse-Effectneutropenia while receiving MMF.
Score Text
0.9736 Multiple myeloma complicated by Adverse-Effectcongestive heart failure following first administration of recombinant alpha - interferon.
0.9142 Multiple myeloma complicated by congestive heart failure following first administration of Drugrecombinant alpha - interferon .
Score Text
0.9997 Thus, Drugtacrolimus - induced HUS is a rare cause of ARF in nephrotic syndrome.
0.9981 Thus, tacrolimus - induced Adverse-EffectHUS is a rare cause of ARF in nephrotic syndrome.
0.9965 Thus, tacrolimus - induced HUS is a rare cause of Adverse-EffectARF in nephrotic syndrome.
Score Text
0.9996 According to the Naranjo probability scale, the papular eruption was probably caused by Drugmethotrexate .
0.9924 According to the Naranjo probability scale, the Adverse-Effectpapular eruption was probably caused by methotrexate.
Score Text
0.9995 Cerebral demyelinating disease developed in a patient during adjuvant therapy with Druglevamisole for malignant melanoma.
0.9838 Adverse-EffectCerebral demyelinating disease developed in a patient during adjuvant therapy with levamisole for malignant melanoma.
Score Text
0.9990 However, re - initiation of Drugsunitinib treatment was followed by bilateral breast enlargement again.
0.9818 However, re - initiation of sunitinib treatment was followed by Adverse-Effectbilateral breast enlargement again.
Score Text
0.9975 Two patients developed diabetic coma when taking a combination of a Drugthiazide diuretic and propranolol.
0.9965 Two patients developed diabetic coma when taking a combination of a thiazide diuretic and Drugpropranolol .
0.9937 Two patients developed Adverse-Effectdiabetic coma when taking a combination of a thiazide diuretic and propranolol.
Score Text
0.9994 Surprisingly, we found that three patients appeared to develop tardive OGC while taking Drugclozapine .
0.9931 Surprisingly, we found that three patients appeared to develop Adverse-Effecttardive OGC while taking clozapine.
Score Text
0.9995 So far, few cases of pulmonary side effects caused by Drugticlopidine have been reported.
0.9844 So far, few cases of Adverse-Effectpulmonary side effects caused by ticlopidine have been reported.
Score Text
0.9988 CONCLUSION : The present findings suggest that Drugfluvoxamine can cause increased libido in some patients.
0.9907 CONCLUSION : The present findings suggest that fluvoxamine can cause Adverse-Effectincreased libido in some patients.
Score Text
0.9991 Renal hypophosphatemia in this patient was caused by the erroneous intake of 1 g Drugdoxycycline .
0.9865 Adverse-EffectRenal hypophosphatemia in this patient was caused by the erroneous intake of 1 g doxycycline.
Score Text
0.9997 Fatal pulmonary fibrosis induced by Drugpaclitaxel : a case report and review of the literature.
0.9856 Adverse-EffectFatal pulmonary fibrosis induced by paclitaxel : a case report and review of the literature.
Score Text
0.9992 Adrenal suppression in a fetus due to administration of Drugmethylprednisolone has hitherto been rarely published.
0.9792 Adverse-EffectAdrenal suppression in a fetus due to administration of methylprednisolone has hitherto been rarely published.
Score Text
0.9985 Cis - retinoic acid ( RA ) may further increase the risk of developing Adverse-EffectBMTN .
0.9658 DrugCis - retinoic acid ( RA ) may further increase the risk of developing BMTN.
0.9597 Cis - retinoic acid ( DrugRA ) may further increase the risk of developing BMTN.
Score Text
0.9991 We describe 3 cases of Drugdiphenhydramine - induced cardiac toxicity that were responsive to bicarbonate.
0.9915 We describe 3 cases of diphenhydramine - induced Adverse-Effectcardiac toxicity that were responsive to bicarbonate.
Score Text
0.9991 DrugPropoxyphene - induced wide QRS complex dysrhythmia responsive to sodium bicarbonate - - a case report.
0.9788 Propoxyphene - induced Adverse-Effectwide QRS complex dysrhythmia responsive to sodium bicarbonate - - a case report.
Score Text
0.9993 Pleuropulmonary fibrosis after long - term treatment with the dopamine agonist Drugpergolide for Parkinson Disease.
0.9894 Adverse-EffectPleuropulmonary fibrosis after long - term treatment with the dopamine agonist pergolide for Parkinson Disease.
Score Text
0.9853 Acute onset of Adverse-Effectnephrotic syndrome during interferon - alpha retreatment for chronic active hepatitis C.
0.9682 Acute onset of nephrotic syndrome during Druginterferon - alpha retreatment for chronic active hepatitis C.
Score Text
0.9991 Sweet's syndrome associated with Drugsargramostim ( granulocyte - macrophage colony stimulating factor ) treatment.
0.9822 Adverse-EffectSweet's syndrome associated with sargramostim ( granulocyte - macrophage colony stimulating factor ) treatment.
Score Text
0.9995 We report the first case of Drugdoxycycline - induced hypoglycemia in a young nondiabetic man.
0.9980 We report the first case of doxycycline - induced Adverse-Effecthypoglycemia in a young nondiabetic man.
Score Text
0.9862 Under the suspicion of amiodarone - induced Adverse-Effectacute pancreatitis , amiodarone was substituted by propafenone.
0.9327 Under the suspicion of Drugamiodarone - induced acute pancreatitis, amiodarone was substituted by propafenone.
Score Text
0.9995 A diagnosis of Druginfliximab - induced lupus was made and the drug treatment was withdrawn.
0.9982 A diagnosis of infliximab - induced Adverse-Effectlupus was made and the drug treatment was withdrawn.
Score Text
0.9966 Aggressive management of doxorubicin - induced Adverse-Effectcardiomyopathy associated with'low'doses of doxorubicin.
0.9422 Aggressive management of Drugdoxorubicin - induced cardiomyopathy associated with'low'doses of doxorubicin.
0.8350 Aggressive management of doxorubicin - induced cardiomyopathy associated with'low'doses of Drugdoxorubicin .
Score Text
0.9994 Hypertension develops in most patients after transplantation when immunosuppression is based on cyclosporine and Drugprednisone .
0.9993 Hypertension develops in most patients after transplantation when immunosuppression is based on Drugcyclosporine and prednisone.
0.9983 Adverse-EffectHypertension develops in most patients after transplantation when immunosuppression is based on cyclosporine and prednisone.
Score Text
0.9995 However, each infant demonstrated hemodynamic decompensation shortly after Drugverapamil administration and required cardiopulmonary resuscitation.
0.9876 However, each infant demonstrated Adverse-Effecthemodynamic decompensation shortly after verapamil administration and required cardiopulmonary resuscitation.
Score Text
0.9995 A case of aseptic pleuropericarditis in a patient with chronic plaque psoriasis under Drugmethotrexate therapy.
0.9804 A case of Adverse-Effectaseptic pleuropericarditis in a patient with chronic plaque psoriasis under methotrexate therapy.
Score Text
0.9995 We report a case of a bullous lichenoid eruption due to the intake of Drugcaptopril .
0.9870 We report a case of a Adverse-Effectbullous lichenoid eruption due to the intake of captopril.
Score Text
0.9934 Therapy with IFN - beta has rarely been associated with the development of Adverse-Effectautoimmune disorders .
0.9692 Therapy with DrugIFN - beta has rarely been associated with the development of autoimmune disorders.
Score Text
0.9990 The side effects of DrugMMF , such as bone marrow toxicity, have been reported.
0.9857 The side effects of MMF, such as Adverse-Effectbone marrow toxicity , have been reported.
Score Text
0.9985 Adverse-EffectHypoglycemia induced by long - acting somatostatin analogues in a patient with nonfunctional neuroendocrine tumor.
0.9973 Hypoglycemia induced by long - acting Drugsomatostatin analogues in a patient with nonfunctional neuroendocrine tumor.
Score Text
0.9996 PURPOSE : Symptomatic visual field constriction thought to be associated with Drugvigabatrin has been reported.
0.9639 PURPOSE : Symptomatic Adverse-Effectvisual field constriction thought to be associated with vigabatrin has been reported.
Score Text
0.9993 An 11 - day - old infant became lethargic and apneic after a single drop of Drugbrimonidine .
0.9972 An 11 - day - old infant became Adverse-Effectlethargic and apneic after a single drop of brimonidine.
0.9956 An 11 - day - old infant became lethargic and Adverse-Effectapneic after a single drop of brimonidine.
Score Text
0.9993 Ballistic movements due to ischemic infarcts after intravenous Drugheroin overdose : report of two cases.
0.9838 Adverse-EffectBallistic movements due to ischemic infarcts after intravenous heroin overdose : report of two cases.
0.9766 Ballistic movements due to Adverse-Effectischemic infarcts after intravenous heroin overdose : report of two cases.
Score Text
0.9989 Although myelosuppression is mild, immunosuppression and superinfection are potential hazards of treatment with DrugDCF .
0.9745 Although myelosuppression is mild, immunosuppression and Adverse-Effectsuperinfection are potential hazards of treatment with DCF.
0.9418 Although myelosuppression is mild, Adverse-Effectimmunosuppression and superinfection are potential hazards of treatment with DCF.
Score Text
0.9984 To our knowledge, this recurrence of Drugamiodarone pulmonary toxicity has not been reported previously.
0.8608 To our knowledge, this recurrence of amiodarone Adverse-Effectpulmonary toxicity has not been reported previously.
Score Text
0.9994 CONCLUSION : Squamous metaplasia in these cases appears to be a consequence of Drugprogestin therapy.
0.9793 CONCLUSION : Adverse-EffectSquamous metaplasia in these cases appears to be a consequence of progestin therapy.
Score Text
0.9989 We describe a patient in whom noncardiogenic pulmonary edema developed during intrabiliary infusion of Drugmonooctanoin .
0.9843 We describe a patient in whom Adverse-Effectnoncardiogenic pulmonary edema developed during intrabiliary infusion of monooctanoin.
Score Text
0.9993 Occurrence of withdrawal dyskinesia indicates that the neuroleptic effects of Drugamoxapine may be clinically significant.
0.9953 Occurrence of withdrawal Adverse-Effectdyskinesia indicates that the neuroleptic effects of amoxapine may be clinically significant.
Score Text
0.9942 Pulmonary fibrosis is a severe complication associated with bis - chloronitrosourea ( DrugBCNU ) therapy.
0.9893 Adverse-EffectPulmonary fibrosis is a severe complication associated with bis - chloronitrosourea ( BCNU ) therapy.
0.9662 Pulmonary fibrosis is a severe complication associated with Drugbis - chloronitrosourea ( BCNU ) therapy.
Score Text
0.9996 Clinicians should be aware of the possibility that Drugvinorelbine may cause SIADH and possibly hypokalemia.
0.9981 Clinicians should be aware of the possibility that vinorelbine may cause SIADH and possibly Adverse-Effecthypokalemia .
0.9979 Clinicians should be aware of the possibility that vinorelbine may cause Adverse-EffectSIADH and possibly hypokalemia.
Score Text
0.9993 Early recognition of renal toxicity of high - dose Drugmethotrexate therapy : a case report.
0.9885 Early recognition of Adverse-Effectrenal toxicity of high - dose methotrexate therapy : a case report.
Score Text
0.9981 Reactivation of cytomegalovirus probably followed the treatment of Wegener's granulomatosis with corticosteroids and Drugazathioprine .
0.9504 Adverse-EffectReactivation of cytomegalovirus probably followed the treatment of Wegener's granulomatosis with corticosteroids and azathioprine.
Score Text
0.9948 Adverse-EffectInfections are a major adverse effect during the treatment with anti - TNF - alpha.
0.9483 Infections are a major adverse effect during the treatment with Druganti - TNF - alpha .
Score Text
0.9994 A 15 - kg weight gain developed in a patient during the third week of Drugibuprofen therapy.
0.9824 A Adverse-Effect15 - kg weight gain developed in a patient during the third week of ibuprofen therapy.
Score Text
0.9995 Nephrogenic diabetes insipidus ( NDI ) is a well - documented complication of Druglithium use.
0.9965 Nephrogenic diabetes insipidus ( Adverse-EffectNDI ) is a well - documented complication of lithium use.
0.9820 Adverse-EffectNephrogenic diabetes insipidus ( NDI ) is a well - documented complication of lithium use.
Score Text
0.9987 Introduction of Drugetanercept was also clinically effective but followed by development of severe heart failure.
0.9915 Introduction of etanercept was also clinically effective but followed by development of Adverse-Effectsevere heart failure .
Score Text
0.9698 Nineteen cases of unusual enhanced Drugvincristine neurotoxicity related to itraconazole have been reported in children.
0.9315 Nineteen cases of unusual enhanced vincristine neurotoxicity related to Drugitraconazole have been reported in children.
0.8451 Nineteen cases of unusual enhanced vincristine Adverse-Effectneurotoxicity related to itraconazole have been reported in children.
Score Text
0.9990 DrugPropranolol : an unrecognized cause of central nervous system dysfunction in patients undergoing cardiopulmonary bypass.
0.9804 Propranolol : an unrecognized cause of Adverse-Effectcentral nervous system dysfunction in patients undergoing cardiopulmonary bypass.
Score Text
0.9984 Severe acidosis in patients taking Drugmetformin - - rapid reversal and survival despite high APACHE score.
0.9888 Adverse-EffectSevere acidosis in patients taking metformin - - rapid reversal and survival despite high APACHE score.
Score Text
0.9994 We report on a child with fatal Drugvalproate - related hepatotoxic effects despite this supplementation.
0.9736 We report on a child with fatal valproate - related Adverse-Effecthepatotoxic effects despite this supplementation.
We report on a child with Adverse-Effectfatal valproate - related hepatotoxic effects despite this supplementation.
Score Text
0.9994 Hypogammaglobulinemia associated with Druggold therapy : evidence for a partial maturation blockade of B cells.
0.9966 Adverse-EffectHypogammaglobulinemia associated with gold therapy : evidence for a partial maturation blockade of B cells.
Score Text
0.9973 DrugErythromycin is a macrolide antibiotic that may increase the risk of lovastatin - induced rhabdomyolysis.
0.9965 Erythromycin is a macrolide antibiotic that may increase the risk of lovastatin - induced Adverse-Effectrhabdomyolysis .
0.9961 Erythromycin is a macrolide antibiotic that may increase the risk of Druglovastatin - induced rhabdomyolysis.
Score Text
0.9992 The mechanism of anaphylactoid reaction to Drugzomepirac in this case, therefore, remains unclear.
0.9864 The mechanism of Adverse-Effectanaphylactoid reaction to zomepirac in this case, therefore, remains unclear.
Score Text
0.9993 However, the occurrence and management of akathisia induced by Drugfluvoxamine have not been described.
0.9964 However, the occurrence and management of Adverse-Effectakathisia induced by fluvoxamine have not been described.
Score Text
0.9970 Upon discontinuation of DrugMTX , her ascites resolved, and her arthritis became more active.
0.9944 Upon discontinuation of MTX, her Adverse-Effectascites resolved, and her arthritis became more active.
Score Text
0.9996 Pulmonary fibrosis is a complication of Drugpaclitaxel therapy that may occur despite treatments with corticosteroids.
0.9916 Adverse-EffectPulmonary fibrosis is a complication of paclitaxel therapy that may occur despite treatments with corticosteroids.
Score Text
0.9994 Onset of male gynaecomastia in a patient treated with Drugsunitinib for metastatic renal cell carcinoma.
0.9703 Onset of male Adverse-Effectgynaecomastia in a patient treated with sunitinib for metastatic renal cell carcinoma.
Score Text
0.9980 Adverse-EffectMethemoglobinemia after axillary block with bupivacaine and additional injection of lidocaine in the operative field.
0.9976 Methemoglobinemia after axillary block with Drugbupivacaine and additional injection of lidocaine in the operative field.
0.9968 Methemoglobinemia after axillary block with bupivacaine and additional injection of Druglidocaine in the operative field.
Score Text
0.9994 Acute dystonia with thalamic and brainstem lesions after initial Drugpenicillamine treatment in Wilson's disease.
0.9850 Adverse-EffectAcute dystonia with thalamic and brainstem lesions after initial penicillamine treatment in Wilson's disease.
0.9714 Acute dystonia with Adverse-Effectthalamic and brainstem lesions after initial penicillamine treatment in Wilson's disease.
Score Text
0.9868 In two patients Drugclozapine was reinstated after risperidone was discontinued ; serum triglyceride levels increased.
0.9740 In two patients clozapine was reinstated after risperidone was discontinued ; Adverse-Effectserum triglyceride levels increased .
Score Text
0.9993 DrugNifedipine may induce, or aggravate, pre - existing, gastro - oesophageal reflux.
0.9587 Nifedipine may induce, or aggravate, pre - existing, Adverse-Effectgastro - oesophageal reflux .
Score Text
0.9943 A major limitation in the use of amphotericin B is its potential to cause Adverse-Effectnephrotoxicity .
0.9778 A major limitation in the use of Drugamphotericin B is its potential to cause nephrotoxicity.
Score Text
0.9991 After receiving 3 doses of Drugifosfamide / mesna, she was found to be unresponsive.
0.9988 After receiving 3 doses of ifosfamide / Drugmesna , she was found to be unresponsive.
0.9920 After receiving 3 doses of ifosfamide / mesna, she was found to be Adverse-Effectunresponsive .
Score Text
0.9984 Adverse-EffectRhabdomyolysis caused by tocolysis with oral ritodrine hydrochloride in a pregnant patient with myotonic dystrophy.
0.9844 Rhabdomyolysis caused by tocolysis with oral Drugritodrine hydrochloride in a pregnant patient with myotonic dystrophy.
Score Text
0.9996 A case of SIADH associated with Drugdesipramine treatment in an elderly depressed woman is described.
0.9980 A case of Adverse-EffectSIADH associated with desipramine treatment in an elderly depressed woman is described.
Score Text
0.9983 We assume that rIFN - gamma induced the de novo development of Adverse-EffectSLE in our patient.
0.9742 We assume that DrugrIFN - gamma induced the de novo development of SLE in our patient.
Score Text
0.9986 Adverse-EffectHypernatraemia induced by sodium polystyrene sulphonate ( Kayexalate ) in two extremely low birth weight newborns.
0.9947 Hypernatraemia induced by sodium polystyrene sulphonate ( DrugKayexalate ) in two extremely low birth weight newborns.
0.9712 Hypernatraemia induced by Drugsodium polystyrene sulphonate ( Kayexalate ) in two extremely low birth weight newborns.
Score Text
0.9995 DrugRifampicin - induced adrenal insufficiency in the acquired immunodeficiency syndrome : difficulties in diagnosis and treatment.
0.9897 Rifampicin - induced Adverse-Effectadrenal insufficiency in the acquired immunodeficiency syndrome : difficulties in diagnosis and treatment.
Score Text
0.9859 Rituximab - CHOP induced Adverse-Effectinterstitial pneumonitis in patients with disseminated extranodal marginal zone B cell lymphoma.
0.9578 DrugRituximab - CHOP induced interstitial pneumonitis in patients with disseminated extranodal marginal zone B cell lymphoma.
Score Text
0.9705 Early - onset acute transverse myelitis following Drughepatitis B vaccination and respiratory infection : case report.
0.9689 Early - onset Adverse-Effectacute transverse myelitis following hepatitis B vaccination and respiratory infection : case report.
Score Text
0.9992 A case is presented which illustrates a probably fatal interaction between Drugminoxidil and a coagulation disorder.
0.9527 A case is presented which illustrates a probably Adverse-Effectfatal interaction between minoxidil and a coagulation disorder.
Score Text
0.9988 A patient developed transient, acute myopia while on Drugisotretinoin ( Accutane ) therapy for acne.
0.9987 A patient developed transient, acute myopia while on isotretinoin ( DrugAccutane ) therapy for acne.
0.9835 A patient developed transient, Adverse-Effectacute myopia while on isotretinoin ( Accutane ) therapy for acne.
Score Text
0.9994 A patient that received Drugmethadone for cancer - associated pain developed myoclonus as a side effect.
0.9987 A patient that received methadone for cancer - associated pain developed Adverse-Effectmyoclonus as a side effect.
Score Text
0.9995 Recovery of the tubular dysfunction took 15 days following cessation of the offending drug, DrugAmikacin .
0.9904 Recovery of the Adverse-Effecttubular dysfunction took 15 days following cessation of the offending drug, Amikacin.
Score Text
0.9994 Renal toxicities have been reported in less than one percent of the patients receiving Drugciprofloxacin therapy.
0.9916 Adverse-EffectRenal toxicities have been reported in less than one percent of the patients receiving ciprofloxacin therapy.
Score Text
0.9997 Myoglobinuria and acute renal failure were observed in two patients with Drugvasopressin - treated gastrointestinal hemorrhage.
0.9970 Adverse-EffectMyoglobinuria and acute renal failure were observed in two patients with vasopressin - treated gastrointestinal hemorrhage.
0.9873 Myoglobinuria and Adverse-Effectacute renal failure were observed in two patients with vasopressin - treated gastrointestinal hemorrhage.
Score Text
0.9954 Valproic acid induced Adverse-Effectcoma is presented in an adult patient without a history of metabolic disease.
0.9867 DrugValproic acid induced coma is presented in an adult patient without a history of metabolic disease.
Score Text
0.9986 We report two patients with infectious mononucleosis - like syndrome induced by Drugsalazosulfapyridine ( SASP ).
0.9978 We report two patients with infectious mononucleosis - like syndrome induced by salazosulfapyridine ( DrugSASP ).
0.9724 We report two patients with Adverse-Effectinfectious mononucleosis - like syndrome induced by salazosulfapyridine ( SASP ).
Score Text
0.9996 over the past 3 years there have been several reports of uveitis associated with Drugrifabutin therapy.
0.9980 over the past 3 years there have been several reports of Adverse-Effectuveitis associated with rifabutin therapy.
Score Text
0.9978 Posterior leukoencephalopathy following cisplatin, Drugbleomycin and vinblastine therapy for germ cell tumor of the ovary.
0.9976 Posterior leukoencephalopathy following Drugcisplatin , bleomycin and vinblastine therapy for germ cell tumor of the ovary.
0.9970 Posterior leukoencephalopathy following cisplatin, bleomycin and Drugvinblastine therapy for germ cell tumor of the ovary.
0.9767 Adverse-EffectPosterior leukoencephalopathy following cisplatin, bleomycin and vinblastine therapy for germ cell tumor of the ovary.
Score Text
0.9977 Colonic mucosal necrosis following administration of calcium polystryrene sulfonate ( DrugKalimate ) in a uremic patient.
0.9868 Adverse-EffectColonic mucosal necrosis following administration of calcium polystryrene sulfonate ( Kalimate ) in a uremic patient.
0.9677 Colonic mucosal necrosis following administration of Drugcalcium polystryrene sulfonate ( Kalimate ) in a uremic patient.
Score Text
0.9994 Two patients are described in whom subtle cognitive impairments are associated with therapeutic doses of Drugamoxapine .
0.9838 Two patients are described in whom subtle Adverse-Effectcognitive impairments are associated with therapeutic doses of amoxapine.
Score Text
0.9995 Thus, tardive seizures in our cases are thought to be related to piperacillin and Drugcefotiam .
0.9995 Thus, tardive seizures in our cases are thought to be related to Drugpiperacillin and cefotiam.
0.9897 Thus, Adverse-Effecttardive seizures in our cases are thought to be related to piperacillin and cefotiam.
Score Text
0.9995 Secondary leukemia in a child with neuroblastoma while on oral Drugetoposide : what is the cause?
0.8589 Adverse-EffectSecondary leukemia in a child with neuroblastoma while on oral etoposide : what is the cause?
Score Text
0.9995 The incidence of angioedema secondary to Druglosartan , an angiotensin II receptor antagonist, is unknown.
0.9979 The incidence of Adverse-Effectangioedema secondary to losartan, an angiotensin II receptor antagonist, is unknown.
Score Text
0.9988 A case report of a patient with probable cisplatin and bleomycin - induced Adverse-EffectTMA is presented.
0.9972 A case report of a patient with probable cisplatin and Drugbleomycin - induced TMA is presented.
0.9954 A case report of a patient with probable Drugcisplatin and bleomycin - induced TMA is presented.
Score Text
0.9876 Adverse-EffectSkin necrosis secondary to low - molecular weight heparin in a patient with antiphospholipid antibody syndrome.
0.9601 Skin necrosis secondary to Druglow - molecular weight heparin in a patient with antiphospholipid antibody syndrome.
Score Text
0.9892 These case reports provide evidence that 5 - aminosalicylic acid may induce Adverse-Effectacute pancreatitis after long term treatment.
0.9777 These case reports provide evidence that Drug5 - aminosalicylic acid may induce acute pancreatitis after long term treatment.
Score Text
0.9995 The fifth patient exhibited paraesthesia and agitation caused by Drugolanzapine that was misdiagnosed as psychotic agitation.
0.9978 The fifth patient exhibited Adverse-Effectparaesthesia and agitation caused by olanzapine that was misdiagnosed as psychotic agitation.
0.9964 The fifth patient exhibited paraesthesia and Adverse-Effectagitation caused by olanzapine that was misdiagnosed as psychotic agitation.
Score Text
0.9994 Severe respiratory syncytial virus pulmonary infection in a patient treated with Drugfludarabine for chronic lymphocytic leukemia.
0.9459 Adverse-EffectSevere respiratory syncytial virus pulmonary infection in a patient treated with fludarabine for chronic lymphocytic leukemia.
Score Text
0.9978 We report here a case of cardiovascular and neurological depression induced by Drugoxymetalzoline in a toddler.
0.9510 We report here a case of cardiovascular and Adverse-Effectneurological depression induced by oxymetalzoline in a toddler.
Score Text
0.9920 Dihydropyrimidine dehydrogenase deficiency : a pharmacogenetic defect causing severe adverse reactions to Drug5 - fluorouracil - based chemotherapy.
0.9649 Dihydropyrimidine dehydrogenase deficiency : a pharmacogenetic defect causing Adverse-Effectsevere adverse reactions to 5 - fluorouracil - based chemotherapy.
Score Text
0.9921 Adverse-EffectThrombotic stroke associated with the use of porcine factor VIII in a patient with acquired haemophilia.
0.9714 Thrombotic stroke associated with the use of Drugporcine factor VIII in a patient with acquired haemophilia.
Score Text
0.9996 We describe four patients who had seizures while receiving Drugofloxacin ; no other causes were evident.
0.9987 We describe four patients who had Adverse-Effectseizures while receiving ofloxacin ; no other causes were evident.
Score Text
0.9981 We report two adults who received Druggabapentin ( GBP ) and subsequently developed behavioural side effects.
0.9956 We report two adults who received gabapentin ( DrugGBP ) and subsequently developed behavioural side effects.
0.9827 We report two adults who received gabapentin ( GBP ) and subsequently developed Adverse-Effectbehavioural side effects .
Score Text
0.9991 When tuberculosis patients on Drugisoniazid eat certain varieties of fish they may develop a histamine reaction.
0.9896 When tuberculosis patients on isoniazid eat certain varieties of fish they may develop a Adverse-Effecthistamine reaction .
Score Text
0.9995 We report a case of exfoliative dermatitis clearly linked to intravenous and intraperitoneal administration of Drugtobramycin .
0.9878 We report a case of Adverse-Effectexfoliative dermatitis clearly linked to intravenous and intraperitoneal administration of tobramycin.
Score Text
0.9991 Within 24 hours of fluid restriction and cessation of Drugdesmopressin , her symptoms and hyponatremia resolved.
0.9977 Within 24 hours of fluid restriction and cessation of desmopressin, her symptoms and Adverse-Effecthyponatremia resolved.
Score Text
0.9996 Hepatitis with bridging fibrosis and reversible hepatic insufficiency in a woman with rheumatoid arthritis taking Drugmethotrexate .
0.9985 Adverse-EffectHepatitis with bridging fibrosis and reversible hepatic insufficiency in a woman with rheumatoid arthritis taking methotrexate.
0.9852 Hepatitis with Adverse-Effectbridging fibrosis and reversible hepatic insufficiency in a woman with rheumatoid arthritis taking methotrexate.
0.9766 Hepatitis with bridging fibrosis and Adverse-Effectreversible hepatic insufficiency in a woman with rheumatoid arthritis taking methotrexate.
Score Text
0.9993 A 64 - year - old man with schizophrenia developed myoclonic jerks when given higher doses of Drugquetiapine .
0.9931 A 64 - year - old man with schizophrenia developed Adverse-Effectmyoclonic jerks when given higher doses of quetiapine.
Score Text
0.9595 Acute renal failure is a rare complication following the administration of intravenous Drugimmunoglobulin ( IVIG ).
0.7604 Adverse-EffectAcute renal failure is a rare complication following the administration of intravenous immunoglobulin ( IVIG ).
0.5427 Acute Adverse-Effectrenal failure is a rare complication following the administration of intravenous immunoglobulin ( IVIG ).
Score Text
0.9982 It is concluded that simultaneous administration of Drugciprofloxacin and tazobactam / piperacillin may cause marked thrombocytosis.
0.9979 It is concluded that simultaneous administration of ciprofloxacin and Drugtazobactam / piperacillin may cause marked thrombocytosis.
0.9975 It is concluded that simultaneous administration of ciprofloxacin and tazobactam / Drugpiperacillin may cause marked thrombocytosis.
0.9951 It is concluded that simultaneous administration of ciprofloxacin and tazobactam / piperacillin may cause marked Adverse-Effectthrombocytosis .
Score Text
0.9994 The present report describes the first case of acute pancreatitis associated with Drugdanazol treatment of endometriosis.
0.9855 The present report describes the first case of Adverse-Effectacute pancreatitis associated with danazol treatment of endometriosis.
Score Text
0.9993 Emergence of Philadelphia positive chronic myeloid leukaemia during treatment with Drughydroxyurea for Philadelphia negative essential thrombocythaemia.
0.9631 Emergence of Adverse-EffectPhiladelphia positive chronic myeloid leukaemia during treatment with hydroxyurea for Philadelphia negative essential thrombocythaemia.
Score Text
0.9996 The patient experienced muscle twitches, tremulousness, and anxiety on day 17 of Drugfoscarnet therapy.
0.9977 The patient experienced muscle twitches, tremulousness, and Adverse-Effectanxiety on day 17 of foscarnet therapy.
0.9970 The patient experienced muscle twitches, Adverse-Effecttremulousness , and anxiety on day 17 of foscarnet therapy.
0.9885 The patient experienced Adverse-Effectmuscle twitches , tremulousness, and anxiety on day 17 of foscarnet therapy.
Score Text
0.9921 Adverse-EffectScrotal ulceration induced by all - trans retinoic acid in a patient with acute promyelocytic leukemia.
0.9525 Scrotal ulceration induced by Drugall - trans retinoic acid in a patient with acute promyelocytic leukemia.
Scrotal ulceration induced by all - trans Drugretinoic acid in a patient with acute promyelocytic leukemia.
Score Text
0.9994 Acute Drugesmolol toxicity may be self - limiting because of its extremely short half - life.
0.6531 Acute Adverse-Effectesmolol toxicity may be self - limiting because of its extremely short half - life.
Score Text
0.9961 We present a surprising case of a woman schizophrenic patient treated with Drugclozapine suffering from EPS.
0.9951 We present a surprising case of a woman schizophrenic patient treated with clozapine suffering from Adverse-EffectEPS .
Score Text
0.9996 This is the first description, to our knowledge, of ductopenia apparently caused by Drugclindamycin .
0.9983 This is the first description, to our knowledge, of Adverse-Effectductopenia apparently caused by clindamycin.
Score Text
0.9995 To our knowledge, this case is the first published report of Druglevofloxacin - induced TEN.
0.9992 To our knowledge, this case is the first published report of levofloxacin - induced Adverse-EffectTEN .
Score Text
0.9959 Cutaneous sarcoidosis during interferon alfa and Drugribavirin treatment of hepatitis C virus infection : two cases.
0.9899 Adverse-EffectCutaneous sarcoidosis during interferon alfa and ribavirin treatment of hepatitis C virus infection : two cases.
0.9879 Cutaneous sarcoidosis during Druginterferon alfa and ribavirin treatment of hepatitis C virus infection : two cases.
Score Text
0.9890 Adverse-EffectLichen planus induced by hepatitis B vaccination : a new case and review of the literature.
0.9666 Lichen planus induced by Drughepatitis B vaccination : a new case and review of the literature.
Score Text
0.9996 Contact dermatitis due to Drugbudesonide : report of five cases and review of the Japanese literature.
0.9897 Adverse-EffectContact dermatitis due to budesonide : report of five cases and review of the Japanese literature.
Score Text
0.9995 Potential mechanisms involved in the occurrence of ischemic colitis in patients receiving Drugtegaserod are also discussed.
0.9927 Potential mechanisms involved in the occurrence of Adverse-Effectischemic colitis in patients receiving tegaserod are also discussed.
Score Text
0.9994 In four patients, spasm occurred spontaneous and in one patient after 0. 05 mg of Drugergonovine .
0.9975 In four patients, Adverse-Effectspasm occurred spontaneous and in one patient after 0. 05 mg of ergonovine.
Score Text
0.9983 There is a dose - effect relationship between Drugdoxorubicin and the incidence of symptomatic cardiac failure.
0.9832 There is a dose - effect relationship between doxorubicin and the incidence of Adverse-Effectsymptomatic cardiac failure .
Score Text
0.9996 A rechallenge, performed in both patients, confirmed the diagnosis of Drugmesalamine - induced pancreatitis.
0.9985 A rechallenge, performed in both patients, confirmed the diagnosis of mesalamine - induced Adverse-Effectpancreatitis .
Score Text
0.9994 CONCLUSION : The findings in these two patients suggest that Drugcolchicine may delay corneal wound healing.
0.9394 CONCLUSION : The findings in these two patients suggest that colchicine may Adverse-Effectdelay corneal wound healing .
Score Text
0.9994 A 69 - year - old man developed pure red cell aplasia after taking Drugfenoprofen for ten months.
0.9780 A 69 - year - old man developed Adverse-Effectpure red cell aplasia after taking fenoprofen for ten months.
Score Text
0.9994 New onset of CD may be considered as an immune - mediated injury induced by Drugetanercept .
0.9717 New onset of CD may be considered as an Adverse-Effectimmune - mediated injury induced by etanercept.
0.9674 New onset of Adverse-EffectCD may be considered as an immune - mediated injury induced by etanercept.
Score Text
0.9992 Three patients with no history of asthma or allergy developed bronchospasm while taking Drugpropranolol for hypertension.
0.9987 Three patients with no history of asthma or allergy developed Adverse-Effectbronchospasm while taking propranolol for hypertension.
Score Text
0.9956 OBJECTIVE : To report a case of DrugCarbamazepine toxicity following the administration of Oxybutynin and Dantrolene.
0.9922 OBJECTIVE : To report a case of Carbamazepine toxicity following the administration of Oxybutynin and DrugDantrolene .
0.9887 OBJECTIVE : To report a case of Carbamazepine toxicity following the administration of DrugOxybutynin and Dantrolene.
0.9079 OBJECTIVE : To report a case of Adverse-EffectCarbamazepine toxicity following the administration of Oxybutynin and Dantrolene.
Score Text
0.9996 The delayed encephalopathy developed 9 and 22 months respectively after the first dose of intrathecal Drugmethotrexate .
0.9950 The delayed Adverse-Effectencephalopathy developed 9 and 22 months respectively after the first dose of intrathecal methotrexate.
Score Text
0.9896 Adverse-EffectHepatotoxicity associated with choline magnesium trisalicylate : case report and review of salicylate - induced hepatotoxicity.
0.9708 Hepatotoxicity associated with choline magnesium trisalicylate : case report and review of salicylate - induced Adverse-Effecthepatotoxicity .
0.7307 Hepatotoxicity associated with choline magnesium trisalicylate : case report and review of Drugsalicylate - induced hepatotoxicity.
Hepatotoxicity associated with Drugcholine magnesium trisalicylate : case report and review of salicylate - induced hepatotoxicity.
Score Text
0.9992 DrugSulfasalazine has been associated with bronchopulmonary complications of inflammatory bowel disease ( IBD ) in adults.
0.9861 Sulfasalazine has been associated with bronchopulmonary complications of inflammatory bowel disease ( Adverse-EffectIBD ) in adults.
0.9663 Sulfasalazine has been associated with Adverse-Effectbronchopulmonary complications of inflammatory bowel disease ( IBD ) in adults.
Score Text
0.9751 DrugZoledronic acid - induced severe hypocalcaemia in a prostate cancer patient with extensive osteoblastic bone metastases.
0.9722 Zoledronic acid - induced Adverse-Effectsevere hypocalcaemia in a prostate cancer patient with extensive osteoblastic bone metastases.
Score Text
0.9994 DrugInfliximab therapy may cause a lupus - like syndrome that is reversible upon discontinuing this agent.
0.9831 Infliximab therapy may cause a Adverse-Effectlupus - like syndrome that is reversible upon discontinuing this agent.
Score Text
0.9990 DISCUSSION : This case shows that switching to Drugzidovudine potentially can lead to a hyperlactatemia relapse.
0.9761 DISCUSSION : This case shows that switching to zidovudine potentially can lead to a Adverse-Effecthyperlactatemia relapse .
Score Text
0.9995 A 15 - year follow - up of Drugphenytoin - induced unilateral gingival hyperplasia : a case report.
0.9840 A 15 - year follow - up of phenytoin - induced Adverse-Effectunilateral gingival hyperplasia : a case report.
Score Text
0.9990 This finding suggests that Drugfluvoxamine can precipitate Schneiderian first - rank symptoms in some susceptible patients.
0.9783 This finding suggests that fluvoxamine can precipitate Adverse-EffectSchneiderian first - rank symptoms in some susceptible patients.
Score Text
0.9988 The hearing impairment and Adverse-Effecttinnitus were gradually reduced after PTU withdrawal and corticosteroid and azathioprine treatment.
0.9935 The hearing impairment and tinnitus were gradually reduced after DrugPTU withdrawal and corticosteroid and azathioprine treatment.
0.9820 The Adverse-Effecthearing impairment and tinnitus were gradually reduced after PTU withdrawal and corticosteroid and azathioprine treatment.
Score Text
0.9980 The changes were progressive regardless of discontinuation of Drugcyclophosphamide and led to severe restrictive ventilatory defect.
0.9737 The changes were progressive regardless of discontinuation of cyclophosphamide and led to Adverse-Effectsevere restrictive ventilatory defect .
Score Text
0.9996 Severe hyperkalemia occurred in a patient with radiation pneumonitis and glaucoma shortly after beginning Drugprednisone therapy.
0.7859 Adverse-EffectSevere hyperkalemia occurred in a patient with radiation pneumonitis and glaucoma shortly after beginning prednisone therapy.
Score Text
0.9994 Glomerulonephritis in Drugprocainamide induced lupus erythematosus : report of a case and review of the literature.
0.9855 Adverse-EffectGlomerulonephritis in procainamide induced lupus erythematosus : report of a case and review of the literature.
0.9837 Glomerulonephritis in procainamide induced Adverse-Effectlupus erythematosus : report of a case and review of the literature.
Score Text
0.9957 Atrial fibrillation was induced by diltiazem in two patients and verapamil induced Adverse-Effectsyncope in one patient.
0.9619 Atrial fibrillation was induced by diltiazem in two patients and Drugverapamil induced syncope in one patient.
0.9431 Adverse-EffectAtrial fibrillation was induced by diltiazem in two patients and verapamil induced syncope in one patient.
0.8201 Atrial fibrillation was induced by Drugdiltiazem in two patients and verapamil induced syncope in one patient.
Score Text
0.9995 OBJECTIVE : To present a single case of Drugzuclopenthixol - induced priapism and a literature review.
0.9984 OBJECTIVE : To present a single case of zuclopenthixol - induced Adverse-Effectpriapism and a literature review.
Score Text
0.9990 A case of Drugallopurinol hypersensitivity, possibly the first in a black African, is reported.
0.8979 A case of allopurinol Adverse-Effecthypersensitivity , possibly the first in a black African, is reported.
Score Text
0.9956 Prolonged used of Drughydroxyurea in patients with ET may lead to therapy - associated acute leukemia.
0.9908 Prolonged used of hydroxyurea in patients with ET may lead to therapy - associated Adverse-Effectacute leukemia .
Score Text
0.9995 DrugSulfasalazine - induced hypersensitivity syndrome and hemophagocytic syndrome associated with reactivation of Epstein - Barr virus.
0.9937 Sulfasalazine - induced hypersensitivity syndrome and Adverse-Effecthemophagocytic syndrome associated with reactivation of Epstein - Barr virus.
0.9923 Sulfasalazine - induced Adverse-Effecthypersensitivity syndrome and hemophagocytic syndrome associated with reactivation of Epstein - Barr virus.
Score Text
0.9993 In one child, a second course of Drugcarbamazepine resulted in a return of the dystonia.
0.9975 In one child, a second course of carbamazepine resulted in a return of the Adverse-Effectdystonia .
Score Text
0.9995 RESULTS : Two patients with ocular inflammation of unknown origin developed severe chorioretinitis after DrugIVTA injection.
0.9861 RESULTS : Two patients with ocular inflammation of unknown origin developed Adverse-Effectsevere chorioretinitis after IVTA injection.
Score Text
0.9994 Flumazenil reversal of Drugbenzodiazepine - induced sedation for a patient with severe pre - ECT anxiety.
0.9969 Flumazenil reversal of benzodiazepine - induced Adverse-Effectsedation for a patient with severe pre - ECT anxiety.
Score Text
0.9996 These multiple overlapping factors probably lead to rhabdomyolysis in a minority of patients receiving Drugvasopressin infusion.
0.9967 These multiple overlapping factors probably lead to Adverse-Effectrhabdomyolysis in a minority of patients receiving vasopressin infusion.
Score Text
0.9993 Six patients with rheumatoid arthritis developed a syndrome resembling lupus erythematosus while being treated with Drugpenicillamine .
0.9884 Six patients with rheumatoid arthritis developed a syndrome resembling Adverse-Effectlupus erythematosus while being treated with penicillamine.
Score Text
0.9752 Adverse-EffectAcute neutrophilic dermatosis induced by all - trans - retinoic acid treatment for acute promyelocytic leukemia.
0.9478 Acute neutrophilic dermatosis induced by Drugall - trans - retinoic acid treatment for acute promyelocytic leukemia.
Score Text
0.9987 A second episode of jaundice followed the intravaginal administration of a mixture of furazolidone and Drugnifuroxime .
0.9986 A second episode of jaundice followed the intravaginal administration of a mixture of Drugfurazolidone and nifuroxime.
0.9983 A second episode of Adverse-Effectjaundice followed the intravaginal administration of a mixture of furazolidone and nifuroxime.
Score Text
0.9993 In addition, the tachycardia persisted and was repeatedly spontaneously reinitiated for prolonged periods after Drugprocainamide .
0.9972 In addition, the Adverse-Effecttachycardia persisted and was repeatedly spontaneously reinitiated for prolonged periods after procainamide.
Score Text
0.9994 Within 6 months of Drugpranlukast withdrawal, anemia resolved and urinary sediment and renal function normalized.
0.9962 Within 6 months of pranlukast withdrawal, Adverse-Effectanemia resolved and urinary sediment and renal function normalized.
Score Text
0.9841 Successful treatment of hyperthyroidism with amiodarone in a patient with propylthiouracil - induced Adverse-Effectacute hepatic failure .
0.9713 Successful treatment of hyperthyroidism with amiodarone in a patient with Drugpropylthiouracil - induced acute hepatic failure.
Score Text
0.9995 An objective causality assessment suggests that the JHR in our patient was probably related to Drugpenicillin .
0.9977 An objective causality assessment suggests that the Adverse-EffectJHR in our patient was probably related to penicillin.
Score Text
0.9867 Adverse-EffectAcute pancreatitis in a child with idiopathic ulcerative colitis on long - term 5 - aminosalicylic acid therapy.
0.9779 Acute pancreatitis in a child with idiopathic ulcerative colitis on long - term Drug5 - aminosalicylic acid therapy.
Score Text
0.9991 Systemic disease, most commonly renal dysfunction, preceded all 30 reported cases of Drugacyclovir neurotoxicity.
0.9249 Systemic disease, most commonly renal dysfunction, preceded all 30 reported cases of acyclovir Adverse-Effectneurotoxicity .
Score Text
0.9995 Two cases of polymorphic ventricular tachycardia induced by the administration of Drugverapamil against paroxysmal supraventricular tachycardia.
0.9848 Two cases of Adverse-Effectpolymorphic ventricular tachycardia induced by the administration of verapamil against paroxysmal supraventricular tachycardia.
Score Text
0.9995 This is the first case of Drughydroxyurea - induced acute interstitial pneumonitis reported in the literature.
0.9860 This is the first case of hydroxyurea - induced Adverse-Effectacute interstitial pneumonitis reported in the literature.
Score Text
0.9995 The sub - conjunctival haematoma in a patient receiving Drugwarfarin can pose a significant management challenge.
0.9827 The Adverse-Effectsub - conjunctival haematoma in a patient receiving warfarin can pose a significant management challenge.
Score Text
0.9992 DrugGemcitabine therapy has been associated with radiation recall reactions when used in the treatment of carcinoma.
0.9880 Gemcitabine therapy has been associated with Adverse-Effectradiation recall reactions when used in the treatment of carcinoma.
Score Text
0.9994 Skin necrosis is a rare complication of subcutaneous Drugheparin therapy that usually occurs at injection sites.
0.9924 Adverse-EffectSkin necrosis is a rare complication of subcutaneous heparin therapy that usually occurs at injection sites.
Score Text
0.9990 It may cause a severe adverse drug reaction with multiorgan involvement known as Drugdapsone hypersensitivity syndrome.
0.9257 It may cause a severe adverse drug reaction with multiorgan involvement known as dapsone Adverse-Effecthypersensitivity syndrome .
Score Text
0.9995 Reversible sclerotic changes of lumbar spine and femur due to long - term oral Drugisotretinoin therapy.
0.9359 Adverse-EffectReversible sclerotic changes of lumbar spine and femur due to long - term oral isotretinoin therapy.
Reversible Adverse-Effectsclerotic changes of lumbar spine and femur due to long - term oral isotretinoin therapy.
Score Text
0.9990 We explored ophthalmic and neurologic findings in two children who have been exposed prenatally to DrugVGB .
0.9798 We explored Adverse-Effectophthalmic and neurologic findings in two children who have been exposed prenatally to VGB.
Score Text
0.9818 The possible role of Druginterferon beta in the pathogenesis of sarcoidosis in this patient is discussed.
0.9677 The possible role of interferon beta in the pathogenesis of Adverse-Effectsarcoidosis in this patient is discussed.
Score Text
0.9980 We observed transient panhypogammaglobulinaemia in a patient with neuropsychiatric SLE after treatment with prednisolone and Drugcyclophosphamide .
0.9980 We observed transient panhypogammaglobulinaemia in a patient with neuropsychiatric SLE after treatment with Drugprednisolone and cyclophosphamide.
0.7591 We observed transient Adverse-Effectpanhypogammaglobulinaemia in a patient with neuropsychiatric SLE after treatment with prednisolone and cyclophosphamide.
Score Text
0.9811 Massive prolapse of the urethral mucosa following periurethral injection of Drugcalcium hydroxylapatite for stress urinary incontinence.
0.8187 Massive prolapse of the Adverse-Effecturethral mucosa following periurethral injection of calcium hydroxylapatite for stress urinary incontinence.
0.7621 Adverse-EffectMassive prolapse of the urethral mucosa following periurethral injection of calcium hydroxylapatite for stress urinary incontinence.
Massive Adverse-Effectprolapse of the urethral mucosa following periurethral injection of calcium hydroxylapatite for stress urinary incontinence.
Score Text
0.9996 This is the second report of acute lung injury and diffuse alveolar damage caused by Drugmefloquine .
0.9883 This is the second report of acute lung injury and Adverse-Effectdiffuse alveolar damage caused by mefloquine.
0.9880 This is the second report of Adverse-Effectacute lung injury and diffuse alveolar damage caused by mefloquine.
Score Text
0.9808 Adverse-EffectSudden death in an infant from methemoglobinemia after administration of " sweet spirits of nitre ".
0.9478 Sudden death in an infant from methemoglobinemia after administration of " Drugsweet spirits of nitre ".
Score Text
0.9859 A patient with rheumatoid arthritis developed an acute intrahepatic cholestasis after 100 mg of Drugsodium aurothiomalate .
0.9846 A patient with rheumatoid arthritis developed an Adverse-Effectacute intrahepatic cholestasis after 100 mg of sodium aurothiomalate.
A patient with rheumatoid arthritis developed an acute Adverse-Effectintrahepatic cholestasis after 100 mg of sodium aurothiomalate.
Score Text
0.9984 Acute myopathy with selective degeneration of myosin filaments following status asthmaticus treated with methylprednisolone and Drugvecuronium .
0.9984 Acute myopathy with selective degeneration of myosin filaments following status asthmaticus treated with Drugmethylprednisolone and vecuronium.
0.9838 Adverse-EffectAcute myopathy with selective degeneration of myosin filaments following status asthmaticus treated with methylprednisolone and vecuronium.
0.9750 Acute myopathy with selective Adverse-Effectdegeneration of myosin filaments following status asthmaticus treated with methylprednisolone and vecuronium.
Score Text
0.9994 We discuss the association between Drugcarbamazepine and hyponatremia and the causes of hyponatremia after cardiopulmonary bypass.
0.9880 We discuss the association between carbamazepine and Adverse-Effecthyponatremia and the causes of hyponatremia after cardiopulmonary bypass.
0.9928 We discuss the association between carbamazepine and hyponatremia and the causes of Adverse-Effecthyponatremia after cardiopulmonary bypass.
Score Text
0.9994 A case of Drugbarbiturate - induced submassive hepatic necrosis is presented and the literature is reviewed.
0.9862 A case of barbiturate - induced Adverse-Effectsubmassive hepatic necrosis is presented and the literature is reviewed.
Score Text
0.9994 A reversible toxic liver damage was observed in a non - alcoholic woman treated with Drugdisulfiram .
0.9862 A Adverse-Effectreversible toxic liver damage was observed in a non - alcoholic woman treated with disulfiram.
Score Text
0.9958 Haemolytic - uraemic syndrome complicating long - term mitomycin C and Drug5 - fluorouracil therapy for gastric carcinoma.
0.9858 Haemolytic - uraemic syndrome complicating long - term Drugmitomycin C and 5 - fluorouracil therapy for gastric carcinoma.
0.9850 Adverse-EffectHaemolytic - uraemic syndrome complicating long - term mitomycin C and 5 - fluorouracil therapy for gastric carcinoma.
Score Text
0.9991 DrugZidovudine use in pregnancy : a report on 104 cases and the occurrence of birth defects.
0.9891 Zidovudine use in pregnancy : a report on 104 cases and the occurrence of Adverse-Effectbirth defects .
Score Text
0.9987 Coagulopathy associated with the use of cephalosporin or Drugmoxalactam antibiotics in acute and chronic renal failure.
0.9985 Adverse-EffectCoagulopathy associated with the use of cephalosporin or moxalactam antibiotics in acute and chronic renal failure.
0.9985 Coagulopathy associated with the use of Drugcephalosporin or moxalactam antibiotics in acute and chronic renal failure.
Score Text
0.9858 Pulmonary hemorrhage as a clinical manifestation of hemolytic - uremic syndrome associated with Drugmitomycin C therapy.
0.9840 Adverse-EffectPulmonary hemorrhage as a clinical manifestation of hemolytic - uremic syndrome associated with mitomycin C therapy.
0.9775 Pulmonary hemorrhage as a clinical manifestation of Adverse-Effecthemolytic - uremic syndrome associated with mitomycin C therapy.
Score Text
0.9992 Syringotropic hypersensitivity reaction associated with Druginfliximab and leflunomide combination therapy in a child with psoriatic arthritis.
0.9992 Syringotropic hypersensitivity reaction associated with infliximab and Drugleflunomide combination therapy in a child with psoriatic arthritis.
0.9855 Adverse-EffectSyringotropic hypersensitivity reaction associated with infliximab and leflunomide combination therapy in a child with psoriatic arthritis.
Score Text
0.9995 This is the first report of a catatonic syndrome occurring in a patient receiving Drugdisulfiram treatment.
0.9946 This is the first report of a Adverse-Effectcatatonic syndrome occurring in a patient receiving disulfiram treatment.
Score Text
0.9990 DLST is a good diagnostic tool for DrugAZA allergy, especially for severe drug allergy cases.
0.9662 DLST is a good diagnostic tool for AZA Adverse-Effectallergy , especially for severe drug allergy cases.
Score Text
0.9993 A case of Drugtimolol - associated heart failure in a 73 - year old white man is reported.
0.9938 A case of timolol - associated Adverse-Effectheart failure in a 73 - year old white man is reported.
Score Text
0.9986 We describe a renal transplant recipient maintained on cyclosporine and Drugprednisone developing Nocardia Asteroides brain abscess.
0.9984 We describe a renal transplant recipient maintained on Drugcyclosporine and prednisone developing Nocardia Asteroides brain abscess.
0.9823 We describe a renal transplant recipient maintained on cyclosporine and prednisone developing Adverse-EffectNocardia Asteroides brain abscess .
Score Text
0.9995 Visceral leishmaniasis and macrophagic activation syndrome in a patient with rheumatoid arthritis under treatment with Drugadalimumab .
0.9842 Visceral leishmaniasis and Adverse-Effectmacrophagic activation syndrome in a patient with rheumatoid arthritis under treatment with adalimumab.
0.9794 Adverse-EffectVisceral leishmaniasis and macrophagic activation syndrome in a patient with rheumatoid arthritis under treatment with adalimumab.
Score Text
0.9826 Cholesterol crystal embolization - associated Adverse-Effectrenal failure after therapy with recombinant tissue - type plasminogen activator.
0.9435 Adverse-EffectCholesterol crystal embolization - associated renal failure after therapy with recombinant tissue - type plasminogen activator.
0.8778 Cholesterol crystal embolization - associated renal failure after therapy with recombinant Drugtissue - type plasminogen activator .
0.8588 Cholesterol crystal embolization - associated renal failure after therapy with Drugrecombinant tissue - type plasminogen activator .
Score Text
0.9995 DrugHeparin - induced thrombocytopenia complicated with massive thrombosis of the inferior vena cava after filter placement.
0.9958 Heparin - induced Adverse-Effectthrombocytopenia complicated with massive thrombosis of the inferior vena cava after filter placement.
0.9642 Heparin - induced thrombocytopenia complicated with Adverse-Effectmassive thrombosis of the inferior vena cava after filter placement.
Score Text
0.9995 Cholelithiasis and thrombosis of the central retinal vein in a renal transplant recipient treated with Drugcyclosporin .
0.9980 Adverse-EffectCholelithiasis and thrombosis of the central retinal vein in a renal transplant recipient treated with cyclosporin.
0.9792 Cholelithiasis and Adverse-Effectthrombosis of the central retinal vein in a renal transplant recipient treated with cyclosporin.
Score Text
0.9991 Young children undergoing Drugcisplatin chemotherapy are known to be at risk for progressive sensorineural hearing loss.
0.9705 Young children undergoing cisplatin chemotherapy are known to be at risk for Adverse-Effectprogressive sensorineural hearing loss .
Score Text
0.9995 Prolongation of the QT interval and ventricular tachyarrhymias have been described in patients on Drugamiodarone therapy.
0.9870 Prolongation of the QT interval and Adverse-Effectventricular tachyarrhymias have been described in patients on amiodarone therapy.
0.9752 Adverse-EffectProlongation of the QT interval and ventricular tachyarrhymias have been described in patients on amiodarone therapy.
Score Text
0.9947 Diarrhea - associated over - anticoagulation in a patient taking Drugwarfarin : therapeutic role of cholestyramine.
0.9377 Adverse-EffectDiarrhea - associated over - anticoagulation in a patient taking warfarin : therapeutic role of cholestyramine.
Score Text
0.9994 The patient whose case is reviewed had migraine headaches and received Drugmethysergide maleate for 13 years.
0.9891 The patient whose case is reviewed had Adverse-Effectmigraine headaches and received methysergide maleate for 13 years.
Score Text
0.9987 CONCLUSIONS : Acute severe hepatitis though rare is occasionally observed with EGFR inhibitors gefitinib or Drugerlotinib .
0.9985 CONCLUSIONS : Acute severe hepatitis though rare is occasionally observed with EGFR inhibitors Druggefitinib or erlotinib.
0.9309 CONCLUSIONS : Adverse-EffectAcute severe hepatitis though rare is occasionally observed with EGFR inhibitors gefitinib or erlotinib.
Score Text
0.9994 Hypoxia is a predisposing factor for premature ductal closure and often occurs after maternal Drugindomethacin therapy.
0.9950 Adverse-EffectHypoxia is a predisposing factor for premature ductal closure and often occurs after maternal indomethacin therapy.
0.9801 Hypoxia is a predisposing factor for Adverse-Effectpremature ductal closure and often occurs after maternal indomethacin therapy.
Score Text
0.9987 Patients should be informed about the risk of osteonecrosis when taking Drugdexamethasone as an antiemetic drug.
0.9928 Patients should be informed about the risk of Adverse-Effectosteonecrosis when taking dexamethasone as an antiemetic drug.
Score Text
0.9995 Rapid onset of Drugquetiapine - induced diabetic ketoacidosis in an elderly patient : a case report.
0.9874 Rapid onset of quetiapine - induced Adverse-Effectdiabetic ketoacidosis in an elderly patient : a case report.
Score Text
0.9993 On the other hand, Drugaspirin may have promoted the enlargement of spontaneous hemorrhage from meningioma.
0.9762 On the other hand, aspirin may have promoted the Adverse-Effectenlargement of spontaneous hemorrhage from meningioma.
Score Text
0.9994 Renal failure after high - dose Drugmethotrexate in a child homozygous for MTHFR C677 T polymorphism.
0.9939 Adverse-EffectRenal failure after high - dose methotrexate in a child homozygous for MTHFR C677 T polymorphism.
Score Text
0.9996 Fatal interstitial pneumonitis associated with Drugdocetaxel administration in a patient with hormone - refractory prostate cancer.
0.9846 Adverse-EffectFatal interstitial pneumonitis associated with docetaxel administration in a patient with hormone - refractory prostate cancer.
Score Text
0.9574 In vitro inhibition of hematopoiesis in a patient with systemic sclerosis treated with DrugD - penicillamine .
0.9555 In vitro Adverse-Effectinhibition of hematopoiesis in a patient with systemic sclerosis treated with D - penicillamine.
Score Text
0.9995 Severe adenovirus pneumonia ( AVP ) following Druginfliximab infusion for the treatment of Crohn's disease.
0.9912 Severe adenovirus pneumonia ( Adverse-EffectAVP ) following infliximab infusion for the treatment of Crohn's disease.
0.7624 Adverse-EffectSevere adenovirus pneumonia ( AVP ) following infliximab infusion for the treatment of Crohn's disease.
Score Text
0.9937 Capecitabine was discontinued and the Adverse-Effectallergic reactions resolved after the woman took diphenhydramine for 1 week.
0.9883 DrugCapecitabine was discontinued and the allergic reactions resolved after the woman took diphenhydramine for 1 week.
Score Text
0.9995 We present a unique case of GTBM in a patient with myeloma following treatment with DrugMelphalan .
0.9983 We present a unique case of Adverse-EffectGTBM in a patient with myeloma following treatment with Melphalan.
Score Text
0.9992 Based on our findings, it is thus concluded that Drugcisplatin may cause C. difficile colitis.
0.9829 Based on our findings, it is thus concluded that cisplatin may cause Adverse-EffectC. difficile colitis .
Score Text
0.9974 Administration of excessive Druginsulin induced hypoglycemia within 4 to 8 hours, followed by rebound hyperglycemia.
0.9964 Administration of excessive insulin induced Adverse-Effecthypoglycemia within 4 to 8 hours, followed by rebound hyperglycemia.
0.9355 Administration of excessive insulin induced hypoglycemia within 4 to 8 hours, followed by Adverse-Effectrebound hyperglycemia .
Score Text
0.9995 A case of Drugfluoxetine induced seizures, in a person with Down syndrome, is described.
0.9988 A case of fluoxetine induced Adverse-Effectseizures , in a person with Down syndrome, is described.
Score Text
0.9925 Adverse-EffectPulmonary edema occurred 24 hours after intravenous ritodrine therapy and 10 hours after subcutaneous terbutaline therapy.
0.9896 Pulmonary edema occurred 24 hours after intravenous Drugritodrine therapy and 10 hours after subcutaneous terbutaline therapy.
0.9645 Pulmonary edema occurred 24 hours after intravenous ritodrine therapy and 10 hours after subcutaneous Drugterbutaline therapy.
Score Text
0.9988 After treatment with a beta - sympathomimetic drug ( DrugPartusisten ) one fetus developed supraventricular tachycardia.
0.9855 After treatment with a beta - sympathomimetic drug ( Partusisten ) one fetus developed Adverse-Effectsupraventricular tachycardia .
Score Text
0.9913 DrugChlorambucil central nervous toxicity : a significant side effect of chlorambucil therapy in childhood nephrotic syndrome.
0.9294 Chlorambucil Adverse-Effectcentral nervous toxicity : a significant side effect of chlorambucil therapy in childhood nephrotic syndrome.
0.9870 Chlorambucil central nervous toxicity : a significant side effect of Drugchlorambucil therapy in childhood nephrotic syndrome.
Score Text
0.9987 The pulmonary toxicity of Druggold salts is an uncommon cause of life - threatening respiratory failure.
0.9672 The Adverse-Effectpulmonary toxicity of gold salts is an uncommon cause of life - threatening respiratory failure.
0.8891 The pulmonary toxicity of gold salts is an uncommon cause of life - threatening Adverse-Effectrespiratory failure .
Score Text
0.9897 Antacid and Drugsucralfate - induced hypophosphatemic osteomalacia : a case report and review of the literature.
0.9864 Antacid and sucralfate - induced Adverse-Effecthypophosphatemic osteomalacia : a case report and review of the literature.
Score Text
0.9995 Following are two clinical case reports demonstrating profound cerebral edema associated with implantation of DrugGliadel wafers.
0.9898 Following are two clinical case reports demonstrating profound Adverse-Effectcerebral edema associated with implantation of Gliadel wafers.
Score Text
0.9995 Severe visual loss after a single dose of Drugvincristine in a patient with spinal cord astrocytoma.
0.9770 Adverse-EffectSevere visual loss after a single dose of vincristine in a patient with spinal cord astrocytoma.
Score Text
0.9995 Thus any case of severe neutropenia occurring in a patient receiving Drugolanzapine is alarming to clinicians.
0.9505 Thus any case of Adverse-Effectsevere neutropenia occurring in a patient receiving olanzapine is alarming to clinicians.
Score Text
0.9685 The 9 other reported cases of DrugD - penicillamine induced rapidly progressive glomerulonephritis have been reviewed.
0.9659 The 9 other reported cases of D - penicillamine induced Adverse-Effectrapidly progressive glomerulonephritis have been reviewed.
Score Text
0.9989 Pigmentary disorders are recognized adverse effects of the semi - synthetic tetracycline derivative antibiotic, Drugminocycline .
0.9910 Adverse-EffectPigmentary disorders are recognized adverse effects of the semi - synthetic tetracycline derivative antibiotic, minocycline.
Score Text
0.9858 Adverse-EffectHerpes simplex esophagitis in a renal transplant patient treated with cyclosporine A : a case report.
0.9818 Herpes simplex esophagitis in a renal transplant patient treated with Drugcyclosporine A : a case report.
Score Text
0.9995 We describe a patient with idiopathic RLS who developed augmentation after 8 months of Druglevodopa treatment.
0.9958 We describe a patient with idiopathic RLS who developed Adverse-Effectaugmentation after 8 months of levodopa treatment.
Score Text
0.9990 Two patients with osteomyelitis who developed reversible cholestatic jaundice during treatment with Drugoxacillin derivatives are described.
0.8738 Two patients with osteomyelitis who developed Adverse-Effectreversible cholestatic jaundice during treatment with oxacillin derivatives are described.
Score Text
0.9988 Only one report links Drugphenylpropanolamine consumption to an intracerebral hemorrhage in a patient with an AVM.
0.9544 Only one report links phenylpropanolamine consumption to an Adverse-Effectintracerebral hemorrhage in a patient with an AVM.
Score Text
0.9996 DrugOlanzapine - induced hyperglycaemic coma and neuroleptic malignant syndrome : case report and review of literature.
0.9894 Olanzapine - induced Adverse-Effecthyperglycaemic coma and neuroleptic malignant syndrome : case report and review of literature.
0.9884 Olanzapine - induced hyperglycaemic coma and Adverse-Effectneuroleptic malignant syndrome : case report and review of literature.
Score Text
0.9993 In all cases, seizures were controlled by withdrawal of Drugphenytoin and reduction of drug levels.
0.9968 In all cases, Adverse-Effectseizures were controlled by withdrawal of phenytoin and reduction of drug levels.
Score Text
0.9994 A young patient experienced marked sinus tachycardia while smoking marijuana and receiving therapeutic doses of Drugnortriptyline .
0.9877 A young patient experienced marked Adverse-Effectsinus tachycardia while smoking marijuana and receiving therapeutic doses of nortriptyline.
Score Text
0.9995 A severe form of exophthalmos resulting from Druglithium therapy has not been described in the literature.
0.9953 A severe form of Adverse-Effectexophthalmos resulting from lithium therapy has not been described in the literature.
Score Text
0.9986 Adverse-EffectBulbar and pseudobulbar palsy complicating therapy with high - dose cytosine arabinoside in children with leukemia.
0.9915 Bulbar and Adverse-Effectpseudobulbar palsy complicating therapy with high - dose cytosine arabinoside in children with leukemia.
0.9785 Bulbar and pseudobulbar palsy complicating therapy with high - dose Drugcytosine arabinoside in children with leukemia.
Score Text
0.9992 The cause of his bleeding was a severe thrombocytopoaenia, induced by chronic ingestion of Drugquinine .
0.9029 The cause of his bleeding was a Adverse-Effectsevere thrombocytopoaenia , induced by chronic ingestion of quinine.
Score Text
0.9709 DrugL - asparaginase - induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children.
0.9871 L - asparaginase - induced Adverse-Effectposterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children.
L - asparaginase - induced Adverse-Effectposterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children.
Score Text
0.9994 Nevertheless, the coagulopathy seemed to be most closely associated with the administration of the Drugcephalosporin .
0.9980 Nevertheless, the Adverse-Effectcoagulopathy seemed to be most closely associated with the administration of the cephalosporin.
Score Text
0.9979 Favorable outcome of de novo hepatitis B infection after liver transplantation with lamivudine and Drugadefovir therapy.
0.9973 Favorable outcome of de novo hepatitis B infection after liver transplantation with Druglamivudine and adefovir therapy.
0.9740 Favorable outcome of de novo Adverse-Effecthepatitis B infection after liver transplantation with lamivudine and adefovir therapy.
Score Text
0.9995 Thrombocytosis induced by Drugenoxaparin has been reported as a rare adverse effect of this medication in adults.
0.9973 Adverse-EffectThrombocytosis induced by enoxaparin has been reported as a rare adverse effect of this medication in adults.
Score Text
0.9991 This is the first report of non - convulsive status epilepticus provoked by Drugtiagabine in adolescent patients.
0.9755 This is the first report of Adverse-Effectnon - convulsive status epilepticus provoked by tiagabine in adolescent patients.
Score Text
0.9986 L - asparaginase - induced Adverse-Effectpancreatitis has been reported during or closely following administration of the drug.
0.9699 DrugL - asparaginase - induced pancreatitis has been reported during or closely following administration of the drug.
Score Text
0.9994 The majority of radiation recall reactions attributed to Druggemcitabine are reported to affect internal tissue or organs.
0.9881 The majority of Adverse-Effectradiation recall reactions attributed to gemcitabine are reported to affect internal tissue or organs.
Score Text
0.9883 Adverse-EffectMinimal change disease in a patient receiving IFN - alpha therapy for chronic hepatitis C virus infection.
0.9731 Minimal change disease in a patient receiving DrugIFN - alpha therapy for chronic hepatitis C virus infection.
Score Text
0.9985 DrugClozapine - induced eosinophilia and switch to quetiapine in a patient with chronic schizophrenia with suicidal tendencies.
0.9976 Clozapine - induced Adverse-Effecteosinophilia and switch to quetiapine in a patient with chronic schizophrenia with suicidal tendencies.
Score Text
0.9910 In association with this tocolysis, Adverse-Effecturinary calculus of magnesium ammonium phosphate occurred at 34 weeks gestation.
0.9670 In association with this tocolysis, urinary calculus of Drugmagnesium ammonium phosphate occurred at 34 weeks gestation.
Score Text
0.9977 Cessation of D - Pen and the start of corticosteroid therapy were followed by recovery from Adverse-Effectbicytopenia .
0.9679 Cessation of DrugD - Pen and the start of corticosteroid therapy were followed by recovery from bicytopenia.
Score Text
0.9995 We report on a 37 - year - old female who complained of moderate hair loss during Drugparoxetine treatment.
0.9667 We report on a 37 - year - old female who complained of moderate Adverse-Effecthair loss during paroxetine treatment.
Score Text
0.9996 These novel findings may offer specific therapeutic targets in the treatment of DrugBCNU - associated pulmonary fibrosis.
0.9911 These novel findings may offer specific therapeutic targets in the treatment of BCNU - associated Adverse-Effectpulmonary fibrosis .
Score Text
0.9994 An insulin - dependent diabetic patient with nephropathy developed severe acidosis after treatment with Drugacetazolamide for glaucoma.
0.9822 An insulin - dependent diabetic patient with nephropathy developed Adverse-Effectsevere acidosis after treatment with acetazolamide for glaucoma.
Score Text
0.9993 Interstitial lung disease ( ILD ) related to therapy with the drug Druggefitinib has been well reported.
0.9927 Interstitial lung disease ( Adverse-EffectILD ) related to therapy with the drug gefitinib has been well reported.
0.9865 Adverse-EffectInterstitial lung disease ( ILD ) related to therapy with the drug gefitinib has been well reported.
Score Text
0.9994 CONCLUSIONS : This study confirmed that in most patients DrugMTX - induced liver cirrhosis is not aggressive.
0.9901 CONCLUSIONS : This study confirmed that in most patients MTX - induced Adverse-Effectliver cirrhosis is not aggressive.
Score Text
0.9908 Since tamoxifen therapy can induce Adverse-Effectendometrial disorders , surveillance schemes of women taking tamoxifen have been recommended.
0.9876 Since Drugtamoxifen therapy can induce endometrial disorders, surveillance schemes of women taking tamoxifen have been recommended.
0.9703 Since tamoxifen therapy can induce endometrial disorders, surveillance schemes of women taking Drugtamoxifen have been recommended.
Score Text
0.9985 Intravenous cytarabine and Drugmethotrexate appear to act synergistically to enhance the potential for central nervous system toxicity.
0.9984 Intravenous Drugcytarabine and methotrexate appear to act synergistically to enhance the potential for central nervous system toxicity.
0.9796 Intravenous cytarabine and methotrexate appear to act synergistically to enhance the potential for Adverse-Effectcentral nervous system toxicity .
Score Text
0.9996 CONCLUSIONS : The fundus picture shown in these cases may be typical of ASPPC after DrugIVTA injection.
0.9942 CONCLUSIONS : The fundus picture shown in these cases may be typical of Adverse-EffectASPPC after IVTA injection.
Score Text
0.9979 CONCLUSIONS : DrugLTG overdose may result in a severe but reversible encephalopathy, a previously undescribed phenomenon.
0.7497 CONCLUSIONS : LTG overdose may result in a severe but reversible Adverse-Effectencephalopathy , a previously undescribed phenomenon.
Score Text
0.9993 Several such HBV reactivations were reported after combined Drugrituximab and multiagent chemotherapy for B - cell lymphomas.
0.9813 Several such Adverse-EffectHBV reactivations were reported after combined rituximab and multiagent chemotherapy for B - cell lymphomas.
Score Text
0.9992 Acute renal insufficiency is known to occur in patients who are taking Drugciprofloxacin , particularly the elderly.
0.9650 Adverse-EffectAcute renal insufficiency is known to occur in patients who are taking ciprofloxacin, particularly the elderly.
Score Text
0.9991 Soon after its introduction in 1952, Drugchlorpromazine was noted to induce symptoms resembling Parkinson's disease.
0.6055 Soon after its introduction in 1952, chlorpromazine was noted to induce Adverse-Effectsymptoms resembling Parkinson's disease .
Score Text
0.9984 A young woman with epilepsy had tonic - clonic seizures during antineoplastic therapy with Drugadriamycin and cisplatin.
0.9982 A young woman with epilepsy had tonic - clonic seizures during antineoplastic therapy with adriamycin and Drugcisplatin .
0.9698 A young woman with epilepsy had Adverse-Effecttonic - clonic seizures during antineoplastic therapy with adriamycin and cisplatin.
Score Text
0.9993 We describe six patients who developed tardive dyskinesia after treatment with Drugsulpiride for depression or gastrointestinal symptoms.
0.9909 We describe six patients who developed Adverse-Effecttardive dyskinesia after treatment with sulpiride for depression or gastrointestinal symptoms.
Score Text
0.9984 Two heroin addicts, aged 34 and 19 years, developed ballistic movements after intravenous Drugheroin overdose.
0.9936 Two heroin addicts, aged 34 and 19 years, developed Adverse-Effectballistic movements after intravenous heroin overdose.
Score Text
0.9856 Generalised pustular psoriasis induced by Drugcyclosporin a withdrawal responding to the tumour necrosis factor alpha inhibitor etanercept.
0.9855 Adverse-EffectGeneralised pustular psoriasis induced by cyclosporin a withdrawal responding to the tumour necrosis factor alpha inhibitor etanercept.
Score Text
0.9889 Clozapine - induced Adverse-Effecttardive dyskinesia in schizophrenic patients taking clozapine as a first - line antipsychotic drug.
0.9677 DrugClozapine - induced tardive dyskinesia in schizophrenic patients taking clozapine as a first - line antipsychotic drug.
Score Text
0.9995 Interstitial pneumonitis and alveolar hemorrhage complicating use of Drugrituximab : case report and review of the literature.
0.9874 Adverse-EffectInterstitial pneumonitis and alveolar hemorrhage complicating use of rituximab : case report and review of the literature.
0.9871 Interstitial pneumonitis and Adverse-Effectalveolar hemorrhage complicating use of rituximab : case report and review of the literature.
Score Text
0.9994 Use of the Naranjo probability scale determined the association between Drugcephalosporin use and leukopenia to be probable.
0.9963 Use of the Naranjo probability scale determined the association between cephalosporin use and Adverse-Effectleukopenia to be probable.
Score Text
0.9993 CONCLUSIONS : DrugAmantadine can cause reversible corneal edema but can irreversibly reduce the density of endothelial cells.
0.9765 CONCLUSIONS : Amantadine can cause Adverse-Effectreversible corneal edema but can irreversibly reduce the density of endothelial cells.
Score Text
0.9981 Failure of plasmapheresis, corticosteroids and thionamides to ameliorate a case of protracted Drugamiodarone - induced thyroiditis.
0.9978 Failure of plasmapheresis, corticosteroids and thionamides to ameliorate a case of protracted amiodarone - induced Adverse-Effectthyroiditis .
Score Text
0.9991 An asymptomatic HIV - infected woman experienced right - sided renal colicky pain during treatment with Drugindinavir .
0.9837 An asymptomatic HIV - infected woman experienced right - sided Adverse-Effectrenal colicky pain during treatment with indinavir.
Score Text
0.9993 The temporal relationship suggests that the spinal cord infarction may be related to the use of Drugzolmitriptan .
0.9879 The temporal relationship suggests that the Adverse-Effectspinal cord infarction may be related to the use of zolmitriptan.
Score Text
0.9881 To date, there have been few reports of Adverse-Effectvisual disturbances associated with BTX - B use.
0.9774 To date, there have been few reports of visual disturbances associated with DrugBTX - B use.
Score Text
0.9996 We describe two cases of acute pancreatitis that occurred after long term Drugmesalamine therapy for ulcerative colitis.
0.9775 We describe two cases of Adverse-Effectacute pancreatitis that occurred after long term mesalamine therapy for ulcerative colitis.
Score Text
0.9981 Despite administration of phenytoin and lorazepam, the Adverse-Effectseizures persisted and occurred only during amphotercin B administration.
0.9806 Despite administration of phenytoin and lorazepam, the seizures persisted and occurred only during Drugamphotercin B administration.
Score Text
0.9480 In both patients the Adverse-Effectrippling phenomena worsened with pyridostigmine treatment but markedly improved after immunosuppression with azathioprine.
0.9220 In both patients the rippling phenomena worsened with Drugpyridostigmine treatment but markedly improved after immunosuppression with azathioprine.
0.7934 In both patients the rippling phenomena worsened with pyridostigmine treatment but markedly improved after immunosuppression with Drugazathioprine .
Score Text
0.9359 Acute hyperphosphatemia caused by Drugsodium phosphate enema in a patient with liver dysfunction and chronic renal failure.
Acute Adverse-Effecthyperphosphatemia caused by sodium phosphate enema in a patient with liver dysfunction and chronic renal failure.
Score Text
0.9833 A new case of Adverse-EffectCreutzfeldt - Jakob disease associated with human growth hormone therapy in New Zealand.
0.9700 A new case of Creutzfeldt - Jakob disease associated with Drughuman growth hormone therapy in New Zealand.
Score Text
0.9994 The Naranjo probability scale suggests a highly probable relationship between AIN and Drugpantoprazole therapy in this patient.
0.9963 The Naranjo probability scale suggests a highly probable relationship between Adverse-EffectAIN and pantoprazole therapy in this patient.
Score Text
0.9988 Inadvertent subsequent rechallenge with celiprolol led to recurrence of the Adverse-Effectpneumonitis , 10 weeks after drug readministration.
0.9968 Inadvertent subsequent rechallenge with Drugceliprolol led to recurrence of the pneumonitis, 10 weeks after drug readministration.
Score Text
0.9997 This is the first report of acute kidney injury due to Drugzonisamide - induced DRESS / DIHS.
0.9977 This is the first report of acute kidney injury due to zonisamide - induced Adverse-EffectDRESS / DIHS.
0.9974 This is the first report of acute kidney injury due to zonisamide - induced DRESS / Adverse-EffectDIHS .
0.9692 This is the first report of Adverse-Effectacute kidney injury due to zonisamide - induced DRESS / DIHS.
Score Text
0.9974 Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life - threatening Drugvincristine neurotoxicity.
0.7719 Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life - threatening vincristine Adverse-Effectneurotoxicity .
Early recognition of hereditary motor and sensory neuropathy type 1 can avoid Adverse-Effectlife - threatening vincristine neurotoxicity .
Score Text
0.9814 It is tempting to speculate that interferon alpha may be involved in the pathogenesis of Adverse-Effectlichen nitidus .
0.9802 It is tempting to speculate that Druginterferon alpha may be involved in the pathogenesis of lichen nitidus.
Score Text
0.9993 These data indicated that Druginfliximab possibly triggered production of granulocyte and neutrophil autoantibodies with resultant autoimmune agranulocytosis.
0.9867 These data indicated that infliximab possibly triggered production of granulocyte and neutrophil autoantibodies with resultant Adverse-Effectautoimmune agranulocytosis .
0.9026 These data indicated that infliximab possibly triggered Adverse-Effectproduction of granulocyte and neutrophil autoantibodies with resultant autoimmune agranulocytosis.
Score Text
0.9994 Clinicians should be aware of fasting hypoglycemia as an unusual but potentially serious complication of Drugdisopyramide therapy.
0.9725 Clinicians should be aware of Adverse-Effectfasting hypoglycemia as an unusual but potentially serious complication of disopyramide therapy.
Score Text
0.9993 DrugIFNalpha - induced recurrence of Graves'disease ten years after thyroidectomy in chronic viral hepatitis C.
0.9858 IFNalpha - induced recurrence of Adverse-EffectGraves'disease ten years after thyroidectomy in chronic viral hepatitis C.
Score Text
0.9995 Following 7 days of Drugtigecycline she developed severe abdominal pain and elevated pancreatic enzymes suggesting acute pancreatitis.
0.9818 Following 7 days of tigecycline she developed severe abdominal pain and elevated pancreatic enzymes suggesting Adverse-Effectacute pancreatitis .
0.9760 Following 7 days of tigecycline she developed Adverse-Effectsevere abdominal pain and elevated pancreatic enzymes suggesting acute pancreatitis.
0.9750 Following 7 days of tigecycline she developed severe abdominal pain and Adverse-Effectelevated pancreatic enzymes suggesting acute pancreatitis.
Score Text
0.9997 Since its FDA approval in 2002, there are no known citations of Drugezetimibe - induced pancreatitis.
0.9984 Since its FDA approval in 2002, there are no known citations of ezetimibe - induced Adverse-Effectpancreatitis .
Score Text
0.9989 We describe a case of life - threatening hyponatremia associated with Drugsibutramine use in an obese woman.
0.9713 We describe a case of life - threatening Adverse-Effecthyponatremia associated with sibutramine use in an obese woman.
Score Text
0.9994 A 14 - year - old girl with newly diagnosed SLE developed a pruritic bullous eruption while on Drugprednisone .
0.9901 A 14 - year - old girl with newly diagnosed SLE developed a Adverse-Effectpruritic bullous eruption while on prednisone.
Score Text
0.9994 CONCLUSION : DrugTamoxifen may cause malignant transformation of endometriosis through atypical endometriosis even in the postmenopausal state.
0.9669 CONCLUSION : Tamoxifen may cause Adverse-Effectmalignant transformation of endometriosis through atypical endometriosis even in the postmenopausal state.
Score Text
0.9992 Administration of Drugpyridoxine to an infant after a long period of convulsions was followed by acute hypotonia.
0.9911 Administration of pyridoxine to an infant after a long period of convulsions was followed by Adverse-Effectacute hypotonia .
Score Text
0.9993 A case report of fatal Drugdapsone - induced agranulocytosis in an Indian mid - borderline leprosy patient.
0.9979 A case report of fatal dapsone - induced Adverse-Effectagranulocytosis in an Indian mid - borderline leprosy patient.
Score Text
0.9929 Warfarin - induced skin necrosis and heparin - induced Adverse-Effectthrombocytopenia following mitral valve replacement for marantic endocarditis.
0.7253 DrugWarfarin - induced skin necrosis and heparin - induced thrombocytopenia following mitral valve replacement for marantic endocarditis.
0.7013 Warfarin - induced skin necrosis and Drugheparin - induced thrombocytopenia following mitral valve replacement for marantic endocarditis.
0.5326 Warfarin - induced Adverse-Effectskin necrosis and heparin - induced thrombocytopenia following mitral valve replacement for marantic endocarditis.
0.5174 Warfarin - induced skin necrosis and heparin - induced thrombocytopenia following Drugmitral valve replacement for marantic endocarditis.
Score Text
0.9976 Clinicians should be vigilant when monitoring for cardiotoxicity in patients receiving Drugpentamidine throughout the duration of therapy.
0.9923 Clinicians should be vigilant when monitoring for Adverse-Effectcardiotoxicity in patients receiving pentamidine throughout the duration of therapy.
Score Text
0.9995 We present a depressive patient who developed mild parkinsonian signs and camptocormia after the introduction of Drugolanzapine .
0.9962 We present a depressive patient who developed mild parkinsonian signs and Adverse-Effectcamptocormia after the introduction of olanzapine.
0.9867 We present a depressive patient who developed Adverse-Effectmild parkinsonian signs and camptocormia after the introduction of olanzapine.
Score Text
0.9995 Despite the underlying hepatitis C, this case represents renal abnormalities consistent with DrugIFNalpha therapy for CML.
0.9892 Despite the underlying hepatitis C, this case represents Adverse-Effectrenal abnormalities consistent with IFNalpha therapy for CML.
Score Text
0.9987 The ocular motor disturbances are probably an expression of regional Drug5 - FU neurotoxicity primarily affecting the brain stem.
0.9727 The Adverse-Effectocular motor disturbances are probably an expression of regional 5 - FU neurotoxicity primarily affecting the brain stem.
0.9357 The ocular motor disturbances are probably an expression of regional 5 - FU Adverse-Effectneurotoxicity primarily affecting the brain stem.
Score Text
0.9995 RESULTS : DrugQuetiapine was associated with leucopenia in two patients and clinically apparent agranulocytosis in one patient.
0.9969 RESULTS : Quetiapine was associated with leucopenia in two patients and clinically apparent Adverse-Effectagranulocytosis in one patient.
0.9968 RESULTS : Quetiapine was associated with Adverse-Effectleucopenia in two patients and clinically apparent agranulocytosis in one patient.
Score Text
0.9963 In a 61 - year - old man receiving chronic low - dosage Drugamiodarone an interstitial pneumopathy was observed.
0.9866 In a 61 - year - old man receiving chronic low - dosage amiodarone an Adverse-Effectinterstitial pneumopathy was observed.
Score Text
0.9982 Cerebrovascular complications of L - asparaginase therapy in children with leukemia : Adverse-Effectaphasia and other neuropsychological deficits.
0.9902 Cerebrovascular complications of L - asparaginase therapy in children with leukemia : aphasia and other Adverse-Effectneuropsychological deficits .
0.9680 Cerebrovascular complications of DrugL - asparaginase therapy in children with leukemia : aphasia and other neuropsychological deficits.
0.8472 Adverse-EffectCerebrovascular complications of L - asparaginase therapy in children with leukemia : aphasia and other neuropsychological deficits.
Score Text
0.9995 A case of Drugmetoclopramide - induced oculogyric crisis in a 16 - year - old girl with cystic fibrosis.
0.9935 A case of metoclopramide - induced Adverse-Effectoculogyric crisis in a 16 - year - old girl with cystic fibrosis.
Score Text
0.9994 We describe a case of severe aplastic anemia ( AA ) that was probably induced by Druglenalidomide .
0.9702 We describe a case of Adverse-Effectsevere aplastic anemia ( AA ) that was probably induced by lenalidomide.
0.9608 We describe a case of severe aplastic anemia ( Adverse-EffectAA ) that was probably induced by lenalidomide.
Score Text
0.9983 Case report : Drugdapsone hypersensitivity syndrome associated with treatment of the bite of a brown recluse spider.
0.9270 Case report : dapsone Adverse-Effecthypersensitivity syndrome associated with treatment of the bite of a brown recluse spider.
Score Text
0.9774 Experience with five patients in whom impaired renal function developed early during Drugamphotericin B therapy is reported.
0.9652 Experience with five patients in whom Adverse-Effectimpaired renal function developed early during amphotericin B therapy is reported.
Score Text
0.9988 METHODS : We report a patient who had an anaphylactic reaction during the intravenous infusion of Drugcyclosporine .
0.9900 METHODS : We report a patient who had an Adverse-Effectanaphylactic reaction during the intravenous infusion of cyclosporine.
Score Text
0.9993 CONCLUSION : There may be an association between Drugraloxifene and the development of malignant mixed mesodermal tumor.
0.9825 CONCLUSION : There may be an association between raloxifene and the development of Adverse-Effectmalignant mixed mesodermal tumor .
Score Text
0.9993 BACKGROUND : To describe the occurrence of ocular hypertension in four patients following injection of Drugranibizumab intravitreally.
0.9918 BACKGROUND : To describe the occurrence of Adverse-Effectocular hypertension in four patients following injection of ranibizumab intravitreally.
Score Text
0.9993 DrugVancomycin is the most frequently implicated drug, but other agents have been reported to cause LABD.
0.9987 Vancomycin is the most frequently implicated drug, but other agents have been reported to cause Adverse-EffectLABD .
Score Text
0.9995 Two of our patients developed TD after 23 months and 34 months of Drugziprasidone monotherapy, respectively.
0.9970 Two of our patients developed Adverse-EffectTD after 23 months and 34 months of ziprasidone monotherapy, respectively.
Score Text
0.9986 While both Drugamiodarone and digoxin can cause permanent visual changes, the ocular effects are often reversible.
0.9985 While both amiodarone and Drugdigoxin can cause permanent visual changes, the ocular effects are often reversible.
0.9781 While both amiodarone and digoxin can cause permanent visual changes, the Adverse-Effectocular effects are often reversible.
0.9676 While both amiodarone and digoxin can cause permanent Adverse-Effectvisual changes , the ocular effects are often reversible.
Score Text
0.9995 A fatal massive pulmonary embolus developed in a patient treated with Drugstreptokinase for acute deep vein thrombosis.
0.9821 A Adverse-Effectfatal massive pulmonary embolus developed in a patient treated with streptokinase for acute deep vein thrombosis.
Score Text
0.9804 L - Carnitine supplementation has been recommended to prevent the Adverse-Effectfatal hepatotoxic effects associated with valproic acid.
0.9788 L - Carnitine supplementation has been recommended to prevent the fatal hepatotoxic effects associated with Drugvalproic acid .
Score Text
0.9952 Biopsy - proven acute interstitial nephritis associated with the tyrosine kinase inhibitor Drugsunitinib : a class effect?
0.9768 Biopsy - proven Adverse-Effectacute interstitial nephritis associated with the tyrosine kinase inhibitor sunitinib : a class effect?
Score Text
0.9993 Four patients receiving high - dose Drugtamoxifen for greater than 1 year have demonstrated similar retinal changes.
0.9855 Four patients receiving high - dose tamoxifen for greater than 1 year have demonstrated similar Adverse-Effectretinal changes .
Score Text
0.9989 After five and six weeks of continuous oral administration of Drugmethylprednisolone , the boys developed steroid diabetes.
0.9939 After five and six weeks of continuous oral administration of methylprednisolone, the boys developed Adverse-Effectsteroid diabetes .
Score Text
0.9994 Multiple complications of Drugpropylthiouracil treatment : granulocytopenia, eosinophilia, skin reaction and hepatitis with lymphocyte sensitization.
0.9974 Multiple complications of propylthiouracil treatment : granulocytopenia, eosinophilia, skin reaction and Adverse-Effecthepatitis with lymphocyte sensitization.
0.9973 Multiple complications of propylthiouracil treatment : Adverse-Effectgranulocytopenia , eosinophilia, skin reaction and hepatitis with lymphocyte sensitization.
0.9968 Multiple complications of propylthiouracil treatment : granulocytopenia, Adverse-Effecteosinophilia , skin reaction and hepatitis with lymphocyte sensitization.
0.9880 Multiple complications of propylthiouracil treatment : granulocytopenia, eosinophilia, Adverse-Effectskin reaction and hepatitis with lymphocyte sensitization.
0.9536 Multiple complications of propylthiouracil treatment : granulocytopenia, eosinophilia, skin reaction and hepatitis with Adverse-Effectlymphocyte sensitization .
Score Text
0.9990 Myoclonus and seizures in a patient with parkinsonism : induction by Druglevodopa and its confirmation on SEPs.
0.9990 Adverse-EffectMyoclonus and seizures in a patient with parkinsonism : induction by levodopa and its confirmation on SEPs.
0.9986 Myoclonus and Adverse-Effectseizures in a patient with parkinsonism : induction by levodopa and its confirmation on SEPs.
Score Text
0.9995 We report a patient of organic bipolar affective disorder who developed hiccups with the atypical antipsychotic Drugaripiprazole .
0.9983 We report a patient of organic bipolar affective disorder who developed Adverse-Effecthiccups with the atypical antipsychotic aripiprazole.
Score Text
0.9988 Based on the history and clinical features, a diagnosis of Druginsulin - induced lipohypertrophy was made.
0.9970 Based on the history and clinical features, a diagnosis of insulin - induced Adverse-Effectlipohypertrophy was made.
Score Text
0.9995 We present a neonate with a seizure disorder who acutely developed pupillary mydriasis secondary to Druglidocaine overdose.
0.9895 We present a neonate with a seizure disorder who acutely developed Adverse-Effectpupillary mydriasis secondary to lidocaine overdose.
Score Text
0.9994 There are, however, case studies describing patients experiencing recurrences of tics following treatment with Drugatomoxetine .
0.9961 There are, however, case studies describing patients experiencing recurrences of Adverse-Effecttics following treatment with atomoxetine.
Score Text
0.9780 We report the use of pamidronate for acute, severe hypercalcemia secondary to iatrogenic Drugvitamin D poisoning.
0.8507 We report the use of pamidronate for acute, Adverse-Effectsevere hypercalcemia secondary to iatrogenic vitamin D poisoning.
0.7589 We report the use of pamidronate for acute, severe hypercalcemia secondary to iatrogenic Adverse-Effectvitamin D poisoning .
0.6314 We report the use of Drugpamidronate for acute, severe hypercalcemia secondary to iatrogenic vitamin D poisoning.
Score Text
0.9993 We present a case of photo - onycholysis in a patient treated with Drugdoxycycline for acne vulgaris.
0.9781 We present a case of Adverse-Effectphoto - onycholysis in a patient treated with doxycycline for acne vulgaris.
Score Text
0.9873 We herein report this rare case of acute onset of Adverse-Effectnephrotic syndrome during interferon - alpha retreatment.
0.9631 We herein report this rare case of acute onset of nephrotic syndrome during Druginterferon - alpha retreatment.
Score Text
0.9995 The occurrence of severe AIHA in CLL patients treated with Drugfludarabine has been reported by several authors.
0.9938 The occurrence of severe Adverse-EffectAIHA in CLL patients treated with fludarabine has been reported by several authors.
Score Text
0.9833 We present the first case of a patient with priapism after oral intake of the phenothiazine Drugprothipendylhydrochloride .
0.9826 We present the first case of a patient with Adverse-Effectpriapism after oral intake of the phenothiazine prothipendylhydrochloride.
Score Text
0.9990 Acute asymptomatic hepatitis in a healthy normal volunteer exposed to 2 oral doses of Drugamodiaquine and artesunate.
0.9989 Acute asymptomatic hepatitis in a healthy normal volunteer exposed to 2 oral doses of amodiaquine and Drugartesunate .
0.9656 Adverse-EffectAcute asymptomatic hepatitis in a healthy normal volunteer exposed to 2 oral doses of amodiaquine and artesunate.
Acute Adverse-Effectasymptomatic hepatitis in a healthy normal volunteer exposed to 2 oral doses of amodiaquine and artesunate.
Score Text
0.9995 This case highlights the possible development of acute coronary syndrome as a side effect of DrugCapecitabine therapy.
0.9869 This case highlights the possible development of Adverse-Effectacute coronary syndrome as a side effect of Capecitabine therapy.
Score Text
0.9714 Adverse-EffectAvascular necrosis of the femoral head in patients with prostate cancer treated with cyproterone acetate and radiotherapy.
0.9680 Avascular necrosis of the femoral head in patients with prostate cancer treated with Drugcyproterone acetate and radiotherapy.
Score Text
0.9995 DrugTorsemide appears to also be a part of a long list of agents that can cause pancreatitis.
0.9986 Torsemide appears to also be a part of a long list of agents that can cause Adverse-Effectpancreatitis .
Score Text
0.9994 Acute renal failure most likely was secondary to the nephrotoxic effect of Drugcaptopril on chronically hypoperfused kidneys.
0.9401 Adverse-EffectAcute renal failure most likely was secondary to the nephrotoxic effect of captopril on chronically hypoperfused kidneys.
Score Text
0.9992 The patient was given Drugmethimazole instead of propylthiouracil but, 10 weeks later, agranulocytosis again occurred.
0.9973 The patient was given methimazole instead of propylthiouracil but, 10 weeks later, Adverse-Effectagranulocytosis again occurred.
Score Text
0.9974 The present case is the first report of Adverse-Effecthypercalcemia induced by vitamin D3 ointment and thiazide simultaneously.
0.9953 The present case is the first report of hypercalcemia induced by vitamin D3 ointment and Drugthiazide simultaneously.
0.9898 The present case is the first report of hypercalcemia induced by Drugvitamin D3 ointment and thiazide simultaneously.
Score Text
0.9996 We describe a case of Drugclozapine - induced seizures in a patient with treatment - resistant schizophrenia.
0.9988 We describe a case of clozapine - induced Adverse-Effectseizures in a patient with treatment - resistant schizophrenia.
Score Text
0.9992 Pleuropulmonary changes during treatment of Parkinson's disease with a long - acting ergot derivative, Drugcabergoline .
0.9918 Adverse-EffectPleuropulmonary changes during treatment of Parkinson's disease with a long - acting ergot derivative, cabergoline.
Score Text
0.9972 However, because Drugdiphenhydramine also exhibits type IA sodium channel blockade, cardiac toxicity is also possible.
0.9872 However, because diphenhydramine also exhibits type IA sodium channel blockade, Adverse-Effectcardiac toxicity is also possible.
Score Text
0.9992 While 40 mg / day of Drugprednisolone improved hepatic dysfunction dramatically, her diabetic milieu deteriorated seriously.
0.9417 While 40 mg / day of prednisolone improved hepatic dysfunction dramatically, her Adverse-Effectdiabetic milieu deteriorated seriously.
Score Text
0.9965 Two cases of Adverse-Effecthypothyroidism in patients with chronic hepatitis C treated with recombinant alpha interferon are reported.
0.9623 Two cases of hypothyroidism in patients with chronic hepatitis C treated with Drugrecombinant alpha interferon are reported.
Score Text
0.9996 We report DrugAZA - induced drug eruption that developed in two cases of systemic scleroderma with polymyositis.
0.9880 We report AZA - induced Adverse-Effectdrug eruption that developed in two cases of systemic scleroderma with polymyositis.
Score Text
0.9996 The condition should be suspected in patients who develop unexplained abdominal pain or collapse following Drugvasopressin treatment.
0.9912 The condition should be suspected in patients who develop unexplained Adverse-Effectabdominal pain or collapse following vasopressin treatment.
0.9772 The condition should be suspected in patients who develop unexplained abdominal pain or Adverse-Effectcollapse following vasopressin treatment.
Score Text
0.9991 Reversal of Druggold - induced neutropenia with granulocyte colony - stimulating factor ( G - CSF ).
0.9978 Reversal of gold - induced Adverse-Effectneutropenia with granulocyte colony - stimulating factor ( G - CSF ).
Score Text
0.9996 Psychosis in a 12 - year - old HIV - positive girl with an increased serum concentration of Drugefavirenz .
0.9987 Adverse-EffectPsychosis in a 12 - year - old HIV - positive girl with an increased serum concentration of efavirenz.
Score Text
0.9993 A 35 - year - old man with seropositive rheumatoid arthritis developed selective IgA deficiency during treatment with Drugfenclofenac .
0.9899 A 35 - year - old man with seropositive rheumatoid arthritis developed selective Adverse-EffectIgA deficiency during treatment with fenclofenac.
Score Text
0.9979 We report a case of recurrent torsades de pointes following treatment with pentavalent antimonial drugs and Drugamiodarone .
0.9742 We report a case of recurrent Adverse-Effecttorsades de pointes following treatment with pentavalent antimonial drugs and amiodarone.
Score Text
0.9991 SUBSEQUENT COURSE : The nephrosis resolved almost completely once the Druginterferon was stopped and after immunosuppressive treatment.
0.9955 SUBSEQUENT COURSE : The Adverse-Effectnephrosis resolved almost completely once the interferon was stopped and after immunosuppressive treatment.
Score Text
0.9995 Asthenozoospermia : possible association with long - term exposure to an anti - epileptic drug of Drugcarbamazepine .
0.9964 Adverse-EffectAsthenozoospermia : possible association with long - term exposure to an anti - epileptic drug of carbamazepine.
Score Text
0.9994 PURPOSE : We studied a case of vortex keratopathy that was associated with the use of Drugatovaquone .
0.9868 PURPOSE : We studied a case of Adverse-Effectvortex keratopathy that was associated with the use of atovaquone.
Score Text
0.9995 OBJECTIVE : To report 2 cases of nonconvulsive status epilepticus ( NCSE ) following infusion of Drugifosfamide .
0.9913 OBJECTIVE : To report 2 cases of nonconvulsive status epilepticus ( Adverse-EffectNCSE ) following infusion of ifosfamide.
0.9800 OBJECTIVE : To report 2 cases of Adverse-Effectnonconvulsive status epilepticus ( NCSE ) following infusion of ifosfamide.
Score Text
0.9991 The cause is presumed to be secondary to hypercoagulability due to Drugasparaginase - induced antithrombin III deficiency.
0.9836 The cause is presumed to be secondary to hypercoagulability due to asparaginase - induced Adverse-Effectantithrombin III deficiency .
Score Text
0.9995 OBJECTIVE : To describe the development of Drugvalproate - related reproductive endocrine disorders in women with epilepsy.
0.9868 OBJECTIVE : To describe the development of valproate - related Adverse-Effectreproductive endocrine disorders in women with epilepsy.
Score Text
0.9992 Physicians treating patients with Drugmethotrexate for juvenile rheumatoid arthritis must be aware of this extraarticular side effect.
0.9103 Physicians treating patients with methotrexate for juvenile rheumatoid arthritis must be aware of this Adverse-Effectextraarticular side effect .
Score Text
0.9949 Slow acetylator genotypes as a possible risk factor for infectious mononucleosis - like syndrome induced by Drugsalazosulfapyridine .
0.9769 Slow acetylator genotypes as a possible risk factor for Adverse-Effectinfectious mononucleosis - like syndrome induced by salazosulfapyridine.
Score Text
0.9997 We report the first case, to our knowledge, of Drugrituximab - related autoimmune hemolytic anemia.
0.9865 We report the first case, to our knowledge, of rituximab - related Adverse-Effectautoimmune hemolytic anemia .
Score Text
0.9995 A depressed woman with no history of bipolar illness developed a manic episode during treatment with Drugfluoxetine .
0.9925 A depressed woman with no history of bipolar illness developed a Adverse-Effectmanic episode during treatment with fluoxetine.
Score Text
0.9988 With Drugitraconazole , hepatotoxic reactions have only very rarely been reported, and histologic data are lacking.
0.6515 With itraconazole, Adverse-Effecthepatotoxic reactions have only very rarely been reported, and histologic data are lacking.
0.9858 With itraconazole, Adverse-Effecthepatotoxic reactions have only very rarely been reported, and histologic data are lacking.
Score Text
0.9987 The other woman had rheumatoid arthritis and developed acute tubular necrosis after treatment with Druggentamicin and cefoxitin.
0.9980 The other woman had rheumatoid arthritis and developed acute tubular necrosis after treatment with gentamicin and Drugcefoxitin .
0.9893 The other woman had rheumatoid arthritis and developed Adverse-Effectacute tubular necrosis after treatment with gentamicin and cefoxitin.
Score Text
0.9996 OBJECTIVE : To report a case of possible Drugfoscarnet - induced severe hypomagnesemia and other electrolyte disorders.
0.9927 OBJECTIVE : To report a case of possible foscarnet - induced severe hypomagnesemia and other Adverse-Effectelectrolyte disorders .
0.9872 OBJECTIVE : To report a case of possible foscarnet - induced Adverse-Effectsevere hypomagnesemia and other electrolyte disorders.
Score Text
0.9921 CONCLUSION : Lipoid pneumonia as a result of Drugmineral oil aspiration still occurs in the pediatric population.
0.9887 CONCLUSION : Adverse-EffectLipoid pneumonia as a result of mineral oil aspiration still occurs in the pediatric population.
Score Text
0.9995 Secretory endometrial adenocarcinoma in a patient on Drugtamoxifen for breast cancer : a report of a case.
0.9717 Adverse-EffectSecretory endometrial adenocarcinoma in a patient on tamoxifen for breast cancer : a report of a case.
Score Text
0.9996 METHODS : Five cases of contact dermatitis due to Drugbudesonide , a nonhalogenated steroid, are described.
0.9875 METHODS : Five cases of Adverse-Effectcontact dermatitis due to budesonide, a nonhalogenated steroid, are described.
Score Text
0.9922 We describe 2 children with cerebral palsy who suffered significant Adverse-Effectmorbidity immediately after treatment with hyperbaric oxygen.
0.9843 We describe 2 children with cerebral palsy who suffered significant morbidity immediately after treatment with Drughyperbaric oxygen .
Score Text
0.9975 Cyclosporine is a potent inhibitor of simvastatin metabolism, and may therefore facilitate simvastatin - induced Adverse-Effectrhabdomyolysis .
0.9937 DrugCyclosporine is a potent inhibitor of simvastatin metabolism, and may therefore facilitate simvastatin - induced rhabdomyolysis.
0.9759 Cyclosporine is a potent inhibitor of simvastatin metabolism, and may therefore facilitate Drugsimvastatin - induced rhabdomyolysis.
Score Text
0.9991 To our knowledge, no prior cases of Drugpenicillamine - induced TTP in RA have been reported.
0.9953 To our knowledge, no prior cases of penicillamine - induced Adverse-EffectTTP in RA have been reported.
Score Text
0.9996 We report two patients with acne vulgaris with a fourth type of Drugminocycline - induced cutaneous pigmentation.
0.9936 We report two patients with acne vulgaris with a fourth type of minocycline - induced Adverse-Effectcutaneous pigmentation .
Score Text
0.9984 Tumor lysis syndrome after transcatheter arterial infusion of Drugcisplatin and embolization therapy for liver metastases of melanoma.
0.9868 Adverse-EffectTumor lysis syndrome after transcatheter arterial infusion of cisplatin and embolization therapy for liver metastases of melanoma.
Score Text
0.9993 Severe cardiomyopathy following treatment with the tumour necrosis factor - alpha inhibitor Drugadalimumab for Crohn's disease.
0.9394 Adverse-EffectSevere cardiomyopathy following treatment with the tumour necrosis factor - alpha inhibitor adalimumab for Crohn's disease.
Score Text
0.9827 Detection of antineutrophil cytoplasmic antibody in a patient with L - tryptophan induced Adverse-Effecteosinophilia - myalgia syndrome .
0.9654 Detection of antineutrophil cytoplasmic antibody in a patient with DrugL - tryptophan induced eosinophilia - myalgia syndrome.
Score Text
0.9993 A patient with seropositive rheumatoid arthritis developed ascites while taking weekly doses of Drugmethotrexate ( MTX ).
0.9988 A patient with seropositive rheumatoid arthritis developed ascites while taking weekly doses of methotrexate ( DrugMTX ).
0.9986 A patient with seropositive rheumatoid arthritis developed Adverse-Effectascites while taking weekly doses of methotrexate ( MTX ).
Score Text
0.9996 We describe 3 elderly patients with moderate to severe ataxia that occurred while they were taking Drugpropafenone .
0.9666 We describe 3 elderly patients with moderate to severe Adverse-Effectataxia that occurred while they were taking propafenone.
Score Text
0.9976 DrugAluminum intoxication, along with other factors, was considered to be the cause of TC development.
0.9895 Aluminum intoxication, along with other factors, was considered to be the cause of Adverse-EffectTC development.
0.8917 Adverse-EffectAluminum intoxication , along with other factors, was considered to be the cause of TC development.
Score Text
0.9994 Transient central diabetes insipidus in the setting of underlying chronic nephrogenic diabetes insipidus associated with Druglithium use.
0.9641 Adverse-EffectTransient central diabetes insipidus in the setting of underlying chronic nephrogenic diabetes insipidus associated with lithium use.
Score Text
0.9991 Prolongation of the QT interval observed in a Japanese patient with vivax malaria following treatment with Drughalofantrine .
0.9725 Adverse-EffectProlongation of the QT interval observed in a Japanese patient with vivax malaria following treatment with halofantrine.
Score Text
0.9995 We report the first histopathologically documented case of oral mucosa pigmentation after OLP treatment with topical Drugtacrolimus .
0.9857 We report the first histopathologically documented case of Adverse-Effectoral mucosa pigmentation after OLP treatment with topical tacrolimus.
Score Text
0.9994 After cessation of Drugamantadine , the edema resolved, and the endothelial cell densities were < or = 600 / mm.
0.9972 After cessation of amantadine, the Adverse-Effectedema resolved, and the endothelial cell densities were < or = 600 / mm.
Score Text
0.9995 A possible mechanism for focal neurological deficit in brain - damaged patients on Drugphenytoin therapy is discussed.
0.9780 A possible mechanism for Adverse-Effectfocal neurological deficit in brain - damaged patients on phenytoin therapy is discussed.
Score Text
0.9995 Acute generalized exanthematous pustulosis caused by Drugmorphine , confirmed by positive patch test and lymphocyte transformation test.
0.9678 Adverse-EffectAcute generalized exanthematous pustulosis caused by morphine, confirmed by positive patch test and lymphocyte transformation test.
Score Text
0.9992 OBJECTIVE : To report a patient developing fulminant liver failure while being treated with Drugclarithromycin for pneumonia.
0.9878 OBJECTIVE : To report a patient developing Adverse-Effectfulminant liver failure while being treated with clarithromycin for pneumonia.
Score Text
0.9993 One patient suffered coronary artery vasospasm, attributed to the use of topical 1 : 1000 Drugepinephrine during surgery.
0.9850 One patient suffered Adverse-Effectcoronary artery vasospasm , attributed to the use of topical 1 : 1000 epinephrine during surgery.
Score Text
0.9993 DrugAcetazolamide may have accelerated the development of osteomalacia by several mechanisms, including increased renal calcium excretion.
0.9979 Acetazolamide may have accelerated the development of Adverse-Effectosteomalacia by several mechanisms, including increased renal calcium excretion.
Score Text
0.9970 The incidence of 5 - fluorouracil ( Drug5 - FU ) - related cardiotoxicity seems to be dosage and schedule dependent.
0.9965 The incidence of 5 - fluorouracil ( 5 - FU ) - related Adverse-Effectcardiotoxicity seems to be dosage and schedule dependent.
0.9962 The incidence of Drug5 - fluorouracil ( 5 - FU ) - related cardiotoxicity seems to be dosage and schedule dependent.
Score Text
0.9995 A case of acute respiratory failure due to diaphragmatic weakness following Drugadalimumab therapy for psoriasis is described.
0.9852 A case of Adverse-Effectacute respiratory failure due to diaphragmatic weakness following adalimumab therapy for psoriasis is described.
0.5635 A case of acute respiratory failure due to Adverse-Effectdiaphragmatic weakness following adalimumab therapy for psoriasis is described.
Score Text
0.9988 DrugIndinavir - associated nephrolithiasis and chronic interstitial nephritis were the only possible causes identified in this patient.
0.9931 Indinavir - associated Adverse-Effectnephrolithiasis and chronic interstitial nephritis were the only possible causes identified in this patient.
0.9400 Indinavir - associated nephrolithiasis and chronic Adverse-Effectinterstitial nephritis were the only possible causes identified in this patient.
Score Text
0.9897 Diagnosis of Adverse-Effecthypothyroidism during treatment can be difficult because of the common side effects of alpha interferon.
0.9451 Diagnosis of hypothyroidism during treatment can be difficult because of the common side effects of Drugalpha interferon .
Score Text
0.9835 OBJECTIVE : To report a case of Adverse-Effectcutaneous and hematologic toxicity in a patient treated with IL - 2.
0.9705 OBJECTIVE : To report a case of cutaneous and hematologic toxicity in a patient treated with DrugIL - 2 .
Score Text
0.9989 Improved awareness of and further investigation into the neurotoxic effects of Drugofloxacin may enhance its safe use.
0.9821 Improved awareness of and further investigation into the Adverse-Effectneurotoxic effects of ofloxacin may enhance its safe use.
Score Text
0.9954 Several possible explanations of the mechanism of renal failure associated with the use of Drugdextran - 40 are discussed.
0.9923 Several possible explanations of the mechanism of Adverse-Effectrenal failure associated with the use of dextran - 40 are discussed.
Score Text
0.9990 We postulate that the bolus of Drugsulprostone resulted in possible coronary spasm that resulted in cardiac arrest.
0.9910 We postulate that the bolus of sulprostone resulted in possible coronary spasm that resulted in Adverse-Effectcardiac arrest .
0.9866 We postulate that the bolus of sulprostone resulted in possible Adverse-Effectcoronary spasm that resulted in cardiac arrest.
Score Text
0.9989 Neurophysiological mechanisms which aid in elucidating the role of Drugdisulfiram in the etiology of catatonia are discussed.
0.9968 Neurophysiological mechanisms which aid in elucidating the role of disulfiram in the etiology of Adverse-Effectcatatonia are discussed.
Score Text
0.9982 There is documentation of ocular toxicity with Drugethambutol when administered at dosages generally pronounced as being safe.
0.9854 There is documentation of Adverse-Effectocular toxicity with ethambutol when administered at dosages generally pronounced as being safe.
Score Text
0.9833 Hydrocortisone may decrease the incidence of mortality associated with Adverse-Effectcardiac arrhythmias in children receiving amphotericin B overdoses.
0.9794 Hydrocortisone may decrease the incidence of Adverse-Effectmortality associated with cardiac arrhythmias in children receiving amphotericin B overdoses.
0.9784 Hydrocortisone may decrease the incidence of mortality associated with cardiac arrhythmias in children receiving Drugamphotericin B overdoses.
Score Text
0.9995 There are no previous reports in the literature about the emergence of CML during treatment with Drughydroxyurea .
0.9974 There are no previous reports in the literature about the emergence of Adverse-EffectCML during treatment with hydroxyurea.
Score Text
0.9993 An infertile patient with amenorrhea - galactorrhea syndrome lost vision during a pregnancy occurring after DrugBromocryptine treatment.
0.9631 An infertile patient with amenorrhea - galactorrhea syndrome Adverse-Effectlost vision during a pregnancy occurring after Bromocryptine treatment.
Score Text
0.9994 Herein, we present a patient with severe and prolonged hypoglycemia after long - acting Drugoctreotide treatment.
0.8601 Herein, we present a patient with severe and prolonged Adverse-Effecthypoglycemia after long - acting octreotide treatment.
Herein, we present a patient with severe and Adverse-Effectprolonged hypoglycemia after long - acting octreotide treatment.
Score Text
0.9995 We describe a case of pneumonitis following local administration of Drugmethotrexate for nonsurgical termination of an ectopic pregnancy.
0.9986 We describe a case of Adverse-Effectpneumonitis following local administration of methotrexate for nonsurgical termination of an ectopic pregnancy.
Score Text
0.9996 Progressive hypoxemia mandated endotracheal intubation 1 week after Drugrituximab administration and led to death 4 weeks after admission.
0.9888 Adverse-EffectProgressive hypoxemia mandated endotracheal intubation 1 week after rituximab administration and led to death 4 weeks after admission.
Score Text
0.9984 Adverse-EffectHUS has been reported after several anticancer chemotherapies and most often after mitomycin C - based chemotherapy regimens.
0.9880 HUS has been reported after several anticancer chemotherapies and most often after Drugmitomycin C - based chemotherapy regimens.
Score Text
0.9987 RESULTS : Evidence of neurological improvement and rehabilitation potential after severe myelopathy due to intrathecal injection of Drugdoxorubicin .
0.9692 RESULTS : Evidence of neurological improvement and rehabilitation potential after Adverse-Effectsevere myelopathy due to intrathecal injection of doxorubicin.
Score Text
0.9968 Adverse-EffectHyperkalaemia with renal tubular dysfunction by sulfamethoxazole - trimethoprim for Pneumocystis carinii pneumonia in patients with lymphoid malignancy.
0.9854 Hyperkalaemia with Adverse-Effectrenal tubular dysfunction by sulfamethoxazole - trimethoprim for Pneumocystis carinii pneumonia in patients with lymphoid malignancy.
0.7867 Hyperkalaemia with renal tubular dysfunction by Drugsulfamethoxazole - trimethoprim for Pneumocystis carinii pneumonia in patients with lymphoid malignancy.
Score Text
0.9992 CONCLUSION : DrugAtovaquone should be added to the list of agents causing vortex keratopathy involving the corneal epithelium.
0.9879 CONCLUSION : Atovaquone should be added to the list of agents causing Adverse-Effectvortex keratopathy involving the corneal epithelium.
Score Text
0.9992 Posterior reversible encephalopathy syndrome associated with Drugmethotrexate neurotoxicity : conventional magnetic resonance and diffusion - weighted imaging findings.
0.9175 Adverse-EffectPosterior reversible encephalopathy syndrome associated with methotrexate neurotoxicity : conventional magnetic resonance and diffusion - weighted imaging findings.
Score Text
0.9993 A 23 - year - old woman with systemic lupus erythematosus had a severe hypersensitivity reaction to the drug Drugibuprofen .
0.9485 A 23 - year - old woman with systemic lupus erythematosus had a Adverse-Effectsevere hypersensitivity reaction to the drug ibuprofen.
Score Text
0.9982 We report a case of Graves'hyperthyroidism induced by long - term Druginterferon ( IFN ) therapy.
0.9973 We report a case of Graves'hyperthyroidism induced by long - term interferon ( DrugIFN ) therapy.
0.9806 We report a case of Adverse-EffectGraves'hyperthyroidism induced by long - term interferon ( IFN ) therapy.
Score Text
0.9995 We describe a case of ulcerative proctitis after Drugibuprofen treatment in a girl with juvenile systemic lupus erythematosus.
0.9878 We describe a case of Adverse-Effectulcerative proctitis after ibuprofen treatment in a girl with juvenile systemic lupus erythematosus.
Score Text
0.9992 These cases indicate that Drugsulpiride can cause tardive dyskinesia and that this drug should be administered with caution.
0.9910 These cases indicate that sulpiride can cause Adverse-Effecttardive dyskinesia and that this drug should be administered with caution.
Score Text
0.9988 Premature closure of the ductus arteriosus : variable response among monozygotic twins after in utero exposure to Drugindomethacin .
0.9687 Adverse-EffectPremature closure of the ductus arteriosus : variable response among monozygotic twins after in utero exposure to indomethacin.
Score Text
0.9994 When vague symptoms develop during Drugdesmopressin therapy, hyponatremia must be considered as part of the differential diagnosis.
0.9954 When vague symptoms develop during desmopressin therapy, Adverse-Effecthyponatremia must be considered as part of the differential diagnosis.
0.9797 When Adverse-Effectvague symptoms develop during desmopressin therapy, hyponatremia must be considered as part of the differential diagnosis.
Score Text
0.9995 A 78 - year - old man with a transvenous cardioverter defibrillator system developed frequent shocks during oral Drugprocainamide therapy.
0.9878 A 78 - year - old man with a transvenous cardioverter defibrillator system developed frequent Adverse-Effectshocks during oral procainamide therapy.
Score Text
0.9989 Transient left homonymous hemianopsia and encephalopathy following treatment of testicular carcinoma with cisplatinum, vinblastine, and Drugbleomycin .
0.9988 Transient left homonymous hemianopsia and encephalopathy following treatment of testicular carcinoma with cisplatinum, Drugvinblastine , and bleomycin.
0.9986 Transient left homonymous hemianopsia and encephalopathy following treatment of testicular carcinoma with Drugcisplatinum , vinblastine, and bleomycin.
0.9943 Transient left homonymous hemianopsia and Adverse-Effectencephalopathy following treatment of testicular carcinoma with cisplatinum, vinblastine, and bleomycin.
0.8590 Adverse-EffectTransient left homonymous hemianopsia and encephalopathy following treatment of testicular carcinoma with cisplatinum, vinblastine, and bleomycin.
Score Text
0.9879 Pirmenol hydrochloride - induced Adverse-EffectQT prolongation and T wave inversion on electrocardiogram during treatment for symptomatic atrial fibrillation.
0.9839 Pirmenol hydrochloride - induced QT prolongation and Adverse-EffectT wave inversion on electrocardiogram during treatment for symptomatic atrial fibrillation.
0.9751 DrugPirmenol hydrochloride - induced QT prolongation and T wave inversion on electrocardiogram during treatment for symptomatic atrial fibrillation.
Score Text
0.9994 Reported are three children who developed progressive paraparesis after intrathecal Drugmethotrexate administration followed by complete or partial recovery.
0.9796 Reported are three children who developed Adverse-Effectprogressive paraparesis after intrathecal methotrexate administration followed by complete or partial recovery.
Score Text
0.9975 Dexamethasone treatment of amiodarone - induced Adverse-Effectthyrotoxicosis ( AIT ) with or without persistent administration of the drug.
0.9918 Dexamethasone treatment of Drugamiodarone - induced thyrotoxicosis ( AIT ) with or without persistent administration of the drug.
Score Text
0.9995 Gallstones and bile sludge are common side effects of Drugoctreotide therapy but rarely become symptomatic or require treatment.
0.9971 Adverse-EffectGallstones and bile sludge are common side effects of octreotide therapy but rarely become symptomatic or require treatment.
0.9905 Gallstones and Adverse-Effectbile sludge are common side effects of octreotide therapy but rarely become symptomatic or require treatment.
Score Text
0.9974 DrugIsoniazid inhibits the conversion of tryptophan to niacin and may induce pellagra, particularly in poorly nourished patients.
0.9942 Isoniazid inhibits the conversion of tryptophan to niacin and may induce Adverse-Effectpellagra , particularly in poorly nourished patients.
Score Text
0.9995 DISCUSSION : A review of the cases of SS with implication of Drugmirtazapine as the cause was performed.
0.9938 DISCUSSION : A review of the cases of Adverse-EffectSS with implication of mirtazapine as the cause was performed.
Score Text
0.9972 Both 6 - MP and DrugAZA are widely used and are known to cause hepatotoxicity in a proportion of patients.
0.9969 Both 6 - MP and AZA are widely used and are known to cause Adverse-Effecthepatotoxicity in a proportion of patients.
0.9950 Both Drug6 - MP and AZA are widely used and are known to cause hepatotoxicity in a proportion of patients.
Score Text
0.9976 We report a case of radiotherapy - enhanced Drugaminoglutethimide skin toxicity in a patient with metastatic breast cancer.
0.9091 We report a case of radiotherapy - enhanced aminoglutethimide Adverse-Effectskin toxicity in a patient with metastatic breast cancer.
Score Text
0.9987 It is increasingly recognized that dose adjustment of oral Drugvalacyclovir in renal failure is necessary to avoid neurotoxicity.
0.9960 It is increasingly recognized that dose adjustment of oral valacyclovir in renal failure is necessary to avoid Adverse-Effectneurotoxicity .
Score Text
0.9861 Long - term follow - up after Adverse-Effectneoplastic seeding complicating percutaneous ethanol injection for treatment of hepatocellular carcinoma.
0.9857 Long - term follow - up after neoplastic seeding complicating percutaneous Drugethanol injection for treatment of hepatocellular carcinoma.
Score Text
0.9990 Administration of lamotrigine, especially in combination with valproic acid, may lead to the development of Adverse-EffectTEN .
0.9893 Administration of Druglamotrigine , especially in combination with valproic acid, may lead to the development of TEN.
0.9779 Administration of lamotrigine, especially in combination with Drugvalproic acid , may lead to the development of TEN.
Score Text
0.9996 We believe that this is the first report of secretory carcinoma of the endometrium associated with Drugtamoxifen use.
0.9731 We believe that this is the first report of Adverse-Effectsecretory carcinoma of the endometrium associated with tamoxifen use.
Score Text
0.9996 To our knowledge, four cases of interstitial pneumonitis associated with Drugfludarabine have been reported in medical literature.
0.9875 To our knowledge, four cases of Adverse-Effectinterstitial pneumonitis associated with fludarabine have been reported in medical literature.
Score Text
0.9992 Two cases of widespread cutaneous vasculitis are described in association with Drugdiltiazem , a recently introduced calcium antagonist.
0.9834 Two cases of widespread Adverse-Effectcutaneous vasculitis are described in association with diltiazem, a recently introduced calcium antagonist.
Score Text
0.9925 To our knowledge, this is the first reported case of Adverse-Effectbromide intoxication due to pyridostigmine bromide administration.
0.9765 To our knowledge, this is the first reported case of bromide intoxication due to Drugpyridostigmine bromide administration.
Score Text
0.9993 DrugVerapamil is widely used for the termination of paroxysmal supraventricular tachycardia ( PSVT ) with little proarrhythmic effect.
0.9748 Verapamil is widely used for the termination of paroxysmal supraventricular tachycardia ( PSVT ) with little Adverse-Effectproarrhythmic effect .
Score Text
0.9992 However, the amount of Drugprednisone required to maintain normotension resulted in Cushingoid features and has been discontinued.
0.9881 However, the amount of prednisone required to maintain normotension resulted in Adverse-EffectCushingoid features and has been discontinued.
Score Text
0.9995 This is a case of Drugpseudoephedrine - induced intracerebral hemorrhage in a patient with an underlying vascular malformation.
0.9905 This is a case of pseudoephedrine - induced Adverse-Effectintracerebral hemorrhage in a patient with an underlying vascular malformation.
Score Text
0.9993 DrugNitrofurantoin - induced pulmonary toxicity during pregnancy : a report of a case and review of the literature.
0.9897 Nitrofurantoin - induced Adverse-Effectpulmonary toxicity during pregnancy : a report of a case and review of the literature.
Score Text
0.9982 Knowledge regarding potential adverse effects of DrugCAP is paramount and dose modification is indicated with development of neurotoxicity.
0.9969 Knowledge regarding potential adverse effects of CAP is paramount and dose modification is indicated with development of Adverse-Effectneurotoxicity .
Score Text
0.9854 A 75 - year - old man developed Adverse-Effectbilateral lower leg edema 6 months after switching from troglitazone to pioglitazone.
0.9180 A 75 - year - old man developed bilateral lower leg edema 6 months after switching from troglitazone to Drugpioglitazone .
0.9155 A 75 - year - old man developed bilateral lower leg edema 6 months after switching from Drugtroglitazone to pioglitazone.
Score Text
0.9994 A patient with an allergy to a macrolide antibiotic was given Drugtacrolimus and developed a sudden cutaneous reaction.
0.9910 A patient with an allergy to a macrolide antibiotic was given tacrolimus and developed a Adverse-Effectsudden cutaneous reaction .
Score Text
0.9994 However, there are few reports in the literature of Drugampicillin as a cause of acute interstitial nephritis.
0.9795 However, there are few reports in the literature of ampicillin as a cause of Adverse-Effectacute interstitial nephritis .
Score Text
0.9995 Pulmonary eosinophilia or granulomas, classically seen in previously reported cases of Drugmethotrexate pneumonitis, were not observed.
0.9955 Pulmonary eosinophilia or Adverse-Effectgranulomas , classically seen in previously reported cases of methotrexate pneumonitis, were not observed.
0.9796 Adverse-EffectPulmonary eosinophilia or granulomas, classically seen in previously reported cases of methotrexate pneumonitis, were not observed.
0.8327 Pulmonary eosinophilia or granulomas, classically seen in previously reported cases of methotrexate Adverse-Effectpneumonitis , were not observed.
Score Text
0.9991 Acute myelogenous leukemia in patients receiving Drugchlorambucil as long - term adjuvant chemotherapy for stage II breast cancer.
0.9790 Adverse-EffectAcute myelogenous leukemia in patients receiving chlorambucil as long - term adjuvant chemotherapy for stage II breast cancer.
Score Text
0.9987 Adverse-EffectHepatoxicity is a rare complication of SRL therapy and may be connected with some diagnostic and / or therapeutic problems.
0.9952 Hepatoxicity is a rare complication of DrugSRL therapy and may be connected with some diagnostic and / or therapeutic problems.
Score Text
0.9688 RESULTS : Replacing Drugvalproate with lamotrigine resulted in a decrease in serum testosterone concentrations in all 3 women.
0.9711 RESULTS : Replacing valproate with lamotrigine resulted in a Adverse-Effectdecrease in serum testosterone concentrations in all 3 women.
RESULTS : Replacing valproate with lamotrigine resulted in a decrease in Adverse-Effectserum testosterone concentrations in all 3 women.
Score Text
0.9989 DrugTacrolimus ( FK506 ), an immunosuppressant, has been associated with mutism in adults after liver transplant.
0.9983 Tacrolimus ( DrugFK506 ), an immunosuppressant, has been associated with mutism in adults after liver transplant.
0.9950 Tacrolimus ( FK506 ), an immunosuppressant, has been associated with Adverse-Effectmutism in adults after liver transplant.
Score Text
0.9995 Both the longitudinal melanonychia and the multiple skin cancers first appeared after approximately 6 months of Drughydroxyurea treatment.
0.9878 Both the Adverse-Effectlongitudinal melanonychia and the multiple skin cancers first appeared after approximately 6 months of hydroxyurea treatment.
0.9876 Both the longitudinal melanonychia and the Adverse-Effectmultiple skin cancers first appeared after approximately 6 months of hydroxyurea treatment.
Score Text
0.9995 The NZ Pharmacovigilance Centre has received 7 additional reports of severe infections in patients with RA taking Drugleflunomide .
0.9787 The NZ Pharmacovigilance Centre has received 7 additional reports of Adverse-Effectsevere infections in patients with RA taking leflunomide.
Score Text
0.9984 DrugINH , which is a leading cause of drug eruptions in the above group of drugs was withdrawn.
0.9366 INH, which is a leading cause of Adverse-Effectdrug eruptions in the above group of drugs was withdrawn.
Score Text
0.9994 We report two cases of cerebrospinal fluid eosinophilia ( CSFE ) secondary to the intraventricular administration of Drugvancomycin .
0.9810 We report two cases of Adverse-Effectcerebrospinal fluid eosinophilia ( CSFE ) secondary to the intraventricular administration of vancomycin.
0.9794 We report two cases of cerebrospinal fluid eosinophilia ( Adverse-EffectCSFE ) secondary to the intraventricular administration of vancomycin.
Score Text
0.9994 DISCUSSION : The Naranjo probability scale indicated a probable relationship between Drugsertraline treatment and the onset of rhabdomyolysis.
0.9972 DISCUSSION : The Naranjo probability scale indicated a probable relationship between sertraline treatment and the onset of Adverse-Effectrhabdomyolysis .
Score Text
0.9974 CONCLUSION : We have introduced a case of Adverse-Effectanaphylaxis by calcitonin that suggest an IgE mediated hypersensitivity reaction.
0.9919 CONCLUSION : We have introduced a case of anaphylaxis by Drugcalcitonin that suggest an IgE mediated hypersensitivity reaction.
Score Text
0.9841 No explanation for this delay was found, other than the possibility that Drugmagnesium sulfate treatment impeded lactogenesis.
0.9627 No explanation for this delay was found, other than the possibility that magnesium sulfate treatment Adverse-Effectimpeded lactogenesis .
Score Text
0.9994 Here we report Drugramipril - induced cutaneous vasculitis in a patient who required steroid therapy to control it.
0.9817 Here we report ramipril - induced Adverse-Effectcutaneous vasculitis in a patient who required steroid therapy to control it.
Score Text
0.9971 DrugHydroxyurea associated with concomitant occurrence of diffuse longitudinal melanonychia and multiple squamous cell carcinomas in an elderly subject.
0.9854 Hydroxyurea associated with concomitant occurrence of Adverse-Effectdiffuse longitudinal melanonychia and multiple squamous cell carcinomas in an elderly subject.
0.9815 Hydroxyurea associated with concomitant occurrence of diffuse longitudinal melanonychia and Adverse-Effectmultiple squamous cell carcinomas in an elderly subject.
Score Text
0.9992 This case suggests the importance of careful observation for extramedullary relapse in patients who are treated with DrugATRA .
0.9860 This case suggests the importance of careful observation for Adverse-Effectextramedullary relapse in patients who are treated with ATRA.
Score Text
0.9836 With the increasing use of Cyclosporine A in transplant patients, the incidence of Adverse-Effectherpes esophagitis may increase.
0.9798 With the increasing use of DrugCyclosporine A in transplant patients, the incidence of herpes esophagitis may increase.
Score Text
0.9991 DrugIsotretinoin , a drug used for the treatment of acne, has been shown to have teratogenic effects.
0.9882 Isotretinoin, a drug used for the treatment of acne, has been shown to have Adverse-Effectteratogenic effects .
Score Text
0.9992 The Drugazathioprine dose was low ( 1 mg / kg ) and pancytopenia occurred after 56 days therapy.
0.9965 The azathioprine dose was low ( 1 mg / kg ) and Adverse-Effectpancytopenia occurred after 56 days therapy.
Score Text
0.9995 We report 3 patients with severe hepatocellular damage due to DrugCPA therapy, 2 with fatal fulminant hepatitis.
0.9855 We report 3 patients with severe hepatocellular damage due to CPA therapy, 2 with Adverse-Effectfatal fulminant hepatitis .
0.9759 We report 3 patients with Adverse-Effectsevere hepatocellular damage due to CPA therapy, 2 with fatal fulminant hepatitis.
Score Text
0.9977 This case study describes an atypical case of refractory, sodium warfarin - induced necrotizing fasciitis and Adverse-Effectmyonecrosis .
0.9910 This case study describes an atypical case of refractory, sodium warfarin - induced Adverse-Effectnecrotizing fasciitis and myonecrosis.
0.9861 This case study describes an atypical case of refractory, Drugsodium warfarin - induced necrotizing fasciitis and myonecrosis.
Score Text
0.9993 A 77 - year - old man developed ankle, hand, and facial swelling 2 weeks after starting Drugrosiglitazone .
0.9788 A 77 - year - old man developed Adverse-Effectankle, hand, and facial swelling 2 weeks after starting rosiglitazone.
Score Text
0.9986 It has been reported that Drugfluoroquinolone antimicrobials prolong the corrected QT interval but rarely cause torsade de pointes.
0.9767 It has been reported that fluoroquinolone antimicrobials prolong the corrected QT interval but rarely cause Adverse-Effecttorsade de pointes .
Score Text
0.9986 Beneficial effect of low - dose mianserin on fluvoxamine - induced Adverse-Effectakathisia in an obsessive - compulsive patient.
0.9938 Beneficial effect of low - dose mianserin on Drugfluvoxamine - induced akathisia in an obsessive - compulsive patient.
Score Text
0.9995 DrugLinezolid - associated acute interstitial nephritis and drug rash with eosinophilia and systemic symptoms ( DRESS ) syndrome.
0.9855 Linezolid - associated acute interstitial nephritis and drug rash with eosinophilia and systemic symptoms ( Adverse-EffectDRESS ) syndrome.
0.9812 Linezolid - associated Adverse-Effectacute interstitial nephritis and drug rash with eosinophilia and systemic symptoms ( DRESS ) syndrome.
0.9425 Linezolid - associated acute interstitial nephritis and Adverse-Effectdrug rash with eosinophilia and systemic symptoms ( DRESS ) syndrome.
Score Text
0.9987 Immunosuppression elicited by the extensive administration of Drugprednisolone was suspected for the initiation of the generalized mite infestation.
0.9331 Immunosuppression elicited by the extensive administration of prednisolone was suspected for the initiation of the generalized Adverse-Effectmite infestation .
Score Text
0.9995 BACKGROUND : Aphthous stomatitis, a common mucocutaneous disorder, is a well accepted complication of Drugsirolimus therapy.
0.9899 BACKGROUND : Adverse-EffectAphthous stomatitis , a common mucocutaneous disorder, is a well accepted complication of sirolimus therapy.
Score Text
0.9995 The authors report two cases of acute dystonic reactions ( ADRs ) as a side effect of Druglamivudine .
0.9908 The authors report two cases of acute dystonic reactions ( Adverse-EffectADRs ) as a side effect of lamivudine.
0.9882 The authors report two cases of Adverse-Effectacute dystonic reactions ( ADRs ) as a side effect of lamivudine.
Score Text
0.9990 A 52 - year - old woman developed symmetric sensorimotor polyneuropathy and cerebellar syndrome after 24 months of Drugamiodarone treatment.
0.9908 A 52 - year - old woman developed symmetric sensorimotor polyneuropathy and Adverse-Effectcerebellar syndrome after 24 months of amiodarone treatment.
0.9849 A 52 - year - old woman developed Adverse-Effectsymmetric sensorimotor polyneuropathy and cerebellar syndrome after 24 months of amiodarone treatment.
Score Text
0.9995 It is hoped that this case report creates awareness that Drugofloxacin - induced toxic epidermal necrolysis is possible.
0.9864 It is hoped that this case report creates awareness that ofloxacin - induced Adverse-Effecttoxic epidermal necrolysis is possible.
Score Text
0.9862 A second possibility is an interaction between Drugclarithromycin and isradipine, potentially increasing the hepatic toxicity of isradipine.
0.9821 A second possibility is an interaction between clarithromycin and Drugisradipine , potentially increasing the hepatic toxicity of isradipine.
0.9550 A second possibility is an interaction between clarithromycin and isradipine, potentially Adverse-Effectincreasing the hepatic toxicity of isradipine.
0.9538 A second possibility is an interaction between clarithromycin and isradipine, potentially increasing the hepatic toxicity of Drugisradipine .
Score Text
0.9907 These cases highlight the occurrence of Adverse-Effectlivedo reticularis as an uncommon side - effect of interferon alpha treatment.
0.9821 These cases highlight the occurrence of livedo reticularis as an uncommon side - effect of Druginterferon alpha treatment.
Score Text
0.9994 CONCLUSION : Significant weight loss is a potential adverse event in patients with rheumatoid arthritis treated with Drugleflunomide .
0.9924 CONCLUSION : Significant Adverse-Effectweight loss is a potential adverse event in patients with rheumatoid arthritis treated with leflunomide.
Score Text
0.9886 We report a case of Adverse-Effectacne fulminans occurring during treatment with 13 - cis - retinoic acid for cystic acne.
0.9506 We report a case of acne fulminans occurring during treatment with Drug13 - cis - retinoic acid for cystic acne.
Score Text
0.9996 Fever and maculopapular rashes appeared at 10 days after Drugphenytoin initiation, and then the drug was discontinued.
0.9940 Fever and Adverse-Effectmaculopapular rashes appeared at 10 days after phenytoin initiation, and then the drug was discontinued.
0.9833 Adverse-EffectFever and maculopapular rashes appeared at 10 days after phenytoin initiation, and then the drug was discontinued.
Score Text
0.9990 This case and other published evidence should alert physicians to the possibility of fatal Drugerlotinib - induced ILD.
0.9986 This case and other published evidence should alert physicians to the possibility of fatal erlotinib - induced Adverse-EffectILD .
Score Text
0.9990 The ototoxicity of Drugquinine can accurately be studied with ultrahigh frequency audiometry ( up to 20 kHz ).
0.9928 The Adverse-Effectototoxicity of quinine can accurately be studied with ultrahigh frequency audiometry ( up to 20 kHz ).
Score Text
0.9996 One case of priapism occurred during Drugheparin therapy for a previous surgical operation to the knee is reported.
0.9986 One case of Adverse-Effectpriapism occurred during heparin therapy for a previous surgical operation to the knee is reported.
Score Text
0.9993 This prompted us to suspect that DrugddI might be responsible for fulminant hepatitis in all three AIDS patients.
0.9893 This prompted us to suspect that ddI might be responsible for Adverse-Effectfulminant hepatitis in all three AIDS patients.
Score Text
0.9995 Drug eruption caused by Drugazathioprine : value of using the drug - induced lymphocytes stimulation test for diagnosis.
0.9876 Adverse-EffectDrug eruption caused by azathioprine : value of using the drug - induced lymphocytes stimulation test for diagnosis.
Score Text
0.9994 Reye syndrome ( RS ) is believed to occur infrequently among children receiving long - term Drugaspirin therapy.
0.9940 Adverse-EffectReye syndrome ( RS ) is believed to occur infrequently among children receiving long - term aspirin therapy.
0.9642 Reye syndrome ( Adverse-EffectRS ) is believed to occur infrequently among children receiving long - term aspirin therapy.
Score Text
0.9994 A retrospective study was conducted of 40 Drugloperamide poisoning cases recorded at the Centre National d'Informations Toxicologiques Veterinaires.
0.9197 A retrospective study was conducted of 40 Adverse-Effectloperamide poisoning cases recorded at the Centre National d'Informations Toxicologiques Veterinaires.
Score Text
0.9992 The case of a bipolar patient who developed thyrotoxicosis with severe exophthalmos while on Druglithium therapy is described.
0.9958 The case of a bipolar patient who developed Adverse-Effectthyrotoxicosis with severe exophthalmos while on lithium therapy is described.
0.9686 The case of a bipolar patient who developed thyrotoxicosis with Adverse-Effectsevere exophthalmos while on lithium therapy is described.
Score Text
0.9929 Reports of colonic perforation as a result of the administration of calcium polystyrene sulfonate and Drugsorbitol are rare.
0.9904 Reports of Adverse-Effectcolonic perforation as a result of the administration of calcium polystyrene sulfonate and sorbitol are rare.
0.9625 Reports of colonic perforation as a result of the administration of Drugcalcium polystyrene sulfonate and sorbitol are rare.
Score Text
0.9995 BACKGROUND : Ovarian cancer arising from an endometriotic cyst in a postmenopausal woman under Drugtamoxifen therapy is rare.
0.9924 BACKGROUND : Adverse-EffectOvarian cancer arising from an endometriotic cyst in a postmenopausal woman under tamoxifen therapy is rare.
Score Text
0.9991 Administration of steroid and decreasing the dose of DrugPTU produced a good clinical response and the ANCA disappeared.
0.9973 Administration of steroid and decreasing the dose of PTU produced a good clinical response and the Adverse-EffectANCA disappeared.
Score Text
0.9992 Prior reports have emphasized the tubular and interstitial lesions associated with intermittent or discontinuous Drugrifampin therapy for tuberculosis.
0.9647 Prior reports have emphasized the Adverse-Effecttubular and interstitial lesions associated with intermittent or discontinuous rifampin therapy for tuberculosis.
Score Text
0.9993 We report a case of a scleroderma - like reaction induced by long - term administration of DrugUFT .
0.9865 We report a case of a Adverse-Effectscleroderma - like reaction induced by long - term administration of UFT.
Score Text
0.9895 DrugFludarabine induced lung toxicity must be considered in all patients who develop unexplained lung disease while receiving fludarabine.
0.9845 Fludarabine induced lung toxicity must be considered in all patients who develop unexplained Adverse-Effectlung disease while receiving fludarabine.
0.9570 Fludarabine induced Adverse-Effectlung toxicity must be considered in all patients who develop unexplained lung disease while receiving fludarabine.
Fludarabine induced lung toxicity must be considered in all patients who develop unexplained lung disease while receiving Drugfludarabine .
Score Text
0.9983 DrugPhenylpropanolamine ( PPA ) recently has been publicly implicated as a cause of stroke and other neurologic events.
0.9977 Phenylpropanolamine ( DrugPPA ) recently has been publicly implicated as a cause of stroke and other neurologic events.
0.9874 Phenylpropanolamine ( PPA ) recently has been publicly implicated as a cause of Adverse-Effectstroke and other neurologic events.
0.9873 Phenylpropanolamine ( PPA ) recently has been publicly implicated as a cause of stroke and other Adverse-Effectneurologic events .
Score Text
0.9995 This is the first case, to our knowledge, of onset of prolonged Druginfliximab - induced lupus.
0.9988 This is the first case, to our knowledge, of onset of prolonged infliximab - induced Adverse-Effectlupus .
Score Text
0.9987 DrugRitonavir should be added to the list of drugs that can induce adverse cutaneous reactions in HIV patients.
0.9847 Ritonavir should be added to the list of drugs that can induce Adverse-Effectadverse cutaneous reactions in HIV patients.
Score Text
0.9991 High - dose Drugmethylprednisolone in a pregnant woman with Crohn's disease and adrenal suppression in her newborn.
0.9847 High - dose methylprednisolone in a pregnant woman with Crohn's disease and Adverse-Effectadrenal suppression in her newborn.
Score Text
0.9993 A 55 - year - old woman developed symptoms suggestive of hepatitis 12 weeks after first receiving Drugmethyldopa for hypertension.
0.9965 A 55 - year - old woman developed symptoms suggestive of Adverse-Effecthepatitis 12 weeks after first receiving methyldopa for hypertension.
Score Text
0.9954 Successful recovery from interstitial pneumonitis, induced by Drugbicalutamide and leuprorelin acetate given as treatment for prostate cancer.
0.9851 Successful recovery from Adverse-Effectinterstitial pneumonitis , induced by bicalutamide and leuprorelin acetate given as treatment for prostate cancer.
0.9783 Successful recovery from interstitial pneumonitis, induced by bicalutamide and Drugleuprorelin acetate given as treatment for prostate cancer.
Score Text
0.9992 After the patient discontinued Drugrifampicin , the skin lesions cleared completely within 5 weeks without any systemic medication.
0.9915 After the patient discontinued rifampicin, the Adverse-Effectskin lesions cleared completely within 5 weeks without any systemic medication.
Score Text
0.9994 DrugMannitol - induced ARF responds promptly to hemodialysis with rapid resolution of anuria and recovery of renal failure.
0.9975 Mannitol - induced Adverse-EffectARF responds promptly to hemodialysis with rapid resolution of anuria and recovery of renal failure.
Score Text
0.9992 In a patient with severe renovascular hypertension, nonoliguric acute renal failure developed after she received Drugcaptopril treatment.
0.9804 In a patient with severe renovascular hypertension, Adverse-Effectnonoliguric acute renal failure developed after she received captopril treatment.
Score Text
0.9841 We present a case of Adverse-Effectcutaneous leucocytoclastic vasculitis in which amphotericin B might presumably be the aetiological factor.
0.9829 We present a case of cutaneous leucocytoclastic vasculitis in which Drugamphotericin B might presumably be the aetiological factor.
Score Text
0.9987 This is the first report of an adverse effect of fetal renal circulation by maternal ingestion of Drugnimesulide .
0.8952 This is the first report of an adverse effect of Adverse-Effectfetal renal circulation by maternal ingestion of nimesulide.
This is the first report of an Adverse-Effectadverse effect of fetal renal circulation by maternal ingestion of nimesulide.
Score Text
0.9990 We report on a patient who developed hypersensitivity pneumonitis during treatment with the beta - blocker, Drugceliprolol .
0.9766 We report on a patient who developed Adverse-Effecthypersensitivity pneumonitis during treatment with the beta - blocker, celiprolol.
Score Text
0.9995 He developed recurrent skin rash, fever, hypereosinophilia, and acute renal failure after rechallenge with Drugchlorambucil .
0.9952 He developed recurrent skin rash, fever, Adverse-Effecthypereosinophilia , and acute renal failure after rechallenge with chlorambucil.
0.9878 He developed recurrent skin rash, fever, hypereosinophilia, and Adverse-Effectacute renal failure after rechallenge with chlorambucil.
0.9866 He developed recurrent skin rash, Adverse-Effectfever , hypereosinophilia, and acute renal failure after rechallenge with chlorambucil.
0.9849 He developed recurrent Adverse-Effectskin rash , fever, hypereosinophilia, and acute renal failure after rechallenge with chlorambucil.
Score Text
0.9994 We report a male patient with advanced AIDS who developed hypercalcemia 2 weeks after institution of DrugrhGH therapy.
0.9978 We report a male patient with advanced AIDS who developed Adverse-Effecthypercalcemia 2 weeks after institution of rhGH therapy.
Score Text
0.9994 A rare case of advanced ovarian carcinoma who developed difficulty walking 25 days after treatment with weekly Drugpaclitaxel .
0.9908 A rare case of advanced ovarian carcinoma who developed Adverse-Effectdifficulty walking 25 days after treatment with weekly paclitaxel.
Score Text
0.9996 We report two cases that developed acute myeloid leukaemia ( AML ) during Drugtamoxifen therapy for breast cancer.
0.9903 We report two cases that developed acute myeloid leukaemia ( Adverse-EffectAML ) during tamoxifen therapy for breast cancer.
0.9852 We report two cases that developed Adverse-Effectacute myeloid leukaemia ( AML ) during tamoxifen therapy for breast cancer.
Score Text
0.9983 We report three cases of severe hypocalcaemia associated with i. v. Drugbisphosphonate treatment in patients with multiple myeloma.
0.9344 We report three cases of Adverse-Effectsevere hypocalcaemia associated with i. v. bisphosphonate treatment in patients with multiple myeloma.
Score Text
0.9660 The authors report two cases of delayed elimination of methotrexate in patients receiving Drugciprofloxacin , with severe toxicity.
0.6428 The authors report two cases of delayed elimination of Drugmethotrexate in patients receiving ciprofloxacin, with severe toxicity.
0.5697 The authors report two cases of Adverse-Effectdelayed elimination of methotrexate in patients receiving ciprofloxacin, with severe toxicity.
0.9239 The authors report two cases of delayed elimination of methotrexate in patients receiving ciprofloxacin, with Adverse-Effectsevere toxicity .
The authors report two cases of delayed elimination of methotrexate in patients receiving ciprofloxacin, with severe Adverse-Effecttoxicity .
Score Text
0.9987 Administration of Drugamantadine was associated with psychotic decompensations in two schizophrenic patients being maintained on concomitant neuroleptic medication.
0.9846 Administration of amantadine was associated with Adverse-Effectpsychotic decompensations in two schizophrenic patients being maintained on concomitant neuroleptic medication.
Score Text
0.9988 Two patients are described who developed sensory neuropathy after the ingestion of 30. 6 and 114 g Drugmetronidazole respectively.
0.9894 Two patients are described who developed Adverse-Effectsensory neuropathy after the ingestion of 30. 6 and 114 g metronidazole respectively.
Score Text
0.9870 Adverse-EffectFatal ventricular fibrillation after treatment with digoxin in a 27 - year - old man with mitral leaflet prolapse syndrome.
0.9805 Fatal ventricular fibrillation after treatment with Drugdigoxin in a 27 - year - old man with mitral leaflet prolapse syndrome.
Score Text
0.9994 We report a case of interstitial pulmonary disease that occurred together with lymphocytic colitis during treatment with Drugticlopidine .
0.9900 We report a case of interstitial pulmonary disease that occurred together with Adverse-Effectlymphocytic colitis during treatment with ticlopidine.
0.9842 We report a case of Adverse-Effectinterstitial pulmonary disease that occurred together with lymphocytic colitis during treatment with ticlopidine.
Score Text
0.9956 These skin lesions may be induced or worsened during antiviral therapy with interferon - alpha ( DrugIFN ).
0.9790 These Adverse-Effectskin lesions may be induced or worsened during antiviral therapy with interferon - alpha ( IFN ).
0.9676 These skin lesions may be induced or worsened during antiviral therapy with Druginterferon - alpha ( IFN ).
Score Text
0.9986 After treatment with Drugcimetidine , there was a rapid deterioration with decreased oxygen saturation and arterial PO2 values.
0.5623 After treatment with cimetidine, there was a rapid deterioration with Adverse-Effectdecreased oxygen saturation and arterial PO2 values.
0.7231 After treatment with cimetidine, there was a rapid Adverse-Effectdeterioration with decreased oxygen saturation and arterial PO2 values.
Score Text
0.9992 DrugFlecainide overdose can rapidly result in profound cardiovascular collapse, and is associated with a relatively high mortality.
0.9816 Flecainide overdose can rapidly result in profound Adverse-Effectcardiovascular collapse , and is associated with a relatively high mortality.
Score Text
0.9983 The three reported cases demonstrate that Drugtroglitazone is an idiosyncratic hepatotoxin that can lead to irreversible liver injury.
0.9780 The three reported cases demonstrate that troglitazone is an idiosyncratic hepatotoxin that can lead to Adverse-Effectirreversible liver injury .
Score Text
0.9995 OBJECTIVE : The aim of this paper is to describe a case of increased libido during Drugfluvoxamine therapy.
0.9903 OBJECTIVE : The aim of this paper is to describe a case of Adverse-Effectincreased libido during fluvoxamine therapy.
Score Text
0.9993 The development of erythroid leukemia plus carcinoma in these two men suggests mutagenic change secondary to Drugcyclophosphamide therapy.
0.9862 The development of erythroid leukemia plus Adverse-Effectcarcinoma in these two men suggests mutagenic change secondary to cyclophosphamide therapy.
Score Text
0.9992 Acute renal failure with severe tubulointerstitial changes in a patient with minimal change nephrotic syndrome treated with Drugenalapril .
0.9740 Acute renal failure with Adverse-Effectsevere tubulointerstitial changes in a patient with minimal change nephrotic syndrome treated with enalapril.
0.8912 Adverse-EffectAcute renal failure with severe tubulointerstitial changes in a patient with minimal change nephrotic syndrome treated with enalapril.
Score Text
0.9994 DISCUSSION : To our knowledge this is the first reported case of tuberculous uveitis following treatment with Drugetanercept .
0.9887 DISCUSSION : To our knowledge this is the first reported case of Adverse-Effecttuberculous uveitis following treatment with etanercept.
Score Text
0.9959 L - asparaginase - induced Adverse-Effectpancreatitis is an uncommon but potential lethal complication of the treatment of leukemia.
0.9856 L - asparaginase - induced pancreatitis is an uncommon but potential Adverse-Effectlethal complication of the treatment of leukemia.
0.9692 DrugL - asparaginase - induced pancreatitis is an uncommon but potential lethal complication of the treatment of leukemia.
Score Text
0.9991 The cases of two asthmatic patients who became hypokalemic after inhalation of normal doses of Drugalbuterol are presented.
0.9939 The cases of two asthmatic patients who became Adverse-Effecthypokalemic after inhalation of normal doses of albuterol are presented.
Score Text
0.9875 How low can you go? Use of very low dosage of Druggold in patients with mucocutaneous reactions.
0.9678 How low can you go? Use of very low dosage of gold in patients with Adverse-Effectmucocutaneous reactions .
Score Text
0.9994 Rhabdomyolysis associated with Drugclozapine treatment in a patient with decreased calcium - dependent potassium permeability of cell membranes.
0.9984 Adverse-EffectRhabdomyolysis associated with clozapine treatment in a patient with decreased calcium - dependent potassium permeability of cell membranes.
Score Text
0.9666 Adverse-EffectPosterior reversible encephalopathy syndrome ( PRES ) induced by cyclosporine use in a patient with collapsing focal glomeruloesclerosis.
0.9091 Posterior reversible encephalopathy syndrome ( PRES ) induced by Drugcyclosporine use in a patient with collapsing focal glomeruloesclerosis.
Posterior reversible encephalopathy syndrome ( DrugPRES ) induced by cyclosporine use in a patient with collapsing focal glomeruloesclerosis.
Posterior reversible encephalopathy syndrome ( PRES ) induced by Adverse-Effectcyclosporine use in a patient with collapsing focal glomeruloesclerosis.
Score Text
0.9992 The association of Drugvenlafaxine treatment with ischaemic events could be explained by its unique pharmacological and haemodynamic properties.
0.9141 The association of venlafaxine treatment with Adverse-Effectischaemic events could be explained by its unique pharmacological and haemodynamic properties.
Score Text
0.9995 OBJECTIVE : To report a case of a diffuse papular eruption following treatment of psoriasis with Drugmethotrexate injections.
0.9836 OBJECTIVE : To report a case of a Adverse-Effectdiffuse papular eruption following treatment of psoriasis with methotrexate injections.
Score Text
0.9984 Attenuation of Drugasparaginase - induced hyperglycemia after substitution of the Erwinia carotovora for the Escherichia coli enzyme preparation.
0.9978 Attenuation of asparaginase - induced Adverse-Effecthyperglycemia after substitution of the Erwinia carotovora for the Escherichia coli enzyme preparation.
Score Text
0.9981 Posthypoglycemic hyperglycemia ( rebound hyperglycemia ) after overdosing of Druginsulin was diagnosed in 6 cats with diabetes mellitus.
0.9859 Adverse-EffectPosthypoglycemic hyperglycemia ( rebound hyperglycemia ) after overdosing of insulin was diagnosed in 6 cats with diabetes mellitus.
0.9437 Posthypoglycemic hyperglycemia ( Adverse-Effectrebound hyperglycemia ) after overdosing of insulin was diagnosed in 6 cats with diabetes mellitus.
Score Text
0.9956 A case of Drugclozapine - induced tonic - clonic seizures managed with valproate : implications for clinical care.
0.9850 A case of clozapine - induced Adverse-Effecttonic - clonic seizures managed with valproate : implications for clinical care.
Score Text
0.9993 This report describes a case of neuroleptic malignant syndrome due to Drugrisperidone in a child with Joubert syndrome.
0.9864 This report describes a case of Adverse-Effectneuroleptic malignant syndrome due to risperidone in a child with Joubert syndrome.
Score Text
0.9966 It has been suggested that Adverse-EffectPPE caused by cytarabine does not recur with subsequent cytarabine re - challenge.
0.9324 It has been suggested that PPE caused by Drugcytarabine does not recur with subsequent cytarabine re - challenge.
0.5246 It has been suggested that PPE caused by cytarabine does not recur with subsequent Drugcytarabine re - challenge.
Score Text
0.9972 Treatment of amiodarone - induced Adverse-Effectthyrotoxicosis ( AIT ) with thionamide, lithium or radioactive iodine is ineffective.
0.9936 Treatment of Drugamiodarone - induced thyrotoxicosis ( AIT ) with thionamide, lithium or radioactive iodine is ineffective.
Score Text
0.9976 A 68 - year - old female patient with advanced ovarian carcinoma collapsed whilst receiving a carboplatin and Drugcyclophosphamide infusion.
0.9973 A 68 - year - old female patient with advanced ovarian carcinoma collapsed whilst receiving a Drugcarboplatin and cyclophosphamide infusion.
0.9912 A 68 - year - old female patient with advanced ovarian carcinoma Adverse-Effectcollapsed whilst receiving a carboplatin and cyclophosphamide infusion.
Score Text
0.9995 DrugImidazoline intoxication due to overdose or accidental ingestion but also after normal therapeutic usage is frequent in children.
0.8765 Adverse-EffectImidazoline intoxication due to overdose or accidental ingestion but also after normal therapeutic usage is frequent in children.
Score Text
0.9989 The occurrence of Adverse-EffectBMTN in two children treated with RA in our unit is unlikely to be coincidental.
0.9986 The occurrence of BMTN in two children treated with DrugRA in our unit is unlikely to be coincidental.
Score Text
0.9995 Multiple pulmonary nodules : an unusual presentation of Drugfludarabine pulmonary toxicity : case report and review of literature.
0.9751 Adverse-EffectMultiple pulmonary nodules : an unusual presentation of fludarabine pulmonary toxicity : case report and review of literature.
0.6834 Multiple pulmonary nodules : an unusual presentation of fludarabine Adverse-Effectpulmonary toxicity : case report and review of literature.
Score Text
0.9991 Extrapyramidal symptoms are well - documented complications of therapy with Drughaloperidol , even when small doses are used.
0.9909 Adverse-EffectExtrapyramidal symptoms are well - documented complications of therapy with haloperidol, even when small doses are used.
Score Text
0.8168 Case report : Adverse-Effectlife - threatening hypoglycaemia associated with sulfadoxine - pyrimethamine, a commonly used antimalarial drug.
0.7266 Case report : life - threatening hypoglycaemia associated with Drugsulfadoxine - pyrimethamine , a commonly used antimalarial drug.
Score Text
0.9995 DrugBenzocaine , an ester - type local anesthetic, was believed responsible for apparent methemoglobinemia in a cat.
0.9964 Benzocaine, an ester - type local anesthetic, was believed responsible for apparent Adverse-Effectmethemoglobinemia in a cat.
Score Text
0.9987 We report a case of NEH masquerading as cutaneous vasculitis in a woman receiving Drugcyclophosphamide for lupus nephritis.
0.9949 We report a case of Adverse-EffectNEH masquerading as cutaneous vasculitis in a woman receiving cyclophosphamide for lupus nephritis.
Score Text
0.9967 We report two cases of Drugtenofovir ( TDF ) - associated nephrotoxicity in perinatally HIV - infected adolescents.
0.9954 We report two cases of tenofovir ( DrugTDF ) - associated nephrotoxicity in perinatally HIV - infected adolescents.
0.9953 We report two cases of tenofovir ( TDF ) - associated Adverse-Effectnephrotoxicity in perinatally HIV - infected adolescents.
Score Text
0.9993 DrugMethotrexate may rarely provoke serositis, even with low doses and after just a few weeks of therapy.
0.9980 Methotrexate may rarely provoke Adverse-Effectserositis , even with low doses and after just a few weeks of therapy.
Score Text
0.9992 In addition, Drugethambutol rarely causes visual loss during the early period or when given at lower doses.
0.9921 In addition, ethambutol rarely causes Adverse-Effectvisual loss during the early period or when given at lower doses.
Score Text
0.9993 Cushing's syndrome persisted more than 6 months while DrugTCA concentrations remained detectable for at least 80 days.
0.9831 Adverse-EffectCushing's syndrome persisted more than 6 months while TCA concentrations remained detectable for at least 80 days.
Score Text
0.9987 Two patients with bipolar affective disorder and a history of bronchospastic phenomena experienced Adverse-Effecttremor during lithium carbonate therapy.
0.9904 Two patients with bipolar affective disorder and a history of bronchospastic phenomena experienced tremor during Druglithium carbonate therapy.
Score Text
0.9992 RESULTS : Both patients experienced a previously unreported side effect - - falling backward - - associated with Drugbupropion use.
0.9908 RESULTS : Both patients experienced a previously unreported side effect - - Adverse-Effectfalling backward - - associated with bupropion use.
Score Text
0.9992 Vision declined after treatment with Drugmethylprednisolone , after which fundus examination became consistent with progressive outer retinal necrosis.
0.9954 Adverse-EffectVision declined after treatment with methylprednisolone, after which fundus examination became consistent with progressive outer retinal necrosis.
Score Text
0.9995 A patient with chronic myelomonocytic leukemia developed drug - induced pulmonary toxicity after using low dose oral Drugetoposide .
0.9900 A patient with chronic myelomonocytic leukemia developed drug - induced Adverse-Effectpulmonary toxicity after using low dose oral etoposide.
Score Text
0.9991 Physicians should be aware of the possible association between the use of Drugalteplase and the development of subfascial hemorrhage.
0.9889 Physicians should be aware of the possible association between the use of alteplase and the development of Adverse-Effectsubfascial hemorrhage .
Score Text
0.9993 A patient, while on intravenous Drugritodrine therapy for preterm labor, experienced an episode of acute chest pain.
0.9904 A patient, while on intravenous ritodrine therapy for preterm labor, experienced an episode of Adverse-Effectacute chest pain .
Score Text
0.9998 Fever, lymphadenopathy, eosinophilia, lymphocytosis, hepatitis, and dermatitis : a severe adverse reaction to Drugminocycline .
0.9981 Fever, lymphadenopathy, eosinophilia, lymphocytosis, hepatitis, and Adverse-Effectdermatitis : a severe adverse reaction to minocycline.
0.9981 Fever, lymphadenopathy, eosinophilia, lymphocytosis, Adverse-Effecthepatitis , and dermatitis : a severe adverse reaction to minocycline.
0.9972 Fever, lymphadenopathy, Adverse-Effecteosinophilia , lymphocytosis, hepatitis, and dermatitis : a severe adverse reaction to minocycline.
0.9961 Fever, lymphadenopathy, eosinophilia, Adverse-Effectlymphocytosis , hepatitis, and dermatitis : a severe adverse reaction to minocycline.
0.9957 Fever, Adverse-Effectlymphadenopathy , eosinophilia, lymphocytosis, hepatitis, and dermatitis : a severe adverse reaction to minocycline.
0.9878 Adverse-EffectFever , lymphadenopathy, eosinophilia, lymphocytosis, hepatitis, and dermatitis : a severe adverse reaction to minocycline.
Score Text
0.9994 A case of Erythema Multiforme Bullosum in patient of lepromatous leprosy with pulmonary tuberculosis due to DrugRifampicin is described.
0.9802 A case of Adverse-EffectErythema Multiforme Bullosum in patient of lepromatous leprosy with pulmonary tuberculosis due to Rifampicin is described.
Score Text
0.9995 CONCLUSIONS : DrugColchicine - induced myopathy should be excluded in patients with FMF who present with generalized muscle weakness.
0.9977 CONCLUSIONS : Colchicine - induced Adverse-Effectmyopathy should be excluded in patients with FMF who present with generalized muscle weakness.
0.8260 CONCLUSIONS : Colchicine - induced myopathy should be excluded in patients with FMF who present with Adverse-Effectgeneralized muscle weakness .
Score Text
0.9814 Because of a Adverse-Effecthypersensitivity reaction , initial therapy with penicillin G and gentamicin was stopped and substituted with cefazolin.
0.9707 Because of a hypersensitivity reaction, initial therapy with Drugpenicillin G and gentamicin was stopped and substituted with cefazolin.
0.9431 Because of a hypersensitivity reaction, initial therapy with penicillin G and Druggentamicin was stopped and substituted with cefazolin.
Score Text
0.9964 The authors describe a case of neuroleptic malignant syndrome that occurred in a patient on Drugamitriptyline and lithium carbonate.
0.9901 The authors describe a case of neuroleptic malignant syndrome that occurred in a patient on amitriptyline and Druglithium carbonate .
0.9875 The authors describe a case of Adverse-Effectneuroleptic malignant syndrome that occurred in a patient on amitriptyline and lithium carbonate.
Score Text
0.9991 Typically, drug - induced neutropenia occurs in a patient receiving a semisynthetic Drugpenicillin for two weeks or more.
0.9983 Typically, drug - induced Adverse-Effectneutropenia occurs in a patient receiving a semisynthetic penicillin for two weeks or more.
Score Text
0.9993 DrugMethimazole - induced aplastic anemia in third exposure : successful treatment with recombinant human granulocyte colony - stimulating factor.
0.9925 Methimazole - induced Adverse-Effectaplastic anemia in third exposure : successful treatment with recombinant human granulocyte colony - stimulating factor.
Score Text
0.9966 The newborn manifested a four day course of Adverse-Effectlethargy with unexplained high lithium levels in the adult toxic range.
0.9945 The newborn manifested a four day course of lethargy with unexplained high Druglithium levels in the adult toxic range.
Score Text
0.9936 We experienced 2 cases of mequitazine - induced Adverse-Effectphotosensitivity reaction in patients who took mequitazine for their dermatologic problems.
0.9768 We experienced 2 cases of Drugmequitazine - induced photosensitivity reaction in patients who took mequitazine for their dermatologic problems.
0.8451 We experienced 2 cases of mequitazine - induced photosensitivity reaction in patients who took Drugmequitazine for their dermatologic problems.
Score Text
0.9982 CONCLUSION : Fixed drug eruption is associated with many drugs but this is the first such report with Drugomeprazole .
0.9932 CONCLUSION : Fixed drug Adverse-Effecteruption is associated with many drugs but this is the first such report with omeprazole.
Score Text
0.9992 FSGS induced by DrugAdriamycin ( Pharmacia & Upjohn, Columbus, OH ) has been observed experimentally in rats.
0.9985 Adverse-EffectFSGS induced by Adriamycin ( Pharmacia & Upjohn, Columbus, OH ) has been observed experimentally in rats.
Score Text
0.9864 Adverse-EffectPulmonary leukostasis secondary to all - trans retinoic acid in the treatment of acute promyelocytic leukemia in first relapse.
0.9534 Pulmonary leukostasis secondary to Drugall - trans retinoic acid in the treatment of acute promyelocytic leukemia in first relapse.
Score Text
0.9996 An objective causality assessment by use of the Naranjo probability scale revealed that NCSE due to Drugifosfamide was probable.
0.9976 An objective causality assessment by use of the Naranjo probability scale revealed that Adverse-EffectNCSE due to ifosfamide was probable.
Score Text
0.9994 A patient with acute esophageal variceal bleeding developed fatal rhabdomyolysis during treatment with a continuous intravenous infusion of Drugvasopressin .
0.9886 A patient with acute esophageal variceal bleeding developed Adverse-Effectfatal rhabdomyolysis during treatment with a continuous intravenous infusion of vasopressin.
Score Text
0.9809 Electrocardiographic findings and laboratory data indicated a diagnosis of Adverse-Effectacute myocardial infarction due to the L - thyroxine therapy.
0.9689 Electrocardiographic findings and laboratory data indicated a diagnosis of acute myocardial infarction due to the DrugL - thyroxine therapy.
Score Text
0.9958 Establishment of diuresis with fluids and IV administration of calcium may provide successful treatment of Drugmagnesium toxicosis in horses.
0.8562 Establishment of diuresis with fluids and IV administration of calcium may provide successful treatment of Adverse-Effectmagnesium toxicosis in horses.
Score Text
0.9994 We describe a patient who presented with bloody diarrhoea after 15 mg Drugmeloxicam daily for 10 days for osteoarthritis.
0.9887 We describe a patient who presented with Adverse-Effectbloody diarrhoea after 15 mg meloxicam daily for 10 days for osteoarthritis.
Score Text
0.9933 Four cases of Adverse-Effectoesophageal damage associated with ingestion of the urinary anti - spasmodic agent emepronium bromide are described.
0.9772 Four cases of oesophageal damage associated with ingestion of the urinary anti - spasmodic agent Drugemepronium bromide are described.
Score Text
0.9992 A case of heatstroke is reported in a 32 - year - old man diagnosed with schizophrenia and on Drugclozapine monotherapy.
0.9964 A case of Adverse-Effectheatstroke is reported in a 32 - year - old man diagnosed with schizophrenia and on clozapine monotherapy.
Score Text
0.9995 Due to discomfort, diplopia and lagophthalmos, the haematoma necessitated suspension of Drugwarfarin therapy and a surgical evacuation.
0.9936 Due to discomfort, diplopia and lagophthalmos, the Adverse-Effecthaematoma necessitated suspension of warfarin therapy and a surgical evacuation.
0.9903 Due to discomfort, Adverse-Effectdiplopia and lagophthalmos, the haematoma necessitated suspension of warfarin therapy and a surgical evacuation.
0.9884 Due to Adverse-Effectdiscomfort , diplopia and lagophthalmos, the haematoma necessitated suspension of warfarin therapy and a surgical evacuation.
0.9820 Due to discomfort, diplopia and Adverse-Effectlagophthalmos , the haematoma necessitated suspension of warfarin therapy and a surgical evacuation.
Score Text
0.9764 Adverse-EffectAtypical ventricular tachycardia ( torsade de pointes ) induced by amiodarone : arrhythmia previously induced by quinidine and disopyramide.
0.9756 Atypical ventricular tachycardia ( Adverse-Effecttorsade de pointes ) induced by amiodarone : arrhythmia previously induced by quinidine and disopyramide.
0.9404 Atypical ventricular tachycardia ( torsade de pointes ) induced by amiodarone : Adverse-Effectarrhythmia previously induced by quinidine and disopyramide.
0.9219 Atypical ventricular tachycardia ( torsade de pointes ) induced by Drugamiodarone : arrhythmia previously induced by quinidine and disopyramide.
0.6185 Atypical ventricular tachycardia ( torsade de pointes ) induced by amiodarone : arrhythmia previously induced by quinidine and Drugdisopyramide .
0.5836 Atypical ventricular tachycardia ( torsade de pointes ) induced by amiodarone : arrhythmia previously induced by Drugquinidine and disopyramide.
Score Text
0.9994 OBJECTIVE : To describe a case of Drugsertraline - induced rhabdomyolysis in an elderly patient with dementia and comorbidities.
0.9974 OBJECTIVE : To describe a case of sertraline - induced Adverse-Effectrhabdomyolysis in an elderly patient with dementia and comorbidities.
Score Text
0.9991 Fatal eosinophilia myalgia syndrome in a marrow transplant patient attributed to total parenteral nutrition with a solution containing Drugtryptophan .
0.9835 Adverse-EffectFatal eosinophilia myalgia syndrome in a marrow transplant patient attributed to total parenteral nutrition with a solution containing tryptophan.
Score Text
0.9994 We report the first case of a patient in a Drugpromethazine - induced coma responding to treatment with flumazenil.
0.9941 We report the first case of a patient in a promethazine - induced Adverse-Effectcoma responding to treatment with flumazenil.
Score Text
0.9911 DrugMineral oil , a hydrocarbon, may not elicit a normal protective cough reflex and may impair mucociliary transport.
0.9579 Mineral oil, a hydrocarbon, may not elicit a normal protective cough reflex and may Adverse-Effectimpair mucociliary transport .
Score Text
0.9996 We report 3 children with epilepsy who developed facial motor tics after initiation of DrugCBZ for complex partial seizures.
0.9911 We report 3 children with epilepsy who developed Adverse-Effectfacial motor tics after initiation of CBZ for complex partial seizures.
Score Text
0.9995 A 43 - year - old white man developed a shallow erosion of a psoriatic plaque after chronic administration of Drugmethotrexate .
0.9702 A 43 - year - old white man developed a shallow Adverse-Effecterosion of a psoriatic plaque after chronic administration of methotrexate.
Score Text
0.9996 One case of Drugtacrolimus - induced hepatic VOD developing after lung transplantation ( LT ) has been recently reported.
0.9937 One case of tacrolimus - induced Adverse-Effecthepatic VOD developing after lung transplantation ( LT ) has been recently reported.
Score Text
0.9995 While the mechanism of Drugdextran - associated renal failure remains unsolved, plasma exchange seems to be effective therapy.
0.9921 While the mechanism of dextran - associated Adverse-Effectrenal failure remains unsolved, plasma exchange seems to be effective therapy.
Score Text
0.9988 Adverse-EffectMyoclonus and seizures disappeared after discontinuation of L - dopa and the introduction of valproate sodium ( VPA ).
0.9985 Myoclonus and Adverse-Effectseizures disappeared after discontinuation of L - dopa and the introduction of valproate sodium ( VPA ).
0.9683 Myoclonus and seizures disappeared after discontinuation of DrugL - dopa and the introduction of valproate sodium ( VPA ).
0.9902 Myoclonus and seizures disappeared after discontinuation of L - dopa and the introduction of valproate sodium ( DrugVPA ).
0.9724 Myoclonus and seizures disappeared after discontinuation of L - dopa and the introduction of Drugvalproate sodium ( VPA ).
Score Text
0.9996 CASE DESCRIPTION : A 59 - year - old man with known neurocysticercosis developed a large cerebral infarction during Drugpraziquantel therapy.
0.9874 CASE DESCRIPTION : A 59 - year - old man with known neurocysticercosis developed a Adverse-Effectlarge cerebral infarction during praziquantel therapy.
Score Text
0.9995 Atypical endometriosis may act as a precancerous lesion in the process of Drugtamoxifen - induced malignant transformation of endometriosis.
0.9794 Atypical endometriosis may act as a precancerous lesion in the process of tamoxifen - induced Adverse-Effectmalignant transformation of endometriosis .
Score Text
0.9984 Mechanisms and triggering factors of hypoglycaemia induced by Drugmefloquine and some other anti - malarial quinine analogues are discussed.
0.9937 Mechanisms and triggering factors of Adverse-Effecthypoglycaemia induced by mefloquine and some other anti - malarial quinine analogues are discussed.
Score Text
0.9874 a 67 - year - old man with bipolar disorder developed a Adverse-EffectCreutzfeldt - Jakob like syndrome during lithium carbonate treatment.
0.9853 a 67 - year - old man with bipolar disorder developed a Creutzfeldt - Jakob like syndrome during Druglithium carbonate treatment.
Score Text
0.9993 DrugTiagabine overdose causes an unusual array of neurological symptoms, many similar to reported adverse effects during therapeutic use.
0.7767 Tiagabine overdose causes an unusual array of Adverse-Effectneurological symptoms , many similar to reported adverse effects during therapeutic use.
Tiagabine overdose causes an Adverse-Effectunusual array of neurological symptoms , many similar to reported adverse effects during therapeutic use.
Score Text
0.9975 Increased lash length, thickness, and pigmentation are well - documented side effects of Drugprostaglandin analog glaucoma drops.
0.9853 Increased lash length, thickness, and Adverse-Effectpigmentation are well - documented side effects of prostaglandin analog glaucoma drops.
0.9637 Adverse-EffectIncreased lash length , thickness, and pigmentation are well - documented side effects of prostaglandin analog glaucoma drops.
Score Text
0.9997 We have reported six cases of Drugmetoclopramide - induced parkinsonism seen in consultation over a two - year period.
0.9985 We have reported six cases of metoclopramide - induced Adverse-Effectparkinsonism seen in consultation over a two - year period.
Score Text
0.9984 METHOD : We describe two patients who presented with diabetic ketoacidosis after treatment with Drugquetiapine and risperidone, respectively.
0.9983 METHOD : We describe two patients who presented with diabetic ketoacidosis after treatment with quetiapine and Drugrisperidone , respectively.
0.9839 METHOD : We describe two patients who presented with Adverse-Effectdiabetic ketoacidosis after treatment with quetiapine and risperidone, respectively.
Score Text
0.9995 We describe two cases of PSVT that changed to non - sustained polymorphic ventricular tachycardia after administration of Drugverapamil .
0.9362 We describe two cases of PSVT that changed to Adverse-Effectnon - sustained polymorphic ventricular tachycardia after administration of verapamil.
Score Text
0.9995 Gastric tumor, endometrial carcinoma and cervical adenocarcinoma in situ were detected after treatment with Drugtamoxifen for breast cancer.
0.9912 Adverse-EffectGastric tumor , endometrial carcinoma and cervical adenocarcinoma in situ were detected after treatment with tamoxifen for breast cancer.
0.9892 Gastric tumor, endometrial carcinoma and Adverse-Effectcervical adenocarcinoma in situ were detected after treatment with tamoxifen for breast cancer.
0.9882 Gastric tumor, Adverse-Effectendometrial carcinoma and cervical adenocarcinoma in situ were detected after treatment with tamoxifen for breast cancer.
Score Text
0.9860 Intravenous sodium bicarbonate appears to be indicated prophylactically in combating the associated metabolic acidosis due to absorbed Drugformic acid .
0.9656 Intravenous sodium bicarbonate appears to be indicated prophylactically in combating the associated Adverse-Effectmetabolic acidosis due to absorbed formic acid.
Score Text
0.9994 We describe a detailed case of fulminant hepatitis induced by Drugnevirapine ( Viramune ) and treated by liver transplantation.
0.9994 We describe a detailed case of fulminant hepatitis induced by nevirapine ( DrugViramune ) and treated by liver transplantation.
0.9908 We describe a detailed case of Adverse-Effectfulminant hepatitis induced by nevirapine ( Viramune ) and treated by liver transplantation.
Score Text
0.9961 Interferon - alpha - induced Adverse-Effecthyperthyroidism : a three - stage evolution from silent thyroiditis towards Graves'disease.
0.9629 DrugInterferon - alpha - induced hyperthyroidism : a three - stage evolution from silent thyroiditis towards Graves'disease.
Score Text
0.9992 A diagnosis of masked Drugtheophylline poisoning should be considered in similar situations involving a rapid decrease of insulin requirements.
0.8430 A diagnosis of masked Adverse-Effecttheophylline poisoning should be considered in similar situations involving a rapid decrease of insulin requirements.
Score Text
0.9996 To our knowledge, our report is one of the first on shock and angio - oedema from Drugirbesartan .
0.9896 To our knowledge, our report is one of the first on shock and Adverse-Effectangio - oedema from irbesartan.
0.9814 To our knowledge, our report is one of the first on Adverse-Effectshock and angio - oedema from irbesartan.
Score Text
0.9992 The authors report a case of Balint syndrome with irreversible posterior leukoencephalopathy on MRI following intrathecal Drugmethotrexate and cytarabine.
0.9992 The authors report a case of Balint syndrome with irreversible posterior leukoencephalopathy on MRI following intrathecal methotrexate and Drugcytarabine .
0.9745 The authors report a case of Adverse-EffectBalint syndrome with irreversible posterior leukoencephalopathy on MRI following intrathecal methotrexate and cytarabine.
0.8717 The authors report a case of Balint syndrome with irreversible Adverse-Effectposterior leukoencephalopathy on MRI following intrathecal methotrexate and cytarabine.
Score Text
0.9973 Aseptic meningitis, hemolytic anemia, hepatitis, and orthostatic hypotension in a patient treated with trimethoprim - Drugsulfamethoxazole .
0.9969 Aseptic meningitis, hemolytic anemia, Adverse-Effecthepatitis , and orthostatic hypotension in a patient treated with trimethoprim - sulfamethoxazole.
0.9937 Adverse-EffectAseptic meningitis , hemolytic anemia, hepatitis, and orthostatic hypotension in a patient treated with trimethoprim - sulfamethoxazole.
0.9931 Aseptic meningitis, Adverse-Effecthemolytic anemia , hepatitis, and orthostatic hypotension in a patient treated with trimethoprim - sulfamethoxazole.
0.9913 Aseptic meningitis, hemolytic anemia, hepatitis, and Adverse-Effectorthostatic hypotension in a patient treated with trimethoprim - sulfamethoxazole.
0.9902 Aseptic meningitis, hemolytic anemia, hepatitis, and orthostatic hypotension in a patient treated with Drugtrimethoprim - sulfamethoxazole.
Score Text
0.9952 Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed Adverse-Effectpancreatitis caused by meglumine antimoniate.
0.9673 Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by Drugmeglumine antimoniate .
0.5456 Successful treatment of visceral leishmaniasis with allopurinol plus Drugketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate.
Score Text
0.9811 CONCLUSIONS : The administration of Drugprostaglandin E1 to neonates can cause gastric - outlet obstruction due to antral hyperplasia.
0.9801 CONCLUSIONS : The administration of prostaglandin E1 to neonates can cause Adverse-Effectgastric - outlet obstruction due to antral hyperplasia.
0.9392 CONCLUSIONS : The administration of prostaglandin E1 to neonates can cause gastric - outlet obstruction due to Adverse-Effectantral hyperplasia .
Score Text
0.9995 We report the first case of rhabdomyolysis related to the administration of Drugclarithromycin without concurrent use of other medications.
0.9979 We report the first case of Adverse-Effectrhabdomyolysis related to the administration of clarithromycin without concurrent use of other medications.
Score Text
0.9996 We describe 2 cases of SJS related to Drugnevirapine use and review the literature on this newly recognized association.
0.9981 We describe 2 cases of Adverse-EffectSJS related to nevirapine use and review the literature on this newly recognized association.
Score Text
0.9944 Used injudiciously, Drugnaloxone can lead to withdrawal syndrome, return of severe pain, and other adverse effects.
0.9920 Used injudiciously, naloxone can lead to Adverse-Effectwithdrawal syndrome , return of severe pain, and other adverse effects.
0.9842 Used injudiciously, naloxone can lead to withdrawal syndrome, return of Adverse-Effectsevere pain , and other adverse effects.
Score Text
0.9994 The case concerns the sudden death of a 29 - year - old male during Drugclozapine therapy started 2 weeks before.
0.9967 The case concerns the Adverse-Effectsudden death of a 29 - year - old male during clozapine therapy started 2 weeks before.
Score Text
0.9981 Prior neurologic illness or CNS insult of any kind is known to increase the vulnerability to neurotoxicity of Druglithium .
0.9903 Prior neurologic illness or CNS insult of any kind is known to increase the vulnerability to Adverse-Effectneurotoxicity of lithium.
Score Text
0.9996 The objective of this report is to describe a case of fixed drug eruption that occurred during Drugomeprazole treatment.
0.9813 The objective of this report is to describe a case of fixed drug Adverse-Effecteruption that occurred during omeprazole treatment.
Score Text
0.9975 Iatrogenic Cushing syndrome after epidural Drugtriamcinolone injections in an HIV type 1 - infected patient receiving therapy with ritonavir - lopinavir.
0.9855 Adverse-EffectIatrogenic Cushing syndrome after epidural triamcinolone injections in an HIV type 1 - infected patient receiving therapy with ritonavir - lopinavir.
Score Text
0.9987 The clinical symptoms of gastric mucosa foveolar hyperplasia due to long - term DrugPGE1 therapy simulate hypertrophic pyloric stenosis.
0.9804 The clinical symptoms of Adverse-Effectgastric mucosa foveolar hyperplasia due to long - term PGE1 therapy simulate hypertrophic pyloric stenosis.
Score Text
0.9987 Occasionally, despite good therapeutic response, Drugclozapine must be stopped due to dangerous side effects such as agranulocytosis.
0.9980 Occasionally, despite good therapeutic response, clozapine must be stopped due to dangerous side effects such as Adverse-Effectagranulocytosis .
Score Text
0.9994 Findings on discontinuation and rechallenge supported the assumption that the hair loss was a side effect of the Drugparoxetine .
0.9927 Findings on discontinuation and rechallenge supported the assumption that the Adverse-Effecthair loss was a side effect of the paroxetine.
Score Text
0.9995 Psoriasis triggered by toll - like receptor 7 agonist Drugimiquimod in the presence of dermal plasmacytoid dendritic cell precursors.
0.9984 Adverse-EffectPsoriasis triggered by toll - like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors.
Score Text
0.9919 Iatrogenic hypercalcemia due to vitamin D3 ointment ( 1, 24 ( OH ) 2D3 ) combined with Drugthiazide diuretics in a case of psoriasis.
0.9787 Iatrogenic hypercalcemia due to Drugvitamin D3 ointment ( 1, 24 ( OH ) 2D3 ) combined with thiazide diuretics in a case of psoriasis.
0.9669 Iatrogenic hypercalcemia due to vitamin D3 ointment ( Drug1, 24 ( OH ) 2D3 ) combined with thiazide diuretics in a case of psoriasis.
0.9713 Adverse-EffectIatrogenic hypercalcemia due to vitamin D3 ointment ( 1, 24 ( OH ) 2D3 ) combined with thiazide diuretics in a case of psoriasis.
Iatrogenic Adverse-Effecthypercalcemia due to vitamin D3 ointment ( 1, 24 ( OH ) 2D3 ) combined with thiazide diuretics in a case of psoriasis.
Score Text
0.9995 A patient with ulcerative colitis developed skin pigmentation and diffuse pulmonary shadowing without respiratory symptomatology, while taking Drugsulfasalazine .
0.9887 A patient with ulcerative colitis developed Adverse-Effectskin pigmentation and diffuse pulmonary shadowing without respiratory symptomatology, while taking sulfasalazine.
0.9844 A patient with ulcerative colitis developed skin pigmentation and Adverse-Effectdiffuse pulmonary shadowing without respiratory symptomatology, while taking sulfasalazine.
Score Text
0.9994 In this case, CIPS was considered to be probably associated with Drugcyclosporine according to the Naranjo probability scale.
0.9985 In this case, Adverse-EffectCIPS was considered to be probably associated with cyclosporine according to the Naranjo probability scale.
Score Text
0.9988 This treatment has the potential to cause severe vision loss as a result of intractable Drugcorticosteroid - induced glaucoma.
0.9965 This treatment has the potential to cause severe vision loss as a result of intractable corticosteroid - induced Adverse-Effectglaucoma .
0.9541 This treatment has the potential to cause Adverse-Effectsevere vision loss as a result of intractable corticosteroid - induced glaucoma.
Score Text
0.9973 DrugLithium neurotoxicity should be considered in Creutzfeldt - Jakob disease differential diagnosis, serial electroencephalograms being the most valuable.
0.9658 Lithium neurotoxicity should be considered in Adverse-EffectCreutzfeldt - Jakob disease differential diagnosis, serial electroencephalograms being the most valuable.
0.8859 Lithium Adverse-Effectneurotoxicity should be considered in Creutzfeldt - Jakob disease differential diagnosis, serial electroencephalograms being the most valuable.
Adverse-EffectLithium neurotoxicity should be considered in Creutzfeldt - Jakob disease differential diagnosis, serial electroencephalograms being the most valuable.
Score Text
0.9987 We report a case of penile fibrosis after intracavernous self - injection of a combination of Drugphentolamine and papaverine.
0.9987 We report a case of penile fibrosis after intracavernous self - injection of a combination of phentolamine and Drugpapaverine .
0.9900 We report a case of Adverse-Effectpenile fibrosis after intracavernous self - injection of a combination of phentolamine and papaverine.
Score Text
0.9989 We report the first case of a 54 - year - old Turkish woman who presented with ceftriaxone - induced Adverse-EffectFDE .
0.9948 We report the first case of a 54 - year - old Turkish woman who presented with Drugceftriaxone - induced FDE.
Score Text
0.9985 We report such a series of patients who had transient asymptomatic bradycardia after being treated with continuous infusion Drug5 - FU .
0.9760 We report such a series of patients who had Adverse-Effecttransient asymptomatic bradycardia after being treated with continuous infusion 5 - FU.
Score Text
0.9964 Relief by naloxone of Drugmorphine - induced spasm of the sphincter of Oddi in a post - cholecystectomy patient.
0.9960 Relief by naloxone of morphine - induced Adverse-Effectspasm of the sphincter of Oddi in a post - cholecystectomy patient.
Score Text
0.9912 The present report suggests that Drugclarithromycin coadministration induces increased plasma carbamazepine concentrations, which may result in carbamazepine toxicity.
0.9877 The present report suggests that clarithromycin coadministration induces increased plasma carbamazepine concentrations, which may result in Drugcarbamazepine toxicity.
0.9848 The present report suggests that clarithromycin coadministration induces increased plasma Drugcarbamazepine concentrations, which may result in carbamazepine toxicity.
0.6427 The present report suggests that clarithromycin coadministration induces increased plasma carbamazepine concentrations, which may result in Adverse-Effectcarbamazepine toxicity .
The present report suggests that clarithromycin coadministration induces Adverse-Effectincreased plasma carbamazepine concentrations, which may result in carbamazepine toxicity.
Score Text
0.9969 A case of Drugphenobarbital exacerbation of a preexisting maladaptive behavior partially suppressed by chlorpromazine and misinterpreted as chlorpromazine efficacy.
0.9344 A case of phenobarbital Adverse-Effectexacerbation of a preexisting maladaptive behavior partially suppressed by chlorpromazine and misinterpreted as chlorpromazine efficacy.
0.5273 A case of Adverse-Effectphenobarbital exacerbation of a preexisting maladaptive behavior partially suppressed by chlorpromazine and misinterpreted as chlorpromazine efficacy.
Score Text
0.9893 Adverse-EffectIntracranial hemorrhage and focal seizures secondary to use of L - asparaginase during induction therapy of acute lymphocytic leukemia.
0.9864 Intracranial hemorrhage and Adverse-Effectfocal seizures secondary to use of L - asparaginase during induction therapy of acute lymphocytic leukemia.
0.9683 Intracranial hemorrhage and focal seizures secondary to use of DrugL - asparaginase during induction therapy of acute lymphocytic leukemia.
Score Text
0.9985 A case of prolonged Drugsuxamethonium apnoea successfully terminated by the infusion of a commercial preparation of serumcholinesterase is reported.
0.9061 A case of prolonged suxamethonium Adverse-Effectapnoea successfully terminated by the infusion of a commercial preparation of serumcholinesterase is reported.
Score Text
0.9988 After the Drugchlorambucil was discontinued, the wbc count began to slowly rise and the patient developed clinical AML.
0.9982 After the chlorambucil was discontinued, the wbc count began to slowly rise and the patient developed clinical Adverse-EffectAML .
Score Text
0.9995 We describe 2 patients with prior amputation who experienced phantom limb pain ( PLP ) after receiving Drugpaclitaxel therapy.
0.9948 We describe 2 patients with prior amputation who experienced phantom limb pain ( Adverse-EffectPLP ) after receiving paclitaxel therapy.
0.9891 We describe 2 patients with prior amputation who experienced Adverse-Effectphantom limb pain ( PLP ) after receiving paclitaxel therapy.
Score Text
0.9971 Localized panniculitis and subsequent Adverse-Effectlipoatrophy with subcutaneous glatiramer acetate ( Copaxone ) injection for the treatment of multiple sclerosis.
0.9930 Localized panniculitis and subsequent lipoatrophy with subcutaneous glatiramer acetate ( DrugCopaxone ) injection for the treatment of multiple sclerosis.
0.9791 Localized panniculitis and subsequent lipoatrophy with subcutaneous Drugglatiramer acetate ( Copaxone ) injection for the treatment of multiple sclerosis.
0.9776 Adverse-EffectLocalized panniculitis and subsequent lipoatrophy with subcutaneous glatiramer acetate ( Copaxone ) injection for the treatment of multiple sclerosis.
Score Text
0.9964 The aim of our paper was to describe hepatotoxicity of Drugsirolimus ( SRL ) in a kidney graft recipient.
0.9937 The aim of our paper was to describe Adverse-Effecthepatotoxicity of sirolimus ( SRL ) in a kidney graft recipient.
Score Text
0.9995 We report a case of drug - induced pemphigus caused by an angiotensin - converting enzyme inhibitor, Drugcaptopril .
0.9984 We report a case of drug - induced Adverse-Effectpemphigus caused by an angiotensin - converting enzyme inhibitor, captopril.
Score Text
0.9951 OBJECTIVE : To report teicoplanin - related Adverse-Effectneutropenia that developed after an episode of neutropenia induced by vancomycin therapy.
0.9787 OBJECTIVE : To report teicoplanin - related neutropenia that developed after an episode of Adverse-Effectneutropenia induced by vancomycin therapy.
0.8851 OBJECTIVE : To report Drugteicoplanin - related neutropenia that developed after an episode of neutropenia induced by vancomycin therapy.
0.8835 OBJECTIVE : To report teicoplanin - related neutropenia that developed after an episode of neutropenia induced by Drugvancomycin therapy.
Score Text
0.9996 Two patients with HLH developed Drugetoposide - related secondary acute myeloid leukemia ( sAML ) following therapy for HLH.
0.9834 Two patients with HLH developed etoposide - related Adverse-Effectsecondary acute myeloid leukemia ( sAML ) following therapy for HLH.
0.9828 Two patients with HLH developed etoposide - related secondary acute myeloid leukemia ( Adverse-EffectsAML ) following therapy for HLH.
Score Text
0.9993 The first patient is undergoing hemodialysis and, though responding to Drugsunitinib , is having significant fatigue and hypertension.
0.9991 The first patient is undergoing hemodialysis and, though responding to sunitinib, is having significant Adverse-Effectfatigue and hypertension.
0.9991 The first patient is undergoing hemodialysis and, though responding to sunitinib, is having significant fatigue and Adverse-Effecthypertension .
Score Text
0.9991 This communication describes a patient who developed Schneiderian first - rank symptoms in the course of treatment with Drugfluvoxamine .
0.9821 This communication describes a patient who developed Adverse-EffectSchneiderian first - rank symptoms in the course of treatment with fluvoxamine.
Score Text
0.9885 Initiation of Drugposaconazole led to clinical improvement until the patient's demise from bacteremic vancomycin - resistant enterococcal peritonitis.
0.9279 Initiation of posaconazole led to clinical improvement until the patient's demise from bacteremic vancomycin - resistant Adverse-Effectenterococcal peritonitis .
Score Text
0.9933 Red blood cell anemia in a patient with pemphigus vulgaris induced by the use of mycophenolate mofetil and Drugprednisone .
0.9789 Adverse-EffectRed blood cell anemia in a patient with pemphigus vulgaris induced by the use of mycophenolate mofetil and prednisone.
0.9675 Red blood cell anemia in a patient with pemphigus vulgaris induced by the use of Drugmycophenolate mofetil and prednisone.
Score Text
0.9984 After 3 - to 13 - month period of therapy without Drugindapamide , glucose levels of all patients decreased and diabetes disappeared.
0.9962 After 3 - to 13 - month period of therapy without indapamide, glucose levels of all patients decreased and Adverse-Effectdiabetes disappeared.
Score Text
0.9994 OBJECTIVE : To report a case of severe apnea in an infant exposed to Druglamotrigine through breast - feeding.
0.9824 OBJECTIVE : To report a case of Adverse-Effectsevere apnea in an infant exposed to lamotrigine through breast - feeding.
Score Text
0.9994 According to the Naranjo adverse drug reaction probability scale, Drugtigecycline was the probable cause of her acute pancreatitis.
0.9750 According to the Naranjo adverse drug reaction probability scale, tigecycline was the probable cause of her Adverse-Effectacute pancreatitis .
Score Text
0.9983 The time course of events suggested that amphotericin B was the cause of the Adverse-Effectseizures in this AIDS patient.
0.9819 The time course of events suggested that Drugamphotericin B was the cause of the seizures in this AIDS patient.
Score Text
0.9991 The case history and toxicological findings of an infant fatality involving Drugpseudoephedrine , brompheniramine, and dextromethorphan are presented.
0.9990 The case history and toxicological findings of an infant fatality involving pseudoephedrine, brompheniramine, and Drugdextromethorphan are presented.
0.9990 The case history and toxicological findings of an infant fatality involving pseudoephedrine, Drugbrompheniramine , and dextromethorphan are presented.
0.9779 The case history and toxicological findings of an infant Adverse-Effectfatality involving pseudoephedrine, brompheniramine, and dextromethorphan are presented.
Score Text
0.9969 This regimen could prove useful for other patients who develop hypersensitivity reactions to Drugcarboplatin and allow therapy to continue.
0.8828 This regimen could prove useful for other patients who develop Adverse-Effecthypersensitivity reactions to carboplatin and allow therapy to continue.
0.9795 This regimen could prove useful for other patients who develop Adverse-Effecthypersensitivity reactions to carboplatin and allow therapy to continue.
Score Text
0.9996 The most common side effects associated with Drugamifostine are nausea, vomiting, hypotension, hypocalcemia and allergic reactions.
0.9983 The most common side effects associated with amifostine are nausea, vomiting, hypotension, Adverse-Effecthypocalcemia and allergic reactions.
0.9983 The most common side effects associated with amifostine are nausea, vomiting, Adverse-Effecthypotension , hypocalcemia and allergic reactions.
0.9979 The most common side effects associated with amifostine are nausea, Adverse-Effectvomiting , hypotension, hypocalcemia and allergic reactions.
0.9969 The most common side effects associated with amifostine are Adverse-Effectnausea , vomiting, hypotension, hypocalcemia and allergic reactions.
0.9939 The most common side effects associated with amifostine are nausea, vomiting, hypotension, hypocalcemia and Adverse-Effectallergic reactions .
Score Text
0.9967 A 51 - year old physically fit woman experienced angio - oedema and hypotensive shock after Drugirbesartan ingestion requiring noradrenaline infusion.
0.9925 A 51 - year old physically fit woman experienced angio - oedema and Adverse-Effecthypotensive shock after irbesartan ingestion requiring noradrenaline infusion.
0.9868 A 51 - year old physically fit woman experienced Adverse-Effectangio - oedema and hypotensive shock after irbesartan ingestion requiring noradrenaline infusion.
Score Text
0.9995 This case supports the assessment that MH and diabetes are associated diseases and that Drugcresol could possibly trigger MH.
0.9937 This case supports the assessment that MH and diabetes are associated diseases and that cresol could possibly trigger Adverse-EffectMH .
Score Text
0.9973 This is the third report of reversible hepatic decompensation associated with prolonged DrugMTX therapy in patients with rheumatoid arthritis.
0.9696 This is the third report of reversible Adverse-Effecthepatic decompensation associated with prolonged MTX therapy in patients with rheumatoid arthritis.
Score Text
0.9995 A patient is described who developed a poorly differentiated sarcoma after Drugcyclophosphamide was used to treat his rheumatoid arthritis.
0.9832 A patient is described who developed a poorly differentiated Adverse-Effectsarcoma after cyclophosphamide was used to treat his rheumatoid arthritis.
Score Text
0.9990 Both Drugcolchicine and statin therapy may be associated with myopathy, which usually occurs after several months of therapy.
0.9989 Both colchicine and Drugstatin therapy may be associated with myopathy, which usually occurs after several months of therapy.
0.9986 Both colchicine and statin therapy may be associated with Adverse-Effectmyopathy , which usually occurs after several months of therapy.
Score Text
0.9993 We report two patients with anhedonic ejaculation ( ejaculation without orgasm ) associated with initiation of treatment with Drugdesipramine .
0.9830 We report two patients with Adverse-Effectanhedonic ejaculation ( ejaculation without orgasm ) associated with initiation of treatment with desipramine.
0.9166 We report two patients with anhedonic ejaculation ( Adverse-Effectejaculation without orgasm ) associated with initiation of treatment with desipramine.
Score Text
0.9996 RESULTS : Including our own patient, a total of 26 cases of Druggemcitabine - associated HUS were identified.
0.9988 RESULTS : Including our own patient, a total of 26 cases of gemcitabine - associated Adverse-EffectHUS were identified.
Score Text
0.9948 We describe a 5 - year - old girl showed recovery of Drugvincristine induced cranial polyneuropathy with pyridoxine and pyridostigmine treatment.
0.9883 We describe a 5 - year - old girl showed recovery of vincristine induced Adverse-Effectcranial polyneuropathy with pyridoxine and pyridostigmine treatment.
Score Text
0.9960 She was placed on adjuvant DrugAdriamycin ( doxorubicin ) chemotherapy, but 6 months later died of Adriamycin toxicity.
0.9948 She was placed on adjuvant Adriamycin ( Drugdoxorubicin ) chemotherapy, but 6 months later died of Adriamycin toxicity.
0.9896 She was placed on adjuvant Adriamycin ( doxorubicin ) chemotherapy, but 6 months later died of DrugAdriamycin toxicity.
0.9647 She was placed on adjuvant Adriamycin ( doxorubicin ) chemotherapy, but 6 months later Adverse-Effectdied of Adriamycin toxicity.
0.9153 She was placed on adjuvant Adriamycin ( doxorubicin ) chemotherapy, but 6 months later died of Adverse-EffectAdriamycin toxicity .
Score Text
0.9959 DrugQuinine and its isomer quinidine are well - known causes of iatrogenic hypoglycaemia, due to excessive insulin secretion.
0.9930 Quinine and its isomer Drugquinidine are well - known causes of iatrogenic hypoglycaemia, due to excessive insulin secretion.
0.9868 Quinine and its isomer quinidine are well - known causes of Adverse-Effectiatrogenic hypoglycaemia , due to excessive insulin secretion.
Score Text
0.9996 However, he developed acute renal failure, hyperkalemia, and hyperuricemia 30 d after receiving the Drugsorafenib treatment.
0.9976 However, he developed acute renal failure, hyperkalemia, and Adverse-Effecthyperuricemia 30 d after receiving the sorafenib treatment.
0.9970 However, he developed acute renal failure, Adverse-Effecthyperkalemia , and hyperuricemia 30 d after receiving the sorafenib treatment.
0.9836 However, he developed Adverse-Effectacute renal failure , hyperkalemia, and hyperuricemia 30 d after receiving the sorafenib treatment.
Score Text
0.9993 CONCLUSION : A woman receiving Drugenoxaparin every 12 hours developed signs and symptoms of hepatotoxicity after the second dose.
0.9967 CONCLUSION : A woman receiving enoxaparin every 12 hours developed signs and symptoms of Adverse-Effecthepatotoxicity after the second dose.
Score Text
0.9981 She had been on DrugCopaxone 20 mg / day treatment for 2 years when she first exhibited gastrointestinal symptoms.
0.9918 She had been on Copaxone 20 mg / day treatment for 2 years when she first exhibited Adverse-Effectgastrointestinal symptoms .
Score Text
0.9984 However, dermatologists should be cautious about a photosensitivity reaction induced by Drugmequitazine or other phenothiazine - derivative drugs.
0.9068 However, dermatologists should be cautious about a Adverse-Effectphotosensitivity reaction induced by mequitazine or other phenothiazine - derivative drugs.
0.9864 However, dermatologists should be cautious about a Adverse-Effectphotosensitivity reaction induced by mequitazine or other phenothiazine - derivative drugs.
Score Text
0.9996 To date, this is the first reported case of what appears to be isolated thrombocytopenia associated with Druglansoprazole .
0.9961 To date, this is the first reported case of what appears to be isolated Adverse-Effectthrombocytopenia associated with lansoprazole.
Score Text
0.9991 This report describes the first case of Druginsulin - induced cardiac failure in a patient without underlying heart disease.
0.9938 This report describes the first case of insulin - induced Adverse-Effectcardiac failure in a patient without underlying heart disease.
Score Text
0.9849 Patients receiving neutral protamine Hagedorn ( NPH ) insulin are at increased risk for the development of Adverse-Effectprotamine hypersensitivity .
0.9057 Patients receiving Drugneutral protamine Hagedorn ( NPH ) insulin are at increased risk for the development of protamine hypersensitivity.
0.5008 Patients receiving neutral Drugprotamine Hagedorn ( NPH ) insulin are at increased risk for the development of protamine hypersensitivity.
Score Text
0.9993 Radiation recall from Druggemcitabine is rare, but can potentially arise in any site that has been previously irradiated.
0.9901 Adverse-EffectRadiation recall from gemcitabine is rare, but can potentially arise in any site that has been previously irradiated.
Score Text
0.9994 Neutropenia is an infrequent complication following administration of the angiotensin - converting enzyme ( ACE ) inhibitor, Drugcaptopril .
0.9982 Adverse-EffectNeutropenia is an infrequent complication following administration of the angiotensin - converting enzyme ( ACE ) inhibitor, captopril.
Score Text
0.9955 Cholestatic liver disease with Adverse-Effectductopenia ( vanishing bile duct syndrome ) after administration of clindamycin and trimethoprim - sulfamethoxazole.
0.9930 Cholestatic liver disease with ductopenia ( vanishing bile duct syndrome ) after administration of Drugclindamycin and trimethoprim - sulfamethoxazole.
0.9862 Adverse-EffectCholestatic liver disease with ductopenia ( vanishing bile duct syndrome ) after administration of clindamycin and trimethoprim - sulfamethoxazole.
0.9817 Cholestatic liver disease with ductopenia ( Adverse-Effectvanishing bile duct syndrome ) after administration of clindamycin and trimethoprim - sulfamethoxazole.
0.7034 Cholestatic liver disease with ductopenia ( vanishing bile duct syndrome ) after administration of clindamycin and Drugtrimethoprim - sulfamethoxazole .
Score Text
0.9995 Physicians should keep in mind that taxanes such as Drugpaclitaxel have the potential to cause pneumonitis and lung fibrosis.
0.9988 Physicians should keep in mind that taxanes such as paclitaxel have the potential to cause Adverse-Effectpneumonitis and lung fibrosis.
0.9899 Physicians should keep in mind that taxanes such as paclitaxel have the potential to cause pneumonitis and Adverse-Effectlung fibrosis .
Score Text
0.9993 Hypersensitivity to Drugaspirin can be manifested as acute asthma, urticaria and / or angioedema, or a systemic anaphylactoid reaction.
0.9972 Hypersensitivity to aspirin can be manifested as acute asthma, Adverse-Effecturticaria and / or angioedema, or a systemic anaphylactoid reaction.
0.9969 Hypersensitivity to aspirin can be manifested as acute asthma, urticaria and / or Adverse-Effectangioedema , or a systemic anaphylactoid reaction.
0.9830 Hypersensitivity to aspirin can be manifested as acute asthma, urticaria and / or angioedema, or a Adverse-Effectsystemic anaphylactoid reaction .
0.9904 Hypersensitivity to aspirin can be manifested as Adverse-Effectacute asthma , urticaria and / or angioedema, or a systemic anaphylactoid reaction.
Score Text
0.9992 Intravitreal Drugtriamcinolone may have had an influence on the exacerbation of retinochoroiditis in the posterior pole of the patient.
0.9743 Intravitreal triamcinolone may have had an influence on the Adverse-Effectexacerbation of retinochoroiditis in the posterior pole of the patient.
Score Text
0.9817 A 30 - year - old pharmacist suffered from Adverse-Effectacute allergic contact dermatitis due to 4 - chloro - 7 - nitrobenzofurazan ( NBD - Cl ).
0.9615 A 30 - year - old pharmacist suffered from acute allergic contact dermatitis due to 4 - chloro - 7 - nitrobenzofurazan ( DrugNBD - Cl ).
0.9409 A 30 - year - old pharmacist suffered from acute allergic contact dermatitis due to Drug4 - chloro - 7 - nitrobenzofurazan ( NBD - Cl ).
Score Text
0.9994 Pneumonitis is emerging as one of the most unpredictable and potentially serious, adverse effects of treatment with DrugMTX .
0.9974 Adverse-EffectPneumonitis is emerging as one of the most unpredictable and potentially serious, adverse effects of treatment with MTX.
Score Text
0.9993 The female patient received Drugclozapine in a daily dose of 400 mg, which induced agranulocytosis after 2 months.
0.9986 The female patient received clozapine in a daily dose of 400 mg, which induced Adverse-Effectagranulocytosis after 2 months.
Score Text
0.9959 She continued to receive regular Druginsulin 4 times per day over the following 3 years with only occasional hives.
0.9916 She continued to receive regular insulin 4 times per day over the following 3 years with only occasional Adverse-Effecthives .
Score Text
0.9992 DrugPropoxyphene - induced wide complex dysrhythmia responsive to sodium bicarbonate therapy has not been previously reported in the literature.
0.9835 Propoxyphene - induced Adverse-Effectwide complex dysrhythmia responsive to sodium bicarbonate therapy has not been previously reported in the literature.
Score Text
0.9920 Adverse-EffectProgressive anemia following combination therapy with interferon - alpha and interleukin - 2 in a patient with metastatic renal cell carcinoma.
0.9753 Progressive anemia following combination therapy with interferon - alpha and Druginterleukin - 2 in a patient with metastatic renal cell carcinoma.
0.9708 Progressive anemia following combination therapy with Druginterferon - alpha and interleukin - 2 in a patient with metastatic renal cell carcinoma.
Score Text
0.9976 Visual changes secondary to initiation of Drugamiodarone : a case report and review involving ocular management in cardiac polypharmacy.
0.9939 Adverse-EffectVisual changes secondary to initiation of amiodarone : a case report and review involving ocular management in cardiac polypharmacy.
Score Text
0.9978 Metabolic balance studies and rechallenge with hydrochlorothiazide were undertaken to investigate the mechanism of the thiazide - induced Adverse-Effecthyponatremia .
0.9658 Metabolic balance studies and rechallenge with Drughydrochlorothiazide were undertaken to investigate the mechanism of the thiazide - induced hyponatremia.
0.9721 Metabolic balance studies and rechallenge with hydrochlorothiazide were undertaken to investigate the mechanism of the Drugthiazide - induced hyponatremia.
Score Text
0.9978 Adverse-EffectGoiter and hypothyroidism during re - treatment with amiodarone in a patient who previously experienced amiodarone - induced thyrotoxicosis.
0.9771 Goiter and Adverse-Effecthypothyroidism during re - treatment with amiodarone in a patient who previously experienced amiodarone - induced thyrotoxicosis.
0.9644 Goiter and hypothyroidism during re - treatment with amiodarone in a patient who previously experienced amiodarone - induced Adverse-Effectthyrotoxicosis .
0.8658 Goiter and hypothyroidism during re - treatment with amiodarone in a patient who previously experienced Drugamiodarone - induced thyrotoxicosis.
0.8296 Goiter and hypothyroidism during re - treatment with Drugamiodarone in a patient who previously experienced amiodarone - induced thyrotoxicosis.
Score Text
0.9970 Other thiazolidinediones currently in clinical trials may be able to provide the therapeutic benefits of Drugtroglitazone without significant hepatotoxicity.
0.9534 Other thiazolidinediones currently in clinical trials may be able to provide the therapeutic benefits of troglitazone without significant Adverse-Effecthepatotoxicity .
Score Text
0.9981 Our case is the second one in which hemorrhage from a meningioma may have been induced by Drugaspirin prophylaxis.
0.9978 Our case is the second one in which Adverse-Effecthemorrhage from a meningioma may have been induced by aspirin prophylaxis.
Score Text
0.9991 The authors report one case of incomplete posterior hyaloid detachment ( PHD ) following intravitreal Drugpegaptanib to treat DME.
0.9753 The authors report one case of Adverse-Effectincomplete posterior hyaloid detachment ( PHD ) following intravitreal pegaptanib to treat DME.
0.9853 The authors report one case of incomplete posterior hyaloid detachment ( Adverse-EffectPHD ) following intravitreal pegaptanib to treat DME.
Score Text
0.9715 DrugL - DOPA - induced excessive daytime sleepiness in PD : a placebo - controlled case with MSLT assessment.
0.6509 L - DOPA - induced excessive Adverse-Effectdaytime sleepiness in PD : a placebo - controlled case with MSLT assessment.
0.8773 L - DOPA - induced Adverse-Effectexcessive daytime sleepiness in PD : a placebo - controlled case with MSLT assessment.
Score Text
0.9985 Nine azotemic patients who developed a Adverse-Effectcoagulopathy associated with the use of either cephalosporin or moxalactam antibiotics are reported.
0.9982 Nine azotemic patients who developed a coagulopathy associated with the use of either Drugcephalosporin or moxalactam antibiotics are reported.
0.9979 Nine azotemic patients who developed a coagulopathy associated with the use of either cephalosporin or Drugmoxalactam antibiotics are reported.
Score Text
0.9894 Two patients treated with Drugalprazolam had histories suggestive of a bipolar disorder and developed lithium - responsive manic episodes.
0.9792 Two patients treated with alprazolam had histories suggestive of a bipolar disorder and developed lithium - responsive Adverse-Effectmanic episodes .
0.9732 Two patients treated with alprazolam had histories suggestive of a bipolar disorder and developed Druglithium - responsive manic episodes.
Score Text
0.9985 A patient with generalized MG was effectively managed with DrugMM but developed CNS lymphoma after 3 years of treatment.
0.9931 A patient with generalized MG was effectively managed with MM but developed Adverse-EffectCNS lymphoma after 3 years of treatment.
Score Text
0.9987 High - dose intravenous Drugmannitol infusion in various clinical settings may result in acute renal failure ( ARF ).
0.9957 High - dose intravenous mannitol infusion in various clinical settings may result in acute renal failure ( Adverse-EffectARF ).
0.9887 High - dose intravenous mannitol infusion in various clinical settings may result in Adverse-Effectacute renal failure ( ARF ).
Score Text
0.9992 This progressed to tracheal compression with stridor after he had taken some Drugaspirin for relief of the neck pain.
0.9887 This progressed to Adverse-Effecttracheal compression with stridor after he had taken some aspirin for relief of the neck pain.
Score Text
0.9994 CONCLUSIONS : There was a temporal relationship between the onset of nonconvulsive status epilepticus and initiation of Drugifosfamide infusion.
0.9842 CONCLUSIONS : There was a temporal relationship between the onset of Adverse-Effectnonconvulsive status epilepticus and initiation of ifosfamide infusion.
Score Text
0.9991 CONCLUSIONS : Clinicians should be aware that Crohn's disease is a potential novel adverse drug effect of DrugCopaxone .
0.9751 CONCLUSIONS : Clinicians should be aware that Adverse-EffectCrohn's disease is a potential novel adverse drug effect of Copaxone.
Score Text
0.9994 We report a 45 - year - old psoriasis patient who developed eruptive mollusca contagiosa during an antipsoriatic treatment with Drugefalizumab .
0.9855 We report a 45 - year - old psoriasis patient who developed Adverse-Effecteruptive mollusca contagiosa during an antipsoriatic treatment with efalizumab.
Score Text
0.9994 We report a case of Sweet's syndrome in association with Drugsargramostim treatment following chemotherapy for acute myelogenous leukemia.
0.9824 We report a case of Adverse-EffectSweet's syndrome in association with sargramostim treatment following chemotherapy for acute myelogenous leukemia.
Score Text
0.9900 Scleroderma - like reaction induced by uracil - tegafur ( DrugUFT ), a second - generation anticancer agent.
0.9850 Adverse-EffectScleroderma - like reaction induced by uracil - tegafur ( UFT ), a second - generation anticancer agent.
0.9259 Scleroderma - like reaction induced by Druguracil - tegafur ( UFT ), a second - generation anticancer agent.
Score Text
0.9992 OBJECTIVE : We report a case of cutaneous KS lesions in a patient affected by CML treated with Drugimatinib .
0.9858 OBJECTIVE : We report a case of Adverse-Effectcutaneous KS lesions in a patient affected by CML treated with imatinib.
Score Text
0.9964 A case of a 53 - year - old man who developed acute pneumonitis after Drugbleomycin and moderate oxygen administration is presented.
0.9824 A case of a 53 - year - old man who developed acute pneumonitis after bleomycin and moderate Drugoxygen administration is presented.
0.9758 A case of a 53 - year - old man who developed Adverse-Effectacute pneumonitis after bleomycin and moderate oxygen administration is presented.
Score Text
0.9956 Caution is, therefore, needed to prevent undesired accumulation of DrugTCA that may lead to protracted Cushing's syndrome.
0.9702 Caution is, therefore, needed to prevent undesired accumulation of TCA that may lead to protracted Adverse-EffectCushing's syndrome .
Score Text
0.9994 In a postoperative patient with pre - existent myasthenia gravis, oral Drugverapamil caused a marked exacerbation in myasthenic weakness.
0.9635 In a postoperative patient with pre - existent myasthenia gravis, oral verapamil caused a marked Adverse-Effectexacerbation in myasthenic weakness .
Score Text
0.9978 The concomitant use, however, of Drugcolchicine and statin has been associated with the rapid onset of muscle weakness.
0.9973 The concomitant use, however, of colchicine and Drugstatin has been associated with the rapid onset of muscle weakness.
0.9922 The concomitant use, however, of colchicine and statin has been associated with the rapid onset of Adverse-Effectmuscle weakness .
Score Text
0.9980 A 64 - year - old man presented with Adverse-Effectproteinuria during postoperative interferon ( IFN ) - beta therapy against malignant melanoma.
0.7965 A 64 - year - old man presented with proteinuria during postoperative Druginterferon ( IFN ) - beta therapy against malignant melanoma.
0.5163 A 64 - year - old man presented with proteinuria during postoperative interferon ( DrugIFN ) - beta therapy against malignant melanoma.
Score Text
0.9994 Recognition of a potential drug - induced Fanconi syndrome is important when managing pediatric oncology patients previously treated with Drugifosfamide .
0.9937 Recognition of a potential drug - induced Adverse-EffectFanconi syndrome is important when managing pediatric oncology patients previously treated with ifosfamide.
Score Text
0.9973 We experienced a case of chronic renal failure in a patient suffering from acute hemorrhagic gastritis associated with DrugAZ intoxication.
0.9895 We experienced a case of chronic renal failure in a patient suffering from Adverse-Effectacute hemorrhagic gastritis associated with AZ intoxication.
0.7112 We experienced a case of chronic renal failure in a patient suffering from acute hemorrhagic gastritis associated with Adverse-EffectAZ intoxication .
0.5287 We experienced a case of chronic Adverse-Effectrenal failure in a patient suffering from acute hemorrhagic gastritis associated with AZ intoxication.
Score Text
0.9976 The patient's other comorbidities and medications have not been suggested as possible interactions with sertraline that can cause Adverse-Effectrhabdomyolysis .
0.9915 The patient's other comorbidities and medications have not been suggested as possible interactions with Drugsertraline that can cause rhabdomyolysis.
Score Text
0.9994 To the best of the authors'knowledge, this is the first reported case of DrugPropecia - associated cataract.
0.9990 To the best of the authors'knowledge, this is the first reported case of Propecia - associated Adverse-Effectcataract .
Score Text
0.9993 RESULTS : Our patient developed Crohn's disease while on DrugCopaxone treatment as a consequence of long - term immunosuppression.
0.9795 RESULTS : Our patient developed Crohn's disease while on Copaxone treatment as a consequence of Adverse-Effectlong - term immunosuppression .
RESULTS : Our patient developed Adverse-EffectCrohn's disease while on Copaxone treatment as a consequence of long - term immunosuppression.
Score Text
0.9994 In this report, we describe a fatal Druggemcitabine - induced pulmonary toxicity in a patient with gallbladder metastatic adenocarcinoma.
0.9893 In this report, we describe a fatal gemcitabine - induced Adverse-Effectpulmonary toxicity in a patient with gallbladder metastatic adenocarcinoma.
Score Text
0.9992 We suggest that Drugmeloxicam might have intestinal toxic effects when taken in high doses, because of reduced COX - 2 selectivity.
0.9849 We suggest that meloxicam might have Adverse-Effectintestinal toxic effects when taken in high doses, because of reduced COX - 2 selectivity.
Score Text
0.9992 A chronic reaction associated with long - term treatment with Drugnitrofurantoin has also been reported and causes irreversible pulmonary fibrosis.
0.9178 A chronic reaction associated with long - term treatment with nitrofurantoin has also been reported and causes irreversible Adverse-Effectpulmonary fibrosis .
Score Text
0.9979 One patient developed severe hyponatremia with serum Na + of 108 mEq / L when Drughydrochlorothiazide was given to control hypertension.
0.9800 One patient developed Adverse-Effectsevere hyponatremia with serum Na + of 108 mEq / L when hydrochlorothiazide was given to control hypertension.
Score Text
0.9995 We describe a 43 - year - old man who developed signs and symptoms of bilateral optic neuropathy during treatment with Drugethambutol .
0.9825 We describe a 43 - year - old man who developed signs and symptoms of Adverse-Effectbilateral optic neuropathy during treatment with ethambutol.
Score Text
0.9970 We report a case of noncardiogenic pulmonary edema developed after therapeutic trial of DrugEO as sclerosing agent for esophageal varix.
0.9870 We report a case of Adverse-Effectnoncardiogenic pulmonary edema developed after therapeutic trial of EO as sclerosing agent for esophageal varix.
Score Text
0.9966 CONCLUSION : A patient with CHF and ESRD developed myoclonic muscle spasms after receiving Drugdobutamine by continuous i. v. infusion.
0.9862 CONCLUSION : A patient with CHF and ESRD developed Adverse-Effectmyoclonic muscle spasms after receiving dobutamine by continuous i. v. infusion.
Score Text
0.9995 We report a case of an 11 - year - old boy who experienced an anaphylactic reaction after administration of Drugbacitracin ointment.
0.9939 We report a case of an 11 - year - old boy who experienced an Adverse-Effectanaphylactic reaction after administration of bacitracin ointment.
Score Text
0.9983 These two cases highlight the importance of considering Druglopinavir / ritonavir induced arrhythmias when dealing with HIV - positive individuals.
0.9980 These two cases highlight the importance of considering lopinavir / Drugritonavir induced arrhythmias when dealing with HIV - positive individuals.
0.9967 These two cases highlight the importance of considering lopinavir / ritonavir induced Adverse-Effectarrhythmias when dealing with HIV - positive individuals.
Score Text
0.9996 On the other hand, DrugMTX - induced pneumonitis seems to be very rare in psoriatic arthritis ( PsA ).
0.9987 On the other hand, MTX - induced Adverse-Effectpneumonitis seems to be very rare in psoriatic arthritis ( PsA ).
Score Text
0.9783 Patients treated with captopril who develop " Adverse-Effectatypical cholangitis " should be suspected of having captopril - associated liver damage.
0.9687 Patients treated with captopril who develop " atypical cholangitis " should be suspected of having captopril - associated Adverse-Effectliver damage .
0.9396 Patients treated with Drugcaptopril who develop " atypical cholangitis " should be suspected of having captopril - associated liver damage.
0.8816 Patients treated with captopril who develop " atypical cholangitis " should be suspected of having Drugcaptopril - associated liver damage.
0.5360 Patients treated with captopril who develop " Adverse-Effectatypical cholangitis " should be suspected of having captopril - associated liver damage.
0.5358 Patients treated with captopril who develop " Adverse-Effectatypical cholangitis " should be suspected of having captopril - associated liver damage.
0.5184 Patients treated with captopril who develop " Adverse-Effectatypical cholangitis " should be suspected of having captopril - associated liver damage.
Score Text
0.9997 He developed fever, nausea, diarrhea, and malaise and stopped taking on the third day after commencing DrugPentasa .
0.9992 He developed fever, nausea, Adverse-Effectdiarrhea , and malaise and stopped taking on the third day after commencing Pentasa.
0.9984 He developed fever, nausea, diarrhea, and Adverse-Effectmalaise and stopped taking on the third day after commencing Pentasa.
0.9981 He developed fever, Adverse-Effectnausea , diarrhea, and malaise and stopped taking on the third day after commencing Pentasa.
0.9940 He developed Adverse-Effectfever , nausea, diarrhea, and malaise and stopped taking on the third day after commencing Pentasa.
Score Text
0.9871 The authors'results suggest that L - dopa may cause Adverse-Effectdaytime somnolence in some patients with Parkinson's disease.
0.9731 The authors'results suggest that DrugL - dopa may cause daytime somnolence in some patients with Parkinson's disease.
Score Text
0.9995 The aim of this study was to describe the occurrence of acute coronary syndromes in 3 cases of Drugrituximab infusions.
0.9892 The aim of this study was to describe the occurrence of Adverse-Effectacute coronary syndromes in 3 cases of rituximab infusions.
Score Text
0.9995 Despite a very low complication rate, several severe arterial thrombotic events have been reported following Drugthrombin injection of pseudoaneurysms.
0.9827 Despite a very low complication rate, several Adverse-Effectsevere arterial thrombotic events have been reported following thrombin injection of pseudoaneurysms.
Score Text
0.9992 In the first patient, two episodes of ventricular tachycardia requiring cardioversion occurred in close temporal sequence with administering Drugbretylium .
0.9884 In the first patient, two episodes of Adverse-Effectventricular tachycardia requiring cardioversion occurred in close temporal sequence with administering bretylium.
Score Text
0.9972 OBJECTIVE : To report a case of multiple episodes of Adverse-Effectseizure activity in an AIDS patent following amphotericin B infusion.
0.9833 OBJECTIVE : To report a case of multiple episodes of seizure activity in an AIDS patent following Drugamphotericin B infusion.
Score Text
0.9996 A drug addict with staphylococcal endocarditis treated with Drugmethicillin , who developed massive proteinuria and acute nephritic syndrome is described.
0.9925 A drug addict with staphylococcal endocarditis treated with methicillin, who developed Adverse-Effectmassive proteinuria and acute nephritic syndrome is described.
0.9894 A drug addict with staphylococcal endocarditis treated with methicillin, who developed massive proteinuria and Adverse-Effectacute nephritic syndrome is described.
Score Text
0.9992 CONCLUSIONS : Prolonged exposure to Drugitraconazole , administered either continuously or intermittently, may precipitate severe and irreversible hepatotoxic events.
0.7655 CONCLUSIONS : Prolonged exposure to itraconazole, administered either continuously or intermittently, may precipitate Adverse-Effectsevere and irreversible hepatotoxic events .
Score Text
0.9993 The patient's defects may be due to Drugmethimazole teratogenicity or could represent a previously undescribed syndrome affecting ectodermal structures.
0.9522 The patient's defects may be due to methimazole Adverse-Effectteratogenicity or could represent a previously undescribed syndrome affecting ectodermal structures.
Score Text
0.9954 Gestational diabetes was no less severe ( degree of hyperglycaemia, need for insulin therapy ) when associated with Drugnorethisterone .
0.9900 Adverse-EffectGestational diabetes was no less severe ( degree of hyperglycaemia, need for insulin therapy ) when associated with norethisterone.
Score Text
0.9988 Uveitis during treatment of disseminated Mycobacterium avium - intracellulare complex infection with the combination of rifabutin, Drugclarithromycin and ethambutol.
0.9986 Uveitis during treatment of disseminated Mycobacterium avium - intracellulare complex infection with the combination of rifabutin, clarithromycin and Drugethambutol .
0.9985 Adverse-EffectUveitis during treatment of disseminated Mycobacterium avium - intracellulare complex infection with the combination of rifabutin, clarithromycin and ethambutol.
0.9985 Uveitis during treatment of disseminated Mycobacterium avium - intracellulare complex infection with the combination of Drugrifabutin , clarithromycin and ethambutol.
Score Text
0.9992 Following several of these courses of therapy, respiratory distress occurred 9 to 12 days after the Drugchlorambucil was given.
0.9929 Following several of these courses of therapy, Adverse-Effectrespiratory distress occurred 9 to 12 days after the chlorambucil was given.
Score Text
0.9958 Three cases of acute renal toxicity in patients receiving long - term therapy with mitomycin C and Drug5 - fluorouracil are reported.
0.9844 Three cases of acute renal toxicity in patients receiving long - term therapy with Drugmitomycin C and 5 - fluorouracil are reported.
0.9801 Three cases of Adverse-Effectacute renal toxicity in patients receiving long - term therapy with mitomycin C and 5 - fluorouracil are reported.
Score Text
0.9967 DrugRamipril - induced cutaneous vasculitis is particularly rare and our case was atypical because the patient had tolerated lisinopril before.
0.9912 Ramipril - induced Adverse-Effectcutaneous vasculitis is particularly rare and our case was atypical because the patient had tolerated lisinopril before.
Score Text
0.9991 We report on a young adolescent with benign intracranial hypertension which we attribute to the use of Drugminocycline for acne.
0.9769 We report on a young adolescent with Adverse-Effectbenign intracranial hypertension which we attribute to the use of minocycline for acne.
Score Text
0.9860 An adolescent male developed Adverse-Effectacute pancreatitis and pseudocyst of the pancreas 16 weeks after cessation of intramuscular L - asparaginase.
0.9825 An adolescent male developed acute pancreatitis and Adverse-Effectpseudocyst of the pancreas 16 weeks after cessation of intramuscular L - asparaginase.
0.9711 An adolescent male developed acute pancreatitis and pseudocyst of the pancreas 16 weeks after cessation of intramuscular DrugL - asparaginase .
Score Text
0.9839 Four cases of Adverse-Effectfat embolism are described in infants receiving prolonged intravenous infusion of fat ( Intralipid 20 % ).
0.9737 Four cases of fat embolism are described in infants receiving prolonged intravenous infusion of fat ( DrugIntralipid 20 % ).
Score Text
0.9990 According to the Naranjo probability scale, the relationship of Druggemcitabine treatment with cutaneous eruption in our patient is possible.
0.9770 According to the Naranjo probability scale, the relationship of gemcitabine treatment with Adverse-Effectcutaneous eruption in our patient is possible.
Score Text
0.9854 A boy with chronic neutropenia and recurrent inflammatory skin lesions developed Adverse-Effectmultiple erythematous nodules following administration of G - CSF.
0.9753 A boy with chronic neutropenia and recurrent inflammatory skin lesions developed multiple erythematous nodules following administration of DrugG - CSF .
Score Text
0.9986 Despite the known pulmonary side effects of Drugnitrofurantoin , there is no report of this toxicity occurring in pregnant patients.
0.9829 Despite the known Adverse-Effectpulmonary side effects of nitrofurantoin, there is no report of this toxicity occurring in pregnant patients.
Score Text
0.9993 Evidence is shown in this report that Drugadenosine was associated with dangerous worsening of arrhythmia in patients with atrial flutter.
0.9800 Evidence is shown in this report that adenosine was associated with dangerous worsening of Adverse-Effectarrhythmia in patients with atrial flutter.
Score Text
0.9995 A third patient experienced disabling neurotoxicity in the extremity of a prior ulnar nerve and tendon transposition after receiving Drugpaclitaxel .
0.9803 A third patient experienced Adverse-Effectdisabling neurotoxicity in the extremity of a prior ulnar nerve and tendon transposition after receiving paclitaxel.
Score Text
0.9995 The authors report a case of urinary incontinence ( UI ) that occurred in a woman after administration of Drugvenlafaxine .
0.9976 The authors report a case of urinary incontinence ( Adverse-EffectUI ) that occurred in a woman after administration of venlafaxine.
0.9885 The authors report a case of Adverse-Effecturinary incontinence ( UI ) that occurred in a woman after administration of venlafaxine.
Score Text
0.9970 Four days after intravenous Zoledronic acid, the patient presented to emergency room with complaints of carpopedal spasm and Adverse-Effectbronchospasm .
0.9931 Four days after intravenous Zoledronic acid, the patient presented to emergency room with complaints of Adverse-Effectcarpopedal spasm and bronchospasm.
0.9729 Four days after intravenous DrugZoledronic acid , the patient presented to emergency room with complaints of carpopedal spasm and bronchospasm.
Score Text
0.9993 Four patients who manifested symptoms of the antiepileptic drug ( AED ) hypersensitivity syndrome during therapy with Drugcarbamazepine are reported.
0.9593 Four patients who manifested symptoms of the antiepileptic drug ( AED ) Adverse-Effecthypersensitivity syndrome during therapy with carbamazepine are reported.
Score Text
0.9985 A review of the literature revealed two other cases of hepatic angiosarcoma in patients after long - term Drugcyclophosphamide treatment.
0.9895 A review of the literature revealed two other cases of Adverse-Effecthepatic angiosarcoma in patients after long - term cyclophosphamide treatment.
Score Text
0.9989 The neurotoxicity seen with DrugHDARAC is dose - related and has occurred in up to 60 percent of treated patients.
0.9976 The Adverse-Effectneurotoxicity seen with HDARAC is dose - related and has occurred in up to 60 percent of treated patients.
Score Text
0.9968 Intra - neural ceroid - like pigment following the treatment of lepromatous leprosy with Drugclofazimine ( B663 ; Lamprene ).
0.9965 Intra - neural ceroid - like pigment following the treatment of lepromatous leprosy with clofazimine ( B663 ; DrugLamprene ).
0.9955 Intra - neural ceroid - like pigment following the treatment of lepromatous leprosy with clofazimine ( DrugB663 ; Lamprene ).
0.9771 Adverse-EffectIntra - neural ceroid - like pigment following the treatment of lepromatous leprosy with clofazimine ( B663 ; Lamprene ).
Score Text
0.9986 This is the first report on the histopathological findings of thyroid tissue from a patient with Drugamiodarone - induced hypothyroidism.
0.9960 This is the first report on the histopathological findings of thyroid tissue from a patient with amiodarone - induced Adverse-Effecthypothyroidism .
Score Text
0.9980 Herein, we describe 2 patients who developed unusual CD8 + cutaneous lymphoproliferative disorders after treatment with efalizumab and Druginfliximab .
0.9972 Herein, we describe 2 patients who developed unusual CD8 + cutaneous lymphoproliferative disorders after treatment with Drugefalizumab and infliximab.
0.9799 Herein, we describe 2 patients who developed unusual Adverse-EffectCD8 + cutaneous lymphoproliferative disorders after treatment with efalizumab and infliximab.
Score Text
0.9993 After excluding other causes of long QT syndrome, the DrugHCQ was suspected as the cause of her ventricular tachycardia.
0.9824 After excluding other causes of long QT syndrome, the HCQ was suspected as the cause of her Adverse-Effectventricular tachycardia .
Score Text
0.9992 We conclude that neurosurgeons and neurologists should be aware of calcium antagonist - - related ileus in patients treated with Drugnimodipine .
0.9921 We conclude that neurosurgeons and neurologists should be aware of calcium antagonist - - related Adverse-Effectileus in patients treated with nimodipine.
Score Text
0.9994 NMS is a drug - related response to various medications, such as DrugHaloperidol , which the patient was receiving.
0.9980 Adverse-EffectNMS is a drug - related response to various medications, such as Haloperidol, which the patient was receiving.
Score Text
0.9721 The noted increase in the theophylline level after Drugzafirlukast administration is in contrast to the original reports by the manufacturer.
0.9653 The noted increase in the Drugtheophylline level after zafirlukast administration is in contrast to the original reports by the manufacturer.
0.7393 The noted Adverse-Effectincrease in the theophylline level after zafirlukast administration is in contrast to the original reports by the manufacturer.
Score Text
0.9995 To our knowledge, this is the first case of Drugivermectin - induced severe liver disease published in the literature.
0.9904 To our knowledge, this is the first case of ivermectin - induced Adverse-Effectsevere liver disease published in the literature.
Score Text
0.9840 Adverse-EffectPalpable purpuric skin lesions on the anterior surface of both legs appeared on the 55th day of amphotericin B treatment.
0.9833 Palpable purpuric skin lesions on the anterior surface of both legs appeared on the 55th day of Drugamphotericin B treatment.
Score Text
0.9994 Three years later, treatment with Drugampicillin caused another episode of cholestatic hepatitis with cholestasis and duct paucity on rebiopsy.
0.9928 Three years later, treatment with ampicillin caused another episode of cholestatic hepatitis with Adverse-Effectcholestasis and duct paucity on rebiopsy.
0.9891 Three years later, treatment with ampicillin caused another episode of Adverse-Effectcholestatic hepatitis with cholestasis and duct paucity on rebiopsy.
0.9877 Three years later, treatment with ampicillin caused another episode of cholestatic hepatitis with cholestasis and Adverse-Effectduct paucity on rebiopsy.
Score Text
0.9957 Teicoplanin - induced agranulocytosis that followed vancomycin - induced Adverse-Effectagranulocytosis suggests a possible cross - reactivity between the 2 drugs.
0.9544 Teicoplanin - induced agranulocytosis that followed Drugvancomycin - induced agranulocytosis suggests a possible cross - reactivity between the 2 drugs.
0.8805 Teicoplanin - induced Adverse-Effectagranulocytosis that followed vancomycin - induced agranulocytosis suggests a possible cross - reactivity between the 2 drugs.
0.8686 DrugTeicoplanin - induced agranulocytosis that followed vancomycin - induced agranulocytosis suggests a possible cross - reactivity between the 2 drugs.
Score Text
0.9996 This unusual pattern of low - grade endometrial carcinoma adds to the spectrum of uterine neoplasia associated with Drugtamoxifen therapy.
0.9874 This unusual pattern of low - grade endometrial carcinoma adds to the spectrum of Adverse-Effectuterine neoplasia associated with tamoxifen therapy.
0.9179 This unusual pattern of Adverse-Effectlow - grade endometrial carcinoma adds to the spectrum of uterine neoplasia associated with tamoxifen therapy.
Score Text
0.9994 This is a case report of subtle, mild hypothermia in a 54 - year old female patient receiving Drugrisperidone for schizophrenia.
0.9264 This is a case report of subtle, mild Adverse-Effecthypothermia in a 54 - year old female patient receiving risperidone for schizophrenia.
Score Text
0.9940 Infliximab and its serious adverse effects are discussed, and other cases of Adverse-Effectosteomyelitis with infliximab use are also reviewed.
0.9399 Infliximab and its serious adverse effects are discussed, and other cases of osteomyelitis with Druginfliximab use are also reviewed.
0.9208 DrugInfliximab and its serious adverse effects are discussed, and other cases of osteomyelitis with infliximab use are also reviewed.
Score Text
0.9985 This is a unique autopsy case of hepatocellular carcinoma closely related to Drugdiethylstilbestrol ( DES ) therapy for prostatic cancer.
0.9952 This is a unique autopsy case of hepatocellular carcinoma closely related to diethylstilbestrol ( DrugDES ) therapy for prostatic cancer.
0.9896 This is a unique autopsy case of Adverse-Effecthepatocellular carcinoma closely related to diethylstilbestrol ( DES ) therapy for prostatic cancer.
Score Text
0.9995 DrugVigabatrin - induced visual field defects are at present the most important safety issue in the use of the drug.
0.9890 Vigabatrin - induced Adverse-Effectvisual field defects are at present the most important safety issue in the use of the drug.
Score Text
0.9994 We report the case of a child with metastatic osteosarcoma, who experienced an anaphylactic / anaphylactoid reaction to Drugmethotrexate .
0.9800 We report the case of a child with metastatic osteosarcoma, who experienced an Adverse-Effectanaphylactic / anaphylactoid reaction to methotrexate.
0.8443 We report the case of a child with metastatic osteosarcoma, who experienced an anaphylactic / Adverse-Effectanaphylactoid reaction to methotrexate.
0.7172 We report the case of a child with metastatic osteosarcoma, who experienced an anaphylactic Adverse-Effect/ anaphylactoid reaction to methotrexate.
Score Text
0.8480 Complications of chemotherapy for a synovial sarcoma in an eight - year old boy included cisplatinum Adverse-Effectnephrotoxicity and adriamycin cardiotoxicity.
0.8074 Complications of chemotherapy for a synovial sarcoma in an eight - year old boy included Drugcisplatinum nephrotoxicity and adriamycin cardiotoxicity.
0.9095 Complications of chemotherapy for a synovial sarcoma in an eight - year old boy included cisplatinum nephrotoxicity and Adverse-Effectadriamycin cardiotoxicity .
0.7480 Complications of chemotherapy for a synovial sarcoma in an eight - year old boy included Adverse-Effectcisplatinum nephrotoxicity and adriamycin cardiotoxicity.
Complications of chemotherapy for a synovial sarcoma in an eight - year old boy included cisplatinum nephrotoxicity and Drugadriamycin cardiotoxicity.
Complications of chemotherapy for a synovial sarcoma in an eight - year old boy included cisplatinum nephrotoxicity and adriamycin Adverse-Effectcardiotoxicity .
Score Text
0.9994 RTA is one type of nephrotoxicity induced by DrugFK506 , and it is reversible in mild cases when appropriately treated.
0.9966 Adverse-EffectRTA is one type of nephrotoxicity induced by FK506, and it is reversible in mild cases when appropriately treated.
0.9808 RTA is one type of Adverse-Effectnephrotoxicity induced by FK506, and it is reversible in mild cases when appropriately treated.
Score Text
0.9993 Three male patients aged 78 - 83 years are presented, in whom severe hepatotoxic reactions emerged after DrugCPA administration.
0.8939 Three male patients aged 78 - 83 years are presented, in whom Adverse-Effectsevere hepatotoxic reactions emerged after CPA administration.
Score Text
0.9806 Two patients with Adverse-Effectextrapyramidal side effects after the use of fluphenazine decanoate were evaluated by means of IBZM - SPECT.
0.9685 Two patients with extrapyramidal side effects after the use of Drugfluphenazine decanoate were evaluated by means of IBZM - SPECT.
Score Text
0.9996 Muscle biopsy revealed variation in muscle fiber size and few vacuolated fibers which were features of Drugcolchicine - induced myopathy.
0.9929 Muscle biopsy revealed variation in muscle fiber size and few vacuolated fibers which were features of colchicine - induced Adverse-Effectmyopathy .
0.9834 Muscle biopsy revealed variation in muscle fiber size and few Adverse-Effectvacuolated fibers which were features of colchicine - induced myopathy.
0.9574 Muscle biopsy revealed Adverse-Effectvariation in muscle fiber size and few vacuolated fibers which were features of colchicine - induced myopathy.
Score Text
0.9895 Allergic side effects of DrugAZA are rare, and reported allergic skin eruptions from AZA are very limited in Japan.
0.9872 Allergic side effects of AZA are rare, and reported Adverse-Effectallergic skin eruptions from AZA are very limited in Japan.
0.9862 Allergic side effects of AZA are rare, and reported allergic skin eruptions from DrugAZA are very limited in Japan.
Score Text
0.9995 Adverse effects of Drugamiodarone including pulmonary toxicity, hepatotoxicity, aggravation of arrhythmia, and thyroid diseases are well understood.
0.9945 Adverse effects of amiodarone including pulmonary toxicity, Adverse-Effecthepatotoxicity , aggravation of arrhythmia, and thyroid diseases are well understood.
0.9910 Adverse effects of amiodarone including Adverse-Effectpulmonary toxicity , hepatotoxicity, aggravation of arrhythmia, and thyroid diseases are well understood.
0.9905 Adverse effects of amiodarone including pulmonary toxicity, hepatotoxicity, aggravation of arrhythmia, and Adverse-Effectthyroid diseases are well understood.
0.9795 Adverse effects of amiodarone including pulmonary toxicity, hepatotoxicity, Adverse-Effectaggravation of arrhythmia , and thyroid diseases are well understood.
Score Text
0.9982 The patient presented with fulminant microangiopathic hemolytic anemia and thrombocytopenia within 48 hr of initiating therapy with trimethoprim - Drugsulfamethoxazole .
0.9962 The patient presented with fulminant microangiopathic hemolytic anemia and thrombocytopenia within 48 hr of initiating therapy with Drugtrimethoprim - sulfamethoxazole.
0.9942 The patient presented with fulminant microangiopathic hemolytic anemia and Adverse-Effectthrombocytopenia within 48 hr of initiating therapy with trimethoprim - sulfamethoxazole.
0.9856 The patient presented with Adverse-Effectfulminant microangiopathic hemolytic anemia and thrombocytopenia within 48 hr of initiating therapy with trimethoprim - sulfamethoxazole.
Score Text
0.9984 CONCLUSIONS : For all patients with Drugvancomycin - induced neutropenia, possible cross - reactivity of teicoplanin should be monitored.
0.9982 CONCLUSIONS : For all patients with vancomycin - induced Adverse-Effectneutropenia , possible cross - reactivity of teicoplanin should be monitored.
Score Text
0.9828 Reinstitution of penicillamine treatment caused a recurrence thus proving a causal relationship between penicillamine and the described Adverse-Effectnail - changes .
0.8582 Reinstitution of penicillamine treatment caused a recurrence thus proving a causal relationship between Drugpenicillamine and the described nail - changes.
0.6889 Reinstitution of Drugpenicillamine treatment caused a recurrence thus proving a causal relationship between penicillamine and the described nail - changes.
Score Text
0.9800 OBJECTIVE : To investigate the mechanisms involved in Adverse-Effecthypersensitivity reactions to cyclosporine and determine the feasibility of future cyclosporine use.
0.9279 OBJECTIVE : To investigate the mechanisms involved in hypersensitivity reactions to Drugcyclosporine and determine the feasibility of future cyclosporine use.
0.9183 OBJECTIVE : To investigate the mechanisms involved in hypersensitivity reactions to cyclosporine and determine the feasibility of future Drugcyclosporine use.
Score Text
0.9992 A case of tuberculosis in a patient on Efalizumab and DrugEtanercept for treatment of refractory palmopustular psoriasis and psoriatic arthritis.
0.9992 A case of tuberculosis in a patient on DrugEfalizumab and Etanercept for treatment of refractory palmopustular psoriasis and psoriatic arthritis.
0.9919 A case of Adverse-Effecttuberculosis in a patient on Efalizumab and Etanercept for treatment of refractory palmopustular psoriasis and psoriatic arthritis.
Score Text
0.9941 Development of Adverse-Effectnephrotic syndrome in a patient with acute myeloblastic leukemia after treatment with macrophage - colony - stimulating factor.
0.9557 Development of nephrotic syndrome in a patient with acute myeloblastic leukemia after treatment with Drugmacrophage - colony - stimulating factor .
Score Text
0.9995 Typical symptoms of active CD occurred 11, 12, and 26 months after start of Drugetanercept therapy, respectively.
0.9867 Typical symptoms of active Adverse-EffectCD occurred 11, 12, and 26 months after start of etanercept therapy, respectively.
Score Text
0.9991 The dermatology literature heretofore has not noted that anemia is a side effect of patients taking DrugMMF to treat pemphigus.
0.9985 The dermatology literature heretofore has not noted that Adverse-Effectanemia is a side effect of patients taking MMF to treat pemphigus.
Score Text
0.9943 We report a girl with the Rett syndrome who had acute encephalopathy probably induced by calcium hopantenate ( DrugHOPA ).
0.9921 We report a girl with the Rett syndrome who had acute encephalopathy probably induced by Drugcalcium hopantenate ( HOPA ).
0.9856 We report a girl with the Rett syndrome who had Adverse-Effectacute encephalopathy probably induced by calcium hopantenate ( HOPA ).
Score Text
0.9992 Increased awareness is needed on the possible occurrence of LPD resembling gastric cancer in rheumatoid arthritis patients treated with DrugMTX .
0.9969 Increased awareness is needed on the possible occurrence of Adverse-EffectLPD resembling gastric cancer in rheumatoid arthritis patients treated with MTX.
0.7042 Increased awareness is needed on the possible occurrence of LPD resembling Adverse-Effectgastric cancer in rheumatoid arthritis patients treated with MTX.
Score Text
0.9901 Adverse-EffectOptic neuropathy developed in a patient with rheumatoid arthritis who had been receiving D - penicillamine for about 1 year.
0.9722 Optic neuropathy developed in a patient with rheumatoid arthritis who had been receiving DrugD - penicillamine for about 1 year.
Score Text
0.9993 Surgeons and physicians should therefore be aware of the potential for RTA to occur with DrugFK506 after any organ transplantation.
0.9948 Surgeons and physicians should therefore be aware of the potential for Adverse-EffectRTA to occur with FK506 after any organ transplantation.
Score Text
0.9992 We report 4 patients who developed symptoms of myasthenia gravis within 2 weeks of starting treatment with a Drugstatin drug.
0.9930 We report 4 patients who developed symptoms of Adverse-Effectmyasthenia gravis within 2 weeks of starting treatment with a statin drug.
Score Text
0.9973 She was treated with Pancrease MT 16, but had consistent Adverse-Effectvomiting 1 to 2 hours after administration of enzymes.
0.9770 She was treated with DrugPancrease MT 16 , but had consistent vomiting 1 to 2 hours after administration of enzymes.
Score Text
0.9975 We report here a rare case of ritodrine - hydrochloride - induced Adverse-Effectrhabdomyolysis in a pregnant patient with myotonic dystrophy.
0.9778 We report here a rare case of Drugritodrine - hydrochloride - induced rhabdomyolysis in a pregnant patient with myotonic dystrophy.
Score Text
0.9797 Our literature review revealed an additional six cases of onset of Adverse-Effectinflammatory arthritis in MS patients receiving IFN - beta.
0.9738 Our literature review revealed an additional six cases of onset of inflammatory arthritis in MS patients receiving DrugIFN - beta .
Score Text
0.9818 Imatinib mesylate - related Adverse-Effectfatal acute hepatic failure in a patient with chronic myeloid leukaemia and chronic hepatitis B infection.
0.9647 DrugImatinib mesylate - related fatal acute hepatic failure in a patient with chronic myeloid leukaemia and chronic hepatitis B infection.
Score Text
0.9851 PURPOSE : To describe bilateral optic neuritis that occurred as an adverse effect of recombinant and natural Druginterferon alpha administration.
0.9838 PURPOSE : To describe Adverse-Effectbilateral optic neuritis that occurred as an adverse effect of recombinant and natural interferon alpha administration.
Score Text
0.9995 Our findings reveal that even in patients without a history of seizures, Drugpregabalin can cause a cortical negative myoclonus.
0.9854 Our findings reveal that even in patients without a history of seizures, pregabalin can cause a Adverse-Effectcortical negative myoclonus .
Score Text
0.9952 Disseminated intravascular coagulation associated with acute hemoglobinemia or Adverse-Effecthemoglobinuria following Rh ( 0 ) ( D ) immune globulin intravenous administration for immune thrombocytopenic purpura.
0.9841 Disseminated intravascular coagulation associated with Adverse-Effectacute hemoglobinemia or hemoglobinuria following Rh ( 0 ) ( D ) immune globulin intravenous administration for immune thrombocytopenic purpura.
0.9786 Adverse-EffectDisseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rh ( 0 ) ( D ) immune globulin intravenous administration for immune thrombocytopenic purpura.
0.9396 Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following DrugRh ( 0 ) ( D ) immune globulin intravenous administration for immune thrombocytopenic purpura.
Score Text
0.9996 Pneumocystis pneumonia should be considered in asthmatic patients taking Drugmethotrexate who present with fever, pulmonary infiltrates, and hypoxia.
0.9985 Pneumocystis pneumonia should be considered in asthmatic patients taking methotrexate who present with fever, pulmonary infiltrates, and Adverse-Effecthypoxia .
0.9864 Adverse-EffectPneumocystis pneumonia should be considered in asthmatic patients taking methotrexate who present with fever, pulmonary infiltrates, and hypoxia.
0.9855 Pneumocystis pneumonia should be considered in asthmatic patients taking methotrexate who present with Adverse-Effectfever , pulmonary infiltrates, and hypoxia.
0.9609 Pneumocystis pneumonia should be considered in asthmatic patients taking methotrexate who present with fever, Adverse-Effectpulmonary infiltrates , and hypoxia.
Score Text
0.9982 ADH hypersecretion in relation to plasma osmolality was reversed by Drugmizoribin withdrawal, suggesting that bredinin might adversely induce SIADH.
0.9719 ADH hypersecretion in relation to plasma osmolality was reversed by mizoribin withdrawal, suggesting that bredinin might adversely induce Adverse-EffectSIADH .
0.8256 Adverse-EffectADH hypersecretion in relation to plasma osmolality was reversed by mizoribin withdrawal, suggesting that bredinin might adversely induce SIADH.
0.8517 ADH hypersecretion in relation to Adverse-Effectplasma osmolality was reversed by mizoribin withdrawal, suggesting that bredinin might adversely induce SIADH.
ADH hypersecretion in relation to plasma osmolality was reversed by mizoribin withdrawal, suggesting that Drugbredinin might adversely induce SIADH.
Score Text
0.9991 The known side effects of Drugsibutramine , ie, hypertension and tachycardia, depend on its adrenergic and serotoninergic effects.
0.9935 The known side effects of sibutramine, ie, hypertension and Adverse-Effecttachycardia , depend on its adrenergic and serotoninergic effects.
0.9927 The known side effects of sibutramine, ie, Adverse-Effecthypertension and tachycardia, depend on its adrenergic and serotoninergic effects.
Score Text
0.9995 During the anti - tuberculous therapy, visual loss can be related to Drugethambutol toxicity or the tuberculosis infection itself.
0.9909 During the anti - tuberculous therapy, Adverse-Effectvisual loss can be related to ethambutol toxicity or the tuberculosis infection itself.
Score Text
0.9936 Late development of diabetes mellitus after interferon - alfa and Drugribavirin therapy for chronic hepatitis C : a case report.
0.9932 Late development of Adverse-Effectdiabetes mellitus after interferon - alfa and ribavirin therapy for chronic hepatitis C : a case report.
0.9771 Late development of diabetes mellitus after Druginterferon - alfa and ribavirin therapy for chronic hepatitis C : a case report.
Score Text
0.9990 OBJECTIVES : To describe clinical and pathologic findings in patients noted to develop lower gastrointestinal symptoms when exposed to Drugrofecoxib .
0.9765 OBJECTIVES : To describe clinical and pathologic findings in patients noted to develop Adverse-Effectlower gastrointestinal symptoms when exposed to rofecoxib.
Score Text
0.9993 The probability of developing acute leukemia in this study was not significantly correlated to the total cumulative dosage of DrugTreosulfan .
0.9891 The probability of developing Adverse-Effectacute leukemia in this study was not significantly correlated to the total cumulative dosage of Treosulfan.
Score Text
0.9910 DrugCarboplatin hypersensitivity induced by low - dose paclitaxel / carboplatin in multiple platinum - treated patients with recurrent ovarian cancer.
0.9843 Carboplatin hypersensitivity induced by low - dose Drugpaclitaxel / carboplatin in multiple platinum - treated patients with recurrent ovarian cancer.
0.9819 Carboplatin hypersensitivity induced by low - dose paclitaxel / Drugcarboplatin in multiple platinum - treated patients with recurrent ovarian cancer.
0.8826 Carboplatin Adverse-Effecthypersensitivity induced by low - dose paclitaxel / carboplatin in multiple platinum - treated patients with recurrent ovarian cancer.
Score Text
0.9983 Elderly patients for whom Drugnitrate has been prescribed should be warned of the occurrence of hypotension, leading to unconsciousness.
0.9980 Elderly patients for whom nitrate has been prescribed should be warned of the occurrence of Adverse-Effecthypotension , leading to unconsciousness.
0.9979 Elderly patients for whom nitrate has been prescribed should be warned of the occurrence of hypotension, leading to Adverse-Effectunconsciousness .
Score Text
0.9994 DrugQuetiapine and obsessive - compulsive symptoms ( OCS ) : case report and review of atypical antipsychotic - induced OCS.
0.9931 Quetiapine and obsessive - compulsive symptoms ( Adverse-EffectOCS ) : case report and review of atypical antipsychotic - induced OCS.
0.9817 Quetiapine and Adverse-Effectobsessive - compulsive symptoms ( OCS ) : case report and review of atypical antipsychotic - induced OCS.
0.9588 Quetiapine and obsessive - compulsive symptoms ( OCS ) : case report and review of atypical antipsychotic - induced Adverse-EffectOCS .
Score Text
0.9991 Unintended exposure to Drugacyclovir early in pregnancy, which is not uncommon, may cause excessive maternal and physician anxiety.
0.8427 Unintended exposure to acyclovir early in pregnancy, which is not uncommon, may cause Adverse-Effectexcessive maternal and physician anxiety .
Score Text
0.9993 After the second Druginfliximab infusion, he was found to have a severe transient neutropenia ( 0. 5 x 10 ( 9 ) / L ).
0.9462 After the second infliximab infusion, he was found to have a Adverse-Effectsevere transient neutropenia ( 0. 5 x 10 ( 9 ) / L ).
Score Text
0.9873 INTERPRETATION : When high doses of fluticasone propionate are used, growth may be retarded and Adverse-Effectadrenal suppression may occur.
0.9787 INTERPRETATION : When high doses of Drugfluticasone propionate are used, growth may be retarded and adrenal suppression may occur.
0.9607 INTERPRETATION : When high doses of fluticasone propionate are used, Adverse-Effectgrowth may be retarded and adrenal suppression may occur.
Score Text
0.9809 OBJECTIVE : To report the first five cases of Drugamphotericin B overdose with secondary cardiac complications in a pediatric population.
0.9584 OBJECTIVE : To report the first five cases of amphotericin B overdose with secondary Adverse-Effectcardiac complications in a pediatric population.
Score Text
0.9991 Because Drugpsoralens sensitize skin to ultraviolet A light, phototoxic reactions are the most frequent adverse effect of this treatment.
0.9933 Because psoralens sensitize skin to ultraviolet A light, Adverse-Effectphototoxic reactions are the most frequent adverse effect of this treatment.
Score Text
0.9993 A unique case of a transient, nonpigmenting fixed drug eruption caused by the radiopaque contrast medium Drugiothalamate is reported.
0.8677 A unique case of a transient, nonpigmenting Adverse-Effectfixed drug eruption caused by the radiopaque contrast medium iothalamate is reported.
Score Text
0.9994 A case of Drughalothane induced hepatitis is reported in a middle aged woman who underwent gastric surgery for morbid obesity.
0.9979 A case of halothane induced Adverse-Effecthepatitis is reported in a middle aged woman who underwent gastric surgery for morbid obesity.
Score Text
0.9941 With the first cyclosporine dose, the patient complained of Adverse-Effectleg pain that was most severe during the cyclosporine infusion.
0.9852 With the first Drugcyclosporine dose, the patient complained of leg pain that was most severe during the cyclosporine infusion.
0.9837 With the first cyclosporine dose, the patient complained of leg pain that was most severe during the Drugcyclosporine infusion.
Score Text
0.9887 Colonic necrosis is known as a rare complication following the administration of DrugKayexalate ( sodium polystryrene sulfonate ) in sorbitol.
0.9865 Adverse-EffectColonic necrosis is known as a rare complication following the administration of Kayexalate ( sodium polystryrene sulfonate ) in sorbitol.
0.9527 Colonic necrosis is known as a rare complication following the administration of Kayexalate ( Drugsodium polystryrene sulfonate ) in sorbitol.
Score Text
0.9991 It is suggested therefore that Drugmethotrexate be added to the list of agents capable of inducing diffuse interstitial pulmonary fibrosis.
0.9738 It is suggested therefore that methotrexate be added to the list of agents capable of inducing Adverse-Effectdiffuse interstitial pulmonary fibrosis .
Score Text
0.9970 The renal insufficiency of three patients and the timing of the seizures implicate accumulation of Drugofloxacin as a contributing factor.
0.9945 The renal insufficiency of three patients and the timing of the Adverse-Effectseizures implicate accumulation of ofloxacin as a contributing factor.
0.9745 The Adverse-Effectrenal insufficiency of three patients and the timing of the seizures implicate accumulation of ofloxacin as a contributing factor.
Score Text
0.9994 Although an association between exposure to Drugbleomycin and the development of scleroderma has been suspected, few cases are reported.
0.9975 Although an association between exposure to bleomycin and the development of Adverse-Effectscleroderma has been suspected, few cases are reported.
Score Text
0.9994 The cause of death was determined to be acute intoxication by Drugolanzapine , and the manner of death was accidental.
0.9903 The cause of death was determined to be Adverse-Effectacute intoxication by olanzapine, and the manner of death was accidental.
Score Text
0.9990 We recommended periodic examination of the serum proteins in patients receiving Drugdiphenylhydantoin in order to detect development of monoclonal gammopathy.
0.9878 We recommended periodic examination of the serum proteins in patients receiving diphenylhydantoin in order to detect development of Adverse-Effectmonoclonal gammopathy .
Score Text
0.9967 Acute non - lymphocytic leukemia in patients with ovarian carcinoma following long - term treatment with DrugTreosulfan ( = dihydroxybusulfan ).
0.9951 Acute non - lymphocytic leukemia in patients with ovarian carcinoma following long - term treatment with Treosulfan ( = Drugdihydroxybusulfan ).
0.9683 Adverse-EffectAcute non - lymphocytic leukemia in patients with ovarian carcinoma following long - term treatment with Treosulfan ( = dihydroxybusulfan ).
Score Text
0.9995 In our patient, DIAN possibly was related to Drugcefuroxime , but the patient did not experience associated allergic symptoms.
0.9944 In our patient, Adverse-EffectDIAN possibly was related to cefuroxime, but the patient did not experience associated allergic symptoms.
Score Text
0.9995 CASES : Two postmenopausal women treated with Drugtamoxifen and progestational agents for breast carcinoma developed uterine enlargement and intermittent spotting.
0.9920 CASES : Two postmenopausal women treated with tamoxifen and progestational agents for breast carcinoma developed Adverse-Effectuterine enlargement and intermittent spotting.
0.9910 CASES : Two postmenopausal women treated with tamoxifen and progestational agents for breast carcinoma developed uterine enlargement and Adverse-Effectintermittent spotting .
Score Text
0.9984 As far as we know, this is the first case report of acute hemorrhagic gastritis associated with DrugAZ intoxication.
0.9843 As far as we know, this is the first case report of Adverse-Effectacute hemorrhagic gastritis associated with AZ intoxication.
0.5770 As far as we know, this is the first case report of acute hemorrhagic gastritis associated with Adverse-EffectAZ intoxication .
Score Text
0.9994 DrugRitonavir acted as a CYP3A4 inhibitor, diminishing carbamazepine metabolism and provoking an increase in serum levels and clinical toxicity.
0.9779 Ritonavir acted as a CYP3A4 inhibitor, Adverse-Effectdiminishing carbamazepine metabolism and provoking an increase in serum levels and clinical toxicity.
0.9769 Ritonavir acted as a CYP3A4 inhibitor, diminishing carbamazepine metabolism and provoking an Adverse-Effectincrease in serum levels and clinical toxicity.
0.6867 Ritonavir acted as a CYP3A4 inhibitor, diminishing carbamazepine metabolism and provoking an increase in serum levels and Adverse-Effectclinical toxicity .
Score Text
0.9781 Diagnosis of Adverse-Effectsclerosing glomerulonephritis occurred in this patient during anastrozole use, suggesting a newly defined side effect of anastrozole.
0.9345 Diagnosis of sclerosing glomerulonephritis occurred in this patient during Druganastrozole use, suggesting a newly defined side effect of anastrozole.
0.6437 Diagnosis of sclerosing glomerulonephritis occurred in this patient during anastrozole use, suggesting a newly defined side effect of Druganastrozole .
Score Text
0.9995 We report a patient who developed spontaneous splenic infarction after the use of Drugsumatriptan for the treatment of migraine headache.
0.9872 We report a patient who developed Adverse-Effectspontaneous splenic infarction after the use of sumatriptan for the treatment of migraine headache.
Score Text
0.9989 A potential role for renal and hepatic impairment in the observed protracted course of Drugamiodarone - induced thyrotoxicosis is suggested.
0.9964 A potential role for renal and hepatic impairment in the observed protracted course of amiodarone - induced Adverse-Effectthyrotoxicosis is suggested.
Score Text
0.9995 OBJECTIVE : To report a case of marked elevation of serum creatine kinase ( CK ) associated with Drugolanzapine therapy.
0.9769 OBJECTIVE : To report a case of marked Adverse-Effectelevation of serum creatine kinase ( CK ) associated with olanzapine therapy.
Score Text
0.9983 A 21 - year - old patient developed Adverse-Effectrhabdomyolysis during his nineteenth week of treatment with clozapine for drug - resistant schizophrenia.
0.9974 A 21 - year - old patient developed rhabdomyolysis during his nineteenth week of treatment with Drugclozapine for drug - resistant schizophrenia.
Score Text
0.9994 We report the first case of acute renal failure with hyperkalemia associated with the recently marketed direct renin inhibitor Drugaliskiren .
0.9935 We report the first case of acute renal failure with Adverse-Effecthyperkalemia associated with the recently marketed direct renin inhibitor aliskiren.
0.9781 We report the first case of Adverse-Effectacute renal failure with hyperkalemia associated with the recently marketed direct renin inhibitor aliskiren.
Score Text
0.9760 A case is reported of theophylline intoxication due to a dramatic decrease in theophylline clearance following concomitant administration of Drugviloxazine .
0.9503 A case is reported of Drugtheophylline intoxication due to a dramatic decrease in theophylline clearance following concomitant administration of viloxazine.
0.8408 A case is reported of Adverse-Effecttheophylline intoxication due to a dramatic decrease in theophylline clearance following concomitant administration of viloxazine.
0.8555 A case is reported of theophylline intoxication due to a dramatic decrease in Drugtheophylline clearance following concomitant administration of viloxazine.
A case is reported of theophylline intoxication due to a dramatic Adverse-Effectdecrease in theophylline clearance following concomitant administration of viloxazine.
Score Text
0.9852 Postoperative hypocalcemic tetany caused by fleet phospho - soda preparation in a patient taking Drugalendronate sodium : report of a case.
0.9821 Postoperative Adverse-Effecthypocalcemic tetany caused by fleet phospho - soda preparation in a patient taking alendronate sodium : report of a case.
0.9598 Postoperative hypocalcemic tetany caused by Drugfleet phospho - soda preparation in a patient taking alendronate sodium : report of a case.
Score Text
0.9987 The patient expired after seven cycles of treatment had been completed because of pulmonary fibrosis and the drug toxicity of Drugbleomycin .
0.9848 The patient expired after seven cycles of treatment had been completed because of Adverse-Effectpulmonary fibrosis and the drug toxicity of bleomycin.
Score Text
0.9993 Thus, we confirm that desensitization may be a safe procedure in patients with cancer who experience Drugmethotrexate - induced anaphylaxis.
0.9979 Thus, we confirm that desensitization may be a safe procedure in patients with cancer who experience methotrexate - induced Adverse-Effectanaphylaxis .
Score Text
0.9990 A 10 - year - old girl with Lennox - Gastaut syndrome who received intravenous Druglorazepam for atypical absence status seizures is reported.
0.9919 A 10 - year - old girl with Lennox - Gastaut syndrome who received intravenous lorazepam for atypical absence status Adverse-Effectseizures is reported.
Score Text
0.9944 The induction of Adverse-Effecthypoglycaemia with PAS in this patient suggests a potential role for PAS in the treatment of diabetes mellitus.
0.9389 The induction of hypoglycaemia with DrugPAS in this patient suggests a potential role for PAS in the treatment of diabetes mellitus.
0.5010 The induction of hypoglycaemia with PAS in this patient suggests a potential role for DrugPAS in the treatment of diabetes mellitus.
Score Text
0.9990 In two patients, Drugapomorphine remained effective in the morning, but increased the intensity of the dyskinesias in the afternoon.
0.9930 In two patients, apomorphine remained effective in the morning, but increased the intensity of the Adverse-Effectdyskinesias in the afternoon.
Score Text
0.9993 The visual loss in this patient seems to result from Drugphenol neurotoxicity rather than mechanical compression of the intraorbital optic nerve.
0.9892 The Adverse-Effectvisual loss in this patient seems to result from phenol neurotoxicity rather than mechanical compression of the intraorbital optic nerve.
0.9045 The visual loss in this patient seems to result from phenol Adverse-Effectneurotoxicity rather than mechanical compression of the intraorbital optic nerve.
Score Text
0.9996 Here we describe another case of VOD occurring after LT, but in which the causative role was played by Drugazathioprine .
0.9986 Here we describe another case of Adverse-EffectVOD occurring after LT, but in which the causative role was played by azathioprine.
Score Text
0.9978 OBJECTIVE : To report the safe use of fluorouracil in a patient with breast cancer who had allergic reactions to Drugcapecitabine .
0.9878 OBJECTIVE : To report the safe use of fluorouracil in a patient with breast cancer who had Adverse-Effectallergic reactions to capecitabine.
Score Text
0.9973 METHODS : The patient required insulin desensitization for severe urticaria, Adverse-Effectangioedema , and occasional wheezing resulting from her insulin dose.
0.9963 METHODS : The patient required insulin desensitization for severe urticaria, angioedema, and occasional Adverse-Effectwheezing resulting from her insulin dose.
0.9943 METHODS : The patient required Druginsulin desensitization for severe urticaria, angioedema, and occasional wheezing resulting from her insulin dose.
0.9941 METHODS : The patient required insulin desensitization for severe urticaria, angioedema, and occasional wheezing resulting from her Druginsulin dose.
0.9902 METHODS : The patient required insulin desensitization for Adverse-Effectsevere urticaria , angioedema, and occasional wheezing resulting from her insulin dose.
Score Text
0.9978 Adverse-EffectArrhythmias and cardiac arrest have been reported during amphotericin B administration but no effective technique has been described to prevent them.
0.9945 Arrhythmias and Adverse-Effectcardiac arrest have been reported during amphotericin B administration but no effective technique has been described to prevent them.
0.9811 Arrhythmias and cardiac arrest have been reported during Drugamphotericin B administration but no effective technique has been described to prevent them.
Score Text
0.9931 We describe the first case of de novo asthma following treatment with the angiotensin converting enzyme ( ACE ) inhibitor Drugcaptopril .
0.9873 We describe the first case of de novo Adverse-Effectasthma following treatment with the angiotensin converting enzyme ( ACE ) inhibitor captopril.
Score Text
0.9968 We report two new cases of Adverse-Effectsarcoidosis in two patients with hepatitis C virus infection treated with interferon alfa and ribavirin.
0.9956 We report two new cases of sarcoidosis in two patients with hepatitis C virus infection treated with interferon alfa and Drugribavirin .
0.9891 We report two new cases of sarcoidosis in two patients with hepatitis C virus infection treated with Druginterferon alfa and ribavirin.
Score Text
0.9992 BACKGROUND : DrugMethotrexate ( MTX ) may induce liver damage, which in some psoriatics will lead to fibrosis or cirrhosis.
0.9986 BACKGROUND : Methotrexate ( DrugMTX ) may induce liver damage, which in some psoriatics will lead to fibrosis or cirrhosis.
0.9985 BACKGROUND : Methotrexate ( MTX ) may induce liver damage, which in some psoriatics will lead to fibrosis or Adverse-Effectcirrhosis .
0.9983 BACKGROUND : Methotrexate ( MTX ) may induce liver damage, which in some psoriatics will lead to Adverse-Effectfibrosis or cirrhosis.
0.9900 BACKGROUND : Methotrexate ( MTX ) may induce Adverse-Effectliver damage , which in some psoriatics will lead to fibrosis or cirrhosis.
Score Text
0.9994 Inhaled Drugtobramycin solution - associated recurrent eosinophilia and severe persistent bronchospasm in a patient with cystic fibrosis : a case report.
0.9836 Inhaled tobramycin solution - associated recurrent eosinophilia and Adverse-Effectsevere persistent bronchospasm in a patient with cystic fibrosis : a case report.
0.9753 Inhaled tobramycin solution - associated Adverse-Effectrecurrent eosinophilia and severe persistent bronchospasm in a patient with cystic fibrosis : a case report.
Score Text
0.9985 Within 3 weeks of beginning continuous daily Drugisoniazid and rifampin therapy for pulmonary tuberculosis, a patient developed acute renal failure.
0.9984 Within 3 weeks of beginning continuous daily isoniazid and Drugrifampin therapy for pulmonary tuberculosis, a patient developed acute renal failure.
0.9886 Within 3 weeks of beginning continuous daily isoniazid and rifampin therapy for pulmonary tuberculosis, a patient developed Adverse-Effectacute renal failure .
Score Text
0.9907 Patient B developed perioral and upper extremity paresthesias during the fourth cycle of DrugCAP alone ( 2500 mg / m2 ).
0.9808 Patient B developed Adverse-Effectperioral and upper extremity paresthesias during the fourth cycle of CAP alone ( 2500 mg / m2 ).
Score Text
0.9995 Moreover, these findings suggest that the incidence of BOOP following Drugrituximab therapy may be higher than has been previously appreciated.
0.9987 Moreover, these findings suggest that the incidence of Adverse-EffectBOOP following rituximab therapy may be higher than has been previously appreciated.
Score Text
0.9993 This compound, used by adults in the child's home, had caused accidental Drugtheophylline poisoning, mimicking diabetic ketoacidosis.
0.8118 This compound, used by adults in the child's home, had caused accidental Adverse-Effecttheophylline poisoning , mimicking diabetic ketoacidosis.
Score Text
0.9994 Up to four percent of patients treated with Drugimatinib may develop hepatotoxicity, which usually resolves with discontinuation of the drug.
0.9978 Up to four percent of patients treated with imatinib may develop Adverse-Effecthepatotoxicity , which usually resolves with discontinuation of the drug.
Score Text
0.9983 L - Thyroxine - induced Adverse-Effectleukopenia in a patient with Hashimoto's disease : involvement of suppressor - cytotoxic T cells.
0.9739 DrugL - Thyroxine - induced leukopenia in a patient with Hashimoto's disease : involvement of suppressor - cytotoxic T cells.
Score Text
0.9965 Methotrexate - induced Adverse-Effectleukoencephalopathy is treatable with high - dose folinic acid : a case report and analysis of the literature.
0.9964 DrugMethotrexate - induced leukoencephalopathy is treatable with high - dose folinic acid : a case report and analysis of the literature.
Score Text
0.9995 We report a case of hyperpigmentation due to Drugbleomycin treatment in a patient with acquired immune deficiency syndrome ( AIDS ).
0.9960 We report a case of Adverse-Effecthyperpigmentation due to bleomycin treatment in a patient with acquired immune deficiency syndrome ( AIDS ).
Score Text
0.9995 Although Drugfluoxetine - induced headache occurred in one patient, the other five reported no side effects at the doses used.
0.9989 Although fluoxetine - induced Adverse-Effectheadache occurred in one patient, the other five reported no side effects at the doses used.
Score Text
0.9994 DrugRifampin can be associated with severe adverse effects such as hepatitis, acute renal failure, hemolytic anemia, and thrombocytopenia.
0.9983 Rifampin can be associated with severe adverse effects such as Adverse-Effecthepatitis , acute renal failure, hemolytic anemia, and thrombocytopenia.
0.9975 Rifampin can be associated with severe adverse effects such as hepatitis, acute renal failure, hemolytic anemia, and Adverse-Effectthrombocytopenia .
0.9921 Rifampin can be associated with severe adverse effects such as hepatitis, acute renal failure, Adverse-Effecthemolytic anemia , and thrombocytopenia.
0.9858 Rifampin can be associated with severe adverse effects such as hepatitis, Adverse-Effectacute renal failure , hemolytic anemia, and thrombocytopenia.
Score Text
0.9996 To date, eight cases of TEN and one of SJS related to Druglamotrigine administration have been reported in the literature.
0.9987 To date, eight cases of Adverse-EffectTEN and one of SJS related to lamotrigine administration have been reported in the literature.
0.9966 To date, eight cases of TEN and one of Adverse-EffectSJS related to lamotrigine administration have been reported in the literature.
Score Text
0.9993 DISCUSSION : Patients with Drug5 - FU - induced ectropion experience tender, red, scaled lids, making contact lens wear difficult.
0.9976 DISCUSSION : Patients with 5 - FU - induced Adverse-Effectectropion experience tender, red, scaled lids, making contact lens wear difficult.
0.9333 DISCUSSION : Patients with 5 - FU - induced ectropion experience Adverse-Effecttender, red, scaled lids , making contact lens wear difficult.
Score Text
0.9993 We present the case of a 5 - year - old girl who developed bilateral vocal cord paralysis following preoperative peritonsillar Drugbupivacaine infiltration.
0.9879 We present the case of a 5 - year - old girl who developed Adverse-Effectbilateral vocal cord paralysis following preoperative peritonsillar bupivacaine infiltration.
Score Text
0.9968 It remains to be seen whether the Adverse-Effecthepatotoxicity associated with troglitazone is a drug - class effect or specific to troglitazone.
0.9760 It remains to be seen whether the hepatotoxicity associated with Drugtroglitazone is a drug - class effect or specific to troglitazone.
0.9500 It remains to be seen whether the hepatotoxicity associated with troglitazone is a drug - class effect or specific to Drugtroglitazone .
Score Text
0.9993 Severe hepatotoxicity from Drugphenobarbital occurred in an infant boy who had a complicated illness with chronic bilateral subdural hematomas and sepsis.
0.9583 Adverse-EffectSevere hepatotoxicity from phenobarbital occurred in an infant boy who had a complicated illness with chronic bilateral subdural hematomas and sepsis.
Score Text
0.9995 To the best of our knowledge, this is the first case of Druglithium - associated CDI and NDI presenting concurrently.
0.9984 To the best of our knowledge, this is the first case of lithium - associated Adverse-EffectCDI and NDI presenting concurrently.
0.9976 To the best of our knowledge, this is the first case of lithium - associated CDI and Adverse-EffectNDI presenting concurrently.
Score Text
0.9992 OBJECTIVE : To report the finding of squamous metaplasia within endometrial glands occurring as a result of Drugprogestin therapy of hyperplasia.
0.9777 OBJECTIVE : To report the finding of Adverse-Effectsquamous metaplasia within endometrial glands occurring as a result of progestin therapy of hyperplasia.
OBJECTIVE : To report the finding of Adverse-Effectsquamous metaplasia within endometrial glands occurring as a result of progestin therapy of hyperplasia.
Score Text
0.9962 It was concluded that potassium loss occurred by a non - renal ( intestinal ) route in Drugphosphate - induced hypokalemia.
0.9932 It was concluded that potassium loss occurred by a non - renal ( intestinal ) route in phosphate - induced Adverse-Effecthypokalemia .
0.9851 It was concluded that Adverse-Effectpotassium loss occurred by a non - renal ( intestinal ) route in phosphate - induced hypokalemia.
Score Text
0.9712 CONCLUSION : Significant ocular complications such as an irreversible decrease of visual acuity may develop in patients treated with Drugpegylated interferon .
0.9692 CONCLUSION : Significant Adverse-Effectocular complications such as an irreversible decrease of visual acuity may develop in patients treated with pegylated interferon.
0.5947 CONCLUSION : Significant ocular complications such as an Adverse-Effectirreversible decrease of visual acuity may develop in patients treated with pegylated interferon.
0.8878 CONCLUSION : Significant ocular complications such as an irreversible Adverse-Effectdecrease of visual acuity may develop in patients treated with pegylated interferon.
Score Text
0.9822 CD4 T - lymphocyte depletion, myelosuppression, and subsequent severe infections are the major side effects of Drugfludarabine phosphate therapy.
0.9783 CD4 T - lymphocyte depletion, Adverse-Effectmyelosuppression , and subsequent severe infections are the major side effects of fludarabine phosphate therapy.
0.9732 Adverse-EffectCD4 T - lymphocyte depletion , myelosuppression, and subsequent severe infections are the major side effects of fludarabine phosphate therapy.
0.9681 CD4 T - lymphocyte depletion, myelosuppression, and subsequent Adverse-Effectsevere infections are the major side effects of fludarabine phosphate therapy.
Score Text
0.9995 METHODS : Repeated blood samples were drawn in a patient with severe Drugacyclovir overdose who developed coma and nonoliguric renal failure.
0.9910 METHODS : Repeated blood samples were drawn in a patient with severe acyclovir overdose who developed Adverse-Effectcoma and nonoliguric renal failure.
0.9904 METHODS : Repeated blood samples were drawn in a patient with severe acyclovir overdose who developed coma and Adverse-Effectnonoliguric renal failure .
Score Text
0.9989 CONCLUSION : This is, to our knowledge, the first report of severe myelopathy following accidental intrathecal administration of Drugdoxorubicin .
0.9821 CONCLUSION : This is, to our knowledge, the first report of Adverse-Effectsevere myelopathy following accidental intrathecal administration of doxorubicin.
Score Text
0.9993 We report the case of a man, treated with Drugmesalazine for Crohn's disease who developed drug - induced pericarditis.
0.9984 We report the case of a man, treated with mesalazine for Crohn's disease who developed drug - induced Adverse-Effectpericarditis .
Score Text
0.9891 The authors presented a case of Adverse-Effectpulmonary hypertension during lithium therapy, while she has been on lithium for 6 years.
0.9685 The authors presented a case of pulmonary hypertension during Druglithium therapy, while she has been on lithium for 6 years.
0.6043 The authors presented a case of pulmonary hypertension during lithium therapy, while she has been on Druglithium for 6 years.
Score Text
0.9991 Following the institution of intravenous therapy with Drugacyclovir , the patient developed fever, hemoptysis, and a pleural friction rub.
0.9987 Following the institution of intravenous therapy with acyclovir, the patient developed fever, Adverse-Effecthemoptysis , and a pleural friction rub.
0.9908 Following the institution of intravenous therapy with acyclovir, the patient developed Adverse-Effectfever , hemoptysis, and a pleural friction rub.
0.9898 Following the institution of intravenous therapy with acyclovir, the patient developed fever, hemoptysis, and a Adverse-Effectpleural friction rub .
Score Text
0.9987 We report 3 cases of children with acute lymphoblastic leukemia who developed Adverse-Effectseizures and altered sensorium after L - asparaginase therapy.
0.9917 We report 3 cases of children with acute lymphoblastic leukemia who developed seizures and Adverse-Effectaltered sensorium after L - asparaginase therapy.
0.9770 We report 3 cases of children with acute lymphoblastic leukemia who developed seizures and altered sensorium after DrugL - asparaginase therapy.
Score Text
0.9996 CONCLUSION : There are only a few confirmed cases of Druggemcitabine - associated HUS despite the widespread use of the drug.
0.9982 CONCLUSION : There are only a few confirmed cases of gemcitabine - associated Adverse-EffectHUS despite the widespread use of the drug.
Score Text
0.9989 We report a case of acute generalized exanthematous pustulosis ( AGEP ) induced by Drugsalazosulfapyridine in a patient with ulcerative colitis.
0.9799 We report a case of Adverse-Effectacute generalized exanthematous pustulosis ( AGEP ) induced by salazosulfapyridine in a patient with ulcerative colitis.
0.9879 We report a case of acute generalized exanthematous pustulosis ( Adverse-EffectAGEP ) induced by salazosulfapyridine in a patient with ulcerative colitis.
Score Text
0.9991 We presented a patient with status asthmaticus treated with a combination of Drugtheophylline and prednisone who developed a perforated gastric ulcer.
0.9990 We presented a patient with status asthmaticus treated with a combination of theophylline and Drugprednisone who developed a perforated gastric ulcer.
0.9800 We presented a patient with status asthmaticus treated with a combination of theophylline and prednisone who developed a Adverse-Effectperforated gastric ulcer .
Score Text
0.9993 The patient described feeling cold with worsening headache and chills approximately one hour after infusion of the first dose of Drugpenicillin .
0.9971 The patient described feeling cold with worsening headache and Adverse-Effectchills approximately one hour after infusion of the first dose of penicillin.
0.9935 The patient described Adverse-Effectfeeling cold with worsening headache and chills approximately one hour after infusion of the first dose of penicillin.
0.9850 The patient described feeling cold with Adverse-Effectworsening headache and chills approximately one hour after infusion of the first dose of penicillin.
Score Text
0.9989 The capacity of Drugzuclopenthixol to induce priapism is thought to be due to its antagonist activity on alpha - adrenergic receptors.
0.9976 The capacity of zuclopenthixol to induce Adverse-Effectpriapism is thought to be due to its antagonist activity on alpha - adrenergic receptors.
Score Text
0.9993 After discontinuing Drugcaptopril and starting systemic steroids, her symptomatology rapidly improved, and her eosinophilia and radiographic abnormalities both resolved.
0.9923 After discontinuing captopril and starting systemic steroids, her symptomatology rapidly improved, and her Adverse-Effecteosinophilia and radiographic abnormalities both resolved.
0.9644 After discontinuing captopril and starting systemic steroids, her symptomatology rapidly improved, and her eosinophilia and Adverse-Effectradiographic abnormalities both resolved.
Score Text
0.9995 We report a 13 year - old male who developed life - threatening anaphylaxis early in the course of DrugIncrelex therapy.
0.9931 We report a 13 year - old male who developed life - threatening Adverse-Effectanaphylaxis early in the course of Increlex therapy.
Score Text
0.9994 PURPOSE : To report patients who presented to the oculoplastics department for repair of cicatrical entropion after topical use of Drugdipivefrin .
0.9902 PURPOSE : To report patients who presented to the oculoplastics department for repair of Adverse-Effectcicatrical entropion after topical use of dipivefrin.
Score Text
0.9984 CONCLUSION : Long - term treatment with Drugrifabutin may have a reversible and previously undescribed side - effect on retinal function.
CONCLUSION : Long - term treatment with rifabutin may have a reversible and previously undescribed Adverse-Effectside - effect on retinal function .
Score Text
0.9992 OBJECTIVE : DrugClozapine causes few extrapyramidal symptoms and is recommended as a treatment drug for severe tardive dyskinesia ( TD ).
0.9886 OBJECTIVE : Clozapine causes few Adverse-Effectextrapyramidal symptoms and is recommended as a treatment drug for severe tardive dyskinesia ( TD ).
Score Text
0.9995 We report the case of a 27 - year - old Indian woman who developed maculopapular rash and angioedema secondary to Drugcarbamazepine administration.
0.9970 We report the case of a 27 - year - old Indian woman who developed maculopapular rash and Adverse-Effectangioedema secondary to carbamazepine administration.
0.9929 We report the case of a 27 - year - old Indian woman who developed Adverse-Effectmaculopapular rash and angioedema secondary to carbamazepine administration.
Score Text
0.9987 The present study describes a patient who had unusual weight fluctuation under corticosteroid and psychotropic treatment such as mianserin and Drugaripiprazole .
0.9980 The present study describes a patient who had unusual weight fluctuation under corticosteroid and psychotropic treatment such as Drugmianserin and aripiprazole.
0.9847 The present study describes a patient who had Adverse-Effectunusual weight fluctuation under corticosteroid and psychotropic treatment such as mianserin and aripiprazole.
Score Text
0.9988 We report a patient who developed Drugheparin associated thrombocytopenia during continuous arteriovenous haemofiltration and discuss its implications and alternative anticoagulant treatment.
0.9972 We report a patient who developed heparin associated Adverse-Effectthrombocytopenia during continuous arteriovenous haemofiltration and discuss its implications and alternative anticoagulant treatment.
Score Text
0.9994 The case of an adult who developed both hepatic dysfunction and an impaired macrophage migration after exposure to Drugcimetidine is discussed.
0.9853 The case of an adult who developed both Adverse-Effecthepatic dysfunction and an impaired macrophage migration after exposure to cimetidine is discussed.
0.9725 The case of an adult who developed both hepatic dysfunction and an Adverse-Effectimpaired macrophage migration after exposure to cimetidine is discussed.
Score Text
0.9992 DrugIbuprofen rarely causes lower gastrointestinal adverse reactions but has been implicated in systemic and local side effects in patients with lupus.
0.7419 Ibuprofen rarely causes lower Adverse-Effectgastrointestinal adverse reactions but has been implicated in systemic and local side effects in patients with lupus.
0.8398 Ibuprofen rarely causes Adverse-Effectlower gastrointestinal adverse reactions but has been implicated in systemic and local side effects in patients with lupus.
Score Text
0.9996 Presently, treatment of acute Drugibuprofen intoxication with complications requires supportive therapy until the symptoms resolve over 24 to 48 hours.
0.8918 Presently, treatment of acute Adverse-Effectibuprofen intoxication with complications requires supportive therapy until the symptoms resolve over 24 to 48 hours.
Score Text
0.9994 The international literature regarding opportunistic infections after immunosuppressive therapy with Drugalemtuzumab with particular attention on fungal infections has also been reviewed.
0.9907 The international literature regarding opportunistic infections after immunosuppressive therapy with alemtuzumab with particular attention on Adverse-Effectfungal infections has also been reviewed.
0.8817 The international literature regarding Adverse-Effectopportunistic infections after immunosuppressive therapy with alemtuzumab with particular attention on fungal infections has also been reviewed.
Score Text
0.9995 Investigation confirmed the diagnosis of rhabdomyolysis, and discontinuation of Drugcolchicine resulted in resolution of clinical and biochemical features of rhabdomylysis.
0.9946 Investigation confirmed the diagnosis of rhabdomyolysis, and discontinuation of colchicine resulted in resolution of clinical and biochemical features of Adverse-Effectrhabdomylysis .
Score Text
0.9994 We describe a 15 - year - old female patient diagnosed with acute lymphoblastic leukemia presenting with status epilepticus after receiving intrathecal Drugmethotrexate .
0.9477 We describe a 15 - year - old female patient diagnosed with Adverse-Effectacute lymphoblastic leukemia presenting with status epilepticus after receiving intrathecal methotrexate.
Score Text
0.9994 The mechanism by which Drugsunitinib induces gynaecomastia is thought to be associated with an unknown direct action on breast hormonal receptors.
0.9975 The mechanism by which sunitinib induces Adverse-Effectgynaecomastia is thought to be associated with an unknown direct action on breast hormonal receptors.
Score Text
0.9996 In the following case report, a patient developed acute interstitial nephritis with renal failure and exfoliative dermatitis following Drugampicillin therapy.
0.9899 In the following case report, a patient developed acute interstitial nephritis with renal failure and Adverse-Effectexfoliative dermatitis following ampicillin therapy.
0.9890 In the following case report, a patient developed acute interstitial nephritis with Adverse-Effectrenal failure and exfoliative dermatitis following ampicillin therapy.
0.9862 In the following case report, a patient developed Adverse-Effectacute interstitial nephritis with renal failure and exfoliative dermatitis following ampicillin therapy.
Score Text
0.9990 We describe two dark - skinned patients who developed hyperpigmented skin and tongue lesions during combination therapy with IFN and Drugribavirin .
0.9986 We describe two dark - skinned patients who developed hyperpigmented skin and tongue lesions during combination therapy with DrugIFN and ribavirin.
0.9903 We describe two dark - skinned patients who developed Adverse-Effecthyperpigmented skin and tongue lesions during combination therapy with IFN and ribavirin.
0.9893 We describe two dark - skinned patients who developed hyperpigmented skin and Adverse-Effecttongue lesions during combination therapy with IFN and ribavirin.
Score Text
0.9996 OBJECTIVE : To report a case of Drugcolchicine - induced myopathy in a teenager with familial Mediterranean fever ( FMF ).
0.9985 OBJECTIVE : To report a case of colchicine - induced Adverse-Effectmyopathy in a teenager with familial Mediterranean fever ( FMF ).
Score Text
0.9993 A case of basilar invagination which is thought to have arisen from the patient's intrauterine exposure to Drugphenytoin is presented.
0.9908 A case of Adverse-Effectbasilar invagination which is thought to have arisen from the patient's intrauterine exposure to phenytoin is presented.
Score Text
0.9824 Interferon - alpha - induced Adverse-Effectfocal segmental glomerulosclerosis in chronic myelogenous leukemia : a case report and review of the literature.
0.9665 DrugInterferon - alpha - induced focal segmental glomerulosclerosis in chronic myelogenous leukemia : a case report and review of the literature.
Score Text
0.9992 We describe rupture of a cerebral arterial aneurysm in a 32 year old hypertensive woman following the introduction of Drugnifedipine treatment.
0.9785 We describe Adverse-Effectrupture of a cerebral arterial aneurysm in a 32 year old hypertensive woman following the introduction of nifedipine treatment.
Score Text
0.9988 Presentation of three palliative care patients who were given Drugketamine as an analgesic and subsequently developed significant and debilitating urological symptoms.
0.9918 Presentation of three palliative care patients who were given ketamine as an analgesic and subsequently developed significant and debilitating Adverse-Effecturological symptoms .
Score Text
0.9994 A patient with the Wolff - Parkinson - White syndrome presented with incessant orthodromic atrioventricular tachycardia following initiation of Drugprocainamide therapy.
0.9612 A patient with the Wolff - Parkinson - White syndrome presented with Adverse-Effectincessant orthodromic atrioventricular tachycardia following initiation of procainamide therapy.
Score Text
0.9995 OBJECTIVE : To report a case of linear immunoglobulin ( Ig ) A bullous dermatosis ( LABD ) induced by Druggemcitabine .
0.9879 OBJECTIVE : To report a case of linear immunoglobulin ( Ig ) A bullous dermatosis ( Adverse-EffectLABD ) induced by gemcitabine.
0.9448 OBJECTIVE : To report a case of Adverse-Effectlinear immunoglobulin ( Ig ) A bullous dermatosis ( LABD ) induced by gemcitabine.
Score Text
0.9991 The Naranjo probability scale indicated a probable relationship between apnea and exposure to Druglamotrigine through breast - feeding in this infant.
0.9973 The Naranjo probability scale indicated a probable relationship between Adverse-Effectapnea and exposure to lamotrigine through breast - feeding in this infant.
Score Text
0.9995 In patients with Drugmethotrexate - induced anaphylaxis, discontinuation of treatment may increase the risk of death due to cancer progression.
0.9983 In patients with methotrexate - induced Adverse-Effectanaphylaxis , discontinuation of treatment may increase the risk of death due to cancer progression.
0.6594 In patients with methotrexate - induced anaphylaxis, discontinuation of treatment may increase the risk of Adverse-Effectdeath due to cancer progression.
Score Text
0.9956 On the fifth day of tocolysis with magnesium sulfate, Drugnifedipine , terbutaline and betamethasone, edema developed in both labia.
0.9941 On the fifth day of tocolysis with magnesium sulfate, nifedipine, terbutaline and betamethasone, Adverse-Effectedema developed in both labia.
0.9937 On the fifth day of tocolysis with magnesium sulfate, nifedipine, Drugterbutaline and betamethasone, edema developed in both labia.
0.9920 On the fifth day of tocolysis with magnesium sulfate, nifedipine, terbutaline and Drugbetamethasone , edema developed in both labia.
0.9865 On the fifth day of tocolysis with Drugmagnesium sulfate , nifedipine, terbutaline and betamethasone, edema developed in both labia.
Score Text
0.9985 We report a case of Adverse-Effectseizure associated with L - asparaginase therapy but no evidence of hemorrhagic or thrombotic cerebrovascular events.
0.9732 We report a case of seizure associated with DrugL - asparaginase therapy but no evidence of hemorrhagic or thrombotic cerebrovascular events.
Score Text
0.9992 A 28 year old white schizophrenic male has been under Drugrisperidone monotherapy for about one year when he developed dyskinetic movements.
0.9925 A 28 year old white schizophrenic male has been under risperidone monotherapy for about one year when he developed Adverse-Effectdyskinetic movements .
Score Text
0.9889 The second patient, who developed cholestasis after receiving trimethoprim - sulfamethoxazole, had marked Adverse-Effectduct paucity in the liver biopsy.
0.9859 The second patient, who developed Adverse-Effectcholestasis after receiving trimethoprim - sulfamethoxazole, had marked duct paucity in the liver biopsy.
The second patient, who developed cholestasis after receiving Drugtrimethoprim - sulfamethoxazole , had marked duct paucity in the liver biopsy.
Score Text
0.9995 DrugTiclopidine - induced aplastic anemia : two new case reports, review, and meta - analysis of 55 additional cases.
0.9931 Ticlopidine - induced Adverse-Effectaplastic anemia : two new case reports, review, and meta - analysis of 55 additional cases.
Score Text
0.9982 Fulminant hepatic failure developed in a 24 - year - old black woman who had been treated with Drugpropylthiouracil and propranolol for hyperthyroidism.
0.9975 Fulminant hepatic failure developed in a 24 - year - old black woman who had been treated with propylthiouracil and Drugpropranolol for hyperthyroidism.
0.9872 Adverse-EffectFulminant hepatic failure developed in a 24 - year - old black woman who had been treated with propylthiouracil and propranolol for hyperthyroidism.
Score Text
0.9994 Children receiving Drugzonisamide should be monitored for oligohidrosis and the development of neurological symptoms associated with an elevation of body temperature.
0.9952 Children receiving zonisamide should be monitored for Adverse-Effectoligohidrosis and the development of neurological symptoms associated with an elevation of body temperature.
0.9865 Children receiving zonisamide should be monitored for oligohidrosis and the development of Adverse-Effectneurological symptoms associated with an elevation of body temperature.
Score Text
0.9995 A 72 - year - old woman with a history of thyrotoxicosis presented with sore throat and fever two weeks after starting Drugcarbimazole .
0.9913 A 72 - year - old woman with a history of thyrotoxicosis presented with Adverse-Effectsore throat and fever two weeks after starting carbimazole.
0.9885 A 72 - year - old woman with a history of thyrotoxicosis presented with sore throat and Adverse-Effectfever two weeks after starting carbimazole.
Score Text
0.9989 Soon after introduction of Druginsulin therapy, she developed severe anasarca, including marked peripheral oedema, ascites and pleural effusion.
0.9969 Soon after introduction of insulin therapy, she developed severe anasarca, including marked peripheral oedema, Adverse-Effectascites and pleural effusion.
0.9909 Soon after introduction of insulin therapy, she developed severe anasarca, including marked peripheral oedema, ascites and Adverse-Effectpleural effusion .
0.9892 Soon after introduction of insulin therapy, she developed severe anasarca, including marked Adverse-Effectperipheral oedema , ascites and pleural effusion.
0.9831 Soon after introduction of insulin therapy, she developed Adverse-Effectsevere anasarca , including marked peripheral oedema, ascites and pleural effusion.
Score Text
0.9992 DrugNiacin causes a reversible toxic cystoid maculopathy that occurs in approximately 0. 67 % of patients taking high doses of the drug.
0.9728 Niacin causes a Adverse-Effectreversible toxic cystoid maculopathy that occurs in approximately 0. 67 % of patients taking high doses of the drug.
Score Text
0.9987 After the addition of Drugcitalopram , a desmethylclomipramine plasma level increase and an 8 - hydroacy - desmethylclomipramine plasma level decrease were observed.
0.9852 After the addition of citalopram, a Adverse-Effectdesmethylclomipramine plasma level increase and an 8 - hydroacy - desmethylclomipramine plasma level decrease were observed.
0.9752 After the addition of citalopram, a desmethylclomipramine plasma level increase and an Adverse-Effect8 - hydroacy - desmethylclomipramine plasma level decrease were observed.
Score Text
0.9995 An 8 - year - old child with familial Mediterranean fever exhibited signs of Drugcolchicine intoxication while receiving prophylactic doses of the drug.
0.9266 An 8 - year - old child with familial Mediterranean fever exhibited signs of Adverse-Effectcolchicine intoxication while receiving prophylactic doses of the drug.
Score Text
0.9971 Two patients treated with 5 - fluorouracil ( 5 - FU ) for disseminated adenocarcinoma of the colon developed cerebellar dysfunction typical of Drug5 - FU neurotoxicity.
0.9969 Two patients treated with Drug5 - fluorouracil ( 5 - FU ) for disseminated adenocarcinoma of the colon developed cerebellar dysfunction typical of 5 - FU neurotoxicity.
0.9965 Two patients treated with 5 - fluorouracil ( Drug5 - FU ) for disseminated adenocarcinoma of the colon developed cerebellar dysfunction typical of 5 - FU neurotoxicity.
0.9891 Two patients treated with 5 - fluorouracil ( 5 - FU ) for disseminated adenocarcinoma of the colon developed Adverse-Effectcerebellar dysfunction typical of 5 - FU neurotoxicity.
0.9544 Two patients treated with 5 - fluorouracil ( 5 - FU ) for disseminated adenocarcinoma of the colon developed cerebellar dysfunction typical of 5 - FU Adverse-Effectneurotoxicity .
Score Text
0.9985 We describe the first documented case of Drugazathioprine - induced severe myelosuppression due to thiopurine methyltransferase deficiency in autoimmune liver disease.
0.5549 We describe the first documented case of azathioprine - induced severe Adverse-Effectmyelosuppression due to thiopurine methyltransferase deficiency in autoimmune liver disease.
0.9742 We describe the first documented case of azathioprine - induced Adverse-Effectsevere myelosuppression due to thiopurine methyltransferase deficiency in autoimmune liver disease.
Score Text
0.9995 We recommend that clinicians monitor patients for signs and symptoms of pancreatitis, including abdominal pain, during treatment with Drugtigecycline .
0.9958 We recommend that clinicians monitor patients for signs and symptoms of pancreatitis, including Adverse-Effectabdominal pain , during treatment with tigecycline.
0.9953 We recommend that clinicians monitor patients for signs and symptoms of Adverse-Effectpancreatitis , including abdominal pain, during treatment with tigecycline.
Score Text
0.9995 DrugBortezomib - induced paralytic ileus is a potential gastrointestinal side effect of this first - in - class anticancer proteasome inhibitor.
0.9910 Bortezomib - induced Adverse-Effectparalytic ileus is a potential gastrointestinal side effect of this first - in - class anticancer proteasome inhibitor.
0.9697 Bortezomib - induced paralytic ileus is a potential Adverse-Effectgastrointestinal side effect of this first - in - class anticancer proteasome inhibitor.
Score Text
0.9974 The male patient was treated with 225 - mg / day Drugclozapine and the time to the diagnosis of agranulocytosis was 6 weeks.
0.9962 The male patient was treated with 225 - mg / day clozapine and the time to the diagnosis of Adverse-Effectagranulocytosis was 6 weeks.
Score Text
0.9994 BACKGROUND : How to best treat psychotic patients who have had past Drugclozapine - induced agranulocytosis or granulocytopenia remains a problem.
0.9975 BACKGROUND : How to best treat psychotic patients who have had past clozapine - induced agranulocytosis or Adverse-Effectgranulocytopenia remains a problem.
0.9974 BACKGROUND : How to best treat psychotic patients who have had past clozapine - induced Adverse-Effectagranulocytosis or granulocytopenia remains a problem.
Score Text
0.9995 We have cared for three children in whom four episodes of dystonia proceeding to opisthotonus occurred in association with Drugcarbamazepine use.
0.9980 We have cared for three children in whom four episodes of dystonia proceeding to Adverse-Effectopisthotonus occurred in association with carbamazepine use.
0.9952 We have cared for three children in whom four episodes of Adverse-Effectdystonia proceeding to opisthotonus occurred in association with carbamazepine use.
Score Text
0.9995 Ten hours after the second Drugmethotrexate injection, the patient experienced a diffuse pruritic papular eruption located mainly on the limbs.
0.9866 Ten hours after the second methotrexate injection, the patient experienced a Adverse-Effectdiffuse pruritic papular eruption located mainly on the limbs.
Score Text
0.9993 Cryptococcus neoformans fatal sepsis in a chronic lymphocytic leukemia patient treated with Drugalemtuzumab : case report and review of the literature.
0.9841 Adverse-EffectCryptococcus neoformans fatal sepsis in a chronic lymphocytic leukemia patient treated with alemtuzumab : case report and review of the literature.
Score Text
0.9993 CONCLUSIONS : The pathogenesis of Drugmethotrexate - induced papular eruption in collagen vascular diseases may suggest cutaneous small - vessel vasculitis.
0.9843 CONCLUSIONS : The pathogenesis of methotrexate - induced Adverse-Effectpapular eruption in collagen vascular diseases may suggest cutaneous small - vessel vasculitis.
0.6170 CONCLUSIONS : The pathogenesis of methotrexate - induced papular eruption in collagen vascular diseases may suggest Adverse-Effectcutaneous small - vessel vasculitis .
Score Text
0.9866 The patient developed Adverse-Effectoccipital infarcts and was found to have extremely elevated levels of PPA in his blood and dialysis fluid.
The patient developed occipital infarcts and was found to have extremely elevated levels of DrugPPA in his blood and dialysis fluid.
The patient developed occipital infarcts and was found to have Adverse-Effectextremely elevated levels of PPA in his blood and dialysis fluid.
Score Text
0.9988 Two cases of childhood - onset schizophrenia associated with Drugclozapine - induced akathisia responsive to beta - blocker treatment are described.
0.9978 Two cases of childhood - onset schizophrenia associated with clozapine - induced Adverse-Effectakathisia responsive to beta - blocker treatment are described.
Score Text
0.9988 Adverse-EffectPolymyositis is a rare complication of interferon alpha treatment as a result of immune - modulating role of the drug itself.
0.9840 Polymyositis is a rare complication of Druginterferon alpha treatment as a result of immune - modulating role of the drug itself.
Score Text
0.9991 On the next day, after a total dose of only 600 mg of Drugdanazol , gingival bleeding and purpura occurred.
0.9987 On the next day, after a total dose of only 600 mg of danazol, gingival bleeding and Adverse-Effectpurpura occurred.
0.9922 On the next day, after a total dose of only 600 mg of danazol, Adverse-Effectgingival bleeding and purpura occurred.
Score Text
0.9994 We describe two patients with aspergillus arthritis of the knee joint following Drugfludarabine - based non - myeloablative stem cell transplantation.
0.9737 We describe two patients with Adverse-Effectaspergillus arthritis of the knee joint following fludarabine - based non - myeloablative stem cell transplantation.
Score Text
0.9988 Concurrent acute megaloblastic anaemia and pneumonitis : a severe side - effect of low - dose Drugmethotrexate therapy during rheumatoid arthritis.
0.9967 Concurrent acute megaloblastic anaemia and Adverse-Effectpneumonitis : a severe side - effect of low - dose methotrexate therapy during rheumatoid arthritis.
0.7416 Concurrent Adverse-Effectacute megaloblastic anaemia and pneumonitis : a severe side - effect of low - dose methotrexate therapy during rheumatoid arthritis.
Adverse-EffectConcurrent acute megaloblastic anaemia and pneumonitis : a severe side - effect of low - dose methotrexate therapy during rheumatoid arthritis.
Score Text
0.9958 We present findings from three patients who experienced a psoriasiform eruption apparently due to the antiepileptic agents sodium valproate and Drugcarbamazepine .
0.9930 We present findings from three patients who experienced a Adverse-Effectpsoriasiform eruption apparently due to the antiepileptic agents sodium valproate and carbamazepine.
0.9553 We present findings from three patients who experienced a psoriasiform eruption apparently due to the antiepileptic agents Drugsodium valproate and carbamazepine.
Score Text
0.9742 A case of a 21 - year - old woman who had developed mild hepatotoxicity while receiving Drugcholine magnesium trisalicylate therapy is described.
0.6535 A case of a 21 - year - old woman who had developed mild Adverse-Effecthepatotoxicity while receiving choline magnesium trisalicylate therapy is described.
0.8785 A case of a 21 - year - old woman who had developed Adverse-Effectmild hepatotoxicity while receiving choline magnesium trisalicylate therapy is described.
Score Text
0.9982 PURPOSE : DrugTopiramate - induced angle - closure glaucoma ( TiACG ) is believed to be related to its sulfonamide moiety.
0.9859 PURPOSE : Topiramate - induced Adverse-Effectangle - closure glaucoma ( TiACG ) is believed to be related to its sulfonamide moiety.
Score Text
0.9993 CONCLUSIONS : We report this case of the concomitant appearance of multiple skin cancers and nail changes associated with Drughydroxyurea use.
0.9894 CONCLUSIONS : We report this case of the concomitant appearance of multiple skin cancers and Adverse-Effectnail changes associated with hydroxyurea use.
0.9834 CONCLUSIONS : We report this case of the concomitant appearance of Adverse-Effectmultiple skin cancers and nail changes associated with hydroxyurea use.
Score Text
0.9993 The authors report on two patients with corneal ulcers refractory to conventional treatment while the patients were undergoing oral Drugcolchicine therapy.
0.7547 The authors report on two patients with Adverse-Effectcorneal ulcers refractory to conventional treatment while the patients were undergoing oral colchicine therapy.
0.7430 The authors report on two patients with Adverse-Effectcorneal ulcers refractory to conventional treatment while the patients were undergoing oral colchicine therapy.
0.5529 The authors report on two patients with Adverse-Effectcorneal ulcers refractory to conventional treatment while the patients were undergoing oral colchicine therapy.
0.5324 The authors report on two patients with Adverse-Effectcorneal ulcers refractory to conventional treatment while the patients were undergoing oral colchicine therapy.
Score Text
0.9899 OBJECTIVE : To report a case of fatal hyperkalemia owing to Drugsuccinylcholine administration in a patient with mucositis secondary to chemotherapy.
0.9871 OBJECTIVE : To report a case of Adverse-Effectfatal hyperkalemia owing to succinylcholine administration in a patient with mucositis secondary to chemotherapy.
Score Text
0.9993 A 52 - year - old Black woman on Drugphenytoin therapy for post - traumatic epilepsy developed transient hemiparesis contralateral to the injury.
0.9699 A 52 - year - old Black woman on phenytoin therapy for post - traumatic epilepsy developed Adverse-Effecttransient hemiparesis contralateral to the injury.
Score Text
0.9917 The pharmacology and toxicology of chloral hydrate are discussed with particular reference to the Adverse-Effectcardiac arrhythmias that are seen with overdosage.
0.9804 The pharmacology and toxicology of Drugchloral hydrate are discussed with particular reference to the cardiac arrhythmias that are seen with overdosage.
Score Text
0.9995 To our knowledge, this is the first case of Druggriseofulvin - exacerbated lupus in which nephrotic syndrome has been observed.
0.9845 To our knowledge, this is the first case of griseofulvin - exacerbated Adverse-Effectlupus in which nephrotic syndrome has been observed.
0.9630 To our knowledge, this is the first case of griseofulvin - exacerbated lupus in which Adverse-Effectnephrotic syndrome has been observed.
Score Text
0.9987 We report in detail an unusual adverse reaction to Druginfliximab therapy, a drug - induced lupus - like clinical syndrome.
0.9810 We report in detail an unusual adverse reaction to infliximab therapy, a drug - induced Adverse-Effectlupus - like clinical syndrome .
Score Text
0.9856 When the disease recurred conventional Drugamphotericin B was used again, but had to be stopped because of severe side effects.
0.8919 When the disease recurred conventional amphotericin B was used again, but had to be stopped because of Adverse-Effectsevere side effects .
Score Text
0.9870 We report a case of acute hyperphosphatemia secondary to rectal administration of Drugsodium phosphate and sodium biphosphate ( Fleet enema ).
0.9822 We report a case of acute hyperphosphatemia secondary to rectal administration of sodium phosphate and Drugsodium biphosphate ( Fleet enema ).
0.5684 We report a case of acute Adverse-Effecthyperphosphatemia secondary to rectal administration of sodium phosphate and sodium biphosphate ( Fleet enema ).
Score Text
0.9981 A case of phenytoin - induced Adverse-Effecthepatitis with mononucleosis is reported, and syndromes associated with phenytoin hypersensitivity reactions are discussed.
0.9654 A case of Drugphenytoin - induced hepatitis with mononucleosis is reported, and syndromes associated with phenytoin hypersensitivity reactions are discussed.
0.9328 A case of phenytoin - induced hepatitis with Adverse-Effectmononucleosis is reported, and syndromes associated with phenytoin hypersensitivity reactions are discussed.
0.8485 A case of phenytoin - induced hepatitis with mononucleosis is reported, and syndromes associated with Drugphenytoin hypersensitivity reactions are discussed.
0.6192 A case of phenytoin - induced hepatitis with mononucleosis is reported, and syndromes associated with Adverse-Effectphenytoin hypersensitivity reactions are discussed.
A case of phenytoin - induced hepatitis with mononucleosis is reported, and syndromes associated with phenytoin Adverse-Effecthypersensitivity reactions are discussed.
Score Text
0.9992 CONCLUSIONS : DrugClarithromycin may be a cause of fulminant liver failure either alone or by inhibiting the metabolism of other drugs.
0.9881 CONCLUSIONS : Clarithromycin may be a cause of Adverse-Effectfulminant liver failure either alone or by inhibiting the metabolism of other drugs.
Score Text
0.9991 We describe a patient who developed NEH on three separate occasions provoked by two different chemotherapeutic agents - - cytarabine and Drugmitoxantrone .
0.9991 We describe a patient who developed NEH on three separate occasions provoked by two different chemotherapeutic agents - - Drugcytarabine and mitoxantrone.
0.9953 We describe a patient who developed Adverse-EffectNEH on three separate occasions provoked by two different chemotherapeutic agents - - cytarabine and mitoxantrone.
Score Text
0.9991 OBJECTIVES : A delayed stroke - like leukoencephalopathy has been observed in patients receiving Drugmethotrexate ( MTX ) for childhood leukemia.
0.9987 OBJECTIVES : A delayed stroke - like leukoencephalopathy has been observed in patients receiving methotrexate ( DrugMTX ) for childhood leukemia.
0.9707 OBJECTIVES : A delayed Adverse-Effectstroke - like leukoencephalopathy has been observed in patients receiving methotrexate ( MTX ) for childhood leukemia.
Score Text
0.9984 A case of acute subdural haematoma originating spontaneously from an angiomatous meningioma in a patient receiving prophylactic Drugaspirin therapy is presented.
0.9796 A case of Adverse-Effectacute subdural haematoma originating spontaneously from an angiomatous meningioma in a patient receiving prophylactic aspirin therapy is presented.
Score Text
0.9991 We describe a 41 yr old leprosy patient treated for 10 yrs with Drugclofazimine who underwent laparotomy for severe abdominal pain.
0.9450 We describe a 41 yr old leprosy patient treated for 10 yrs with clofazimine who underwent laparotomy for severe Adverse-Effectabdominal pain .
0.5764 We describe a 41 yr old leprosy patient treated for 10 yrs with clofazimine who underwent Adverse-Effectlaparotomy for severe abdominal pain.
Score Text
0.9949 Brugada type electrocardiographic changes induced by concomitant use of lithium and Drugpropafenone in patient with Wolff - Parkinson - White syndrome.
0.9902 Brugada type electrocardiographic changes induced by concomitant use of Druglithium and propafenone in patient with Wolff - Parkinson - White syndrome.
0.9773 Adverse-EffectBrugada type electrocardiographic changes induced by concomitant use of lithium and propafenone in patient with Wolff - Parkinson - White syndrome.
Score Text
0.9986 We evaluated a patient who developed a psychotic disorder after 4 months of Drugisoniazid prophylaxis for a positive tuberculosis tine test.
0.9909 We evaluated a patient who developed a Adverse-Effectpsychotic disorder after 4 months of isoniazid prophylaxis for a positive tuberculosis tine test.
Score Text
0.9974 To our knowledge, these cases are the first published reports of lovastatin - induced Adverse-Effectrhabdomyolysis associated with azithromycin and clarithromycin.
0.9971 To our knowledge, these cases are the first published reports of lovastatin - induced rhabdomyolysis associated with azithromycin and Drugclarithromycin .
0.9969 To our knowledge, these cases are the first published reports of Druglovastatin - induced rhabdomyolysis associated with azithromycin and clarithromycin.
0.9963 To our knowledge, these cases are the first published reports of lovastatin - induced rhabdomyolysis associated with Drugazithromycin and clarithromycin.
Score Text
0.9991 A 60 year - old woman with chronic renal failure developed acute proximal muscle weakness after receiving a regular dosage of Drugcolchicine .
0.9841 A 60 year - old woman with chronic renal failure developed Adverse-Effectacute proximal muscle weakness after receiving a regular dosage of colchicine.
A 60 year - old woman with chronic renal failure developed acute Adverse-Effectproximal muscle weakness after receiving a regular dosage of colchicine.
Score Text
0.9995 OBJECTIVE : To report a fatal case of toxic epidermal necrolysis in a man who was treated with oral Drugofloxacin for epididymitis.
0.9582 OBJECTIVE : To report a fatal case of Adverse-Effecttoxic epidermal necrolysis in a man who was treated with oral ofloxacin for epididymitis.
Score Text
0.9944 Dural sinus thrombosis developed in two children with acute lymphoblastic leukemia during induction treatment with vincristine sulfate, Drugprednisone , and asparaginase.
0.9930 Dural sinus thrombosis developed in two children with acute lymphoblastic leukemia during induction treatment with vincristine sulfate, prednisone, and Drugasparaginase .
0.9842 Adverse-EffectDural sinus thrombosis developed in two children with acute lymphoblastic leukemia during induction treatment with vincristine sulfate, prednisone, and asparaginase.
0.9822 Dural sinus thrombosis developed in two children with acute lymphoblastic leukemia during induction treatment with Drugvincristine sulfate , prednisone, and asparaginase.
Score Text
0.9991 We present the first case ( to our knowledge ) of a potentially serious drug - drug interaction between zafirlukast and Drugtheophylline .
0.9991 We present the first case ( to our knowledge ) of a potentially serious drug - drug interaction between Drugzafirlukast and theophylline.
0.9657 We present the first case ( to our knowledge ) of a potentially serious Adverse-Effectdrug - drug interaction between zafirlukast and theophylline.
Score Text
0.9994 The fetal Drugvalproate syndrome ( FVS ) is characterized by distinctive facial appearance, major and minor malformations, and developmental delay.
0.9962 The fetal valproate syndrome ( Adverse-EffectFVS ) is characterized by distinctive facial appearance, major and minor malformations, and developmental delay.
0.9878 The fetal valproate syndrome ( FVS ) is characterized by distinctive facial appearance, major and minor malformations, and Adverse-Effectdevelopmental delay .
0.9812 The fetal valproate syndrome ( FVS ) is characterized by Adverse-Effectdistinctive facial appearance , major and minor malformations, and developmental delay.
0.9673 The fetal valproate syndrome ( FVS ) is characterized by distinctive facial appearance, Adverse-Effectmajor and minor malformations , and developmental delay.
0.6023 The Adverse-Effectfetal valproate syndrome ( FVS ) is characterized by distinctive facial appearance, major and minor malformations, and developmental delay.
Score Text
0.9986 This patient rapidly progressed from mild neurotoxicity to fatal encephalopathy after one dose of intrathecal Drugmethotrexate during his third cycle of chemotherapy.
0.9876 This patient rapidly progressed from mild neurotoxicity to Adverse-Effectfatal encephalopathy after one dose of intrathecal methotrexate during his third cycle of chemotherapy.
0.9801 This patient rapidly progressed from Adverse-Effectmild neurotoxicity to fatal encephalopathy after one dose of intrathecal methotrexate during his third cycle of chemotherapy.
Score Text
0.9990 She died within six weeks of developing congestive heart failure coupled with liver failure due to haemosiderosis despite regular use of Drugdesferrioxamine .
0.9942 She died within six weeks of developing congestive heart failure coupled with Adverse-Effectliver failure due to haemosiderosis despite regular use of desferrioxamine.
0.9914 She died within six weeks of developing congestive heart failure coupled with liver failure due to Adverse-Effecthaemosiderosis despite regular use of desferrioxamine.
0.9873 She died within six weeks of developing Adverse-Effectcongestive heart failure coupled with liver failure due to haemosiderosis despite regular use of desferrioxamine.
Score Text
0.9891 A second patient with a similar glucose tolerance test result showed Adverse-Effectpostprandial hyperglycemia when treated similarly with betamethasone valerate cream 0. 1 %.
0.9682 A second patient with a similar glucose tolerance test result showed postprandial hyperglycemia when treated similarly with Drugbetamethasone valerate cream 0. 1 %.
Score Text
0.9996 We describe the clinical and liver biopsy morphologic features for 4 patients with Drugminocycline - induced autoimmune hepatitis ( group 1 ).
0.9918 We describe the clinical and liver biopsy morphologic features for 4 patients with minocycline - induced Adverse-Effectautoimmune hepatitis ( group 1 ).
Score Text
0.9995 Without other causes for the hyponatremia, she was diagnosed with the syndrome of inappropriate antidiuretic hormone, presumably caused by Drugdesmopressin .
0.9672 Without other causes for the Adverse-Effecthyponatremia , she was diagnosed with the syndrome of inappropriate antidiuretic hormone, presumably caused by desmopressin.
0.9544 Without other causes for the hyponatremia, she was diagnosed with the Adverse-Effectsyndrome of inappropriate antidiuretic hormone , presumably caused by desmopressin.
Score Text
0.9783 In contrast to chronic or subacute thyroiditis, Graves'disease rarely complicates DrugIFN - alpha therapy for chronic viral C hepatitis.
0.7993 In contrast to chronic or subacute thyroiditis, Adverse-EffectGraves'disease rarely complicates IFN - alpha therapy for chronic viral C hepatitis.
0.6416 In contrast to chronic or Adverse-Effectsubacute thyroiditis , Graves'disease rarely complicates IFN - alpha therapy for chronic viral C hepatitis.
Score Text
0.9975 We report the case of a female acromegalic patient in whom multiple hepatic adenomas appeared soon after Drugdanazol treatment for uterine fibromatosis.
0.9758 We report the case of a female acromegalic patient in whom multiple Adverse-Effecthepatic adenomas appeared soon after danazol treatment for uterine fibromatosis.
Score Text
0.9904 CONCLUSIONS : We have seen an increased incidence of acute DrugINH neurotoxicity because of the resurgence of TB in New York City.
0.9141 CONCLUSIONS : We have seen an increased incidence of acute INH Adverse-Effectneurotoxicity because of the resurgence of TB in New York City.
Score Text
0.9915 Adverse-EffectParalytic ileus in patients undergoing bortezomib treatment has been reported, although a definite attribution to bortezomib administration has not been established.
0.9581 Paralytic ileus in patients undergoing Drugbortezomib treatment has been reported, although a definite attribution to bortezomib administration has not been established.
0.8984 Paralytic ileus in patients undergoing bortezomib treatment has been reported, although a definite attribution to Drugbortezomib administration has not been established.
Score Text
0.9988 STUDY DESIGN : Case report of a 31 - year - old woman who presented with toxic myelopathy due to intrathecal administration of Drugdoxorubicin .
0.9901 STUDY DESIGN : Case report of a 31 - year - old woman who presented with Adverse-Effecttoxic myelopathy due to intrathecal administration of doxorubicin.
Score Text
0.9997 DrugColchicine - induced rhabdomyolysis is a rare complication, and the postulated mechanisms and risk factors for this severe complication are discussed.
0.9981 Colchicine - induced Adverse-Effectrhabdomyolysis is a rare complication, and the postulated mechanisms and risk factors for this severe complication are discussed.
Score Text
0.9984 Telescoped digits of the hands and feet developed in a 69 - year - old male with severe chronic tophaceous gout during Drugallopurinol treatment.
0.9701 Adverse-EffectTelescoped digits of the hands and feet developed in a 69 - year - old male with severe chronic tophaceous gout during allopurinol treatment.
Score Text
0.9921 Although other nitrites induce methemoglobinemia, exposure to methyl nitrite during phenylpropanolamine production appears to be a new cause of occupational Adverse-Effectmethemoglobinemia .
0.9822 Although other nitrites induce methemoglobinemia, exposure to Drugmethyl nitrite during phenylpropanolamine production appears to be a new cause of occupational methemoglobinemia.
0.9735 Although other nitrites induce Adverse-Effectmethemoglobinemia , exposure to methyl nitrite during phenylpropanolamine production appears to be a new cause of occupational methemoglobinemia.
Score Text
0.9814 FINDINGS : Six children with growth retardation noted after treatment with high - dose fluticasone propionate were found to have Adverse-Effectadrenal suppression .
0.9761 FINDINGS : Six children with Adverse-Effectgrowth retardation noted after treatment with high - dose fluticasone propionate were found to have adrenal suppression.
0.9726 FINDINGS : Six children with growth retardation noted after treatment with high - dose Drugfluticasone propionate were found to have adrenal suppression.
Score Text
0.9968 Thus, the possible in vivo effects of insulin on adipocytes were clearly observed in this case of insulin - induced Adverse-Effectlipohypertrophy .
0.7648 Thus, the possible in vivo effects of insulin on adipocytes were clearly observed in this case of Druginsulin - induced lipohypertrophy.
0.9265 Thus, the possible in vivo effects of Druginsulin on adipocytes were clearly observed in this case of insulin - induced lipohypertrophy.
Score Text
0.9995 DrugNaproxen is a commonly used nonsteroidal anti - inflammatory drug ( NSAID ) whose side effects include tinnitus and transient hearing loss.
0.9986 Naproxen is a commonly used nonsteroidal anti - inflammatory drug ( NSAID ) whose side effects include Adverse-Effecttinnitus and transient hearing loss.
0.9903 Naproxen is a commonly used nonsteroidal anti - inflammatory drug ( NSAID ) whose side effects include tinnitus and Adverse-Effecttransient hearing loss .
Score Text
0.9993 We reviewed the records of 3 patients with lymphoproliferative disorders who experienced acute coronary syndromes associated with their initial infusion of Drugrituximab .
0.9916 We reviewed the records of 3 patients with lymphoproliferative disorders who experienced Adverse-Effectacute coronary syndromes associated with their initial infusion of rituximab.
Score Text
0.9994 The patient, a 28 - year - old man suffering from panic disorder, developed several first - rank symptoms during Drugfluvoxamine administration.
0.9870 The patient, a 28 - year - old man suffering from panic disorder, developed several Adverse-Effectfirst - rank symptoms during fluvoxamine administration.
Score Text
0.9968 Although this G - CSF - driven Adverse-Effectleucocytosis was alarming it did not appear to have adversely affected the patient's prognosis.
0.9711 Although this DrugG - CSF - driven leucocytosis was alarming it did not appear to have adversely affected the patient's prognosis.
Score Text
0.9985 We also describe a new, noninvasive method to assess Drugmagnesium - induced neuromuscular block when curariform muscle relaxant was given simultaneously.
0.9932 We also describe a new, noninvasive method to assess magnesium - induced Adverse-Effectneuromuscular block when curariform muscle relaxant was given simultaneously.
Score Text
0.9986 Acute non - lymphocytic leukemia occurred in eight women following long - term treatment with DrugTreosulfan ( = dihydroxybusulfan ) for ovarian carcinoma.
0.9975 Acute non - lymphocytic leukemia occurred in eight women following long - term treatment with Treosulfan ( = Drugdihydroxybusulfan ) for ovarian carcinoma.
0.9658 Adverse-EffectAcute non - lymphocytic leukemia occurred in eight women following long - term treatment with Treosulfan ( = dihydroxybusulfan ) for ovarian carcinoma.
Score Text
0.9945 We concluded that the colonic ulcer and the sigmoidovesical fistula had been caused by the administration of calcium polystyrene sulfonate and Drugsorbitol .
0.9931 We concluded that the Adverse-Effectcolonic ulcer and the sigmoidovesical fistula had been caused by the administration of calcium polystyrene sulfonate and sorbitol.
0.9850 We concluded that the colonic ulcer and the Adverse-Effectsigmoidovesical fistula had been caused by the administration of calcium polystyrene sulfonate and sorbitol.
0.9503 We concluded that the colonic ulcer and the sigmoidovesical fistula had been caused by the administration of Drugcalcium polystyrene sulfonate and sorbitol.
Score Text
0.9861 This case suggests that Drugacyclovir when given intravenously in doses of 10 mg / kg may result in increased serum lithium concentrations.
0.9525 This case suggests that acyclovir when given intravenously in doses of 10 mg / kg may result in increased serum Druglithium concentrations.
This case suggests that acyclovir when given intravenously in doses of 10 mg / kg may result in Adverse-Effectincreased serum lithium concentrations.
Score Text
0.9995 Acute delirium resulting from Druglevofloxacin therapy is an exceedingly rare complication that has been thought to occur more commonly in elderly patients.
0.9864 Adverse-EffectAcute delirium resulting from levofloxacin therapy is an exceedingly rare complication that has been thought to occur more commonly in elderly patients.
Score Text
0.9919 Sixteen hours after the first administration of IFN, IFN was suspended by the symptoms of congestive heart failure ( Adverse-EffectCHF ).
0.9855 Sixteen hours after the first administration of IFN, IFN was suspended by the symptoms of Adverse-Effectcongestive heart failure ( CHF ).
0.9269 Sixteen hours after the first administration of IFN, DrugIFN was suspended by the symptoms of congestive heart failure ( CHF ).
Score Text
0.9991 The case of a 4 - year - old girl with Drugvalproate - induced stupor and electroencephalographic pattern of increased fast activity is reported.
0.9990 The case of a 4 - year - old girl with valproate - induced Adverse-Effectstupor and electroencephalographic pattern of increased fast activity is reported.
Score Text
0.9975 We report a case of biopsy proven Adverse-Effectmyositis whose symptoms began within 10 days of receiving leuprolide acetate therapy for prostate cancer.
0.9808 We report a case of biopsy proven myositis whose symptoms began within 10 days of receiving Drugleuprolide acetate therapy for prostate cancer.
Score Text
0.9985 Adverse-EffectOsteonecrosis is a serious side effect of antiemetic treatment with dexamethasone and this serious complication should be incorporated in the current guidelines.
0.9974 Osteonecrosis is a serious side effect of antiemetic treatment with Drugdexamethasone and this serious complication should be incorporated in the current guidelines.
Score Text
0.9990 Case report : lack of control of diabetes and weight gain in a patient on initiation and rechallenge of therapy with Drugolanzapine .
0.9963 Case report : lack of control of diabetes and Adverse-Effectweight gain in a patient on initiation and rechallenge of therapy with olanzapine.
0.9866 Case report : lack of control of Adverse-Effectdiabetes and weight gain in a patient on initiation and rechallenge of therapy with olanzapine.
Score Text
0.9996 She developed a generalized rash and itching, sore throat, and dizziness approximately 4 hours after the first dose of Drugcapecitabine .
0.9976 She developed a generalized rash and Adverse-Effectitching , sore throat, and dizziness approximately 4 hours after the first dose of capecitabine.
0.9967 She developed a generalized rash and itching, sore throat, and Adverse-Effectdizziness approximately 4 hours after the first dose of capecitabine.
0.9935 She developed a Adverse-Effectgeneralized rash and itching, sore throat, and dizziness approximately 4 hours after the first dose of capecitabine.
0.9917 She developed a generalized rash and itching, Adverse-Effectsore throat , and dizziness approximately 4 hours after the first dose of capecitabine.
Score Text
0.9989 We described the occurrence of L - dopa - induced Adverse-Effectmyoclonus and seizures in a case of parkinsonism with its SEPs findings.
0.9977 We described the occurrence of L - dopa - induced myoclonus and Adverse-Effectseizures in a case of parkinsonism with its SEPs findings.
0.9787 We described the occurrence of DrugL - dopa - induced myoclonus and seizures in a case of parkinsonism with its SEPs findings.
Score Text
0.9905 A patient developed Adverse-Effectrestless legs symptoms paralleling the course of interferon - alpha ( IFN alpha ) therapy for chronic hepatitis C.
0.9814 A patient developed restless legs symptoms paralleling the course of interferon - alpha ( DrugIFN alpha ) therapy for chronic hepatitis C.
0.9723 A patient developed restless legs symptoms paralleling the course of Druginterferon - alpha ( IFN alpha ) therapy for chronic hepatitis C.
Score Text
0.9854 In the other patient, a 78 - year - old woman, Neisseria mucosa knee arthritis occurred after a single Drugsodium hyaluronate injection.
0.9773 In the other patient, a 78 - year - old woman, Adverse-EffectNeisseria mucosa knee arthritis occurred after a single sodium hyaluronate injection.
Score Text
0.9996 Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with Drugfluoxetine treatment of depression and obsessive - compulsive disorder.
0.9814 Prominent eye movements during NREM sleep and Adverse-EffectREM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive - compulsive disorder.
0.9600 Adverse-EffectProminent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive - compulsive disorder.
Score Text
0.9988 In patients with chronic heart failure, Drugspironolactone added to conventional treatment may lead to serious and, occasionally, fatal hyperkalaemia.
0.9525 In patients with chronic heart failure, spironolactone added to conventional treatment may lead to serious and, occasionally, Adverse-Effectfatal hyperkalaemia .
In patients with chronic heart failure, spironolactone added to conventional treatment may lead to Adverse-Effectserious and, occasionally, fatal hyperkalaemia .
Score Text
0.9990 We report a case of Adverse-Effectvitiligo that occurred during the second month of interferon alpha 2a therapy for chronic active hepatitis C.
0.9794 We report a case of vitiligo that occurred during the second month of Druginterferon alpha 2a therapy for chronic active hepatitis C.
Score Text
0.9992 Second, we report a case of neutropenia, which proved to be fatal in a schizophrenia patient receiving olanzapine and Drugthiazide .
0.9992 Second, we report a case of neutropenia, which proved to be fatal in a schizophrenia patient receiving Drugolanzapine and thiazide.
0.9980 Second, we report a case of Adverse-Effectneutropenia , which proved to be fatal in a schizophrenia patient receiving olanzapine and thiazide.
Score Text
0.9974 The results of the ultrasound examination combined with clinical anamnesis allowed diagnosis of gastric mucosa foveolar hyperplasia due to prolonged DrugPGE1 therapy.
0.9758 The results of the ultrasound examination combined with clinical anamnesis allowed diagnosis of Adverse-Effectgastric mucosa foveolar hyperplasia due to prolonged PGE1 therapy.
Score Text
0.9991 The potential role of Drugpropranolol in inducing central nervous system disturbances is emphasized, and the literature on the subject is reviewed.
0.9833 The potential role of propranolol in inducing Adverse-Effectcentral nervous system disturbances is emphasized, and the literature on the subject is reviewed.
Score Text
0.9902 Therefore, we concluded that this patient's pulmonary disease was caused by Drugcalcium stearate , an additive for an antihistaminic drug.
0.9748 Therefore, we concluded that this patient's Adverse-Effectpulmonary disease was caused by calcium stearate, an additive for an antihistaminic drug.
Score Text
0.9989 DATA SYNTHESIS : A 49 - year - old man developed symptoms of severe psychosis concomitant with Drugciprofloxacin ( 250 mg bid ) treatment.
0.9727 DATA SYNTHESIS : A 49 - year - old man developed symptoms of Adverse-Effectsevere psychosis concomitant with ciprofloxacin ( 250 mg bid ) treatment.
Score Text
0.9997 We present a patient with human immunodeficiency virus infection under treatment with Drugfoscarnet for CMV retinitis who complained of thirst and polyuria.
0.9993 We present a patient with human immunodeficiency virus infection under treatment with foscarnet for CMV retinitis who complained of thirst and Adverse-Effectpolyuria .
0.9984 We present a patient with human immunodeficiency virus infection under treatment with foscarnet for CMV retinitis who complained of Adverse-Effectthirst and polyuria.
Score Text
0.9991 We report a fatal case of acute interstitial pneumonitis in a patient treated with Drugcarmustine ( BCNU ) for a brain tumor.
0.9988 We report a fatal case of acute interstitial pneumonitis in a patient treated with carmustine ( DrugBCNU ) for a brain tumor.
0.9604 We report a fatal case of Adverse-Effectacute interstitial pneumonitis in a patient treated with carmustine ( BCNU ) for a brain tumor.
0.5407 We report a Adverse-Effectfatal case of acute interstitial pneumonitis in a patient treated with carmustine ( BCNU ) for a brain tumor.
We report a Adverse-Effectfatal case of acute interstitial pneumonitis in a patient treated with carmustine ( BCNU ) for a brain tumor.
Score Text
0.9903 CASE SUMMARY : A 10 - year - old white girl with bilateral optic glioma developed a hypersensitivity reaction to Drugcarboplatin after nine courses.
0.8115 CASE SUMMARY : A 10 - year - old white girl with bilateral optic glioma developed a Adverse-Effecthypersensitivity reaction to carboplatin after nine courses.
0.9802 CASE SUMMARY : A 10 - year - old white girl with bilateral optic glioma developed a Adverse-Effecthypersensitivity reaction to carboplatin after nine courses.
Score Text
0.9983 We report the case of a young healthy woman who presented an early overanticoagulation when receiving Drugacenocoumarol for a first thromboembolic episode.
0.9889 We report the case of a young healthy woman who presented an early Adverse-Effectoveranticoagulation when receiving acenocoumarol for a first thromboembolic episode.
Score Text
0.9994 Beginning ductopenia was present in two, suggesting that Drugitraconazole might be responsible for the occurrence of prolonged drug - induced cholangiopathy.
0.9983 Beginning Adverse-Effectductopenia was present in two, suggesting that itraconazole might be responsible for the occurrence of prolonged drug - induced cholangiopathy.
0.9950 Beginning ductopenia was present in two, suggesting that itraconazole might be responsible for the occurrence of prolonged drug - induced Adverse-Effectcholangiopathy .
Score Text
0.9995 Early - onset Drugpentamidine - associated second - degree heart block and sinus bradycardia : case report and review of the literature.
0.9919 Early - onset pentamidine - associated second - degree heart block and Adverse-Effectsinus bradycardia : case report and review of the literature.
0.9763 Early - onset pentamidine - associated Adverse-Effectsecond - degree heart block and sinus bradycardia : case report and review of the literature.
Score Text
0.9972 CONCLUSION : We believe this to be the first reported case of rhGH - induced Adverse-Effecthypercalcemia in an HIV - infected patient.
0.9972 CONCLUSION : We believe this to be the first reported case of DrugrhGH - induced hypercalcemia in an HIV - infected patient.
Score Text
0.9997 We reported a case of Drugdisulfiram - induced hepatitis with unique clinical features and compared our case with others in the literature.
0.9989 We reported a case of disulfiram - induced Adverse-Effecthepatitis with unique clinical features and compared our case with others in the literature.
Score Text
0.9966 We report a case of severe hypotension associated with intravenous Drugvalproate used to treat status epilepticus in an 11 - year - old girl.
0.5539 We report a case of severe Adverse-Effecthypotension associated with intravenous valproate used to treat status epilepticus in an 11 - year - old girl.
0.8276 We report a case of Adverse-Effectsevere hypotension associated with intravenous valproate used to treat status epilepticus in an 11 - year - old girl.
Score Text
0.9988 AIM : To report three cases of extensive skin necrosis in cirrhotic patients treated with the vasoconstrictor agent Drugterlipressin ( Glypressin ).
0.9988 AIM : To report three cases of extensive skin necrosis in cirrhotic patients treated with the vasoconstrictor agent terlipressin ( DrugGlypressin ).
0.9904 AIM : To report three cases of extensive Adverse-Effectskin necrosis in cirrhotic patients treated with the vasoconstrictor agent terlipressin ( Glypressin ).
Score Text
0.9941 The occurrence of neuromuscular blockade and the resulting potentiation of muscle relaxants during magnesium sulfate ( DrugMgSO4 ) administration is well known.
0.9886 The occurrence of Adverse-Effectneuromuscular blockade and the resulting potentiation of muscle relaxants during magnesium sulfate ( MgSO4 ) administration is well known.
0.9872 The occurrence of neuromuscular blockade and the resulting potentiation of muscle relaxants during Drugmagnesium sulfate ( MgSO4 ) administration is well known.
0.9850 The occurrence of neuromuscular blockade and the resulting Adverse-Effectpotentiation of muscle relaxants during magnesium sulfate ( MgSO4 ) administration is well known.
Score Text
0.9992 Thirty patients with hepatic reactions to Drugcyclofenil , a non - steroidal drug with a stimulating effect on ovulation, are reviewed.
0.9813 Thirty patients with Adverse-Effecthepatic reactions to cyclofenil, a non - steroidal drug with a stimulating effect on ovulation, are reviewed.
Score Text
0.9990 His symptoms of brain stem compression were alleviated and the role of Drugphenytoin in the production of his craniocervical abnormality is discussed.
0.9667 His symptoms of brain stem compression were alleviated and the role of phenytoin in the production of his Adverse-Effectcraniocervical abnormality is discussed.
0.9254 His symptoms of Adverse-Effectbrain stem compression were alleviated and the role of phenytoin in the production of his craniocervical abnormality is discussed.
Score Text
0.9989 The second had acute cystitis and was treated by sulphonamide and the third developed Adverse-Effectmyopia coincident with metronidazole treatment for trichomonas vaginalis.
0.9763 The second had acute cystitis and was treated by Drugsulphonamide and the third developed myopia coincident with metronidazole treatment for trichomonas vaginalis.
0.8458 The second had acute cystitis and was treated by sulphonamide and the third developed myopia coincident with Drugmetronidazole treatment for trichomonas vaginalis.
Score Text
0.9995 The renal biopsy showed focal segmental glomerulosclerosis, which has only been previously reported in two cases of CML treated with DrugIFNalpha .
0.9833 The renal biopsy showed Adverse-Effectfocal segmental glomerulosclerosis , which has only been previously reported in two cases of CML treated with IFNalpha.
Score Text
0.9991 The most commonly recognized toxic effect of Drugethambutol is optic neuropathy, which generally is considered uncommon and reversible in medical literature.
0.9805 The most commonly recognized toxic effect of ethambutol is Adverse-Effectoptic neuropathy , which generally is considered uncommon and reversible in medical literature.
Score Text
0.9980 Based on the clinical status of the patient, it was suspected that several conditions contributed to the abnormal hypersensitivity to Drugwarfarin .
0.9885 Based on the clinical status of the patient, it was suspected that several conditions contributed to the Adverse-Effectabnormal hypersensitivity to warfarin.
Score Text
0.9988 A case is presented in which a 68 - year - old man became delirious after being withdrawn from a low dosage of Drugalprazolam .
0.9957 A case is presented in which a 68 - year - old man became Adverse-Effectdelirious after being withdrawn from a low dosage of alprazolam.
Score Text
0.9992 However, Drugadenosine shortens the antegrade refractoriness of accessory atrioventricular connections and may cause acceleration of the ventricular rate during atrial fibrillation.
0.9803 However, adenosine shortens the antegrade refractoriness of accessory atrioventricular connections and may cause Adverse-Effectacceleration of the ventricular rate during atrial fibrillation.
Score Text
0.9984 Nonspecific but significant abnormalities have been described in the infants of women treated with Drugdisulfiram in the first trimester of their pregnancies.
0.9329 Nonspecific but Adverse-Effectsignificant abnormalities have been described in the infants of women treated with disulfiram in the first trimester of their pregnancies.
0.9908 Nonspecific but significant Adverse-Effectabnormalities have been described in the infants of women treated with disulfiram in the first trimester of their pregnancies.
Score Text
0.9989 Toxicity, pharmacokinetics, and in vitro hemodialysis clearance of Drugifosfamide and metabolites in an anephric pediatric patient with Wilms'tumor.
0.9968 Adverse-EffectToxicity , pharmacokinetics, and in vitro hemodialysis clearance of ifosfamide and metabolites in an anephric pediatric patient with Wilms'tumor.
Score Text
0.9992 The case resembles two previously reported cases of optic neuropathy which occurred in patients with Wilson's disease who were receiving Drugpenicillamine .
0.9899 The case resembles two previously reported cases of Adverse-Effectoptic neuropathy which occurred in patients with Wilson's disease who were receiving penicillamine.
Score Text
0.9974 In the present paper, we discuss the first Japanese vivax malaria patient whose QT interval was prolonged after treatment with Drughalofantrine .
0.9185 In the present paper, we discuss the first Japanese vivax malaria patient whose Adverse-EffectQT interval was prolonged after treatment with halofantrine.
Score Text
0.9934 Adverse-EffectAnaphylactoid shock , disseminated intravascular coagulation, and anuric renal failure requiring dialysis occurred in a patient receiving zomepirac sodium for toothache.
0.9860 Anaphylactoid shock, disseminated intravascular coagulation, and Adverse-Effectanuric renal failure requiring dialysis occurred in a patient receiving zomepirac sodium for toothache.
0.9824 Anaphylactoid shock, Adverse-Effectdisseminated intravascular coagulation , and anuric renal failure requiring dialysis occurred in a patient receiving zomepirac sodium for toothache.
0.9702 Anaphylactoid shock, disseminated intravascular coagulation, and anuric renal failure requiring dialysis occurred in a patient receiving Drugzomepirac sodium for toothache.
Anaphylactoid shock, disseminated intravascular coagulation, and anuric renal failure requiring dialysis occurred in a patient receiving Drugzomepirac sodium for toothache.
Score Text
0.9983 High - resolution computed tomography scan findings were consistent with ILD, which was sufficient to diagnose as Drugerlotinib - induced ILD.
0.9962 High - resolution computed tomography scan findings were consistent with ILD, which was sufficient to diagnose as erlotinib - induced Adverse-EffectILD .
Score Text
0.9990 She had been taking Drugnabumetone for 6 months, but had discontinued the agent 2 weeks before admission due to progressive edema.
0.9726 She had been taking nabumetone for 6 months, but had discontinued the agent 2 weeks before admission due to progressive Adverse-Effectedema .
Score Text
0.9934 The reversal of heparin by protamine may cause severe hemodynamic deterioration, characterized by systemic hypotension, pulmonary hypertension, and Adverse-Effectbronchoconstriction .
0.9923 The reversal of heparin by protamine may cause severe hemodynamic deterioration, characterized by systemic hypotension, Adverse-Effectpulmonary hypertension , and bronchoconstriction.
0.9881 The reversal of heparin by protamine may cause severe hemodynamic deterioration, characterized by Adverse-Effectsystemic hypotension , pulmonary hypertension, and bronchoconstriction.
0.9773 The reversal of heparin by protamine may cause Adverse-Effectsevere hemodynamic deterioration , characterized by systemic hypotension, pulmonary hypertension, and bronchoconstriction.
The reversal of heparin by Drugprotamine may cause severe hemodynamic deterioration, characterized by systemic hypotension, pulmonary hypertension, and bronchoconstriction.
Score Text
0.9984 PURPOSE : To report a case of angiographically documented cystoid macula edema occurring after switching a pseudophakic patient from Druglatanoprost to bimatoprost.
0.9980 PURPOSE : To report a case of angiographically documented cystoid macula edema occurring after switching a pseudophakic patient from latanoprost to Drugbimatoprost .
0.9862 PURPOSE : To report a case of angiographically documented Adverse-Effectcystoid macula edema occurring after switching a pseudophakic patient from latanoprost to bimatoprost.
Score Text
0.9970 The Adverse-Effectnodules regressed after withdrawal of methotrexate therapy in one patient and were arrested with the addition of hydroxychloroquine in the other.
0.9836 The nodules regressed after withdrawal of Drugmethotrexate therapy in one patient and were arrested with the addition of hydroxychloroquine in the other.
Score Text
0.9995 CONCLUSIONS : Clinicians should be aware of the possible association of thrombocytopenia with Druglansoprazole and discontinue the drug if thrombocytopenia becomes apparent.
0.9930 CONCLUSIONS : Clinicians should be aware of the possible association of Adverse-Effectthrombocytopenia with lansoprazole and discontinue the drug if thrombocytopenia becomes apparent.
Score Text
0.9992 To our knowledge, these cases represent the first reports of DrugTDF - associated irreversible renal failure and rickets in pediatric patients.
0.9982 To our knowledge, these cases represent the first reports of TDF - associated irreversible renal failure and Adverse-Effectrickets in pediatric patients.
0.9696 To our knowledge, these cases represent the first reports of TDF - associated Adverse-Effectirreversible renal failure and rickets in pediatric patients.
Score Text
0.9992 DrugCyclosporin side effects included hirsutism, hypertension, increased blood levels of urea and creatinine, and abnormalities in liver function tests.
0.9981 Cyclosporin side effects included hirsutism, Adverse-Effecthypertension , increased blood levels of urea and creatinine, and abnormalities in liver function tests.
0.9973 Cyclosporin side effects included Adverse-Effecthirsutism , hypertension, increased blood levels of urea and creatinine, and abnormalities in liver function tests.
0.9596 Cyclosporin side effects included hirsutism, hypertension, increased blood levels of urea and creatinine, and Adverse-Effectabnormalities in liver function tests .
0.9187 Cyclosporin side effects included hirsutism, hypertension, Adverse-Effectincreased blood levels of urea and creatinine , and abnormalities in liver function tests.
0.9191 Cyclosporin side effects included hirsutism, hypertension, Adverse-Effectincreased blood levels of urea and creatinine, and abnormalities in liver function tests.
0.8538 Cyclosporin side effects included hirsutism, hypertension, Adverse-Effectincreased blood levels of urea and creatinine, and abnormalities in liver function tests.
Score Text
0.9993 Atrioventricular block complicating Drugamiodarone - induced hypothyroidism in a patient with pre - excitation and rate - dependent bilateral bundle branch block.
0.9902 Adverse-EffectAtrioventricular block complicating amiodarone - induced hypothyroidism in a patient with pre - excitation and rate - dependent bilateral bundle branch block.
0.9855 Atrioventricular block complicating amiodarone - induced Adverse-Effecthypothyroidism in a patient with pre - excitation and rate - dependent bilateral bundle branch block.
Score Text
0.9996 Behavioral side effects associated with Drugclonazepam may include agitation, aggression, hyperactivity, irritability, property destruction, and temper tantrums.
0.9981 Behavioral side effects associated with clonazepam may include agitation, Adverse-Effectaggression , hyperactivity, irritability, property destruction, and temper tantrums.
0.9981 Behavioral side effects associated with clonazepam may include agitation, aggression, hyperactivity, Adverse-Effectirritability , property destruction, and temper tantrums.
0.9972 Behavioral side effects associated with clonazepam may include Adverse-Effectagitation , aggression, hyperactivity, irritability, property destruction, and temper tantrums.
0.9958 Behavioral side effects associated with clonazepam may include agitation, aggression, Adverse-Effecthyperactivity , irritability, property destruction, and temper tantrums.
0.9945 Behavioral side effects associated with clonazepam may include agitation, aggression, hyperactivity, irritability, Adverse-Effectproperty destruction , and temper tantrums.
0.9921 Behavioral side effects associated with clonazepam may include agitation, aggression, hyperactivity, irritability, property destruction, and Adverse-Effecttemper tantrums .
Score Text
0.9995 OBJECTIVE : To determine the frequency of weight loss in patients treated with Drugleflunomide for rheumatoid arthritis at an arthritis referral center.
0.9882 OBJECTIVE : To determine the frequency of Adverse-Effectweight loss in patients treated with leflunomide for rheumatoid arthritis at an arthritis referral center.
Score Text
0.9685 A well - recognized complication of Drugethambutol use is optic neuropathy, but the potential ocular toxicity of isoniazid is often overlooked.
0.9621 A well - recognized complication of ethambutol use is Adverse-Effectoptic neuropathy , but the potential ocular toxicity of isoniazid is often overlooked.
0.8415 A well - recognized complication of ethambutol use is optic neuropathy, but the potential Adverse-Effectocular toxicity of isoniazid is often overlooked.
0.8264 A well - recognized complication of ethambutol use is optic neuropathy, but the potential ocular toxicity of Drugisoniazid is often overlooked.
Score Text
0.9992 CONCLUSIONS : The increasing prevalence of Type 2 diabetes and its treatment with Drugmetformin might result in more cases of lactic acidosis.
0.9919 CONCLUSIONS : The increasing prevalence of Type 2 diabetes and its treatment with metformin might result in more cases of Adverse-Effectlactic acidosis .
Score Text
0.9850 Treatment of APL in pregnancy is controversial as the use of DrugATRA has been questioned due to the teratogenic effect of retinoids.
0.9675 Treatment of APL in pregnancy is controversial as the use of ATRA has been questioned due to the Adverse-Effectteratogenic effect of retinoids.
Score Text
0.9982 RESULTS : One case of recurrent primary peritoneal carcinoma previously treated with a Drugcarboplatin - based regimen, developed a platinum hypersensitivity.
0.9913 RESULTS : One case of recurrent primary peritoneal carcinoma previously treated with a carboplatin - based regimen, developed a Adverse-Effectplatinum hypersensitivity .
Score Text
0.9690 Controversy concerning the nephrotoxicity of Druglithium is discussed, and recommendations for the evaluation of renal failure during lithium therapy are provided.
0.9672 Controversy concerning the nephrotoxicity of lithium is discussed, and recommendations for the evaluation of Adverse-Effectrenal failure during lithium therapy are provided.
0.9476 Controversy concerning the nephrotoxicity of lithium is discussed, and recommendations for the evaluation of renal failure during Druglithium therapy are provided.
0.8845 Controversy concerning the Adverse-Effectnephrotoxicity of lithium is discussed, and recommendations for the evaluation of renal failure during lithium therapy are provided.
Score Text
0.9994 PURPOSE : To describe bilateral corneal endothelial dysfunction in a patient with Parkinson disease who was treated with long - term Drugamantadine .
0.9837 PURPOSE : To describe Adverse-Effectbilateral corneal endothelial dysfunction in a patient with Parkinson disease who was treated with long - term amantadine.
Score Text
0.9996 DrugMethotrexate - induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis : report of five cases and review of the literature.
0.9985 Methotrexate - induced Adverse-Effectpneumonitis in patients with rheumatoid arthritis and psoriatic arthritis : report of five cases and review of the literature.
Score Text
0.9996 Type I second - degree AV block ( Mobitz type I, Wenckebach AV block ) during Drugritodrine therapy for preterm labor.
0.9875 Type I second - degree AV block ( Mobitz type I, Adverse-EffectWenckebach AV block ) during ritodrine therapy for preterm labor.
0.9850 Type I second - degree AV block ( Adverse-EffectMobitz type I , Wenckebach AV block ) during ritodrine therapy for preterm labor.
0.9746 Adverse-EffectType I second - degree AV block ( Mobitz type I, Wenckebach AV block ) during ritodrine therapy for preterm labor.
Score Text
0.9981 We present the case of a 58 - year - old woman who ingested more than 35 g of Drugcaffeine in a suicide attempt.
0.9542 We present the case of a 58 - year - old woman who ingested more than 35 g of caffeine in a Adverse-Effectsuicide attempt .
Score Text
0.9986 Insulin - dependent diabetes mellitus developed in a young woman 8 weeks after the initiation of Drugdanazol for treatment of pelvic endometriosis.
0.9698 Adverse-EffectInsulin - dependent diabetes mellitus developed in a young woman 8 weeks after the initiation of danazol for treatment of pelvic endometriosis.
Score Text
0.9878 A patient with coccidioidal meningitis was treated with intrathecally administered amphotericin B, and an Adverse-Effectacute toxic delirium with EEG abnormalities developed.
0.9844 A patient with coccidioidal meningitis was treated with intrathecally administered Drugamphotericin B , and an acute toxic delirium with EEG abnormalities developed.
0.9728 A patient with coccidioidal meningitis was treated with intrathecally administered amphotericin B, and an acute toxic delirium with Adverse-EffectEEG abnormalities developed.
Score Text
0.9973 We report a 46 - yr - old woman with ovarian carcinoma who developed porphyria cutanea tarda while undergoing treatment with cisplatin and Drugcyclophosphamide .
0.9969 We report a 46 - yr - old woman with ovarian carcinoma who developed porphyria cutanea tarda while undergoing treatment with Drugcisplatin and cyclophosphamide.
0.9885 We report a 46 - yr - old woman with ovarian carcinoma who developed Adverse-Effectporphyria cutanea tarda while undergoing treatment with cisplatin and cyclophosphamide.
Score Text
0.9970 Based on these findings, the patient was diagnosed with diabetes insipidus secondary to Druglithium therapy and was treated successfully with amiloride.
0.9792 Based on these findings, the patient was diagnosed with Adverse-Effectdiabetes insipidus secondary to lithium therapy and was treated successfully with amiloride.
Score Text
0.9996 Thus, the patient's clinical course and workup strongly support a diagnosis of Druglenalidomide - induced hypersensitivity pneumonitis - like syndrome.
0.9834 Thus, the patient's clinical course and workup strongly support a diagnosis of lenalidomide - induced Adverse-Effecthypersensitivity pneumonitis - like syndrome .
Score Text
0.9991 Severe C. difficile colitis occurred in 2 patients ( 6. 1 % ) after receiving Drugcisplatin - based combination chemotherapy for ovarian malignancies.
0.8962 Severe Adverse-EffectC. difficile colitis occurred in 2 patients ( 6. 1 % ) after receiving cisplatin - based combination chemotherapy for ovarian malignancies.
Score Text
0.9995 Physicians should be aware of the potential for developing a Druggemcitabine - induced radiation recall reaction resulting in hemodynamically significant pericardial effusion.
0.9880 Physicians should be aware of the potential for developing a gemcitabine - induced radiation recall reaction resulting in hemodynamically significant Adverse-Effectpericardial effusion .
0.9855 Physicians should be aware of the potential for developing a gemcitabine - induced Adverse-Effectradiation recall reaction resulting in hemodynamically significant pericardial effusion.
Score Text
0.9972 A cause - effect relationship to capecitabine was suggested due to resolution of Adverse-Effectheadache with capecitabine withdrawal and reappearance with capecitabine rechallenge.
0.8569 A cause - effect relationship to capecitabine was suggested due to resolution of headache with Drugcapecitabine withdrawal and reappearance with capecitabine rechallenge.
0.7759 A cause - effect relationship to Drugcapecitabine was suggested due to resolution of headache with capecitabine withdrawal and reappearance with capecitabine rechallenge.
Score Text
0.9995 This report highlights a case of drug - induced dysphagia in a patient receiving Drughaloperidol for obsessive nocturnal thoughts and auditory disturbances.
0.9979 This report highlights a case of drug - induced Adverse-Effectdysphagia in a patient receiving haloperidol for obsessive nocturnal thoughts and auditory disturbances.
Score Text
0.9973 Does the use of insulin in a patient with liver dysfunction increase water retention in the body, i. e. cause insulin Adverse-Effectoedema ?
0.9808 Does the use of Druginsulin in a patient with liver dysfunction increase water retention in the body, i. e. cause insulin oedema?
0.8657 Does the use of insulin in a patient with liver dysfunction increase water retention in the body, i. e. cause Adverse-Effectinsulin oedema ?
Score Text
0.9985 This article describes the case of a 25 - year - old man found dead at home who had been prescribed Drugolanzapine for schizophrenia.
0.9914 This article describes the case of a 25 - year - old man found Adverse-Effectdead at home who had been prescribed olanzapine for schizophrenia.
Score Text
0.9990 It is very likely that the Drugdexamethasone used in the antiemetic drug regimen contributed to the development of osteonecrosis in these patients.
0.9974 It is very likely that the dexamethasone used in the antiemetic drug regimen contributed to the development of Adverse-Effectosteonecrosis in these patients.
Score Text
0.9979 Adverse-EffectAngioedema , a rare side effect of carbamazepine, involves vascular leakage in dermis and subcutis mediated by immunoglobulin E and / or bradykinins.
0.9971 Angioedema, a rare side effect of Drugcarbamazepine , involves vascular leakage in dermis and subcutis mediated by immunoglobulin E and / or bradykinins.
Score Text
0.9991 Like other atypical neuroleptics Drugolanzapine is considered to show a reduced prevalence of extrapyramidal side effects when compared to classical neuroleptic drugs.
0.9791 Like other atypical neuroleptics olanzapine is considered to show a reduced prevalence of Adverse-Effectextrapyramidal side effects when compared to classical neuroleptic drugs.
Score Text
0.9994 The favourable outcome in these two patients contrasts with the fatal outcome of the two other reported cases of Drugnitrofurantoin induced BOOP.
0.9592 The favourable outcome in these two patients contrasts with the Adverse-Effectfatal outcome of the two other reported cases of nitrofurantoin induced BOOP.
0.9973 The favourable outcome in these two patients contrasts with the fatal outcome of the two other reported cases of nitrofurantoin induced Adverse-EffectBOOP .
The favourable outcome in these two patients contrasts with the fatal outcome of the two other reported cases of Adverse-Effectnitrofurantoin induced BOOP .
Score Text
0.9986 RESULTS : A clinical diagnosis of fixed drug eruption owing to use of the PDE5 inhibitor Drugtadalafil ( Cialis ) was made.
0.9972 RESULTS : A clinical diagnosis of fixed drug eruption owing to use of the PDE5 inhibitor tadalafil ( DrugCialis ) was made.
0.8867 RESULTS : A clinical diagnosis of Adverse-Effectfixed drug eruption owing to use of the PDE5 inhibitor tadalafil ( Cialis ) was made.
Score Text
0.9994 Protease inhibitors ( ritonavir and saquinavir ) were added to the treatment and the patient developed progressive ataxia related to Drugcarbamazepine toxicity.
0.9991 Protease inhibitors ( Drugritonavir and saquinavir ) were added to the treatment and the patient developed progressive ataxia related to carbamazepine toxicity.
0.9989 Protease inhibitors ( ritonavir and Drugsaquinavir ) were added to the treatment and the patient developed progressive ataxia related to carbamazepine toxicity.
0.8999 Protease inhibitors ( ritonavir and saquinavir ) were added to the treatment and the patient developed Adverse-Effectprogressive ataxia related to carbamazepine toxicity.
0.7616 Protease inhibitors ( ritonavir and saquinavir ) were added to the treatment and the patient developed progressive ataxia related to Adverse-Effectcarbamazepine toxicity .
Score Text
0.9992 A 56 - year - old male parkinsonian patient developed a unique behavioral change following the oral administration of Drugcinepazide , a cerebral vasodilator.
0.9835 A 56 - year - old male parkinsonian patient developed a unique Adverse-Effectbehavioral change following the oral administration of cinepazide, a cerebral vasodilator.
Score Text
0.9996 Ovarian endometrioid adenocarcinoma arising from an endometriotic cyst in a postmenopausal woman under Drugtamoxifen therapy for breast cancer : a case report.
0.9802 Adverse-EffectOvarian endometrioid adenocarcinoma arising from an endometriotic cyst in a postmenopausal woman under tamoxifen therapy for breast cancer : a case report.
Score Text
0.9916 This is the first case of TMP - SMX - induced Adverse-Effecthypersensitivity syndrome associated with the reactivation of a latent viral infection.
0.9702 This is the first case of DrugTMP - SMX - induced hypersensitivity syndrome associated with the reactivation of a latent viral infection.
Score Text
0.9987 We report a case of 48 - year - old woman with seizure disorder on divalproex sodium ( Depakote ) who presented with Adverse-Effectdyspnea .
0.9957 We report a case of 48 - year - old woman with seizure disorder on divalproex sodium ( DrugDepakote ) who presented with dyspnea.
0.9862 We report a case of 48 - year - old woman with seizure disorder on Drugdivalproex sodium ( Depakote ) who presented with dyspnea.
Score Text
0.9995 Skin rash began after 2 weeks of treatment, and signs of hepatocellular failure developed 3 weeks after Drugphenobarbital had been started.
0.9923 Adverse-EffectSkin rash began after 2 weeks of treatment, and signs of hepatocellular failure developed 3 weeks after phenobarbital had been started.
0.9912 Skin rash began after 2 weeks of treatment, and signs of Adverse-Effecthepatocellular failure developed 3 weeks after phenobarbital had been started.
Score Text
0.9853 OBJECTIVE : To report a case of severe Drugchloroquine toxicity in the presence of high - grade chloroquine - resistant Plasmodium vivax.
0.8007 OBJECTIVE : To report a case of Adverse-Effectsevere chloroquine toxicity in the presence of high - grade chloroquine - resistant Plasmodium vivax.
0.5136 OBJECTIVE : To report a case of severe Adverse-Effectchloroquine toxicity in the presence of high - grade chloroquine - resistant Plasmodium vivax.
Score Text
0.9984 RESULTS : DrugEthambutol , and to a lesser extent isoniazid, are both implicated in the development of visually related side effects.
0.9971 RESULTS : Ethambutol, and to a lesser extent Drugisoniazid , are both implicated in the development of visually related side effects.
0.8924 RESULTS : Ethambutol, and to a lesser extent isoniazid, are both implicated in the Adverse-Effectdevelopment of visually related side effects .
Score Text
0.9993 Our objective is to present a retrospective analysis of the DWI findings in four patients who suffered subacute neurotoxicity after intrathecal DrugMTX .
0.9729 Our objective is to present a retrospective analysis of the DWI findings in four patients who suffered Adverse-Effectsubacute neurotoxicity after intrathecal MTX.
Score Text
0.9990 Rituximab - based therapy for Druggemcitabine - induced hemolytic uremic syndrome in a patient with metastatic pancreatic adenocarcinoma : a case report.
0.9864 Rituximab - based therapy for gemcitabine - induced Adverse-Effecthemolytic uremic syndrome in a patient with metastatic pancreatic adenocarcinoma : a case report.
Score Text
0.9975 We report a patient receiving chronic Druglithium therapy who presented with a transient CDI occurring in the setting of underlying chronic NDI.
0.9810 We report a patient receiving chronic lithium therapy who presented with a transient Adverse-EffectCDI occurring in the setting of underlying chronic NDI.
Score Text
0.9988 Syndrome of inappropriate secretion of ADH ( SIADH ) following Drugcisplatin administration in a pulmonary adenocarcinoma patient with a malignant pleural effusion.
0.9924 Syndrome of inappropriate secretion of ADH ( Adverse-EffectSIADH ) following cisplatin administration in a pulmonary adenocarcinoma patient with a malignant pleural effusion.
0.9634 Adverse-EffectSyndrome of inappropriate secretion of ADH ( SIADH ) following cisplatin administration in a pulmonary adenocarcinoma patient with a malignant pleural effusion.
Score Text
0.9947 In this paper, we report a patient with primary anti - phospholipid syndrome treated by Drugcorticosteroid , who developed disseminated nocardiosis.
0.9899 In this paper, we report a patient with primary anti - phospholipid syndrome treated by corticosteroid, who developed Adverse-Effectdisseminated nocardiosis .
Score Text
0.9995 A wide variety of adverse central nervous system effects have been reported in association with Drugpropafenone ; dizziness is the most common.
0.9848 A wide variety of adverse central nervous system effects have been reported in association with propafenone ; Adverse-Effectdizziness is the most common.
0.9765 A wide variety of Adverse-Effectadverse central nervous system effects have been reported in association with propafenone ; dizziness is the most common.
Score Text
0.9996 Pulmonary hemorrhage is an uncommon feature in the HUS, and seems to appear especially in the HUS associated with DrugMMC therapy.
0.9970 Pulmonary hemorrhage is an uncommon feature in the HUS, and seems to appear especially in the Adverse-EffectHUS associated with MMC therapy.
0.9961 Pulmonary hemorrhage is an uncommon feature in the Adverse-EffectHUS , and seems to appear especially in the HUS associated with MMC therapy.
0.9871 Adverse-EffectPulmonary hemorrhage is an uncommon feature in the HUS, and seems to appear especially in the HUS associated with MMC therapy.
Score Text
0.9857 The Center for Disease Control has received numerous reports of an Adverse-Effecteosinophilia - myalgia syndrome related to products containing L - tryptophan.
0.9645 The Center for Disease Control has received numerous reports of an eosinophilia - myalgia syndrome related to products containing DrugL - tryptophan .
Score Text
0.9994 We report a case of fatal pulmonary toxicity in a patient with advanced non - small cell lung cancer who received Drugerlotinib .
0.9833 We report a case of Adverse-Effectfatal pulmonary toxicity in a patient with advanced non - small cell lung cancer who received erlotinib.
Score Text
0.9985 We report a 76 - year - old man who developed an acute blistering eruption following high - dose Drugpenicillin treatment for pneumococcal septicaemia.
0.9872 We report a 76 - year - old man who developed an Adverse-Effectacute blistering eruption following high - dose penicillin treatment for pneumococcal septicaemia.
Score Text
0.9989 The spectrum of renal lesions occurring during antituberculous therapy, particularly in association with Drugrifampin , may be wider than previously suspected.
0.9917 The spectrum of Adverse-Effectrenal lesions occurring during antituberculous therapy, particularly in association with rifampin, may be wider than previously suspected.
Score Text
0.9800 Complications associated with primary and secondary perforation of the bladder following immediate instillations of Drugepirubicin after transurethral resection of superficial urothelial tumours.
0.9752 Complications associated with Adverse-Effectprimary and secondary perforation of the bladder following immediate instillations of epirubicin after transurethral resection of superficial urothelial tumours.
Score Text
0.9807 2 - Chloro - deoxyadenosine induces durable complete remission in Castleman's disease but may accelerate its transformation to Adverse-Effectnon - Hodgkin's lymphoma .
0.8421 Drug2 - Chloro - deoxyadenosine induces durable complete remission in Castleman's disease but may accelerate its transformation to non - Hodgkin's lymphoma.
Score Text
0.9994 A 42 year old man, treated for testicular carcinoma with combination chemotherapy that included Drugbleomycin , developed life threatening interstitial pneumonitis.
0.9873 A 42 year old man, treated for testicular carcinoma with combination chemotherapy that included bleomycin, developed life threatening Adverse-Effectinterstitial pneumonitis .
Score Text
0.9941 Severe histological osteomalacia developed in a woman with Crohn's disease 2 years after ileal resection and the start of Drugcholestyramine therapy.
0.8602 Severe histological Adverse-Effectosteomalacia developed in a woman with Crohn's disease 2 years after ileal resection and the start of cholestyramine therapy.
Score Text
0.9871 We report the first case of herpes esophagitis in a renal transplant patient treated with DrugCyclosporine A while on chronic steroid therapy.
0.9851 We report the first case of Adverse-Effectherpes esophagitis in a renal transplant patient treated with Cyclosporine A while on chronic steroid therapy.
Score Text
0.9929 A case is reported of a 40 year old woman treated with intraventricular DrugIL - 2 for leptomeningeal disease who developed progressive cognitive dysfunction.
0.9386 A case is reported of a 40 year old woman treated with intraventricular IL - 2 for leptomeningeal disease who developed progressive Adverse-Effectcognitive dysfunction .
Score Text
0.9982 Although the essential cause of PV is unclear, its onset has occasionally been associated with drug therapy, in particular Drugpenicillamine .
0.9912 Although the essential cause of Adverse-EffectPV is unclear, its onset has occasionally been associated with drug therapy, in particular penicillamine.
Score Text
0.9985 A case history of a 15 - year - old boy who developed incapacitating tardive dyskinesia that resolved during treatment with Drugdeanol is presented.
0.9791 A case history of a 15 - year - old boy who developed incapacitating Adverse-Effecttardive dyskinesia that resolved during treatment with deanol is presented.
Score Text
0.9995 These cases suggest the possibility that, in some patients, leukopenia or agranulocytosis during Drugolanzapine treatment might be dose - related.
0.9980 These cases suggest the possibility that, in some patients, Adverse-Effectleukopenia or agranulocytosis during olanzapine treatment might be dose - related.
0.9977 These cases suggest the possibility that, in some patients, leukopenia or Adverse-Effectagranulocytosis during olanzapine treatment might be dose - related.
Score Text
0.9986 Interferon - induced Adverse-Effectpsychosis as a " psychiatric contraindication " to hepatitis C treatment : a review and case - based discussion.
0.9971 DrugInterferon - induced psychosis as a " psychiatric contraindication " to hepatitis C treatment : a review and case - based discussion.
Score Text
0.9914 CONCLUSIONS : The use of fluorouracil treatment with careful monitoring can be considered in a patient with mild allergic reactions to Drugcapecitabine .
0.9069 CONCLUSIONS : The use of fluorouracil treatment with careful monitoring can be considered in a patient with mild Adverse-Effectallergic reactions to capecitabine.
Score Text
0.9980 In patients with a known access to INH, Adverse-Effectseizures should be considered to be caused by INH toxicity unless proved otherwise.
0.9965 In patients with a known access to INH, seizures should be considered to be caused by DrugINH toxicity unless proved otherwise.
Score Text
0.9996 During the first treatment, dysarthria and ataxia were seen after completion of the patient's eighth and final dose of DrugHDARAC .
0.9988 During the first treatment, Adverse-Effectdysarthria and ataxia were seen after completion of the patient's eighth and final dose of HDARAC.
0.9988 During the first treatment, dysarthria and Adverse-Effectataxia were seen after completion of the patient's eighth and final dose of HDARAC.
Score Text
0.9996 OBJECTIVE : To describe onset of syndrome of inappropriate antidiuretic hormone ( SIADH ) associated with Drugvinorelbine therapy for advanced breast cancer.
0.9951 OBJECTIVE : To describe onset of syndrome of inappropriate antidiuretic hormone ( Adverse-EffectSIADH ) associated with vinorelbine therapy for advanced breast cancer.
0.9781 OBJECTIVE : To describe onset of Adverse-Effectsyndrome of inappropriate antidiuretic hormone ( SIADH ) associated with vinorelbine therapy for advanced breast cancer.
Score Text
0.9929 Pancreatitis has been associated with the tetracycline class of antibiotics and concerns about Drugtigecycline - induced acute pancreatitis have recently been raised.
0.9865 Pancreatitis has been associated with the tetracycline class of antibiotics and concerns about tigecycline - induced Adverse-Effectacute pancreatitis have recently been raised.
Score Text
0.9994 Only one case of severe symptomatic hepatitis occurring after pulse therapy with Drugitraconazole for onychomycosis and requiring transplantation has been reported previously.
0.9832 Only one case of Adverse-Effectsevere symptomatic hepatitis occurring after pulse therapy with itraconazole for onychomycosis and requiring transplantation has been reported previously.
Score Text
0.9995 OBJECTIVE : To report a case of rapidly occurring hyperglycemia that occurred in a geriatric patient 3 days after treatment with Drugolanzapine .
0.9977 OBJECTIVE : To report a case of rapidly occurring Adverse-Effecthyperglycemia that occurred in a geriatric patient 3 days after treatment with olanzapine.
Score Text
0.9986 While on a maximal dose of Drugphenylephrine she developed prominent positive U waves, which disappeared with the cessation of the drug.
0.9847 While on a maximal dose of phenylephrine she developed prominent Adverse-Effectpositive U waves , which disappeared with the cessation of the drug.
Score Text
0.9995 It is suggested that the fatal stroke may have resulted from arterial spasm caused by Drugergotamine overdosage and possibly complicated by thrombosis.
0.9885 It is suggested that the fatal stroke may have resulted from Adverse-Effectarterial spasm caused by ergotamine overdosage and possibly complicated by thrombosis.
0.9844 It is suggested that the Adverse-Effectfatal stroke may have resulted from arterial spasm caused by ergotamine overdosage and possibly complicated by thrombosis.
Score Text
0.9994 Electro - oculography, electroretinography, visual evoked potentials, and multifocal electroretinography in patients with Drugvigabatrin - attributed visual field constriction.
0.9866 Electro - oculography, electroretinography, visual evoked potentials, and multifocal electroretinography in patients with vigabatrin - attributed Adverse-Effectvisual field constriction .
Score Text
0.9892 Recombinant VIIa concentrate in the management of bleeding following prothrombin complex concentrate - related Adverse-Effectmyocardial infarction in patients with haemophilia and inhibitors.
0.9687 Recombinant VIIa concentrate in the management of bleeding following Drugprothrombin complex concentrate - related myocardial infarction in patients with haemophilia and inhibitors.
Score Text
0.9993 We report a case of fatal fulminant hepatitis caused by the use of Drugdisulfiram in a man with previously normal hepatocellular function.
0.9823 We report a case of Adverse-Effectfatal fulminant hepatitis caused by the use of disulfiram in a man with previously normal hepatocellular function.
Score Text
0.9996 We describe a 73 - year - old woman who developed serious systemic vasculitis with associated thrombocytopenia in the course of treatment with Drugcladribine .
0.9983 We describe a 73 - year - old woman who developed serious systemic vasculitis with associated Adverse-Effectthrombocytopenia in the course of treatment with cladribine.
0.7229 We describe a 73 - year - old woman who developed serious Adverse-Effectsystemic vasculitis with associated thrombocytopenia in the course of treatment with cladribine.
Score Text
0.9994 A combination of behavioural and cognitive adverse effects is illustrated in this case report of a recurrent Drugtriazolam - induced eating disorder.
0.9955 A combination of behavioural and cognitive adverse effects is illustrated in this case report of a recurrent triazolam - induced Adverse-Effecteating disorder .
Score Text
0.9974 Extra caution should be taken in using Drugoctreotide or its long - acting analog in patients otherwise predisposed to intrahepatic bile stasis.
0.9729 Extra caution should be taken in using octreotide or its long - acting analog in patients otherwise predisposed to Adverse-Effectintrahepatic bile stasis .
Score Text
0.9992 We report 3 cases of HIV - 1 infected patients who experienced symptomatic angiolipomas shortly after starting antiretroviral therapy including the protease inhibitor Drugindinavir .
0.5069 We report 3 cases of HIV - 1 infected patients who experienced symptomatic Adverse-Effectangiolipomas shortly after starting antiretroviral therapy including the protease inhibitor indinavir.
0.9573 We report 3 cases of HIV - 1 infected patients who experienced Adverse-Effectsymptomatic angiolipomas shortly after starting antiretroviral therapy including the protease inhibitor indinavir.
Score Text
0.9989 In this case Drugsenna was likely the cause of a subacute cholestatic hepatitis exemplifying again the potential role of herbal related liver injury.
0.9684 In this case senna was likely the cause of a Adverse-Effectsubacute cholestatic hepatitis exemplifying again the potential role of herbal related liver injury.
0.9380 In this case senna was likely the cause of a subacute cholestatic hepatitis exemplifying again the potential role of herbal related Adverse-Effectliver injury .
Score Text
0.9969 Chronic myelogenous leukemia ( CML ), hepatitis C, and interferon alpha ( DrugIFNalpha ) have all been associated with renal dysfunction.
0.9910 Chronic myelogenous leukemia ( CML ), hepatitis C, and interferon alpha ( IFNalpha ) have all been associated with Adverse-Effectrenal dysfunction .
0.9885 Chronic myelogenous leukemia ( CML ), hepatitis C, and Druginterferon alpha ( IFNalpha ) have all been associated with renal dysfunction.
Score Text
0.9948 The authors conclude that among patients taking high doses of oral Drugniacin only those who experience visual symptoms need to be ophthalmologically evaluated.
0.9900 The authors conclude that among patients taking high doses of oral niacin only those who experience Adverse-Effectvisual symptoms need to be ophthalmologically evaluated.
Score Text
0.9985 A 37 - year - old woman with relapsing invasive vertebral aspergillosis received intravenous DrugVRC and developed angio - oedema 10 days after starting therapy.
0.9900 A 37 - year - old woman with relapsing invasive vertebral aspergillosis received intravenous VRC and developed Adverse-Effectangio - oedema 10 days after starting therapy.
Score Text
0.9979 This case demonstrates the association of selective IgA deficiency with remission in rheumatoid arthritis induced by fenclofenac as well as aurothiomalate and Drugsulphasalazine .
0.9978 This case demonstrates the association of selective IgA deficiency with remission in rheumatoid arthritis induced by Drugfenclofenac as well as aurothiomalate and sulphasalazine.
0.9978 This case demonstrates the association of selective IgA deficiency with remission in rheumatoid arthritis induced by fenclofenac as well as Drugaurothiomalate and sulphasalazine.
0.9872 This case demonstrates the association of selective Adverse-EffectIgA deficiency with remission in rheumatoid arthritis induced by fenclofenac as well as aurothiomalate and sulphasalazine.
Score Text
0.9973 METHODS : A 55 - year - old woman became stuporous after overdose with Druglamotrigine ( LTG ) and valproic acid ( VPA ) tablets.
0.9964 METHODS : A 55 - year - old woman became Adverse-Effectstuporous after overdose with lamotrigine ( LTG ) and valproic acid ( VPA ) tablets.
0.9958 METHODS : A 55 - year - old woman became stuporous after overdose with lamotrigine ( LTG ) and valproic acid ( DrugVPA ) tablets.
0.9953 METHODS : A 55 - year - old woman became stuporous after overdose with lamotrigine ( DrugLTG ) and valproic acid ( VPA ) tablets.
0.9894 METHODS : A 55 - year - old woman became stuporous after overdose with lamotrigine ( LTG ) and Drugvalproic acid ( VPA ) tablets.
Score Text
0.9993 She received an accidental 450 - mg bolus injection of Drugmorphine intrathecally and developed hypertension, status epilepticus, intracerebral hemorrhage, and respiratory failure.
0.9981 She received an accidental 450 - mg bolus injection of morphine intrathecally and developed Adverse-Effecthypertension , status epilepticus, intracerebral hemorrhage, and respiratory failure.
0.9957 She received an accidental 450 - mg bolus injection of morphine intrathecally and developed hypertension, status epilepticus, intracerebral hemorrhage, and Adverse-Effectrespiratory failure .
0.9914 She received an accidental 450 - mg bolus injection of morphine intrathecally and developed hypertension, status epilepticus, Adverse-Effectintracerebral hemorrhage , and respiratory failure.
0.9865 She received an accidental 450 - mg bolus injection of morphine intrathecally and developed hypertension, Adverse-Effectstatus epilepticus , intracerebral hemorrhage, and respiratory failure.
Score Text
0.9959 A 49 - year - old man with Crohn's disease treated with Drugprednisone and mesalamine ( 5 - ASA ) developed worsening respiratory distress and fever.
0.9956 A 49 - year - old man with Crohn's disease treated with prednisone and Drugmesalamine ( 5 - ASA ) developed worsening respiratory distress and fever.
0.9838 A 49 - year - old man with Crohn's disease treated with prednisone and mesalamine ( 5 - ASA ) developed worsening respiratory distress and Adverse-Effectfever .
0.9771 A 49 - year - old man with Crohn's disease treated with prednisone and mesalamine ( 5 - ASA ) developed Adverse-Effectworsening respiratory distress and fever.
0.9642 A 49 - year - old man with Crohn's disease treated with prednisone and mesalamine ( Drug5 - ASA ) developed worsening respiratory distress and fever.
Score Text
0.9950 Massive pulmonary embolism due to late - onset heparin - induced Adverse-Effectthrombocytopenia following coronary artery bypass graft surgery : successful treatment with lepirudin.
0.9937 Massive pulmonary embolism due to late - onset Drugheparin - induced thrombocytopenia following coronary artery bypass graft surgery : successful treatment with lepirudin.
0.9490 Adverse-EffectMassive pulmonary embolism due to late - onset heparin - induced thrombocytopenia following coronary artery bypass graft surgery : successful treatment with lepirudin.
Score Text
0.9996 Methemoglobinemia is another common finding among patients receiving Drugdapsone therapy, but rarely does it result in prominent symptoms other than transient pallor.
0.9978 Adverse-EffectMethemoglobinemia is another common finding among patients receiving dapsone therapy, but rarely does it result in prominent symptoms other than transient pallor.
Score Text
0.9996 Physicians using this " new " drug must be aware of the potential danger of Drugsulfonamide - induced injury to the urinary tract.
0.9525 Physicians using this " new " drug must be aware of the potential danger of sulfonamide - induced Adverse-Effectinjury to the urinary tract .
Score Text
0.9714 Since the bronchospasm was relieved with discontinuation of propranolol and supportive bronchodilator therapy, the Adverse-Effectbronchospasm was believed to be caused by propranolol.
0.9302 Since the bronchospasm was relieved with discontinuation of Drugpropranolol and supportive bronchodilator therapy, the bronchospasm was believed to be caused by propranolol.
0.9004 Since the bronchospasm was relieved with discontinuation of propranolol and supportive bronchodilator therapy, the bronchospasm was believed to be caused by Drugpropranolol .
0.8952 Since the Adverse-Effectbronchospasm was relieved with discontinuation of propranolol and supportive bronchodilator therapy, the bronchospasm was believed to be caused by propranolol.
Score Text
0.9786 Destructive thyrotoxicosis appeared 4 - 6 months after starting IFN - alpha, followed by Adverse-EffectGraves'hyperthyroidism within 8 to 11 months.
0.9763 Destructive thyrotoxicosis appeared 4 - 6 months after starting DrugIFN - alpha , followed by Graves'hyperthyroidism within 8 to 11 months.
0.9269 Destructive Adverse-Effectthyrotoxicosis appeared 4 - 6 months after starting IFN - alpha, followed by Graves'hyperthyroidism within 8 to 11 months.
Score Text
0.9810 Adverse-EffectSagittal sinus thrombosis associated with transient free protein S deficiency after L - asparaginase treatment : case report and review of the literature.
0.9667 Sagittal sinus thrombosis associated with transient free protein S deficiency after DrugL - asparaginase treatment : case report and review of the literature.
0.9649 Sagittal sinus thrombosis associated with Adverse-Effecttransient free protein S deficiency after L - asparaginase treatment : case report and review of the literature.
Score Text
0.9990 Reversible leukopenia was documented in an 81 - year - old woman treated with adjunctive Drugibopamine 100 mg t. i. d. for chronic congestive heart failure.
0.8100 Adverse-EffectReversible leukopenia was documented in an 81 - year - old woman treated with adjunctive ibopamine 100 mg t. i. d. for chronic congestive heart failure.
Score Text
0.9966 The possibility of severe rhabdomyolysis should be considered in a patient with water intoxication due to massive ingestion of Drugcaffeine - containing beverages.
0.9483 The possibility of severe rhabdomyolysis should be considered in a patient with Adverse-Effectwater intoxication due to massive ingestion of caffeine - containing beverages.
0.8624 The possibility of severe Adverse-Effectrhabdomyolysis should be considered in a patient with water intoxication due to massive ingestion of caffeine - containing beverages.
0.5865 The possibility of Adverse-Effectsevere rhabdomyolysis should be considered in a patient with water intoxication due to massive ingestion of caffeine - containing beverages.
Score Text
0.9789 The second patient developed both autoimmune thyroid disease and a refractory pre - patellar bursitis after 50 months of DrugIFN - beta therapy.
0.9748 The second patient developed both autoimmune thyroid disease and a Adverse-Effectrefractory pre - patellar bursitis after 50 months of IFN - beta therapy.
0.9718 The second patient developed both Adverse-Effectautoimmune thyroid disease and a refractory pre - patellar bursitis after 50 months of IFN - beta therapy.
Score Text
0.9986 Amiodarone hydrochloride, a new antiarrhythmic agent, has been associated with pulmonary toxicity characterized by Adverse-Effectcough , dyspnea and diffuse pulmonary infiltrates.
0.9984 Amiodarone hydrochloride, a new antiarrhythmic agent, has been associated with pulmonary toxicity characterized by cough, Adverse-Effectdyspnea and diffuse pulmonary infiltrates.
0.9896 Amiodarone hydrochloride, a new antiarrhythmic agent, has been associated with Adverse-Effectpulmonary toxicity characterized by cough, dyspnea and diffuse pulmonary infiltrates.
0.9874 Amiodarone hydrochloride, a new antiarrhythmic agent, has been associated with pulmonary toxicity characterized by cough, dyspnea and Adverse-Effectdiffuse pulmonary infiltrates .
0.9788 DrugAmiodarone hydrochloride , a new antiarrhythmic agent, has been associated with pulmonary toxicity characterized by cough, dyspnea and diffuse pulmonary infiltrates.
Score Text
0.9481 The biochemistry of paracetamol Adverse-Effecthepatotoxicity is outlined and the increased susceptibility of alcoholic patients to the hepatotoxic effects of paracetamol is remarked upon.
0.9409 The biochemistry of Drugparacetamol hepatotoxicity is outlined and the increased susceptibility of alcoholic patients to the hepatotoxic effects of paracetamol is remarked upon.
0.8755 The biochemistry of paracetamol hepatotoxicity is outlined and the increased susceptibility of alcoholic patients to the hepatotoxic effects of Drugparacetamol is remarked upon.
0.6493 The biochemistry of paracetamol hepatotoxicity is outlined and the increased susceptibility of alcoholic patients to the Adverse-Effecthepatotoxic effects of paracetamol is remarked upon.
0.7184 The biochemistry of Adverse-Effectparacetamol hepatotoxicity is outlined and the increased susceptibility of alcoholic patients to the hepatotoxic effects of paracetamol is remarked upon.
Score Text
0.9993 We report the development of squamous - cell carcinoma within a basal - cell epithelioma that was treated with intralesional injections of Drug5 - FU .
0.9763 We report the development of Adverse-Effectsquamous - cell carcinoma within a basal - cell epithelioma that was treated with intralesional injections of 5 - FU.
Score Text
0.9980 A patient presented with a painful, oedematous, cyanosed hand having injected a solution of diamorphine and Drugmethylphenidate into his radial artery.
0.9979 A patient presented with a painful, oedematous, cyanosed hand having injected a solution of Drugdiamorphine and methylphenidate into his radial artery.
0.5163 A patient presented with a Adverse-Effectpainful , oedematous, cyanosed hand having injected a solution of diamorphine and methylphenidate into his radial artery.
A patient presented with a Adverse-Effectpainful, oedematous, cyanosed hand having injected a solution of diamorphine and methylphenidate into his radial artery.
Score Text
0.9995 We report on three patients who developed acute liver damage during therapy with Drugitraconazole , and in whom liver biopsy specimens were obtained.
0.9838 We report on three patients who developed Adverse-Effectacute liver damage during therapy with itraconazole, and in whom liver biopsy specimens were obtained.
We report on three patients who developed acute Adverse-Effectliver damage during therapy with itraconazole, and in whom liver biopsy specimens were obtained.
Score Text
0.9971 Thiopurine methyltransferase deficiency occurs at a frequency of one in 300 and is associated with profound myelosuppression after a short course of Drugazathioprine .
0.9840 Thiopurine methyltransferase deficiency occurs at a frequency of one in 300 and is associated with profound Adverse-Effectmyelosuppression after a short course of azathioprine.
Score Text
0.9994 AIM : To report a patient with diabetic rubeosis who suffered from acute retinal ischemic change and stroke after intravitreal injection of Drugbevacizumab .
0.9928 AIM : To report a patient with diabetic rubeosis who suffered from acute retinal ischemic change and Adverse-Effectstroke after intravitreal injection of bevacizumab.
0.9849 AIM : To report a patient with diabetic rubeosis who suffered from Adverse-Effectacute retinal ischemic change and stroke after intravitreal injection of bevacizumab.
Score Text
0.9992 This is a case report of possible association of Drugmethylphenidate and enuresis in an 11 - year - old boy with attention deficit hyperactivity disorder.
0.9924 This is a case report of possible association of methylphenidate and Adverse-Effectenuresis in an 11 - year - old boy with attention deficit hyperactivity disorder.
Score Text
0.9940 Methylene blue in the treatment and prevention of Drugifosfamide - induced encephalopathy : report of 12 cases and a review of the literature.
0.9972 Methylene blue in the treatment and prevention of ifosfamide - induced Adverse-Effectencephalopathy : report of 12 cases and a review of the literature.
Methylene blue in the treatment and prevention of Adverse-Effectifosfamide - induced encephalopathy : report of 12 cases and a review of the literature.
Score Text
0.9996 NCSE, an epileptic disorder in which typical convulsive activity is absent, has previously been reported in only 4 patients receiving Drugifosfamide .
0.9989 Adverse-EffectNCSE , an epileptic disorder in which typical convulsive activity is absent, has previously been reported in only 4 patients receiving ifosfamide.
Score Text
0.9996 This is the first case of HBV reactivation occurring during the year following Drugrituximab monotherapy in the absence of any other immunosuppressive factor.
0.9910 This is the first case of Adverse-EffectHBV reactivation occurring during the year following rituximab monotherapy in the absence of any other immunosuppressive factor.
Score Text
0.9850 We describe a case of subcutaneous metastasis along the needle track after percutaneous Drugethanol injection ( PEI ) for treatment of hepatocellular carcinoma.
0.9655 We describe a case of Adverse-Effectsubcutaneous metastasis along the needle track after percutaneous ethanol injection ( PEI ) for treatment of hepatocellular carcinoma.
0.9501 We describe a case of subcutaneous metastasis along the needle track after percutaneous ethanol injection ( DrugPEI ) for treatment of hepatocellular carcinoma.
0.8603 We describe a case of subcutaneous metastasis along the needle track after percutaneous Drugethanol injection ( PEI ) for treatment of hepatocellular carcinoma.
Score Text
0.9988 This report describes an unexpected drug - induced Adverse-Effecthepatitis in a previously healthy young woman exposed to 2 doses of amodiaquine and artesunate.
0.9987 This report describes an unexpected drug - induced hepatitis in a previously healthy young woman exposed to 2 doses of amodiaquine and Drugartesunate .
0.9985 This report describes an unexpected drug - induced hepatitis in a previously healthy young woman exposed to 2 doses of Drugamodiaquine and artesunate.
Score Text
0.9831 Adverse-EffectTumor - volume increase at beginning of primary treatment with topical interferon alpha 2 - beta in a case of conjunctiva - cornea intraepithelial neoplasia.
0.9563 Tumor - volume increase at beginning of primary treatment with topical Druginterferon alpha 2 - beta in a case of conjunctiva - cornea intraepithelial neoplasia.
Score Text
0.9950 This entity is probably related to a combination of high doses of corticosteroids, Drugvecuronium administration and metabolic abnormalities associated with respiratory failure.
0.9923 This entity is probably related to a combination of high doses of corticosteroids, vecuronium administration and metabolic abnormalities associated with Adverse-Effectrespiratory failure .
Score Text
0.9993 We describe a patient who, after receiving his first dose of Drugpregabalin to relieve neuropathic pain, presented with a negative myoclonus.
0.9876 We describe a patient who, after receiving his first dose of pregabalin to relieve neuropathic pain, presented with a Adverse-Effectnegative myoclonus .
Score Text
0.9830 We describe a patient who had a systemic allergic contact dermatitis to Drug8 - MOP develop during her second course of PUVA treatment for psoriasis.
0.9785 We describe a patient who had a Adverse-Effectsystemic allergic contact dermatitis to 8 - MOP develop during her second course of PUVA treatment for psoriasis.
Score Text
0.9994 In two of these cases akathisia resolved after withdrawal of Drugolanzapine and substitution by a classical or an atypical neuroleptic agent, respectively.
0.9978 In two of these cases Adverse-Effectakathisia resolved after withdrawal of olanzapine and substitution by a classical or an atypical neuroleptic agent, respectively.
Score Text
0.9989 Although the movement disorder could not with certainty be attributed to Drugtrazodone alone, the drug at least acted as an eliciting agent.
0.9862 Although the Adverse-Effectmovement disorder could not with certainty be attributed to trazodone alone, the drug at least acted as an eliciting agent.
Score Text
0.9995 DISCUSSION : Central nervous system ( CNS ) toxicity has been described with Drugifosfamide , with most cases reported in the pediatric population.
0.8372 DISCUSSION : Adverse-EffectCentral nervous system ( CNS ) toxicity has been described with ifosfamide, with most cases reported in the pediatric population.
Score Text
0.9991 Albeit rare among Western patients, such Druglithium - associated thyroid dysfunctions appeared to be more likely to occur in Hong Kong Chinese.
0.9882 Albeit rare among Western patients, such lithium - associated Adverse-Effectthyroid dysfunctions appeared to be more likely to occur in Hong Kong Chinese.
Score Text
0.9994 Fever caused by the use of Drugfurosemide was proved ; the fever resolved after discontinuation of this medication and recurred after its reintroduction.
0.9942 Adverse-EffectFever caused by the use of furosemide was proved ; the fever resolved after discontinuation of this medication and recurred after its reintroduction.
Score Text
0.9914 We describe a 10 - year - old boy with ulcerative colitis who developed Adverse-Effectacute pancreatitis while on long - term treatment with 5 - aminosalicylic acid.
0.9785 We describe a 10 - year - old boy with ulcerative colitis who developed acute pancreatitis while on long - term treatment with Drug5 - aminosalicylic acid .
Score Text
0.9996 This case represents the third example of erythroid aplasia associated with an anti - inflammatory agent and the first instance due to Drugfenoprofen .
0.9905 This case represents the third example of Adverse-Effecterythroid aplasia associated with an anti - inflammatory agent and the first instance due to fenoprofen.
Score Text
0.9993 After approximately two weeks of Drugsertraline treatment he noted an intense itching sensation in his scalp after eating a piece of chocolate cake.
0.9828 After approximately two weeks of sertraline treatment he noted an Adverse-Effectintense itching sensation in his scalp after eating a piece of chocolate cake.
Score Text
0.9995 Eosinophilia has been encountered from 0. 2 to 61. 7 % in Drugclozapine - treated patients, mostly with a transient course and spontaneous remission.
0.9980 Adverse-EffectEosinophilia has been encountered from 0. 2 to 61. 7 % in clozapine - treated patients, mostly with a transient course and spontaneous remission.
Score Text
0.9875 Acute intravascular hemolysis developed when a diabetic patient, previously treated with glyburide, was started on another oral sulfonylurea drug, Drugchlorpropamide .
0.9840 Acute intravascular hemolysis developed when a diabetic patient, previously treated with Drugglyburide , was started on another oral sulfonylurea drug, chlorpropamide.
0.9780 Adverse-EffectAcute intravascular hemolysis developed when a diabetic patient, previously treated with glyburide, was started on another oral sulfonylurea drug, chlorpropamide.
Score Text
0.9994 Thus, clinical recognition of sleep disordered breathing should be taken into account when rheumatoid arthritis patients are to be treated with Druginfliximab .
0.9799 Thus, clinical recognition of Adverse-Effectsleep disordered breathing should be taken into account when rheumatoid arthritis patients are to be treated with infliximab.
Score Text
0.9779 A patient with disseminated herpes zoster developed a syndrome of inappropriate antidiuretic hormone and profound hyponatremia secondary to the administration of Drugadenine arabinoside .
0.9702 A patient with disseminated herpes zoster developed a Adverse-Effectsyndrome of inappropriate antidiuretic hormone and profound hyponatremia secondary to the administration of adenine arabinoside.
0.9511 A patient with disseminated herpes zoster developed a syndrome of inappropriate antidiuretic hormone and profound Adverse-Effecthyponatremia secondary to the administration of adenine arabinoside.
Score Text
0.9996 CASE REPORT : We report a case of acute severe hepatitis resulting from Drugerlotinib monotherapy in a patient with locally advanced pancreatic cancer.
0.9610 CASE REPORT : We report a case of Adverse-Effectacute severe hepatitis resulting from erlotinib monotherapy in a patient with locally advanced pancreatic cancer.
Score Text
0.9994 Described here are 2 patients who developed thrombotic microangiopathy of the kidneys after receiving high cumulative doses of the new anticancer drug Druggemcitabine .
0.9860 Described here are 2 patients who developed Adverse-Effectthrombotic microangiopathy of the kidneys after receiving high cumulative doses of the new anticancer drug gemcitabine.
Score Text
0.9995 We report the first case of Drugchlorambucil - induced DRESS syndrome in a 70 - year - old man recently diagnosed with chronic lymphocytic leukaemia.
0.9927 We report the first case of chlorambucil - induced Adverse-EffectDRESS syndrome in a 70 - year - old man recently diagnosed with chronic lymphocytic leukaemia.
Score Text
0.9996 In this report, we describe a patient receiving Druglenalidomide in whom dyspnea, fever, hypoxia, and diffuse pulmonary infiltrates developed.
0.9982 In this report, we describe a patient receiving lenalidomide in whom Adverse-Effectdyspnea , fever, hypoxia, and diffuse pulmonary infiltrates developed.
0.9982 In this report, we describe a patient receiving lenalidomide in whom dyspnea, fever, Adverse-Effecthypoxia , and diffuse pulmonary infiltrates developed.
0.9896 In this report, we describe a patient receiving lenalidomide in whom dyspnea, Adverse-Effectfever , hypoxia, and diffuse pulmonary infiltrates developed.
0.9813 In this report, we describe a patient receiving lenalidomide in whom dyspnea, fever, hypoxia, and Adverse-Effectdiffuse pulmonary infiltrates developed.
Score Text
0.9989 Based on the Naranjo probability scale, serotonin syndrome was a probable adverse reaction associated with co - administration of Drugcitalopram and fentanyl.
0.9988 Based on the Naranjo probability scale, serotonin syndrome was a probable adverse reaction associated with co - administration of citalopram and Drugfentanyl .
0.9890 Based on the Naranjo probability scale, Adverse-Effectserotonin syndrome was a probable adverse reaction associated with co - administration of citalopram and fentanyl.
Score Text
0.9990 METHOD : The authors followed a patient with chronic HCV who received Druginterferon and ribavirin and who developed hallucinations ultimately requiring psychiatric hospitalization.
0.9990 METHOD : The authors followed a patient with chronic HCV who received interferon and Drugribavirin and who developed hallucinations ultimately requiring psychiatric hospitalization.
0.9987 METHOD : The authors followed a patient with chronic HCV who received interferon and ribavirin and who developed Adverse-Effecthallucinations ultimately requiring psychiatric hospitalization.
Score Text
0.9990 Case 2 : A 43 - year - old male alcoholic remained completely abstinent with Drugcyanamide treatment for 5 years and complained of general fatigue.
0.9931 Case 2 : A 43 - year - old male alcoholic remained completely abstinent with cyanamide treatment for 5 years and complained of Adverse-Effectgeneral fatigue .
Score Text
0.9991 A healthy, 30 - year - old man, exposed to Drugsulindac on two separate occasions, had an incapacitating isolated idential sensory neuropathy.
0.9674 A healthy, 30 - year - old man, exposed to sulindac on two separate occasions, had an incapacitating Adverse-Effectisolated idential sensory neuropathy .
Score Text
0.9994 According to the Naranjo et al. adverse - reaction probability scale, Drugenoxaparin was the probable cause of hepatotoxicity in this patient.
0.9968 According to the Naranjo et al. adverse - reaction probability scale, enoxaparin was the probable cause of Adverse-Effecthepatotoxicity in this patient.
Score Text
0.9995 CONCLUSIONS : Clinicians treating elderly patients with Drugolanzapine should be aware of the potential for rapidly developing hyperglycemia and monitor such patients accordingly.
0.9976 CONCLUSIONS : Clinicians treating elderly patients with olanzapine should be aware of the potential for rapidly developing Adverse-Effecthyperglycemia and monitor such patients accordingly.
Score Text
0.9992 We describe a patient with extranodal non - Hodgkin lymphoma who developed systemic candidiasis after treatment with a Drugcyclophosphamide - based chemotherapy regimen.
0.9933 We describe a patient with extranodal non - Hodgkin lymphoma who developed Adverse-Effectsystemic candidiasis after treatment with a cyclophosphamide - based chemotherapy regimen.
Score Text
0.9975 Mitomycin C ( MMC ) is an alkylating agent that has been recently associated with the hemolytic - uremic syndrome ( Adverse-EffectHUS ).
0.9944 Mitomycin C ( DrugMMC ) is an alkylating agent that has been recently associated with the hemolytic - uremic syndrome ( HUS ).
0.9876 DrugMitomycin C ( MMC ) is an alkylating agent that has been recently associated with the hemolytic - uremic syndrome ( HUS ).
0.9867 Mitomycin C ( MMC ) is an alkylating agent that has been recently associated with the Adverse-Effecthemolytic - uremic syndrome ( HUS ).
Score Text
0.9994 DISCUSSION : DrugOlanzapine , like other atypical antipsychotic drugs, may cause muscle injury with concomitant elevations of serum CK of muscle origin.
0.9621 DISCUSSION : Olanzapine, like other atypical antipsychotic drugs, may cause Adverse-Effectmuscle injury with concomitant elevations of serum CK of muscle origin.
DISCUSSION : Olanzapine, like other atypical antipsychotic drugs, may cause Adverse-Effectmuscle injury with concomitant elevations of serum CK of muscle origin.
Score Text
0.9994 CASE SUMMARY : Two children with attention deficit disorder treated with Drugmethylphenidate as a simple drug developed fixed drug eruption of the scrotum.
0.9433 CASE SUMMARY : Two children with attention deficit disorder treated with methylphenidate as a simple drug developed Adverse-Effectfixed drug eruption of the scrotum .
Score Text
0.9974 CONCLUSIONS : Jet - injection devices might constitute a helpful method to treat those patients affected by severe human insulin - induced Adverse-Effectlipoatrophy .
0.9907 CONCLUSIONS : Jet - injection devices might constitute a helpful method to treat those patients affected by severe Drughuman insulin - induced lipoatrophy.
Score Text
0.9992 Akathisia is a relatively rare side effect with the newer atypical antipsychotic agents, particularly Drugclozapine , and is easily misdiagnosed in children.
0.9986 Adverse-EffectAkathisia is a relatively rare side effect with the newer atypical antipsychotic agents, particularly clozapine, and is easily misdiagnosed in children.
Score Text
0.9995 METHODS / RESULTS : This paper presents a new case of Drugrifabutin uveitis and a review of the various published reports to date.
0.8683 METHODS / RESULTS : This paper presents a new case of rifabutin Adverse-Effectuveitis and a review of the various published reports to date.
Score Text
0.9993 Effect of beta - blockade on symptomatic Drugdexamethasone - induced hypertrophic obstructive cardiomyopathy in premature infants : three case reports and literature review.
0.9841 Effect of beta - blockade on symptomatic dexamethasone - induced Adverse-Effecthypertrophic obstructive cardiomyopathy in premature infants : three case reports and literature review.
Score Text
0.9935 OBJECTIVES : To describe the presentation and treatment of acute Drugisoniazid ( INH ) neurotoxicity appearing at an inner - city municipal hospital.
0.9880 OBJECTIVES : To describe the presentation and treatment of acute isoniazid ( DrugINH ) neurotoxicity appearing at an inner - city municipal hospital.
0.9641 OBJECTIVES : To describe the presentation and treatment of acute isoniazid ( INH ) Adverse-Effectneurotoxicity appearing at an inner - city municipal hospital.
Score Text
0.9992 An 11 - year - old boy developed a severe enteropathy 2 years after initiation of Drugclofazimine treatment for graft - versus - host disease.
0.9756 An 11 - year - old boy developed a Adverse-Effectsevere enteropathy 2 years after initiation of clofazimine treatment for graft - versus - host disease.
Score Text
0.9976 Because the cerebellar toxicity may be worsened by continuation of therapy after initial onset of symptoms, prompt termination of DrugHDARAC is recommended.
0.9870 Because the Adverse-Effectcerebellar toxicity may be worsened by continuation of therapy after initial onset of symptoms, prompt termination of HDARAC is recommended.
Score Text
0.9918 To our knowledge, this is the first case of spontaneous remission of MTX - associated Adverse-Effectgastric LPD after discontinuation of MTX therapy.
0.9561 To our knowledge, this is the first case of spontaneous remission of DrugMTX - associated gastric LPD after discontinuation of MTX therapy.
0.7789 To our knowledge, this is the first case of spontaneous remission of MTX - associated gastric LPD after discontinuation of DrugMTX therapy.
Score Text
0.9851 CONCLUSION : Under certain circumstances topical Drugbrimonidine can cause paradoxical raised IOP necessitating vigilance in follow - up of patients on topical brimonidine.
0.9714 CONCLUSION : Under certain circumstances topical brimonidine can cause Adverse-Effectparadoxical raised IOP necessitating vigilance in follow - up of patients on topical brimonidine.
0.9298 CONCLUSION : Under certain circumstances topical brimonidine can cause Adverse-Effectparadoxical raised IOP necessitating vigilance in follow - up of patients on topical brimonidine.
Score Text
0.9988 A case of Drugpropranolol overdose complicated by esophageal spasm preventing extrication of an orogastric lavage tube and relieved by intravenous glucagon is presented.
0.9768 A case of propranolol overdose complicated by Adverse-Effectesophageal spasm preventing extrication of an orogastric lavage tube and relieved by intravenous glucagon is presented.
Score Text
0.9995 We present the first case of ovarian endometrioid carcinoma and endometriosis in a postmenopausal patient who was treated with Drugtamoxifen for breast cancer.
0.9939 We present the first case of ovarian endometrioid carcinoma and Adverse-Effectendometriosis in a postmenopausal patient who was treated with tamoxifen for breast cancer.
0.9830 We present the first case of Adverse-Effectovarian endometrioid carcinoma and endometriosis in a postmenopausal patient who was treated with tamoxifen for breast cancer.
Score Text
0.9992 Clinicians should be cognizant of this possibility and consider a diagnosis of HDAs in patients with ongoing thrombosis who are receiving Drugheparin therapy.
0.8735 Clinicians should be cognizant of this possibility and consider a diagnosis of HDAs in patients with ongoing Adverse-Effectthrombosis who are receiving heparin therapy.
0.8767 Clinicians should be cognizant of this possibility and consider a diagnosis of Adverse-EffectHDAs in patients with ongoing thrombosis who are receiving heparin therapy.
Score Text
0.9851 Second cancers including various types of hematological malignancy have been reported in patients with hairy cell leukemia treated with chemotherapy or Druginterferon alfa .
0.9641 Adverse-EffectSecond cancers including various types of hematological malignancy have been reported in patients with hairy cell leukemia treated with chemotherapy or interferon alfa.
0.9513 Second cancers including various types of Adverse-Effecthematological malignancy have been reported in patients with hairy cell leukemia treated with chemotherapy or interferon alfa.
Score Text
0.9961 The abnormal rhythm disappeared with the withdrawal of Drugpropranolol and when the drug was restarted a 2 / 1 S - A block was seen.
0.9850 The Adverse-Effectabnormal rhythm disappeared with the withdrawal of propranolol and when the drug was restarted a 2 / 1 S - A block was seen.
Score Text
0.9995 In both cases, high fever, skin rash, liver dysfunction and atypical lymphocytosis developed 3 weeks after initiating treatment with DrugSASP .
0.9946 In both cases, Adverse-Effecthigh fever , skin rash, liver dysfunction and atypical lymphocytosis developed 3 weeks after initiating treatment with SASP.
0.9936 In both cases, high fever, Adverse-Effectskin rash , liver dysfunction and atypical lymphocytosis developed 3 weeks after initiating treatment with SASP.
0.9834 In both cases, high fever, skin rash, liver dysfunction and Adverse-Effectatypical lymphocytosis developed 3 weeks after initiating treatment with SASP.
0.9794 In both cases, high fever, skin rash, Adverse-Effectliver dysfunction and atypical lymphocytosis developed 3 weeks after initiating treatment with SASP.
Score Text
0.9956 We report the specifics of 12 cases of severe hypertension after the intraoperative use of topical Drugphenylephrine , submucosal epinephrine, or both.
0.9926 We report the specifics of 12 cases of severe hypertension after the intraoperative use of topical phenylephrine, submucosal Drugepinephrine , or both.
0.9851 We report the specifics of 12 cases of Adverse-Effectsevere hypertension after the intraoperative use of topical phenylephrine, submucosal epinephrine, or both.
Score Text
0.9996 RESULTS : Three patients who developed symptoms of inflammatory bowel disease ( IBD ) during Drugrofecoxib exposure are described along with pathology findings.
0.9924 RESULTS : Three patients who developed symptoms of inflammatory bowel disease ( Adverse-EffectIBD ) during rofecoxib exposure are described along with pathology findings.
0.9812 RESULTS : Three patients who developed symptoms of Adverse-Effectinflammatory bowel disease ( IBD ) during rofecoxib exposure are described along with pathology findings.
Score Text
0.9991 We report a case of secondary glaucoma caused by epithelial downgrowth in which filtration surgery was performed with adjunctive use of subconjunctival Drug5 - fluorouracil .
0.9906 We report a case of secondary Adverse-Effectglaucoma caused by epithelial downgrowth in which filtration surgery was performed with adjunctive use of subconjunctival 5 - fluorouracil.
Score Text
0.9990 We report an allogeneic bone marrow transplant recipient who developed CMV infection refractory to sequential therapy with ganciclovir, foscarnet, and Drugcidofovir .
0.9990 We report an allogeneic bone marrow transplant recipient who developed CMV infection refractory to sequential therapy with Drugganciclovir , foscarnet, and cidofovir.
0.9989 We report an allogeneic bone marrow transplant recipient who developed CMV infection refractory to sequential therapy with ganciclovir, Drugfoscarnet , and cidofovir.
0.9941 We report an allogeneic bone marrow transplant recipient who developed Adverse-EffectCMV infection refractory to sequential therapy with ganciclovir, foscarnet, and cidofovir.
Score Text
0.9977 Adverse-EffectPtosis occurring 24 h after chloroquine therapy, with full recovery 48 h after cessation of chloroquine, has not been described previously.
0.9925 Ptosis occurring 24 h after Drugchloroquine therapy, with full recovery 48 h after cessation of chloroquine, has not been described previously.
0.9884 Ptosis occurring 24 h after chloroquine therapy, with full recovery 48 h after cessation of Drugchloroquine , has not been described previously.
Score Text
0.9996 Dyspnea, hypoxemia, and pleuritic chest pain occurred within 24 hours of Drugrituximab administration, and there was no other apparent explanation.
0.9982 Adverse-EffectDyspnea , hypoxemia, and pleuritic chest pain occurred within 24 hours of rituximab administration, and there was no other apparent explanation.
0.9975 Dyspnea, Adverse-Effecthypoxemia , and pleuritic chest pain occurred within 24 hours of rituximab administration, and there was no other apparent explanation.
0.9898 Dyspnea, hypoxemia, and Adverse-Effectpleuritic chest pain occurred within 24 hours of rituximab administration, and there was no other apparent explanation.
Score Text
0.9987 Emphasis is given to the differentiation of Drugdiphenylhydantoin induced gingival hyperplasia from the angiomatous enlargement of the gingiva before any treatment is planned.
0.9927 Emphasis is given to the differentiation of diphenylhydantoin induced Adverse-Effectgingival hyperplasia from the angiomatous enlargement of the gingiva before any treatment is planned.
Score Text
0.9979 Most cases of Adverse-Effectpancreatitis associated with L - asparaginase toxicity are self - limiting and respond favorably to nasogastric decompression and intravenous hyperalimentation.
0.9681 Most cases of pancreatitis associated with DrugL - asparaginase toxicity are self - limiting and respond favorably to nasogastric decompression and intravenous hyperalimentation.
0.4759 Most cases of pancreatitis associated with Adverse-EffectL - asparaginase toxicity are self - limiting and respond favorably to nasogastric decompression and intravenous hyperalimentation.
Score Text
0.9994 We present a case of significant over - anticoagulation temporally associated with a bout of protracted diarrhea in a patient on Drugwarfarin therapy.
0.9713 We present a case of significant Adverse-Effectover - anticoagulation temporally associated with a bout of protracted diarrhea in a patient on warfarin therapy.
0.8912 We present a case of significant over - anticoagulation temporally associated with a bout of protracted Adverse-Effectdiarrhea in a patient on warfarin therapy.
Score Text
0.9993 Regardless of a negative history of asthma, therefore, life - threatening bronchospasm must be considered a possible complication of Drugpropranolol therapy.
0.9778 Regardless of a negative history of asthma, therefore, life - threatening Adverse-Effectbronchospasm must be considered a possible complication of propranolol therapy.
Score Text
0.9994 After three weeks of Drugcarbamazepine therapy, the patient arrived at the emergency department ( ED ) with severe agitation and aggressive behavior.
0.9936 After three weeks of carbamazepine therapy, the patient arrived at the emergency department ( ED ) with severe agitation and Adverse-Effectaggressive behavior .
0.9916 After three weeks of carbamazepine therapy, the patient arrived at the emergency department ( ED ) with Adverse-Effectsevere agitation and aggressive behavior.
Score Text
0.9970 We report the case of intoxication of a 41 - year - old female patient suffering from major depression with Drugmirtazapine complicated by severe hypothermia.
0.9859 We report the case of Adverse-Effectintoxication of a 41 - year - old female patient suffering from major depression with mirtazapine complicated by severe hypothermia.
0.7986 We report the case of intoxication of a 41 - year - old female patient suffering from major depression with mirtazapine complicated by Adverse-Effectsevere hypothermia .
Score Text
0.9898 A 57 - year - old woman developed Adverse-Effectpulmonary sarcoidosis during therapy with interferon beta for advanced renal cell carcinoma metastatic to mediastinal lymph nodes.
0.9865 A 57 - year - old woman developed pulmonary sarcoidosis during therapy with Druginterferon beta for advanced renal cell carcinoma metastatic to mediastinal lymph nodes.
Score Text
0.9945 In addition to the recognized arrhythmic complications, the authors emphasize myocardial necrosis as a possible further manifestation of Drugamsacrine - related cardiotoxicity.
0.9926 In addition to the recognized arrhythmic complications, the authors emphasize myocardial necrosis as a possible further manifestation of amsacrine - related Adverse-Effectcardiotoxicity .
0.8592 In addition to the recognized arrhythmic complications, the authors emphasize Adverse-Effectmyocardial necrosis as a possible further manifestation of amsacrine - related cardiotoxicity.
Score Text
0.9996 This article presents a case of an atypical localized cutaneous eruption with an unusual course and protracted resolution time associated with Drugsorafenib therapy.
0.9511 This article presents a case of an Adverse-Effectatypical localized cutaneous eruption with an unusual course and protracted resolution time associated with sorafenib therapy.
Score Text
0.9917 Infant twins sustained severe circumoral and pharyngeal burns from a concentrated solution of Drugbenzalkonium ( Zephiran ) chloride prescribed for treatment of candidiasis.
0.9915 Infant twins sustained severe circumoral and pharyngeal burns from a concentrated solution of benzalkonium ( DrugZephiran ) chloride prescribed for treatment of candidiasis.
0.8723 Infant twins sustained Adverse-Effectsevere circumoral and pharyngeal burns from a concentrated solution of benzalkonium ( Zephiran ) chloride prescribed for treatment of candidiasis.
Infant twins sustained severe Adverse-Effectcircumoral and pharyngeal burns from a concentrated solution of benzalkonium ( Zephiran ) chloride prescribed for treatment of candidiasis.
Score Text
0.9979 Epstein - Barr virus - associated lymphoproliferative disorder in a patient with rheumatoid arthritis on methotrexate and Drugrofecoxib : idiosyncratic reaction or pharmacogenetics?
0.9976 Epstein - Barr virus - associated lymphoproliferative disorder in a patient with rheumatoid arthritis on Drugmethotrexate and rofecoxib : idiosyncratic reaction or pharmacogenetics?
0.9600 Adverse-EffectEpstein - Barr virus - associated lymphoproliferative disorder in a patient with rheumatoid arthritis on methotrexate and rofecoxib : idiosyncratic reaction or pharmacogenetics?
Score Text
0.9988 DrugNorethisterone in these 69 pregnancies accounted for 33. 3 % ( 5 of 15 ) cases of clitoral hypertrophy diagnosed in 100, 756 consecutive births.
0.9916 Norethisterone in these 69 pregnancies accounted for 33. 3 % ( 5 of 15 ) cases of Adverse-Effectclitoral hypertrophy diagnosed in 100, 756 consecutive births.
Score Text
0.9989 The ocular toxicity of DrugDCF , previously described as conjunctivitis, appears to be a keratitis of moderate severity which requires further study.
0.9947 The ocular toxicity of DCF, previously described as conjunctivitis, appears to be a Adverse-Effectkeratitis of moderate severity which requires further study.
0.9897 The ocular toxicity of DCF, previously described as Adverse-Effectconjunctivitis , appears to be a keratitis of moderate severity which requires further study.
0.9536 The Adverse-Effectocular toxicity of DCF, previously described as conjunctivitis, appears to be a keratitis of moderate severity which requires further study.
Score Text
0.9995 We report a rare case of recurrent ( stuttering ) priapism in a patient with protein C deficiency while maintained on DrugWarfarin therapy.
0.9696 We report a rare case of recurrent ( Adverse-Effectstuttering ) priapism in a patient with protein C deficiency while maintained on Warfarin therapy.
0.9147 We report a rare case of recurrent ( stuttering ) Adverse-Effectpriapism in a patient with protein C deficiency while maintained on Warfarin therapy.
Score Text
0.9978 We report a case of severe respiratory failure due to Druggold salt toxicity in a patient suffering from rheumatoid arthritis requiring mechanical ventilation.
0.7047 We report a case of severe Adverse-Effectrespiratory failure due to gold salt toxicity in a patient suffering from rheumatoid arthritis requiring mechanical ventilation.
0.8865 We report a case of Adverse-Effectsevere respiratory failure due to gold salt toxicity in a patient suffering from rheumatoid arthritis requiring mechanical ventilation.
Score Text
0.9921 He was diagnosed with possible Adverse-Effectserotonin syndrome ; his symptoms resolved after clomipramine was stopped but before clozapine was restarted eight days later.
0.9585 He was diagnosed with possible serotonin syndrome ; his symptoms resolved after Drugclomipramine was stopped but before clozapine was restarted eight days later.
0.7189 He was diagnosed with possible serotonin syndrome ; his symptoms resolved after clomipramine was stopped but before Drugclozapine was restarted eight days later.
Score Text
0.9973 Since amiodarone was first marketed in 1992 in Japan, the incidence of amiodarone - induced Adverse-Effectthyrotoxicosis ( AIT ) has been increasing.
0.9414 Since amiodarone was first marketed in 1992 in Japan, the incidence of Drugamiodarone - induced thyrotoxicosis ( AIT ) has been increasing.
0.8776 Since amiodarone was first marketed in 1992 in Japan, the incidence of amiodarone - induced thyrotoxicosis ( Adverse-EffectAIT ) has been increasing.
0.5573 Since Drugamiodarone was first marketed in 1992 in Japan, the incidence of amiodarone - induced thyrotoxicosis ( AIT ) has been increasing.
Score Text
0.9993 A patient suffering from a rare enzyme deficiency developed a malignant neuroleptic syndrome after having been treated with one single dose of Drughaloperidol .
0.9889 A patient suffering from a rare enzyme deficiency developed a Adverse-Effectmalignant neuroleptic syndrome after having been treated with one single dose of haloperidol.
Score Text
0.9934 One of the subjects who was using extemporaneous topical minoxidil had Adverse-Effecthypertension and arteriosclerotic disease and the other died of a myocardial infarction.
0.9915 One of the subjects who was using extemporaneous topical Drugminoxidil had hypertension and arteriosclerotic disease and the other died of a myocardial infarction.
0.9885 One of the subjects who was using extemporaneous topical minoxidil had hypertension and arteriosclerotic disease and the other died of a Adverse-Effectmyocardial infarction .
0.9765 One of the subjects who was using extemporaneous topical minoxidil had hypertension and Adverse-Effectarteriosclerotic disease and the other died of a myocardial infarction.
Score Text
0.9849 Adverse-EffectAutoimmune thyroid disease is a common side - effect of interferon - alpha ( IFN - alpha ) treatment of viral hepatitis C.
0.9667 Autoimmune thyroid disease is a common side - effect of Druginterferon - alpha ( IFN - alpha ) treatment of viral hepatitis C.
0.9537 Autoimmune thyroid disease is a common side - effect of interferon - alpha ( DrugIFN - alpha ) treatment of viral hepatitis C.
Score Text
0.9964 A noninvasive method in the differential diagnosis of vecuronium - induced and Drugmagnesium - induced protracted neuromuscular block in a severely preeclamptic patient.
0.9898 A noninvasive method in the differential diagnosis of Drugvecuronium - induced and magnesium - induced protracted neuromuscular block in a severely preeclamptic patient.
0.9708 A noninvasive method in the differential diagnosis of vecuronium - induced and magnesium - induced Adverse-Effectprotracted neuromuscular block in a severely preeclamptic patient.
Score Text
0.9991 The patient received only the ophthalmic Drugsulfonamide , and it was used for one day, but he developed Stevens - Johnson syndrome.
0.9829 The patient received only the ophthalmic sulfonamide, and it was used for one day, but he developed Adverse-EffectStevens - Johnson syndrome .
Score Text
0.9930 This review presents the first case series of DIC associated with acute hemoglobinemia or Adverse-Effecthemoglobinuria following anti - D IGIV administration for ITP.
0.9927 This review presents the first case series of Adverse-EffectDIC associated with acute hemoglobinemia or hemoglobinuria following anti - D IGIV administration for ITP.
0.9891 This review presents the first case series of DIC associated with Adverse-Effectacute hemoglobinemia or hemoglobinuria following anti - D IGIV administration for ITP.
0.9750 This review presents the first case series of DIC associated with acute hemoglobinemia or hemoglobinuria following Druganti - D IGIV administration for ITP.
Score Text
0.9889 Patient A reported Adverse-Effectright leg weakness ( foot drop ) during week 4 of CAP - XRT ( 1600 mg / m2 ).
0.9872 Patient A reported right leg weakness ( Adverse-Effectfoot drop ) during week 4 of CAP - XRT ( 1600 mg / m2 ).
0.9733 Patient A reported right leg weakness ( foot drop ) during week 4 of DrugCAP - XRT ( 1600 mg / m2 ).
Score Text
0.9984 Two case reports of bilateral granulomatous anterior uveitis are described in patients with open angle glaucoma treated with Drugmetripranolol 0. 6 % eye drops.
0.9841 Two case reports of Adverse-Effectbilateral granulomatous anterior uveitis are described in patients with open angle glaucoma treated with metripranolol 0. 6 % eye drops.
Score Text
0.9994 CASE SUMMARY : A 58 - year - old white woman developed fulminant liver failure while being treated with the macrolide antibiotic Drugclarithromycin for pneumonia.
0.9896 CASE SUMMARY : A 58 - year - old white woman developed Adverse-Effectfulminant liver failure while being treated with the macrolide antibiotic clarithromycin for pneumonia.
Score Text
0.9991 DrugMethamphetamine ' s extensive physiologic effects, inconsistent street purity, and multiple routes of administration offer many possibilities for injury to the cornea.
0.9742 Methamphetamine's extensive physiologic effects, inconsistent street purity, and multiple routes of administration offer many possibilities for Adverse-Effectinjury to the cornea .
Score Text
0.9977 TREATMENT / OUTCOME : Standard anti - tuberculosis therapy was administered but was complicated by interaction with cyclosporine and drug - induced Adverse-Effectcholestasis .
0.9972 TREATMENT / OUTCOME : Standard anti - tuberculosis therapy was administered but was complicated by interaction with Drugcyclosporine and drug - induced cholestasis.
Score Text
0.9990 We suggest that objective evaluation of retinal function with electrophysiological methods should be performed in patients with visual disturbance during treatment with Drugrifabutin .
0.9776 We suggest that objective evaluation of retinal function with electrophysiological methods should be performed in patients with Adverse-Effectvisual disturbance during treatment with rifabutin.
Score Text
0.9989 After reviewing the literature we suggest the CPM was a complication of Druglithium toxicity which affected the lateral geniculate nucleus which produced blindness.
0.9960 After reviewing the literature we suggest the CPM was a complication of lithium toxicity which affected the lateral geniculate nucleus which produced Adverse-Effectblindness .
0.9935 After reviewing the literature we suggest the Adverse-EffectCPM was a complication of lithium toxicity which affected the lateral geniculate nucleus which produced blindness.
Score Text
0.9993 The pathophysiological mechanisms remain unknown, although the drug could act through massive cytokines liberation after destruction of CD20 positive cells by Drugrituximab .
0.9659 The pathophysiological mechanisms remain unknown, although the drug could act through Adverse-Effectmassive cytokines liberation after destruction of CD20 positive cells by rituximab.
0.9564 The pathophysiological mechanisms remain unknown, although the drug could act through massive cytokines liberation after Adverse-Effectdestruction of CD20 positive cells by rituximab.
Score Text
0.9995 We report a case of a patient with Drugciprofloxacin - induced SJS and acute onset of VBDS, and reviewed the related literature.
0.9973 We report a case of a patient with ciprofloxacin - induced Adverse-EffectSJS and acute onset of VBDS, and reviewed the related literature.
0.9973 We report a case of a patient with ciprofloxacin - induced SJS and acute onset of Adverse-EffectVBDS , and reviewed the related literature.
Score Text
0.9994 CONCLUSION : DrugZidovudine is well a known cause of anaemia and thus should be used with caution in the initiation of antiretroviral therapy.
0.9977 CONCLUSION : Zidovudine is well a known cause of Adverse-Effectanaemia and thus should be used with caution in the initiation of antiretroviral therapy.
Score Text
0.9993 Motor fluctuations appear after 2 - 3 years of Druglevodopa treatment, and affect at least 50 % of patients after five years.
0.9927 Adverse-EffectMotor fluctuations appear after 2 - 3 years of levodopa treatment, and affect at least 50 % of patients after five years.
Score Text
0.9988 The second patient experienced mild nitritoid symptoms following several DrugGSTM injections prior experiencing a cerebrovascular accident within several hours of her next injection.
0.9890 The second patient experienced Adverse-Effectmild nitritoid symptoms following several GSTM injections prior experiencing a cerebrovascular accident within several hours of her next injection.
0.7810 The second patient experienced mild nitritoid symptoms following several GSTM injections prior experiencing a Adverse-Effectcerebrovascular accident within several hours of her next injection.
Score Text
0.9958 We describe a case of fibrosing alveolitis, diagnosed by lung biopsy, in a patient receiving Drugamiodarone which responded to corticosteroid therapy.
0.9866 We describe a case of Adverse-Effectfibrosing alveolitis , diagnosed by lung biopsy, in a patient receiving amiodarone which responded to corticosteroid therapy.
Score Text
0.9991 One type of SMON is associated with acrodermatitis enteropathica which has a very high frequency of occurrence in association with administration of Drugclioquinol .
0.9925 One type of Adverse-EffectSMON is associated with acrodermatitis enteropathica which has a very high frequency of occurrence in association with administration of clioquinol.
0.9796 One type of SMON is associated with Adverse-Effectacrodermatitis enteropathica which has a very high frequency of occurrence in association with administration of clioquinol.
Score Text
0.9995 Intrahepatic cholestasis and cutaneous bullae associated with Drugglibenclamide therapy are described in a 61 - year - old diabetic patient who presented wit hypoglycaemic coma.
0.9914 Intrahepatic cholestasis and Adverse-Effectcutaneous bullae associated with glibenclamide therapy are described in a 61 - year - old diabetic patient who presented wit hypoglycaemic coma.
0.9901 Adverse-EffectIntrahepatic cholestasis and cutaneous bullae associated with glibenclamide therapy are described in a 61 - year - old diabetic patient who presented wit hypoglycaemic coma.
Score Text
0.9791 We present a case of severe unilateral posterior scleritis associated with Drugzoledronic acid administration that was recognized and treated in a timely manner.
0.9761 We present a case of Adverse-Effectsevere unilateral posterior scleritis associated with zoledronic acid administration that was recognized and treated in a timely manner.
Score Text
0.9993 Both had impaired lung function and abnormal computed tomographic scans, and their condition improved when Drugnitrofurantoin was withdrawn and corticosteroid treatment commenced.
0.9469 Both had impaired lung function and Adverse-Effectabnormal computed tomographic scans , and their condition improved when nitrofurantoin was withdrawn and corticosteroid treatment commenced.
0.9386 Both had Adverse-Effectimpaired lung function and abnormal computed tomographic scans, and their condition improved when nitrofurantoin was withdrawn and corticosteroid treatment commenced.
Score Text
0.9988 We report the first biopsy confirmed occurrence of acute interstitial nephritis in a patient receiving treatment with DrugSunitinib for metastatic renal cell cancer.
0.9795 We report the first biopsy confirmed occurrence of Adverse-Effectacute interstitial nephritis in a patient receiving treatment with Sunitinib for metastatic renal cell cancer.
Score Text
0.9974 DrugMeperidine - associated central nervous system ( CNS ) excitatory toxicities are believed to be caused by accumulation of the active metabolite normeperidine.
0.7770 Meperidine - associated Adverse-Effectcentral nervous system ( CNS ) excitatory toxicities are believed to be caused by accumulation of the active metabolite normeperidine.
0.5135 Meperidine - associated central nervous system ( CNS ) excitatory toxicities are believed to be caused by Adverse-Effectaccumulation of the active metabolite normeperidine .
0.9671 Meperidine - associated central nervous system ( CNS ) excitatory toxicities are believed to be caused by Adverse-Effectaccumulation of the active metabolite normeperidine.
Score Text
0.9877 Amiodarone is well recognized as an anti - arrhythmic drug containing a high dose of iodine with considerable potential to cause Adverse-Effectthyroid dysfunction .
0.9856 DrugAmiodarone is well recognized as an anti - arrhythmic drug containing a high dose of iodine with considerable potential to cause thyroid dysfunction.
0.5127 Amiodarone is well recognized as an anti - arrhythmic drug containing a high dose of Drugiodine with considerable potential to cause thyroid dysfunction.
Score Text
0.9995 A case report of the hypersensitivity syndrome occurring in a patient being treated with Drugdapsone for a brown recluse spider bite is presented.
0.9911 A case report of the Adverse-Effecthypersensitivity syndrome occurring in a patient being treated with dapsone for a brown recluse spider bite is presented.
Score Text
0.9953 Physicians who use sulfasalazine to treat patients with inflammatory bowel disease should be aware of the signs of sulfasalazine - induced Adverse-Effectlupus syndrome .
0.9775 Physicians who use sulfasalazine to treat patients with inflammatory bowel disease should be aware of the signs of Drugsulfasalazine - induced lupus syndrome.
0.8945 Physicians who use Drugsulfasalazine to treat patients with inflammatory bowel disease should be aware of the signs of sulfasalazine - induced lupus syndrome.
Score Text
0.9995 In this article, we describe a Japanese patient with severe interstitial pneumonia probably caused by Drugsorafenib treatment for metastatic renal cell carcinoma.
0.8152 In this article, we describe a Japanese patient with Adverse-Effectsevere interstitial pneumonia probably caused by sorafenib treatment for metastatic renal cell carcinoma.
0.8862 In this article, we describe a Japanese patient with severe Adverse-Effectinterstitial pneumonia probably caused by sorafenib treatment for metastatic renal cell carcinoma.
Score Text
0.9994 Recognizing early signs of HMSN, such as areflexia and pes cavus deformity, can prevent severe neurotoxicity of polychemotherapy by avoiding Drugvincristine .
0.8656 Recognizing early signs of HMSN, such as areflexia and pes cavus deformity, can prevent Adverse-Effectsevere neurotoxicity of polychemotherapy by avoiding vincristine.
Score Text
0.9994 She was diagnosed with Epstein - Barr virus - associated polymorphic lymphoproliferative disorder ( LPD ) due to immunodeficiency caused by DrugMTX administration.
0.9807 She was diagnosed with Epstein - Barr virus - associated polymorphic lymphoproliferative disorder ( Adverse-EffectLPD ) due to immunodeficiency caused by MTX administration.
0.9705 She was diagnosed with Epstein - Barr virus - associated polymorphic lymphoproliferative disorder ( LPD ) due to Adverse-Effectimmunodeficiency caused by MTX administration.
0.8888 She was diagnosed with Adverse-EffectEpstein - Barr virus - associated polymorphic lymphoproliferative disorder ( LPD ) due to immunodeficiency caused by MTX administration.
Score Text
0.9994 We present three cases from the Provincial Toxicology Center of British Columbia, Canada in which suicidal overdose deaths were associated with Drugquetiapine .
0.9715 We present three cases from the Provincial Toxicology Center of British Columbia, Canada in which Adverse-Effectsuicidal overdose deaths were associated with quetiapine.
Score Text
0.9991 Although Drugtaxol has shown significant activity in advanced ovarian cancer, peripheral neuropathy is likely to become the major dose - limiting toxicity.
0.9773 Although taxol has shown significant activity in advanced ovarian cancer, Adverse-Effectperipheral neuropathy is likely to become the major dose - limiting toxicity.
Score Text
0.9986 It was concluded that ANCA is closely related to the pathogenesis of crescentic glomerulonephritis and that treatment with DrugPTU appeared to induce ANCA.
0.9970 It was concluded that ANCA is closely related to the pathogenesis of crescentic glomerulonephritis and that treatment with PTU appeared to induce Adverse-EffectANCA .
0.9946 It was concluded that Adverse-EffectANCA is closely related to the pathogenesis of crescentic glomerulonephritis and that treatment with PTU appeared to induce ANCA.
Score Text
0.9971 We recommend the cautious use of ketorolac in patients with underlying illnesses where NSAID - induced Adverse-Effectototoxicity could result in adverse otologic consequences.
0.9863 We recommend the cautious use of Drugketorolac in patients with underlying illnesses where NSAID - induced ototoxicity could result in adverse otologic consequences.
Score Text
0.9980 Adverse-EffectAnaphylaxis to cisplatin is an infrequent life - threatening complication which may occur even in patients who have received prior treatment with cisplatin.
0.9474 Anaphylaxis to Drugcisplatin is an infrequent life - threatening complication which may occur even in patients who have received prior treatment with cisplatin.
Score Text
0.9987 We describe a case of significant elevation of serum transaminases in a patient treated with Drug6 - TG for a flare of Crohn's disease.
0.9805 We describe a case of significant Adverse-Effectelevation of serum transaminases in a patient treated with 6 - TG for a flare of Crohn's disease.
Score Text
0.9784 RESULTS : Similar to previous findings of drug - induced Adverse-Effectvortex keratopathy , atovaquone vortex keratopathy is presumably caused by its lipophilic properties.
0.9135 RESULTS : Similar to previous findings of drug - induced vortex keratopathy, atovaquone Adverse-Effectvortex keratopathy is presumably caused by its lipophilic properties.
0.8975 RESULTS : Similar to previous findings of drug - induced vortex keratopathy, Drugatovaquone vortex keratopathy is presumably caused by its lipophilic properties.
Score Text
0.9995 CONCLUSION : Although a definite association has not been proven, clinicians should be aware of the possibility of agranulocytosis while using Drugquetiapine .
0.9971 CONCLUSION : Although a definite association has not been proven, clinicians should be aware of the possibility of Adverse-Effectagranulocytosis while using quetiapine.
Score Text
0.9995 A 54 - year - old man developed TEN 4 weeks after beginning Druglamotrigine for complex partial seizures related to a glioblastoma multiforme brain tumor.
0.9989 A 54 - year - old man developed Adverse-EffectTEN 4 weeks after beginning lamotrigine for complex partial seizures related to a glioblastoma multiforme brain tumor.
Score Text
0.9740 We have safely used recombinant factor VIIa to treat bleeding in the immediate and long - term period following PCC - related Adverse-EffectMI .
0.9485 We have safely used recombinant factor VIIa to treat bleeding in the immediate and long - term period following DrugPCC - related MI.
0.6563 We have safely used Drugrecombinant factor VIIa to treat bleeding in the immediate and long - term period following PCC - related MI.
Score Text
0.9995 We report a patient with inoperable pancreatic cancer who developed gastrointestinal bleeding secondary to radiation - recall related to Druggemcitabine and review literature.
0.9909 We report a patient with inoperable pancreatic cancer who developed Adverse-Effectgastrointestinal bleeding secondary to radiation - recall related to gemcitabine and review literature.
0.9819 We report a patient with inoperable pancreatic cancer who developed gastrointestinal bleeding secondary to Adverse-Effectradiation - recall related to gemcitabine and review literature.
Score Text
0.9883 METHODS : Adverse-EffectGrowth retardation was observed in six severely asthmatic children after introduction of high - dose fluticasone propionate treatment ( dry powder ).
0.9786 METHODS : Growth retardation was observed in six severely asthmatic children after introduction of high - dose Drugfluticasone propionate treatment ( dry powder ).
Score Text
0.9994 We report the case of a 40 - year - old woman who developed fulminant hepatic failure and aplastic anaemia following a course of oral Drugflucloxacillin .
0.9915 We report the case of a 40 - year - old woman who developed fulminant hepatic failure and Adverse-Effectaplastic anaemia following a course of oral flucloxacillin.
0.9876 We report the case of a 40 - year - old woman who developed Adverse-Effectfulminant hepatic failure and aplastic anaemia following a course of oral flucloxacillin.
Score Text
0.9988 The hospital course of the acute renal failure is presented with a review of the literature on cases of acute renal failure after DrugIVIG .
0.9711 The hospital course of the acute renal failure is presented with a review of the literature on cases of Adverse-Effectacute renal failure after IVIG.
Score Text
0.9931 Use of the Naranjo probability scale indicated a highly probable relationship between the observed Adverse-Effectcardiac toxicity and amphotericin B deoxycholate therapy in this patient.
0.9741 Use of the Naranjo probability scale indicated a highly probable relationship between the observed cardiac toxicity and Drugamphotericin B deoxycholate therapy in this patient.
Score Text
0.9931 We describe 2 patients with cutaneous lupus erythematosus who developed severe Drugdapsone reaction after low dose therapy, with a fatal outcome in one.
0.7561 We describe 2 patients with cutaneous lupus erythematosus who developed severe dapsone reaction after low dose therapy, with a Adverse-Effectfatal outcome in one.
0.6010 We describe 2 patients with cutaneous lupus erythematosus who developed severe Adverse-Effectdapsone reaction after low dose therapy, with a fatal outcome in one.
0.8940 We describe 2 patients with cutaneous lupus erythematosus who developed severe dapsone reaction after low dose therapy, with a Adverse-Effectfatal outcome in one.
Score Text
0.9995 CONCLUSIONS : Because of its structural similarity to the other vinca alkaloids, Drugvinorelbine is believed to be responsible for SIADH in our patient.
0.9976 CONCLUSIONS : Because of its structural similarity to the other vinca alkaloids, vinorelbine is believed to be responsible for Adverse-EffectSIADH in our patient.
Score Text
0.9923 Interferon - based treatments have the potential to decrease the burden of disease, but are complicated by side effects, including Adverse-Effectneuropsychiatric symptoms .
0.9894 DrugInterferon - based treatments have the potential to decrease the burden of disease, but are complicated by side effects, including neuropsychiatric symptoms.
Score Text
0.9988 Severe osteomalacia was present in two epileptic patients who were under long - term treatment with congeners of phenytoin, phenobarbital, and Drugacetazolamide .
0.9987 Severe osteomalacia was present in two epileptic patients who were under long - term treatment with congeners of phenytoin, Drugphenobarbital , and acetazolamide.
0.9985 Severe osteomalacia was present in two epileptic patients who were under long - term treatment with congeners of Drugphenytoin , phenobarbital, and acetazolamide.
0.6728 Adverse-EffectSevere osteomalacia was present in two epileptic patients who were under long - term treatment with congeners of phenytoin, phenobarbital, and acetazolamide.
Score Text
0.9991 Acute myeloid leukemia and lung cancer occurring in a chronic lymphocytic leukemia patient treated with Drugfludarabine and autologous peripheral blood stem - cell transplantation.
0.9905 Acute myeloid leukemia and Adverse-Effectlung cancer occurring in a chronic lymphocytic leukemia patient treated with fludarabine and autologous peripheral blood stem - cell transplantation.
0.9796 Adverse-EffectAcute myeloid leukemia and lung cancer occurring in a chronic lymphocytic leukemia patient treated with fludarabine and autologous peripheral blood stem - cell transplantation.
Score Text
0.9998 OBJECTIVE : 1 ) To describe a patient with rheumatoid arthritis receiving Drugadalimumab who developed fever, pancytopenia, splenomegaly, and extreme hyperferritinemia.
0.9977 OBJECTIVE : 1 ) To describe a patient with rheumatoid arthritis receiving adalimumab who developed fever, Adverse-Effectpancytopenia , splenomegaly, and extreme hyperferritinemia.
0.9975 OBJECTIVE : 1 ) To describe a patient with rheumatoid arthritis receiving adalimumab who developed fever, pancytopenia, Adverse-Effectsplenomegaly , and extreme hyperferritinemia.
0.9903 OBJECTIVE : 1 ) To describe a patient with rheumatoid arthritis receiving adalimumab who developed fever, pancytopenia, splenomegaly, and Adverse-Effectextreme hyperferritinemia .
0.9888 OBJECTIVE : 1 ) To describe a patient with rheumatoid arthritis receiving adalimumab who developed Adverse-Effectfever , pancytopenia, splenomegaly, and extreme hyperferritinemia.
Score Text
0.9995 The hyperpigmentation was diffuse scattered, flagellate like and linear streaking which was thought to be mainly related to the skin toxicity of Drugbleomycin .
0.9808 The hyperpigmentation was diffuse scattered, flagellate like and linear streaking which was thought to be mainly related to the Adverse-Effectskin toxicity of bleomycin.
Score Text
0.9917 OBJECTIVE : This case report outlines a significant type of morbidity due to continued use of Druggabapentin during an episode of acute renal failure.
0.9503 OBJECTIVE : This case report outlines a significant type of morbidity due to continued use of gabapentin during an episode of Adverse-Effectacute renal failure .
Score Text
0.9993 The findings were judged to be consistent with soft - tissue injury associated with intravenous administration of Drugphenytoin , also termed purple glove syndrome.
0.9849 The findings were judged to be consistent with Adverse-Effectsoft - tissue injury associated with intravenous administration of phenytoin, also termed purple glove syndrome.
0.9845 The findings were judged to be consistent with soft - tissue injury associated with intravenous administration of phenytoin, also termed Adverse-Effectpurple glove syndrome .
Score Text
0.9937 Several case reports of Adverse-Effectaplastic anemia with use of acetazolamide, and two cases with use of methazolamide, have appeared in the literature.
0.9842 Several case reports of aplastic anemia with use of Drugacetazolamide , and two cases with use of methazolamide, have appeared in the literature.
0.9773 Several case reports of aplastic anemia with use of acetazolamide, and two cases with use of Drugmethazolamide , have appeared in the literature.
Score Text
0.9993 A 2 - year - old mentally retarded boy with frontal lobe epilepsy presented with an episode that resembled heat stroke during the administration of Drugzonisamide .
0.9923 A 2 - year - old mentally retarded boy with frontal lobe epilepsy presented with an episode that resembled Adverse-Effectheat stroke during the administration of zonisamide.
Score Text
0.9973 Fracture of the femoral neck occurred in one patient during DrugPSL therapy, although the relationship between the fracture and PSL therapy was uncertain.
0.9817 Adverse-EffectFracture of the femoral neck occurred in one patient during PSL therapy, although the relationship between the fracture and PSL therapy was uncertain.
Score Text
0.9962 Despite a postulated dopaminergic mechanism, there seems to have been only one previous report of Drugamantadine ' s precipitating psychosis in a schizophrenic patient.
0.9734 Despite a postulated dopaminergic mechanism, there seems to have been only one previous report of amantadine's Adverse-Effectprecipitating psychosis in a schizophrenic patient.
Score Text
0.9992 We report a 78 - year - old man who had acute unilateral total visual loss after retrogasserian Drugphenol injection for the treatment of trigeminal neuralgia.
0.9886 We report a 78 - year - old man who had Adverse-Effectacute unilateral total visual loss after retrogasserian phenol injection for the treatment of trigeminal neuralgia.
Score Text
0.9994 In addition to its known effect on gallbladder stasis, Drugoctreotide alters bile acid composition and may thus hasten intrahepatic sludge and stone formation.
0.9679 In addition to its known effect on gallbladder stasis, octreotide alters bile acid composition and may thus Adverse-Effecthasten intrahepatic sludge and stone formation.
0.9593 In addition to its known effect on gallbladder stasis, octreotide alters bile acid composition and may thus hasten intrahepatic sludge and Adverse-Effectstone formation .
0.9169 In addition to its known effect on Adverse-Effectgallbladder stasis , octreotide alters bile acid composition and may thus hasten intrahepatic sludge and stone formation.
0.8598 In addition to its known effect on gallbladder stasis, octreotide Adverse-Effectalters bile acid composition and may thus hasten intrahepatic sludge and stone formation.
Score Text
0.9993 To our knowledge, this is the first case reported in the English literature of a generalized exanthem due to subcutaneous injection of Drugenoxaparin .
0.9885 To our knowledge, this is the first case reported in the English literature of a Adverse-Effectgeneralized exanthem due to subcutaneous injection of enoxaparin.
Score Text
0.9987 In keeping with findings in the literature, the aortic wall in this case was damaged by secondary changes following irradiation and DrugBleomycin treatment.
0.8952 In keeping with findings in the literature, the Adverse-Effectaortic wall in this case was damaged by secondary changes following irradiation and Bleomycin treatment.
Score Text
0.9991 We report the case of a patient with increased cerebral cortical excitability following intoxication with Drugflupirtine , a centrally acting analgesic and antispastic drug.
0.9791 We report the case of a patient with Adverse-Effectincreased cerebral cortical excitability following intoxication with flupirtine, a centrally acting analgesic and antispastic drug.
Score Text
0.9929 A 10 - year - old asthmatic boy began to suffer from Adverse-Effecturticarial rash and moderately severe bronchospasm after 8 weeks'treatment with disodium cromoglycate.
0.9724 A 10 - year - old asthmatic boy began to suffer from urticarial rash and moderately severe bronchospasm after 8 weeks'treatment with Drugdisodium cromoglycate .
0.9526 A 10 - year - old asthmatic boy began to suffer from urticarial rash and Adverse-Effectmoderately severe bronchospasm after 8 weeks'treatment with disodium cromoglycate.
Score Text
0.9989 We report a case of long lasting respiratory depression after intravenous administration of Drugmorphine to a 7 year old girl with haemolytic uraemic syndrome.
0.9884 We report a case of long lasting Adverse-Effectrespiratory depression after intravenous administration of morphine to a 7 year old girl with haemolytic uraemic syndrome.
Score Text
0.9860 We believe that these skin eruptions belong to a spectrum of Adverse-Effectneutrophilic dermatoses that can be induced or aggravated by G - CSF therapy.
0.9860 We believe that these Adverse-Effectskin eruptions belong to a spectrum of neutrophilic dermatoses that can be induced or aggravated by G - CSF therapy.
0.9752 We believe that these skin eruptions belong to a spectrum of neutrophilic dermatoses that can be induced or aggravated by DrugG - CSF therapy.
Score Text
0.9994 We describe the clinical course of 2 patients with Crohn's disease ( CD ) in whom lymphoma was diagnosed after treatment with Druginfliximab .
0.9966 We describe the clinical course of 2 patients with Crohn's disease ( CD ) in whom Adverse-Effectlymphoma was diagnosed after treatment with infliximab.
Score Text
0.9996 Ovarian endometrioid carcinoma and endometriosis developing in a postmenopausal breast cancer patient during Drugtamoxifen therapy : a case report and review of the literature.
0.9969 Ovarian endometrioid carcinoma and Adverse-Effectendometriosis developing in a postmenopausal breast cancer patient during tamoxifen therapy : a case report and review of the literature.
0.9833 Adverse-EffectOvarian endometrioid carcinoma and endometriosis developing in a postmenopausal breast cancer patient during tamoxifen therapy : a case report and review of the literature.
Score Text
0.9866 We report here two cases of Adverse-Effectdyserythropoietic anaemia associated with long - term linezolid use that share striking similarities to chloramphenicol - associated myelotoxicity.
0.9718 We report here two cases of dyserythropoietic anaemia associated with long - term Druglinezolid use that share striking similarities to chloramphenicol - associated myelotoxicity.
0.9633 We report here two cases of dyserythropoietic anaemia associated with long - term linezolid use that share striking similarities to chloramphenicol - associated Adverse-Effectmyelotoxicity .
0.9125 We report here two cases of dyserythropoietic anaemia associated with long - term linezolid use that share striking similarities to Drugchloramphenicol - associated myelotoxicity.
Score Text
0.9995 With the negative viral serologies, the clinical picture was most consistent with an infectious mononucleosis - like syndrome produced by the Drugminocycline ingestion.
0.7272 With the negative viral serologies, the clinical picture was most consistent with an infectious Adverse-Effectmononucleosis - like syndrome produced by the minocycline ingestion.
Score Text
0.9992 The association between Drugheparin and priapism is often recognized ; abnormal platelet aggregation could play a role in the pathogenesis of this side effect.
0.9946 The association between heparin and Adverse-Effectpriapism is often recognized ; abnormal platelet aggregation could play a role in the pathogenesis of this side effect.
0.9676 The association between heparin and priapism is often recognized ; Adverse-Effectabnormal platelet aggregation could play a role in the pathogenesis of this side effect.
Score Text
0.9993 We describe a premenopausal woman who, while having Drugtamoxifen due to a diagnosis of in situ ductal carcinoma, developed endometriosis requiring surgery.
0.9983 We describe a premenopausal woman who, while having tamoxifen due to a diagnosis of in situ ductal carcinoma, developed Adverse-Effectendometriosis requiring surgery.
Score Text
0.9994 This case describes fulminant hepatic failure in a patient taking Drugdisulfiram with no previous liver disease and report of being compliant with alcohol abstinence.
0.9862 This case describes Adverse-Effectfulminant hepatic failure in a patient taking disulfiram with no previous liver disease and report of being compliant with alcohol abstinence.
Score Text
0.9990 Ophthalmologists should be aware of the ocular side effects of DrugIFN therapy and carefully monitor patients for the possible occurrence of hypoalbuminemia and thrombocytopenia.
0.9966 Ophthalmologists should be aware of the ocular side effects of IFN therapy and carefully monitor patients for the possible occurrence of Adverse-Effecthypoalbuminemia and thrombocytopenia.
0.9958 Ophthalmologists should be aware of the ocular side effects of IFN therapy and carefully monitor patients for the possible occurrence of hypoalbuminemia and Adverse-Effectthrombocytopenia .
0.9641 Ophthalmologists should be aware of the Adverse-Effectocular side effects of IFN therapy and carefully monitor patients for the possible occurrence of hypoalbuminemia and thrombocytopenia.
Score Text
0.9884 The authors describe Adverse-Effectpericardial hemorrhage , which is related to the use of low - dose acetylsalicylic acid in a patient with essential thrombocythemia.
0.9841 The authors describe pericardial hemorrhage, which is related to the use of low - dose Drugacetylsalicylic acid in a patient with essential thrombocythemia.
Score Text
0.9992 The case of a 29 - year - old man suffering from falciparum malaria disease who got a reversible hearing loss from Drugquinine therapy is presented.
0.9890 The case of a 29 - year - old man suffering from falciparum malaria disease who got a Adverse-Effectreversible hearing loss from quinine therapy is presented.
Score Text
0.9996 We describe a case of interstitial hypoxaemiant pneumonitis probably related to Drugflecainide in a patient with the LEOPARD syndrome, a rare congenital disorder.
0.9828 We describe a case of Adverse-Effectinterstitial hypoxaemiant pneumonitis probably related to flecainide in a patient with the LEOPARD syndrome, a rare congenital disorder.
Score Text
0.9995 To our knowledge, the syndrome of fever, pulmonary infiltrates, and pleural effusion following use of Drugacyclovir has not been previously reported.
0.9897 To our knowledge, the syndrome of Adverse-Effectfever , pulmonary infiltrates, and pleural effusion following use of acyclovir has not been previously reported.
0.9850 To our knowledge, the syndrome of fever, pulmonary infiltrates, and Adverse-Effectpleural effusion following use of acyclovir has not been previously reported.
0.9773 To our knowledge, the syndrome of fever, Adverse-Effectpulmonary infiltrates , and pleural effusion following use of acyclovir has not been previously reported.
Score Text
0.9855 We report two patients who developed intense Adverse-Effectlivedo reticularis clearly related to the administration of interferon alpha 2b as an adjuvant therapy for melanoma.
0.9702 We report two patients who developed intense livedo reticularis clearly related to the administration of Druginterferon alpha 2b as an adjuvant therapy for melanoma.
Score Text
0.9983 This profile should trigger a " red flag " as to the possibility of Drugphenobarbital behavioral side effects or exacerbation of preexisting maladaptive behaviors.
0.9712 This profile should trigger a " red flag " as to the possibility of phenobarbital behavioral side effects or Adverse-Effectexacerbation of preexisting maladaptive behaviors .
0.9579 This profile should trigger a " red flag " as to the possibility of phenobarbital Adverse-Effectbehavioral side effects or exacerbation of preexisting maladaptive behaviors.
0.5645 This profile should trigger a " red flag " as to the possibility of Adverse-Effectphenobarbital behavioral side effects or exacerbation of preexisting maladaptive behaviors.
Score Text
0.9959 A 70 - year - old man was admitted to our hospital because of Adverse-Effectdyspnea after taking an antihistaminic agent ( homochlorcyclizine hydrochloride ) for itching.
0.9784 A 70 - year - old man was admitted to our hospital because of dyspnea after taking an antihistaminic agent ( Drughomochlorcyclizine hydrochloride ) for itching.
Score Text
0.9994 Marked QT prolongation and torsades de pointes secondary to acute ischemia in an elderly man taking Drugdofetilide for atrial fibrillation : a cautionary tale.
0.9865 Marked QT prolongation and Adverse-Effecttorsades de pointes secondary to acute ischemia in an elderly man taking dofetilide for atrial fibrillation : a cautionary tale.
0.9815 Adverse-EffectMarked QT prolongation and torsades de pointes secondary to acute ischemia in an elderly man taking dofetilide for atrial fibrillation : a cautionary tale.
0.9702 Marked QT prolongation and torsades de pointes secondary to Adverse-Effectacute ischemia in an elderly man taking dofetilide for atrial fibrillation : a cautionary tale.
Score Text
0.9991 A case is described of severe splenic hemorrhage and rupture which developed 3 h after completion of DrugtPA infusion for suspected acute myocardial infarction.
0.9834 A case is described of Adverse-Effectsevere splenic hemorrhage and rupture which developed 3 h after completion of tPA infusion for suspected acute myocardial infarction.
Score Text
0.9908 The authors present a case report of a Adverse-Effectgranulomatous reaction leading to urethral prolapse, 3 months after the transurethral injection of calcium hydroxylapatite.
0.9860 The authors present a case report of a granulomatous reaction leading to Adverse-Effecturethral prolapse , 3 months after the transurethral injection of calcium hydroxylapatite.
0.9786 The authors present a case report of a granulomatous reaction leading to urethral prolapse, 3 months after the transurethral injection of Drugcalcium hydroxylapatite .
Score Text
0.9988 After only the third dose of Drugpentamidine , it was noted that the patient's heart rate had decreased to 48 beats / minute.
0.9653 After only the third dose of pentamidine, it was noted that the patient's Adverse-Effectheart rate had decreased to 48 beats / minute.
Score Text
0.9947 However, prolongation of 5 - FU half - life and an increase in INR have been reported with the concurrent use of 5 - FU and Drugwarfarin .
0.9929 However, prolongation of 5 - FU half - life and an increase in INR have been reported with the concurrent use of Drug5 - FU and warfarin.
0.9807 However, prolongation of 5 - FU half - life and an Adverse-Effectincrease in INR have been reported with the concurrent use of 5 - FU and warfarin.
Score Text
0.9995 The association with prolonged unopposed estrogen - like stimulation with Drugtamoxifen as a possible factor in the development of ovarian endometrioid carcinoma is discussed.
0.9791 The association with prolonged unopposed estrogen - like stimulation with tamoxifen as a possible factor in the development of Adverse-Effectovarian endometrioid carcinoma is discussed.
Score Text
0.9996 OBJECTIVE : To describe a patient with asymptomatic bronchial asthma and hypertension who developed an acute asthma attack after receiving sustained - release Drugverapamil .
0.9079 OBJECTIVE : To describe a patient with asymptomatic bronchial asthma and hypertension who developed an Adverse-Effectacute asthma attack after receiving sustained - release verapamil.
0.9926 OBJECTIVE : To describe a patient with asymptomatic bronchial asthma and hypertension who developed an Adverse-Effectacute asthma attack after receiving sustained - release verapamil.
Score Text
0.9994 We report a 53 - year - old - man who developed rippling muscle disease ( RMD ) 2 months after starting Drugsimvastatin therapy for hypercholesterolemia.
0.9930 We report a 53 - year - old - man who developed rippling muscle disease ( Adverse-EffectRMD ) 2 months after starting simvastatin therapy for hypercholesterolemia.
0.9859 We report a 53 - year - old - man who developed Adverse-Effectrippling muscle disease ( RMD ) 2 months after starting simvastatin therapy for hypercholesterolemia.
Score Text
0.9986 This case report describes a 38 - year - old male in whom SIADH was strongly suspected secondary to DrugTegretol therapy to control a seizure disorder.
0.9928 This case report describes a 38 - year - old male in whom Adverse-EffectSIADH was strongly suspected secondary to Tegretol therapy to control a seizure disorder.
Score Text
0.9993 PURPOSE : The aim of this study was to report on the possible development of corneal endothelial deposits resulting from the use of Drugrifabutin .
0.9893 PURPOSE : The aim of this study was to report on the possible development of Adverse-Effectcorneal endothelial deposits resulting from the use of rifabutin.
Score Text
0.9996 METHODS : In an institutional practice setting, two women, aged 25 and 45, developed acute myopia after starting Drugtopiramate for epilepsy.
0.9947 METHODS : In an institutional practice setting, two women, aged 25 and 45, developed Adverse-Effectacute myopia after starting topiramate for epilepsy.
Score Text
0.9934 Our case points to the need for increased awareness by the general pediatricians of the potential hazards of Drugmineral oil use for chronic constipation.
0.9220 Our case points to the need for increased awareness by the general pediatricians of the Adverse-Effectpotential hazards of mineral oil use for chronic constipation.
Score Text
0.9990 Although lung specimens were lacking from these three patients, it is suggested that the pulmonary toxicity of DrugCCNU may be dose - related.
0.9897 Although lung specimens were lacking from these three patients, it is suggested that the Adverse-Effectpulmonary toxicity of CCNU may be dose - related.
Score Text
0.9980 DrugBaclofen withdrawal syndrome resulting from underdosing of oral baclofen should be considered as a potential source of prolonged fever in the intensive care unit.
0.9975 Baclofen withdrawal syndrome resulting from underdosing of oral Drugbaclofen should be considered as a potential source of prolonged fever in the intensive care unit.
0.9576 Baclofen Adverse-Effectwithdrawal syndrome resulting from underdosing of oral baclofen should be considered as a potential source of prolonged fever in the intensive care unit.
0.6245 Baclofen withdrawal syndrome resulting from underdosing of oral baclofen should be considered as a potential source of prolonged Adverse-Effectfever in the intensive care unit.
Score Text
0.9240 PURPOSE : We evaluated the in vitro hemodialysis ratio and subsequent toxicity and pharmacokinetics of Drugifosfamide in an anephric patient with Wilms'tumor.
0.8246 PURPOSE : We evaluated the in vitro hemodialysis ratio and subsequent Adverse-Effecttoxicity and pharmacokinetics of ifosfamide in an anephric patient with Wilms'tumor.
PURPOSE : We evaluated the in vitro hemodialysis ratio and subsequent toxicity and pharmacokinetics of Adverse-Effectifosfamide in an anephric patient with Wilms'tumor.
PURPOSE : We evaluated the in vitro hemodialysis ratio and subsequent Drugtoxicity and pharmacokinetics of ifosfamide in an anephric patient with Wilms'tumor.
Score Text
0.9994 RESULTS : Five of 70 patients who had begun Drugleflunomide therapy had significant weight loss that could not be linked to other identifiable etiologies.
0.9966 RESULTS : Five of 70 patients who had begun leflunomide therapy had significant Adverse-Effectweight loss that could not be linked to other identifiable etiologies.
Score Text
0.9983 Eleven days after initiation of therapy with Drugamiodarone , the patient experienced syncope and was noted to have recurrent episodes of polymorphous ventricular tachycardia.
0.9976 Eleven days after initiation of therapy with amiodarone, the patient experienced Adverse-Effectsyncope and was noted to have recurrent episodes of polymorphous ventricular tachycardia.
0.9867 Eleven days after initiation of therapy with amiodarone, the patient experienced syncope and was noted to have recurrent episodes of Adverse-Effectpolymorphous ventricular tachycardia .
Score Text
0.9995 Severe loss of vision after removal of cataract caused by intravitreal Drugtriamcinolone in combination with photodynamic therapy for exudative age - related macular degeneration.
0.9935 Severe loss of vision after removal of Adverse-Effectcataract caused by intravitreal triamcinolone in combination with photodynamic therapy for exudative age - related macular degeneration.
0.9475 Adverse-EffectSevere loss of vision after removal of cataract caused by intravitreal triamcinolone in combination with photodynamic therapy for exudative age - related macular degeneration.
Score Text
0.9989 BACKGROUND : The risk / benefit ratio of Drugwarfarin therapy changes in the over 75s, when haemorrhagic side - effects become more common.
0.9759 BACKGROUND : The risk / benefit ratio of warfarin therapy changes in the over 75s, when Adverse-Effecthaemorrhagic side - effects become more common.
Score Text
0.9994 We present a case report of a patient who developed a prolonged QT while being treated with oral Drugmethadone for a chronic pain syndrome.
0.9885 We present a case report of a patient who developed a Adverse-Effectprolonged QT while being treated with oral methadone for a chronic pain syndrome.
Score Text
0.9929 DISCUSSION : Methotrexate - induced Adverse-Effectpapular eruption is rarely reported shortly after beginning methotrexate therapy in patients with acute exacerbation of collagen vascular diseases.
0.9844 DISCUSSION : DrugMethotrexate - induced papular eruption is rarely reported shortly after beginning methotrexate therapy in patients with acute exacerbation of collagen vascular diseases.
0.6666 DISCUSSION : Methotrexate - induced papular eruption is rarely reported shortly after beginning Drugmethotrexate therapy in patients with acute exacerbation of collagen vascular diseases.
Score Text
0.9992 RESULTS : Both cases presented here describe corneal ulcers that persisted and showed signs of worsening during weeks of frequent topical dosing with Drugmoxifloxacin .
0.9896 RESULTS : Both cases presented here describe Adverse-Effectcorneal ulcers that persisted and showed signs of worsening during weeks of frequent topical dosing with moxifloxacin.
Score Text
0.9985 We present a case of hemolytic - uremic syndrome that developed during the 4th cycle of combination chemotherapy with oxaliplatin, 5 - fluorouracil and Drugleucovorin .
0.9985 We present a case of hemolytic - uremic syndrome that developed during the 4th cycle of combination chemotherapy with oxaliplatin, Drug5 - fluorouracil and leucovorin.
0.9985 We present a case of hemolytic - uremic syndrome that developed during the 4th cycle of combination chemotherapy with Drugoxaliplatin , 5 - fluorouracil and leucovorin.
0.9848 We present a case of Adverse-Effecthemolytic - uremic syndrome that developed during the 4th cycle of combination chemotherapy with oxaliplatin, 5 - fluorouracil and leucovorin.
Score Text
0.9990 The authors think that although Druglamivudine is widely used and well tolerated, it can cause ADRs, which are reversible after drug withdrawal.
0.9984 The authors think that although lamivudine is widely used and well tolerated, it can cause Adverse-EffectADRs , which are reversible after drug withdrawal.
Score Text
0.9996 The case of a patient with infectious mononucleosis treated with Drugcephalexin who later showed a rash is presented and the previous literature is reviewed.
0.9974 The case of a patient with infectious mononucleosis treated with cephalexin who later showed a Adverse-Effectrash is presented and the previous literature is reviewed.
Score Text
0.9992 Twenty - four hours after the administration of Druggemcitabine , a symmetric, bullous, herpetiform eruption appeared on his trunk and upper limbs.
0.9407 Twenty - four hours after the administration of gemcitabine, a Adverse-Effectsymmetric, bullous, herpetiform eruption appeared on his trunk and upper limbs.
Score Text
0.9969 We report 4 patients, 2 on Drugmethylphenidate and 2 on dextroamphetamine who presented with acral cyanosis, livedo reticularis, or Raynaud phenomenon.
0.9951 We report 4 patients, 2 on methylphenidate and 2 on Drugdextroamphetamine who presented with acral cyanosis, livedo reticularis, or Raynaud phenomenon.
0.9913 We report 4 patients, 2 on methylphenidate and 2 on dextroamphetamine who presented with Adverse-Effectacral cyanosis , livedo reticularis, or Raynaud phenomenon.
0.9911 We report 4 patients, 2 on methylphenidate and 2 on dextroamphetamine who presented with acral cyanosis, livedo reticularis, or Adverse-EffectRaynaud phenomenon .
0.9906 We report 4 patients, 2 on methylphenidate and 2 on dextroamphetamine who presented with acral cyanosis, Adverse-Effectlivedo reticularis , or Raynaud phenomenon.
Score Text
0.9831 From these data, Adverse-Effectacute generalized dystonia with brainstem and thalamic lesions may occur in WD patients after an initial d - penicillamine therapy.
0.9738 From these data, acute generalized dystonia with Adverse-Effectbrainstem and thalamic lesions may occur in WD patients after an initial d - penicillamine therapy.
0.9718 From these data, acute generalized dystonia with brainstem and thalamic lesions may occur in WD patients after an initial Drugd - penicillamine therapy.
Score Text
0.9886 We present a case report of a patient with typhoid fever who experienced a Adverse-Effecthypersensitivity reaction subsequent to the infusion of chloramphenicol sodium succinate.
0.9711 We present a case report of a patient with typhoid fever who experienced a hypersensitivity reaction subsequent to the infusion of Drugchloramphenicol sodium succinate .
Score Text
0.9841 A patient who had been treated with large doses of thyroid hormone for several years developed features of secondary Adverse-Effecthypothyroidism after thyroid hormone withdrawal.
0.9831 A patient who had been treated with large doses of Drugthyroid hormone for several years developed features of secondary hypothyroidism after thyroid hormone withdrawal.
Score Text
0.9989 Seizures occurred in two patients with probable Alzheimer's disease who were receiving long - term treatment with Drugmetrifonate , an irreversible acetylcholinesterase inhibitor.
0.9988 Adverse-EffectSeizures occurred in two patients with probable Alzheimer's disease who were receiving long - term treatment with metrifonate, an irreversible acetylcholinesterase inhibitor.
Score Text
0.9992 RESULTS : A previously healthy 42 - year - old woman presented with acute - onset delirium with psychotic features as a consequence of Druglevofloxacin therapy.
RESULTS : A previously healthy 42 - year - old woman presented with Adverse-Effectacute - onset delirium with psychotic features as a consequence of levofloxacin therapy.
Score Text
0.9994 The exacerbation of psoriasis was accompanied by a massive induction of lesional type I interferon activity, detected by MxA expression after Drugimiquimod therapy.
0.9840 The Adverse-Effectexacerbation of psoriasis was accompanied by a massive induction of lesional type I interferon activity, detected by MxA expression after imiquimod therapy.
Score Text
0.9986 Although adverse effects are usually mild, the author reports here a case of leucocytopenia and thrombocytopenia with Drugquetiapine treatment that required its discontinuation.
0.9972 Although adverse effects are usually mild, the author reports here a case of Adverse-Effectleucocytopenia and thrombocytopenia with quetiapine treatment that required its discontinuation.
0.9961 Although adverse effects are usually mild, the author reports here a case of leucocytopenia and Adverse-Effectthrombocytopenia with quetiapine treatment that required its discontinuation.
Score Text
0.9969 DrugMethanol toxicity can cause severe central nervous system insult in which a characteristic pattern of bilateral putaminal injury is noted on brain imaging studies.
0.9676 Methanol toxicity can cause severe central nervous system insult in which a characteristic pattern of Adverse-Effectbilateral putaminal injury is noted on brain imaging studies.
0.9377 Methanol toxicity can cause Adverse-Effectsevere central nervous system insult in which a characteristic pattern of bilateral putaminal injury is noted on brain imaging studies.
Adverse-EffectMethanol toxicity can cause severe central nervous system insult in which a characteristic pattern of bilateral putaminal injury is noted on brain imaging studies.
Score Text
0.9904 We report on a 14 - year - old boy with severe haemophilia A who developed a Adverse-Effectportal vein thrombosis during continuous infusion of F VIII.
0.9792 We report on a 14 - year - old boy with severe haemophilia A who developed a portal vein thrombosis during continuous infusion of DrugF VIII .
Score Text
0.9991 CONCLUSIONS : The 3 cases presented here illustrate the development of reproductive endocrine disorders after the initiation of Drugvalproate therapy in women with epilepsy.
0.9874 CONCLUSIONS : The 3 cases presented here illustrate the development of Adverse-Effectreproductive endocrine disorders after the initiation of valproate therapy in women with epilepsy.
Score Text
0.9995 We report a case of severe AVP three weeks following the administration of Druginfliximab for the treatment of Crohn's disease ( CD ).
0.9874 We report a case of Adverse-Effectsevere AVP three weeks following the administration of infliximab for the treatment of Crohn's disease ( CD ).
Score Text
0.9978 CONCLUSION : During and after DrugIFN therapy, OCT is a useful examination technique for revealing macular edema in patients who have decreased vision.
0.9810 CONCLUSION : During and after IFN therapy, OCT is a useful examination technique for revealing Adverse-Effectmacular edema in patients who have decreased vision.
0.9326 CONCLUSION : During and after IFN therapy, OCT is a useful examination technique for revealing macular edema in patients who have Adverse-Effectdecreased vision .
Score Text
0.9969 The increasing prevalence of methamphetamine abuse and the severity of the associated ulcers should alert ophthalmologists to the problem of methamphetamine - related Adverse-Effectkeratitis .
0.9955 The increasing prevalence of methamphetamine abuse and the severity of the associated Adverse-Effectulcers should alert ophthalmologists to the problem of methamphetamine - related keratitis.
0.9559 The increasing prevalence of Drugmethamphetamine abuse and the severity of the associated ulcers should alert ophthalmologists to the problem of methamphetamine - related keratitis.
0.9172 The increasing prevalence of methamphetamine abuse and the severity of the associated ulcers should alert ophthalmologists to the problem of Drugmethamphetamine - related keratitis.
Score Text
0.9974 A patient with Parkinson's disease, initially treated with Drugbromocriptine and subsequently with cabergoline, developed progressive pleuropulmonary abnormalities during the latter therapy.
0.9968 A patient with Parkinson's disease, initially treated with bromocriptine and subsequently with Drugcabergoline , developed progressive pleuropulmonary abnormalities during the latter therapy.
0.9707 A patient with Parkinson's disease, initially treated with bromocriptine and subsequently with cabergoline, developed progressive Adverse-Effectpleuropulmonary abnormalities during the latter therapy.
Score Text
0.9997 It is believed that this is the first reported case of reversible Drugazathioprine - induced cholestasis associated with histological evidence of bile duct injury.
0.9983 It is believed that this is the first reported case of reversible azathioprine - induced Adverse-Effectcholestasis associated with histological evidence of bile duct injury.
Score Text
0.9992 The pathogenic mechanisms involved in the development of Drugadriamycin cardiomyopathy are reviewed, and the possible synergistic effect of other antitumor antibiotics is discussed.
0.8933 The pathogenic mechanisms involved in the development of adriamycin Adverse-Effectcardiomyopathy are reviewed, and the possible synergistic effect of other antitumor antibiotics is discussed.
Score Text
0.9990 One should therefore be aware of possible extrapyramidal side effects with Drugolanzapine that are reduced compared to classical neuroleptic drugs but not completely eliminated.
0.9789 One should therefore be aware of possible Adverse-Effectextrapyramidal side effects with olanzapine that are reduced compared to classical neuroleptic drugs but not completely eliminated.
Score Text
0.9978 Development of Adverse-Effectsarcoidosis during interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C - - a case report and review of the literature.
0.9965 Development of sarcoidosis during interferon alpha 2b and Drugribavirin combination therapy for chronic hepatitis C - - a case report and review of the literature.
0.9834 Development of sarcoidosis during Druginterferon alpha 2b and ribavirin combination therapy for chronic hepatitis C - - a case report and review of the literature.
0.5607 Development of sarcoidosis during Druginterferon alpha 2b and ribavirin combination therapy for chronic hepatitis C - - a case report and review of the literature.
Score Text
0.9986 Exacerbation of Druganthracycline - induced early chronic cardiomyopathy with ATRA : role of B - type natriuretic peptide as an indicator of cardiac dysfunction.
0.9821 Exacerbation of anthracycline - induced Adverse-Effectearly chronic cardiomyopathy with ATRA : role of B - type natriuretic peptide as an indicator of cardiac dysfunction.
0.5246 Exacerbation of anthracycline - induced early chronic cardiomyopathy with ATRA : role of B - type natriuretic peptide as an indicator of Adverse-Effectcardiac dysfunction .
Score Text
0.9995 RESULTS : A male and a female patient with spasticity treated with intrathecal Drugbaclofen were recognized to have sexual dysfunction side effects from treatment.
0.9795 RESULTS : A male and a female patient with spasticity treated with intrathecal baclofen were recognized to have Adverse-Effectsexual dysfunction side effects from treatment.
Score Text
0.9926 The diagnosis of Adverse-Effecthypothermia was delayed until it was apparent for several days but resolved with the discontinuation of risperidone and continuation of clozapine.
0.9816 The diagnosis of hypothermia was delayed until it was apparent for several days but resolved with the discontinuation of Drugrisperidone and continuation of clozapine.
0.9808 The diagnosis of hypothermia was delayed until it was apparent for several days but resolved with the discontinuation of risperidone and continuation of Drugclozapine .
Score Text
0.9991 Other potential causes of renal failure were not present in our patient and his renal function gradually recovered with the cessation of Drugsuramin treatment.
0.9922 Other potential causes of Adverse-Effectrenal failure were not present in our patient and his renal function gradually recovered with the cessation of suramin treatment.
Score Text
0.9992 In this paper we report a case of Drugnimodipine overdosage resulting in prolonged hypotension and hypoxemia, which was successfully treated with calcium gluconate.
0.9981 In this paper we report a case of nimodipine overdosage resulting in prolonged hypotension and Adverse-Effecthypoxemia , which was successfully treated with calcium gluconate.
0.9715 In this paper we report a case of nimodipine overdosage resulting in Adverse-Effectprolonged hypotension and hypoxemia, which was successfully treated with calcium gluconate.
Score Text
0.9988 The first case concerns a 70 - year - old man who developed severe aplastic anemia 7 weeks after treatment with 500 mg of Drugticlopidine daily.
0.7078 The first case concerns a 70 - year - old man who developed severe Adverse-Effectaplastic anemia 7 weeks after treatment with 500 mg of ticlopidine daily.
0.9564 The first case concerns a 70 - year - old man who developed Adverse-Effectsevere aplastic anemia 7 weeks after treatment with 500 mg of ticlopidine daily.
Score Text
0.9995 Thus, an immunological mechanism might be involved in the mechanism of Drugpirmenol - induced QT prolongation and T wave inversion on the electrocardiogram.
0.9901 Thus, an immunological mechanism might be involved in the mechanism of pirmenol - induced Adverse-EffectQT prolongation and T wave inversion on the electrocardiogram.
0.9824 Thus, an immunological mechanism might be involved in the mechanism of pirmenol - induced QT prolongation and Adverse-EffectT wave inversion on the electrocardiogram.
Score Text
0.9994 DISCUSSION : DrugColchicine , the most important drug in treatment of FMF, can cause myopathy in patients with impaired renal and hepatic function.
0.9984 DISCUSSION : Colchicine, the most important drug in treatment of FMF, can cause Adverse-Effectmyopathy in patients with impaired renal and hepatic function.
Score Text
0.9724 After other potential causes of liver toxicity were excluded, DrugTMP - SMX was determined to be the cause of his acute liver toxicity.
0.9546 After other potential causes of liver toxicity were excluded, TMP - SMX was determined to be the cause of his Adverse-Effectacute liver toxicity .
0.9322 After other potential causes of Adverse-Effectliver toxicity were excluded, TMP - SMX was determined to be the cause of his acute liver toxicity.
Score Text
0.9993 The autopsy findings and a detailed medical history supported the conclusion that Drugclozapine - induced hypersensitivity myocarditis was the most likely cause of death.
0.9874 The autopsy findings and a detailed medical history supported the conclusion that clozapine - induced Adverse-Effecthypersensitivity myocarditis was the most likely cause of death.
Score Text
0.9982 Moreover, treatment with immunosuppressive drugs such as cyclosporine, cisplatin, tacrolimus, and interferon - alpha can induce a condition resembling Adverse-EffectRPLS .
0.9976 Moreover, treatment with immunosuppressive drugs such as cyclosporine, cisplatin, Drugtacrolimus , and interferon - alpha can induce a condition resembling RPLS.
0.9970 Moreover, treatment with immunosuppressive drugs such as Drugcyclosporine , cisplatin, tacrolimus, and interferon - alpha can induce a condition resembling RPLS.
0.9969 Moreover, treatment with immunosuppressive drugs such as cyclosporine, Drugcisplatin , tacrolimus, and interferon - alpha can induce a condition resembling RPLS.
0.9705 Moreover, treatment with immunosuppressive drugs such as cyclosporine, cisplatin, tacrolimus, and Druginterferon - alpha can induce a condition resembling RPLS.
Score Text
0.9906 We have recently encountered a patient with acquired haemophilia who developed a Adverse-Effectthrombotic left middle cerebral artery distribution stroke while being treated with pFVIII.
0.8679 We have recently encountered a patient with acquired haemophilia who developed a thrombotic left middle cerebral artery distribution stroke while being treated with DrugpFVIII .
Score Text
0.9899 We believe this is the first report of Adverse-Effectmyocardial infarction due to coronary spasm, demonstrated by angiography associated with L - thyroxine therapy.
0.9706 We believe this is the first report of myocardial infarction due to coronary spasm, demonstrated by angiography associated with DrugL - thyroxine therapy.
0.8920 We believe this is the first report of myocardial infarction due to Adverse-Effectcoronary spasm , demonstrated by angiography associated with L - thyroxine therapy.
Score Text
0.9996 We present the case of an adult Crohn's disease patient with a parvovirus B19 infection and leukopenia during long - term DrugAZA therapy.
0.9973 We present the case of an adult Crohn's disease patient with a parvovirus B19 infection and Adverse-Effectleukopenia during long - term AZA therapy.
Score Text
0.9993 DrugThalidomide neuropathy is often associated with proximal weakness and may progress even after discontinuation of treatment, in the phenomenon of'coasting '.
0.9636 Thalidomide neuropathy is often associated with Adverse-Effectproximal weakness and may progress even after discontinuation of treatment, in the phenomenon of'coasting '.
0.9247 Thalidomide Adverse-Effectneuropathy is often associated with proximal weakness and may progress even after discontinuation of treatment, in the phenomenon of'coasting '.
Score Text
0.9971 The possibility of phenytoin hypersensitivity reactions should be considered when patients receiving phenytoin have unusual symptoms, particularly fever, rash, and Adverse-Effectlymphadenopathy .
0.9950 The possibility of phenytoin hypersensitivity reactions should be considered when patients receiving phenytoin have unusual symptoms, particularly fever, Adverse-Effectrash , and lymphadenopathy.
0.9872 The possibility of Drugphenytoin hypersensitivity reactions should be considered when patients receiving phenytoin have unusual symptoms, particularly fever, rash, and lymphadenopathy.
0.9856 The possibility of phenytoin hypersensitivity reactions should be considered when patients receiving Drugphenytoin have unusual symptoms, particularly fever, rash, and lymphadenopathy.
0.9840 The possibility of phenytoin hypersensitivity reactions should be considered when patients receiving phenytoin have unusual symptoms, particularly Adverse-Effectfever , rash, and lymphadenopathy.
0.9359 The possibility of phenytoin Adverse-Effecthypersensitivity reactions should be considered when patients receiving phenytoin have unusual symptoms, particularly fever, rash, and lymphadenopathy.
0.5432 The possibility of Adverse-Effectphenytoin hypersensitivity reactions should be considered when patients receiving phenytoin have unusual symptoms, particularly fever, rash, and lymphadenopathy.
Score Text
0.9995 She was administered Drugmetoclopramide because of nausea and, within 2 hours, developed agitation, dysarthria, diaphoresis, and a movement disorder.
0.9986 She was administered metoclopramide because of nausea and, within 2 hours, developed agitation, dysarthria, Adverse-Effectdiaphoresis , and a movement disorder.
0.9984 She was administered metoclopramide because of nausea and, within 2 hours, developed agitation, Adverse-Effectdysarthria , diaphoresis, and a movement disorder.
0.9981 She was administered metoclopramide because of nausea and, within 2 hours, developed Adverse-Effectagitation , dysarthria, diaphoresis, and a movement disorder.
0.9977 She was administered metoclopramide because of nausea and, within 2 hours, developed agitation, dysarthria, diaphoresis, and a Adverse-Effectmovement disorder .
Score Text
0.9992 Four Chinese female patients who suffered from manic - depressive disorder and underlying autoimmune thyroiditis developed transient episodes of thyrotoxicosis during maintenance Druglithium therapy.
0.9965 Four Chinese female patients who suffered from manic - depressive disorder and underlying autoimmune thyroiditis developed transient episodes of Adverse-Effectthyrotoxicosis during maintenance lithium therapy.
Score Text
0.9995 The patient described in this paper was a 78 - year - old diabetic man who developed oral lesions of PV following institution of Drugglibenclamide therapy.
0.9857 The patient described in this paper was a 78 - year - old diabetic man who developed Adverse-Effectoral lesions of PV following institution of glibenclamide therapy.
Score Text
0.9954 OBJECTIVE : To report on the possible development of Adverse-Effectserotonin syndrome in a patient receiving clomipramine after clozapine was withdrawn from the treatment regimen.
0.9513 OBJECTIVE : To report on the possible development of serotonin syndrome in a patient receiving Drugclomipramine after clozapine was withdrawn from the treatment regimen.
0.9276 OBJECTIVE : To report on the possible development of serotonin syndrome in a patient receiving clomipramine after Drugclozapine was withdrawn from the treatment regimen.
Score Text
0.9996 We describe two patients with rheumatoid factor - positive, polyarticular - onset juvenile rheumatoid arthritis in whom accelerated nodulosis developed during Drugmethotrexate therapy.
0.9875 We describe two patients with rheumatoid factor - positive, polyarticular - onset juvenile rheumatoid arthritis in whom Adverse-Effectaccelerated nodulosis developed during methotrexate therapy.
Score Text
0.9993 Development of an extensive skin rash following a single dose of DrugMTX may be an early warning sign for life - threatening bone marrow aplasia.
0.9866 Development of an Adverse-Effectextensive skin rash following a single dose of MTX may be an early warning sign for life - threatening bone marrow aplasia.
Score Text
0.9995 However, follow - up revealed that gestational diabetes when associated with Drugnorethisterone had a lesser risk of emerging diabetes mellitus and impaired glucose tolerance.
0.9801 However, follow - up revealed that Adverse-Effectgestational diabetes when associated with norethisterone had a lesser risk of emerging diabetes mellitus and impaired glucose tolerance.
0.9665 However, follow - up revealed that gestational diabetes when associated with norethisterone had a lesser risk of emerging diabetes mellitus and Adverse-Effectimpaired glucose tolerance .
0.9616 However, follow - up revealed that gestational diabetes when associated with norethisterone had a lesser risk of emerging Adverse-Effectdiabetes mellitus and impaired glucose tolerance.
Score Text
0.9933 After administration of Oxybutynin concomitantly with an increase in the dose of Dantrolene, she presented the clinical symptoms and laboratory finding of DrugCarbamazepine intoxication.
0.9385 After administration of Oxybutynin concomitantly with an increase in the dose of Dantrolene, she presented the clinical symptoms and laboratory finding of Adverse-EffectCarbamazepine intoxication .
0.9083 After administration of DrugOxybutynin concomitantly with an increase in the dose of Dantrolene, she presented the clinical symptoms and laboratory finding of Carbamazepine intoxication.
0.7613 After administration of Oxybutynin concomitantly with an increase in the dose of DrugDantrolene , she presented the clinical symptoms and laboratory finding of Carbamazepine intoxication.
Score Text
0.9993 We report a case of Drugcodeine intoxication in the neonate, in which the drug was prescribed for cough control during an emergency department visit.
0.8589 We report a case of Adverse-Effectcodeine intoxication in the neonate, in which the drug was prescribed for cough control during an emergency department visit.
Score Text
0.9991 We report 5 cases of acute reversible renal failure coinciding with the onset of treatment with Drugcaptopril in patients with severe drug - resistant hypertension.
0.9839 We report 5 cases of Adverse-Effectacute reversible renal failure coinciding with the onset of treatment with captopril in patients with severe drug - resistant hypertension.
Score Text
0.9992 We present a fatal case of subacute Drugmethanol toxicity with associated diffuse brain involvement, including bilateral putaminal necrosis and cerebral edema with ventricular compression.
0.9894 We present a fatal case of subacute methanol toxicity with associated diffuse brain involvement, including bilateral putaminal necrosis and Adverse-Effectcerebral edema with ventricular compression.
0.9881 We present a fatal case of subacute methanol toxicity with associated Adverse-Effectdiffuse brain involvement , including bilateral putaminal necrosis and cerebral edema with ventricular compression.
0.9879 We present a fatal case of subacute methanol toxicity with associated diffuse brain involvement, including Adverse-Effectbilateral putaminal necrosis and cerebral edema with ventricular compression.
0.9844 We present a fatal case of subacute methanol toxicity with associated diffuse brain involvement, including bilateral putaminal necrosis and cerebral edema with Adverse-Effectventricular compression .
0.8690 We present a Adverse-Effectfatal case of subacute methanol toxicity with associated diffuse brain involvement, including bilateral putaminal necrosis and cerebral edema with ventricular compression.
We present a fatal case of subacute Adverse-Effectmethanol toxicity with associated diffuse brain involvement, including bilateral putaminal necrosis and cerebral edema with ventricular compression.
Score Text
0.9984 Abrupt, accidental withdrawal of Drugtrihexyphenidyl triggered severe exacerbation of the cranial dystonia associated with inspiratory stridor and acute respiratory difficulties, prompting emergency admission.
0.9889 Abrupt, accidental withdrawal of trihexyphenidyl triggered severe exacerbation of the cranial dystonia associated with Adverse-Effectinspiratory stridor and acute respiratory difficulties, prompting emergency admission.
0.9863 Abrupt, accidental withdrawal of trihexyphenidyl triggered severe exacerbation of the cranial dystonia associated with inspiratory stridor and Adverse-Effectacute respiratory difficulties , prompting emergency admission.
0.8852 Abrupt, accidental withdrawal of trihexyphenidyl triggered severe exacerbation of the Adverse-Effectcranial dystonia associated with inspiratory stridor and acute respiratory difficulties, prompting emergency admission.
Score Text
0.9941 Such a case induced by Adverse-Effecthypothyroidism complicating long - term therapy with amiodarone in a 45 year old woman with pre - excitation is presented.
0.9647 Such a case induced by hypothyroidism complicating long - term therapy with Drugamiodarone in a 45 year old woman with pre - excitation is presented.
Score Text
0.9994 After having received Druggemcitabine on day 1 of the second course, the patient developed dry cough, subfebrile temperatures and dyspnea within 48 h.
0.9987 After having received gemcitabine on day 1 of the second course, the patient developed dry cough, subfebrile temperatures and Adverse-Effectdyspnea within 48 h.
0.9937 After having received gemcitabine on day 1 of the second course, the patient developed dry cough, Adverse-Effectsubfebrile temperatures and dyspnea within 48 h.
0.9936 After having received gemcitabine on day 1 of the second course, the patient developed Adverse-Effectdry cough , subfebrile temperatures and dyspnea within 48 h.
Score Text
0.9997 We report a case of a young woman with SLE and thrombocytopenia, who developed severe perspiration, headache, and seizure after receiving Drugcyclosporine .
0.9989 We report a case of a young woman with SLE and thrombocytopenia, who developed severe perspiration, Adverse-Effectheadache , and seizure after receiving cyclosporine.
0.9986 We report a case of a young woman with SLE and thrombocytopenia, who developed severe perspiration, headache, and Adverse-Effectseizure after receiving cyclosporine.
0.9918 We report a case of a young woman with SLE and thrombocytopenia, who developed Adverse-Effectsevere perspiration , headache, and seizure after receiving cyclosporine.
Score Text
0.9996 The more common grade 3 or 4 adverse effects of Drugsunitinib include hypertension, fatigue, hand - foot syndrome, elevated lipase and lymphopenia.
0.9989 The more common grade 3 or 4 adverse effects of sunitinib include Adverse-Effecthypertension , fatigue, hand - foot syndrome, elevated lipase and lymphopenia.
0.9989 The more common grade 3 or 4 adverse effects of sunitinib include hypertension, Adverse-Effectfatigue , hand - foot syndrome, elevated lipase and lymphopenia.
0.9982 The more common grade 3 or 4 adverse effects of sunitinib include hypertension, fatigue, hand - foot syndrome, elevated lipase and Adverse-Effectlymphopenia .
0.9925 The more common grade 3 or 4 adverse effects of sunitinib include hypertension, fatigue, hand - foot syndrome, Adverse-Effectelevated lipase and lymphopenia.
0.9784 The more common grade 3 or 4 adverse effects of sunitinib include hypertension, fatigue, Adverse-Effecthand - foot syndrome , elevated lipase and lymphopenia.
Score Text
0.9994 Four patients in whom pulmonary oedema developed during tocolysis with Drughexoprenaline are described and the aetiological factors and pathogenesis of this potentially lethal complication discussed.
0.9893 Four patients in whom Adverse-Effectpulmonary oedema developed during tocolysis with hexoprenaline are described and the aetiological factors and pathogenesis of this potentially lethal complication discussed.
Score Text
0.9897 We present a case of a diabetic patient taking glyburide who was prescribed Drugciprofloxacin and developed prolonged hypoglycemia, which persisted for over 24 hours.
0.9881 We present a case of a diabetic patient taking Drugglyburide who was prescribed ciprofloxacin and developed prolonged hypoglycemia, which persisted for over 24 hours.
0.9869 We present a case of a diabetic patient taking glyburide who was prescribed ciprofloxacin and developed Adverse-Effectprolonged hypoglycemia , which persisted for over 24 hours.
Score Text
0.9994 DrugZiprasidone is an atypical antipsychotic drug that is believed to have a low propensity for inducing extrapyramidal symptoms, including tardive dyskinesia ( TD ).
0.9921 Ziprasidone is an atypical antipsychotic drug that is believed to have a low propensity for inducing extrapyramidal symptoms, including Adverse-Effecttardive dyskinesia ( TD ).
0.9889 Ziprasidone is an atypical antipsychotic drug that is believed to have a low propensity for inducing Adverse-Effectextrapyramidal symptoms , including tardive dyskinesia ( TD ).
0.9770 Ziprasidone is an atypical antipsychotic drug that is believed to have a low propensity for inducing extrapyramidal symptoms, including tardive dyskinesia ( Adverse-EffectTD ).
Score Text
0.9978 Drug - induced Adverse-Effecthepatitis in an acromegalic patient during combined treatment with pegvisomant and octreotide long - acting repeatable attributed to the use of pegvisomant.
0.9889 Drug - induced hepatitis in an acromegalic patient during combined treatment with pegvisomant and Drugoctreotide long - acting repeatable attributed to the use of pegvisomant.
0.9844 Drug - induced hepatitis in an acromegalic patient during combined treatment with Drugpegvisomant and octreotide long - acting repeatable attributed to the use of pegvisomant.
0.9804 Drug - induced hepatitis in an acromegalic patient during combined treatment with pegvisomant and octreotide long - acting repeatable attributed to the use of Drugpegvisomant .
Score Text
0.9986 MATERIALS AND METHODS : We present two cases of significant morbidity related to primary and secondary perforation of the bladder following two instillations of Drugepirubicin .
0.9735 MATERIALS AND METHODS : We present two cases of significant morbidity related to Adverse-Effectprimary and secondary perforation of the bladder following two instillations of epirubicin.
Score Text
0.9994 Our patient developed both nephrogenic diabetes insipidus and renal tubular acidosis with a temporal pattern that demonstrated a link between Drugfoscarnet therapy and these abnormalities.
0.9846 Our patient developed both nephrogenic diabetes insipidus and Adverse-Effectrenal tubular acidosis with a temporal pattern that demonstrated a link between foscarnet therapy and these abnormalities.
0.9786 Our patient developed both Adverse-Effectnephrogenic diabetes insipidus and renal tubular acidosis with a temporal pattern that demonstrated a link between foscarnet therapy and these abnormalities.
Score Text
0.9995 There have been numerous case reports of hyperglycemia with Drugolanzapine in the literature, but none reported hyperglycemia within days of initiation of the medication.
0.9932 There have been numerous case reports of Adverse-Effecthyperglycemia with olanzapine in the literature, but none reported hyperglycemia within days of initiation of the medication.
0.9866 There have been numerous case reports of hyperglycemia with olanzapine in the literature, but none reported Adverse-Effecthyperglycemia within days of initiation of the medication.
Score Text
0.9964 To our knowledge, drug - induced Adverse-Effectfever has not been reported with the use of diltiazem hydrochloride, a commonly prescribed calcium channel blocker.
0.9864 To our knowledge, drug - induced fever has not been reported with the use of Drugdiltiazem hydrochloride , a commonly prescribed calcium channel blocker.
Score Text
0.9959 We present the case of a postictal patient with Adverse-Effectlethargy , hyperammonemia, otherwise normal liver function tests, and a therapeutic valproic acid level.
0.9879 We present the case of a postictal patient with lethargy, hyperammonemia, otherwise normal liver function tests, and a therapeutic Drugvalproic acid level.
0.9858 We present the case of a postictal patient with lethargy, Adverse-Effecthyperammonemia , otherwise normal liver function tests, and a therapeutic valproic acid level.
Score Text
0.9981 In two patients with mycosis fungoides, a squamous cell carcinoma developed during therapy with Drugpsoralens plus long - wave ultraviolet radiation ( PUVA ).
0.9823 In two patients with mycosis fungoides, a Adverse-Effectsquamous cell carcinoma developed during therapy with psoralens plus long - wave ultraviolet radiation ( PUVA ).
Score Text
0.9988 Sunburn may sometimes be a major injury in Drugpsoralen users because high doses or inappropriate use of the drug may render the skin extremely sensitive.
0.9943 Adverse-EffectSunburn may sometimes be a major injury in psoralen users because high doses or inappropriate use of the drug may render the skin extremely sensitive.
0.9752 Sunburn may sometimes be a major injury in psoralen users because high doses or inappropriate use of the drug may render the Adverse-Effectskin extremely sensitive .
Score Text
0.9990 A 35 - year - old nephrotic man developed acute renal failure with serum creatinine to 1543 micromol / l after a month of therapy with Drugenalapril .
0.9875 A 35 - year - old nephrotic man developed Adverse-Effectacute renal failure with serum creatinine to 1543 micromol / l after a month of therapy with enalapril.
Score Text
0.9993 A 33 - year - old man with a history of recreational Drugbenztropine abuse presented to the emergency department with confusion, abdominal pain, and distention.
0.9986 A 33 - year - old man with a history of recreational benztropine abuse presented to the emergency department with confusion, abdominal pain, and Adverse-Effectdistention .
0.9976 A 33 - year - old man with a history of recreational benztropine abuse presented to the emergency department with confusion, Adverse-Effectabdominal pain , and distention.
0.9908 A 33 - year - old man with a history of recreational benztropine abuse presented to the emergency department with Adverse-Effectconfusion , abdominal pain, and distention.
Score Text
0.9952 We report a fatal case of toxic epidermal necrolysis ( Adverse-EffectTEN ) resulting from a high dose of cytosine arabinoside ( ARA - C ).
0.9749 We report a fatal case of toxic epidermal necrolysis ( TEN ) resulting from a high dose of Drugcytosine arabinoside ( ARA - C ).
0.9698 We report a fatal case of toxic epidermal necrolysis ( TEN ) resulting from a high dose of cytosine arabinoside ( DrugARA - C ).
0.9664 We report a fatal case of Adverse-Effecttoxic epidermal necrolysis ( TEN ) resulting from a high dose of cytosine arabinoside ( ARA - C ).
Score Text
0.9996 We report a third case of a 6 - week - old infant with Escherichia coli sepsis who received Drugampicillin and other antibiotics and subsequently developed TEN.
0.9990 We report a third case of a 6 - week - old infant with Escherichia coli sepsis who received ampicillin and other antibiotics and subsequently developed Adverse-EffectTEN .
Score Text
0.9992 A 58 - year old patient is reported who developed an ischaemic cerebrovascular accident 22 hours after successful thrombolysis with Drugstreptokinase for life - threatening pulmonary emboli.
0.9895 A 58 - year old patient is reported who developed an Adverse-Effectischaemic cerebrovascular accident 22 hours after successful thrombolysis with streptokinase for life - threatening pulmonary emboli.
Score Text
0.9946 It should be recognized that Drugibuprofen may be associated with salt and water retention in the same fashion as previously described with phenylbutazone and indomethacin.
0.9847 It should be recognized that ibuprofen may be associated with salt and water retention in the same fashion as previously described with phenylbutazone and Drugindomethacin .
0.9761 It should be recognized that ibuprofen may be associated with salt and water retention in the same fashion as previously described with Drugphenylbutazone and indomethacin.
0.9695 It should be recognized that ibuprofen may be associated with Adverse-Effectsalt and water retention in the same fashion as previously described with phenylbutazone and indomethacin.
Score Text
0.9994 To our knowledge, we describe the first reported case of isolated paresthesia and peripheral neuropathy, without systemic involvement, secondary to Drugsulindac administration.
0.9868 To our knowledge, we describe the first reported case of isolated paresthesia and Adverse-Effectperipheral neuropathy , without systemic involvement, secondary to sulindac administration.
0.9867 To our knowledge, we describe the first reported case of Adverse-Effectisolated paresthesia and peripheral neuropathy, without systemic involvement, secondary to sulindac administration.
Score Text
0.9995 DrugMetoclopramide - induced parkinsonism is not rare, and appropriate dose reduction in patients with renal failure will help reduce the incidence of this morbidity.
0.9981 Metoclopramide - induced Adverse-Effectparkinsonism is not rare, and appropriate dose reduction in patients with renal failure will help reduce the incidence of this morbidity.
Score Text
0.9993 DISCUSSION : DrugPhenolphthalein is the active ingredient in several over - the - counter laxative preparations and has only rarely been reported to cause TEN.
0.9988 DISCUSSION : Phenolphthalein is the active ingredient in several over - the - counter laxative preparations and has only rarely been reported to cause Adverse-EffectTEN .
Score Text
0.9992 Charcoal haemoperfusion and cysteamine therapy led to the rapid removal of the Drugparacetamol from the body and consequently prevented the development of severe hepatic necrosis.
0.9792 Charcoal haemoperfusion and cysteamine therapy led to the rapid removal of the paracetamol from the body and consequently prevented the development of Adverse-Effectsevere hepatic necrosis .
Score Text
0.9993 We report on three patients with acute schizophrenia, who developed severe akathisia during treatment with Drugolanzapine ( 20 - 25 mg / d ).
0.8542 We report on three patients with acute schizophrenia, who developed Adverse-Effectsevere akathisia during treatment with olanzapine ( 20 - 25 mg / d ).
0.5390 We report on three patients with acute schizophrenia, who developed severe Adverse-Effectakathisia during treatment with olanzapine ( 20 - 25 mg / d ).
Score Text
0.9995 Multiple syncopal episodes started to occur during Drugthalidomide treatment, and a Holter electrocardiogram showed multiple abnormalities, with an episode of sustained ventricular tachycardia.
0.9852 Multiple syncopal episodes started to occur during thalidomide treatment, and a Holter electrocardiogram showed multiple abnormalities, with an episode of Adverse-Effectsustained ventricular tachycardia .
0.9796 Adverse-EffectMultiple syncopal episodes started to occur during thalidomide treatment, and a Holter electrocardiogram showed multiple abnormalities, with an episode of sustained ventricular tachycardia.
Score Text
0.9994 He had an immediate hypersensitivity reaction during the initiation of the DrugMTX infusion with diffuse urticaria, facial swelling, cough, and chest tightness.
0.9871 He had an immediate Adverse-Effecthypersensitivity reaction during the initiation of the MTX infusion with diffuse urticaria, facial swelling, cough, and chest tightness.
0.9805 He had an immediate hypersensitivity reaction during the initiation of the MTX infusion with diffuse urticaria, facial swelling, Adverse-Effectcough , and chest tightness.
0.9527 He had an immediate hypersensitivity reaction during the initiation of the MTX infusion with diffuse urticaria, Adverse-Effectfacial swelling , cough, and chest tightness.
0.8906 He had an immediate hypersensitivity reaction during the initiation of the MTX infusion with diffuse urticaria, facial swelling, cough, and Adverse-Effectchest tightness .
0.7855 He had an immediate hypersensitivity reaction during the initiation of the MTX infusion with Adverse-Effectdiffuse urticaria , facial swelling, cough, and chest tightness.
Score Text
0.9921 This report presents a case of Adverse-Effectcolon perforation which occurred 4 months after treatment with intraperitoneal chromic phosphate for stage IB ovarian papillary serous cystadenocarcinoma.
0.9833 This report presents a case of colon perforation which occurred 4 months after treatment with intraperitoneal Drugchromic phosphate for stage IB ovarian papillary serous cystadenocarcinoma.
Score Text
0.9991 We suggest that Drugitraconazole should be added to the list of drugs that may be responsible for a drug - induced vanishing bile duct syndrome.
0.9851 We suggest that itraconazole should be added to the list of drugs that may be responsible for a drug - induced Adverse-Effectvanishing bile duct syndrome .
Score Text
0.9949 AIM : Report of a case of a woman patient who developed celiac disease after pegylated interferon alpha - 2a and Drugribavirin use for chronic hepatitis C.
0.9935 AIM : Report of a case of a woman patient who developed Adverse-Effectceliac disease after pegylated interferon alpha - 2a and ribavirin use for chronic hepatitis C.
0.9709 AIM : Report of a case of a woman patient who developed celiac disease after Drugpegylated interferon alpha - 2a and ribavirin use for chronic hepatitis C.
Score Text
0.9978 These findings suggest that Adverse-Effectbicytopenia in this patient was caused by D - Pen and may be due to different sensitivities in the hematopoietic lineage.
0.9778 These findings suggest that bicytopenia in this patient was caused by DrugD - Pen and may be due to different sensitivities in the hematopoietic lineage.
Score Text
0.9811 We describe a case of needle - track Adverse-Effectcutaneous seeding of hepatocellular carcinoma ( HCC ) after sonographically guided percutaneous ethanol injection ( PEI ).
0.9315 We describe a case of needle - track cutaneous seeding of hepatocellular carcinoma ( HCC ) after sonographically guided percutaneous Drugethanol injection ( PEI ).
0.9771 We describe a case of needle - track cutaneous seeding of hepatocellular carcinoma ( HCC ) after sonographically guided percutaneous Drugethanol injection ( PEI ).
0.9610 We describe a case of needle - track cutaneous seeding of hepatocellular carcinoma ( HCC ) after sonographically guided percutaneous ethanol injection ( DrugPEI ).
0.6429 We describe a case of needle - track cutaneous seeding of hepatocellular carcinoma ( DrugHCC ) after sonographically guided percutaneous ethanol injection ( PEI ).
Score Text
0.9995 This article reports the occurrence of Drugrifampin - associated thrombocytopenia in an indigent patient after a four - month lapse in therapy for pulmonary tuberculosis.
0.9977 This article reports the occurrence of rifampin - associated Adverse-Effectthrombocytopenia in an indigent patient after a four - month lapse in therapy for pulmonary tuberculosis.
Score Text
0.9736 Recent studies have shown that under experimental conditions Drugferrous sulfate may reduce the gastrointestinal absorption of orally administered levothyroxine sodium in patients with primary hypothyroidism.
Recent studies have shown that under experimental conditions ferrous sulfate may Adverse-Effectreduce the gastrointestinal absorption of orally administered levothyroxine sodium in patients with primary hypothyroidism.
Score Text
0.9989 We postulate that Drugcyclosporin , possibly together with ganciclovir, can produce transient brain stem or neuromuscular dysfunction with eye movement abnormality in occasional patients.
0.9982 We postulate that cyclosporin, possibly together with Drugganciclovir , can produce transient brain stem or neuromuscular dysfunction with eye movement abnormality in occasional patients.
0.9757 We postulate that cyclosporin, possibly together with ganciclovir, can produce Adverse-Effecttransient brain stem or neuromuscular dysfunction with eye movement abnormality in occasional patients.
0.9659 We postulate that cyclosporin, possibly together with ganciclovir, can produce transient brain stem or neuromuscular dysfunction with Adverse-Effecteye movement abnormality in occasional patients.
Score Text
0.9957 We believe that this is the first description of acute hepatitis caused by an idiosyncratic adverse reaction to Druggliclazide or to one of its metabolites.
0.9893 We believe that this is the first description of Adverse-Effectacute hepatitis caused by an idiosyncratic adverse reaction to gliclazide or to one of its metabolites.
Score Text
0.9994 The second is a 29 - year - old man with CD in whom nodular sclerosing Hodgkin's lymphoma was diagnosed 3 weeks after infusion with Druginfliximab .
0.9791 The second is a 29 - year - old man with CD in whom Adverse-Effectnodular sclerosing Hodgkin's lymphoma was diagnosed 3 weeks after infusion with infliximab.
Score Text
0.9992 Five personal observations of an acute amnestic episode in younger individuals after intake of Drugclioquinol are described together with three observations from the medical literature.
0.9850 Five personal observations of an Adverse-Effectacute amnestic episode in younger individuals after intake of clioquinol are described together with three observations from the medical literature.
Score Text
0.9982 In this case, interferon alpha induced Adverse-Effectpolymyositis and cardiomyopathy is diagnosed in a 33 - yr - old male patient with history of chronic hepatitis B.
0.9978 In this case, interferon alpha induced polymyositis and Adverse-Effectcardiomyopathy is diagnosed in a 33 - yr - old male patient with history of chronic hepatitis B.
0.9854 In this case, Druginterferon alpha induced polymyositis and cardiomyopathy is diagnosed in a 33 - yr - old male patient with history of chronic hepatitis B.
Score Text
0.9995 Case 3 : A 29 - year - old female alcoholic complained of general fatigue and a slight fever after 1. 5 years of abstinence with Drugcyanamide treatment.
0.9889 Case 3 : A 29 - year - old female alcoholic complained of general fatigue and a slight Adverse-Effectfever after 1. 5 years of abstinence with cyanamide treatment.
0.9954 Case 3 : A 29 - year - old female alcoholic complained of Adverse-Effectgeneral fatigue and a slight fever after 1. 5 years of abstinence with cyanamide treatment.
Case 3 : A 29 - year - old female alcoholic complained of general Adverse-Effectfatigue and a slight fever after 1. 5 years of abstinence with cyanamide treatment.
Score Text
0.9995 A twelve year - old - girl with idiopathic partial epilepsy with secondary generalization, developed acute psychosis 10 days after the administration of Druglevetiracetam .
0.9931 A twelve year - old - girl with idiopathic partial epilepsy with secondary generalization, developed Adverse-Effectacute psychosis 10 days after the administration of levetiracetam.
Score Text
0.9995 In addition to disease refractoriness, rare instances of disease progression from chronic phase to blast crisis during Drugimatinib therapy have recently been anecdotally reported.
0.9883 In addition to disease refractoriness, rare instances of disease progression from chronic phase to Adverse-Effectblast crisis during imatinib therapy have recently been anecdotally reported.
Score Text
0.9784 The authors suggest that in patients with corneal ulcers refractory to conventional treatment who are receiving Drugcolchicine , cessation of colchicine therapy should be considered.
0.8307 The authors suggest that in patients with Adverse-Effectcorneal ulcers refractory to conventional treatment who are receiving colchicine, cessation of colchicine therapy should be considered.
0.9561 The authors suggest that in patients with corneal ulcers refractory to conventional treatment who are receiving colchicine, cessation of Drugcolchicine therapy should be considered.
Score Text
0.9983 OBJECTIVE : To describe a case of cefazolin - induced Adverse-Effectleukopenia in a critically ill patient who developed this adverse reaction upon rechallenge with cefoxitin.
0.9862 OBJECTIVE : To describe a case of Drugcefazolin - induced leukopenia in a critically ill patient who developed this adverse reaction upon rechallenge with cefoxitin.
Score Text
0.9979 We describe a case of infection with Mycobacterium abscessus in a 67 - year - old woman receiving Druginfliximab as a component of her therapy for RA.
0.9534 We describe a case of infection with Adverse-EffectMycobacterium abscessus in a 67 - year - old woman receiving infliximab as a component of her therapy for RA.
Score Text
0.9899 This case study is the second report of localized purpura after prolonged Druglamotrigine treatment suggesting this may be an atypical lamotrigine - induced drug reaction.
0.9793 This case study is the second report of Adverse-Effectlocalized purpura after prolonged lamotrigine treatment suggesting this may be an atypical lamotrigine - induced drug reaction.
Score Text
0.9993 After identification of the index patient, additional inquiry revealed that the patient's mother was hospitalized previously for overwhelming sepsis associated with Drugmetamizole use.
0.9883 After identification of the index patient, additional inquiry revealed that the patient's mother was hospitalized previously for overwhelming Adverse-Effectsepsis associated with metamizole use.
Score Text
0.9915 Although a few case reports link Drugmetronidazole with the development of pseudomembranous colitis, albendazole has not been associated with the development of this condition.
0.9905 Although a few case reports link metronidazole with the development of Adverse-Effectpseudomembranous colitis , albendazole has not been associated with the development of this condition.
Score Text
0.9801 Three cases of Adverse-Effectpseudocyst of the pancreas in two women and one man have previously been reported with the use of intravenous L - asparaginase.
0.9680 Three cases of pseudocyst of the pancreas in two women and one man have previously been reported with the use of intravenous DrugL - asparaginase .
Score Text
0.9995 The oligohidrosis caused by Drugzonisamide was reversible in that the patient regained the ability to sweat within 2 weeks of the cessation of drug administration.
0.9972 The Adverse-Effectoligohidrosis caused by zonisamide was reversible in that the patient regained the ability to sweat within 2 weeks of the cessation of drug administration.
Score Text
0.9991 Massive DrugCBZ OD may produce a reversible encephalopathy that includes cortical hyperexcitability, a profound burst - suppression EEG pattern, and cranial nerve areflexia.
0.9888 Massive CBZ OD may produce a reversible encephalopathy that includes cortical hyperexcitability, a profound burst - suppression EEG pattern, and Adverse-Effectcranial nerve areflexia .
0.9797 Massive CBZ OD may produce a reversible encephalopathy that includes Adverse-Effectcortical hyperexcitability , a profound burst - suppression EEG pattern, and cranial nerve areflexia.
0.9629 Massive CBZ OD may produce a Adverse-Effectreversible encephalopathy that includes cortical hyperexcitability, a profound burst - suppression EEG pattern, and cranial nerve areflexia.
0.9536 Massive CBZ OD may produce a reversible encephalopathy that includes cortical hyperexcitability, a Adverse-Effectprofound burst - suppression EEG pattern , and cranial nerve areflexia.
0.9789 Massive CBZ OD may produce a reversible encephalopathy that includes cortical hyperexcitability, a profound burst - suppression EEG pattern, and cranial Adverse-Effectnerve areflexia .
Score Text
0.9995 Progressive interstitial fibrosis with roentgenographic honeycombing developed in the case of a psoriatic patient who had been on a regimen of Drugmethotrexate for 18 years.
0.9827 Adverse-EffectProgressive interstitial fibrosis with roentgenographic honeycombing developed in the case of a psoriatic patient who had been on a regimen of methotrexate for 18 years.
Score Text
0.9990 Case 4 : A 61 - year - old male alcoholic who remained completely abstinent while taking Drugcyanamide for 3 years showed slight elevation of serum transaminases.
0.9789 Case 4 : A 61 - year - old male alcoholic who remained completely abstinent while taking cyanamide for 3 years showed slight Adverse-Effectelevation of serum transaminases .
Score Text
0.9985 A retrospective review of TTP patients with Drugquinine - associated thrombotic microangiopathy ( TMA ) for whom ADAMTS13 was measured before plasma exchange was performed.
0.9840 A retrospective review of TTP patients with quinine - associated Adverse-Effectthrombotic microangiopathy ( TMA ) for whom ADAMTS13 was measured before plasma exchange was performed.
0.9279 A retrospective review of TTP patients with quinine - associated thrombotic microangiopathy ( Adverse-EffectTMA ) for whom ADAMTS13 was measured before plasma exchange was performed.
Score Text
0.9967 We describe children and adolescents with chronic hematologic and oncologic diseases who exhibited drug - seeking behavior or anticholinergic symptoms with the use of Drugdiphenhydramine .
0.9918 We describe children and adolescents with chronic hematologic and oncologic diseases who exhibited drug - seeking behavior or Adverse-Effectanticholinergic symptoms with the use of diphenhydramine.
0.9884 We describe children and adolescents with chronic hematologic and oncologic diseases who exhibited Adverse-Effectdrug - seeking behavior or anticholinergic symptoms with the use of diphenhydramine.
Score Text
0.9995 Three patients are reported without a history of angina pectoris who had clinical and electrocardiographic evidence of myocardial ischemia during and immediately after DrugBCNU infusion.
0.9902 Three patients are reported without a history of angina pectoris who had clinical and electrocardiographic evidence of Adverse-Effectmyocardial ischemia during and immediately after BCNU infusion.
Score Text
0.9994 No cases of renal acidosis, and only one case of nephrogenic diabetes insipidus, has been previously reported as a complication of Drugfoscarnet treatment.
0.9704 No cases of renal acidosis, and only one case of Adverse-Effectnephrogenic diabetes insipidus , has been previously reported as a complication of foscarnet treatment.
0.9803 No cases of Adverse-Effectrenal acidosis , and only one case of nephrogenic diabetes insipidus, has been previously reported as a complication of foscarnet treatment.
Score Text
0.9982 Clinicians have been aware of lithium toxicity for many years and traditionally have administered thiazide diuretics for lithium - induced Adverse-Effectpolyuria and nephrogenic diabetes insipidus.
0.9819 Clinicians have been aware of Druglithium toxicity for many years and traditionally have administered thiazide diuretics for lithium - induced polyuria and nephrogenic diabetes insipidus.
0.9818 Clinicians have been aware of lithium toxicity for many years and traditionally have administered thiazide diuretics for lithium - induced polyuria and Adverse-Effectnephrogenic diabetes insipidus .
0.9728 Clinicians have been aware of lithium toxicity for many years and traditionally have administered thiazide diuretics for Druglithium - induced polyuria and nephrogenic diabetes insipidus.
0.9717 Clinicians have been aware of lithium toxicity for many years and traditionally have administered Drugthiazide diuretics for lithium - induced polyuria and nephrogenic diabetes insipidus.
Clinicians have been aware of Adverse-Effectlithium toxicity for many years and traditionally have administered thiazide diuretics for lithium - induced polyuria and nephrogenic diabetes insipidus.
Score Text
0.9983 Thrombotic thrombocytopenic purpura ( TTP ) developed in a patient with seropositive rheumatoid arthritis ( RA ) after 2 1 / 2 months of treatment with Drugpenicillamine .
0.9961 Thrombotic thrombocytopenic purpura ( Adverse-EffectTTP ) developed in a patient with seropositive rheumatoid arthritis ( RA ) after 2 1 / 2 months of treatment with penicillamine.
0.9884 Adverse-EffectThrombotic thrombocytopenic purpura ( TTP ) developed in a patient with seropositive rheumatoid arthritis ( RA ) after 2 1 / 2 months of treatment with penicillamine.
Score Text
0.9748 These evolutional changes in both proteinuria and glomerular histology suggest a close linkage between the DrugM - CSF treatment and macrophage - related glomerular injury.
0.9547 These evolutional changes in both proteinuria and glomerular histology suggest a close linkage between the M - CSF treatment and Adverse-Effectmacrophage - related glomerular injury .
Score Text
0.9976 A previous review described data on 15 patients who experienced acute hemoglobinemia or Adverse-Effecthemoglobinuria following anti - D IGIV administration for ITP or secondary thrombocytopenia.
0.9878 A previous review described data on 15 patients who experienced Adverse-Effectacute hemoglobinemia or hemoglobinuria following anti - D IGIV administration for ITP or secondary thrombocytopenia.
0.9721 A previous review described data on 15 patients who experienced acute hemoglobinemia or hemoglobinuria following Druganti - D IGIV administration for ITP or secondary thrombocytopenia.
0.6501 A previous review described data on 15 patients who experienced acute hemoglobinemia or hemoglobinuria following Druganti - D IGIV administration for ITP or secondary thrombocytopenia.
Score Text
0.9992 This is an image and brief case report of a 13 - year - old boy who presented with severe rash and systemic symptoms after starting Drugoxcarbazepine .
0.9814 This is an image and brief case report of a 13 - year - old boy who presented with Adverse-Effectsevere rash and systemic symptoms after starting oxcarbazepine.
Score Text
0.9974 The authors describe a case of oral - facial dyskinesia that occurred after discontinuation of Drugamoxapine , and antidepressant which may also have neuroleptic effects.
0.9843 The authors describe a case of Adverse-Effectoral - facial dyskinesia that occurred after discontinuation of amoxapine, and antidepressant which may also have neuroleptic effects.
Score Text
0.9858 After gastric - outlet obstruction was recognized in several infants who received Drugprostaglandin E1 , we studied the association between the drug and this complication.
0.9812 After Adverse-Effectgastric - outlet obstruction was recognized in several infants who received prostaglandin E1, we studied the association between the drug and this complication.
Score Text
0.9986 Adverse-EffectGynecomastia developed in two epileptic patients some months after the addition of oral fluoresone 750 mg daily to the phenobarbital and phenytoin already being administered.
0.9940 Gynecomastia developed in two epileptic patients some months after the addition of oral fluoresone 750 mg daily to the phenobarbital and Drugphenytoin already being administered.
0.9939 Gynecomastia developed in two epileptic patients some months after the addition of oral fluoresone 750 mg daily to the Drugphenobarbital and phenytoin already being administered.
0.9909 Gynecomastia developed in two epileptic patients some months after the addition of oral Drugfluoresone 750 mg daily to the phenobarbital and phenytoin already being administered.
Score Text
0.9995 We report a case admitted with a first - detected, symptomatic paroxysmal atrial fibrillation in a healthy patient after self - medication with Drugvardenafil .
0.9776 We report a case admitted with a first - detected, Adverse-Effectsymptomatic paroxysmal atrial fibrillation in a healthy patient after self - medication with vardenafil.
Score Text
0.9994 CONCLUSIONS : We present a case of a patient with CML who developed KS 12 months after starting treatment with Drugimatinib 400 mg / d.
0.9972 CONCLUSIONS : We present a case of a patient with CML who developed Adverse-EffectKS 12 months after starting treatment with imatinib 400 mg / d.
Score Text
0.9814 The probable proarrhythmic action of Drugamiodarone , although rare, is reviewed along with a discussion of the novel use of intravenous magnesium sulfate therapy.
0.8363 The probable Adverse-Effectproarrhythmic action of amiodarone, although rare, is reviewed along with a discussion of the novel use of intravenous magnesium sulfate therapy.
Score Text
0.9976 We report three cases of IFN beta induced Adverse-Effecthepatitis in MS and discuss the pathology findings and possible mechanisms of drug - induced liver injury.
0.9874 We report three cases of DrugIFN beta induced hepatitis in MS and discuss the pathology findings and possible mechanisms of drug - induced liver injury.
0.9768 We report three cases of IFN beta induced hepatitis in MS and discuss the pathology findings and possible mechanisms of drug - induced Adverse-Effectliver injury .
Score Text
0.9981 We conclude that low - dose DrugHU therapy in patients with thalassemia intermedia may increase total Hb levels sufficiently to eliminate the need for transfusions.
0.8792 We conclude that low - dose HU therapy in patients with thalassemia intermedia may Adverse-Effectincrease total Hb levels sufficiently to eliminate the need for transfusions.
0.9514 We conclude that low - dose HU therapy in patients with thalassemia intermedia may Adverse-Effectincrease total Hb levels sufficiently to eliminate the need for transfusions.
Score Text
0.9994 This case report describes the development of asymptomatic visual field defects ( VFDs ) in a psychiatric patient with bipolar disorder receiving adjunctive Drugtiagabine treatment.
0.9841 This case report describes the development of asymptomatic visual field defects ( Adverse-EffectVFDs ) in a psychiatric patient with bipolar disorder receiving adjunctive tiagabine treatment.
0.9103 This case report describes the development of asymptomatic Adverse-Effectvisual field defects ( VFDs ) in a psychiatric patient with bipolar disorder receiving adjunctive tiagabine treatment.
0.9584 This case report describes the development of Adverse-Effectasymptomatic visual field defects ( VFDs ) in a psychiatric patient with bipolar disorder receiving adjunctive tiagabine treatment.
Score Text
0.9991 DrugAmiodarone was the third drug to induce AVT in this patient ; she received 200 mg / day six days per week for six months.
0.9985 Amiodarone was the third drug to induce Adverse-EffectAVT in this patient ; she received 200 mg / day six days per week for six months.
Score Text
0.9991 Three days after receiving intravitreal injection of Drugbevacizumab ( 1. 25 mg in 0. 1 ml ), he developed acute vision loss and change of consciousness.
0.9926 Three days after receiving intravitreal injection of bevacizumab ( 1. 25 mg in 0. 1 ml ), he developed Adverse-Effectacute vision loss and change of consciousness.
0.9875 Three days after receiving intravitreal injection of bevacizumab ( 1. 25 mg in 0. 1 ml ), he developed acute vision loss and Adverse-Effectchange of consciousness .
Score Text
0.9993 Two of these patients, who also received the anti - emetic Drugprochlorperazine , lost consciousness for 48 - 72 h and then fully recovered.
0.9810 Two of these patients, who also received the anti - emetic prochlorperazine, Adverse-Effectlost consciousness for 48 - 72 h and then fully recovered.
Score Text
0.9853 CONCLUSIONS : This is the second case report that describes gemcitabine - induced Adverse-Effectradiation recall in rectus abdominus muscles after gemcitabine - based radiation therapy.
0.9669 CONCLUSIONS : This is the second case report that describes Druggemcitabine - induced radiation recall in rectus abdominus muscles after gemcitabine - based radiation therapy.
0.5815 CONCLUSIONS : This is the second case report that describes gemcitabine - induced radiation recall in rectus abdominus muscles after Druggemcitabine - based radiation therapy.
Score Text
0.9995 The 5 patients had severe renovascular disease which might thus represent a significant risk factor in the development of Drugcaptopril - induced acute renal failure.
0.9877 The 5 patients had severe renovascular disease which might thus represent a significant risk factor in the development of captopril - induced Adverse-Effectacute renal failure .
Score Text
0.9994 Although vasculitis has been reported in the course of hairy cell leukaemia, it has only rarely been reported as the consequence of Drugcladribine treatment.
0.9971 Although Adverse-Effectvasculitis has been reported in the course of hairy cell leukaemia, it has only rarely been reported as the consequence of cladribine treatment.
Score Text
0.9937 Treatment of ELP in children is generally supportive, with the symptoms and roentgenographic abnormalities resolving within months after stopping the use of Drugmineral oil .
0.9804 Treatment of Adverse-EffectELP in children is generally supportive, with the symptoms and roentgenographic abnormalities resolving within months after stopping the use of mineral oil.
0.9758 Treatment of ELP in children is generally supportive, with the symptoms and Adverse-Effectroentgenographic abnormalities resolving within months after stopping the use of mineral oil.
Score Text
0.9993 This case illustrates that the hemophagocytic syndrome associated with reactivation of EBV can occur as part of drug hypersensitivity reactions in RA patients taking Drugsulfasalazine .
0.9916 This case illustrates that the Adverse-Effecthemophagocytic syndrome associated with reactivation of EBV can occur as part of drug hypersensitivity reactions in RA patients taking sulfasalazine.
Score Text
0.9826 One patient was an 80 - year - old woman who was admitted for Adverse-EffectStaphylococcus aureus knee arthritis after several intraarticular injections of sodium hyaluronate and corticosteroids.
0.9816 One patient was an 80 - year - old woman who was admitted for Staphylococcus aureus knee arthritis after several intraarticular injections of sodium hyaluronate and Drugcorticosteroids .
0.9768 One patient was an 80 - year - old woman who was admitted for Staphylococcus aureus knee arthritis after several intraarticular injections of Drugsodium hyaluronate and corticosteroids.
Score Text
0.9996 The incidence of oral - Drugverapamil - induced hypotension in the presence of concomitant beta - adrenergic blockade by the oral route is quite rare.
0.9985 The incidence of oral - verapamil - induced Adverse-Effecthypotension in the presence of concomitant beta - adrenergic blockade by the oral route is quite rare.
Score Text
0.9633 Painful neutrophilic skin lesions were observed in two children receiving Druggranulocyte colony - stimulating factor ( G - CSF ) for treatment of idiopathic neutropenia.
0.9536 Painful neutrophilic skin lesions were observed in two children receiving granulocyte colony - stimulating factor ( DrugG - CSF ) for treatment of idiopathic neutropenia.
0.7585 Painful Adverse-Effectneutrophilic skin lesions were observed in two children receiving granulocyte colony - stimulating factor ( G - CSF ) for treatment of idiopathic neutropenia.
0.6853 Adverse-EffectPainful neutrophilic skin lesions were observed in two children receiving granulocyte colony - stimulating factor ( G - CSF ) for treatment of idiopathic neutropenia.
Adverse-EffectPainful neutrophilic skin lesions were observed in two children receiving granulocyte colony - stimulating factor ( G - CSF ) for treatment of idiopathic neutropenia.
Score Text
0.9994 This case had radiation fibrosis, so we suggest that radiation fibrosis may be another contributor of the occurrence of ILD in patients taking Drugerlotinib .
0.9980 This case had radiation fibrosis, so we suggest that radiation fibrosis may be another contributor of the occurrence of Adverse-EffectILD in patients taking erlotinib.
0.9485 This case had radiation fibrosis, so we suggest that Adverse-Effectradiation fibrosis may be another contributor of the occurrence of ILD in patients taking erlotinib.
0.7059 This case had Adverse-Effectradiation fibrosis , so we suggest that radiation fibrosis may be another contributor of the occurrence of ILD in patients taking erlotinib.
Score Text
0.9996 We cared for a patient with progressive renal impairment who presented with blurred vision, QRS broadening and cardiac failure due to chronic Drugcibenzoline intoxication.
0.9943 We cared for a patient with progressive renal impairment who presented with blurred vision, QRS broadening and Adverse-Effectcardiac failure due to chronic cibenzoline intoxication.
0.9922 We cared for a patient with progressive renal impairment who presented with Adverse-Effectblurred vision , QRS broadening and cardiac failure due to chronic cibenzoline intoxication.
0.9908 We cared for a patient with progressive renal impairment who presented with blurred vision, Adverse-EffectQRS broadening and cardiac failure due to chronic cibenzoline intoxication.
0.7055 We cared for a patient with progressive renal impairment who presented with blurred vision, QRS broadening and cardiac failure due to chronic Adverse-Effectcibenzoline intoxication .
Score Text
0.9987 Adverse-EffectSeizures and extrapyramidal symptoms in a patient with Tourette's syndrome, Asperger's syndrome, and multiple sclerosis treated with interferon beta - 1a and clomipramine.
0.9956 Seizures and extrapyramidal symptoms in a patient with Tourette's syndrome, Asperger's syndrome, and multiple sclerosis treated with interferon beta - 1a and Drugclomipramine .
0.9927 Seizures and Adverse-Effectextrapyramidal symptoms in a patient with Tourette's syndrome, Asperger's syndrome, and multiple sclerosis treated with interferon beta - 1a and clomipramine.
0.9684 Seizures and extrapyramidal symptoms in a patient with Tourette's syndrome, Asperger's syndrome, and multiple sclerosis treated with Druginterferon beta - 1a and clomipramine.
Score Text
0.9995 BACKGROUND : DrugColchicine has a known adverse effect on wound healing through its inhibitory effect on tubulin - dependent cell functions and through collagenase activation.
0.8963 BACKGROUND : Colchicine has a known adverse effect on Adverse-Effectwound healing through its inhibitory effect on tubulin - dependent cell functions and through collagenase activation.
BACKGROUND : Colchicine has a known Adverse-Effectadverse effect on wound healing through its inhibitory effect on tubulin - dependent cell functions and through collagenase activation.
BACKGROUND : Colchicine has a known adverse effect on wound healing through its inhibitory effect on tubulin - dependent cell functions and through Adverse-Effectcollagenase activation .
Score Text
0.9969 Thrombolytic therapy with tissue plasminogen activator ( DrugtPA ) for acute myocardial infarction may result in major bleeding complications such as gastrointestinal or intracranial bleeding.
0.9784 Thrombolytic therapy with Drugtissue plasminogen activator ( tPA ) for acute myocardial infarction may result in major bleeding complications such as gastrointestinal or intracranial bleeding.
0.9465 Thrombolytic therapy with tissue plasminogen activator ( tPA ) for acute myocardial infarction may result in major bleeding complications such as Adverse-Effectgastrointestinal or intracranial bleeding .
Score Text
0.9994 We describe the development of cutaneous scleroderma in 3 patients coincident with the use of Drugbleomycin in low cumulative doses of less than 100 U.
0.9882 We describe the development of Adverse-Effectcutaneous scleroderma in 3 patients coincident with the use of bleomycin in low cumulative doses of less than 100 U.
Score Text
0.9983 Drug - induced Adverse-Effectpsychosis resulted from the administration of quinacrine hydrochloride at a dosage of 100 mg twice daily for the treatment of discoid lupus.
0.9849 Drug - induced psychosis resulted from the administration of Drugquinacrine hydrochloride at a dosage of 100 mg twice daily for the treatment of discoid lupus.
Score Text
0.9767 The interval between initiating treatment with interferon alfa and onset of anterior ischemic optic neuropathy was similar to that of interferon - associated Adverse-Effectvascular retinopathy .
0.9662 The interval between initiating treatment with interferon alfa and onset of Adverse-Effectanterior ischemic optic neuropathy was similar to that of interferon - associated vascular retinopathy.
0.9128 The interval between initiating treatment with Druginterferon alfa and onset of anterior ischemic optic neuropathy was similar to that of interferon - associated vascular retinopathy.
0.7067 The interval between initiating treatment with interferon alfa and onset of anterior ischemic optic neuropathy was similar to that of Druginterferon - associated vascular retinopathy.
Score Text
0.9995 We report a case of AILD in an 80 - year - old male who presented with a generalized pruritic maculopapular eruption and fever following Drugdoxycycline administration.
0.9955 We report a case of Adverse-EffectAILD in an 80 - year - old male who presented with a generalized pruritic maculopapular eruption and fever following doxycycline administration.
0.9864 We report a case of AILD in an 80 - year - old male who presented with a Adverse-Effectgeneralized pruritic maculopapular eruption and fever following doxycycline administration.
0.9852 We report a case of AILD in an 80 - year - old male who presented with a generalized pruritic maculopapular eruption and Adverse-Effectfever following doxycycline administration.
Score Text
0.9955 Post marketing studies of Interferon - beta ( IFN beta ) therapy in multiple sclerosis ( MS ) have demonstrated surprisingly high rates of Adverse-Effecthepatotoxicity .
0.9825 Post marketing studies of Interferon - beta ( DrugIFN beta ) therapy in multiple sclerosis ( MS ) have demonstrated surprisingly high rates of hepatotoxicity.
0.9743 Post marketing studies of DrugInterferon - beta ( IFN beta ) therapy in multiple sclerosis ( MS ) have demonstrated surprisingly high rates of hepatotoxicity.
Score Text
0.9975 Hypersensitivity to Drugcarboplatin has been reported in up to 44 % of patients receiving this antineoplastic agent, usually occurring after several courses of treatment.
0.9918 Adverse-EffectHypersensitivity to carboplatin has been reported in up to 44 % of patients receiving this antineoplastic agent, usually occurring after several courses of treatment.
Score Text
0.9989 During her third cycle, she again received Drugcisplatin 100 mg / m2 over 30 minutes and developed palmar pruritus, urticaria, and edema.
0.9982 During her third cycle, she again received cisplatin 100 mg / m2 over 30 minutes and developed palmar pruritus, Adverse-Effecturticaria , and edema.
0.9977 During her third cycle, she again received cisplatin 100 mg / m2 over 30 minutes and developed palmar pruritus, urticaria, and Adverse-Effectedema .
0.9900 During her third cycle, she again received cisplatin 100 mg / m2 over 30 minutes and developed Adverse-Effectpalmar pruritus , urticaria, and edema.
0.7446 During her third cycle, she again received cisplatin Adverse-Effect100 mg / m2 over 30 minutes and developed palmar pruritus, urticaria, and edema.
Score Text
0.9995 The authors report a further case of Drugmethimazole - associated liver damage and present a brief review of eleven previous cases found in the literature.
0.9951 The authors report a further case of methimazole - associated Adverse-Effectliver damage and present a brief review of eleven previous cases found in the literature.
Score Text
0.9992 We report a case of fulminant neuroleptic malignant syndrome in a man aged 70 developing within 12 hours of starting six - hourly intravenous Drugmetoclopramide .
0.5220 We report a case of fulminant Adverse-Effectneuroleptic malignant syndrome in a man aged 70 developing within 12 hours of starting six - hourly intravenous metoclopramide.
0.9537 We report a case of Adverse-Effectfulminant neuroleptic malignant syndrome in a man aged 70 developing within 12 hours of starting six - hourly intravenous metoclopramide.
Score Text
0.9946 We describe 3 AS patients treated with Drugetanercept for active AS who developed new onset of CD while AS related symptoms responded well to etanercept.
0.9921 We describe 3 AS patients treated with etanercept for active AS who developed new onset of Adverse-EffectCD while AS related symptoms responded well to etanercept.
Score Text
0.9866 After a two - month interruption of interferon administration, natural interferon alpha was given but followed by another episode of the same Adverse-Effectneurological manifestations .
0.9798 After a two - month interruption of interferon administration, natural Druginterferon alpha was given but followed by another episode of the same neurological manifestations.
Score Text
0.9994 We describe a patient with androgen - independent prostate cancer in whom PSA continued to decrease for a period of 15 months after Drugflutamide withdrawal.
0.9241 We describe a patient with androgen - independent prostate cancer in whom Adverse-EffectPSA continued to decrease for a period of 15 months after flutamide withdrawal.
Score Text
0.9834 46 - year - old woman developed painful ulcers over her lower abdomen in the form of Adverse-Effectreticulate erythema after injecting interferon beta - 1b subcutaneously for multiple sclerosis.
0.9788 46 - year - old woman developed Adverse-Effectpainful ulcers over her lower abdomen in the form of reticulate erythema after injecting interferon beta - 1b subcutaneously for multiple sclerosis.
0.9670 46 - year - old woman developed painful ulcers over her lower abdomen in the form of reticulate erythema after injecting Druginterferon beta - 1b subcutaneously for multiple sclerosis.
Score Text
0.9994 We report a case of SJS in a 14 - year - old male with nephrotic syndrome, who was treated with oral Drugprednisolone for 6 weeks.
0.9971 We report a case of Adverse-EffectSJS in a 14 - year - old male with nephrotic syndrome, who was treated with oral prednisolone for 6 weeks.
Score Text
0.9994 Data have been published regarding the possibility that Drugtamoxifen may be responsible for the subsequent development of carcinoma of the corpus uteri in these patients.
0.9835 Data have been published regarding the possibility that tamoxifen may be responsible for the subsequent development of Adverse-Effectcarcinoma of the corpus uteri in these patients.
Score Text
0.9995 A 56 - year - old Caucasian man who received concomitant chemotherapy and radiation for head and neck cancer developed fever concurrent with the administration of Drugamifostine .
0.9982 A 56 - year - old Caucasian man who received concomitant chemotherapy and radiation for head and neck cancer developed Adverse-Effectfever concurrent with the administration of amifostine.
Score Text
0.9988 DrugCalcipotriol ( Daivonex R ; Leo Pharmaceuticals, Zurich, Switzerland ) may cause irritation of the skin, whereas allergic reactions are less common.
0.9753 Calcipotriol ( Daivonex R ; Leo Pharmaceuticals, Zurich, Switzerland ) may cause irritation of the skin, whereas Adverse-Effectallergic reactions are less common.
0.9738 Calcipotriol ( Daivonex R ; Leo Pharmaceuticals, Zurich, Switzerland ) may cause Adverse-Effectirritation of the skin , whereas allergic reactions are less common.
Score Text
0.9874 CONCLUSION : Patients with Druginsulin allergy may not have complete resolution of their symptoms after standard desensitization, particularly those patients with concomitant protamine allergy.
0.9622 CONCLUSION : Patients with insulin allergy may not have complete resolution of their symptoms after standard desensitization, particularly those patients with concomitant Adverse-Effectprotamine allergy .
Score Text
0.9768 OBJECTIVE : To report a case of toxin - positive Clostridium difficile - induced colitis ( CDIC ) after use of Drugclindamycin phosphate vaginal cream.
0.9418 OBJECTIVE : To report a case of Adverse-Effecttoxin - positive Clostridium difficile - induced colitis ( CDIC ) after use of clindamycin phosphate vaginal cream.
0.9773 OBJECTIVE : To report a case of toxin - positive Clostridium difficile - induced colitis ( Adverse-EffectCDIC ) after use of clindamycin phosphate vaginal cream.
Score Text
0.9848 Pathogenesis of methotrexate - induced Adverse-Effectpapular eruption in psoriasis may involve immune mechanisms other than those of methotrexate - induced cutaneous vasculitis in collagen vascular disease.
0.9829 Pathogenesis of methotrexate - induced papular eruption in psoriasis may involve immune mechanisms other than those of methotrexate - induced Adverse-Effectcutaneous vasculitis in collagen vascular disease.
0.9612 Pathogenesis of Drugmethotrexate - induced papular eruption in psoriasis may involve immune mechanisms other than those of methotrexate - induced cutaneous vasculitis in collagen vascular disease.
0.9563 Pathogenesis of methotrexate - induced papular eruption in psoriasis may involve immune mechanisms other than those of Drugmethotrexate - induced cutaneous vasculitis in collagen vascular disease.
Score Text
0.9874 Two of the five patients who worsened motorically also developed encephalopathy during Drugrisperidone treatment ; the encephalopathy resolved when the patients were switched to clozapine treatment.
0.9865 Two of the five patients who worsened motorically also developed Adverse-Effectencephalopathy during risperidone treatment ; the encephalopathy resolved when the patients were switched to clozapine treatment.
0.8941 Two of the five patients who Adverse-Effectworsened motorically also developed encephalopathy during risperidone treatment ; the encephalopathy resolved when the patients were switched to clozapine treatment.
0.9381 Two of the five patients who worsened motorically also developed encephalopathy during risperidone treatment ; the encephalopathy resolved when the patients were switched to Drugclozapine treatment.
0.9062 Two of the five patients who worsened motorically also developed encephalopathy during risperidone treatment ; the Adverse-Effectencephalopathy resolved when the patients were switched to clozapine treatment.
Score Text
0.9994 Acute ocular ischemic change may be associated with intravitreal injection of Drugbevacizumab in patients with vascular compromised diabetic retinopathy and / or underlying stenosis of the carotid artery.
0.9851 Adverse-EffectAcute ocular ischemic change may be associated with intravitreal injection of bevacizumab in patients with vascular compromised diabetic retinopathy and / or underlying stenosis of the carotid artery.
Score Text
0.9976 She was receiving phenytoin sodium 300 mg / day ; carbamazepine 200 mg four times daily had been discontinued four days before admission because of Adverse-Effectleukopenia .
0.9923 She was receiving phenytoin sodium 300 mg / day ; Drugcarbamazepine 200 mg four times daily had been discontinued four days before admission because of leukopenia.
0.9733 She was receiving Drugphenytoin sodium 300 mg / day ; carbamazepine 200 mg four times daily had been discontinued four days before admission because of leukopenia.
Score Text
0.9956 His impaired memory was found to be due to the Drugatenolol he was on and he made a complete recovery on withdrawing the beta - blocker.
0.9726 His Adverse-Effectimpaired memory was found to be due to the atenolol he was on and he made a complete recovery on withdrawing the beta - blocker.
Score Text
0.9971 OBJECTIVE : To describe two cases of Adverse-Effectrhabdomyolysis in patients taking lovastatin that were precipitated by the use of the newer macrolide antibiotics clarithromycin and azithromycin.
0.9961 OBJECTIVE : To describe two cases of rhabdomyolysis in patients taking lovastatin that were precipitated by the use of the newer macrolide antibiotics clarithromycin and Drugazithromycin .
0.9958 OBJECTIVE : To describe two cases of rhabdomyolysis in patients taking lovastatin that were precipitated by the use of the newer macrolide antibiotics Drugclarithromycin and azithromycin.
0.9941 OBJECTIVE : To describe two cases of rhabdomyolysis in patients taking Druglovastatin that were precipitated by the use of the newer macrolide antibiotics clarithromycin and azithromycin.
Score Text
0.9983 This experience supports the hypothesis that heparin can be readministered early to patients with heparin - associated thrombocytopenia and Adverse-Effectthrombosis , provided antiplatelet therapy is given.
0.9978 This experience supports the hypothesis that heparin can be readministered early to patients with heparin - associated Adverse-Effectthrombocytopenia and thrombosis, provided antiplatelet therapy is given.
0.9930 This experience supports the hypothesis that heparin can be readministered early to patients with Drugheparin - associated thrombocytopenia and thrombosis, provided antiplatelet therapy is given.
Score Text
0.9993 The frequency and relationship of granulocytopenia caused by sustained - release Drugprocainamide in patients with tachyarrhythmias are briefly discussed, and prior reported cases are reviewed.
0.9966 The frequency and relationship of Adverse-Effectgranulocytopenia caused by sustained - release procainamide in patients with tachyarrhythmias are briefly discussed, and prior reported cases are reviewed.
Score Text
0.9975 To our knowledge, this is the first report of significant hypotension associated with intravenous Drugvalproate in the treatment of status epilepticus in the pediatric population.
0.9974 To our knowledge, this is the first report of significant Adverse-Effecthypotension associated with intravenous valproate in the treatment of status epilepticus in the pediatric population.
Score Text
0.9952 We describe a patient with rheumatoid arthritis treated with Druggold salts, who developed bilateral interstitial pulmonary abnormalities and showed a dramatic response on corticosteroid therapy.
0.9887 We describe a patient with rheumatoid arthritis treated with gold salts, who developed Adverse-Effectbilateral interstitial pulmonary abnormalities and showed a dramatic response on corticosteroid therapy.
Score Text
0.9994 In this case, discontinuing Drugpiroxicam , a nonsteroidal anti - inflammatory drug, and starting a palliative treatment plan helped resolve a patient's ulcers.
0.9888 In this case, discontinuing piroxicam, a nonsteroidal anti - inflammatory drug, and starting a palliative treatment plan helped resolve a patient's Adverse-Effectulcers .
Score Text
0.9991 We observed ventricular fibrillation in 2 patients who presented to the emergency department with pre - excited atrial fibrillation and were given 12 mg of Drugadenosine .
0.9921 We observed Adverse-Effectventricular fibrillation in 2 patients who presented to the emergency department with pre - excited atrial fibrillation and were given 12 mg of adenosine.
Score Text
0.9987 On the 3rd day, an inferior vena cava ( IVC ) filter was placed with a Drugheparin flush, after which massive IVC thrombosis developed.
0.9291 On the 3rd day, an inferior vena cava ( IVC ) filter was placed with a heparin flush, after which massive Adverse-EffectIVC thrombosis developed.
Score Text
0.9991 An 8 - year - old girl, who had been vaccinated with DrugBCG without subsequent regional reactions, developed osteomyelitis in the left calcaneus 7 months later.
0.9464 An 8 - year - old girl, who had been vaccinated with BCG without subsequent regional reactions, developed Adverse-Effectosteomyelitis in the left calcaneus 7 months later.
0.5934 An 8 - year - old girl, who had been vaccinated with BCG without subsequent regional reactions, developed Adverse-Effectosteomyelitis in the left calcaneus 7 months later.
Score Text
0.9993 In a female with acute lymphoblastic leukemia, inadvertent Drugdoxorubicin administration intrathecally caused severe, life - threatening, acute encephalopathy with high - pressure hydrocephalus.
0.9537 In a female with acute lymphoblastic leukemia, inadvertent doxorubicin administration intrathecally caused severe, life - threatening, acute encephalopathy with Adverse-Effecthigh - pressure hydrocephalus .
0.9390 In a female with acute lymphoblastic leukemia, inadvertent doxorubicin administration intrathecally caused severe, life - threatening, Adverse-Effectacute encephalopathy with high - pressure hydrocephalus.
Score Text
0.9992 In conclusion, this case strongly suggests that Druggliclazide can induce acute icteric liver necro - inflammation which may be misdiagnosed clinically as acute viral hepatitis.
0.9802 In conclusion, this case strongly suggests that gliclazide can induce Adverse-Effectacute icteric liver necro - inflammation which may be misdiagnosed clinically as acute viral hepatitis.
Score Text
0.9983 We report a case of reversible DKA and new - onset DM that developed in a demented patient who was treated with Drugquetiapine for 14 days.
0.9913 We report a case of reversible Adverse-EffectDKA and new - onset DM that developed in a demented patient who was treated with quetiapine for 14 days.
0.9697 We report a case of reversible DKA and new - onset Adverse-EffectDM that developed in a demented patient who was treated with quetiapine for 14 days.
Score Text
0.9986 Mean time between initiation of gemcitabine therapy and onset of Adverse-EffectHUS was 7. 4 + / - 3. 5 months, or 21. 9 + / - 10. 9 doses of gemcitabine.
0.9946 Mean time between initiation of Druggemcitabine therapy and onset of HUS was 7. 4 + / - 3. 5 months, or 21. 9 + / - 10. 9 doses of gemcitabine.
0.9920 Mean time between initiation of gemcitabine therapy and onset of HUS was 7. 4 + / - 3. 5 months, or 21. 9 + / - 10. 9 doses of Druggemcitabine .
Score Text
0.9398 DrugSodium phenylbutyrate was added to treatment with HU in two patients, but failed to produce an increase in total Hb despite increasing Hb F levels.
0.9037 Sodium phenylbutyrate was added to treatment with HU in two patients, but failed to produce an increase in total Hb despite Adverse-Effectincreasing Hb F levels.
0.8309 Sodium phenylbutyrate was added to treatment with DrugHU in two patients, but failed to produce an increase in total Hb despite increasing Hb F levels.
0.9138 Sodium phenylbutyrate was added to treatment with HU in two patients, but failed to produce an Adverse-Effectincrease in total Hb despite increasing Hb F levels.
Score Text
0.9893 INTERVENTIONS AND RESULTS : Adverse-EffectCardiac complications were observed in five pediatric patients who received between 4. 6 and 40. 8 mg / kg / d of amphotericin B.
0.9824 INTERVENTIONS AND RESULTS : Cardiac complications were observed in five pediatric patients who received between 4. 6 and 40. 8 mg / kg / d of Drugamphotericin B .
Score Text
0.9954 We describe the case of a nonatopic 17 - year - old girl with bronchial asthma and aspirin intolerance who developed a dramatic anaphylactic reaction to oral Drugprednisone .
0.9857 We describe the case of a nonatopic 17 - year - old girl with bronchial asthma and aspirin intolerance who developed a dramatic Adverse-Effectanaphylactic reaction to oral prednisone.
Score Text
0.9989 There remains a paucity of information pertaining to alternative anticoagulation strategies for use during cardiopulmonary bypass concomitant with Drugheparin - induced thrombocytopenia, especially in children.
0.9977 There remains a paucity of information pertaining to alternative anticoagulation strategies for use during cardiopulmonary bypass concomitant with heparin - induced Adverse-Effectthrombocytopenia , especially in children.
Score Text
0.9993 Renal failure is a rare complication associated with the use of Drugrifampicin for the treatment of tuberculosis, usually occurring well into the course of therapy.
0.9941 Adverse-EffectRenal failure is a rare complication associated with the use of rifampicin for the treatment of tuberculosis, usually occurring well into the course of therapy.
Score Text
0.9966 Of the four patients who responded to DrugHU with an increase in total Hb, all reported symptomatic improvement and three have not required further transfusions.
0.9670 Of the four patients who responded to HU with an Adverse-Effectincrease in total Hb , all reported symptomatic improvement and three have not required further transfusions.
Score Text
0.9992 Although moderate myelosuppression is not uncommonly seen in patients treated with Druglenalidomide , aplastic anemia has not previously been reported to be associated with this agent.
0.9920 Although moderate myelosuppression is not uncommonly seen in patients treated with lenalidomide, Adverse-Effectaplastic anemia has not previously been reported to be associated with this agent.
Score Text
0.9987 The disease - modifying drugs he was taking, cyclosporin and Drugmethotrexate , were stopped, and the lymphoma resolved spontaneously without the use of chemotherapy.
0.9984 The disease - modifying drugs he was taking, Drugcyclosporin and methotrexate, were stopped, and the lymphoma resolved spontaneously without the use of chemotherapy.
0.9970 The disease - modifying drugs he was taking, cyclosporin and methotrexate, were stopped, and the Adverse-Effectlymphoma resolved spontaneously without the use of chemotherapy.
Score Text
0.9994 The results clearly demonstrate that DrugCPH82 was associated with suppression of the endogeneous production of ACTH and cortisol with a concomitant paradoxical picture of clinical hypercortisolism.
0.9632 The results clearly demonstrate that CPH82 was associated with suppression of the endogeneous production of ACTH and cortisol with a concomitant paradoxical picture of clinical Adverse-Effecthypercortisolism .
The results clearly demonstrate that CPH82 was associated with Adverse-Effectsuppression of the endogeneous production of ACTH and cortisol with a concomitant paradoxical picture of clinical hypercortisolism.
Score Text
0.9994 However, peripheral neuropathy and bone marrow depression led to Druglinezolid withdrawal in seven patients, and neuropathy may not be fully reversible in all patients.
0.9940 However, peripheral neuropathy and bone marrow depression led to linezolid withdrawal in seven patients, and Adverse-Effectneuropathy may not be fully reversible in all patients.
0.9862 However, peripheral neuropathy and Adverse-Effectbone marrow depression led to linezolid withdrawal in seven patients, and neuropathy may not be fully reversible in all patients.
0.9855 However, Adverse-Effectperipheral neuropathy and bone marrow depression led to linezolid withdrawal in seven patients, and neuropathy may not be fully reversible in all patients.
Score Text
0.9994 DrugDocetaxel induced Meibomian duct inflammation and blockage is the likely cause of this presentation in a patient with no history of eyelid masses in the past.
0.9856 Docetaxel induced Adverse-EffectMeibomian duct inflammation and blockage is the likely cause of this presentation in a patient with no history of eyelid masses in the past.
Score Text
0.9996 We present a case of stroke after DrugPPA ingestion that occurred 4 months after the recall in an 8 - year - old boy on chronic peritoneal dialysis.
0.9957 We present a case of Adverse-Effectstroke after PPA ingestion that occurred 4 months after the recall in an 8 - year - old boy on chronic peritoneal dialysis.
Score Text
0.9974 The authors describe a case of combined lithium and haloperidol toxicity characterized by hyperpyrexia, severe rigidity, Adverse-Effectmutism , and development of irreversible tardive dyskinesia.
0.9968 The authors describe a case of combined lithium and haloperidol toxicity characterized by Adverse-Effecthyperpyrexia , severe rigidity, mutism, and development of irreversible tardive dyskinesia.
0.9953 The authors describe a case of combined lithium and Drughaloperidol toxicity characterized by hyperpyrexia, severe rigidity, mutism, and development of irreversible tardive dyskinesia.
0.9934 The authors describe a case of combined Druglithium and haloperidol toxicity characterized by hyperpyrexia, severe rigidity, mutism, and development of irreversible tardive dyskinesia.
0.9774 The authors describe a case of combined lithium and haloperidol toxicity characterized by hyperpyrexia, Adverse-Effectsevere rigidity , mutism, and development of irreversible tardive dyskinesia.
0.9378 The authors describe a case of combined lithium and haloperidol toxicity characterized by hyperpyrexia, severe rigidity, mutism, and development of Adverse-Effectirreversible tardive dyskinesia .
Score Text
0.9992 We report a child with yolk sac tumor who developed localized pigmentation after the first course of chemotherapy regimen that included cisplatin, etoposide and Drugbleomycin .
0.9992 We report a child with yolk sac tumor who developed localized pigmentation after the first course of chemotherapy regimen that included cisplatin, Drugetoposide and bleomycin.
0.9992 We report a child with yolk sac tumor who developed localized pigmentation after the first course of chemotherapy regimen that included Drugcisplatin , etoposide and bleomycin.
0.9836 We report a child with yolk sac tumor who developed Adverse-Effectlocalized pigmentation after the first course of chemotherapy regimen that included cisplatin, etoposide and bleomycin.
Score Text
0.9976 The site of thrombosis and the chronological relationship with the Adverse-EffectIIR implicates a hypersensitivity to infliximab in the causation of the venous thrombosis in this case.
0.9976 The site of thrombosis and the chronological relationship with the IIR implicates a hypersensitivity to Druginfliximab in the causation of the venous thrombosis in this case.
0.9219 The site of thrombosis and the chronological relationship with the IIR implicates a hypersensitivity to infliximab in the causation of the Adverse-Effectvenous thrombosis in this case.
0.9049 The site of thrombosis and the chronological relationship with the IIR implicates a Adverse-Effecthypersensitivity to infliximab in the causation of the venous thrombosis in this case.
Score Text
0.9986 The authors describe three families in whom the occurrence of Adverse-EffectFVS in all the siblings strongly suggests hereditary susceptibility to valproic acid - induced adverse outcome.
0.9848 The authors describe three families in whom the occurrence of FVS in all the siblings strongly suggests hereditary susceptibility to Drugvalproic acid - induced adverse outcome.
Score Text
0.9986 We report the case of a 60 - year - old woman who developed erythema and erosions in the axilla and groin while on DrugPLD for breast cancer.
0.9986 We report the case of a 60 - year - old woman who developed Adverse-Effecterythema and erosions in the axilla and groin while on PLD for breast cancer.
0.9094 We report the case of a 60 - year - old woman who developed erythema and Adverse-Effecterosions in the axilla and groin while on PLD for breast cancer.
Score Text
0.9995 A 73 - year - old woman presented with fever and cough 2 weeks after completing the third cycle of Drugfludarabine for chronic lymphocytic leukemia ( CLL ).
0.9976 A 73 - year - old woman presented with fever and Adverse-Effectcough 2 weeks after completing the third cycle of fludarabine for chronic lymphocytic leukemia ( CLL ).
0.9962 A 73 - year - old woman presented with Adverse-Effectfever and cough 2 weeks after completing the third cycle of fludarabine for chronic lymphocytic leukemia ( CLL ).
Score Text
0.9995 We observed 3 diabetic patients with intolerable dizziness followed by nausea and vomiting immediately after an initial administration of the alpha - glucosidase inhibitor, Drugvoglibose .
0.9952 We observed 3 diabetic patients with intolerable dizziness followed by nausea and Adverse-Effectvomiting immediately after an initial administration of the alpha - glucosidase inhibitor, voglibose.
0.9922 We observed 3 diabetic patients with intolerable dizziness followed by Adverse-Effectnausea and vomiting immediately after an initial administration of the alpha - glucosidase inhibitor, voglibose.
0.9820 We observed 3 diabetic patients with Adverse-Effectintolerable dizziness followed by nausea and vomiting immediately after an initial administration of the alpha - glucosidase inhibitor, voglibose.
Score Text
0.9894 Despite minimal short - term side effects and apparent efficacy, chronic treatment of MG with MM may be associated with increased risk of Adverse-Effectlymphoproliferative disorders .
0.8707 Despite minimal short - term side effects and apparent efficacy, chronic treatment of MG with DrugMM may be associated with increased risk of lymphoproliferative disorders.
Score Text
0.9954 A 62 - year - old Indian with diabetic nephropathy controlled with Drugmetformin , developed miliary tuberculosis for which he was treated with rifampicin, isoniazid and ethambutol.
0.9947 A 62 - year - old Indian with diabetic nephropathy controlled with metformin, developed Adverse-Effectmiliary tuberculosis for which he was treated with rifampicin, isoniazid and ethambutol.
0.9924 A 62 - year - old Indian with diabetic nephropathy controlled with metformin, developed miliary tuberculosis for which he was treated with rifampicin, isoniazid and Drugethambutol .
0.9902 A 62 - year - old Indian with diabetic nephropathy controlled with metformin, developed miliary tuberculosis for which he was treated with Drugrifampicin , isoniazid and ethambutol.
0.9891 A 62 - year - old Indian with diabetic nephropathy controlled with metformin, developed miliary tuberculosis for which he was treated with rifampicin, Drugisoniazid and ethambutol.
Score Text
0.9917 We present a case of Drugethylenediamine - induced delayed hypersensitivity reaction in a 46 - year - old woman who received parenteral aminophylline for an acute asthma exacerbation.
0.9887 We present a case of ethylenediamine - induced Adverse-Effectdelayed hypersensitivity reaction in a 46 - year - old woman who received parenteral aminophylline for an acute asthma exacerbation.
0.9540 We present a case of ethylenediamine - induced delayed hypersensitivity reaction in a 46 - year - old woman who received parenteral Drugaminophylline for an acute asthma exacerbation.
Score Text
0.9995 A mentally retarded 23 - year - old woman with myoclonic astatic epilepsy developed an abnormal posture of extreme forward flexion, called camptocormia, during Drugvalproate monotherapy.
0.9970 A mentally retarded 23 - year - old woman with myoclonic astatic epilepsy developed an abnormal posture of extreme forward flexion, called Adverse-Effectcamptocormia , during valproate monotherapy.
0.9276 A mentally retarded 23 - year - old woman with myoclonic astatic epilepsy developed an Adverse-Effectabnormal posture of extreme forward flexion , called camptocormia, during valproate monotherapy.
Score Text
0.9915 To the best of our knowledge, Adverse-Effectcorneoscleral melting in the first postoperative week after a single intraoperative application of mitomycin C has not been reported.
0.9860 To the best of our knowledge, corneoscleral melting in the first postoperative week after a single intraoperative application of Drugmitomycin C has not been reported.
Score Text
0.9988 PURPOSE : To describe spectral - domain optical coherence tomography ( SD - OCT ) and adaptive optics ( AO ) imaging in Drughydroxychloroquine retinal toxicity.
0.9103 PURPOSE : To describe spectral - domain optical coherence tomography ( SD - OCT ) and adaptive optics ( AO ) imaging in hydroxychloroquine Adverse-Effectretinal toxicity .
Score Text
0.9995 One patient who received Drugclindamycin had liver biopsy findings of marked cholestasis, portal inflammation, bile duct injury and bile duct paucity ( ductopenia ).
0.9962 One patient who received clindamycin had liver biopsy findings of marked cholestasis, portal inflammation, bile duct injury and bile duct paucity ( Adverse-Effectductopenia ).
0.9903 One patient who received clindamycin had liver biopsy findings of Adverse-Effectmarked cholestasis , portal inflammation, bile duct injury and bile duct paucity ( ductopenia ).
0.9872 One patient who received clindamycin had liver biopsy findings of marked cholestasis, Adverse-Effectportal inflammation , bile duct injury and bile duct paucity ( ductopenia ).
0.9862 One patient who received clindamycin had liver biopsy findings of marked cholestasis, portal inflammation, Adverse-Effectbile duct injury and bile duct paucity ( ductopenia ).
0.9858 One patient who received clindamycin had liver biopsy findings of marked cholestasis, portal inflammation, bile duct injury and Adverse-Effectbile duct paucity ( ductopenia ).
Score Text
0.9992 We present a case in which Drugdipyridamole induced high - grade atrioventricular ( AV ) block that responded promptly to intravenous aminophylline but not to atropine.
0.9785 We present a case in which dipyridamole induced Adverse-Effecthigh - grade atrioventricular ( AV ) block that responded promptly to intravenous aminophylline but not to atropine.
Score Text
0.9987 We report a case of acute generalized exanthematous pustulosis ( AGEP ) in a 50 - year - old woman that was attributed to the ingestion of Drugnimesulide .
0.9932 We report a case of acute generalized exanthematous pustulosis ( Adverse-EffectAGEP ) in a 50 - year - old woman that was attributed to the ingestion of nimesulide.
0.9821 We report a case of Adverse-Effectacute generalized exanthematous pustulosis ( AGEP ) in a 50 - year - old woman that was attributed to the ingestion of nimesulide.
Score Text
0.9894 A girl with cystic fibrosis and cyclic neutropenia developed an Adverse-Effecterythematous papular eruption without fever or neutrophilia 7 months after commencing therapy with G - CSF.
0.9781 A girl with cystic fibrosis and cyclic neutropenia developed an erythematous papular eruption without fever or neutrophilia 7 months after commencing therapy with DrugG - CSF .
Score Text
0.9983 Life - threatening anaphylactoid reaction to Drugamifostine used with concurrent chemoradiotherapy for nasopharyngeal cancer in a patient with dermatomyositis : a case report with literature review.
0.9876 Life - threatening Adverse-Effectanaphylactoid reaction to amifostine used with concurrent chemoradiotherapy for nasopharyngeal cancer in a patient with dermatomyositis : a case report with literature review.
Score Text
0.9985 To the best of our knowledge only two previous cases of AML have been linked to treatment of HCL with purine analogs, both with Drug2 - chlorodeoxyadenosine .
0.9953 To the best of our knowledge only two previous cases of Adverse-EffectAML have been linked to treatment of HCL with purine analogs, both with 2 - chlorodeoxyadenosine.
Score Text
0.9971 The possible effects of tamoxifen upon the uterus are discussed in this article, in view of reports of tamoxifen associated with endometrial carcinoma and Adverse-Effectendometriosis .
0.9876 The possible effects of tamoxifen upon the uterus are discussed in this article, in view of reports of tamoxifen associated with Adverse-Effectendometrial carcinoma and endometriosis.
0.9762 The possible effects of tamoxifen upon the uterus are discussed in this article, in view of reports of Drugtamoxifen associated with endometrial carcinoma and endometriosis.
0.9840 The possible effects of Drugtamoxifen upon the uterus are discussed in this article, in view of reports of tamoxifen associated with endometrial carcinoma and endometriosis.
Score Text
0.9996 It is suggested that the patient had Drugsulfasalazine - induced lupus, which manifested with serositis and pulmonary parenchymal involvement in the absence of joint symptoms.
0.9970 It is suggested that the patient had sulfasalazine - induced Adverse-Effectlupus , which manifested with serositis and pulmonary parenchymal involvement in the absence of joint symptoms.
0.9940 It is suggested that the patient had sulfasalazine - induced lupus, which manifested with Adverse-Effectserositis and pulmonary parenchymal involvement in the absence of joint symptoms.
0.9871 It is suggested that the patient had sulfasalazine - induced lupus, which manifested with serositis and Adverse-Effectpulmonary parenchymal involvement in the absence of joint symptoms.
Score Text
0.9995 The authors report a case of a patient who received Drugalteplase for acute myocardial infarction and developed spontaneous subfascial hematoma without any evidence of direct trauma.
0.9861 The authors report a case of a patient who received alteplase for acute myocardial infarction and developed spontaneous Adverse-Effectsubfascial hematoma without any evidence of direct trauma.
0.9384 The authors report a case of a patient who received alteplase for acute myocardial infarction and developed Adverse-Effectspontaneous subfascial hematoma without any evidence of direct trauma.
Score Text
0.9995 We report five cases of restless legs syndrome ( RLS ) and periodic limb movements during sleep ( PLMS ) that were probably associated with Drugolanzapine .
0.9962 We report five cases of restless legs syndrome ( Adverse-EffectRLS ) and periodic limb movements during sleep ( PLMS ) that were probably associated with olanzapine.
0.9959 We report five cases of restless legs syndrome ( RLS ) and periodic limb movements during sleep ( Adverse-EffectPLMS ) that were probably associated with olanzapine.
0.9845 We report five cases of Adverse-Effectrestless legs syndrome ( RLS ) and periodic limb movements during sleep ( PLMS ) that were probably associated with olanzapine.
0.9771 We report five cases of restless legs syndrome ( RLS ) and Adverse-Effectperiodic limb movements during sleep ( PLMS ) that were probably associated with olanzapine.
Score Text
0.9933 The successful development and implementation of this protocol will have impact on patients who have anaphylactic reactions to DrugMTX but require this medication for specific diseases.
0.9920 The successful development and implementation of this protocol will have impact on patients who have Adverse-Effectanaphylactic reactions to MTX but require this medication for specific diseases.
Score Text
0.9990 Rapid identification of speech loss linked to DrugFK506 may be important because reduction or cessation of the drug may be associated with reverse of speech loss.
0.9513 Rapid identification of Adverse-Effectspeech loss linked to FK506 may be important because reduction or cessation of the drug may be associated with reverse of speech loss.
Score Text
0.9927 Adverse-EffectOcular hypertension occurred 1 month after the second ranibizumab injection in patients 1 and 3, and 1 month after the first ranibizumab in patient 2.
0.9619 Ocular hypertension occurred 1 month after the second Drugranibizumab injection in patients 1 and 3, and 1 month after the first ranibizumab in patient 2.
0.8901 Ocular hypertension occurred 1 month after the second ranibizumab injection in patients 1 and 3, and 1 month after the first Drugranibizumab in patient 2.
Score Text
0.9993 OBSERVATIONS : We observed aggravation and spreading of a psoriatic plaque when treated topically with the toll - like receptor ( TLR ) 7 agonist Drugimiquimod .
0.9732 OBSERVATIONS : We observed Adverse-Effectaggravation and spreading of a psoriatic plaque when treated topically with the toll - like receptor ( TLR ) 7 agonist imiquimod.
Score Text
0.9911 A 59 - year - old woman with myasthenia gravis who received a large dose of pyridostigmine bromide developed Adverse-Effectpostoperative psychosis and was diagnosed as having bromide intoxication.
0.9859 A 59 - year - old woman with myasthenia gravis who received a large dose of Drugpyridostigmine bromide developed postoperative psychosis and was diagnosed as having bromide intoxication.
0.9770 A 59 - year - old woman with myasthenia gravis who received a large dose of pyridostigmine bromide developed postoperative psychosis and was diagnosed as having Adverse-Effectbromide intoxication .
Score Text
0.9985 BACKGROUND : DrugHydroxyurea is a cytostatic agent used to treat myeloproliferative disorders and long - term treatment is associated with mucocutaneous adverse events and nail hyperpigmentation.
0.9883 BACKGROUND : Hydroxyurea is a cytostatic agent used to treat myeloproliferative disorders and long - term treatment is associated with mucocutaneous adverse events and Adverse-Effectnail hyperpigmentation .
0.9801 BACKGROUND : Hydroxyurea is a cytostatic agent used to treat myeloproliferative disorders and long - term treatment is associated with Adverse-Effectmucocutaneous adverse events and nail hyperpigmentation.
Score Text
0.9850 Due to the increasing use of TMP - SMX in children, clinicians should be aware of this potentially life - threatening, Adverse-Effectimmunemediated hypersensitivity reaction .
0.9692 Due to the increasing use of DrugTMP - SMX in children, clinicians should be aware of this potentially life - threatening, immunemediated hypersensitivity reaction.
Score Text
0.9987 We report a case of generalized cutaneous sclerosis associated with muscle and oesophageal involvement in a patient exposed to herbicides containing bromocil, diuron and Drugaminotriazole .
0.9985 We report a case of generalized cutaneous sclerosis associated with muscle and oesophageal involvement in a patient exposed to herbicides containing Drugbromocil , diuron and aminotriazole.
0.9978 We report a case of generalized cutaneous sclerosis associated with muscle and oesophageal involvement in a patient exposed to herbicides containing bromocil, Drugdiuron and aminotriazole.
0.9724 We report a case of Adverse-Effectgeneralized cutaneous sclerosis associated with muscle and oesophageal involvement in a patient exposed to herbicides containing bromocil, diuron and aminotriazole.
Score Text
0.9994 These findings suggest that the corneal and retinal changes are the result of a toxic effect of Drugtamoxifen when used in the doses and duration described.
0.9803 These findings suggest that the Adverse-Effectcorneal and retinal changes are the result of a toxic effect of tamoxifen when used in the doses and duration described.
Score Text
0.9993 We report a premature infant who developed seizures associated with intraventricular administration of Drugnafcillin and discuss the need for electroencephalographic monitoring of patients receiving intraventricular antibiotics.
0.9988 We report a premature infant who developed Adverse-Effectseizures associated with intraventricular administration of nafcillin and discuss the need for electroencephalographic monitoring of patients receiving intraventricular antibiotics.
Score Text
0.9994 We report the successful treatment of Drugheparin - induced thrombocytopenia and subsequent hemorrhagic complications postoperatively in a 2 - year - old child with Danaparoid ( orgaran ).
0.9966 We report the successful treatment of heparin - induced Adverse-Effectthrombocytopenia and subsequent hemorrhagic complications postoperatively in a 2 - year - old child with Danaparoid ( orgaran ).
0.9921 We report the successful treatment of heparin - induced thrombocytopenia and subsequent Adverse-Effecthemorrhagic complications postoperatively in a 2 - year - old child with Danaparoid ( orgaran ).
Score Text
0.9992 This patient, who had a history of osteoarthritis, had severe hepatitis 5 weeks after being started on Drugdiclofenac for increasing pain in the joints.
0.6239 This patient, who had a history of osteoarthritis, had severe Adverse-Effecthepatitis 5 weeks after being started on diclofenac for increasing pain in the joints.
0.9473 This patient, who had a history of osteoarthritis, had Adverse-Effectsevere hepatitis 5 weeks after being started on diclofenac for increasing pain in the joints.
Score Text
0.9996 DISCUSSION : The main adverse effects of Drugleflunomide consist of diarrhea, nausea, liver enzyme elevation, hypertension, alopecia, and allergic skin reactions.
0.9987 DISCUSSION : The main adverse effects of leflunomide consist of Adverse-Effectdiarrhea , nausea, liver enzyme elevation, hypertension, alopecia, and allergic skin reactions.
0.9985 DISCUSSION : The main adverse effects of leflunomide consist of diarrhea, nausea, liver enzyme elevation, hypertension, Adverse-Effectalopecia , and allergic skin reactions.
0.9982 DISCUSSION : The main adverse effects of leflunomide consist of diarrhea, Adverse-Effectnausea , liver enzyme elevation, hypertension, alopecia, and allergic skin reactions.
0.9980 DISCUSSION : The main adverse effects of leflunomide consist of diarrhea, nausea, liver enzyme elevation, Adverse-Effecthypertension , alopecia, and allergic skin reactions.
0.9921 DISCUSSION : The main adverse effects of leflunomide consist of diarrhea, nausea, liver enzyme elevation, hypertension, alopecia, and Adverse-Effectallergic skin reactions .
0.9852 DISCUSSION : The main adverse effects of leflunomide consist of diarrhea, nausea, Adverse-Effectliver enzyme elevation , hypertension, alopecia, and allergic skin reactions.
Score Text
0.9990 This case supports the view that in Druggold - induced pneumonitis a prolonged treatment with corticosteroids may be necessary, as lung function continued to improve.
0.9984 This case supports the view that in gold - induced Adverse-Effectpneumonitis a prolonged treatment with corticosteroids may be necessary, as lung function continued to improve.
Score Text
0.9971 METHODS : A patient who developed dramatic, permanent vision loss after a 9 - month course of treatment with Drugethambutol and isoniazid for pulmonary tuberculosis is presented.
0.9958 METHODS : A patient who developed dramatic, permanent vision loss after a 9 - month course of treatment with ethambutol and Drugisoniazid for pulmonary tuberculosis is presented.
0.9841 METHODS : A patient who developed dramatic, permanent Adverse-Effectvision loss after a 9 - month course of treatment with ethambutol and isoniazid for pulmonary tuberculosis is presented.
Score Text
0.9994 The occurrence of symptoms that could be ascribed to an acute coronary syndrome should always be taken seriously during the first Drugrituximab infusion and investigated aggressively.
0.9853 The occurrence of symptoms that could be ascribed to an Adverse-Effectacute coronary syndrome should always be taken seriously during the first rituximab infusion and investigated aggressively.
Score Text
0.9895 There have been many reports of probable lithium - induced Adverse-Effectorganic brain syndromes occurring when serum lithium levels are within or close to the therapeutic range.
0.9788 There have been many reports of probable Druglithium - induced organic brain syndromes occurring when serum lithium levels are within or close to the therapeutic range.
0.7507 There have been many reports of probable lithium - induced organic brain syndromes occurring when serum Druglithium levels are within or close to the therapeutic range.
Score Text
0.9936 The case demonstrates that hypersensitivity reaction to pranlukast and resultant Adverse-EffectATIN is possible, and that periodic urine testing in patients receiving pranlukast should be considered.
0.9554 The case demonstrates that hypersensitivity reaction to pranlukast and resultant ATIN is possible, and that periodic urine testing in patients receiving Drugpranlukast should be considered.
0.9458 The case demonstrates that hypersensitivity reaction to Drugpranlukast and resultant ATIN is possible, and that periodic urine testing in patients receiving pranlukast should be considered.
0.9273 The case demonstrates that Adverse-Effecthypersensitivity reaction to pranlukast and resultant ATIN is possible, and that periodic urine testing in patients receiving pranlukast should be considered.
Score Text
0.9996 After 1 week of Drugnefazodone therapy the patient experienced headache, confusion, and " gray areas " in her vision, without abnormal ophthalmologic findings.
0.9988 After 1 week of nefazodone therapy the patient experienced Adverse-Effectheadache , confusion, and " gray areas " in her vision, without abnormal ophthalmologic findings.
0.9948 After 1 week of nefazodone therapy the patient experienced headache, Adverse-Effectconfusion , and " gray areas " in her vision, without abnormal ophthalmologic findings.
0.9662 After 1 week of nefazodone therapy the patient experienced headache, confusion, and " Adverse-Effectgray areas " in her vision, without abnormal ophthalmologic findings.
Score Text
0.9986 The diagnosis was supported by the temporal course of renal deterioration during exposure to Drugcefuroxime and improvement on its discontinuation ; the pattern repeated with rechallenge.
0.9841 The diagnosis was supported by the temporal course of Adverse-Effectrenal deterioration during exposure to cefuroxime and improvement on its discontinuation ; the pattern repeated with rechallenge.
Score Text
0.9936 Although interferon gamma has been implicated in the pathogenesis of sarcoidosis, only a few cases of Adverse-Effectsarcoidosis associated with interferon alpha therapy have been reported.
0.9797 Although interferon gamma has been implicated in the pathogenesis of sarcoidosis, only a few cases of sarcoidosis associated with Druginterferon alpha therapy have been reported.
0.9740 Although Druginterferon gamma has been implicated in the pathogenesis of sarcoidosis, only a few cases of sarcoidosis associated with interferon alpha therapy have been reported.
Score Text
0.9990 Anti - tuberculous drugs had been stopped on the 2nd day of therapy due to development of optic neuritis secondary to Drugethambutol administration at another hospital.
0.9917 Anti - tuberculous drugs had been stopped on the 2nd day of therapy due to development of Adverse-Effectoptic neuritis secondary to ethambutol administration at another hospital.
Score Text
0.9974 A case is presented of a patient who experienced benzodiazepine withdrawal symptoms on discontinuation of Drugnefazodone , an antidepressant that inhibits the cytochrome P450 3A4 isoenzyme.
0.9575 A case is presented of a patient who experienced Adverse-Effectbenzodiazepine withdrawal symptoms on discontinuation of nefazodone, an antidepressant that inhibits the cytochrome P450 3A4 isoenzyme.
Score Text
0.9893 We reported 3 patients who developed acute generalized dystonia and Adverse-Effectakinetic rigid syndrome following an initial therapy with d - penicillamine 125 - 500 mg daily.
0.9856 We reported 3 patients who developed Adverse-Effectacute generalized dystonia and akinetic rigid syndrome following an initial therapy with d - penicillamine 125 - 500 mg daily.
0.9697 We reported 3 patients who developed acute generalized dystonia and akinetic rigid syndrome following an initial therapy with Drugd - penicillamine 125 - 500 mg daily.
Score Text
0.9994 This case presentation is of a patient who had the clinical appearance of epiglottitis, but actually had an oro - pharyngeal dystonic reaction to Drugprochlorperazine .
0.9923 This case presentation is of a patient who had the clinical appearance of Adverse-Effectepiglottitis , but actually had an oro - pharyngeal dystonic reaction to prochlorperazine.
0.9795 This case presentation is of a patient who had the clinical appearance of epiglottitis, but actually had an Adverse-Effectoro - pharyngeal dystonic reaction to prochlorperazine.
Score Text
0.9983 Therapy with IFN - alpha may be associated with a number of neuropsychiatric symptoms, such as Parkinsonism, Adverse-Effectakathisia , seizure, and depressive disorders.
0.9983 Therapy with IFN - alpha may be associated with a number of neuropsychiatric symptoms, such as Parkinsonism, akathisia, Adverse-Effectseizure , and depressive disorders.
0.9961 Therapy with IFN - alpha may be associated with a number of neuropsychiatric symptoms, such as Adverse-EffectParkinsonism , akathisia, seizure, and depressive disorders.
0.9947 Therapy with IFN - alpha may be associated with a number of neuropsychiatric symptoms, such as Parkinsonism, akathisia, seizure, and Adverse-Effectdepressive disorders .
0.9878 Therapy with IFN - alpha may be associated with a number of Adverse-Effectneuropsychiatric symptoms , such as Parkinsonism, akathisia, seizure, and depressive disorders.
0.9755 Therapy with DrugIFN - alpha may be associated with a number of neuropsychiatric symptoms, such as Parkinsonism, akathisia, seizure, and depressive disorders.
Score Text
0.9789 CONCLUSIONS : Low dosages of Drugquinacrine used for malaria prophylaxis can be associated with a delayed, severe maculopathy indistinguishable from chloroquine maculopathy in certain patients.
0.9664 CONCLUSIONS : Low dosages of quinacrine used for malaria prophylaxis can be associated with a delayed, Adverse-Effectsevere maculopathy indistinguishable from chloroquine maculopathy in certain patients.
0.6047 CONCLUSIONS : Low dosages of quinacrine used for malaria prophylaxis can be associated with a delayed, severe maculopathy indistinguishable from chloroquine Adverse-Effectmaculopathy in certain patients.
0.9483 CONCLUSIONS : Low dosages of quinacrine used for malaria prophylaxis can be associated with a delayed, severe Adverse-Effectmaculopathy indistinguishable from chloroquine maculopathy in certain patients.
0.5845 CONCLUSIONS : Low dosages of quinacrine used for malaria prophylaxis can be associated with a delayed, severe maculopathy indistinguishable from Adverse-Effectchloroquine maculopathy in certain patients.
CONCLUSIONS : Low dosages of quinacrine used for malaria prophylaxis can be associated with a delayed, severe maculopathy indistinguishable from Drugchloroquine maculopathy in certain patients.
Score Text
0.9995 However, a recent post - marketing survey in Japan revealed that interstitial pneumonia occurred in 4 among approximately 2 000 Japanese patients treated with Drugsorafenib .
0.9886 However, a recent post - marketing survey in Japan revealed that Adverse-Effectinterstitial pneumonia occurred in 4 among approximately 2 000 Japanese patients treated with sorafenib.
Score Text
0.9994 Three patients received respectively 190 mg, 175 mg, and 196 mg of Drugmethotrexate and developed bilateral pulmonary infiltrates without evidence of peripheral blood eosinophilia.
0.9915 Three patients received respectively 190 mg, 175 mg, and 196 mg of methotrexate and developed Adverse-Effectbilateral pulmonary infiltrates without evidence of peripheral blood eosinophilia.
Score Text
0.9984 An infant who developed Adverse-Effectpancreatitis during meglumine antimoniate treatment for visceral leishmaniasis and who was successfully treated with a combination of allopurinol and ketoconazole is reported.
0.9860 An infant who developed pancreatitis during Drugmeglumine antimoniate treatment for visceral leishmaniasis and who was successfully treated with a combination of allopurinol and ketoconazole is reported.
0.6732 An infant who developed pancreatitis during meglumine antimoniate treatment for visceral leishmaniasis and who was successfully treated with a combination of allopurinol and Drugketoconazole is reported.
Score Text
0.9931 Normalization of generalized retinal function and progression of maculopathy after cessation of therapy in a case of severe Drughydroxychloroquine retinopathy with 19 years follow - up.
0.9361 Normalization of generalized retinal function and progression of maculopathy after cessation of therapy in a case of severe hydroxychloroquine Adverse-Effectretinopathy with 19 years follow - up.
0.9688 Normalization of generalized retinal function and Adverse-Effectprogression of maculopathy after cessation of therapy in a case of severe hydroxychloroquine retinopathy with 19 years follow - up.
Score Text
0.9996 However, as illustrated by these and other cases reported to date, the onset of Drugtroglitazone - induced liver injury is insidious and temporally variable.
0.9934 However, as illustrated by these and other cases reported to date, the onset of troglitazone - induced Adverse-Effectliver injury is insidious and temporally variable.
Score Text
0.9992 A 55 - year - old woman presented an episode of acute urticaria and labial angioedema 60 minutes after ingesting 500 mg of Drugcloxacillin for a skin abscess.
0.9839 A 55 - year - old woman presented an episode of acute urticaria and Adverse-Effectlabial angioedema 60 minutes after ingesting 500 mg of cloxacillin for a skin abscess.
0.9828 A 55 - year - old woman presented an episode of Adverse-Effectacute urticaria and labial angioedema 60 minutes after ingesting 500 mg of cloxacillin for a skin abscess.
Score Text
0.9890 These features have not previously been reported as side effects of glibenclamide therapy, but Adverse-Effectintrahepatic cholestasis may occur with chlorpropamide, a similar sulphonylurea agent.
0.9632 These features have not previously been reported as side effects of glibenclamide therapy, but intrahepatic cholestasis may occur with Drugchlorpropamide , a similar sulphonylurea agent.
0.9814 These features have not previously been reported as side effects of Drugglibenclamide therapy, but intrahepatic cholestasis may occur with chlorpropamide, a similar sulphonylurea agent.
Score Text
0.9899 The relation between Drugtacrolimus treatment and staining was suggested by the appearance of pigmentation during topical tacrolimus treatment and its clinical disappearance when treatment was stopped.
0.9894 The relation between tacrolimus treatment and staining was suggested by the appearance of Adverse-Effectpigmentation during topical tacrolimus treatment and its clinical disappearance when treatment was stopped.
0.9881 The relation between tacrolimus treatment and staining was suggested by the appearance of pigmentation during topical Drugtacrolimus treatment and its clinical disappearance when treatment was stopped.
Score Text
0.9967 The Adverse-Effecthypercalcemia responded to discontinuation of rhGH and a single dose of intravenous pamidronate disodium and has not recurred in 8 months of follow - up.
0.9607 The hypercalcemia responded to discontinuation of DrugrhGH and a single dose of intravenous pamidronate disodium and has not recurred in 8 months of follow - up.
0.8482 The hypercalcemia responded to discontinuation of rhGH and a single dose of intravenous Drugpamidronate disodium and has not recurred in 8 months of follow - up.
Score Text
0.9996 We document the abrupt development of an extensive choroidal detachment after initiation of Drugdorzolamide therapy in a surgically untreated eye with primary open - angle glaucoma.
0.9858 We document the abrupt development of an extensive Adverse-Effectchoroidal detachment after initiation of dorzolamide therapy in a surgically untreated eye with primary open - angle glaucoma.
Score Text
0.9875 We describe a patient with the antiphospholipid syndrome who had Adverse-Effectskin necrosis develop from low - molecular weight heparin therapy at sites distant from injection sites.
0.9689 We describe a patient with the antiphospholipid syndrome who had skin necrosis develop from Druglow - molecular weight heparin therapy at sites distant from injection sites.
Score Text
0.9827 Since this amount of FAB was insufficient to bind all DGTX present in the serum, cardiac DGTX toxicity ( Adverse-Effecttotal AV - block ) persisted.
0.9123 Since this amount of FAB was insufficient to bind all DGTX present in the serum, cardiac DrugDGTX toxicity ( total AV - block ) persisted.
0.6429 Since this amount of FAB was insufficient to bind all DGTX present in the serum, Adverse-Effectcardiac DGTX toxicity ( total AV - block ) persisted.
0.5907 Since this amount of FAB was insufficient to bind Drugall DGTX present in the serum, cardiac DGTX toxicity ( total AV - block ) persisted.
Score Text
0.9989 We report four patients, three of whom first developed Adverse-Effectpsoriasis and one who had an aggravation of the condition during treatment with interferon - alpha.
0.9746 We report four patients, three of whom first developed psoriasis and one who had an aggravation of the condition during treatment with Druginterferon - alpha .
Score Text
0.9988 Three months following splenectomy, multiple abscesses occurred in the muscles of both thighs while the patient was receiving the third course of the DrugCHOP regimen.
0.9809 Three months following splenectomy, Adverse-Effectmultiple abscesses occurred in the muscles of both thighs while the patient was receiving the third course of the CHOP regimen.
Score Text
0.9996 The possible development of a drug - induced vasculitis or lupus - like syndrome should be added to the list of rare toxic effects of Drugvancomycin .
0.9962 The possible development of a drug - induced Adverse-Effectvasculitis or lupus - like syndrome should be added to the list of rare toxic effects of vancomycin.
0.9807 The possible development of a drug - induced vasculitis or Adverse-Effectlupus - like syndrome should be added to the list of rare toxic effects of vancomycin.
Score Text
0.9993 CONCLUSIONS : In these 3 cases, the unique positive ocular finding was corneal endothelial deposits, which may be related to the use of Drugrifabutin .
0.9878 CONCLUSIONS : In these 3 cases, the unique positive ocular finding was Adverse-Effectcorneal endothelial deposits , which may be related to the use of rifabutin.
Score Text
0.9973 Exacerbations of the heart failure were temporally related to the administration of the antitumor antibiotics actinomycin - D ( NSC - 3053 ) and Drugmithramycin ( NSC - 24559 ).
0.9779 Exacerbations of the heart failure were temporally related to the administration of the antitumor antibiotics Drugactinomycin - D ( NSC - 3053 ) and mithramycin ( NSC - 24559 ).
0.9706 Exacerbations of the heart failure were temporally related to the administration of the antitumor antibiotics actinomycin - D ( NSC - 3053 ) and mithramycin ( DrugNSC - 24559 ).
0.9699 Exacerbations of the heart failure were temporally related to the administration of the antitumor antibiotics actinomycin - D ( DrugNSC - 3053 ) and mithramycin ( NSC - 24559 ).
0.8676 Adverse-EffectExacerbations of the heart failure were temporally related to the administration of the antitumor antibiotics actinomycin - D ( NSC - 3053 ) and mithramycin ( NSC - 24559 ).
Score Text
0.9995 A female patient with HER2 positive, metastatic breast cancer presented with pulmonary infiltrates, and a plural effusion dyspnoea after several months of Drugtrastuzumab treatment.
0.9823 A female patient with HER2 positive, metastatic breast cancer presented with Adverse-Effectpulmonary infiltrates , and a plural effusion dyspnoea after several months of trastuzumab treatment.
0.9820 A female patient with HER2 positive, metastatic breast cancer presented with pulmonary infiltrates, and a Adverse-Effectplural effusion dyspnoea after several months of trastuzumab treatment.
Score Text
0.9992 DrugMorphine , an opium alkaloid, frequently causes side effects such as hyperhidrosis and facial flushing, but serious cutaneous adverse drug reactions are seldom observed.
0.9980 Morphine, an opium alkaloid, frequently causes side effects such as Adverse-Effecthyperhidrosis and facial flushing, but serious cutaneous adverse drug reactions are seldom observed.
0.9812 Morphine, an opium alkaloid, frequently causes side effects such as hyperhidrosis and Adverse-Effectfacial flushing , but serious cutaneous adverse drug reactions are seldom observed.
Score Text
0.9868 CONCLUSIONS : Adverse-EffectSpontaneous hemothorax is a rare phenomenon in conjunction with LMWH but should be considered in cases of acute respiratory distress following commencement of LMWH.
0.9819 CONCLUSIONS : Spontaneous hemothorax is a rare phenomenon in conjunction with DrugLMWH but should be considered in cases of acute respiratory distress following commencement of LMWH.
0.9761 CONCLUSIONS : Spontaneous hemothorax is a rare phenomenon in conjunction with LMWH but should be considered in cases of acute respiratory distress following commencement of DrugLMWH .
0.9576 CONCLUSIONS : Spontaneous hemothorax is a rare phenomenon in conjunction with LMWH but should be considered in cases of Adverse-Effectacute respiratory distress following commencement of LMWH.
Score Text
0.9988 A patient suffering from Drugheparin - associated thrombocytopenia ( HAT ), recurrent arteriothromboses, and acute renal failure after treatment with standard heparin is described.
0.9978 A patient suffering from heparin - associated thrombocytopenia ( HAT ), recurrent arteriothromboses, and acute renal failure after treatment with standard Drugheparin is described.
0.9966 A patient suffering from heparin - associated thrombocytopenia ( Adverse-EffectHAT ), recurrent arteriothromboses, and acute renal failure after treatment with standard heparin is described.
0.9954 A patient suffering from heparin - associated Adverse-Effectthrombocytopenia ( HAT ), recurrent arteriothromboses, and acute renal failure after treatment with standard heparin is described.
0.9895 A patient suffering from heparin - associated thrombocytopenia ( HAT ), recurrent arteriothromboses, and Adverse-Effectacute renal failure after treatment with standard heparin is described.
0.9823 A patient suffering from heparin - associated thrombocytopenia ( HAT ), Adverse-Effectrecurrent arteriothromboses , and acute renal failure after treatment with standard heparin is described.
Score Text
0.9986 AIMS : To present a case of Adverse-Effectpiloerection after replacing fluvoxamine maleate with milnacipran hydrochloride, and to analyse this effect based on receptor occupancy theory.
0.9821 AIMS : To present a case of piloerection after replacing Drugfluvoxamine maleate with milnacipran hydrochloride, and to analyse this effect based on receptor occupancy theory.
0.9788 AIMS : To present a case of piloerection after replacing fluvoxamine maleate with Drugmilnacipran hydrochloride , and to analyse this effect based on receptor occupancy theory.
Score Text
0.9849 PURPOSE : To determine the cause of Adverse-Effectspontaneous choroidal hemorrhage in a 67 - year - old man after a myocardial infarction and administration of tissue plasminogen activator.
0.9700 PURPOSE : To determine the cause of spontaneous choroidal hemorrhage in a 67 - year - old man after a myocardial infarction and administration of Drugtissue plasminogen activator .
Score Text
0.9876 In one instance a Adverse-Effectsystemic hypoglycemic reaction resulting in head trauma and confusion ended in an emegency hospital admission following the substitution of acetohexamide for acetazolamide.
0.9864 In one instance a systemic hypoglycemic reaction resulting in Adverse-Effecthead trauma and confusion ended in an emegency hospital admission following the substitution of acetohexamide for acetazolamide.
0.9787 In one instance a systemic hypoglycemic reaction resulting in head trauma and confusion ended in an emegency hospital admission following the substitution of Drugacetohexamide for acetazolamide.
0.9726 In one instance a systemic hypoglycemic reaction resulting in head trauma and Adverse-Effectconfusion ended in an emegency hospital admission following the substitution of acetohexamide for acetazolamide.
Score Text
0.9996 CONCLUSIONS : DrugItraconazole - induced liver injury presents with a cholestatic pattern of injury with damage to the interlobular bile ducts, possibly leading to ductopenia.
0.9958 CONCLUSIONS : Itraconazole - induced liver injury presents with a cholestatic pattern of injury with damage to the interlobular bile ducts, possibly leading to Adverse-Effectductopenia .
0.9864 CONCLUSIONS : Itraconazole - induced Adverse-Effectliver injury presents with a cholestatic pattern of injury with damage to the interlobular bile ducts, possibly leading to ductopenia.
0.9822 CONCLUSIONS : Itraconazole - induced liver injury presents with a Adverse-Effectcholestatic pattern of injury with damage to the interlobular bile ducts, possibly leading to ductopenia.
0.9719 CONCLUSIONS : Itraconazole - induced liver injury presents with a cholestatic pattern of injury with Adverse-Effectdamage to the interlobular bile ducts , possibly leading to ductopenia.
Score Text
0.9991 We report four cases of encephalopathy coincident with elevated aluminum levels as well as one patient who developed seizures while receiving continuous bladder irrigations with Drugalum .
0.9960 We report four cases of encephalopathy coincident with elevated aluminum levels as well as one patient who developed Adverse-Effectseizures while receiving continuous bladder irrigations with alum.
0.9934 We report four cases of Adverse-Effectencephalopathy coincident with elevated aluminum levels as well as one patient who developed seizures while receiving continuous bladder irrigations with alum.
0.9824 We report four cases of encephalopathy coincident with Adverse-Effectelevated aluminum levels as well as one patient who developed seizures while receiving continuous bladder irrigations with alum.
Score Text
0.9987 We experienced a male patient with psoriasis and hypertension whose conditions were treated with tacalcitol ointment and thiazide, respectively, resulting in Adverse-Effecthypercalciuria and hypercalcemia.
0.9985 We experienced a male patient with psoriasis and hypertension whose conditions were treated with tacalcitol ointment and thiazide, respectively, resulting in hypercalciuria and Adverse-Effecthypercalcemia .
0.9978 We experienced a male patient with psoriasis and hypertension whose conditions were treated with Drugtacalcitol ointment and thiazide, respectively, resulting in hypercalciuria and hypercalcemia.
0.8722 We experienced a male patient with psoriasis and hypertension whose conditions were treated with tacalcitol ointment and Drugthiazide , respectively, resulting in hypercalciuria and hypercalcemia.
Score Text
0.9712 While for ribavirin antidepressant effects are not known, we suppose that antidepressants may prevent changes in serotonergic or noradrenergic neurotransmission caused by DrugIFN - alpha .
0.9633 While for ribavirin antidepressant effects are not known, we suppose that antidepressants may prevent Adverse-Effectchanges in serotonergic or noradrenergic neurotransmission caused by IFN - alpha.
Score Text
0.9988 As Druglinezolid has been shown to have hematologic side effects, blood count monitoring is recommended in patients receiving this drug for long - term therapy.
0.9700 As linezolid has been shown to have Adverse-Effecthematologic side effects , blood count monitoring is recommended in patients receiving this drug for long - term therapy.
Score Text
0.9992 Two patients with extrinsic asthma and coexistent insulin - dependent diabetes mellitus sustained an anaphylactoid reaction after the intravenous administration of 50 % solution of Drugdextrose .
0.9932 Two patients with extrinsic asthma and coexistent insulin - dependent diabetes mellitus sustained an Adverse-Effectanaphylactoid reaction after the intravenous administration of 50 % solution of dextrose.
Score Text
0.9994 A patient is described who developed a rapid onset of pulmonary fibrosis following treatment with a new non - steroidal anti - inflammatory drug, Drugnabumetone .
0.9895 A patient is described who developed a rapid onset of Adverse-Effectpulmonary fibrosis following treatment with a new non - steroidal anti - inflammatory drug, nabumetone.
Score Text
0.9992 Although its side effects are few, Drugtamoxifen increases the incidence of proliferative lesions of the endometrium, which theoretically should be preventable with progestational agents.
0.9732 Although its side effects are few, tamoxifen increases the incidence of Adverse-Effectproliferative lesions of the endometrium , which theoretically should be preventable with progestational agents.
Score Text
0.9996 In four patients, thrombosis occurred 2 - 45 days after severe hepatic veno - occlusive disease ( HVOD ) secondary to intensive chemotherapy containing Drugbusulfan .
0.9933 In four patients, Adverse-Effectthrombosis occurred 2 - 45 days after severe hepatic veno - occlusive disease ( HVOD ) secondary to intensive chemotherapy containing busulfan.
0.9930 In four patients, thrombosis occurred 2 - 45 days after severe hepatic veno - occlusive disease ( Adverse-EffectHVOD ) secondary to intensive chemotherapy containing busulfan.
0.9624 In four patients, thrombosis occurred 2 - 45 days after severe Adverse-Effecthepatic veno - occlusive disease ( HVOD ) secondary to intensive chemotherapy containing busulfan.
Score Text
0.9992 CONCLUSIONS : Although Drugbudesonide may be beneficial because of its anti - inflammatory effects, clinicians should be alert to its potential for causing contact dermatitis.
0.9848 CONCLUSIONS : Although budesonide may be beneficial because of its anti - inflammatory effects, clinicians should be alert to its potential for causing Adverse-Effectcontact dermatitis .
Score Text
0.9994 The patient was found to have no motile sperm with a normal sperm count, while taking a dose of 400 mg / day of Drugcarbamazepine .
0.9882 The patient was found to have Adverse-Effectno motile sperm with a normal sperm count, while taking a dose of 400 mg / day of carbamazepine.
Score Text
0.9994 PVT during chemotherapy in children is a rare event and appears to be closely related to intensive chemotherapy containing Drugbusulfan and to be associated with HVOD.
0.9973 Adverse-EffectPVT during chemotherapy in children is a rare event and appears to be closely related to intensive chemotherapy containing busulfan and to be associated with HVOD.
0.9896 PVT during chemotherapy in children is a rare event and appears to be closely related to intensive chemotherapy containing busulfan and to be associated with Adverse-EffectHVOD .
Score Text
0.9988 The development of cutaneous ecchymosis associated with a sudden fall in hemoglobin after the administration of Drugalteplase should strongly suggest the possibility of diffuse subfascial hematoma.
0.9820 The development of Adverse-Effectcutaneous ecchymosis associated with a sudden fall in hemoglobin after the administration of alteplase should strongly suggest the possibility of diffuse subfascial hematoma.
0.9787 The development of cutaneous ecchymosis associated with a Adverse-Effectsudden fall in hemoglobin after the administration of alteplase should strongly suggest the possibility of diffuse subfascial hematoma.
0.9760 The development of cutaneous ecchymosis associated with a sudden fall in hemoglobin after the administration of alteplase should strongly suggest the possibility of Adverse-Effectdiffuse subfascial hematoma .
Score Text
0.9993 RESULTS : A 52 - year - old woman with Parkinson disease who had taken Drugamantadine for 6 years had bilateral corneal edema for 2 months at baseline.
0.9878 RESULTS : A 52 - year - old woman with Parkinson disease who had taken amantadine for 6 years had Adverse-Effectbilateral corneal edema for 2 months at baseline.
Score Text
0.9994 A few recent individual case reports have suggested that a myasthenic syndrome may be associated with Drugstatin treatment, but this association is not well described.
0.9941 A few recent individual case reports have suggested that a Adverse-Effectmyasthenic syndrome may be associated with statin treatment, but this association is not well described.
Score Text
0.9990 We report a case of Drugamiodarone - induced thyrotoxicosis of protracted duration, unresponsive to conventional thionamide therapy, with therapy limited by severe adverse drug reactions.
0.9978 We report a case of amiodarone - induced Adverse-Effectthyrotoxicosis of protracted duration, unresponsive to conventional thionamide therapy, with therapy limited by severe adverse drug reactions.
Score Text
0.9874 We hypothesize that decreased renal elimination of DrugMTX induced by the COX - 2 inhibitor resulted in enhanced hematopoietic toxicity and immunosuppression causing the EBV - associated lymphoproliferative disease.
0.9812 We hypothesize that decreased renal elimination of MTX induced by the COX - 2 inhibitor resulted in enhanced hematopoietic toxicity and Adverse-Effectimmunosuppression causing the EBV - associated lymphoproliferative disease.
0.9789 We hypothesize that decreased renal elimination of MTX induced by the COX - 2 inhibitor resulted in enhanced Adverse-Effecthematopoietic toxicity and immunosuppression causing the EBV - associated lymphoproliferative disease.
0.9311 We hypothesize that decreased renal elimination of MTX induced by the COX - 2 inhibitor resulted in enhanced hematopoietic toxicity and immunosuppression causing the Adverse-EffectEBV - associated lymphoproliferative disease .
Score Text
0.9995 DrugMTX - induced hepatic injury and liver enzyme elevations have been demonstrated after treatment of leukemia, gestational disease and during treatment of psoriasis and rheumatoid arthritis.
0.9918 MTX - induced Adverse-Effecthepatic injury and liver enzyme elevations have been demonstrated after treatment of leukemia, gestational disease and during treatment of psoriasis and rheumatoid arthritis.
0.9881 MTX - induced hepatic injury and Adverse-Effectliver enzyme elevations have been demonstrated after treatment of leukemia, gestational disease and during treatment of psoriasis and rheumatoid arthritis.
Score Text
0.9995 We herein described an additional patient with BCR - ABL ( ela2 ) positive acute lymphoblastic leukemia who developed tumor lysis syndrome after 10 - day treatment with Drugimatinib .
0.9919 We herein described an additional patient with BCR - ABL ( ela2 ) positive acute lymphoblastic leukemia who developed Adverse-Effecttumor lysis syndrome after 10 - day treatment with imatinib.
Score Text
0.9958 This article presents a patient with hypoparathyroidism who was treated with calcium carbonate and Drugcalcitriol resulting in two admissions to the hospital for milk - alkali syndrome.
0.9897 This article presents a patient with hypoparathyroidism who was treated with Drugcalcium carbonate and calcitriol resulting in two admissions to the hospital for milk - alkali syndrome.
0.9461 This article presents a patient with hypoparathyroidism who was treated with calcium carbonate and calcitriol resulting in two admissions to the hospital for Adverse-Effectmilk - alkali syndrome .
Score Text
0.9985 Management of hypophosphatemia induced by high - flux hemodiafiltration for the treatment of Drugvancomycin toxicity : intravenous phosphorus therapy versus use of a phosphorus - enriched dialysate.
0.7735 Management of hypophosphatemia induced by high - flux hemodiafiltration for the treatment of Adverse-Effectvancomycin toxicity : intravenous phosphorus therapy versus use of a phosphorus - enriched dialysate.
0.7747 Management of Adverse-Effecthypophosphatemia induced by high - flux hemodiafiltration for the treatment of vancomycin toxicity : intravenous phosphorus therapy versus use of a phosphorus - enriched dialysate.
Score Text
0.9958 Although this combination agent has been associated with a hypersensitivity syndrome involving cutaneous skin eruptions, pediatric cases of TMP - SMX - induced Adverse-Effecthepatotoxicity are rare.
0.9762 Although this combination agent has been associated with a hypersensitivity syndrome involving cutaneous skin eruptions, pediatric cases of DrugTMP - SMX - induced hepatotoxicity are rare.
0.9390 Although this combination agent has been associated with a Adverse-Effecthypersensitivity syndrome involving cutaneous skin eruptions, pediatric cases of TMP - SMX - induced hepatotoxicity are rare.
0.8684 Although this combination agent has been associated with a hypersensitivity syndrome involving Adverse-Effectcutaneous skin eruptions , pediatric cases of TMP - SMX - induced hepatotoxicity are rare.
Score Text
0.9989 The addition of intrathecal Drugmethotrexate to treatment protocols has increased survival rates in children with acute lymphoblastic leukemia but is also associated with varying degrees of neurotoxicity.
0.9936 The addition of intrathecal methotrexate to treatment protocols has increased survival rates in children with acute lymphoblastic leukemia but is also associated with varying degrees of Adverse-Effectneurotoxicity .
Score Text
0.9992 A teenage girl with crescentic glomerulonephritis had antineutrophil cytoplasmic antibody ( ANCA ) detected after she had received Drugpropylthiouracil ( PTU ) for hyperthyroidism without cutaneous vasculitis.
0.9990 A teenage girl with crescentic glomerulonephritis had antineutrophil cytoplasmic antibody ( ANCA ) detected after she had received propylthiouracil ( DrugPTU ) for hyperthyroidism without cutaneous vasculitis.
0.9552 A teenage girl with crescentic glomerulonephritis had Adverse-Effectantineutrophil cytoplasmic antibody ( ANCA ) detected after she had received propylthiouracil ( PTU ) for hyperthyroidism without cutaneous vasculitis.
Score Text
0.9986 A 64 year old woman with previous history of coronary stenting five days before was admitted in our institution for intracranial bleeding while receiving Drugaspirin and clopidogrel.
0.9976 A 64 year old woman with previous history of coronary stenting five days before was admitted in our institution for intracranial bleeding while receiving aspirin and Drugclopidogrel .
0.9907 A 64 year old woman with previous history of coronary stenting five days before was admitted in our institution for Adverse-Effectintracranial bleeding while receiving aspirin and clopidogrel.
Score Text
0.9193 OBJECTIVE : To study therapy with indapamide impairing carbohydrate metabolism in essential hypertension patients and achieve earlier prevention, diagnoses and treatment of diabetes induced by Drugindapamide .
0.9112 OBJECTIVE : To study therapy with Drugindapamide impairing carbohydrate metabolism in essential hypertension patients and achieve earlier prevention, diagnoses and treatment of diabetes induced by indapamide.
0.8895 OBJECTIVE : To study therapy with indapamide impairing carbohydrate metabolism in essential hypertension patients and achieve earlier prevention, diagnoses and treatment of Adverse-Effectdiabetes induced by indapamide.
0.7866 OBJECTIVE : To study therapy with indapamide impairing Drugcarbohydrate metabolism in essential hypertension patients and achieve earlier prevention, diagnoses and treatment of diabetes induced by indapamide.
OBJECTIVE : To study therapy with indapamide Adverse-Effectimpairing carbohydrate metabolism in essential hypertension patients and achieve earlier prevention, diagnoses and treatment of diabetes induced by indapamide.
Score Text
0.9890 Coadministration of antidepressant agents such as Drugnefazodone , or any other drug that inhibits the CYP3A4 isoenzyme subfamily, should be anticipated to interfere with tacrolimus metabolism.
0.9434 Coadministration of antidepressant agents such as nefazodone, or any other drug that inhibits the CYP3A4 isoenzyme subfamily, should be anticipated to interfere with Drugtacrolimus metabolism.
0.7274 Coadministration of antidepressant agents such as nefazodone, or any other drug that inhibits the CYP3A4 isoenzyme subfamily, should be anticipated to Adverse-Effectinterfere with tacrolimus metabolism .
Score Text
0.9953 BACKGROUND : Reproductive endocrine disorders characterized by menstrual disorders, polycystic ovaries, and Adverse-Effecthyperandrogenism seem to be common among women treated with sodium valproate for epilepsy.
0.9940 BACKGROUND : Reproductive endocrine disorders characterized by Adverse-Effectmenstrual disorders , polycystic ovaries, and hyperandrogenism seem to be common among women treated with sodium valproate for epilepsy.
0.9921 BACKGROUND : Reproductive endocrine disorders characterized by menstrual disorders, Adverse-Effectpolycystic ovaries , and hyperandrogenism seem to be common among women treated with sodium valproate for epilepsy.
0.9894 BACKGROUND : Adverse-EffectReproductive endocrine disorders characterized by menstrual disorders, polycystic ovaries, and hyperandrogenism seem to be common among women treated with sodium valproate for epilepsy.
0.9856 BACKGROUND : Reproductive endocrine disorders characterized by menstrual disorders, polycystic ovaries, and hyperandrogenism seem to be common among women treated with Drugsodium valproate for epilepsy.
Score Text
0.9989 A 52 - year - old, white female developed low - grade fever, Adverse-Effectcough , and dyspnea after 8 weeks treatment with sodium aurothiomalate for rheumatoid arthritis.
0.9979 A 52 - year - old, white female developed low - grade fever, cough, and Adverse-Effectdyspnea after 8 weeks treatment with sodium aurothiomalate for rheumatoid arthritis.
0.9884 A 52 - year - old, white female developed Adverse-Effectlow - grade fever , cough, and dyspnea after 8 weeks treatment with sodium aurothiomalate for rheumatoid arthritis.
0.9843 A 52 - year - old, white female developed low - grade fever, cough, and dyspnea after 8 weeks treatment with Drugsodium aurothiomalate for rheumatoid arthritis.
Score Text
0.9990 We report a case of a 60 - year - old woman affected by squamous lung carcinoma, who developed paroxysmal supraventricular tachycardia during cisplatin and Drugetoposide combination chemotherapy.
0.9987 We report a case of a 60 - year - old woman affected by squamous lung carcinoma, who developed paroxysmal supraventricular tachycardia during Drugcisplatin and etoposide combination chemotherapy.
0.9853 We report a case of a 60 - year - old woman affected by squamous lung carcinoma, who developed Adverse-Effectparoxysmal supraventricular tachycardia during cisplatin and etoposide combination chemotherapy.
Score Text
0.9996 The patient experienced hallucinations, agitation, vomiting, tachycardia and seizures after ingestion of 1050 ( 48 mg / kg ) of extended - release Drugbupropion .
0.9986 The patient experienced hallucinations, agitation, vomiting, Adverse-Effecttachycardia and seizures after ingestion of 1050 ( 48 mg / kg ) of extended - release bupropion.
0.9983 The patient experienced Adverse-Effecthallucinations , agitation, vomiting, tachycardia and seizures after ingestion of 1050 ( 48 mg / kg ) of extended - release bupropion.
0.9978 The patient experienced hallucinations, agitation, vomiting, tachycardia and Adverse-Effectseizures after ingestion of 1050 ( 48 mg / kg ) of extended - release bupropion.
0.9976 The patient experienced hallucinations, agitation, Adverse-Effectvomiting , tachycardia and seizures after ingestion of 1050 ( 48 mg / kg ) of extended - release bupropion.
0.9967 The patient experienced hallucinations, Adverse-Effectagitation , vomiting, tachycardia and seizures after ingestion of 1050 ( 48 mg / kg ) of extended - release bupropion.
Score Text
0.9996 The authors describe Drugvalproate - induced hyperammonemia and mental status changes in an 88 - year - old man, the first known reported case in an elderly patient.
0.9980 The authors describe valproate - induced Adverse-Effecthyperammonemia and mental status changes in an 88 - year - old man, the first known reported case in an elderly patient.
0.9854 The authors describe valproate - induced hyperammonemia and Adverse-Effectmental status changes in an 88 - year - old man, the first known reported case in an elderly patient.
Score Text
0.9994 DISCUSSION : No published clinical studies in patients receiving Drugclindamycin vaginal cream for bacterial vaginosis have documented C. difficile toxin in stool samples of patients with diarrhea.
0.9359 DISCUSSION : No published clinical studies in patients receiving clindamycin vaginal cream for bacterial vaginosis have documented C. difficile toxin in stool samples of patients with Adverse-Effectdiarrhea .
0.9380 DISCUSSION : No published clinical studies in patients receiving clindamycin vaginal cream for bacterial vaginosis have documented Adverse-EffectC. difficile toxin in stool samples of patients with diarrhea.
DISCUSSION : No published clinical studies in patients receiving clindamycin vaginal cream for bacterial vaginosis have documented Adverse-EffectC. difficile toxin in stool samples of patients with diarrhea.
Score Text
0.9994 When thrombosis develops during Drugheparin treatment, it is important to suspect HITTs and to assay for the associated antibodies, regardless of the actual platelet count.
0.9974 When Adverse-Effectthrombosis develops during heparin treatment, it is important to suspect HITTs and to assay for the associated antibodies, regardless of the actual platelet count.
Score Text
0.9990 A patient with Wegener's granulomatosis rapidly developed a circumferential subglottic stenosis while on a Drugcyclophosphamide regimen that had caused resolution of systemic symptoms and pulmonary infiltrates.
0.9898 A patient with Wegener's granulomatosis rapidly developed a Adverse-Effectcircumferential subglottic stenosis while on a cyclophosphamide regimen that had caused resolution of systemic symptoms and pulmonary infiltrates.
Score Text
0.9996 In each of the three reported patients, alteration of eyelid appearance with deepening of the lid sulcus was evident as the result of topical Drugbimatoprost therapy.
0.9832 In each of the three reported patients, alteration of eyelid appearance with Adverse-Effectdeepening of the lid sulcus was evident as the result of topical bimatoprost therapy.
0.9804 In each of the three reported patients, Adverse-Effectalteration of eyelid appearance with deepening of the lid sulcus was evident as the result of topical bimatoprost therapy.
Score Text
0.9959 OBJECTIVE : To evaluate the efficacy of the administration of insulin by a jet - injector device in stopping and reversing severe human insulin - induced Adverse-Effectlipoatrophy .
0.9875 OBJECTIVE : To evaluate the efficacy of the administration of insulin by a jet - injector device in stopping and reversing severe Drughuman insulin - induced lipoatrophy.
0.9322 OBJECTIVE : To evaluate the efficacy of the administration of Druginsulin by a jet - injector device in stopping and reversing severe human insulin - induced lipoatrophy.
Score Text
0.9994 The authors intend to carry out a case - control study on patients treated with Drugtamoxifen for breast carcinoma to reveal the possible presence of endometrial carcinoma.
0.9891 The authors intend to carry out a case - control study on patients treated with tamoxifen for breast carcinoma to reveal the possible presence of Adverse-Effectendometrial carcinoma .
Score Text
0.9977 Therefore, clinicians should pay close attention to possible onset of RD in patients with multiple risk factors for TD, even when DrugSDA therapy is used.
0.9885 Therefore, clinicians should pay close attention to possible onset of Adverse-EffectRD in patients with multiple risk factors for TD, even when SDA therapy is used.
Score Text
0.9973 Children with acute lymphoblastic leukemia ( ALL ), treated with L - asparaginase are at risk for cerebral thrombosis or Adverse-Effecthemorrhage because of coagulation protein deficiencies.
0.9780 Children with acute lymphoblastic leukemia ( ALL ), treated with DrugL - asparaginase are at risk for cerebral thrombosis or hemorrhage because of coagulation protein deficiencies.
0.9725 Children with acute lymphoblastic leukemia ( ALL ), treated with L - asparaginase are at risk for cerebral thrombosis or hemorrhage because of Adverse-Effectcoagulation protein deficiencies .
0.9657 Children with acute lymphoblastic leukemia ( ALL ), treated with L - asparaginase are at risk for Adverse-Effectcerebral thrombosis or hemorrhage because of coagulation protein deficiencies.
Score Text
0.9996 We report the case of a patient with chronic lymphocytic leukemia ( CLL ) who developed fatal intravascular autoimmune hemolytic anemia ( AIHA ) after Drugfludarabine treatment.
0.9965 We report the case of a patient with chronic lymphocytic leukemia ( CLL ) who developed fatal intravascular autoimmune hemolytic anemia ( Adverse-EffectAIHA ) after fludarabine treatment.
0.9853 We report the case of a patient with chronic lymphocytic leukemia ( CLL ) who developed Adverse-Effectfatal intravascular autoimmune hemolytic anemia ( AIHA ) after fludarabine treatment.
Score Text
0.9988 We describe two ELBW infants affected by hyperkalaemia, treated with DrugKayexalate , who developed serious hypernatraemia, that has never been reported before in preterm infants.
0.9927 We describe two ELBW infants affected by hyperkalaemia, treated with Kayexalate, who developed serious Adverse-Effecthypernatraemia , that has never been reported before in preterm infants.
Score Text
0.9997 CONCLUSION : To the best of our knowledge, this is the first time Drugcolchicine intoxication in this age group has been described in the English literature.
0.9367 CONCLUSION : To the best of our knowledge, this is the first time Adverse-Effectcolchicine intoxication in this age group has been described in the English literature.
Score Text
0.9992 Initial treatment with Drugheparin was substituted with thrombolysis, which resulted in clinical improvement and dissolution of right heart thrombus but was followed by fatal intracerebral haemorrhage.
0.9871 Initial treatment with heparin was substituted with thrombolysis, which resulted in clinical improvement and dissolution of right heart thrombus but was followed by Adverse-Effectfatal intracerebral haemorrhage .
Score Text
0.9991 Nine delirious patients suffering from Druglithium intoxication were examined with the Mini - Mental State Exam ( MMS ) to describe the clinical course of the disorder.
0.9738 Nine Adverse-Effectdelirious patients suffering from lithium intoxication were examined with the Mini - Mental State Exam ( MMS ) to describe the clinical course of the disorder.
Score Text
0.9984 Recently, some studies have also reported association between patients with juvenile rheumatoid arthritis ( JRA ) treated with DrugMethotrexate ( MTX ) and malignant lymphoma developing.
0.9976 Recently, some studies have also reported association between patients with juvenile rheumatoid arthritis ( JRA ) treated with Methotrexate ( DrugMTX ) and malignant lymphoma developing.
0.9890 Recently, some studies have also reported association between patients with juvenile rheumatoid arthritis ( JRA ) treated with Methotrexate ( MTX ) and Adverse-Effectmalignant lymphoma developing.
Score Text
0.9963 DrugRifampin ( RFP ) increases hepatic microsomal enzyme activity, and there are case reports of RFP - induced hypothyroidism, all associated with Hashimoto's thyroiditis.
0.9945 Rifampin ( RFP ) increases hepatic microsomal enzyme activity, and there are case reports of RFP - induced Adverse-Effecthypothyroidism , all associated with Hashimoto's thyroiditis.
0.9941 Rifampin ( DrugRFP ) increases hepatic microsomal enzyme activity, and there are case reports of RFP - induced hypothyroidism, all associated with Hashimoto's thyroiditis.
0.9419 Rifampin ( RFP ) increases hepatic microsomal enzyme activity, and there are case reports of RFP - induced hypothyroidism, all associated with Adverse-EffectHashimoto's thyroiditis .
0.9762 Rifampin ( RFP ) increases hepatic microsomal enzyme activity, and there are case reports of DrugRFP - induced hypothyroidism, all associated with Hashimoto's thyroiditis.
Score Text
0.9735 OBJECTIVE : To report the late development of Adverse-Effectimmune - mediated diabetes mellitus after completion of alfa - interferon therapy for hepatitis C in an Asian patient.
0.9659 OBJECTIVE : To report the late development of immune - mediated diabetes mellitus after completion of Drugalfa - interferon therapy for hepatitis C in an Asian patient.
Score Text
0.9995 The authors describe a woman with chronic schizophrenia who experienced delirium, grand mal seizure, and photosensitivity after the addition of Drugpropranolol to her neuroleptic regimen.
0.9988 The authors describe a woman with chronic schizophrenia who experienced Adverse-Effectdelirium , grand mal seizure, and photosensitivity after the addition of propranolol to her neuroleptic regimen.
0.9982 The authors describe a woman with chronic schizophrenia who experienced delirium, grand mal seizure, and Adverse-Effectphotosensitivity after the addition of propranolol to her neuroleptic regimen.
0.9901 The authors describe a woman with chronic schizophrenia who experienced delirium, Adverse-Effectgrand mal seizure , and photosensitivity after the addition of propranolol to her neuroleptic regimen.
Score Text
0.9995 Seven patients with hematologic malignancies who were treated with Drugmiconazole for either suspected or proven fungal infections developed eight episodes of major adverse cardiorespiratory and anaphylactic reactions.
0.9555 Seven patients with hematologic malignancies who were treated with miconazole for either suspected or proven fungal infections developed eight episodes of major adverse Adverse-Effectcardiorespiratory and anaphylactic reactions .
0.9013 Seven patients with hematologic malignancies who were treated with miconazole for either suspected or proven fungal infections developed eight episodes of major Adverse-Effectadverse cardiorespiratory and anaphylactic reactions .
Score Text
0.9981 k bipolar manic - depressive patient, developed while on Druglithium prophylaxis, akathisia at therapeutic serum lithium levels and subsequently bucco - linguo - masticatory dyskinesia.
0.9910 k bipolar manic - depressive patient, developed while on lithium prophylaxis, Adverse-Effectakathisia at therapeutic serum lithium levels and subsequently bucco - linguo - masticatory dyskinesia.
0.9795 k bipolar manic - depressive patient, developed while on lithium prophylaxis, akathisia at therapeutic serum lithium levels and subsequently Adverse-Effectbucco - linguo - masticatory dyskinesia .
Score Text
0.9874 DrugHydroxyurea ( HU ) and sodium phenylbutyrate ( SPB ) have been shown to increase fetal hemoglobin ( Hb F ) levels in patients with thalassemia intermedia.
0.9816 Hydroxyurea ( HU ) and sodium phenylbutyrate ( SPB ) have been shown to Adverse-Effectincrease fetal hemoglobin ( Hb F ) levels in patients with thalassemia intermedia.
0.9584 Hydroxyurea ( HU ) and Drugsodium phenylbutyrate ( SPB ) have been shown to increase fetal hemoglobin ( Hb F ) levels in patients with thalassemia intermedia.
0.9845 Hydroxyurea ( DrugHU ) and sodium phenylbutyrate ( SPB ) have been shown to increase fetal hemoglobin ( Hb F ) levels in patients with thalassemia intermedia.
Score Text
0.9992 The second was an 82 - year - old man receiving Drugticlopidine for 2 years when, during a febrile episode, he was found neutropenic with marrow aplasia.
0.9827 The second was an 82 - year - old man receiving ticlopidine for 2 years when, during a febrile episode, he was found neutropenic with Adverse-Effectmarrow aplasia .
0.9818 The second was an 82 - year - old man receiving ticlopidine for 2 years when, during a febrile episode, he was found Adverse-Effectneutropenic with marrow aplasia.
Score Text
0.9996 A 73 - year - old woman with non - Hodgkin's lymphoma had two episodes of severe, bilateral, sensori - neural hearing loss after Drugvincristine therapy.
0.9274 A 73 - year - old woman with non - Hodgkin's lymphoma had two episodes of severe, bilateral, Adverse-Effectsensori - neural hearing loss after vincristine therapy.
Score Text
0.9990 Fatal radiation myelopathy after high - dose Drugbusulfan and melphalan chemotherapy and radiotherapy for Ewing's sarcoma : a review of the literature and implications for practice.
0.9988 Fatal radiation myelopathy after high - dose busulfan and Drugmelphalan chemotherapy and radiotherapy for Ewing's sarcoma : a review of the literature and implications for practice.
0.9873 Adverse-EffectFatal radiation myelopathy after high - dose busulfan and melphalan chemotherapy and radiotherapy for Ewing's sarcoma : a review of the literature and implications for practice.
Score Text
0.9943 A 57 - year - old man developed chronic, watery diarrhea four weeks after Helicobacter pylori eradication therapy including Druglansoprazole followed by lansoprazole monotherapy for gastroesophageal reflux disease.
0.9930 A 57 - year - old man developed chronic, watery diarrhea four weeks after Helicobacter pylori eradication therapy including lansoprazole followed by Druglansoprazole monotherapy for gastroesophageal reflux disease.
0.6179 A 57 - year - old man developed chronic, Adverse-Effectwatery diarrhea four weeks after Helicobacter pylori eradication therapy including lansoprazole followed by lansoprazole monotherapy for gastroesophageal reflux disease.
A 57 - year - old man developed Adverse-Effectchronic, watery diarrhea four weeks after Helicobacter pylori eradication therapy including lansoprazole followed by lansoprazole monotherapy for gastroesophageal reflux disease.
Score Text
0.9994 BACKGROUND : DrugCyanamide , an aversive agent widely used in Japan, is known to induce various degrees of hepatic lesion with ground - glass inclusion bodies.
0.8157 BACKGROUND : Cyanamide, an aversive agent widely used in Japan, is known to induce various degrees of Adverse-Effecthepatic lesion with ground - glass inclusion bodies .
Score Text
0.9975 BACKGROUND : To assess the nature, incidence, and risk factors of Adverse-Effectretinopathy associated with pegylated interferon and ribavirin combination therapy in chronic hepatitis C patients.
0.9974 BACKGROUND : To assess the nature, incidence, and risk factors of retinopathy associated with pegylated interferon and Drugribavirin combination therapy in chronic hepatitis C patients.
0.9852 BACKGROUND : To assess the nature, incidence, and risk factors of retinopathy associated with Drugpegylated interferon and ribavirin combination therapy in chronic hepatitis C patients.
Score Text
0.9989 These cases were chosen for study because they were all deaths as a result of suicidal ingestion of drugs in which Drugquetiapine was considered a significant factor.
0.9962 These cases were chosen for study because they were all Adverse-Effectdeaths as a result of suicidal ingestion of drugs in which quetiapine was considered a significant factor.
Score Text
0.9992 Exposure of the fetus to Drugindomethacin by administration of the drug to the mother may cause many side effects, including premature closure of the ductus arteriosus.
0.9745 Exposure of the fetus to indomethacin by administration of the drug to the mother may cause many side effects, including Adverse-Effectpremature closure of the ductus arteriosus .
0.9253 Adverse-EffectExposure of the fetus to indomethacin by administration of the drug to the mother may cause many side effects, including premature closure of the ductus arteriosus.
Score Text
0.9826 This increase when clozapine was switched to risperidone and vice versa is consistent with our previous report of Adverse-Effectelevated serum triglyceride levels in clozapine - treated patients.
0.8909 This increase when clozapine was switched to risperidone and vice versa is consistent with our previous report of elevated serum triglyceride levels in Drugclozapine - treated patients.
Score Text
0.9990 A case of toxic hepatitis caused by combination therapy with Drugmethotrexate and etretinate in the treatment of severe psoriasis is presented in a 47 - year - old woman.
0.9988 A case of toxic hepatitis caused by combination therapy with methotrexate and Drugetretinate in the treatment of severe psoriasis is presented in a 47 - year - old woman.
0.9912 A case of Adverse-Effecttoxic hepatitis caused by combination therapy with methotrexate and etretinate in the treatment of severe psoriasis is presented in a 47 - year - old woman.
Score Text
0.9992 We present a case of respiratory failure occurring in a woman at 16 weeks'gestation who was being treated with Drugnitrofurantoin for a urinary tract infection.
0.9931 We present a case of Adverse-Effectrespiratory failure occurring in a woman at 16 weeks'gestation who was being treated with nitrofurantoin for a urinary tract infection.
Score Text
0.9993 DrugTiclopidine is an oral antiplatelet agent frequently utilized in the treatment of cerebrovascular disease and is rarely associated with severe bone marrow suppression, typically aplastic anemia.
0.9940 Ticlopidine is an oral antiplatelet agent frequently utilized in the treatment of cerebrovascular disease and is rarely associated with severe bone marrow suppression, typically Adverse-Effectaplastic anemia .
0.9858 Ticlopidine is an oral antiplatelet agent frequently utilized in the treatment of cerebrovascular disease and is rarely associated with Adverse-Effectsevere bone marrow suppression , typically aplastic anemia.
Score Text
0.9995 Pellagra should be suspected whenever tuberculous patients under treatment with Drugisoniazid develop mental, neurological or gastrointestinal symptoms, even in the absence of typical pellagra dermatitis.
0.9827 Pellagra should be suspected whenever tuberculous patients under treatment with isoniazid develop Adverse-Effectmental, neurological or gastrointestinal symptoms , even in the absence of typical pellagra dermatitis.
Score Text
0.9994 Treatment with Druginfliximab is known to produce an increase of autoantibodies ( antinuclear antibodies, anti - double - stranded DNA ), but not clinical disease.
0.9907 Treatment with infliximab is known to produce an increase of autoantibodies ( Adverse-Effectantinuclear antibodies , anti - double - stranded DNA ), but not clinical disease.
0.9814 Treatment with infliximab is known to produce an Adverse-Effectincrease of autoantibodies ( antinuclear antibodies, anti - double - stranded DNA ), but not clinical disease.
0.9813 Treatment with infliximab is known to produce an increase of autoantibodies ( antinuclear antibodies, Adverse-Effectanti - double - stranded DNA ), but not clinical disease.
Score Text
0.9984 A 21 - year - old man with Tourette's syndrome, pedophilia, Asperger's syndrome, and multiple sclerosis experienced Adverse-Effectseizures after receiving therapy with interferon beta - 1a.
0.9750 A 21 - year - old man with Tourette's syndrome, pedophilia, Asperger's syndrome, and multiple sclerosis experienced seizures after receiving therapy with Druginterferon beta - 1a .
Score Text
0.9976 We present a case of a 58 - year - old female patient with Graves'disease who developed AA in the third exposure to Drugmethimazole ( MMI ).
0.9946 We present a case of a 58 - year - old female patient with Graves'disease who developed Adverse-EffectAA in the third exposure to methimazole ( MMI ).
0.9966 We present a case of a 58 - year - old female patient with Graves'disease who developed AA in the third exposure to methimazole ( DrugMMI ).
Score Text
0.9845 Adverse-EffectHypersensitivity to carboplatin is a rare but real complication of therapy and should be considered in patients presenting with hyperacute changes on ECG whilst receiving carboplatin therapy.
0.9541 Hypersensitivity to carboplatin is a rare but real complication of therapy and should be considered in patients presenting with Adverse-Effecthyperacute changes on ECG whilst receiving carboplatin therapy.
0.8829 Hypersensitivity to Drugcarboplatin is a rare but real complication of therapy and should be considered in patients presenting with hyperacute changes on ECG whilst receiving carboplatin therapy.
0.7118 Hypersensitivity to carboplatin is a rare but real complication of therapy and should be considered in patients presenting with hyperacute changes on ECG whilst receiving Drugcarboplatin therapy.
0.5981 Hypersensitivity to carboplatin is a rare but real complication of therapy and should be considered in patients presenting with hyperacute Adverse-Effectchanges on ECG whilst receiving carboplatin therapy.
Score Text
0.9857 ARA - C is frequently associated with Adverse-Effectdermatologic toxicity , but this is only the second case of toxic epidermal necrolysis described in connection with this drug.
0.9817 ARA - C is frequently associated with dermatologic toxicity, but this is only the second case of Adverse-Effecttoxic epidermal necrolysis described in connection with this drug.
0.9771 DrugARA - C is frequently associated with dermatologic toxicity, but this is only the second case of toxic epidermal necrolysis described in connection with this drug.
Score Text
0.9903 After 5 days of treatment with IL - 2, the patient developed a Adverse-Effecthemorrhagic lesion that progressed to toxic epidermal necrolysis, as well as grade 4 pancytopenia.
0.9878 After 5 days of treatment with IL - 2, the patient developed a hemorrhagic lesion that progressed to toxic epidermal necrolysis, as well as grade 4 Adverse-Effectpancytopenia .
0.9876 After 5 days of treatment with IL - 2, the patient developed a hemorrhagic lesion that progressed to Adverse-Effecttoxic epidermal necrolysis , as well as grade 4 pancytopenia.
0.9854 After 5 days of treatment with DrugIL - 2 , the patient developed a hemorrhagic lesion that progressed to toxic epidermal necrolysis, as well as grade 4 pancytopenia.
Score Text
0.9984 IV Drugpropranolol was used as the initial treatment for his hyperadrenergic state, resulting in a decrease in heart rate but a paroxsymal increase in blood pressure.
0.9788 IV propranolol was used as the initial treatment for his hyperadrenergic state, resulting in a Adverse-Effectdecrease in heart rate but a paroxsymal increase in blood pressure.
0.9678 IV propranolol was used as the initial treatment for his hyperadrenergic state, resulting in a decrease in heart rate but a Adverse-Effectparoxsymal increase in blood pressure .
Score Text
0.9985 The currently available clinical and neuropharmacologic data suggest that carbamazepine may be an antagonist of dopamine and that this property is responsible for the production of Adverse-Effectdystonia .
0.9981 The currently available clinical and neuropharmacologic data suggest that Drugcarbamazepine may be an antagonist of dopamine and that this property is responsible for the production of dystonia.
Score Text
0.9981 All developed mucocutaneous side effects within 20 weeks of beginning i m Druggold therapy, at a time when RA had improved markedly compared to pretreatment status.
0.9889 All developed Adverse-Effectmucocutaneous side effects within 20 weeks of beginning i m gold therapy, at a time when RA had improved markedly compared to pretreatment status.
Score Text
0.9989 We present three patients with paradoxical seizures ; their serum Drugphenytoin levels were 43. 5 mcg / mL, 46. 5 mcg / mL and 38. 3 mcg / mL.
0.9743 We present three patients with paradoxical Adverse-Effectseizures ; their serum phenytoin levels were 43. 5 mcg / mL, 46. 5 mcg / mL and 38. 3 mcg / mL.
Score Text
0.9995 Two cases of lepromatous leprosy with erythema nodosum leprosum who were on high doses of Drugclofazimine , showed discoloration of nail plate, subungual hyperkeratosis and onycholysis.
0.9921 Two cases of lepromatous leprosy with erythema nodosum leprosum who were on high doses of clofazimine, showed discoloration of nail plate, subungual hyperkeratosis and Adverse-Effectonycholysis .
0.9880 Two cases of lepromatous leprosy with erythema nodosum leprosum who were on high doses of clofazimine, showed discoloration of nail plate, Adverse-Effectsubungual hyperkeratosis and onycholysis.
0.9809 Two cases of lepromatous leprosy with erythema nodosum leprosum who were on high doses of clofazimine, showed Adverse-Effectdiscoloration of nail plate , subungual hyperkeratosis and onycholysis.
Score Text
0.9996 CONCLUSIONS : Patients receiving intravitreal injections of Drugbevacizumab should be evaluated for potential systemic risk factors such as carotid insufficiency, coagulopathy and poorly controlled diabetes mellitus.
0.9979 CONCLUSIONS : Patients receiving intravitreal injections of bevacizumab should be evaluated for potential systemic risk factors such as carotid insufficiency, Adverse-Effectcoagulopathy and poorly controlled diabetes mellitus.
0.9879 CONCLUSIONS : Patients receiving intravitreal injections of bevacizumab should be evaluated for potential systemic risk factors such as Adverse-Effectcarotid insufficiency , coagulopathy and poorly controlled diabetes mellitus.
0.9640 CONCLUSIONS : Patients receiving intravitreal injections of bevacizumab should be evaluated for potential systemic risk factors such as carotid insufficiency, coagulopathy and Adverse-Effectpoorly controlled diabetes mellitus .
Score Text
0.9990 A 53 - year - old man developed lower leg edema 4 weeks after Drugrosiglitazone was increased from 4 mg once / day to 4 mg twice / day.
0.9867 A 53 - year - old man developed Adverse-Effectlower leg edema 4 weeks after rosiglitazone was increased from 4 mg once / day to 4 mg twice / day.
Score Text
0.9996 CASE SUMMARY : A 68 - year - old woman developed a dry, irritating cough within one month of starting Drugquinapril therapy for the treatment of essential hypertension.
0.9778 CASE SUMMARY : A 68 - year - old woman developed a dry, Adverse-Effectirritating cough within one month of starting quinapril therapy for the treatment of essential hypertension.
Score Text
0.9975 Three patients who had experienced neuroleptic - induced akathisia in the past reported that the symptoms of Drugfluoxetine - induced akathisia were identical, although somewhat milder.
0.9615 Three patients who had experienced neuroleptic - induced akathisia in the past reported that the symptoms of fluoxetine - induced Adverse-Effectakathisia were identical, although somewhat milder.
0.8583 Three patients who had experienced neuroleptic - induced Adverse-Effectakathisia in the past reported that the symptoms of fluoxetine - induced akathisia were identical, although somewhat milder.
Score Text
0.9977 Shortly after chemotherapy and an injection of pegfilgrastim, the patient developed poorly defined, rapidly progressive erythema, Adverse-Effectedema , and pain in his right forearm.
0.9976 Shortly after chemotherapy and an injection of Drugpegfilgrastim , the patient developed poorly defined, rapidly progressive erythema, edema, and pain in his right forearm.
0.9866 Shortly after chemotherapy and an injection of pegfilgrastim, the patient developed poorly defined, Adverse-Effectrapidly progressive erythema , edema, and pain in his right forearm.
0.9709 Shortly after chemotherapy and an injection of pegfilgrastim, the patient developed poorly defined, rapidly progressive erythema, edema, and Adverse-Effectpain in his right forearm .
Score Text
0.9972 CONCLUSION : The results suggest that olanzapine may be useful in treating patients with clozapine - induced Adverse-Effectgranulocytopenia without the risk of recurrence of hematologic side effects.
0.9682 CONCLUSION : The results suggest that olanzapine may be useful in treating patients with Drugclozapine - induced granulocytopenia without the risk of recurrence of hematologic side effects.
Score Text
0.9995 CONCLUSION : DrugGemcitabine - induced recall pneumonitis is a rarely reported phenomenon and should be taken into account even after extended time interval to the previous radiotherapy.
0.9904 CONCLUSION : Gemcitabine - induced Adverse-Effectrecall pneumonitis is a rarely reported phenomenon and should be taken into account even after extended time interval to the previous radiotherapy.
Score Text
0.9970 In one patient, treatment with DrugDCA was associated with a decrease in blood lactate levels from 11. 2 mM before treatment to 0. 8 mM 16 h later.
0.9849 In one patient, treatment with DCA was associated with a Adverse-Effectdecrease in blood lactate levels from 11. 2 mM before treatment to 0. 8 mM 16 h later.
Score Text
0.9915 Mitomycin - C is used widely in the treatment of malignancies and is associated with serious dose related adverse effects including the occurrence of Adverse-Effecthemolytic uremic syndrome .
0.9646 DrugMitomycin - C is used widely in the treatment of malignancies and is associated with serious dose related adverse effects including the occurrence of hemolytic uremic syndrome.
Score Text
0.9985 Adverse-EffectPancreatitis has been noted to be a complication in 2 - 16 % of patients undergoing treatment with L - asparaginase for a variety of pediatric neoplasms.
0.9694 Pancreatitis has been noted to be a complication in 2 - 16 % of patients undergoing treatment with DrugL - asparaginase for a variety of pediatric neoplasms.
Score Text
0.9992 RESULTS : DrugBrimonidine was observed to cause IOP elevation, confirmed on rechallenge, scoring 8 ( strong probability ) on an adverse drug reaction probability score.
0.9901 RESULTS : Brimonidine was observed to cause Adverse-EffectIOP elevation , confirmed on rechallenge, scoring 8 ( strong probability ) on an adverse drug reaction probability score.
Score Text
0.9987 We describe a case of Adverse-EffectPRES in a patient with collapsing focal glomeruloesclerosis ( collapsing FGS ) with complete recovery after withdrawal of cyclosporine ( CSA ).
0.9985 We describe a case of PRES in a patient with collapsing focal glomeruloesclerosis ( collapsing FGS ) with complete recovery after withdrawal of Drugcyclosporine ( CSA ).
0.9975 We describe a case of PRES in a patient with collapsing focal glomeruloesclerosis ( collapsing FGS ) with complete recovery after withdrawal of cyclosporine ( DrugCSA ).
Score Text
0.9995 Three of 50 patients treated with Drugisotretinoin ( 1 mg / kg / day ) for cystic acne complained of poor night vision and / or excessive glare sensitivity.
0.9809 Three of 50 patients treated with isotretinoin ( 1 mg / kg / day ) for cystic acne complained of Adverse-Effectpoor night vision and / or excessive glare sensitivity.
0.9704 Three of 50 patients treated with isotretinoin ( 1 mg / kg / day ) for cystic acne complained of poor night vision and / or Adverse-Effectexcessive glare sensitivity .
Score Text
0.9992 CASE REPORT : A six - year - old boy with transfusion - dependent beta - thalassaemia developed a unilateral hearing loss shortly after commencing Drugdesferrioxamine therapy.
0.9912 CASE REPORT : A six - year - old boy with transfusion - dependent beta - thalassaemia developed a Adverse-Effectunilateral hearing loss shortly after commencing desferrioxamine therapy.
Score Text
0.9991 CASE : A malignant mixed mesodermal tumor was diagnosed in a 64 - year - old woman with a bicornuate uterus while she was taking Drugraloxifene for osteoporosis prevention.
0.9855 CASE : A Adverse-Effectmalignant mixed mesodermal tumor was diagnosed in a 64 - year - old woman with a bicornuate uterus while she was taking raloxifene for osteoporosis prevention.
Score Text
0.9979 We describe two cases that illustrate the use of lithium in the treatment of veterans with PTSD who complained of serious problems with Adverse-Effectirritability or angry outbursts.
0.9932 We describe two cases that illustrate the use of Druglithium in the treatment of veterans with PTSD who complained of serious problems with irritability or angry outbursts.
0.9866 We describe two cases that illustrate the use of lithium in the treatment of veterans with PTSD who complained of serious problems with irritability or Adverse-Effectangry outbursts .
Score Text
0.9980 DrugDiazepam use by pregnant women can be associated with a later presentation of withdrawal symptoms in the neonate than that induced by the use of other drugs.
0.9779 Diazepam use by pregnant women can be associated with a later presentation of Adverse-Effectwithdrawal symptoms in the neonate than that induced by the use of other drugs.
Score Text
0.9958 She had just finished a 3 - week course of intravenous Drugtobramycin for bronchiectasis and had an elevated serum tobramycin trough level 1 week before the onset of tetany.
0.9932 She had just finished a 3 - week course of intravenous tobramycin for bronchiectasis and had an elevated serum tobramycin trough level 1 week before the onset of Adverse-Effecttetany .
Score Text
0.9568 Although adverse reactions to protamine are reported infrequently and are usually mild, we recently observed the first fatal case of type I anaphylaxis resulting from Drugprotamine .
0.9498 Although adverse reactions to protamine are reported infrequently and are usually mild, we recently observed the first fatal case of Adverse-Effecttype I anaphylaxis resulting from protamine.
0.9477 Although adverse reactions to Drugprotamine are reported infrequently and are usually mild, we recently observed the first fatal case of type I anaphylaxis resulting from protamine.
0.7569 Although adverse reactions to protamine are reported infrequently and are usually mild, we recently observed the first Adverse-Effectfatal case of type I anaphylaxis resulting from protamine.
Score Text
0.9984 The treatment for acidosis and hyperkalaemia should be started as soon as RTA is diagnosed, and the dosage of DrugFK506 should also be reduced if possible.
0.9959 The treatment for acidosis and hyperkalaemia should be started as soon as Adverse-EffectRTA is diagnosed, and the dosage of FK506 should also be reduced if possible.
Score Text
0.9994 DrugLithium is known to cause acute renal failure and tubulo - interstitial disease, but the recently described association with proteinuria or nephrotic syndrome is little recognized.
0.9971 Lithium is known to cause acute renal failure and tubulo - interstitial disease, but the recently described association with Adverse-Effectproteinuria or nephrotic syndrome is little recognized.
0.9913 Lithium is known to cause acute renal failure and tubulo - interstitial disease, but the recently described association with proteinuria or Adverse-Effectnephrotic syndrome is little recognized.
0.9860 Lithium is known to cause Adverse-Effectacute renal failure and tubulo - interstitial disease, but the recently described association with proteinuria or nephrotic syndrome is little recognized.
0.9834 Lithium is known to cause acute renal failure and Adverse-Effecttubulo - interstitial disease , but the recently described association with proteinuria or nephrotic syndrome is little recognized.
Score Text
0.9992 Awareness of this route of intoxication might be important in patients in whom neurologic or psychiatric symptoms develop while large amounts of Druglidocaine cream are being used.
0.9427 Awareness of this route of intoxication might be important in patients in whom neurologic or Adverse-Effectpsychiatric symptoms develop while large amounts of lidocaine cream are being used.
0.6961 Awareness of this route of intoxication might be important in patients in whom Adverse-Effectneurologic or psychiatric symptoms develop while large amounts of lidocaine cream are being used.
Score Text
0.9991 We report a 4 - year - old girl who presented with acute bilateral blindness, a focal seizure and hypertension 10 days after commencing Drugoxybutynin to treat enuresis.
0.9963 We report a 4 - year - old girl who presented with acute bilateral blindness, a focal seizure and Adverse-Effecthypertension 10 days after commencing oxybutynin to treat enuresis.
0.9900 We report a 4 - year - old girl who presented with acute bilateral blindness, a Adverse-Effectfocal seizure and hypertension 10 days after commencing oxybutynin to treat enuresis.
0.9863 We report a 4 - year - old girl who presented with Adverse-Effectacute bilateral blindness , a focal seizure and hypertension 10 days after commencing oxybutynin to treat enuresis.
Score Text
0.9990 The purpose of this study was to examine the incidence and cause of Clostridium difficile colitis occurring after Drugcisplatin - based combination chemotherapy in ovarian cancer patients.
0.9898 The purpose of this study was to examine the incidence and cause of Adverse-EffectClostridium difficile colitis occurring after cisplatin - based combination chemotherapy in ovarian cancer patients.
Score Text
0.9996 Agranulocytosis is a rare adverse effect associated with prolonged Drugvancomycin therapy, and is potentially serious, especially in end stage renal disease ( ESRD ) patients.
0.9980 Adverse-EffectAgranulocytosis is a rare adverse effect associated with prolonged vancomycin therapy, and is potentially serious, especially in end stage renal disease ( ESRD ) patients.
Score Text
0.9991 Two days after administration of DrugKalimate enema, he had profuse hematochezia, and a sigmoidoscopy showed diffuse colonic mucosal necrosis in the rectum and sigmoid colon.
0.9838 Two days after administration of Kalimate enema, he had Adverse-Effectprofuse hematochezia , and a sigmoidoscopy showed diffuse colonic mucosal necrosis in the rectum and sigmoid colon.
0.9154 Two days after administration of Kalimate enema, he had profuse hematochezia, and a sigmoidoscopy showed Adverse-Effectdiffuse colonic mucosal necrosis in the rectum and sigmoid colon.
Two days after administration of Kalimate enema, he had profuse hematochezia, and a sigmoidoscopy showed diffuse Adverse-Effectcolonic mucosal necrosis in the rectum and sigmoid colon.
Score Text
0.9989 RESULTS : A 34 - year - old man acquired visual field defects and severe vision loss in both eyes after intravitreal injection of Drugtriamcinolone for diabetic macular edema.
0.9891 RESULTS : A 34 - year - old man acquired visual field defects and Adverse-Effectsevere vision loss in both eyes after intravitreal injection of triamcinolone for diabetic macular edema.
0.9791 RESULTS : A 34 - year - old man acquired Adverse-Effectvisual field defects and severe vision loss in both eyes after intravitreal injection of triamcinolone for diabetic macular edema.
Score Text
0.9994 METHODS : A case is presented of a 45 - year - old woman on prolonged Druggemcitabine treatment for ovarian cancer who developed HUS and recovered after drug discontinuation.
0.9990 METHODS : A case is presented of a 45 - year - old woman on prolonged gemcitabine treatment for ovarian cancer who developed Adverse-EffectHUS and recovered after drug discontinuation.
Score Text
0.9527 The failure of therapy with disopyramide and mexiletine to reproduce this observation suggests either a previously unreported electrophysiologic effect of, or idiosyncratic response to, Drugprocainamide .
0.9525 The failure of therapy with disopyramide and mexiletine to reproduce this observation suggests either a previously unreported Adverse-Effectelectrophysiologic effect of, or idiosyncratic response to, procainamide.
Score Text
0.9987 In 2 of the 3 cases the patients were also taking lithium carbonate and beta - blockers, both of which could have contributed to the Adverse-Effectincontinence .
0.9920 In 2 of the 3 cases the patients were also taking Druglithium carbonate and beta - blockers, both of which could have contributed to the incontinence.
Score Text
0.9964 Two cases are reported of patients who developed a hematologic malignancy several years after intravesical chemotherapy of superficial bladder cancer with etoglucid, Drugdoxorubicin , and mitomycin C.
0.9959 Two cases are reported of patients who developed a hematologic malignancy several years after intravesical chemotherapy of superficial bladder cancer with Drugetoglucid , doxorubicin, and mitomycin C.
0.9941 Two cases are reported of patients who developed a Adverse-Effecthematologic malignancy several years after intravesical chemotherapy of superficial bladder cancer with etoglucid, doxorubicin, and mitomycin C.
0.9917 Two cases are reported of patients who developed a hematologic malignancy several years after intravesical chemotherapy of superficial bladder cancer with etoglucid, doxorubicin, and Drugmitomycin C .
Score Text
0.9994 Although differential diagnostic alternatives can be considered in all described cases it is very likely that Drugvincristine does cause severe visual loss in a small number of patients.
0.9792 Although differential diagnostic alternatives can be considered in all described cases it is very likely that vincristine does cause Adverse-Effectsevere visual loss in a small number of patients.
Score Text
0.9989 OBJECTIVE : To report a case of neuroleptic malignant syndrome ( NMS ) associated with Drugfluphenazine in a schizophrenic patient and review the literature related to this condition.
0.9894 OBJECTIVE : To report a case of Adverse-Effectneuroleptic malignant syndrome ( NMS ) associated with fluphenazine in a schizophrenic patient and review the literature related to this condition.
0.9874 OBJECTIVE : To report a case of neuroleptic malignant syndrome ( Adverse-EffectNMS ) associated with fluphenazine in a schizophrenic patient and review the literature related to this condition.
Score Text
0.9802 This latest ( third ) report suggests that the safety profile should be reexamined and at least raises the question of potential renal toxicity of Druginterferons in MS.
0.9757 This latest ( third ) report suggests that the safety profile should be reexamined and at least raises the question of potential Adverse-Effectrenal toxicity of interferons in MS.
Score Text
0.9994 After a second dose of Drugmetoclopramide , these symptoms recurred and were associated with confusion, agitation, fever, diaphoresis, tachypnea, tachycardia, and hypertension.
0.9992 After a second dose of metoclopramide, these symptoms recurred and were associated with confusion, agitation, fever, diaphoresis, tachypnea, tachycardia, and Adverse-Effecthypertension .
0.9991 After a second dose of metoclopramide, these symptoms recurred and were associated with confusion, agitation, fever, diaphoresis, Adverse-Effecttachypnea , tachycardia, and hypertension.
0.9990 After a second dose of metoclopramide, these symptoms recurred and were associated with confusion, agitation, fever, diaphoresis, tachypnea, Adverse-Effecttachycardia , and hypertension.
0.9989 After a second dose of metoclopramide, these symptoms recurred and were associated with confusion, agitation, fever, Adverse-Effectdiaphoresis , tachypnea, tachycardia, and hypertension.
0.9983 After a second dose of metoclopramide, these symptoms recurred and were associated with confusion, Adverse-Effectagitation , fever, diaphoresis, tachypnea, tachycardia, and hypertension.
0.9933 After a second dose of metoclopramide, these symptoms recurred and were associated with Adverse-Effectconfusion , agitation, fever, diaphoresis, tachypnea, tachycardia, and hypertension.
0.9925 After a second dose of metoclopramide, these symptoms recurred and were associated with confusion, agitation, Adverse-Effectfever , diaphoresis, tachypnea, tachycardia, and hypertension.
Score Text
0.9987 DrugSulindac ( Clinoril ), a nonsteroidal anti - inflammatory agent, has few reported neurologic toxic effects, all of which have been associated with systemic disease.
0.9983 Sulindac ( DrugClinoril ), a nonsteroidal anti - inflammatory agent, has few reported neurologic toxic effects, all of which have been associated with systemic disease.
0.9816 Sulindac ( Clinoril ), a nonsteroidal anti - inflammatory agent, has few reported Adverse-Effectneurologic toxic effects , all of which have been associated with systemic disease.
Score Text
0.9987 We report a 59 - year - old patient with chronic myeloid leukemia, who developed severe interstitial lung fibrosis after short term and sequential treatment with melphalan and Drugbusulfan .
0.9986 We report a 59 - year - old patient with chronic myeloid leukemia, who developed severe interstitial lung fibrosis after short term and sequential treatment with Drugmelphalan and busulfan.
0.9732 We report a 59 - year - old patient with chronic myeloid leukemia, who developed Adverse-Effectsevere interstitial lung fibrosis after short term and sequential treatment with melphalan and busulfan.
Score Text
0.9990 An association of granulocytopenia, eosinophilia, skin reaction and hepatitis during Drugpropylthiouracil ( PTU ) therapy for thyrotoxicosis in a 47 year old black female is reported.
0.9985 An association of granulocytopenia, eosinophilia, skin reaction and hepatitis during propylthiouracil ( DrugPTU ) therapy for thyrotoxicosis in a 47 year old black female is reported.
0.9976 An association of granulocytopenia, Adverse-Effecteosinophilia , skin reaction and hepatitis during propylthiouracil ( PTU ) therapy for thyrotoxicosis in a 47 year old black female is reported.
0.9970 An association of granulocytopenia, eosinophilia, skin reaction and Adverse-Effecthepatitis during propylthiouracil ( PTU ) therapy for thyrotoxicosis in a 47 year old black female is reported.
0.9957 An association of Adverse-Effectgranulocytopenia , eosinophilia, skin reaction and hepatitis during propylthiouracil ( PTU ) therapy for thyrotoxicosis in a 47 year old black female is reported.
0.9939 An association of granulocytopenia, eosinophilia, Adverse-Effectskin reaction and hepatitis during propylthiouracil ( PTU ) therapy for thyrotoxicosis in a 47 year old black female is reported.
Score Text
0.9987 The authors report five cases of Adverse-Effecttremor related to itraconazole therapy, which occurred within 1 - 12 months of initiating treatment and resolved gradually following itraconazole withdrawal.
0.9680 The authors report five cases of tremor related to Drugitraconazole therapy, which occurred within 1 - 12 months of initiating treatment and resolved gradually following itraconazole withdrawal.
0.9426 The authors report five cases of tremor related to itraconazole therapy, which occurred within 1 - 12 months of initiating treatment and resolved gradually following Drugitraconazole withdrawal.
Score Text
0.9983 In this case, unlike those previously reported, Adverse-Effecthyponatremia recurred 5 months after switching from citalopram to mirtazapine, which is believed to be a safe antidepressant.
0.9946 In this case, unlike those previously reported, hyponatremia recurred 5 months after switching from Drugcitalopram to mirtazapine, which is believed to be a safe antidepressant.
0.9937 In this case, unlike those previously reported, hyponatremia recurred 5 months after switching from citalopram to Drugmirtazapine , which is believed to be a safe antidepressant.
Score Text
0.9985 Torsades de Pointes induced by a combination of Druggarenoxacin and disopyramide and other cytochrome P450, family 3, subfamily A polypeptide - 4 - influencing drugs during hypokalemia due to licorice.
0.9984 Torsades de Pointes induced by a combination of garenoxacin and Drugdisopyramide and other cytochrome P450, family 3, subfamily A polypeptide - 4 - influencing drugs during hypokalemia due to licorice.
0.9828 Adverse-EffectTorsades de Pointes induced by a combination of garenoxacin and disopyramide and other cytochrome P450, family 3, subfamily A polypeptide - 4 - influencing drugs during hypokalemia due to licorice.
Score Text
0.9980 When the data of the 57 patients are evaluated, a reversible direct cytotoxic effect of Drugticlopidine on the pluripotent / bipotent hematopoietic progenitor stem cell is proposed.
0.9327 When the data of the 57 patients are evaluated, a reversible direct Adverse-Effectcytotoxic effect of ticlopidine on the pluripotent / bipotent hematopoietic progenitor stem cell is proposed.
Score Text
0.9965 Our cases constitute the most severe cases of benzarone hepatotoxicity reported so far, and comprise the first cases of ( sub ) fulminant hepatitis and Adverse-Effectcirrhosis related to benzarone.
0.9804 Our cases constitute the most severe cases of Drugbenzarone hepatotoxicity reported so far, and comprise the first cases of ( sub ) fulminant hepatitis and cirrhosis related to benzarone.
0.9498 Our cases constitute the most severe cases of benzarone hepatotoxicity reported so far, and comprise the first cases of ( sub ) fulminant hepatitis and cirrhosis related to Drugbenzarone .
0.8892 Our cases constitute the most severe cases of benzarone Adverse-Effecthepatotoxicity reported so far, and comprise the first cases of ( sub ) fulminant hepatitis and cirrhosis related to benzarone.
Our cases constitute the most severe cases of benzarone hepatotoxicity reported so far, and comprise the first cases of Adverse-Effect( sub ) fulminant hepatitis and cirrhosis related to benzarone.
Score Text
0.9989 Case 2 demonstrated after 40 months on Drugchlorambucil the presence of a balanced translocation, t ( 1 ; 5 ) ( p36 ; q31 ) in 90 % of the cells.
0.9864 Case 2 demonstrated after 40 months on chlorambucil the presence of a Adverse-Effectbalanced translocation , t ( 1 ; 5 ) ( p36 ; q31 ) in 90 % of the cells.
Score Text
0.9943 FDE from Drugcephalosporins has been rarely reported, and to the best of our knowledge there is no published report of ceftriaxone - induced FDE in the literature.
0.9679 Adverse-EffectFDE from cephalosporins has been rarely reported, and to the best of our knowledge there is no published report of ceftriaxone - induced FDE in the literature.
0.9640 FDE from cephalosporins has been rarely reported, and to the best of our knowledge there is no published report of ceftriaxone - induced Adverse-EffectFDE in the literature.
FDE from cephalosporins has been rarely reported, and to the best of our knowledge there is no published report of Drugceftriaxone - induced FDE in the literature.
Score Text
0.9983 CASE REPORT : We report the case of a 58 year old patient who, after 2 days of treatment with Drugroxithromycin and betamethasone, manifested acute pancreatitis.
0.9981 CASE REPORT : We report the case of a 58 year old patient who, after 2 days of treatment with roxithromycin and Drugbetamethasone , manifested acute pancreatitis.
0.9888 CASE REPORT : We report the case of a 58 year old patient who, after 2 days of treatment with roxithromycin and betamethasone, manifested Adverse-Effectacute pancreatitis .
Score Text
0.9994 One patient had a lower average heart rate and two patients had lower average mean blood pressure values during Drugpropranolol treatment, none of which was clinically significant.
0.9620 One patient had a lower average heart rate and two patients had Adverse-Effectlower average mean blood pressure values during propranolol treatment, none of which was clinically significant.
0.8549 One patient had a Adverse-Effectlower average heart rate and two patients had lower average mean blood pressure values during propranolol treatment, none of which was clinically significant.
0.8186 One patient had a lower average heart rate and two patients had Adverse-Effectlower average mean blood pressure values during propranolol treatment, none of which was clinically significant.
Score Text
0.9972 These cases and a review of the literature suggested that Adverse-Effecthepatotoxicity , though rare, should be added to the list of adverse reactions to D - penicillamine.
0.9666 These cases and a review of the literature suggested that hepatotoxicity, though rare, should be added to the list of adverse reactions to DrugD - penicillamine .
Score Text
0.9944 We report the case of a patient with multiple myeloma who developed acute life - threatening water intoxication following treatment with oral indomethacin and low dose intravenous Drugcyclophosphamide .
0.9932 We report the case of a patient with multiple myeloma who developed acute life - threatening water intoxication following treatment with oral Drugindomethacin and low dose intravenous cyclophosphamide.
0.9758 We report the case of a patient with multiple myeloma who developed acute life - threatening Adverse-Effectwater intoxication following treatment with oral indomethacin and low dose intravenous cyclophosphamide.
0.5067 We report the case of a patient with multiple myeloma who developed Adverse-Effectacute life - threatening water intoxication following treatment with oral indomethacin and low dose intravenous cyclophosphamide.
We report the case of a patient with multiple myeloma who developed acute Adverse-Effectlife - threatening water intoxication following treatment with oral indomethacin and low dose intravenous cyclophosphamide.
Score Text
0.9914 We report the occurrence of Adverse-Effectrenal failure due to cholesterol crystal embolization following thrombolytic therapy with intravenous recombinant tissue - type plasminogen activator ( t - PA ).
0.9732 We report the occurrence of renal failure due to Adverse-Effectcholesterol crystal embolization following thrombolytic therapy with intravenous recombinant tissue - type plasminogen activator ( t - PA ).
0.9364 We report the occurrence of renal failure due to cholesterol crystal embolization following thrombolytic therapy with intravenous recombinant tissue - type plasminogen activator ( Drugt - PA ).
0.9022 We report the occurrence of renal failure due to cholesterol crystal embolization following thrombolytic therapy with intravenous Drugrecombinant tissue - type plasminogen activator ( t - PA ).
0.8547 We report the occurrence of renal failure due to cholesterol crystal embolization following thrombolytic therapy with intravenous recombinant Drugtissue - type plasminogen activator ( t - PA ).
Score Text
0.9989 PURPOSE : The occurrence of Adverse-Effectmyoclonus associated with continuous i. v. infusion of dobutamine in a patient with end - stage renal disease ( ESRD ) is described.
0.9985 PURPOSE : The occurrence of myoclonus associated with continuous i. v. infusion of Drugdobutamine in a patient with end - stage renal disease ( ESRD ) is described.
Score Text
0.9987 I saw two patients with kala - azar resistant to sodium stibogluconate who developed cardiac arrest after Drugamphotericin infusion ( in spite of tolerating a test dose ).
0.9955 I saw two patients with kala - azar resistant to sodium stibogluconate who developed Adverse-Effectcardiac arrest after amphotericin infusion ( in spite of tolerating a test dose ).
Score Text
0.9993 However, in order to avoid neuropathic side effects, patients under Drugthalidomide therapy should be monitored every 6 months with nerve conduction studies while taking the drug.
0.9569 However, in order to avoid Adverse-Effectneuropathic side effects , patients under thalidomide therapy should be monitored every 6 months with nerve conduction studies while taking the drug.
Score Text
0.9925 The toxicity and plasma concentrations of ifosfamide, chloroacetaldehyde, and Drug4 - hydroxyifosfamide were then determined over 24 h after a single 1. 6 g / m2 dose of ifosfamide.
0.9911 The toxicity and plasma concentrations of ifosfamide, Drugchloroacetaldehyde , and 4 - hydroxyifosfamide were then determined over 24 h after a single 1. 6 g / m2 dose of ifosfamide.
0.9889 The toxicity and plasma concentrations of Drugifosfamide , chloroacetaldehyde, and 4 - hydroxyifosfamide were then determined over 24 h after a single 1. 6 g / m2 dose of ifosfamide.
0.9873 The toxicity and plasma concentrations of ifosfamide, chloroacetaldehyde, and 4 - hydroxyifosfamide were then determined over 24 h after a single 1. 6 g / m2 dose of Drugifosfamide .
0.9709 The Adverse-Effecttoxicity and plasma concentrations of ifosfamide, chloroacetaldehyde, and 4 - hydroxyifosfamide were then determined over 24 h after a single 1. 6 g / m2 dose of ifosfamide.
Score Text
0.9990 A brief review of reported cases of Drugchloramphenicol hypersensitivity in the English - language literature, as well as possible alternative explanations in this case, are provided.
0.7951 A brief review of reported cases of chloramphenicol Adverse-Effecthypersensitivity in the English - language literature, as well as possible alternative explanations in this case, are provided.
Score Text
0.9761 In this paper, we report a case of 3 years - old boy who developed acute onset tetraparesia following a viral respiratory infecction and Drughepatitis B vaccination .
0.9728 In this paper, we report a case of 3 years - old boy who developed Adverse-Effectacute onset tetraparesia following a viral respiratory infecction and hepatitis B vaccination.
Score Text
0.9986 We describe a patient who developed Adverse-EffectHUS after treatment with mitomycin C ( total dose 144 mg / m2 ) due to a carcinoma of the ascending colon.
0.9900 We describe a patient who developed HUS after treatment with Drugmitomycin C ( total dose 144 mg / m2 ) due to a carcinoma of the ascending colon.
Score Text
0.9870 However, as the use of hepatitis B vaccination is growing, adverse side effects, including Adverse-Effectmental nerve neuropathy , should be observed with an increased frequency.
0.9616 However, as the use of Drughepatitis B vaccination is growing, adverse side effects, including mental nerve neuropathy, should be observed with an increased frequency.
Score Text
0.9838 We describe a relatively healthy, 9 - year - old boy who developed a CA - MRSA skin and Adverse-Effectsoft tissue infection and was treated with TMP - SMX.
0.9688 We describe a relatively healthy, 9 - year - old boy who developed a CA - MRSA skin and soft tissue infection and was treated with DrugTMP - SMX .
0.9540 We describe a relatively healthy, 9 - year - old boy who developed a Adverse-EffectCA - MRSA skin and soft tissue infection and was treated with TMP - SMX.
Score Text
0.9987 The mild immunosuppression that occurs with Drugmethotrexate therapy probably places patients with rheumatoid arthritis at added risk of developing lymphoproliferative diseases, but coincidence can not be excluded.
0.9921 The mild immunosuppression that occurs with methotrexate therapy probably places patients with rheumatoid arthritis at added risk of developing Adverse-Effectlymphoproliferative diseases , but coincidence can not be excluded.
Score Text
0.9993 These are the first reported patients to show mfERG abnormalities that correspond to bitemporal visual field defects and add to the growing evidence that Drugethambutol damages the retina.
0.9853 These are the first reported patients to show Adverse-EffectmfERG abnormalities that correspond to bitemporal visual field defects and add to the growing evidence that ethambutol damages the retina.
0.9824 These are the first reported patients to show mfERG abnormalities that correspond to Adverse-Effectbitemporal visual field defects and add to the growing evidence that ethambutol damages the retina.
Score Text
0.9886 Adverse-EffectMusculoskeletal complaints were the presenting symptoms in four of 44 children ( 9 % ) treated for relapsed Wilms'tumors with ifosfamide, a derivative of cyclophosphamide.
0.9884 Musculoskeletal complaints were the presenting symptoms in four of 44 children ( 9 % ) treated for relapsed Wilms'tumors with Drugifosfamide , a derivative of cyclophosphamide.
0.9763 Musculoskeletal complaints were the presenting symptoms in four of 44 children ( 9 % ) treated for relapsed Wilms'tumors with ifosfamide, a derivative of Drugcyclophosphamide .
Score Text
0.9878 This case suggests that BH - AC, a derivative of cytosine arabinoside ( 1 - beta - D - arabinofuranosylcytosine ) could be a cause of reversible Adverse-Effectencephalopathy syndrome .
0.9707 This case suggests that DrugBH - AC , a derivative of cytosine arabinoside ( 1 - beta - D - arabinofuranosylcytosine ) could be a cause of reversible encephalopathy syndrome.
0.9731 This case suggests that BH - AC, a derivative of Drugcytosine arabinoside ( 1 - beta - D - arabinofuranosylcytosine ) could be a cause of reversible encephalopathy syndrome.
0.9444 This case suggests that BH - AC, a derivative of cytosine arabinoside ( Drug1 - beta - D - arabinofuranosylcytosine ) could be a cause of reversible encephalopathy syndrome.
Score Text
0.9808 Although the data indicate an immune - complex cause for Druggold - salt nephropathy, the incident antigen ( or antigens ) and mechanism of action remain unidentified.
0.9058 Although the data indicate an immune - complex cause for gold - salt Adverse-Effectnephropathy , the incident antigen ( or antigens ) and mechanism of action remain unidentified.
Score Text
0.9976 A 40 - year - old man with a long standing history of rheumatoid arthritis was treated with DrugMTX over a 6 month period and developed an overwhelming hepatic necrosis.
0.9819 A 40 - year - old man with a long standing history of rheumatoid arthritis was treated with MTX over a 6 month period and developed an Adverse-Effectoverwhelming hepatic necrosis .
Score Text
0.9991 We report a case of a 64 - year - old man with secondary adrenocortical insufficiency who has been on a chronic transdermal Drugfentanyl treatment because of sciatic pain syndrome.
0.7641 We report a case of a 64 - year - old man with secondary Adverse-Effectadrenocortical insufficiency who has been on a chronic transdermal fentanyl treatment because of sciatic pain syndrome.
Score Text
0.9959 We now report the first known cancer patient who developed life - threatening complications after treatment with topical Drug5 - FU and was shown subsequently to have profound DPD deficiency.
0.9577 We now report the first known cancer patient who developed Adverse-Effectlife - threatening complications after treatment with topical 5 - FU and was shown subsequently to have profound DPD deficiency.
0.9315 We now report the first known cancer patient who developed life - threatening complications after treatment with topical 5 - FU and was shown subsequently to have profound Adverse-EffectDPD deficiency .
Score Text
0.9991 A 62 - year - old Caucasian man with atrial fibrillation who was taking Drugwarfarin reported an episode of hematochezia ; his international normalized ratio ( INR ) was 1. 74.
0.9973 A 62 - year - old Caucasian man with atrial fibrillation who was taking warfarin reported an episode of Adverse-Effecthematochezia ; his international normalized ratio ( INR ) was 1. 74.
Score Text
0.9993 A 9 - year - old boy developed acute renal failure following intravenous Drugacyclovir ( 30 mg / kg per day ) administered for 6 days to treat herpetic encephalitis.
0.9865 A 9 - year - old boy developed Adverse-Effectacute renal failure following intravenous acyclovir ( 30 mg / kg per day ) administered for 6 days to treat herpetic encephalitis.
Score Text
0.9851 We describe a patient with acute leukemia who developed Horner's syndrome and a Adverse-Effectsevere demyelinating peripheral neuropathy leading to death after receiving high - dose cytosine arabinoside.
0.9824 We describe a patient with acute leukemia who developed Adverse-EffectHorner's syndrome and a severe demyelinating peripheral neuropathy leading to death after receiving high - dose cytosine arabinoside.
0.9794 We describe a patient with acute leukemia who developed Horner's syndrome and a severe demyelinating peripheral neuropathy leading to death after receiving high - dose Drugcytosine arabinoside .
0.8386 We describe a patient with acute leukemia who developed Horner's syndrome and a severe demyelinating peripheral neuropathy leading to Adverse-Effectdeath after receiving high - dose cytosine arabinoside.
Score Text
0.9995 We report a case of a 23 - year - old man who developed a Drugvancomycin - induced anaphylactic reaction in the treatment of methicillin - resistant Staphylococcus aureus infection.
0.9936 We report a case of a 23 - year - old man who developed a vancomycin - induced Adverse-Effectanaphylactic reaction in the treatment of methicillin - resistant Staphylococcus aureus infection.
Score Text
0.9994 We observed 2 cases of hepatotoxicity after a high - dose Drugmethylprednisolone treatment of a demyelinating disease and evaluated the potential relationship in the light of available evidence.
0.9976 We observed 2 cases of Adverse-Effecthepatotoxicity after a high - dose methylprednisolone treatment of a demyelinating disease and evaluated the potential relationship in the light of available evidence.
Score Text
0.9991 Masculinization of a female fetus occurred in 5 of 39 ( 12. 8 % ) exposed to Drugnorethisterone ; all were cases of clitoral hypertrophy not requiring surgical treatment.
0.9859 Masculinization of a female fetus occurred in 5 of 39 ( 12. 8 % ) exposed to norethisterone ; all were cases of Adverse-Effectclitoral hypertrophy not requiring surgical treatment.
0.9709 Adverse-EffectMasculinization of a female fetus occurred in 5 of 39 ( 12. 8 % ) exposed to norethisterone ; all were cases of clitoral hypertrophy not requiring surgical treatment.
Score Text
0.9968 Observations in our patient suggest that the Adverse-Effectleukoencephalopathy that developed in previously reported patients who received 5 - fluorouracil and levamisole may have been caused at least partly by levamisole.
0.9939 Observations in our patient suggest that the leukoencephalopathy that developed in previously reported patients who received Drug5 - fluorouracil and levamisole may have been caused at least partly by levamisole.
0.9926 Observations in our patient suggest that the leukoencephalopathy that developed in previously reported patients who received 5 - fluorouracil and Druglevamisole may have been caused at least partly by levamisole.
0.9838 Observations in our patient suggest that the leukoencephalopathy that developed in previously reported patients who received 5 - fluorouracil and levamisole may have been caused at least partly by Druglevamisole .
Score Text
0.9992 CONCLUSION : In some abstainers who take Drugcyanamide for several years, thin septum - like liver fibrosis progresses along with the emergence of ground - glass hepatocytes.
0.9803 CONCLUSION : In some abstainers who take cyanamide for several years, thin septum - like liver fibrosis progresses along with the emergence of Adverse-Effectground - glass hepatocytes .
0.9541 CONCLUSION : In some abstainers who take cyanamide for several years, thin Adverse-Effectseptum - like liver fibrosis progresses along with the emergence of ground - glass hepatocytes.
Score Text
0.9989 DrugArgatroban is hepatically cleared and may be the preferred direct thrombin inhibitor in the presence of significant renal impairment, but conversely has prolonged effects in hepatic failure.
0.9714 Argatroban is hepatically cleared and may be the preferred direct thrombin inhibitor in the presence of significant renal impairment, but conversely has prolonged effects in Adverse-Effecthepatic failure .
0.9274 Argatroban is hepatically cleared and may be the preferred direct thrombin inhibitor in the presence of significant Adverse-Effectrenal impairment , but conversely has prolonged effects in hepatic failure.
Score Text
0.9986 In patients with cirrhosis, the metabolism of Drugmeperidine is decreased, leading to accumulation of the parent drug and possible CNS depressive effects similar to hepatic encephalopathy.
0.9782 In patients with cirrhosis, the metabolism of meperidine is decreased, leading to Adverse-Effectaccumulation of the parent drug and possible CNS depressive effects similar to hepatic encephalopathy.
0.9626 In patients with cirrhosis, the metabolism of meperidine is decreased, leading to accumulation of the parent drug and possible Adverse-EffectCNS depressive effects similar to hepatic encephalopathy.
Score Text
0.9995 We report a case of hepatolithiasis ( intrahepatic stone ) complicated by gram - negative sepsis in a 37 year old male with acromegaly being treated with Drugoctreotide .
0.9982 We report a case of Adverse-Effecthepatolithiasis ( intrahepatic stone ) complicated by gram - negative sepsis in a 37 year old male with acromegaly being treated with octreotide.
Score Text
0.9978 The Adverse-Effectrash seen in this patient, who was treated with cephalexin, may be similar to the rash seen with ampicillin treatment of patients with infectious mononucleosis.
0.9975 The rash seen in this patient, who was treated with Drugcephalexin , may be similar to the rash seen with ampicillin treatment of patients with infectious mononucleosis.
0.9425 The rash seen in this patient, who was treated with cephalexin, may be similar to the Adverse-Effectrash seen with ampicillin treatment of patients with infectious mononucleosis.
The rash seen in this patient, who was treated with cephalexin, may be similar to the rash seen with Drugampicillin treatment of patients with infectious mononucleosis.
Score Text
0.9931 We report on three observations of parkinsonian patients with levo - dopa - induced Adverse-Effectdiphasic dyskinesias , who received subcutaneous apomorphine to reduce the duration of abnormal movements.
0.9686 We report on three observations of parkinsonian patients with Druglevo - dopa - induced diphasic dyskinesias, who received subcutaneous apomorphine to reduce the duration of abnormal movements.
Score Text
0.9996 We describe two cases of Drugsulfadiazine - induced crystalluria and renal failure in patients with acquired immunodeficiency syndrome, review the pertinent literature, and discuss the pathogenesis.
0.9978 We describe two cases of sulfadiazine - induced Adverse-Effectcrystalluria and renal failure in patients with acquired immunodeficiency syndrome, review the pertinent literature, and discuss the pathogenesis.
0.9945 We describe two cases of sulfadiazine - induced crystalluria and Adverse-Effectrenal failure in patients with acquired immunodeficiency syndrome, review the pertinent literature, and discuss the pathogenesis.
Score Text
0.9946 Although major hazards of treatment of hypophosphatemic osteomalacia with phosphate and calcitriol are secondary hyperparathyroidism and vitamin D intoxication, Adverse-Effectpotassium loss also should be kept in mind.
0.9897 Although major hazards of treatment of hypophosphatemic osteomalacia with phosphate and Drugcalcitriol are secondary hyperparathyroidism and vitamin D intoxication, potassium loss also should be kept in mind.
0.9873 Although major hazards of treatment of hypophosphatemic osteomalacia with Drugphosphate and calcitriol are secondary hyperparathyroidism and vitamin D intoxication, potassium loss also should be kept in mind.
0.9812 Although major hazards of treatment of hypophosphatemic osteomalacia with phosphate and calcitriol are secondary hyperparathyroidism and Adverse-Effectvitamin D intoxication , potassium loss also should be kept in mind.
0.9535 Although major hazards of treatment of hypophosphatemic osteomalacia with phosphate and calcitriol are Adverse-Effectsecondary hyperparathyroidism and vitamin D intoxication, potassium loss also should be kept in mind.
Score Text
0.9979 After 39 hours on Drugargatroban , the infusion was stopped when minor bleeding was observed with a concurrent activated partial thromboplastin time ( aPTT ) of 100 seconds.
0.9948 After 39 hours on argatroban, the infusion was stopped when minor Adverse-Effectbleeding was observed with a concurrent activated partial thromboplastin time ( aPTT ) of 100 seconds.
Score Text
0.9992 This report rules out other causes of toxic epidermal necrolysis and implicates Drugofloxacin in what appears to be an atypical presentation of drug - induced toxic epidermal necrolysis.
0.9707 This report rules out other causes of Adverse-Effecttoxic epidermal necrolysis and implicates ofloxacin in what appears to be an atypical presentation of drug - induced toxic epidermal necrolysis.
0.9668 This report rules out other causes of toxic epidermal necrolysis and implicates ofloxacin in what appears to be an atypical presentation of drug - induced Adverse-Effecttoxic epidermal necrolysis .
Score Text
0.9995 Sensorineural hearing loss due to Drugquinine therapy for malaria has frequently been mentioned in the literature but has not been a subject of research during the last decades.
0.9894 Adverse-EffectSensorineural hearing loss due to quinine therapy for malaria has frequently been mentioned in the literature but has not been a subject of research during the last decades.
Score Text
0.9989 A 31 - year - old female developed multiple episodes of grand mal seizures after combination chemotherapy with cisplatin, vinblastine and Drugbleomycin for germ cell ovarian cancer stage Ic.
0.9988 A 31 - year - old female developed multiple episodes of grand mal seizures after combination chemotherapy with Drugcisplatin , vinblastine and bleomycin for germ cell ovarian cancer stage Ic.
0.9986 A 31 - year - old female developed multiple episodes of grand mal seizures after combination chemotherapy with cisplatin, Drugvinblastine and bleomycin for germ cell ovarian cancer stage Ic.
0.9868 A 31 - year - old female developed multiple episodes of Adverse-Effectgrand mal seizures after combination chemotherapy with cisplatin, vinblastine and bleomycin for germ cell ovarian cancer stage Ic.
Score Text
0.9992 A 12 year old patient with atrial flutter is presented, in whom intravenous Drugadenosine was followed by acceleration of the heart rate to a potentially dangerous arrhythmia.
0.9869 A 12 year old patient with atrial flutter is presented, in whom intravenous adenosine was followed by acceleration of the heart rate to a potentially dangerous Adverse-Effectarrhythmia .
0.9808 A 12 year old patient with atrial flutter is presented, in whom intravenous adenosine was followed by Adverse-Effectacceleration of the heart rate to a potentially dangerous arrhythmia.
Score Text
0.9987 We report a case in which hemorrhage occurred in an asymptomatic falx meningioma known beforehand, after the internal use of low - dose Drugaspirin for 16 months.
0.9985 We report a case in which Adverse-Effecthemorrhage occurred in an asymptomatic falx meningioma known beforehand, after the internal use of low - dose aspirin for 16 months.
Score Text
0.9997 We report a case of hypoglycaemia after Drugmefloquine therapy ( 1, 500 mg over two days ) for severe gastrointestinal cryptosporidiasis in a cachectic AIDS patient with protracted diarrhoea.
0.9975 We report a case of Adverse-Effecthypoglycaemia after mefloquine therapy ( 1, 500 mg over two days ) for severe gastrointestinal cryptosporidiasis in a cachectic AIDS patient with protracted diarrhoea.
Score Text
0.9869 This report describes a case of paradoxical, intravenous valproic acid - induced Adverse-Effectseizure exacerbation in a child with juvenile absence epilepsy, documented by video - electroencephalography.
0.9765 This report describes a case of paradoxical, intravenous Drugvalproic acid - induced seizure exacerbation in a child with juvenile absence epilepsy, documented by video - electroencephalography.
0.7924 This report describes a case of Drugparadoxical , intravenous valproic acid - induced seizure exacerbation in a child with juvenile absence epilepsy, documented by video - electroencephalography.
Score Text
0.9969 That review suggested that patients receiving anti - D IGIV be monitored for those and other potential complications of Adverse-Effecthemoglobinemia , particularly disseminated intravascular coagulation ( DIC ).
0.9856 That review suggested that patients receiving anti - D IGIV be monitored for those and other potential complications of hemoglobinemia, particularly Adverse-Effectdisseminated intravascular coagulation ( DIC ).
0.9740 That review suggested that patients receiving anti - D IGIV be monitored for those and other potential complications of hemoglobinemia, particularly disseminated intravascular coagulation ( Adverse-EffectDIC ).
0.9717 That review suggested that patients receiving Druganti - D IGIV be monitored for those and other potential complications of hemoglobinemia, particularly disseminated intravascular coagulation ( DIC ).
Score Text
0.9968 Mequitazine seemed to play a part similar to chlorpromazine, and absence of mequitazine - induced Adverse-Effectphotosensitivity may be due to a relatively low dosage of the drug.
0.9585 Mequitazine seemed to play a part similar to chlorpromazine, and absence of Drugmequitazine - induced photosensitivity may be due to a relatively low dosage of the drug.
Score Text
0.9991 The authors suggest that Drugrisperidone may increase affect in patients with schizophrenia and that some patients, especially those with anxiety, may have difficulty managing the increase.
0.9613 The authors suggest that risperidone may Adverse-Effectincrease affect in patients with schizophrenia and that some patients, especially those with anxiety, may have difficulty managing the increase.
Score Text
0.9889 The risk of new - onset diabetic ketoacidosis in patients with diabetic risk factors who are taking Drugperospirone hydrochloride or other atypical antipsychotics should be kept in mind.
0.9716 The risk of new - onset Adverse-Effectdiabetic ketoacidosis in patients with diabetic risk factors who are taking perospirone hydrochloride or other atypical antipsychotics should be kept in mind.
Score Text
0.9980 CONCLUSIONS : Among the many presentations of Drugifosfamide neurotoxicity, clinicians should consider NCSE as a possible explanation for changes in consciousness in a patient receiving this agent.
0.9026 CONCLUSIONS : Among the many presentations of ifosfamide Adverse-Effectneurotoxicity , clinicians should consider NCSE as a possible explanation for changes in consciousness in a patient receiving this agent.
0.8477 CONCLUSIONS : Among the many presentations of ifosfamide neurotoxicity, clinicians should consider Adverse-EffectNCSE as a possible explanation for changes in consciousness in a patient receiving this agent.
Score Text
0.9986 This case showed sequential manifestation from transient thyrotoxicosis to the appearance of TSH - receptor autoantibodies, and then the occurrence of Graves'hyperthyroidism during DrugIFN therapy.
0.9878 This case showed sequential manifestation from transient thyrotoxicosis to the appearance of TSH - receptor autoantibodies, and then the occurrence of Adverse-EffectGraves'hyperthyroidism during IFN therapy.
Score Text
0.9995 A transient tonic pupillary response, denervation supersensitivity, and abnormal visual - evoked potentials in Drugquinine toxicity, to our knowledge, have not been previously reported.
0.9855 A transient tonic pupillary response, Adverse-Effectdenervation supersensitivity , and abnormal visual - evoked potentials in quinine toxicity, to our knowledge, have not been previously reported.
0.9842 A Adverse-Effecttransient tonic pupillary response , denervation supersensitivity, and abnormal visual - evoked potentials in quinine toxicity, to our knowledge, have not been previously reported.
0.9572 A transient tonic pupillary response, denervation supersensitivity, and Adverse-Effectabnormal visual - evoked potentials in quinine toxicity, to our knowledge, have not been previously reported.
Score Text
0.9972 An encephalopathy and cardiomyopathy developed in a seventeen - year - old girl with chemotherapy - induced renal failure while receiving an intravesical Drugaluminum infusion for hemorrhagic cystitis.
0.9959 An Adverse-Effectencephalopathy and cardiomyopathy developed in a seventeen - year - old girl with chemotherapy - induced renal failure while receiving an intravesical aluminum infusion for hemorrhagic cystitis.
0.9952 An encephalopathy and Adverse-Effectcardiomyopathy developed in a seventeen - year - old girl with chemotherapy - induced renal failure while receiving an intravesical aluminum infusion for hemorrhagic cystitis.
0.9324 An encephalopathy and cardiomyopathy developed in a seventeen - year - old girl with chemotherapy - induced Adverse-Effectrenal failure while receiving an intravesical aluminum infusion for hemorrhagic cystitis.
Score Text
0.9967 Adverse-EffectPancreatitis is a very rare adverse effect associated with the use of amiodarone, and only four cases of amiodarone - induced pancreatitis have been reported in literature.
0.9892 Pancreatitis is a very rare adverse effect associated with the use of amiodarone, and only four cases of amiodarone - induced Adverse-Effectpancreatitis have been reported in literature.
0.9256 Pancreatitis is a very rare adverse effect associated with the use of amiodarone, and only four cases of Drugamiodarone - induced pancreatitis have been reported in literature.
0.9211 Pancreatitis is a very rare adverse effect associated with the use of Drugamiodarone , and only four cases of amiodarone - induced pancreatitis have been reported in literature.
Score Text
0.9745 CONTEXT : Previous investigators have reported discrepancies between hematologic, marrow morphologic, and cytogenetic responses to Drugimatinib mesylate among patients with chronic myeloid leukemia ( CML ).
0.9723 CONTEXT : Previous investigators have reported Adverse-Effectdiscrepancies between hematologic, marrow morphologic, and cytogenetic responses to imatinib mesylate among patients with chronic myeloid leukemia ( CML ).
Score Text
0.9982 CONCLUSION : The administration of tissue plasminogen activator was responsible for the large extent of Adverse-Effecthemorrhage and should be considered in the differential diagnosis of hemorrhagic choroidal detachment.
0.9706 CONCLUSION : The administration of Drugtissue plasminogen activator was responsible for the large extent of hemorrhage and should be considered in the differential diagnosis of hemorrhagic choroidal detachment.
0.9649 CONCLUSION : The administration of tissue plasminogen activator was responsible for the large extent of hemorrhage and should be considered in the differential diagnosis of Adverse-Effecthemorrhagic choroidal detachment .
Score Text
0.9994 PURPOSE : To describe transient structured visual hallucinations in a patient with vascular age - related macular degeneration ( AMD ), following an intravitreal DrugAvastin - injection.
0.9456 PURPOSE : To describe Adverse-Effecttransient structured visual hallucinations in a patient with vascular age - related macular degeneration ( AMD ), following an intravitreal Avastin - injection.
Score Text
0.9996 Ataxia caused by Drugpropafenone has been reported to the pharmaceutical companies and drug monitoring agencies, but has not been well described or emphasized in the medical literature.
0.9978 Adverse-EffectAtaxia caused by propafenone has been reported to the pharmaceutical companies and drug monitoring agencies, but has not been well described or emphasized in the medical literature.
Score Text
0.9979 A 16 - year - old boy developed fever, generalized rigidity, leukocytosis, and increased serum transaminase and creatine kinase levels while receiving treatment with Drugolanzapine and lithium.
0.9968 A 16 - year - old boy developed fever, generalized rigidity, leukocytosis, and increased serum transaminase and creatine kinase levels while receiving treatment with olanzapine and Druglithium .
0.9939 A 16 - year - old boy developed fever, generalized rigidity, Adverse-Effectleukocytosis , and increased serum transaminase and creatine kinase levels while receiving treatment with olanzapine and lithium.
0.9911 A 16 - year - old boy developed Adverse-Effectfever , generalized rigidity, leukocytosis, and increased serum transaminase and creatine kinase levels while receiving treatment with olanzapine and lithium.
0.9864 A 16 - year - old boy developed fever, Adverse-Effectgeneralized rigidity , leukocytosis, and increased serum transaminase and creatine kinase levels while receiving treatment with olanzapine and lithium.
0.8507 A 16 - year - old boy developed fever, generalized rigidity, leukocytosis, and Adverse-Effectincreased serum transaminase and creatine kinase levels while receiving treatment with olanzapine and lithium.
0.9130 A 16 - year - old boy developed fever, generalized rigidity, leukocytosis, and Adverse-Effectincreased serum transaminase and creatine kinase levels while receiving treatment with olanzapine and lithium.
0.8753 A 16 - year - old boy developed fever, generalized rigidity, leukocytosis, and Adverse-Effectincreased serum transaminase and creatine kinase levels while receiving treatment with olanzapine and lithium.
0.6954 A 16 - year - old boy developed fever, generalized rigidity, leukocytosis, and Adverse-Effectincreased serum transaminase and creatine kinase levels while receiving treatment with olanzapine and lithium.
0.6932 A 16 - year - old boy developed fever, generalized rigidity, leukocytosis, and Adverse-Effectincreased serum transaminase and creatine kinase levels while receiving treatment with olanzapine and lithium.
Score Text
0.9636 We suggest adding this side effect to the list of untoward effects of lidocaine and to the differential diagnosis of fixed Adverse-Effectdilated pupils in neonates treated with lidocaine.
0.9033 We suggest adding this side effect to the list of untoward effects of lidocaine and to the differential diagnosis of fixed dilated pupils in neonates treated with Druglidocaine .
0.9411 We suggest adding this side effect to the list of untoward effects of Druglidocaine and to the differential diagnosis of fixed dilated pupils in neonates treated with lidocaine.
Score Text
0.9979 We conclude that myocardial infarction may develop in patients treated with high - dose Drugglucocorticoids for Graves'ophthalmopathy, and increased blood pressure may herald this complication.
0.9883 We conclude that Adverse-Effectmyocardial infarction may develop in patients treated with high - dose glucocorticoids for Graves'ophthalmopathy, and increased blood pressure may herald this complication.
Score Text
0.9981 After intravitreal injection of triamcinolone acetonide, Adverse-Effectcataract may rapidly develop in eyes that have been intensively treated, topically and systemically, by corticosteroids for several years.
0.9705 After intravitreal injection of Drugtriamcinolone acetonide , cataract may rapidly develop in eyes that have been intensively treated, topically and systemically, by corticosteroids for several years.
Score Text
0.9996 The current study investigated the visual fields and visual electrophysiology of eight patients with known Drugvigabatrin - attributed visual field loss, three of whom were reported previously.
0.9881 The current study investigated the visual fields and visual electrophysiology of eight patients with known vigabatrin - attributed Adverse-Effectvisual field loss , three of whom were reported previously.
Score Text
0.9992 DrugQuinapril is an angiotensin - converting enzyme inhibitor ( ACE - inhibitor ) and overdose can lead to prolonged hypotension and, less frequently, transient renal impairment.
0.9818 Quinapril is an angiotensin - converting enzyme inhibitor ( ACE - inhibitor ) and overdose can lead to Adverse-Effectprolonged hypotension and, less frequently, transient renal impairment.
0.9784 Quinapril is an angiotensin - converting enzyme inhibitor ( ACE - inhibitor ) and overdose can lead to prolonged hypotension and, less frequently, Adverse-Effecttransient renal impairment .
Score Text
0.9992 A 60 - year - old woman with diabetes mellitus ( type 2 ) developed an acute icteric hepatitis - like illness 6 weeks after the initiation of Druggliclazide therapy.
0.9838 A 60 - year - old woman with diabetes mellitus ( type 2 ) developed an Adverse-Effectacute icteric hepatitis - like illness 6 weeks after the initiation of gliclazide therapy.
Score Text
0.9993 A 58 - yr - old male patient with essential thrombocythaemia ( ET ) developed chronic myeloid leukaemia ( CML ) after continuous uneventful treatment with Drughydroxyurea for 18 yr.
0.9920 A 58 - yr - old male patient with essential thrombocythaemia ( ET ) developed chronic myeloid leukaemia ( Adverse-EffectCML ) after continuous uneventful treatment with hydroxyurea for 18 yr.
0.9888 A 58 - yr - old male patient with essential thrombocythaemia ( ET ) developed Adverse-Effectchronic myeloid leukaemia ( CML ) after continuous uneventful treatment with hydroxyurea for 18 yr.
Score Text
0.7894 The purpose of this report is to document a new case of in utero CP exposure with Adverse-Effectmultiple congenital anomalies and to establish an apparent CP embryopathy phenotype.
0.9804 The purpose of this report is to document a new case of in utero CP exposure with multiple congenital anomalies and to establish an apparent Adverse-EffectCP embryopathy phenotype.
The purpose of this report is to document a new case of in utero CP exposure with multiple congenital anomalies and to establish an apparent CP Adverse-Effectembryopathy phenotype.
The purpose of this report is to document a new case of in utero DrugCP exposure with multiple congenital anomalies and to establish an apparent CP embryopathy phenotype.
The purpose of this report is to document a new case of in utero CP exposure with multiple congenital anomalies and to establish an apparent DrugCP embryopathy phenotype.
Score Text
0.9995 OBJECTIVE : To report a case of Drugcalcineurin - induced pain syndrome ( CIPS ) in a child undergoing his second hematopoietic stem cell transplant ( HSCT ).
0.9914 OBJECTIVE : To report a case of calcineurin - induced Adverse-Effectpain syndrome ( CIPS ) in a child undergoing his second hematopoietic stem cell transplant ( HSCT ).
0.7659 OBJECTIVE : To report a case of calcineurin - induced pain syndrome ( Adverse-EffectCIPS ) in a child undergoing his second hematopoietic stem cell transplant ( HSCT ).
Score Text
0.9997 A 58 - year - old woman with rheumatoid arthritis ( RA ) developed fever, skin eruptions, leukocytopenia, and thrombocytopenia, 3 weeks after treatment with Drugsulfasalazine .
0.9984 A 58 - year - old woman with rheumatoid arthritis ( RA ) developed fever, skin eruptions, leukocytopenia, and Adverse-Effectthrombocytopenia , 3 weeks after treatment with sulfasalazine.
0.9981 A 58 - year - old woman with rheumatoid arthritis ( RA ) developed fever, skin eruptions, Adverse-Effectleukocytopenia , and thrombocytopenia, 3 weeks after treatment with sulfasalazine.
0.9937 A 58 - year - old woman with rheumatoid arthritis ( RA ) developed fever, Adverse-Effectskin eruptions , leukocytopenia, and thrombocytopenia, 3 weeks after treatment with sulfasalazine.
0.9899 A 58 - year - old woman with rheumatoid arthritis ( RA ) developed Adverse-Effectfever , skin eruptions, leukocytopenia, and thrombocytopenia, 3 weeks after treatment with sulfasalazine.
Score Text
0.9922 In deciding if tamoxifen therapy is warranted, all potentially life - threatening adverse events associated with tamoxifen should be considered, including endometrial adenocarcinoma or Adverse-Effectuterine sarcoma .
0.9914 In deciding if tamoxifen therapy is warranted, all potentially life - threatening adverse events associated with tamoxifen should be considered, including Adverse-Effectendometrial adenocarcinoma or uterine sarcoma.
0.9910 In deciding if tamoxifen therapy is warranted, all potentially life - threatening adverse events associated with Drugtamoxifen should be considered, including endometrial adenocarcinoma or uterine sarcoma.
0.9757 In deciding if Drugtamoxifen therapy is warranted, all potentially life - threatening adverse events associated with tamoxifen should be considered, including endometrial adenocarcinoma or uterine sarcoma.
Score Text
0.9995 Although various manifestations of Drugpentamidine - induced cardiotoxicity have been reported, to our knowledge, second - degree heart block associated with this agent has not been described.
0.9954 Although various manifestations of pentamidine - induced Adverse-Effectcardiotoxicity have been reported, to our knowledge, second - degree heart block associated with this agent has not been described.
0.9781 Although various manifestations of pentamidine - induced cardiotoxicity have been reported, to our knowledge, Adverse-Effectsecond - degree heart block associated with this agent has not been described.
Score Text
0.9991 We report the syndrome of inappropriate antidiuresis as a much earlier side - effect of Drugcarbamazepine administration in a 29 - year Nigerian female patient with generalized tonic - elonic seizures.
We report the syndrome of inappropriate Adverse-Effectantidiuresis as a much earlier side - effect of carbamazepine administration in a 29 - year Nigerian female patient with generalized tonic - elonic seizures.
Score Text
0.9987 Amphotericin B ( AmB ) is effective, but its use is limited by toxicity : renal impairment, anaemia, fever, malaise, and Adverse-Effecthypokalaemia are common.
0.9985 Amphotericin B ( AmB ) is effective, but its use is limited by toxicity : renal impairment, Adverse-Effectanaemia , fever, malaise, and hypokalaemia are common.
0.9975 Amphotericin B ( AmB ) is effective, but its use is limited by toxicity : renal impairment, anaemia, fever, Adverse-Effectmalaise , and hypokalaemia are common.
0.9955 Amphotericin B ( DrugAmB ) is effective, but its use is limited by toxicity : renal impairment, anaemia, fever, malaise, and hypokalaemia are common.
0.9917 Amphotericin B ( AmB ) is effective, but its use is limited by toxicity : renal impairment, anaemia, Adverse-Effectfever , malaise, and hypokalaemia are common.
0.9889 Amphotericin B ( AmB ) is effective, but its use is limited by toxicity : Adverse-Effectrenal impairment , anaemia, fever, malaise, and hypokalaemia are common.
0.9844 DrugAmphotericin B ( AmB ) is effective, but its use is limited by toxicity : renal impairment, anaemia, fever, malaise, and hypokalaemia are common.
Score Text
0.9991 This case suggests that sarcoidosis and Drugpravastatin , two entities not frequently associated with myotonia, may interact in a synergistic manner to produce severe clinical myotonia in humans.
0.9572 This case suggests that sarcoidosis and pravastatin, two entities not frequently associated with myotonia, may interact in a synergistic manner to produce severe clinical Adverse-Effectmyotonia in humans.
0.8355 This case suggests that sarcoidosis and pravastatin, two entities not frequently associated with Adverse-Effectmyotonia , may interact in a synergistic manner to produce severe clinical myotonia in humans.
Score Text
0.9981 We present two cases of Adverse-Effectanaphylaxis under anaesthesia where return of spontaneous circulation was refractory to epinephrine, but occurred following the administration of the alpha - agonist metaraminol.
0.9951 We present two cases of anaphylaxis under anaesthesia where return of spontaneous circulation was refractory to epinephrine, but occurred following the administration of the alpha - agonist Drugmetaraminol .
Score Text
0.9902 We present the cases of two female patients diagnosed with relapsing - remitting multiple sclerosis ( RRMS ) who developed Adverse-Effectinflammatory musculoskeletal manifestations , following IFN - beta therapy.
0.9748 We present the cases of two female patients diagnosed with relapsing - remitting multiple sclerosis ( RRMS ) who developed inflammatory musculoskeletal manifestations, following DrugIFN - beta therapy.
Score Text
0.9948 OBSERVATIONS : A 48 - year - old woman presented with disfiguring facial edema 10 weeks after she began antiviral therapy with peginterferon alfa - 2a and Drugribavirin for chronic hepatitis C infection.
0.9767 OBSERVATIONS : A 48 - year - old woman presented with Adverse-Effectdisfiguring facial edema 10 weeks after she began antiviral therapy with peginterferon alfa - 2a and ribavirin for chronic hepatitis C infection.
0.9699 OBSERVATIONS : A 48 - year - old woman presented with disfiguring facial edema 10 weeks after she began antiviral therapy with Drugpeginterferon alfa - 2a and ribavirin for chronic hepatitis C infection.
Score Text
0.9986 Adverse-EffectAkathisia appeared to be a common side effect of fluoxetine and generally responded well to treatment with the beta - adrenergic antagonist propranolol, dose reduction, or both.
0.9881 Akathisia appeared to be a common side effect of Drugfluoxetine and generally responded well to treatment with the beta - adrenergic antagonist propranolol, dose reduction, or both.
Score Text
0.9994 We report a 45 - year - old Chinese man with CML and chronic hepatitis B virus infection, on Drugimatinib treatment, presenting with herpetic rash and acute liver failure.
0.9942 We report a 45 - year - old Chinese man with CML and chronic hepatitis B virus infection, on imatinib treatment, presenting with Adverse-Effectherpetic rash and acute liver failure.
0.9918 We report a 45 - year - old Chinese man with CML and chronic hepatitis B virus infection, on imatinib treatment, presenting with herpetic rash and Adverse-Effectacute liver failure .
Score Text
0.9995 Fatal agranulocytosis in an Indian male receiving 100 mg of Drugdapsone daily, hospitalized for mid - borderline leprosy in type I reaction with triple nerve paralysis is reported.
0.9888 Adverse-EffectFatal agranulocytosis in an Indian male receiving 100 mg of dapsone daily, hospitalized for mid - borderline leprosy in type I reaction with triple nerve paralysis is reported.
Score Text
0.9976 We believe that mucositis was a contributing factor to this case of fatal hyperkalemia after administration of Drugsuccinylcholine , with a mechanism similar to that reported with thermal injury.
0.9855 We believe that mucositis was a contributing factor to this case of Adverse-Effectfatal hyperkalemia after administration of succinylcholine, with a mechanism similar to that reported with thermal injury.
0.9806 We believe that Adverse-Effectmucositis was a contributing factor to this case of fatal hyperkalemia after administration of succinylcholine, with a mechanism similar to that reported with thermal injury.
Score Text
0.9990 In eight patients, a mean decrease in serum Na + of 8. 25 + / - 3. 2 mEq / L was observed after a single 200 mg intravenous dose of Druglorcainide .
0.9843 In eight patients, a mean Adverse-Effectdecrease in serum Na + of 8. 25 + / - 3. 2 mEq / L was observed after a single 200 mg intravenous dose of lorcainide.
Score Text
0.9792 Since early symptoms of the toxic effects of theophylline can mimic Adverse-Effectpeptic ulcer disease , cimetidine might be prescribed for the gastrointestinal symptoms with subsequent worsening of theophylline poisoning.
0.9246 Since early symptoms of the toxic effects of Drugtheophylline can mimic peptic ulcer disease, cimetidine might be prescribed for the gastrointestinal symptoms with subsequent worsening of theophylline poisoning.
0.8747 Since early symptoms of the toxic effects of theophylline can mimic peptic ulcer disease, cimetidine might be prescribed for the gastrointestinal symptoms with subsequent worsening of Drugtheophylline poisoning.
Score Text
0.9995 Clinicians should be aware of the signs and symptoms of neurotoxicity during treatment, as well as predisposing factors that put patients receiving Drugmethotrexate at risk for neurotoxic effects.
0.9962 Clinicians should be aware of the signs and symptoms of Adverse-Effectneurotoxicity during treatment, as well as predisposing factors that put patients receiving methotrexate at risk for neurotoxic effects.
Score Text
0.9993 This case describes a 52 - year - old white woman who developed a spontaneous nasal septal perforation after given the antiangiogenic drug, Drugbevacizumab , for metastatic ovarian cancer treatment.
0.9877 This case describes a 52 - year - old white woman who developed a Adverse-Effectspontaneous nasal septal perforation after given the antiangiogenic drug, bevacizumab, for metastatic ovarian cancer treatment.
Score Text
0.9997 This is the first report of a Drugfluoxetine - related death in a child with a confirmed genetic polymorphism of the CYP2D6 gene that results in impaired drug metabolism.
0.9892 This is the first report of a fluoxetine - related Adverse-Effectdeath in a child with a confirmed genetic polymorphism of the CYP2D6 gene that results in impaired drug metabolism.
Score Text
0.9916 Adverse-EffectCutaneous necrosis as a result of interferon alfa is an infrequent complication with unknown pathogenesis, in which a cutaneous local immune - mediated inflammatory process might be involved.
0.9874 Cutaneous necrosis as a result of Druginterferon alfa is an infrequent complication with unknown pathogenesis, in which a cutaneous local immune - mediated inflammatory process might be involved.
Score Text
0.9909 There have been more than 20 observations of the appearance or aggravation of this granulomatosis with Druginterferon alfa and more recently with the combination of interferon alfa plus ribavirin.
0.9897 There have been more than 20 observations of the appearance or aggravation of this Adverse-Effectgranulomatosis with interferon alfa and more recently with the combination of interferon alfa plus ribavirin.
0.9873 There have been more than 20 observations of the appearance or aggravation of this granulomatosis with interferon alfa and more recently with the combination of Druginterferon alfa plus ribavirin.
0.9851 There have been more than 20 observations of the appearance or aggravation of this granulomatosis with interferon alfa and more recently with the combination of interferon alfa plus Drugribavirin .
Score Text
0.9759 We describe a patient with Wilson's disease who presented with neurologic disease, was treated with DrugD - penicillamine , and suffered sudden neurologic deterioration coincident with therapy.
0.9724 We describe a patient with Wilson's disease who presented with neurologic disease, was treated with D - penicillamine, and suffered sudden Adverse-Effectneurologic deterioration coincident with therapy.
Score Text
0.9995 This selective closure of the ductus arteriosus suggests that the affected twin was predisposed to hypoxia and thus was more susceptible to ductal closure in response to Drugindomethacin exposure.
0.9933 This selective closure of the ductus arteriosus suggests that the affected twin was predisposed to Adverse-Effecthypoxia and thus was more susceptible to ductal closure in response to indomethacin exposure.
0.9889 This selective closure of the ductus arteriosus suggests that the affected twin was predisposed to hypoxia and thus was more susceptible to Adverse-Effectductal closure in response to indomethacin exposure.
Score Text
0.9927 This Adverse-Effecteruption emerged after 1 month of therapy with salsalate, persisted for as long as salsalate was administered, and cleared within 3 weeks of discontinuing the medication.
0.9647 This eruption emerged after 1 month of therapy with Drugsalsalate , persisted for as long as salsalate was administered, and cleared within 3 weeks of discontinuing the medication.
0.8928 This eruption emerged after 1 month of therapy with salsalate, persisted for as long as Drugsalsalate was administered, and cleared within 3 weeks of discontinuing the medication.
Score Text
0.9984 We report a case of Adverse-Effectcough following the administration of quinapril, with complete resolution after changing to the alternative ACE inhibitor fosinopril in a patient with essential hypertension.
0.9982 We report a case of cough following the administration of Drugquinapril , with complete resolution after changing to the alternative ACE inhibitor fosinopril in a patient with essential hypertension.
Score Text
0.9986 Recent reports have shown that Decadron ( dexamethasone ; Merck Sharp & Dohme, West Point, Pa ) has a significant antiemetic effect on cisplatin - induced Adverse-Effectvomiting .
0.9929 Recent reports have shown that Decadron ( dexamethasone ; Merck Sharp & Dohme, West Point, Pa ) has a significant antiemetic effect on Drugcisplatin - induced vomiting.
Score Text
0.9324 Prick tests and intradermal tests with a series of dilutions of carboplatin and cisplatin were performed on three patients who had exhibited medium and severe hypersensitivity reactions to Drugcarboplatin .
0.9173 Prick tests and intradermal tests with a series of dilutions of carboplatin and Drugcisplatin were performed on three patients who had exhibited medium and severe hypersensitivity reactions to carboplatin.
0.9097 Prick tests and intradermal tests with a series of dilutions of Drugcarboplatin and cisplatin were performed on three patients who had exhibited medium and severe hypersensitivity reactions to carboplatin.
0.5704 Prick tests and intradermal tests with a series of dilutions of carboplatin and cisplatin were performed on three patients who had exhibited medium and Adverse-Effectsevere hypersensitivity reactions to carboplatin.
Prick tests and intradermal tests with a series of dilutions of carboplatin and cisplatin were performed on three patients who had exhibited medium and Adverse-Effectsevere hypersensitivity reactions to carboplatin.
Score Text
0.9992 We believe that this represents an unusual case of moderate - dose DrugMTX - induced neurotoxicity in a patient with gastric cancer, which has not previously been reported.
0.9973 We believe that this represents an unusual case of moderate - dose MTX - induced Adverse-Effectneurotoxicity in a patient with gastric cancer, which has not previously been reported.
Score Text
0.9971 The chemotherapeutics, including vincristine, actinomycin D, and epirubicin in case 1 and vincristine and actinomycin D in case 2, were given before the Adverse-Effecthepatotoxicity developed.
0.9950 The chemotherapeutics, including vincristine, actinomycin D, and Drugepirubicin in case 1 and vincristine and actinomycin D in case 2, were given before the hepatotoxicity developed.
0.9948 The chemotherapeutics, including Drugvincristine , actinomycin D, and epirubicin in case 1 and vincristine and actinomycin D in case 2, were given before the hepatotoxicity developed.
0.9928 The chemotherapeutics, including vincristine, actinomycin D, and epirubicin in case 1 and Drugvincristine and actinomycin D in case 2, were given before the hepatotoxicity developed.
0.9870 The chemotherapeutics, including vincristine, Drugactinomycin D , and epirubicin in case 1 and vincristine and actinomycin D in case 2, were given before the hepatotoxicity developed.
0.9828 The chemotherapeutics, including vincristine, actinomycin D, and epirubicin in case 1 and vincristine and Drugactinomycin D in case 2, were given before the hepatotoxicity developed.
Score Text
0.9994 We report on a patient with renal artery stenosis who had only 1 kidney and in whom acute renal impairment developed with transient anuria after the administration of Drugcaptopril .
0.9928 We report on a patient with renal artery stenosis who had only 1 kidney and in whom acute renal impairment developed with Adverse-Effecttransient anuria after the administration of captopril.
0.9739 We report on a patient with renal artery stenosis who had only 1 kidney and in whom Adverse-Effectacute renal impairment developed with transient anuria after the administration of captopril.
Score Text
0.9989 Sweet's syndrome is an acute febrile neutrophilic dermatosis that is a known complication of the administration of Drugfilgrastim , a drug that causes increased neutrophil proliferation and differentiation.
0.9761 Adverse-EffectSweet's syndrome is an acute febrile neutrophilic dermatosis that is a known complication of the administration of filgrastim, a drug that causes increased neutrophil proliferation and differentiation.
0.9732 Sweet's syndrome is an Adverse-Effectacute febrile neutrophilic dermatosis that is a known complication of the administration of filgrastim, a drug that causes increased neutrophil proliferation and differentiation.
Score Text
0.9908 Metformin - associated Adverse-Effectlactic acidosis ( MALA ) is a serious metabolic complication that occurs because of metformin accumulation in patients who become dehydrated or developed acute renal failure.
0.9851 DrugMetformin - associated lactic acidosis ( MALA ) is a serious metabolic complication that occurs because of metformin accumulation in patients who become dehydrated or developed acute renal failure.
0.9825 Metformin - associated lactic acidosis ( MALA ) is a serious metabolic complication that occurs because of Drugmetformin accumulation in patients who become dehydrated or developed acute renal failure.
0.9635 Metformin - associated lactic acidosis ( Adverse-EffectMALA ) is a serious metabolic complication that occurs because of metformin accumulation in patients who become dehydrated or developed acute renal failure.
Score Text
0.9995 However, a new episode of neutropenia, with a WBC count of 2. 8 x 10 ( 3 ) / mm3 and ANC of 0. 448 x 10 ( 3 ) / mm3, occurred 11 days after Drugteicoplanin initiation.
0.9983 However, a new episode of Adverse-Effectneutropenia , with a WBC count of 2. 8 x 10 ( 3 ) / mm3 and ANC of 0. 448 x 10 ( 3 ) / mm3, occurred 11 days after teicoplanin initiation.
Score Text
0.9830 We report a case of severe anemia, which responded well to steroid therapy, in a patient receiving DrugIL - 2 plus IFN - alpha for metastatic renal cell carcinoma.
0.9801 We report a case of Adverse-Effectsevere anemia , which responded well to steroid therapy, in a patient receiving IL - 2 plus IFN - alpha for metastatic renal cell carcinoma.
0.9735 We report a case of severe anemia, which responded well to steroid therapy, in a patient receiving IL - 2 plus DrugIFN - alpha for metastatic renal cell carcinoma.
Score Text
0.9986 After extensive neurological'work up ', we realized that the anisocoria was related to the transdermal Drugscopolamine patch that we had prescribed for weaning off the opioid.
0.9980 After extensive neurological'work up ', we realized that the Adverse-Effectanisocoria was related to the transdermal scopolamine patch that we had prescribed for weaning off the opioid.
Score Text
0.9963 We report a patient in whom the anti - depressant trazodone hydrochloride ( DrugMolipaxin , Roussel ), a serotonin antagonist, provoked generalized pustular psoriasis ( GPP ).
0.9888 We report a patient in whom the anti - depressant trazodone hydrochloride ( Molipaxin, Roussel ), a serotonin antagonist, provoked Adverse-Effectgeneralized pustular psoriasis ( GPP ).
0.9820 We report a patient in whom the anti - depressant Drugtrazodone hydrochloride ( Molipaxin, Roussel ), a serotonin antagonist, provoked generalized pustular psoriasis ( GPP ).
0.9701 We report a patient in whom the anti - depressant trazodone hydrochloride ( Molipaxin, Roussel ), a serotonin antagonist, provoked generalized pustular psoriasis ( Adverse-EffectGPP ).
Score Text
0.9993 In addition, there is a report on prolonged ECT seizure related to Drugciprofloxacin , which has an epileptogenic property with a similar action to beta - lactam antibiotics.
0.9655 In addition, there is a report on Adverse-Effectprolonged ECT seizure related to ciprofloxacin, which has an epileptogenic property with a similar action to beta - lactam antibiotics.
Score Text
0.9995 Here, we present a case of Drugsirolimus - associated interstitial pneumonitis in a cardiac transplant recipient that resolved completely with withdrawal of the drug and treatment with corticosteroids.
0.9881 Here, we present a case of sirolimus - associated Adverse-Effectinterstitial pneumonitis in a cardiac transplant recipient that resolved completely with withdrawal of the drug and treatment with corticosteroids.
Score Text
0.9965 In rare cases mitomycin C ( MMC ) may induce cancer - associated hemolytic uremic syndrome, which is characterized by hemolytic anemia, Adverse-Effectthrombocytopenia and progressive renal failure.
0.9946 In rare cases mitomycin C ( MMC ) may induce cancer - associated hemolytic uremic syndrome, which is characterized by Adverse-Effecthemolytic anemia , thrombocytopenia and progressive renal failure.
0.9939 In rare cases mitomycin C ( DrugMMC ) may induce cancer - associated hemolytic uremic syndrome, which is characterized by hemolytic anemia, thrombocytopenia and progressive renal failure.
0.9904 In rare cases Drugmitomycin C ( MMC ) may induce cancer - associated hemolytic uremic syndrome, which is characterized by hemolytic anemia, thrombocytopenia and progressive renal failure.
0.9886 In rare cases mitomycin C ( MMC ) may induce cancer - associated Adverse-Effecthemolytic uremic syndrome , which is characterized by hemolytic anemia, thrombocytopenia and progressive renal failure.
0.9862 In rare cases mitomycin C ( MMC ) may induce cancer - associated hemolytic uremic syndrome, which is characterized by hemolytic anemia, thrombocytopenia and Adverse-Effectprogressive renal failure .
0.5171 In rare cases mitomycin C ( MMC ) may induce Drugcancer - associated hemolytic uremic syndrome, which is characterized by hemolytic anemia, thrombocytopenia and progressive renal failure.
Score Text
0.9982 DrugBisphosphonate - related osteonecrosis of the jaw ( BRONJ ) is reported in up to 18. 6 % of patients treated with intravenous bisphosphonates and can result in significant morbidity.
0.9872 Bisphosphonate - related Adverse-Effectosteonecrosis of the jaw ( BRONJ ) is reported in up to 18. 6 % of patients treated with intravenous bisphosphonates and can result in significant morbidity.
Score Text
0.9991 CONCLUSION : Hypersensitivity reaction should be considered in patients who develop recurrent eosinophilia and deterioration of pulmonary function following the use of Drugtobramycin by inhalation or by intravenous administration.
0.9832 CONCLUSION : Hypersensitivity reaction should be considered in patients who develop recurrent eosinophilia and Adverse-Effectdeterioration of pulmonary function following the use of tobramycin by inhalation or by intravenous administration.
0.9785 CONCLUSION : Hypersensitivity reaction should be considered in patients who develop Adverse-Effectrecurrent eosinophilia and deterioration of pulmonary function following the use of tobramycin by inhalation or by intravenous administration.
Score Text
0.9996 Finally, Drugreserpine toxicity, in particular central nervous system ( CNS ) disturbances, was reported more frequently in patients also receiving barbiturates, suggesting additive CNS effects.
0.8364 Finally, Adverse-Effectreserpine toxicity , in particular central nervous system ( CNS ) disturbances, was reported more frequently in patients also receiving barbiturates, suggesting additive CNS effects.
Score Text
0.9974 RESULTS : At our institution, no children appeared with acute DrugINH neurotoxicity in the period 1985 through 1990, whereas seven patients were treated from 1991 through 1993.
0.9388 RESULTS : At our institution, no children appeared with acute INH Adverse-Effectneurotoxicity in the period 1985 through 1990, whereas seven patients were treated from 1991 through 1993.
Score Text
0.9965 An 83 - year - old man receiving glipizide 10 mg bid developed symptomatic hypoglycemia within three days of adding trimethoprim / Drugsulfamethoxazole ( TMP / SMX ) to his regimen.
0.9960 An 83 - year - old man receiving glipizide 10 mg bid developed symptomatic hypoglycemia within three days of adding Drugtrimethoprim / sulfamethoxazole ( TMP / SMX ) to his regimen.
0.9957 An 83 - year - old man receiving glipizide 10 mg bid developed symptomatic hypoglycemia within three days of adding trimethoprim / sulfamethoxazole ( DrugTMP / SMX ) to his regimen.
0.9954 An 83 - year - old man receiving glipizide 10 mg bid developed symptomatic hypoglycemia within three days of adding trimethoprim / sulfamethoxazole ( TMP / DrugSMX ) to his regimen.
0.9944 An 83 - year - old man receiving Drugglipizide 10 mg bid developed symptomatic hypoglycemia within three days of adding trimethoprim / sulfamethoxazole ( TMP / SMX ) to his regimen.
0.9889 An 83 - year - old man receiving glipizide 10 mg bid developed Adverse-Effectsymptomatic hypoglycemia within three days of adding trimethoprim / sulfamethoxazole ( TMP / SMX ) to his regimen.
Score Text
0.9994 The authors present a case of t - AML that developed in a child with metastatic neuroblastoma 18 months after he received oral Drugetoposide , given for palliation purpose.
0.9874 The authors present a case of Adverse-Effectt - AML that developed in a child with metastatic neuroblastoma 18 months after he received oral etoposide, given for palliation purpose.
Score Text
0.9988 We describe the case of a 50 - year - old woman with advanced non - small cell lung cancer who developed status epilepticus shortly after receiving Drugcisplatin and gemcitabine chemotherapy.
0.9986 We describe the case of a 50 - year - old woman with advanced non - small cell lung cancer who developed status epilepticus shortly after receiving cisplatin and Druggemcitabine chemotherapy.
0.9855 We describe the case of a 50 - year - old woman with advanced non - small cell lung cancer who developed Adverse-Effectstatus epilepticus shortly after receiving cisplatin and gemcitabine chemotherapy.
Score Text
0.9871 We report a rare case of Adverse-Effectcolonic mucosal necrosis following Kalimate ( calcium polystryrene sulfonate ), an analogue of Kayexalate without sorbitol in a 34 - yr - old man.
0.9755 We report a rare case of colonic mucosal necrosis following Kalimate ( Drugcalcium polystryrene sulfonate ), an analogue of Kayexalate without sorbitol in a 34 - yr - old man.
0.9755 We report a rare case of colonic mucosal necrosis following DrugKalimate ( calcium polystryrene sulfonate ), an analogue of Kayexalate without sorbitol in a 34 - yr - old man.
0.9532 We report a rare case of colonic mucosal necrosis following Kalimate ( calcium polystryrene sulfonate ), an analogue of DrugKayexalate without sorbitol in a 34 - yr - old man.
Score Text
0.9992 The most likely cause of liver failure in this patient was, therefore, Drugclarithromycin , which undergoes hepatic metabolism and has been reported to cause fulminant hepatic failure.
0.9841 The most likely cause of liver failure in this patient was, therefore, clarithromycin, which undergoes hepatic metabolism and has been reported to cause Adverse-Effectfulminant hepatic failure .
0.9797 The most likely cause of Adverse-Effectliver failure in this patient was, therefore, clarithromycin, which undergoes hepatic metabolism and has been reported to cause fulminant hepatic failure.
Score Text
0.9990 The development of an IgG lambda - type monoclonal gammopathy and subsequent multiple myeloma in an epilepsy patient on Drugdiphenylhydantoin ( DILANTIN ) therapy for 20 years is reported.
0.9986 The development of an IgG lambda - type monoclonal gammopathy and subsequent multiple myeloma in an epilepsy patient on diphenylhydantoin ( DrugDILANTIN ) therapy for 20 years is reported.
0.9913 The development of an IgG lambda - type monoclonal gammopathy and subsequent Adverse-Effectmultiple myeloma in an epilepsy patient on diphenylhydantoin ( DILANTIN ) therapy for 20 years is reported.
0.9763 The development of an Adverse-EffectIgG lambda - type monoclonal gammopathy and subsequent multiple myeloma in an epilepsy patient on diphenylhydantoin ( DILANTIN ) therapy for 20 years is reported.
Score Text
0.9920 In all three cases, autopsy revealed gross and microscopic features indistinguishable from those seen in the Hamman - Rich syndrome, and Drugmethotrexate hepatotoxicity was present in one.
0.8369 In all three cases, autopsy revealed gross and microscopic features indistinguishable from those seen in the Hamman - Rich syndrome, and methotrexate Adverse-Effecthepatotoxicity was present in one.
Score Text
0.9990 We report a 44 - year - old woman with t - MDS ( refractory anemia with excess blasts ) following treatment of recurrent anaplastic astrocytoma with Drugtemozolomide ( TMZ ).
0.9987 We report a 44 - year - old woman with t - MDS ( refractory anemia with excess blasts ) following treatment of recurrent anaplastic astrocytoma with temozolomide ( DrugTMZ ).
0.9689 We report a 44 - year - old woman with t - MDS ( Adverse-Effectrefractory anemia with excess blasts ) following treatment of recurrent anaplastic astrocytoma with temozolomide ( TMZ ).
Score Text
0.9984 PURPOSE : To report a case of severe corticosteroid - induced Adverse-Effectglaucoma after intravitreal injection of triamcinolone acetate in a 34 - year - old man without a history of glaucoma.
0.9703 PURPOSE : To report a case of severe Drugcorticosteroid - induced glaucoma after intravitreal injection of triamcinolone acetate in a 34 - year - old man without a history of glaucoma.
0.8089 PURPOSE : To report a case of severe corticosteroid - induced glaucoma after intravitreal injection of Drugtriamcinolone acetate in a 34 - year - old man without a history of glaucoma.
Score Text
0.9970 We present two children with acute lymphocytic leukemia who developed Adverse-Effectleukoencephalopathy following administration of a combination of intravenous ara = C and methotrexate during the consolidation phase of chemotherapy.
0.9948 We present two children with acute lymphocytic leukemia who developed leukoencephalopathy following administration of a combination of intravenous ara = C and Drugmethotrexate during the consolidation phase of chemotherapy.
0.9744 We present two children with acute lymphocytic leukemia who developed leukoencephalopathy following administration of a combination of intravenous Drugara = C and methotrexate during the consolidation phase of chemotherapy.
Score Text
0.9994 On the second day of hospitalization, it was noted that the patient's dyspnea and sinus bradycardia could be related to a recent increase in his Drugtimolol dosage.
0.9929 On the second day of hospitalization, it was noted that the patient's Adverse-Effectdyspnea and sinus bradycardia could be related to a recent increase in his timolol dosage.
0.9882 On the second day of hospitalization, it was noted that the patient's dyspnea and Adverse-Effectsinus bradycardia could be related to a recent increase in his timolol dosage.
Score Text
0.9993 Clinicians should be aware that an erythematous and exfoliative rash may be induced by Drugtemozolomide , and be familiar with the pharmacologic and supportive measures necessary for its treatment.
0.9873 Clinicians should be aware that an erythematous and Adverse-Effectexfoliative rash may be induced by temozolomide, and be familiar with the pharmacologic and supportive measures necessary for its treatment.
0.9976 Clinicians should be aware that an Adverse-Effecterythematous and exfoliative rash may be induced by temozolomide, and be familiar with the pharmacologic and supportive measures necessary for its treatment.
Score Text
0.9994 Physicians should be aware of the potential for the development of RS among children who are receiving long - term Drugaspirin therapy for the treatment of systemic inflammatory illnesses.
0.9925 Physicians should be aware of the potential for the development of Adverse-EffectRS among children who are receiving long - term aspirin therapy for the treatment of systemic inflammatory illnesses.
Score Text
0.9996 A review of the literature found 11 children and 2 adults in whom intranasal Drugdesmopressin was associated with hyponatremia, all of whom experienced seizures or altered mental status.
0.9983 A review of the literature found 11 children and 2 adults in whom intranasal desmopressin was associated with hyponatremia, all of whom experienced Adverse-Effectseizures or altered mental status.
0.9958 A review of the literature found 11 children and 2 adults in whom intranasal desmopressin was associated with Adverse-Effecthyponatremia , all of whom experienced seizures or altered mental status.
0.9834 A review of the literature found 11 children and 2 adults in whom intranasal desmopressin was associated with hyponatremia, all of whom experienced seizures or Adverse-Effectaltered mental status .
Score Text
0.9989 OBJECTIVE : To describe a case of severe skin necrosis resulting from peripheral intravenous administration of low - dose Drugvasopressin in a patient with catecholamine - resistant septic shock.
0.8246 OBJECTIVE : To describe a case of severe Adverse-Effectskin necrosis resulting from peripheral intravenous administration of low - dose vasopressin in a patient with catecholamine - resistant septic shock.
0.8866 OBJECTIVE : To describe a case of Adverse-Effectsevere skin necrosis resulting from peripheral intravenous administration of low - dose vasopressin in a patient with catecholamine - resistant septic shock.
Score Text
0.9986 Clinicians who manage cachectic patients, particularly those with protracted diarrhoea and / or receiving anti - malarial drugs including Drugmefloquine , should be aware of the risk of severe hypoglycaemia.
0.9719 Clinicians who manage cachectic patients, particularly those with protracted diarrhoea and / or receiving anti - malarial drugs including mefloquine, should be aware of the risk of Adverse-Effectsevere hypoglycaemia .
Score Text
0.9994 CASE SUMMARY : A 25 - year - old postpartum white woman developed multiple watery stools and abdominal cramping on day 6 of therapy with Drugclindamycin vaginal cream for bacterial vaginosis.
0.9919 CASE SUMMARY : A 25 - year - old postpartum white woman developed multiple watery stools and Adverse-Effectabdominal cramping on day 6 of therapy with clindamycin vaginal cream for bacterial vaginosis.
0.9853 CASE SUMMARY : A 25 - year - old postpartum white woman developed Adverse-Effectmultiple watery stools and abdominal cramping on day 6 of therapy with clindamycin vaginal cream for bacterial vaginosis.
Score Text
0.9991 CONCLUSIONS : Clinicians should be aware of this adverse reaction when facing similar complex neurologic symptoms in patients who are receiving the antibiotic treatment described here, especially Drugvancomycin .
0.9765 CONCLUSIONS : Clinicians should be aware of this adverse reaction when facing similar complex Adverse-Effectneurologic symptoms in patients who are receiving the antibiotic treatment described here, especially vancomycin.
Score Text
0.9991 It is concluded that the aforementioned pathological manifestations were due to chemotherapy and included a pulmonary adverse reaction, a feature never previously associated with oxaliplatinum and Drug5 - fluorouracil regimens.
0.9990 It is concluded that the aforementioned pathological manifestations were due to chemotherapy and included a pulmonary adverse reaction, a feature never previously associated with Drugoxaliplatinum and 5 - fluorouracil regimens.
0.9893 It is concluded that the aforementioned pathological manifestations were due to chemotherapy and included a Adverse-Effectpulmonary adverse reaction , a feature never previously associated with oxaliplatinum and 5 - fluorouracil regimens.
Score Text
0.9941 For patients who suffer from osteogenic sarcoma and have anaphylactic reactions to DrugMTX , this desensitization protocol will allow these patients to continue with needed therapeutic or palliative chemotherapy.
0.9914 For patients who suffer from osteogenic sarcoma and have Adverse-Effectanaphylactic reactions to MTX, this desensitization protocol will allow these patients to continue with needed therapeutic or palliative chemotherapy.
Score Text
0.9952 Here we present the case of a generalized lichen nitidus with involvement of the palms in a patient with hepatitis C after systemic treatment with interferon alpha and Drugribavirin .
0.9814 Here we present the case of a generalized lichen nitidus with involvement of the palms in a patient with hepatitis C after systemic treatment with Druginterferon alpha and ribavirin.
0.9777 Here we present the case of a Adverse-Effectgeneralized lichen nitidus with involvement of the palms in a patient with hepatitis C after systemic treatment with interferon alpha and ribavirin.
Score Text
0.9992 First, a review of the literature produced 41 anecdotic cases of neutropenia or agranulocytosis during treatment with olanzapine ( DrugZyprexa ) reported in a total of 24 publications.
0.9991 First, a review of the literature produced 41 anecdotic cases of neutropenia or agranulocytosis during treatment with Drugolanzapine ( Zyprexa ) reported in a total of 24 publications.
0.9980 First, a review of the literature produced 41 anecdotic cases of Adverse-Effectneutropenia or agranulocytosis during treatment with olanzapine ( Zyprexa ) reported in a total of 24 publications.
0.9976 First, a review of the literature produced 41 anecdotic cases of neutropenia or Adverse-Effectagranulocytosis during treatment with olanzapine ( Zyprexa ) reported in a total of 24 publications.
Score Text
0.9995 DrugCisplatin - induced syndrome of inappropriate antidiuretic hormone ( SIADH ) in a patient with neuroendocrine tumor of the cervix : a case report and review of the literature.
0.9924 Cisplatin - induced syndrome of inappropriate antidiuretic hormone ( Adverse-EffectSIADH ) in a patient with neuroendocrine tumor of the cervix : a case report and review of the literature.
0.9769 Cisplatin - induced Adverse-Effectsyndrome of inappropriate antidiuretic hormone ( SIADH ) in a patient with neuroendocrine tumor of the cervix : a case report and review of the literature.
Score Text
0.9995 A 21 - year - old woman suffering from bipolar affective disorder developed systemic lupus erythematosus ( SLE ) with characteristic laboratory findings, 18 months after starting Drugcarbamazepine maintenance treatment.
0.9944 A 21 - year - old woman suffering from bipolar affective disorder developed systemic lupus erythematosus ( Adverse-EffectSLE ) with characteristic laboratory findings, 18 months after starting carbamazepine maintenance treatment.
0.9836 A 21 - year - old woman suffering from bipolar affective disorder developed Adverse-Effectsystemic lupus erythematosus ( SLE ) with characteristic laboratory findings, 18 months after starting carbamazepine maintenance treatment.
Score Text
0.9982 DISCUSSION : To our knowledge, this is the first case report illustrating neuralgic amyotrophy triggered by exposure to the antibiotics vancomycin, Drugtobramycin , and piperacillin / tazobactam.
0.9982 DISCUSSION : To our knowledge, this is the first case report illustrating neuralgic amyotrophy triggered by exposure to the antibiotics Drugvancomycin , tobramycin, and piperacillin / tazobactam.
0.9980 DISCUSSION : To our knowledge, this is the first case report illustrating neuralgic amyotrophy triggered by exposure to the antibiotics vancomycin, tobramycin, and piperacillin / Drugtazobactam .
0.9977 DISCUSSION : To our knowledge, this is the first case report illustrating neuralgic amyotrophy triggered by exposure to the antibiotics vancomycin, tobramycin, and Drugpiperacillin / tazobactam.
0.9897 DISCUSSION : To our knowledge, this is the first case report illustrating Adverse-Effectneuralgic amyotrophy triggered by exposure to the antibiotics vancomycin, tobramycin, and piperacillin / tazobactam.
Score Text
0.9996 CASE REPORT : We hereby report a case of radiation recall dermatitis and myositis occurring on Druggemcitabine monotherapy, five months after completing chemoradiation for locally advanced pancreatic cancer.
0.9974 CASE REPORT : We hereby report a case of radiation recall dermatitis and Adverse-Effectmyositis occurring on gemcitabine monotherapy, five months after completing chemoradiation for locally advanced pancreatic cancer.
0.9889 CASE REPORT : We hereby report a case of Adverse-Effectradiation recall dermatitis and myositis occurring on gemcitabine monotherapy, five months after completing chemoradiation for locally advanced pancreatic cancer.
Score Text
0.9995 Caution in longterm usage and early recognition of Drugpentazocine toxicity as a neuromuscular complication are important in order to prevent irreversible drug - induced fibrous myopathy and localized neuropathy.
0.9940 Caution in longterm usage and early recognition of pentazocine toxicity as a neuromuscular complication are important in order to prevent irreversible drug - induced fibrous myopathy and localized Adverse-Effectneuropathy .
0.9824 Caution in longterm usage and early recognition of pentazocine toxicity as a neuromuscular complication are important in order to prevent irreversible drug - induced Adverse-Effectfibrous myopathy and localized neuropathy.
0.9652 Caution in longterm usage and early recognition of pentazocine toxicity as a Adverse-Effectneuromuscular complication are important in order to prevent irreversible drug - induced fibrous myopathy and localized neuropathy.
0.5672 Caution in longterm usage and early recognition of Adverse-Effectpentazocine toxicity as a neuromuscular complication are important in order to prevent irreversible drug - induced fibrous myopathy and localized neuropathy.
Score Text
0.9992 A 40 - year - old man with advanced HIV infection and Mycobacterium avium complex infection experienced rapid cognitive decline after commencement of Drugethambutol , and symptoms fully resolved with cessation.
0.9746 A 40 - year - old man with advanced HIV infection and Mycobacterium avium complex infection experienced Adverse-Effectrapid cognitive decline after commencement of ethambutol, and symptoms fully resolved with cessation.
Score Text
0.9993 He was started on Drugdigoxin , 0. 25 mg daily, because of echocardiographically demonstrated left ventricular dilatation and functional impairment ; he died of ventricular fibrillation 15 days later.
0.9861 He was started on digoxin, 0. 25 mg daily, because of echocardiographically demonstrated Adverse-Effectleft ventricular dilatation and functional impairment ; he died of ventricular fibrillation 15 days later.
0.9860 He was started on digoxin, 0. 25 mg daily, because of echocardiographically demonstrated left ventricular dilatation and functional impairment ; he died of Adverse-Effectventricular fibrillation 15 days later.
0.9646 He was started on digoxin, 0. 25 mg daily, because of echocardiographically demonstrated left ventricular dilatation and Adverse-Effectfunctional impairment ; he died of ventricular fibrillation 15 days later.
Score Text
0.9996 We report a case of DrugMMC - related hemolytic uremic syndrome, and discuss the etiologic parameters, clinical aspects, prognosis and treatment modalities of this severe syndrome.
0.9913 We report a case of MMC - related Adverse-Effecthemolytic uremic syndrome , and discuss the etiologic parameters, clinical aspects, prognosis and treatment modalities of this severe syndrome.
Score Text
0.9989 An obese patient, not diabetic, treated with Drugmetformin for some weeks, was referred to us with severe inferior digestive hemorrhage, diagnosed with Meckel's diverticulum.
0.9653 An obese patient, not diabetic, treated with metformin for some weeks, was referred to us with Adverse-Effectsevere inferior digestive hemorrhage , diagnosed with Meckel's diverticulum.
0.6656 An obese patient, not diabetic, treated with metformin for some weeks, was referred to us with severe inferior digestive hemorrhage, diagnosed with Adverse-EffectMeckel's diverticulum .
Score Text
0.9992 A 61 - year - old man with early diffuse cutaneous scleroderma with myositis and progressive interstitial pneumonia developed generalized erythema with high fever 3 weeks after taking Drugsulfamethoxazole / trimethoprim.
0.9992 A 61 - year - old man with early diffuse cutaneous scleroderma with myositis and progressive interstitial pneumonia developed generalized erythema with high fever 3 weeks after taking sulfamethoxazole / Drugtrimethoprim .
0.9904 A 61 - year - old man with early diffuse cutaneous scleroderma with myositis and progressive interstitial pneumonia developed Adverse-Effectgeneralized erythema with high fever 3 weeks after taking sulfamethoxazole / trimethoprim.
Score Text
0.9985 The patient had recurrence of Adverse-Effecturticaria and angioedema a year and a half later, at which point the NPH was stopped and she was desensitized to regular insulin.
0.9984 The patient had recurrence of urticaria and Adverse-Effectangioedema a year and a half later, at which point the NPH was stopped and she was desensitized to regular insulin.
0.9696 The patient had recurrence of urticaria and angioedema a year and a half later, at which point the NPH was stopped and she was desensitized to regular Druginsulin .
0.8994 The patient had recurrence of urticaria and angioedema a year and a half later, at which point the DrugNPH was stopped and she was desensitized to regular insulin.
Score Text
0.9969 The patient was positive for antibody against complexes of heparin and platelet factor 4, and was diagnosed as heparin - induced Adverse-Effectthrombocytopenia with thrombosis syndrome ( HITTS ).
0.9931 The patient was positive for antibody against complexes of heparin and platelet factor 4, and was diagnosed as heparin - induced thrombocytopenia with Adverse-Effectthrombosis syndrome ( HITTS ).
0.9914 The patient was positive for antibody against complexes of heparin and platelet factor 4, and was diagnosed as Drugheparin - induced thrombocytopenia with thrombosis syndrome ( HITTS ).
0.9852 The patient was positive for antibody against complexes of Drugheparin and platelet factor 4, and was diagnosed as heparin - induced thrombocytopenia with thrombosis syndrome ( HITTS ).
Score Text
0.9996 A 73 year - old patient with Wolff - Parkinson - White syndrome and paroxysmic supraventricular tachycardia developed an acute reversible encephalopathy within 15 days of initiation of Drugflecainide .
0.9806 A 73 year - old patient with Wolff - Parkinson - White syndrome and paroxysmic supraventricular tachycardia developed an Adverse-Effectacute reversible encephalopathy within 15 days of initiation of flecainide.
Score Text
0.9987 To the best of our knowledge, this is the first reported patient with captopril - induced Adverse-Effectpemphigus in whom no new lesions developed after subsequent treatment with enalapril.
0.9937 To the best of our knowledge, this is the first reported patient with Drugcaptopril - induced pemphigus in whom no new lesions developed after subsequent treatment with enalapril.
Score Text
0.9990 Although Drugpraziquantel administration may have been effective in killing the parasite in both patients, we are concerned about the production of marked inflammation as a result of treatment.
0.9809 Although praziquantel administration may have been effective in killing the parasite in both patients, we are concerned about the production of marked Adverse-Effectinflammation as a result of treatment.
Score Text
0.9869 OBJECTIVE : To report the occurrence of anterior ischemic optic neuropathy as a complication of treatment with Druginterferon alfa and to consider the possible underlying mechanisms for this association.
0.9799 OBJECTIVE : To report the occurrence of Adverse-Effectanterior ischemic optic neuropathy as a complication of treatment with interferon alfa and to consider the possible underlying mechanisms for this association.
Score Text
0.9891 The authors describe a patient with hemiparesis who developed the syndrome of irreversible lithium - effectuated Adverse-Effectneurotoxicity ( SILENT ) while being treated with lithium for a manic episode.
0.9797 The authors describe a patient with hemiparesis who developed the syndrome of irreversible Druglithium - effectuated neurotoxicity ( SILENT ) while being treated with lithium for a manic episode.
0.9638 The authors describe a patient with hemiparesis who developed the syndrome of irreversible lithium - effectuated neurotoxicity ( SILENT ) while being treated with Druglithium for a manic episode.
Score Text
0.9993 We report a case of unintentional overdose of oral Drugpilocarpine tablets that resulted in bradycardia, mild hypotension, and muscarinic symptoms in a patient with Sjogren's syndrome.
0.9972 We report a case of unintentional overdose of oral pilocarpine tablets that resulted in Adverse-Effectbradycardia , mild hypotension, and muscarinic symptoms in a patient with Sjogren's syndrome.
0.9937 We report a case of unintentional overdose of oral pilocarpine tablets that resulted in bradycardia, mild hypotension, and Adverse-Effectmuscarinic symptoms in a patient with Sjogren's syndrome.
0.9930 We report a case of unintentional overdose of oral pilocarpine tablets that resulted in bradycardia, Adverse-Effectmild hypotension , and muscarinic symptoms in a patient with Sjogren's syndrome.
Score Text
0.9765 Gold - salt therapy may result in Adverse-Effectdamage to proximal tubules that leak renal tubular antigens, which in turn complex with autoantibody and produce an autoimmune membranous nephropathy.
0.9753 DrugGold - salt therapy may result in damage to proximal tubules that leak renal tubular antigens, which in turn complex with autoantibody and produce an autoimmune membranous nephropathy.
0.9707 Gold - salt therapy may result in damage to proximal tubules that leak renal tubular antigens, which in turn complex with autoantibody and produce an Adverse-Effectautoimmune membranous nephropathy .
Score Text
0.9993 In the present paper, we describe two patients with active UC who developed a severe systemic CMV infection during a treatment with an oral microemulsion form of Drugcyclosporine .
0.9814 In the present paper, we describe two patients with active UC who developed a Adverse-Effectsevere systemic CMV infection during a treatment with an oral microemulsion form of cyclosporine.
Score Text
0.9936 When the acute manic state is characterized by marked psychotic symptoms and intense anxiety, it may be associated with increased vulnerability to the development of severe Druglithium neurotoxicity.
0.9359 When the acute manic state is characterized by marked Adverse-Effectpsychotic symptoms and intense anxiety, it may be associated with increased vulnerability to the development of severe lithium neurotoxicity.
0.9228 When the acute manic state is characterized by marked psychotic symptoms and intense anxiety, it may be associated with increased vulnerability to the development of severe lithium Adverse-Effectneurotoxicity .
0.9206 When the acute manic state is characterized by marked psychotic symptoms and Adverse-Effectintense anxiety , it may be associated with increased vulnerability to the development of severe lithium neurotoxicity.
Score Text
0.9994 We report on a patient with an embryonal teratocarcinoma of the testicle who had the syndrome of inappropriate secretion of antidiuretic hormone after receiving a high dose of Drugvinblastine .
0.5115 We report on a patient with an embryonal teratocarcinoma of the testicle who had the syndrome of Adverse-Effectinappropriate secretion of antidiuretic hormone after receiving a high dose of vinblastine.
0.7647 We report on a patient with an embryonal teratocarcinoma of the testicle who had the Adverse-Effectsyndrome of inappropriate secretion of antidiuretic hormone after receiving a high dose of vinblastine.
Score Text
0.9986 Although a lot of Drugamiodarone - induced torsades de pointe have been published, a review of all these cases and the underlying risk - factors has never been made.
0.9807 Although a lot of amiodarone - induced Adverse-Effecttorsades de pointe have been published, a review of all these cases and the underlying risk - factors has never been made.
Score Text
0.9958 Type II heparin - induced Adverse-Effectthrombocytopenia ( HIT ) is an immunological disorder characterized by antibodies to heparin - platelet factor 4 complexes and a high risk of thrombotic complications.
0.9869 Type II Drugheparin - induced thrombocytopenia ( HIT ) is an immunological disorder characterized by antibodies to heparin - platelet factor 4 complexes and a high risk of thrombotic complications.
0.8332 Type II heparin - induced thrombocytopenia ( Adverse-EffectHIT ) is an immunological disorder characterized by antibodies to heparin - platelet factor 4 complexes and a high risk of thrombotic complications.
Score Text
0.9674 Immobilization, while Paget's bone disease was present, and perhaps enhanced activation of dihydrotachysterol by rifampicin, could have led to Adverse-Effectincreased calcium - release into the circulation.
0.9523 Immobilization, while Paget's bone disease was present, and perhaps enhanced activation of Drugdihydrotachysterol by rifampicin, could have led to increased calcium - release into the circulation.
0.7241 Immobilization, while Paget's bone disease was present, and perhaps enhanced activation of dihydrotachysterol by Drugrifampicin , could have led to increased calcium - release into the circulation.
Score Text
0.9992 Although useful in the management of chronic alcoholism, disulfiram is being increasingly associated with a wide spectrum of side effects and untoward medical sequelae, which now include Adverse-Effectcatatonia .
0.9984 Although useful in the management of chronic alcoholism, Drugdisulfiram is being increasingly associated with a wide spectrum of side effects and untoward medical sequelae, which now include catatonia.
Score Text
0.9994 The patient was enrolled in a weight - loss clinic, and his diabetes medications were adjusted. Subsequently, Drugolanzapine was discontinued because of weight gain and uncontrolled diabetes.
0.9874 The patient was enrolled in a weight - loss clinic, and his diabetes medications were adjusted. Subsequently, olanzapine was discontinued because of Adverse-Effectweight gain and uncontrolled diabetes.
0.9508 The patient was enrolled in a weight - loss clinic, and his diabetes medications were adjusted. Subsequently, olanzapine was discontinued because of weight gain and Adverse-Effectuncontrolled diabetes .
Score Text
0.9994 I report a 35 - year - old woman with occult coronary artery disease who experienced cardiac arrest within minutes after receiving a first - time dose of subcutaneous Drugsumatriptan for migraine.
0.9960 I report a 35 - year - old woman with occult coronary artery disease who experienced Adverse-Effectcardiac arrest within minutes after receiving a first - time dose of subcutaneous sumatriptan for migraine.
Score Text
0.9995 Despite a hematologic response in all 3 patients, none of them achieved cytogenetic remission, and all progressed to blast crisis at 7 to 10 months of Drugimatinib therapy.
0.9939 Despite a hematologic response in all 3 patients, none of them achieved cytogenetic remission, and all progressed to Adverse-Effectblast crisis at 7 to 10 months of imatinib therapy.
Score Text
0.9880 Because sumatriptan can cause Adverse-Effectcoronary artery vasospasm , patients with significant risk factors for coronary artery disease should be carefully evaluated for cardiovascular disease prior to the use of sumatriptan.
0.9415 Because Drugsumatriptan can cause coronary artery vasospasm, patients with significant risk factors for coronary artery disease should be carefully evaluated for cardiovascular disease prior to the use of sumatriptan.
0.5781 Because sumatriptan can cause coronary artery vasospasm, patients with significant risk factors for coronary artery disease should be carefully evaluated for cardiovascular disease prior to the use of Drugsumatriptan .
Score Text
0.9982 We report the case of an adult patient with acute lymphoblastic leukemia who presented with repeated transient ischemic attacks followed by a Adverse-Effectseizure during consolidation treatment with L - asparaginase.
0.9904 We report the case of an adult patient with acute lymphoblastic leukemia who presented with repeated Adverse-Effecttransient ischemic attacks followed by a seizure during consolidation treatment with L - asparaginase.
0.9710 We report the case of an adult patient with acute lymphoblastic leukemia who presented with repeated transient ischemic attacks followed by a seizure during consolidation treatment with DrugL - asparaginase .
Score Text
0.9692 Adverse-EffectProliferation of abnormal bone marrow histiocytes , an undesired effect of granulocyte macrophage - colony - stimulating factor therapy in a patient with Hurler's syndrome undergoing bone marrow transplantation.
0.9576 Proliferation of abnormal bone marrow histiocytes, an undesired effect of Druggranulocyte macrophage - colony - stimulating factor therapy in a patient with Hurler's syndrome undergoing bone marrow transplantation.
Score Text
0.9996 The diagnosis was based on the rapid onset of renal failure, presence of eosinophilia, skin rash, and characteristic renal biopsy finding, following the administration of Drugampicillin .
0.9947 The diagnosis was based on the rapid onset of renal failure, presence of eosinophilia, Adverse-Effectskin rash , and characteristic renal biopsy finding, following the administration of ampicillin.
0.9939 The diagnosis was based on the rapid onset of renal failure, presence of Adverse-Effecteosinophilia , skin rash, and characteristic renal biopsy finding, following the administration of ampicillin.
0.9915 The diagnosis was based on the rapid onset of Adverse-Effectrenal failure , presence of eosinophilia, skin rash, and characteristic renal biopsy finding, following the administration of ampicillin.
Score Text
0.9830 Monitoring of liver function tests should be mandatory in patients receiving high doses of Drugcyproterone acetate ; the drug should be withdrawn immediately if abnormal liver function tests are found.
0.8997 Monitoring of liver function tests should be mandatory in patients receiving high doses of cyproterone acetate ; the drug should be withdrawn immediately if Adverse-Effectabnormal liver function tests are found.
Score Text
0.9982 The first patient developed a Adverse-Effectmonoarthritis 2 weeks after initiation of IFN - beta, which persisted during the 14 months of therapy and resolved with discontinuation of the medication.
0.9801 The first patient developed a monoarthritis 2 weeks after initiation of DrugIFN - beta , which persisted during the 14 months of therapy and resolved with discontinuation of the medication.
Score Text
0.9994 DrugNaproxen , the most common offender, has been associated with a dimorphic clinical pattern : a PCT - like presentation and one simulating erythropoietic protoporphyria in the pediatric population.
0.9881 Naproxen, the most common offender, has been associated with a dimorphic clinical pattern : a PCT - like presentation and one simulating Adverse-Effecterythropoietic protoporphyria in the pediatric population.
Score Text
0.9866 Parenteral pyridoxine, the specific antidote for INH - induced Adverse-Effectrefractory seizures , should be readily available in every emergency department in the areas similarly experiencing increasing trends of TB.
0.9734 Parenteral pyridoxine, the specific antidote for DrugINH - induced refractory seizures, should be readily available in every emergency department in the areas similarly experiencing increasing trends of TB.
0.9381 Parenteral Drugpyridoxine , the specific antidote for INH - induced refractory seizures, should be readily available in every emergency department in the areas similarly experiencing increasing trends of TB.
Score Text
0.9994 Alternating sinus rhythm and intermittent sinoatrial ( S - A ) block was observed in a 57 - year - old woman, under treatment for angina with 80 mg Drugpropranolol daily.
0.9756 Adverse-EffectAlternating sinus rhythm and intermittent sinoatrial ( S - A ) block was observed in a 57 - year - old woman, under treatment for angina with 80 mg propranolol daily.
0.9669 Alternating sinus rhythm and Adverse-Effectintermittent sinoatrial ( S - A ) block was observed in a 57 - year - old woman, under treatment for angina with 80 mg propranolol daily.
Score Text
0.9925 We describe the development of Adverse-Effectischemic colitis in a woman who was treated with tegaserod and review the relationship among ischemic colitis, tegaserod use, and irritable bowel syndrome.
0.9918 We describe the development of ischemic colitis in a woman who was treated with Drugtegaserod and review the relationship among ischemic colitis, tegaserod use, and irritable bowel syndrome.
0.9892 We describe the development of ischemic colitis in a woman who was treated with tegaserod and review the relationship among Adverse-Effectischemic colitis , tegaserod use, and irritable bowel syndrome.
0.9864 We describe the development of ischemic colitis in a woman who was treated with tegaserod and review the relationship among ischemic colitis, Drugtegaserod use, and irritable bowel syndrome.
0.9860 We describe the development of ischemic colitis in a woman who was treated with tegaserod and review the relationship among ischemic colitis, tegaserod use, and Adverse-Effectirritable bowel syndrome .
Score Text
0.9992 A 7 - year - old girl developed diabetes mellitus and exocrine pancreatic insufficiency after 3. 5 years of almost continuous treatment with Drugazathioprine and / or prednisone for idiopathic auto - immune haemolytic anaemia.
0.9991 A 7 - year - old girl developed diabetes mellitus and exocrine pancreatic insufficiency after 3. 5 years of almost continuous treatment with azathioprine and / or Drugprednisone for idiopathic auto - immune haemolytic anaemia.
0.9933 A 7 - year - old girl developed Adverse-Effectdiabetes mellitus and exocrine pancreatic insufficiency after 3. 5 years of almost continuous treatment with azathioprine and / or prednisone for idiopathic auto - immune haemolytic anaemia.
0.9909 A 7 - year - old girl developed diabetes mellitus and Adverse-Effectexocrine pancreatic insufficiency after 3. 5 years of almost continuous treatment with azathioprine and / or prednisone for idiopathic auto - immune haemolytic anaemia.
Score Text
0.9929 Flare of Kaposi's sarcoma ( KS ) is well described in immunosuppressed patients treated with corticosteroids and Drugrituximab , but has not yet been reported during treatment with imatinib.
0.9687 Flare of Kaposi's sarcoma ( Adverse-EffectKS ) is well described in immunosuppressed patients treated with corticosteroids and rituximab, but has not yet been reported during treatment with imatinib.
0.9619 Flare of Adverse-EffectKaposi's sarcoma ( KS ) is well described in immunosuppressed patients treated with corticosteroids and rituximab, but has not yet been reported during treatment with imatinib.
Score Text
0.9984 The uncomplicated long - term use of adequately - dosed AZA and stable non - toxic metabolite levels could not acknowledge TPMT deficiency as a primary cause of the Adverse-Effectleukopenia .
0.9962 The uncomplicated long - term use of adequately - dosed DrugAZA and stable non - toxic metabolite levels could not acknowledge TPMT deficiency as a primary cause of the leukopenia.
Score Text
0.9963 Theoretical basal ganglia toxicologic mechanisms of Drugmethanol poisoning are reviewed, and the role of brain imaging studies will regard to diagnosis, prognosis and impact on management is discussed.
0.9101 Theoretical basal ganglia toxicologic mechanisms of Adverse-Effectmethanol poisoning are reviewed, and the role of brain imaging studies will regard to diagnosis, prognosis and impact on management is discussed.
Score Text
0.9994 We report a case of biopsy - proven acute tubulointerstitial nephritis associated with a second course of Drugflurbiprofen , a nonsteroidal anti - inflammatory drug of the propionic acid class.
0.9842 We report a case of biopsy - proven Adverse-Effectacute tubulointerstitial nephritis associated with a second course of flurbiprofen, a nonsteroidal anti - inflammatory drug of the propionic acid class.
Score Text
0.9990 A 17 - year - old boy with refractory psoriatic arthritis and alpha - 1 antitrypsin deficiency who developed a syringotropic hypersensitivity reaction after 9 months of therapy with Druginfliximab and leflunomide is described.
0.9989 A 17 - year - old boy with refractory psoriatic arthritis and alpha - 1 antitrypsin deficiency who developed a syringotropic hypersensitivity reaction after 9 months of therapy with infliximab and Drugleflunomide is described.
0.9929 A 17 - year - old boy with refractory psoriatic arthritis and alpha - 1 antitrypsin deficiency who developed a Adverse-Effectsyringotropic hypersensitivity reaction after 9 months of therapy with infliximab and leflunomide is described.
0.6391 A 17 - year - old boy with refractory psoriatic arthritis and alpha - 1 antitrypsin deficiency who developed a Adverse-Effectsyringotropic hypersensitivity reaction after 9 months of therapy with infliximab and leflunomide is described.
Score Text
0.9987 DrugDipyrone , also known as metamizole, is an analgesic and antipyretic drug that was banned by the United States Food and Drug Administration because of its association with agranulocytosis.
0.9980 Dipyrone, also known as metamizole, is an analgesic and antipyretic drug that was banned by the United States Food and Drug Administration because of its association with Adverse-Effectagranulocytosis .
0.9980 Dipyrone, also known as Drugmetamizole , is an analgesic and antipyretic drug that was banned by the United States Food and Drug Administration because of its association with agranulocytosis.
Score Text
0.9988 This is, to the best of our knowledge, the first report of a case in which agranulocytosis followed treatment with both propylthiouracil and Drugmethimazole in the same patient.
0.9988 This is, to the best of our knowledge, the first report of a case in which agranulocytosis followed treatment with both Drugpropylthiouracil and methimazole in the same patient.
0.9973 This is, to the best of our knowledge, the first report of a case in which Adverse-Effectagranulocytosis followed treatment with both propylthiouracil and methimazole in the same patient.
Score Text
0.9992 Although they had only a few nodules at diagnosis, the nodules increased in number and size 3 to 4 months after the start of Drugmethotrexate therapy in both patients.
0.9910 Although they had only a few nodules at diagnosis, the Adverse-Effectnodules increased in number and size 3 to 4 months after the start of methotrexate therapy in both patients.
0.9867 Although they had only a few Adverse-Effectnodules at diagnosis, the nodules increased in number and size 3 to 4 months after the start of methotrexate therapy in both patients.
Score Text
0.9908 CASE : We present an 11 - year old male with Budd - Chiari syndrome who experienced profound worsening of chronic aphthous ulcers after immunosuppressive therapy was changed from Drugtacrolimus to sirolimus.
0.9905 CASE : We present an 11 - year old male with Budd - Chiari syndrome who experienced profound worsening of chronic aphthous ulcers after immunosuppressive therapy was changed from tacrolimus to Drugsirolimus .
0.9717 CASE : We present an 11 - year old male with Budd - Chiari syndrome who experienced profound Adverse-Effectworsening of chronic aphthous ulcers after immunosuppressive therapy was changed from tacrolimus to sirolimus.
Score Text
0.9995 Though hypotension, dry mouth, and constipation are well - documented possible adverse effects, the possibility of Drugclonidine - induced bradycardia is less well recognized and is rare.
0.9975 Though hypotension, dry mouth, and constipation are well - documented possible adverse effects, the possibility of clonidine - induced Adverse-Effectbradycardia is less well recognized and is rare.
0.9961 Though Adverse-Effecthypotension , dry mouth, and constipation are well - documented possible adverse effects, the possibility of clonidine - induced bradycardia is less well recognized and is rare.
0.9953 Though hypotension, dry mouth, and Adverse-Effectconstipation are well - documented possible adverse effects, the possibility of clonidine - induced bradycardia is less well recognized and is rare.
0.9935 Though hypotension, Adverse-Effectdry mouth , and constipation are well - documented possible adverse effects, the possibility of clonidine - induced bradycardia is less well recognized and is rare.
Score Text
0.9993 CASES : " A " was an 8 - year - old boy with attention deficit and chronic tic disorder who developed obsessive - compulsive symptoms within 2 weeks of starting Drugrisperidone .
0.9893 CASES : " A " was an 8 - year - old boy with attention deficit and chronic tic disorder who developed Adverse-Effectobsessive - compulsive symptoms within 2 weeks of starting risperidone.
Score Text
0.9996 We report a 71 - year male with castration - resistant metastatic prostate cancer who was treated with weekly Drugdocetaxel for 12 weeks and developed significant eye irritation and dryness during treatment.
0.9916 We report a 71 - year male with castration - resistant metastatic prostate cancer who was treated with weekly docetaxel for 12 weeks and developed significant Adverse-Effecteye irritation and dryness during treatment.
Score Text
0.9985 CONCLUSION : All doctors need to be aware of the need to review the indications for Druggabapentin use during periods of acute illness, especially with regard to renal impairment.
0.9878 CONCLUSION : All doctors need to be aware of the need to review the indications for gabapentin use during periods of acute illness, especially with regard to Adverse-Effectrenal impairment .
Score Text
0.9983 In the presented case fluvoxamine - induced Adverse-Effectakathisia in an OCD patient was partially resistant to the anticholinergic agent biperiden, and was successfully treated with the 5 - HT2A / 5 - HT2C antagonist mianserin.
0.9959 In the presented case Drugfluvoxamine - induced akathisia in an OCD patient was partially resistant to the anticholinergic agent biperiden, and was successfully treated with the 5 - HT2A / 5 - HT2C antagonist mianserin.
Score Text
0.9752 The wide use of phenytoin during the recent tuberculosis epidemic makes it imperative to suspect this drug interaction in patients exhibiting clinical features that might be related to Drugphenytoin toxicity.
0.9657 The wide use of Drugphenytoin during the recent tuberculosis epidemic makes it imperative to suspect this drug interaction in patients exhibiting clinical features that might be related to phenytoin toxicity.
0.9326 The wide use of phenytoin during the recent tuberculosis epidemic makes it imperative to suspect this drug interaction in patients exhibiting clinical features that might be related to Adverse-Effectphenytoin toxicity .
Score Text
0.9995 Review of the literature relating to Drugmethicillin - induced nephropathy suggests a hypersensitivity origin for this disorder, but immunologic and ultrastructural investigation to date has failed to elucidate pathogenesis.
0.9973 Review of the literature relating to methicillin - induced Adverse-Effectnephropathy suggests a hypersensitivity origin for this disorder, but immunologic and ultrastructural investigation to date has failed to elucidate pathogenesis.
0.7600 Review of the literature relating to methicillin - induced nephropathy suggests a Adverse-Effecthypersensitivity origin for this disorder, but immunologic and ultrastructural investigation to date has failed to elucidate pathogenesis.
Score Text
0.9993 We hypothesize that Drugcaffeine toxicity injured the muscle cells, which were fragile due to the potassium depletion induced by the coexisting hyponatremia, to result in unusually severe rhabdomyolysis.
0.9461 We hypothesize that caffeine toxicity injured the muscle cells, which were fragile due to the Adverse-Effectpotassium depletion induced by the coexisting hyponatremia, to result in unusually severe rhabdomyolysis.
0.9234 We hypothesize that caffeine toxicity injured the muscle cells, which were fragile due to the potassium depletion induced by the coexisting hyponatremia, to result in unusually severe Adverse-Effectrhabdomyolysis .
0.9000 We hypothesize that caffeine toxicity injured the muscle cells, which were fragile due to the potassium depletion induced by the Adverse-Effectcoexisting hyponatremia , to result in unusually severe rhabdomyolysis.
0.5221 We hypothesize that Adverse-Effectcaffeine toxicity injured the muscle cells, which were fragile due to the potassium depletion induced by the coexisting hyponatremia, to result in unusually severe rhabdomyolysis.
We hypothesize that caffeine toxicity Adverse-Effectinjured the muscle cells , which were fragile due to the potassium depletion induced by the coexisting hyponatremia, to result in unusually severe rhabdomyolysis.
Score Text
0.9985 In conclusion, Adverse-EffectRSDS is a relevant osteoarticular complication in patients receiving either anticalcineurinic drug ( CyA or tacrolimus ), even under monotherapy or with a low steroid dose.
0.9980 In conclusion, RSDS is a relevant osteoarticular complication in patients receiving either anticalcineurinic drug ( CyA or Drugtacrolimus ), even under monotherapy or with a low steroid dose.
0.9973 In conclusion, RSDS is a relevant osteoarticular complication in patients receiving either anticalcineurinic drug ( DrugCyA or tacrolimus ), even under monotherapy or with a low steroid dose.
Score Text
0.9971 We report a case of interstitial pneumonitis induced by Drugbicalutamide and / or leuprorelin acetate given as therapy for prostate cancer, in which the pneumonitis was successfully managed by steroid treatment.
0.9853 We report a case of Adverse-Effectinterstitial pneumonitis induced by bicalutamide and / or leuprorelin acetate given as therapy for prostate cancer, in which the pneumonitis was successfully managed by steroid treatment.
0.9826 We report a case of interstitial pneumonitis induced by bicalutamide and / or Drugleuprorelin acetate given as therapy for prostate cancer, in which the pneumonitis was successfully managed by steroid treatment.
Score Text
0.9939 This case report describes a patient who was previously prescribed Drugalendronate ( Fosamax ) and presented with postoperative hypophosphatemia and hypocalcemic tetany after bowel preparation with Fleet Phospho - Soda.
0.9938 This case report describes a patient who was previously prescribed alendronate ( Fosamax ) and presented with postoperative hypophosphatemia and Adverse-Effecthypocalcemic tetany after bowel preparation with Fleet Phospho - Soda.
0.9888 This case report describes a patient who was previously prescribed alendronate ( Fosamax ) and presented with postoperative Adverse-Effecthypophosphatemia and hypocalcemic tetany after bowel preparation with Fleet Phospho - Soda.
0.9818 This case report describes a patient who was previously prescribed alendronate ( DrugFosamax ) and presented with postoperative hypophosphatemia and hypocalcemic tetany after bowel preparation with Fleet Phospho - Soda.
0.9491 This case report describes a patient who was previously prescribed alendronate ( Fosamax ) and presented with postoperative hypophosphatemia and hypocalcemic tetany after bowel preparation with DrugFleet Phospho - Soda .
0.9310 This case report describes a patient who was previously prescribed alendronate ( Fosamax ) and presented with Adverse-Effectpostoperative hypophosphatemia and hypocalcemic tetany after bowel preparation with Fleet Phospho - Soda.
Score Text
0.9995 Patients from endemic areas referred to transplant centers may be at high risk for disseminated histoplasmosis when treated with long - term Drugprednisone for graft - versus - host disease.
0.9916 Patients from endemic areas referred to transplant centers may be at high risk for Adverse-Effectdisseminated histoplasmosis when treated with long - term prednisone for graft - versus - host disease.
Score Text
0.9978 The third patient had been suffering from serious akathisia while on risperidone, and was cured after switching to olanzapine, but thereafter the patient suffered from Adverse-EffectRLS at nighttime.
0.9857 The third patient had been suffering from serious akathisia while on Drugrisperidone , and was cured after switching to olanzapine, but thereafter the patient suffered from RLS at nighttime.
0.9589 The third patient had been suffering from serious Adverse-Effectakathisia while on risperidone, and was cured after switching to olanzapine, but thereafter the patient suffered from RLS at nighttime.
0.8136 The third patient had been suffering from serious akathisia while on risperidone, and was cured after switching to Drugolanzapine , but thereafter the patient suffered from RLS at nighttime.
Score Text
0.9993 RESULTS : We recently experienced a case of fatal Drugerlotinib - induced ILD, diagnosed based on clinical and radiologic findings, which occurred in a patient with radiation fibrosis.
0.9984 RESULTS : We recently experienced a case of fatal erlotinib - induced Adverse-EffectILD , diagnosed based on clinical and radiologic findings, which occurred in a patient with radiation fibrosis.
Score Text
0.9989 In the second case, five cardiac arrests due to ventricular tachycardia and fibrillation occurred during several hours after beginning a trial of Drugbretylium maintenance therapy for complex ventricular ectopy.
0.9899 In the second case, five cardiac arrests due to ventricular tachycardia and Adverse-Effectfibrillation occurred during several hours after beginning a trial of bretylium maintenance therapy for complex ventricular ectopy.
0.9855 In the second case, five Adverse-Effectcardiac arrests due to ventricular tachycardia and fibrillation occurred during several hours after beginning a trial of bretylium maintenance therapy for complex ventricular ectopy.
0.9651 In the second case, five cardiac arrests due to Adverse-Effectventricular tachycardia and fibrillation occurred during several hours after beginning a trial of bretylium maintenance therapy for complex ventricular ectopy.
Score Text
0.9997 However, one patient exhibited severe hypersensitivity reactions including cardiac arrest and apnea, and another four patients developed eruptions, hypotension, and tachycardia soon after administration of DrugCBDCA .
0.9988 However, one patient exhibited severe hypersensitivity reactions including cardiac arrest and apnea, and another four patients developed eruptions, hypotension, and Adverse-Effecttachycardia soon after administration of CBDCA.
0.9987 However, one patient exhibited severe hypersensitivity reactions including cardiac arrest and apnea, and another four patients developed eruptions, Adverse-Effecthypotension , and tachycardia soon after administration of CBDCA.
0.9976 However, one patient exhibited severe hypersensitivity reactions including cardiac arrest and apnea, and another four patients developed Adverse-Effecteruptions , hypotension, and tachycardia soon after administration of CBDCA.
0.9965 However, one patient exhibited severe hypersensitivity reactions including cardiac arrest and Adverse-Effectapnea , and another four patients developed eruptions, hypotension, and tachycardia soon after administration of CBDCA.
0.9909 However, one patient exhibited severe hypersensitivity reactions including Adverse-Effectcardiac arrest and apnea, and another four patients developed eruptions, hypotension, and tachycardia soon after administration of CBDCA.
0.9823 However, one patient exhibited Adverse-Effectsevere hypersensitivity reactions including cardiac arrest and apnea, and another four patients developed eruptions, hypotension, and tachycardia soon after administration of CBDCA.
Score Text
0.9980 A patient with chronic myeloid leukaemia treated with busulphan for 4 - 5 years, developed signs of busulphan toxicity and portal hypertension with ascites, oesophageal varices and Adverse-Effectjaundice .
0.9967 A patient with chronic myeloid leukaemia treated with busulphan for 4 - 5 years, developed signs of busulphan toxicity and portal hypertension with Adverse-Effectascites , oesophageal varices and jaundice.
0.9901 A patient with chronic myeloid leukaemia treated with busulphan for 4 - 5 years, developed signs of busulphan toxicity and portal hypertension with ascites, Adverse-Effectoesophageal varices and jaundice.
0.9873 A patient with chronic myeloid leukaemia treated with busulphan for 4 - 5 years, developed signs of busulphan toxicity and Adverse-Effectportal hypertension with ascites, oesophageal varices and jaundice.
0.9861 A patient with chronic myeloid leukaemia treated with Drugbusulphan for 4 - 5 years, developed signs of busulphan toxicity and portal hypertension with ascites, oesophageal varices and jaundice.
0.9385 A patient with chronic myeloid leukaemia treated with busulphan for 4 - 5 years, developed signs of Adverse-Effectbusulphan toxicity and portal hypertension with ascites, oesophageal varices and jaundice.
0.7703 A patient with chronic myeloid leukaemia treated with busulphan for 4 - 5 years, developed signs of Drugbusulphan toxicity and portal hypertension with ascites, oesophageal varices and jaundice.
Score Text
0.9988 A 65 - year - old woman, in the intensive care unit because of septic shock and acute renal failure, had a small - bowel obstruction due to DrugAmphojel concretions.
0.9776 A 65 - year - old woman, in the intensive care unit because of septic shock and acute renal failure, had a Adverse-Effectsmall - bowel obstruction due to Amphojel concretions.
Score Text
0.9995 To our knowledge, this is the first case report that demonstrates the occurrence of fever with low - dose Drugamifostine therapy without the manifestation of accompanying rash or hypotension.
0.9963 To our knowledge, this is the first case report that demonstrates the occurrence of Adverse-Effectfever with low - dose amifostine therapy without the manifestation of accompanying rash or hypotension.
Score Text
0.9990 A 17 - year - old boy with acute lymphoblastic leukemia developed acute renal failure within 48 h of an intravenous high - dose Drugmethotrexate ( 5 g / m2 ) infusion.
0.9919 A 17 - year - old boy with acute lymphoblastic leukemia developed Adverse-Effectacute renal failure within 48 h of an intravenous high - dose methotrexate ( 5 g / m2 ) infusion.
Score Text
0.9995 We report the case of a 17 - year - old male who developed chest pain, elevated cardiac biomarkers, and acute left ventricular dysfunction following a single dose of Drugmethylphenidate .
0.9933 We report the case of a 17 - year - old male who developed Adverse-Effectchest pain , elevated cardiac biomarkers, and acute left ventricular dysfunction following a single dose of methylphenidate.
0.9867 We report the case of a 17 - year - old male who developed chest pain, elevated cardiac biomarkers, and Adverse-Effectacute left ventricular dysfunction following a single dose of methylphenidate.
0.9820 We report the case of a 17 - year - old male who developed chest pain, Adverse-Effectelevated cardiac biomarkers , and acute left ventricular dysfunction following a single dose of methylphenidate.
Score Text
0.9966 A fatal pancytopenia occurred in a patient with an history of depression with hypomanic rebounds, admitted for a manic episode and treated with Druglevomepromazine , diazepam and lithium carbonate.
0.9962 A fatal pancytopenia occurred in a patient with an history of depression with hypomanic rebounds, admitted for a manic episode and treated with levomepromazine, Drugdiazepam and lithium carbonate.
0.9930 A fatal pancytopenia occurred in a patient with an history of depression with hypomanic rebounds, admitted for a manic episode and treated with levomepromazine, diazepam and Druglithium carbonate .
0.9889 A Adverse-Effectfatal pancytopenia occurred in a patient with an history of depression with hypomanic rebounds, admitted for a manic episode and treated with levomepromazine, diazepam and lithium carbonate.
Score Text
0.9980 Although tardive dyskinesia is a known adverse reaction of sustained treatment with traditional neuroleptic agents, it was only rarely reported in association with Drugsulpiride , a selective D2 - receptor antagonist.
0.9860 Although Adverse-Effecttardive dyskinesia is a known adverse reaction of sustained treatment with traditional neuroleptic agents, it was only rarely reported in association with sulpiride, a selective D2 - receptor antagonist.
Score Text
0.9941 A 58 - year - old woman developed unilateral acute angle - closure glaucoma four days after the application of a patch of transdermal Drugscopolamine delivery system ( TRANSDERM - V ).
0.9735 A 58 - year - old woman developed Adverse-Effectunilateral acute angle - closure glaucoma four days after the application of a patch of transdermal scopolamine delivery system ( TRANSDERM - V ).
Score Text
0.9995 At the end of his fifth cycle of Drugsunitinib therapy, the patient complained of the development of abnormally large mammary glands associated with pain and peri - areolar erythema.
0.9901 At the end of his fifth cycle of sunitinib therapy, the patient complained of the development of abnormally large mammary glands associated with Adverse-Effectpain and peri - areolar erythema.
0.9892 At the end of his fifth cycle of sunitinib therapy, the patient complained of the development of abnormally large mammary glands associated with pain and Adverse-Effectperi - areolar erythema .
0.6407 At the end of his fifth cycle of sunitinib therapy, the patient complained of the Adverse-Effectdevelopment of abnormally large mammary glands associated with pain and peri - areolar erythema.
0.5423 At the end of his fifth cycle of sunitinib therapy, the patient complained of the development of Adverse-Effectabnormally large mammary glands associated with pain and peri - areolar erythema.
Score Text
0.9893 CONCLUSIONS : This observation of " on - off " risperidone treatment suggests that Drugrisperidone may have worsened both psychiatric and physical manifestations of the mitochondrial disorder in this adolescent.
0.9854 CONCLUSIONS : This observation of " on - off " Drugrisperidone treatment suggests that risperidone may have worsened both psychiatric and physical manifestations of the mitochondrial disorder in this adolescent.
0.8998 CONCLUSIONS : This observation of " on - off " risperidone treatment suggests that risperidone may have worsened both Adverse-Effectpsychiatric and physical manifestations of the mitochondrial disorder in this adolescent.
Score Text
0.9995 A 50 - year - old woman with a history of migraine without aura, predominantly occurring around her menstrual periods, developed a spinal cord lesion following the use of Drugzolmitriptan .
0.9903 A 50 - year - old woman with a history of migraine without aura, predominantly occurring around her menstrual periods, developed a Adverse-Effectspinal cord lesion following the use of zolmitriptan.
Score Text
0.9979 CONCLUSION : Healthcare professionals should be aware of the possible development of serotonin syndrome as a complication of initiation of Drugfentanyl and other phenylpiperidine opioids in patients treated with SSRIs.
0.9947 CONCLUSION : Healthcare professionals should be aware of the possible development of Adverse-Effectserotonin syndrome as a complication of initiation of fentanyl and other phenylpiperidine opioids in patients treated with SSRIs.
Score Text
0.9972 This report describes a case of acute compromise of renal function associated with Adverse-Effecthypotension in a 7 - year - old boy treated with the ACE inhibitor lisinopril and the ARB losartan.
0.9923 This report describes a case of acute compromise of renal function associated with hypotension in a 7 - year - old boy treated with the ACE inhibitor lisinopril and the ARB Druglosartan .
0.9916 This report describes a case of acute compromise of renal function associated with hypotension in a 7 - year - old boy treated with the ACE inhibitor Druglisinopril and the ARB losartan.
0.7035 This report describes a case of Adverse-Effectacute compromise of renal function associated with hypotension in a 7 - year - old boy treated with the ACE inhibitor lisinopril and the ARB losartan.
Score Text
0.9970 The first patient developed mild nitritoid symptoms and pain in a band - like distribution, corresponding to T10 - T12 dermatomes, shortly after gold sodium thiomalate ( DrugGSTM ) injection.
0.9910 The first patient developed Adverse-Effectmild nitritoid symptoms and pain in a band - like distribution, corresponding to T10 - T12 dermatomes, shortly after gold sodium thiomalate ( GSTM ) injection.
0.9863 The first patient developed mild nitritoid symptoms and pain in a band - like distribution, corresponding to Adverse-EffectT10 - T12 dermatomes , shortly after gold sodium thiomalate ( GSTM ) injection.
0.9847 The first patient developed mild nitritoid symptoms and pain in a band - like distribution, corresponding to T10 - T12 dermatomes, shortly after Druggold sodium thiomalate ( GSTM ) injection.
0.9826 The first patient developed mild nitritoid symptoms and Adverse-Effectpain in a band - like distribution, corresponding to T10 - T12 dermatomes, shortly after gold sodium thiomalate ( GSTM ) injection.
Score Text
0.9985 We report the case of an 11 - month - old female infant with a depressed level of consciousness after ingestion of Drugibuprofen whose mental status markedly improved with administration of naloxone.
0.9382 We report the case of an 11 - month - old female infant with a Adverse-Effectdepressed level of consciousness after ingestion of ibuprofen whose mental status markedly improved with administration of naloxone.
Score Text
0.9677 Acute DrugINH neurotoxicity was not suspected on the first admission ; however, when readmitted 4 weeks later with another seizure, the diagnosis of acute INH neurotoxicity was made.
0.9501 Acute INH neurotoxicity was not suspected on the first admission ; however, when readmitted 4 weeks later with another seizure, the diagnosis of acute DrugINH neurotoxicity was made.
0.9229 Acute INH neurotoxicity was not suspected on the first admission ; however, when readmitted 4 weeks later with another seizure, the diagnosis of acute INH Adverse-Effectneurotoxicity was made.
0.9032 Acute INH Adverse-Effectneurotoxicity was not suspected on the first admission ; however, when readmitted 4 weeks later with another seizure, the diagnosis of acute INH neurotoxicity was made.
0.8507 Acute INH neurotoxicity was not suspected on the first admission ; however, when readmitted 4 weeks later with another Adverse-Effectseizure , the diagnosis of acute INH neurotoxicity was made.
0.5362 Acute INH neurotoxicity was not suspected on the first admission ; however, when readmitted 4 weeks later with another seizure, the diagnosis of acute Adverse-EffectINH neurotoxicity was made.
Score Text
0.9995 A 58 - year - old man with advanced renal cell carcinoma developed grade 3 proteinuria ( 8. 5 g / 24 h ) without microscopic hematuria or renal insufficiency five days after Drugtemsirolimus infusion.
0.9339 A 58 - year - old man with advanced renal cell carcinoma developed grade 3 Adverse-Effectproteinuria ( 8. 5 g / 24 h ) without microscopic hematuria or renal insufficiency five days after temsirolimus infusion.
Score Text
0.9996 Two patients treated for chronic myeloid leukemia with high doses of DrugCCNU ( 1100 mg / m2 and 1240 mg / m2, respectively ) developed a fatal pulmonary fibrosis.
0.9898 Two patients treated for chronic myeloid leukemia with high doses of CCNU ( 1100 mg / m2 and 1240 mg / m2, respectively ) developed a Adverse-Effectfatal pulmonary fibrosis .
Score Text
0.9994 We report the cases of two patients who developed acute hepatitis after taking Drugriluzole at the recommended dose ( 100 mg daily ) for 7 and 4 weeks, respectively.
0.9892 We report the cases of two patients who developed Adverse-Effectacute hepatitis after taking riluzole at the recommended dose ( 100 mg daily ) for 7 and 4 weeks, respectively.
We report the cases of two patients who developed acute Adverse-Effecthepatitis after taking riluzole at the recommended dose ( 100 mg daily ) for 7 and 4 weeks, respectively.
Score Text
0.9993 CONCLUSION : A 37 - year - old African - American man with G6PD deficiency developed hemolytic anemia, hepatitis, orthostatic hypotension, and aseptic meningitis simultaneously after using trimethoprim - Drugsulfamethoxazole .
0.9990 CONCLUSION : A 37 - year - old African - American man with G6PD deficiency developed hemolytic anemia, hepatitis, orthostatic hypotension, and aseptic meningitis simultaneously after using Drugtrimethoprim - sulfamethoxazole.
0.9978 CONCLUSION : A 37 - year - old African - American man with G6PD deficiency developed hemolytic anemia, Adverse-Effecthepatitis , orthostatic hypotension, and aseptic meningitis simultaneously after using trimethoprim - sulfamethoxazole.
0.9954 CONCLUSION : A 37 - year - old African - American man with G6PD deficiency developed hemolytic anemia, hepatitis, orthostatic hypotension, and Adverse-Effectaseptic meningitis simultaneously after using trimethoprim - sulfamethoxazole.
0.9952 CONCLUSION : A 37 - year - old African - American man with G6PD deficiency developed Adverse-Effecthemolytic anemia , hepatitis, orthostatic hypotension, and aseptic meningitis simultaneously after using trimethoprim - sulfamethoxazole.
0.9912 CONCLUSION : A 37 - year - old African - American man with G6PD deficiency developed hemolytic anemia, hepatitis, Adverse-Effectorthostatic hypotension , and aseptic meningitis simultaneously after using trimethoprim - sulfamethoxazole.
Score Text
0.9863 Adverse-EffectHashimoto's disease during interferon - alpha therapy in a patient with pre - treatment negative anti - thyroid autoantibodies and with the specific genetic susceptibility to the thyroid disease.
0.9686 Hashimoto's disease during Druginterferon - alpha therapy in a patient with pre - treatment negative anti - thyroid autoantibodies and with the specific genetic susceptibility to the thyroid disease.
Score Text
0.9945 It should be emphasized that the recurrence of Adverse-Effectnephrotic syndrome was observed after the following chemotherapy, including M - CSF, whereas the bone marrow still remained completely remitted.
0.9752 It should be emphasized that the recurrence of nephrotic syndrome was observed after the following chemotherapy, including DrugM - CSF , whereas the bone marrow still remained completely remitted.
Score Text
0.9824 Ceftriaxone was approved in 1997 for the treatment of otitis media despite previous studies that documented an association of ceftriaxone with elevated hepato - biliary enzymes and Adverse-Effecttransient biliary stasis .
0.9807 Ceftriaxone was approved in 1997 for the treatment of otitis media despite previous studies that documented an association of ceftriaxone with Adverse-Effectelevated hepato - biliary enzymes and transient biliary stasis.
0.9580 Ceftriaxone was approved in 1997 for the treatment of otitis media despite previous studies that documented an association of Drugceftriaxone with elevated hepato - biliary enzymes and transient biliary stasis.
0.6878 DrugCeftriaxone was approved in 1997 for the treatment of otitis media despite previous studies that documented an association of ceftriaxone with elevated hepato - biliary enzymes and transient biliary stasis.
Score Text
0.9992 We report a case of a women in whom a malignant mixed mesodermal tumor was diagnosed while she was taking Drugraloxifene , which is also a selective estrogen receptor modulator.
0.9818 We report a case of a women in whom a Adverse-Effectmalignant mixed mesodermal tumor was diagnosed while she was taking raloxifene, which is also a selective estrogen receptor modulator.
Score Text
0.9986 CONCLUSIONS : The risk of drug - induced rhabdomyolysis due to the potential interaction between lovastatin and Drugazithromycin or clarithromycin should be considered before the concomitant use of these agents.
0.9986 CONCLUSIONS : The risk of drug - induced rhabdomyolysis due to the potential interaction between lovastatin and azithromycin or Drugclarithromycin should be considered before the concomitant use of these agents.
0.9985 CONCLUSIONS : The risk of drug - induced rhabdomyolysis due to the potential interaction between Druglovastatin and azithromycin or clarithromycin should be considered before the concomitant use of these agents.
0.9980 CONCLUSIONS : The risk of drug - induced Adverse-Effectrhabdomyolysis due to the potential interaction between lovastatin and azithromycin or clarithromycin should be considered before the concomitant use of these agents.
Score Text
0.9820 Four days after the initial injection of 3. 6 mg of Druggoserelin acetate , severe dyspnea developed due to worsening pleuritis carcinomatosa, which was considered as a flare - up.
0.9780 Four days after the initial injection of 3. 6 mg of goserelin acetate, severe dyspnea developed due to Adverse-Effectworsening pleuritis carcinomatosa , which was considered as a flare - up.
0.9712 Four days after the initial injection of 3. 6 mg of goserelin acetate, Adverse-Effectsevere dyspnea developed due to worsening pleuritis carcinomatosa, which was considered as a flare - up.
0.9286 Four days after the initial injection of 3. 6 mg of goserelin acetate, severe dyspnea developed due to worsening pleuritis carcinomatosa, which was considered as a Adverse-Effectflare - up .
Score Text
0.9934 A 43 - year - old woman with multiple sclerosis ( MS ) had Adverse-Effectnephrotic syndrome 21 months after starting treatment with interferon ( IFN ) - beta - 1b ( subcutaneous administration ).
0.8030 A 43 - year - old woman with multiple sclerosis ( MS ) had nephrotic syndrome 21 months after starting treatment with Druginterferon ( IFN ) - beta - 1b ( subcutaneous administration ).
Score Text
0.9963 BACKGROUND : Interferon ( IFN ) - associated Adverse-Effectretinopathy is typically characterized by retinal hemorrhages and cotton wool spots at the posterior fundus, but visual function is usually maintained.
0.9949 BACKGROUND : DrugInterferon ( IFN ) - associated retinopathy is typically characterized by retinal hemorrhages and cotton wool spots at the posterior fundus, but visual function is usually maintained.
0.9936 BACKGROUND : Interferon ( DrugIFN ) - associated retinopathy is typically characterized by retinal hemorrhages and cotton wool spots at the posterior fundus, but visual function is usually maintained.
0.9920 BACKGROUND : Interferon ( IFN ) - associated retinopathy is typically characterized by Adverse-Effectretinal hemorrhages and cotton wool spots at the posterior fundus, but visual function is usually maintained.
0.9893 BACKGROUND : Interferon ( IFN ) - associated retinopathy is typically characterized by retinal hemorrhages and Adverse-Effectcotton wool spots at the posterior fundus, but visual function is usually maintained.
Score Text
0.9995 Four months after receiving an orthotopic liver transplant, a 51 - year - old man was admitted for progressive liver failure and severe hepatocellular necrosis thought to be due to Drugtacrolimus .
0.9819 Four months after receiving an orthotopic liver transplant, a 51 - year - old man was admitted for progressive liver failure and Adverse-Effectsevere hepatocellular necrosis thought to be due to tacrolimus.
0.9799 Four months after receiving an orthotopic liver transplant, a 51 - year - old man was admitted for Adverse-Effectprogressive liver failure and severe hepatocellular necrosis thought to be due to tacrolimus.
Score Text
0.9980 We present a case of a 20 - year - old woman who ingested 900 mg of Drugglyburide causing refractory hypoglycemia resistant to treatment with intravenous dextrose, glucagon, and diazoxide.
0.5399 We present a case of a 20 - year - old woman who ingested 900 mg of glyburide causing refractory Adverse-Effecthypoglycemia resistant to treatment with intravenous dextrose, glucagon, and diazoxide.
Score Text
0.9990 A 25 - year - old man with a history of mid - borderline ( BB ) Hansen's disease developing a reversal reaction after starting Drugdapsone and rifampin therapy is presented.
0.9990 A 25 - year - old man with a history of mid - borderline ( BB ) Hansen's disease developing a reversal reaction after starting dapsone and Drugrifampin therapy is presented.
0.9922 A 25 - year - old man with a history of mid - borderline ( BB ) Hansen's disease developing a Adverse-Effectreversal reaction after starting dapsone and rifampin therapy is presented.
Score Text
0.9992 One of these was Drugclofazimine , an aniline aposafranine derivative known to produce a ceroid - like pigment in the tissues of patients treated with this drug or lepromatous leprosy.
0.9862 One of these was clofazimine, an aniline aposafranine derivative known to produce a Adverse-Effectceroid - like pigment in the tissues of patients treated with this drug or lepromatous leprosy.
Score Text
0.9911 It was restarted 6 weeks later, and 10 weeks after that, the patient presented with Adverse-Effectfulminant hepatic failure , which resolved rapidly after cessation of nicotinic acid therapy.
0.9821 It was restarted 6 weeks later, and 10 weeks after that, the patient presented with fulminant hepatic failure, which resolved rapidly after cessation of Drugnicotinic acid therapy.
Score Text
0.9993 We report a case of an infant with complex congenital heart disease who was placed on Drugcaptopril for afterload reduction following cardiac surgery and subsequently developed pulmonary infiltrates with eosinophilia.
0.9663 We report a case of an infant with complex congenital heart disease who was placed on captopril for afterload reduction following cardiac surgery and subsequently developed Adverse-Effectpulmonary infiltrates with eosinophilia .
Score Text
0.9893 We report a case of a child with neurodevelopmental delay with chronic constipation and a history of chronic Drugmineral oil ingestion presenting as asymptomatic exogenous lipoid pneumonia ( ELP ).
0.9643 We report a case of a child with neurodevelopmental delay with chronic constipation and a history of chronic mineral oil ingestion presenting as asymptomatic exogenous lipoid pneumonia ( Adverse-EffectELP ).
0.7882 We report a case of a child with neurodevelopmental delay with chronic constipation and a history of chronic mineral oil ingestion presenting as asymptomatic Adverse-Effectexogenous lipoid pneumonia ( ELP ).
0.9698 We report a case of a child with neurodevelopmental delay with chronic constipation and a history of chronic mineral oil ingestion presenting as Adverse-Effectasymptomatic exogenous lipoid pneumonia ( ELP ).
Score Text
0.9965 We report a case of a previously healthy, postmenopausal woman who developed anticonvulsant hypersensitivity syndrome while taking Bellamine S ( belladonna alkaloids ; Drugergotamine ; phenobarbital ) for hot flashes.
0.9960 We report a case of a previously healthy, postmenopausal woman who developed anticonvulsant hypersensitivity syndrome while taking Bellamine S ( belladonna alkaloids ; ergotamine ; Drugphenobarbital ) for hot flashes.
0.9920 We report a case of a previously healthy, postmenopausal woman who developed anticonvulsant hypersensitivity syndrome while taking DrugBellamine S ( belladonna alkaloids ; ergotamine ; phenobarbital ) for hot flashes.
0.9690 We report a case of a previously healthy, postmenopausal woman who developed anticonvulsant hypersensitivity syndrome while taking Bellamine S ( Drugbelladonna alkaloids ; ergotamine ; phenobarbital ) for hot flashes.
0.9592 We report a case of a previously healthy, postmenopausal woman who developed Adverse-Effectanticonvulsant hypersensitivity syndrome while taking Bellamine S ( belladonna alkaloids ; ergotamine ; phenobarbital ) for hot flashes.
0.5447 We report a case of a previously healthy, postmenopausal woman who developed anticonvulsant Adverse-Effecthypersensitivity syndrome while taking Bellamine S ( belladonna alkaloids ; ergotamine ; phenobarbital ) for hot flashes.
Score Text
0.9836 Adverse-EffectPortal vein thrombosis in a patient with severe haemophilia A and F V G1691A mutation during continuous infusion of F VIII after intramural jejunal bleeding - - successful thrombolysis under heparin therapy.
0.9348 Portal vein thrombosis in a patient with severe haemophilia A and F V G1691A mutation during continuous infusion of DrugF VIII after intramural jejunal bleeding - - successful thrombolysis under heparin therapy.
Score Text
0.9995 Oncologists supervising future clinical trials for lung cancer should be alert to the fact that Drugsorafenib can potentially induce serious interstitial lung disease, although this might depend on racial differences.
0.9715 Oncologists supervising future clinical trials for lung cancer should be alert to the fact that sorafenib can potentially induce serious Adverse-Effectinterstitial lung disease , although this might depend on racial differences.
Score Text
0.9986 Escape atrial complexes, which occurred following junctional premature complexes, failed to initiate tachycardia in the control state but tachycardia was always reinitiated by an identical escape sequence after Drugprocainamide .
0.9795 Escape atrial complexes, which occurred following junctional premature complexes, failed to initiate tachycardia in the control state but Adverse-Effecttachycardia was always reinitiated by an identical escape sequence after procainamide.
0.8849 Escape atrial complexes, which occurred following junctional premature complexes, failed to initiate Adverse-Effecttachycardia in the control state but tachycardia was always reinitiated by an identical escape sequence after procainamide.
Score Text
0.9862 Similar to reports in patients receiving gefitinib, those with pathologic findings of UIP on resected lung specimens or known pulmonary fibrosis may be at particular risk for Drugerlotinib pulmonary toxicity.
0.8683 Similar to reports in patients receiving gefitinib, those with pathologic findings of UIP on resected lung specimens or known pulmonary fibrosis may be at particular risk for erlotinib Adverse-Effectpulmonary toxicity .
0.7944 Similar to reports in patients receiving gefitinib, those with pathologic findings of UIP on resected lung specimens or known Adverse-Effectpulmonary fibrosis may be at particular risk for erlotinib pulmonary toxicity.
0.9414 Similar to reports in patients receiving Druggefitinib , those with pathologic findings of UIP on resected lung specimens or known pulmonary fibrosis may be at particular risk for erlotinib pulmonary toxicity.
Score Text
0.9990 We describe a patient who experienced chronic nausea and an episode of confusion while treated with a small, stable dose of oral Drugmorphine in the setting of mild renal insufficiency.
0.9926 We describe a patient who experienced chronic nausea and an episode of Adverse-Effectconfusion while treated with a small, stable dose of oral morphine in the setting of mild renal insufficiency.
0.9751 We describe a patient who experienced Adverse-Effectchronic nausea and an episode of confusion while treated with a small, stable dose of oral morphine in the setting of mild renal insufficiency.
0.5491 We describe a patient who experienced chronic Adverse-Effectnausea and an episode of confusion while treated with a small, stable dose of oral morphine in the setting of mild renal insufficiency.
Score Text
0.9992 A 22 - year - old drug - abuser injected Drugflunitrazepam tablets dissolved in tap water into her left femoral artery and presented with clinical signs of acute ischaemia of the left leg.
0.9692 A 22 - year - old drug - abuser injected flunitrazepam tablets dissolved in tap water into her left femoral artery and presented with clinical signs of Adverse-Effectacute ischaemia of the left leg .
Score Text
0.9992 We report four cases of hemodynamically significant pericardial effusion in patients with refractory lymphoma who were receiving Druggemcitabine , all of whom had a history of mediastinal radiation without subcarinal blocking.
0.9878 We report four cases of hemodynamically significant Adverse-Effectpericardial effusion in patients with refractory lymphoma who were receiving gemcitabine, all of whom had a history of mediastinal radiation without subcarinal blocking.
Score Text
0.9969 Adverse-EffectHyperammonemia has been described as a complication of valproic acid therapy but may often be overlooked as a cause of lethargy in the postictal patient who presents to the emergency department.
0.9964 Hyperammonemia has been described as a complication of valproic acid therapy but may often be overlooked as a cause of Adverse-Effectlethargy in the postictal patient who presents to the emergency department.
0.9867 Hyperammonemia has been described as a complication of Drugvalproic acid therapy but may often be overlooked as a cause of lethargy in the postictal patient who presents to the emergency department.
Score Text
0.9963 A 66 - year - old mand suffering from severe coronary heart disease took Drugdigoxin with suicidal intent an was treated for the ensuing complete atrioventricular block with digoxin - specific antibody fragments.
0.9755 A 66 - year - old mand suffering from severe coronary heart disease took digoxin with suicidal intent an was treated for the ensuing Adverse-Effectcomplete atrioventricular block with digoxin - specific antibody fragments.
Score Text
0.9993 We described a very atypical case of a high stage, high grade endometrial cancer associated with Drugtamoxifen in a 64 - year - old woman with a past history of breast cancer.
0.9572 We described a very atypical case of a high stage, high grade Adverse-Effectendometrial cancer associated with tamoxifen in a 64 - year - old woman with a past history of breast cancer.
Score Text
0.9964 We report the first case of an acute flare of eosinophilic cystitis in a 51 - year - old woman after bladder instillation with dimethyl sulfoxide ( DrugDMSO ) for presumed interstitial cystitis.
0.9908 We report the first case of an acute flare of Adverse-Effecteosinophilic cystitis in a 51 - year - old woman after bladder instillation with dimethyl sulfoxide ( DMSO ) for presumed interstitial cystitis.
0.9846 We report the first case of an acute flare of eosinophilic cystitis in a 51 - year - old woman after bladder instillation with Drugdimethyl sulfoxide ( DMSO ) for presumed interstitial cystitis.
Score Text
0.9956 We conclude that vincristine and actinomycin D were the cause of this rare from of Adverse-Effecthepatotoxicity and that chemotherapy for the underlying malignant disease could be given safely after clinical recovery.
0.9906 We conclude that Drugvincristine and actinomycin D were the cause of this rare from of hepatotoxicity and that chemotherapy for the underlying malignant disease could be given safely after clinical recovery.
0.9885 We conclude that vincristine and Drugactinomycin D were the cause of this rare from of hepatotoxicity and that chemotherapy for the underlying malignant disease could be given safely after clinical recovery.
Score Text
0.9804 Adverse-EffectTransient anuria following administration of angiotensin I - converting enzyme inhibitor ( SQ 14225 ) in a patient with renal artery stenosis of the solitary kidney successfully treated with renal autotransplantation.
0.9771 Transient anuria following administration of angiotensin I - converting enzyme inhibitor ( DrugSQ 14225 ) in a patient with renal artery stenosis of the solitary kidney successfully treated with renal autotransplantation.
Score Text
0.9990 DrugFlutamide withdrawal syndrome is characterized by a decrease in prostate - specific antigen ( PSA ) after flutamide withdrawal in a subset of patients with progressing metastatic carcinoma of the prostate.
0.9990 Flutamide withdrawal syndrome is characterized by a decrease in prostate - specific antigen ( PSA ) after Drugflutamide withdrawal in a subset of patients with progressing metastatic carcinoma of the prostate.
0.9792 Flutamide withdrawal syndrome is characterized by a Adverse-Effectdecrease in prostate - specific antigen ( PSA ) after flutamide withdrawal in a subset of patients with progressing metastatic carcinoma of the prostate.
0.6990 Flutamide Adverse-Effectwithdrawal syndrome is characterized by a decrease in prostate - specific antigen ( PSA ) after flutamide withdrawal in a subset of patients with progressing metastatic carcinoma of the prostate.
Adverse-EffectFlutamide withdrawal syndrome is characterized by a decrease in prostate - specific antigen ( PSA ) after flutamide withdrawal in a subset of patients with progressing metastatic carcinoma of the prostate.
Score Text
0.9990 All patients had taken Drugphenytoin for variable time periods ( range 16 - 80 days ; mean : 40 ) and were on the medication when the skin lesions first appeared.
0.9902 All patients had taken phenytoin for variable time periods ( range 16 - 80 days ; mean : 40 ) and were on the medication when the Adverse-Effectskin lesions first appeared.
Score Text
0.9996 On day 7 of Druglinezolid treatment, the patient developed severe pruritus, macular rash, facial edema, eosinophilia, marked increase in serum creatinine level, and mild hepatitis.
0.9948 On day 7 of linezolid treatment, the patient developed severe pruritus, macular rash, facial edema, Adverse-Effecteosinophilia , marked increase in serum creatinine level, and mild hepatitis.
0.9929 On day 7 of linezolid treatment, the patient developed Adverse-Effectsevere pruritus , macular rash, facial edema, eosinophilia, marked increase in serum creatinine level, and mild hepatitis.
0.9928 On day 7 of linezolid treatment, the patient developed severe pruritus, macular rash, facial edema, eosinophilia, marked increase in serum creatinine level, and Adverse-Effectmild hepatitis .
0.9923 On day 7 of linezolid treatment, the patient developed severe pruritus, Adverse-Effectmacular rash , facial edema, eosinophilia, marked increase in serum creatinine level, and mild hepatitis.
0.9920 On day 7 of linezolid treatment, the patient developed severe pruritus, macular rash, Adverse-Effectfacial edema , eosinophilia, marked increase in serum creatinine level, and mild hepatitis.
0.9796 On day 7 of linezolid treatment, the patient developed severe pruritus, macular rash, facial edema, eosinophilia, Adverse-Effectmarked increase in serum creatinine level , and mild hepatitis.
0.7861 On day 7 of linezolid treatment, the patient developed severe pruritus, macular rash, facial edema, eosinophilia, marked Adverse-Effectincrease in serum creatinine level , and mild hepatitis.
Score Text
0.9993 DrugGemcitabine is a known risk factor for hemolytic uremic syndrome ( HUS ), which can often have a rapidly fatal clinical course despite intervention with steroids, plasmapheresis and hemodialysis.
0.9865 Gemcitabine is a known risk factor for Adverse-Effecthemolytic uremic syndrome ( HUS ), which can often have a rapidly fatal clinical course despite intervention with steroids, plasmapheresis and hemodialysis.
0.9864 Gemcitabine is a known risk factor for hemolytic uremic syndrome ( Adverse-EffectHUS ), which can often have a rapidly fatal clinical course despite intervention with steroids, plasmapheresis and hemodialysis.
Score Text
0.9979 CASE : We report a case of a woman with severe human insulin - induced Adverse-Effectlipoatrophy who has been treated exclusively with recombinant DNA human insulin since the onset of IDDM.
0.9834 CASE : We report a case of a woman with severe Drughuman insulin - induced lipoatrophy who has been treated exclusively with recombinant DNA human insulin since the onset of IDDM.
0.8819 CASE : We report a case of a woman with severe human insulin - induced lipoatrophy who has been treated exclusively with Drugrecombinant DNA human insulin since the onset of IDDM.
0.9853 CASE : We report a case of a woman with severe human insulin - induced lipoatrophy who has been treated exclusively with recombinant DNA human insulin since the onset of Adverse-EffectIDDM .
Score Text
0.9990 We report the first case of polymorphic ventricular tachycardia with normal QT interval associated with the oral use of Druglevofloxacin in the absence of other etiologies known to cause these arrhythmias.
0.9853 We report the first case of Adverse-Effectpolymorphic ventricular tachycardia with normal QT interval associated with the oral use of levofloxacin in the absence of other etiologies known to cause these arrhythmias.
Score Text
0.9993 In this case, it was suspected that a combination of cigarette smoking, pulmonary fibrosis, and low - dose Drugmethotrexate therapy might have promoted the development of lung cancer.
0.9949 In this case, it was suspected that a combination of cigarette smoking, pulmonary fibrosis, and low - dose methotrexate therapy might have promoted the development of Adverse-Effectlung cancer .
Score Text
0.9836 Based on our experience and on previously published data, serum ammonia levels appear to be indicated in all ED patients on valproic acid therapy who present with Adverse-Effectaltered mental status .
0.9812 Based on our experience and on previously published data, serum ammonia levels appear to be indicated in all ED patients on Drugvalproic acid therapy who present with altered mental status.
Score Text
0.9934 CONCLUSIONS : Optic neuritis in combination with other Adverse-Effectneurological signs , simulating multiple sclerosis, should be included in the list of adverse effects of recombinant and natural interferon alpha administration.
0.9933 CONCLUSIONS : Adverse-EffectOptic neuritis in combination with other neurological signs, simulating multiple sclerosis, should be included in the list of adverse effects of recombinant and natural interferon alpha administration.
0.9885 CONCLUSIONS : Optic neuritis in combination with other neurological signs, simulating multiple sclerosis, should be included in the list of adverse effects of recombinant and natural Druginterferon alpha administration.
0.5303 CONCLUSIONS : Optic neuritis in combination with other neurological signs, simulating Adverse-Effectmultiple sclerosis , should be included in the list of adverse effects of recombinant and natural interferon alpha administration.
Score Text
0.9994 In a patient suffering from rheumatoid arthritis, we report the first simultaneous occurrence of two side effects of low - dose Drugmethotrexate : an acute megaloblastic anaemia and a pneumonitis.
0.9985 In a patient suffering from rheumatoid arthritis, we report the first simultaneous occurrence of two side effects of low - dose methotrexate : an acute megaloblastic anaemia and a Adverse-Effectpneumonitis .
0.9906 In a patient suffering from rheumatoid arthritis, we report the first simultaneous occurrence of two side effects of low - dose methotrexate : an Adverse-Effectacute megaloblastic anaemia and a pneumonitis.
Score Text
0.9984 Here we report a patient with newly diagnosed acute promyelocytic leukemia who developed acute focal myositis, Adverse-Effectsynovitis , and possible vasculitis, after receiving all - trans retinoic acid therapy.
0.9913 Here we report a patient with newly diagnosed acute promyelocytic leukemia who developed acute focal myositis, synovitis, and Adverse-Effectpossible vasculitis , after receiving all - trans retinoic acid therapy.
0.9910 Here we report a patient with newly diagnosed acute promyelocytic leukemia who developed Adverse-Effectacute focal myositis , synovitis, and possible vasculitis, after receiving all - trans retinoic acid therapy.
0.9749 Here we report a patient with newly diagnosed acute promyelocytic leukemia who developed acute focal myositis, synovitis, and possible vasculitis, after receiving Drugall - trans retinoic acid therapy.
Score Text
0.9969 CASE REPORT : We report a case of intracerebral hemorrhage occurring in a middle - aged man who suffered from chronic sinusitis and had been ingesting Drugpseudoephedrine daily for one year.
0.9906 CASE REPORT : We report a case of Adverse-Effectintracerebral hemorrhage occurring in a middle - aged man who suffered from chronic sinusitis and had been ingesting pseudoephedrine daily for one year.
Score Text
0.9955 In addition, an immediate erythematous macule was observed on the photopatch test site of Drugmequitazine directly after UV exposure which was similar to the immediate erythema noted in chlorpromazine photoallergy.
0.9911 In addition, an immediate Adverse-Effecterythematous macule was observed on the photopatch test site of mequitazine directly after UV exposure which was similar to the immediate erythema noted in chlorpromazine photoallergy.
0.9686 In addition, an immediate erythematous macule was observed on the photopatch test site of mequitazine directly after UV exposure which was similar to the immediate Adverse-Effecterythema noted in chlorpromazine photoallergy.
In addition, an immediate erythematous macule was observed on the photopatch test site of mequitazine directly after UV exposure which was similar to the Adverse-Effectimmediate erythema noted in chlorpromazine photoallergy.
Score Text
0.9994 We present here a female patient who developed acute bilateral parotitis within minutes of i. v. Drugenalaprilat injection and recovered within 24 hours of stopping the drug and with symptomatic treatment.
0.9848 We present here a female patient who developed Adverse-Effectacute bilateral parotitis within minutes of i. v. enalaprilat injection and recovered within 24 hours of stopping the drug and with symptomatic treatment.
Score Text
0.9994 A patient with intracranial osteosarcoma that arose 16 years after radiation therapy for hereditary retinoblastoma developed fatal cerebral edema and brainstem herniation after she received a single dose of intravenous Drugmethotrexate .
0.9940 A patient with intracranial osteosarcoma that arose 16 years after radiation therapy for hereditary retinoblastoma developed fatal cerebral edema and Adverse-Effectbrainstem herniation after she received a single dose of intravenous methotrexate.
0.9931 A patient with intracranial osteosarcoma that arose 16 years after radiation therapy for hereditary retinoblastoma developed Adverse-Effectfatal cerebral edema and brainstem herniation after she received a single dose of intravenous methotrexate.
Score Text
0.9993 We report the case of a 20 - year - old female with polyarteritis nodosa ( PAN ) who developed bilateral sensorineural hearing loss 25 minutes after receiving 30 mg of intravenous Drugketoralac .
0.9898 We report the case of a 20 - year - old female with polyarteritis nodosa ( PAN ) who developed Adverse-Effectbilateral sensorineural hearing loss 25 minutes after receiving 30 mg of intravenous ketoralac.
Score Text
0.9974 CASE SUMMARIES : Two patients with stable hypothyroidism experienced symptoms of hypothyroidism with increased serum thyroid - stimulating hormone ( TSH ) concentrations after switching from 1 Druglevothyroxine product to another.
0.9820 CASE SUMMARIES : Two patients with stable hypothyroidism experienced symptoms of hypothyroidism with Adverse-Effectincreased serum thyroid - stimulating hormone ( TSH ) concentrations after switching from 1 levothyroxine product to another.
0.9917 CASE SUMMARIES : Two patients with stable hypothyroidism experienced symptoms of Adverse-Effecthypothyroidism with increased serum thyroid - stimulating hormone ( TSH ) concentrations after switching from 1 levothyroxine product to another.
0.9689 CASE SUMMARIES : Two patients with stable hypothyroidism experienced symptoms of hypothyroidism with increased serum thyroid - stimulating hormone ( Adverse-EffectTSH ) concentrations after switching from 1 levothyroxine product to another.
Score Text
0.9992 A search of the United States Food and Drug Administration's Adverse Event Reporting System identified nine cases of Drugoxcarbazepine - associated angioedema in pediatric patients aged 16 years and younger.
0.9977 A search of the United States Food and Drug Administration's Adverse Event Reporting System identified nine cases of oxcarbazepine - associated Adverse-Effectangioedema in pediatric patients aged 16 years and younger.
Score Text
0.9988 This fourth type of cutaneous Drugminocycline hyperpigmentation may be a variant of Type I, but based on clinical, pathological and microanalytical differences, appears to be a new entity.
0.9338 This fourth type of cutaneous minocycline Adverse-Effecthyperpigmentation may be a variant of Type I, but based on clinical, pathological and microanalytical differences, appears to be a new entity.
Score Text
0.9994 This report presents a case of acute lung injury developing within hours after administration of Drugmefloquine for a low - level Plasmodium falciparum malaria, which was persistent despite halofantrine therapy.
0.9878 This report presents a case of Adverse-Effectacute lung injury developing within hours after administration of mefloquine for a low - level Plasmodium falciparum malaria, which was persistent despite halofantrine therapy.
Score Text
0.9991 An evaluation of ovarian structure and function should be considered in women of reproductive age being treated with Drugvalproate for epilepsy, especially if they develop menstrual cycle disturbances during treatment.
0.9871 An evaluation of ovarian structure and function should be considered in women of reproductive age being treated with valproate for epilepsy, especially if they develop Adverse-Effectmenstrual cycle disturbances during treatment.
Score Text
0.9931 We speculate that platelet activation induced by pFVIII may have contributed to Adverse-Effectthrombosis and suggest that pFVIII be used with caution in elderly patients with pre - existing cardiovascular risk factors.
0.9759 We speculate that platelet activation induced by DrugpFVIII may have contributed to thrombosis and suggest that pFVIII be used with caution in elderly patients with pre - existing cardiovascular risk factors.
0.9420 We speculate that Adverse-Effectplatelet activation induced by pFVIII may have contributed to thrombosis and suggest that pFVIII be used with caution in elderly patients with pre - existing cardiovascular risk factors.
Score Text
0.9932 We strongly suspect that this Adverse-Effectlethal anuria was mainly due to ifosfamide, occurring in a patient having received previous cisplatin chemotherapy and with poor kidney perfusion due to transient hypotension.
0.9851 We strongly suspect that this lethal anuria was mainly due to Drugifosfamide , occurring in a patient having received previous cisplatin chemotherapy and with poor kidney perfusion due to transient hypotension.
0.8521 We strongly suspect that this lethal anuria was mainly due to ifosfamide, occurring in a patient having received previous Drugcisplatin chemotherapy and with poor kidney perfusion due to transient hypotension.
Score Text
0.9968 A study following large patient groups on theophylline and a combination of theophylline and steroids might clarify the risk of Adverse-Effectulcer formation in patients being treated with these medications for asthma.
0.9966 A study following large patient groups on Drugtheophylline and a combination of theophylline and steroids might clarify the risk of ulcer formation in patients being treated with these medications for asthma.
0.9954 A study following large patient groups on theophylline and a combination of Drugtheophylline and steroids might clarify the risk of ulcer formation in patients being treated with these medications for asthma.
Score Text
0.9988 CONCLUSION : The chronic use of DrugHCQ for rheumatic diseases, or as an anti - malarial drug, should be balanced against the risk of developing potentially lethal cardiac arrhythmias.
0.8899 CONCLUSION : The chronic use of HCQ for rheumatic diseases, or as an anti - malarial drug, should be balanced against the risk of developing potentially lethal Adverse-Effectcardiac arrhythmias .
0.9846 CONCLUSION : The chronic use of HCQ for rheumatic diseases, or as an anti - malarial drug, should be balanced against the risk of developing potentially Adverse-Effectlethal cardiac arrhythmias .
Score Text
0.9989 When the patient was treated again with Drugfludarabine nine months later, the DAT became positive with anti - IgG and anti - C3d antiglobulins after the second course of treatment.
0.8390 When the patient was treated again with fludarabine nine months later, the Adverse-EffectDAT became positive with anti - IgG and anti - C3d antiglobulins after the second course of treatment.
When the patient was treated again with fludarabine nine months later, the Adverse-EffectDAT became positive with anti - IgG and anti - C3d antiglobulins after the second course of treatment.
Score Text
0.9952 CASE SUMMARIES : While conducting a protocol evaluating the efficacy of intraperitoneal Drugcisplatin and hyperthermia in the treatment of recurrent ovarian cancer, 3 patients were noted to exhibit anaphylactoid reactions.
0.9944 CASE SUMMARIES : While conducting a protocol evaluating the efficacy of intraperitoneal cisplatin and hyperthermia in the treatment of recurrent ovarian cancer, 3 patients were noted to exhibit Adverse-Effectanaphylactoid reactions .
Score Text
0.9582 DrugRecombinant human interferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may exacerbate psoriasis or trigger off its onset.
0.6680 Recombinant human interferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Adverse-Effectexacerbate psoriasis or trigger off its onset .
0.9408 Recombinant human interferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Adverse-Effectexacerbate psoriasis or trigger off its onset.
0.6653 Recombinant human Druginterferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may exacerbate psoriasis or trigger off its onset.
0.6299 Recombinant Drughuman interferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may exacerbate psoriasis or trigger off its onset.
0.5541 Recombinant human interferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Adverse-Effectexacerbate psoriasis or trigger off its onset.
0.5372 Recombinant human interferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Adverse-Effectexacerbate psoriasis or trigger off its onset.
0.5354 Recombinant human interferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Adverse-Effectexacerbate psoriasis or trigger off its onset.
Score Text
0.9987 CONCLUSIONS : The value of multihormonal therapy in breast carcinoma is not established, and the addition of progestogens to Drugtamoxifen may not reduce of developing endometrial lesions, including carcinoma.
0.9980 CONCLUSIONS : The value of multihormonal therapy in breast carcinoma is not established, and the addition of progestogens to tamoxifen may not reduce of developing endometrial lesions, including Adverse-Effectcarcinoma .
0.9831 CONCLUSIONS : The value of multihormonal therapy in breast carcinoma is not established, and the addition of progestogens to tamoxifen may not reduce of developing Adverse-Effectendometrial lesions , including carcinoma.
Score Text
0.9953 CONCLUSIONS : This case describes the clinically significant increase of INR in an elderly patient after adding a chemotherapy regimen of levamisole and Drug5 - FU to a previous regimen of warfarin alone.
0.9941 CONCLUSIONS : This case describes the clinically significant increase of INR in an elderly patient after adding a chemotherapy regimen of Druglevamisole and 5 - FU to a previous regimen of warfarin alone.
0.9936 CONCLUSIONS : This case describes the clinically significant increase of INR in an elderly patient after adding a chemotherapy regimen of levamisole and 5 - FU to a previous regimen of Drugwarfarin alone.
0.9879 CONCLUSIONS : This case describes the clinically significant Adverse-Effectincrease of INR in an elderly patient after adding a chemotherapy regimen of levamisole and 5 - FU to a previous regimen of warfarin alone.
Score Text
0.9982 In addition, a 31 - year - old man with obsessive - compulsive disorder developed Adverse-EffectRBD soon after starting fluoxetine therapy, which persisted at PSG study 19 months after fluoxetine discontinuation.
0.9962 In addition, a 31 - year - old man with obsessive - compulsive disorder developed RBD soon after starting Drugfluoxetine therapy, which persisted at PSG study 19 months after fluoxetine discontinuation.
0.9952 In addition, a 31 - year - old man with obsessive - compulsive disorder developed RBD soon after starting fluoxetine therapy, which persisted at PSG study 19 months after Drugfluoxetine discontinuation.
Score Text
0.9976 Most cardiac surgical patients have had previous exposure to heparin for diagnostic or therapeutic interventions and hence have an increased susceptibility to developing heparin - induced Adverse-Effectthrombocytopenia ( HIT ) postoperatively.
0.9916 Most cardiac surgical patients have had previous exposure to heparin for diagnostic or therapeutic interventions and hence have an increased susceptibility to developing Drugheparin - induced thrombocytopenia ( HIT ) postoperatively.
0.9882 Most cardiac surgical patients have had previous exposure to Drugheparin for diagnostic or therapeutic interventions and hence have an increased susceptibility to developing heparin - induced thrombocytopenia ( HIT ) postoperatively.
0.8503 Most cardiac surgical patients have had previous exposure to heparin for diagnostic or therapeutic interventions and hence have an increased susceptibility to developing heparin - induced thrombocytopenia ( Adverse-EffectHIT ) postoperatively.
Score Text
0.9861 However, given the clinically significant result to the interaction between tolazoline and cimetidine we report, the use of cimetidine in tolazoline induced Adverse-Effectupper gastrointestinal hemorrhage should deserve more attention.
0.9545 However, given the clinically significant result to the interaction between tolazoline and Drugcimetidine we report, the use of cimetidine in tolazoline induced upper gastrointestinal hemorrhage should deserve more attention.
0.9466 However, given the clinically significant result to the interaction between Drugtolazoline and cimetidine we report, the use of cimetidine in tolazoline induced upper gastrointestinal hemorrhage should deserve more attention.
0.9460 However, given the clinically significant result to the interaction between tolazoline and cimetidine we report, the use of Drugcimetidine in tolazoline induced upper gastrointestinal hemorrhage should deserve more attention.
0.9430 However, given the clinically significant result to the interaction between tolazoline and cimetidine we report, the use of cimetidine in Drugtolazoline induced upper gastrointestinal hemorrhage should deserve more attention.
Score Text
0.9916 In this case report, we present clinical and laboratory findings of a case with chronic hepatitis B that developed Adverse-Effectacute dystonia soon after the first dose of pegylated interferon alpha.
0.9721 In this case report, we present clinical and laboratory findings of a case with chronic hepatitis B that developed acute dystonia soon after the first dose of Drugpegylated interferon alpha .
0.9156 In this case report, we present clinical and laboratory findings of a case with chronic Drughepatitis B that developed acute dystonia soon after the first dose of pegylated interferon alpha.
Score Text
0.9978 The induced hyperglycaemia could not be controlled sufficiently, despite a high dose of insulin ( > 110 units / day ), suggesting the existence of insulin insensitivity and Adverse-Effecthyperinsulinaemia .
0.9889 The induced hyperglycaemia could not be controlled sufficiently, despite a high dose of Druginsulin ( > 110 units / day ), suggesting the existence of insulin insensitivity and hyperinsulinaemia.
0.7782 The induced hyperglycaemia could not be controlled sufficiently, despite a high dose of insulin ( > 110 units / day ), suggesting the existence of Adverse-Effectinsulin insensitivity and hyperinsulinaemia.
0.9952 The induced Adverse-Effecthyperglycaemia could not be controlled sufficiently, despite a high dose of insulin ( > 110 units / day ), suggesting the existence of insulin insensitivity and hyperinsulinaemia.
Score Text
0.9992 Continuous EEG monitoring is helpful in managing seizures that occur as a complication of DrugCBZ OD, after the course of recovery or worsening, and in providing assistance with prognosis.
0.9971 Continuous EEG monitoring is helpful in managing Adverse-Effectseizures that occur as a complication of CBZ OD, after the course of recovery or worsening, and in providing assistance with prognosis.
Score Text
0.9943 A 57 - year - old woman with right bundle branch block + LPH and ventricular premature contractions developed complete heart block ( CHB ) following administration of disopyramide phosphate ( DrugNorpace ).
0.9934 A 57 - year - old woman with right bundle branch block + LPH and ventricular premature contractions developed complete heart block ( Adverse-EffectCHB ) following administration of disopyramide phosphate ( Norpace ).
0.9890 A 57 - year - old woman with right bundle branch block + LPH and ventricular premature contractions developed Adverse-Effectcomplete heart block ( CHB ) following administration of disopyramide phosphate ( Norpace ).
0.9789 A 57 - year - old woman with right bundle branch block + LPH and ventricular premature contractions developed complete heart block ( CHB ) following administration of Drugdisopyramide phosphate ( Norpace ).
Score Text
0.9980 Use of the Naranjo adverse drug reaction probability scale indicated a probable relationship ( score of 5 ) between the patient's development of Adverse-Effecthepatotoxicity and the TMP - SMX therapy.
0.9789 Use of the Naranjo adverse drug reaction probability scale indicated a probable relationship ( score of 5 ) between the patient's development of hepatotoxicity and the DrugTMP - SMX therapy.
Score Text
0.9996 A 40 - year - old man with relapsing - remitting multiple sclerosis ( MS ) developed primary central nervous system lymphoma ( PCNSL ) after having received 21 doses of Drugnatalizumab monotherapy.
0.9951 A 40 - year - old man with relapsing - remitting multiple sclerosis ( MS ) developed primary central nervous system lymphoma ( Adverse-EffectPCNSL ) after having received 21 doses of natalizumab monotherapy.
0.9865 A 40 - year - old man with relapsing - remitting multiple sclerosis ( MS ) developed Adverse-Effectprimary central nervous system lymphoma ( PCNSL ) after having received 21 doses of natalizumab monotherapy.
Score Text
0.9971 DrugWarfarin - associated bleeding generally is considered deleterious ; however, in our patient it unmasked an early stage of colon cancer and thus may have saved the patient's life.
0.9627 Warfarin - associated Adverse-Effectbleeding generally is considered deleterious ; however, in our patient it unmasked an early stage of colon cancer and thus may have saved the patient's life.
0.9891 Warfarin - associated bleeding generally is considered Adverse-Effectdeleterious ; however, in our patient it unmasked an early stage of colon cancer and thus may have saved the patient's life.
Score Text
0.9975 A 44 - year - old woman is described in whom amiodarone, Drugdisopyramide , and quinidine, administered alone separately, induced atypical ventricular tachycardia ( AVT, torsade de pointes ).
0.9974 A 44 - year - old woman is described in whom Drugamiodarone , disopyramide, and quinidine, administered alone separately, induced atypical ventricular tachycardia ( AVT, torsade de pointes ).
0.9972 A 44 - year - old woman is described in whom amiodarone, disopyramide, and Drugquinidine , administered alone separately, induced atypical ventricular tachycardia ( AVT, torsade de pointes ).
0.9941 A 44 - year - old woman is described in whom amiodarone, disopyramide, and quinidine, administered alone separately, induced atypical ventricular tachycardia ( Adverse-EffectAVT , torsade de pointes ).
0.9922 A 44 - year - old woman is described in whom amiodarone, disopyramide, and quinidine, administered alone separately, induced Adverse-Effectatypical ventricular tachycardia ( AVT, torsade de pointes ).
0.9908 A 44 - year - old woman is described in whom amiodarone, disopyramide, and quinidine, administered alone separately, induced atypical ventricular tachycardia ( AVT, Adverse-Effecttorsade de pointes ).
Score Text
0.9993 We report four cases of sensorimotor axonal neuropathy in children aged 10 - 15 years, treated with Drugthalidomide for myxopapillary ependymoma, Crohn's disease and recurrent giant aphthous ulceration.
0.9877 We report four cases of Adverse-Effectsensorimotor axonal neuropathy in children aged 10 - 15 years, treated with thalidomide for myxopapillary ependymoma, Crohn's disease and recurrent giant aphthous ulceration.
Score Text
0.9943 OBJECTIVE : To report a case of Adverse-Effectserotonin syndrome associated with interaction between fentanyl and citalopram, as evidenced by medication history, clinical features and reversal following discontinuation of fentanyl.
0.9896 OBJECTIVE : To report a case of serotonin syndrome associated with interaction between fentanyl and Drugcitalopram , as evidenced by medication history, clinical features and reversal following discontinuation of fentanyl.
0.9875 OBJECTIVE : To report a case of serotonin syndrome associated with interaction between Drugfentanyl and citalopram, as evidenced by medication history, clinical features and reversal following discontinuation of fentanyl.
0.9780 OBJECTIVE : To report a case of serotonin syndrome associated with interaction between fentanyl and citalopram, as evidenced by medication history, clinical features and reversal following discontinuation of Drugfentanyl .
Score Text
0.9933 We review the literature on previously reported cases of Adverse-Effectcutaneous necrosis after injection of standard interferon alfa or pegylated interferon alfa - 2b and discuss the different pathophysiologic mechanisms that might be involved.
0.9810 We review the literature on previously reported cases of cutaneous necrosis after injection of standard Druginterferon alfa or pegylated interferon alfa - 2b and discuss the different pathophysiologic mechanisms that might be involved.
0.9614 We review the literature on previously reported cases of cutaneous necrosis after injection of standard interferon alfa or Drugpegylated interferon alfa - 2b and discuss the different pathophysiologic mechanisms that might be involved.
Score Text
0.9923 We present a pediatric patient with leukemia and a severe, L - asparaginase - induced Adverse-Effectnecrotizing pancreatitis , treated successfully with percutaneous drainage used to flush the infected necrotic parts.
0.9800 We present a pediatric patient with leukemia and a severe, DrugL - asparaginase - induced necrotizing pancreatitis, treated successfully with percutaneous drainage used to flush the infected necrotic parts.
Score Text
0.9964 The authors postulate that two types of combined lithium - neuroleptic toxicity occur : a neuroleptic malignant extrapyramidal syndrome and a lithium toxicity that occurs in combination with phenothiazines, primarily Drugthioridazine .
0.9913 The authors postulate that two types of combined lithium - neuroleptic toxicity occur : a Adverse-Effectneuroleptic malignant extrapyramidal syndrome and a lithium toxicity that occurs in combination with phenothiazines, primarily thioridazine.
0.9829 The authors postulate that two types of combined lithium - neuroleptic toxicity occur : a neuroleptic malignant extrapyramidal syndrome and a Druglithium toxicity that occurs in combination with phenothiazines, primarily thioridazine.
0.6940 The authors postulate that two types of combined lithium - neuroleptic toxicity occur : a neuroleptic malignant extrapyramidal syndrome and a Adverse-Effectlithium toxicity that occurs in combination with phenothiazines, primarily thioridazine.
0.9964 The authors postulate that two types of combined lithium - neuroleptic toxicity occur : a neuroleptic malignant extrapyramidal syndrome and a lithium toxicity that occurs in combination with Drugphenothiazines , primarily thioridazine.
0.9789 The authors postulate that two types of combined Druglithium - neuroleptic toxicity occur : a neuroleptic malignant extrapyramidal syndrome and a lithium toxicity that occurs in combination with phenothiazines, primarily thioridazine.
Score Text
0.9911 The possibility can be raised that M - CSF accelerated the underlying renal disease in this case through enhancing macrophage accumulation into the glomerulus, leading to the development of Adverse-Effectnephrotic syndrome .
0.9756 The possibility can be raised that M - CSF accelerated the underlying Adverse-Effectrenal disease in this case through enhancing macrophage accumulation into the glomerulus, leading to the development of nephrotic syndrome.
0.9732 The possibility can be raised that DrugM - CSF accelerated the underlying renal disease in this case through enhancing macrophage accumulation into the glomerulus, leading to the development of nephrotic syndrome.
Score Text
0.9842 We report here on a heretofore undescribed respiratory syncytial virus ( RSV ) infection in a patient with a long - standing history of refractory CLL that was treated with Drugfludarabine phosphate .
0.9733 We report here on a heretofore undescribed Adverse-Effectrespiratory syncytial virus ( RSV ) infection in a patient with a long - standing history of refractory CLL that was treated with fludarabine phosphate.
Score Text
0.9995 We report a case of hyponatremia associated with a grand mal seizure in a 28 month - old child after intra - nasal Drugdesmopressin administration for high fluid intake with nocturnal enuresis.
0.9985 We report a case of Adverse-Effecthyponatremia associated with a grand mal seizure in a 28 month - old child after intra - nasal desmopressin administration for high fluid intake with nocturnal enuresis.
0.9855 We report a case of hyponatremia associated with a Adverse-Effectgrand mal seizure in a 28 month - old child after intra - nasal desmopressin administration for high fluid intake with nocturnal enuresis.
Score Text
0.9995 We report an additional case of Drugisotretinoin teratogenicity in which the patient had agenesis of the cerebellar vermis, multiple leptomeningeal neuroglial heterotopias, hydrocephalus, and abnormalities of the corticospinal tracts.
0.9888 We report an additional case of isotretinoin teratogenicity in which the patient had agenesis of the cerebellar vermis, multiple leptomeningeal neuroglial heterotopias, Adverse-Effecthydrocephalus , and abnormalities of the corticospinal tracts.
0.9731 We report an additional case of isotretinoin Adverse-Effectteratogenicity in which the patient had agenesis of the cerebellar vermis, multiple leptomeningeal neuroglial heterotopias, hydrocephalus, and abnormalities of the corticospinal tracts.
0.9681 We report an additional case of isotretinoin teratogenicity in which the patient had agenesis of the cerebellar vermis, Adverse-Effectmultiple leptomeningeal neuroglial heterotopias , hydrocephalus, and abnormalities of the corticospinal tracts.
0.9655 We report an additional case of isotretinoin teratogenicity in which the patient had agenesis of the cerebellar vermis, multiple leptomeningeal neuroglial heterotopias, hydrocephalus, and Adverse-Effectabnormalities of the corticospinal tracts .
0.9535 We report an additional case of isotretinoin teratogenicity in which the patient had Adverse-Effectagenesis of the cerebellar vermis , multiple leptomeningeal neuroglial heterotopias, hydrocephalus, and abnormalities of the corticospinal tracts.
Score Text
0.9985 However, continued low - dose DrugMTX led, in spite of normal liver tests, 8 years after the last biopsy to liver failure and death in 1 of our patients.
0.9909 However, continued low - dose MTX led, in spite of normal liver tests, 8 years after the last biopsy to liver failure and Adverse-Effectdeath in 1 of our patients.
0.9891 However, continued low - dose MTX led, in spite of normal liver tests, 8 years after the last biopsy to Adverse-Effectliver failure and death in 1 of our patients.
Score Text
0.9980 A 56 - year - old woman with scleroderma developed rapidly progressive glomerulonephritis with epithelial crescents associated with Adverse-Effecthemoptysis after 27 months of D - penicillamine therapy and a cumulative dose of 1, 200 g.
0.9849 A 56 - year - old woman with scleroderma developed rapidly progressive glomerulonephritis with Adverse-Effectepithelial crescents associated with hemoptysis after 27 months of D - penicillamine therapy and a cumulative dose of 1, 200 g.
0.9815 A 56 - year - old woman with scleroderma developed rapidly progressive glomerulonephritis with epithelial crescents associated with hemoptysis after 27 months of DrugD - penicillamine therapy and a cumulative dose of 1, 200 g.
0.9771 A 56 - year - old woman with scleroderma developed Adverse-Effectrapidly progressive glomerulonephritis with epithelial crescents associated with hemoptysis after 27 months of D - penicillamine therapy and a cumulative dose of 1, 200 g.
Score Text
0.9990 In a phase II study of Drughycanthone in patients with breast cancer we have recently observed severe hepatotoxicity, even at lower doses, which resulted in two drug - related deaths.
0.9840 In a phase II study of hycanthone in patients with breast cancer we have recently observed Adverse-Effectsevere hepatotoxicity , even at lower doses, which resulted in two drug - related deaths.
Score Text
0.9954 The development of systemic lupus erythematosus ( Adverse-EffectSLE ) after 38 months of therapy with recombinant human interferon gamma ( rIFN - gamma ) was observed in a patient with rheumatoid arthritis.
0.9859 The development of Adverse-Effectsystemic lupus erythematosus ( SLE ) after 38 months of therapy with recombinant human interferon gamma ( rIFN - gamma ) was observed in a patient with rheumatoid arthritis.
0.9705 The development of systemic lupus erythematosus ( SLE ) after 38 months of therapy with Drugrecombinant human interferon gamma ( rIFN - gamma ) was observed in a patient with rheumatoid arthritis.
0.9688 The development of systemic lupus erythematosus ( SLE ) after 38 months of therapy with recombinant human interferon gamma ( DrugrIFN - gamma ) was observed in a patient with rheumatoid arthritis.
Score Text
0.9986 We report 2 cases of maculopapular eruption and fever in patients infected with human immunodeficiency virus ( HIV ) on the 2nd day of first administration of Drugritonavir , a protease inhibitor.
0.9946 We report 2 cases of Adverse-Effectmaculopapular eruption and fever in patients infected with human immunodeficiency virus ( HIV ) on the 2nd day of first administration of ritonavir, a protease inhibitor.
0.9838 We report 2 cases of maculopapular eruption and Adverse-Effectfever in patients infected with human immunodeficiency virus ( HIV ) on the 2nd day of first administration of ritonavir, a protease inhibitor.
Score Text
0.9953 Even after a strict warning, he took another quinine tablet that evening, which triggered his fifth episode of severe thrombocytopenia, and confirmed the etiology of Drugquinine - induced thrombocytopenia.
0.9877 Even after a strict warning, he took another quinine tablet that evening, which triggered his fifth episode of severe thrombocytopenia, and confirmed the etiology of quinine - induced Adverse-Effectthrombocytopenia .
0.6847 Even after a strict warning, he took another quinine tablet that evening, which triggered his fifth episode of severe Adverse-Effectthrombocytopenia , and confirmed the etiology of quinine - induced thrombocytopenia.
0.8572 Even after a strict warning, he took another quinine tablet that evening, which triggered his fifth episode of Adverse-Effectsevere thrombocytopenia , and confirmed the etiology of quinine - induced thrombocytopenia.
Even after a strict warning, he took another Drugquinine tablet that evening, which triggered his fifth episode of severe thrombocytopenia, and confirmed the etiology of quinine - induced thrombocytopenia.
Score Text
0.9994 Six patients developed peripheral neuropathy and five patients bone marrow depression, blood transfusions were given to three patients and in all five patients bone marrow function normalized after cessation of Druglinezolid .
0.9895 Six patients developed Adverse-Effectperipheral neuropathy and five patients bone marrow depression, blood transfusions were given to three patients and in all five patients bone marrow function normalized after cessation of linezolid.
0.9588 Six patients developed peripheral neuropathy and five patients Adverse-Effectbone marrow depression , blood transfusions were given to three patients and in all five patients bone marrow function normalized after cessation of linezolid.
Score Text
0.9934 Herein is reported an unusual case of coexistent warfarin - induced skin necrosis and heparin - induced Adverse-Effectthrombocytopenia following mitral valve replacement for thromboembolic phenomena associated with marantic endocarditis and bronchial adenocarcinoma.
0.9478 Herein is reported an unusual case of coexistent warfarin - induced Adverse-Effectskin necrosis and heparin - induced thrombocytopenia following mitral valve replacement for thromboembolic phenomena associated with marantic endocarditis and bronchial adenocarcinoma.
0.9430 Herein is reported an unusual case of coexistent Drugwarfarin - induced skin necrosis and heparin - induced thrombocytopenia following mitral valve replacement for thromboembolic phenomena associated with marantic endocarditis and bronchial adenocarcinoma.
0.9001 Herein is reported an unusual case of coexistent warfarin - induced skin necrosis and Drugheparin - induced thrombocytopenia following mitral valve replacement for thromboembolic phenomena associated with marantic endocarditis and bronchial adenocarcinoma.
Score Text
0.9966 BACKGROUND : We describe the ophthalmic features and clinical course of two cases of acute syphilitic posterior placoid chorioretinitis ( ASPPC ) that developed after intravitreal triamcinolone acetonide ( DrugIVTA ) injection.
0.9950 BACKGROUND : We describe the ophthalmic features and clinical course of two cases of acute syphilitic posterior placoid chorioretinitis ( Adverse-EffectASPPC ) that developed after intravitreal triamcinolone acetonide ( IVTA ) injection.
0.9837 BACKGROUND : We describe the ophthalmic features and clinical course of two cases of Adverse-Effectacute syphilitic posterior placoid chorioretinitis ( ASPPC ) that developed after intravitreal triamcinolone acetonide ( IVTA ) injection.
0.9816 BACKGROUND : We describe the ophthalmic features and clinical course of two cases of acute syphilitic posterior placoid chorioretinitis ( ASPPC ) that developed after intravitreal Drugtriamcinolone acetonide ( IVTA ) injection.
Score Text
0.9986 We describe a case of intraoperative gelatine - induced Adverse-Effectanaphylaxis whose diagnosis was delayed as the use of gelatine during surgical procedures was omitted for two times in patient's medical records.
0.9838 We describe a case of intraoperative Druggelatine - induced anaphylaxis whose diagnosis was delayed as the use of gelatine during surgical procedures was omitted for two times in patient's medical records.
0.7594 We describe a case of intraoperative gelatine - induced anaphylaxis whose diagnosis was delayed as the use of Druggelatine during surgical procedures was omitted for two times in patient's medical records.
Score Text
0.9806 Here, we describe a case of Vogt - Koyanagi - Harada disease occurring 4 months after the start of Druginterferon alpha treatment, probably induced by the immunomodulatory effects of interferon.
0.9800 Here, we describe a case of Adverse-EffectVogt - Koyanagi - Harada disease occurring 4 months after the start of interferon alpha treatment, probably induced by the immunomodulatory effects of interferon.
0.6867 Here, we describe a case of Vogt - Koyanagi - Harada disease occurring 4 months after the start of interferon alpha treatment, probably induced by the immunomodulatory effects of Druginterferon .
Score Text
0.9987 Pheripheral edema was observed in five female patients after taking proton pump inhibitors omeprazole, Druglansoprazole , or pantoprazole for 7 - 15 days for peptic acid diseases in recommended standard doses.
0.9986 Pheripheral edema was observed in five female patients after taking proton pump inhibitors Drugomeprazole , lansoprazole, or pantoprazole for 7 - 15 days for peptic acid diseases in recommended standard doses.
0.9986 Pheripheral edema was observed in five female patients after taking proton pump inhibitors omeprazole, lansoprazole, or Drugpantoprazole for 7 - 15 days for peptic acid diseases in recommended standard doses.
0.9930 Adverse-EffectPheripheral edema was observed in five female patients after taking proton pump inhibitors omeprazole, lansoprazole, or pantoprazole for 7 - 15 days for peptic acid diseases in recommended standard doses.
Score Text
0.9996 We describe two patients in whom painful erosions of their psoriasis developed as the presenting sign of Drugmethotrexate toxicity and review the literature, emphasizing the risk factors associated with this manifestation.
0.9142 We describe two patients in whom Adverse-Effectpainful erosions of their psoriasis developed as the presenting sign of methotrexate toxicity and review the literature, emphasizing the risk factors associated with this manifestation.
0.7013 We describe two patients in whom painful erosions of their psoriasis developed as the presenting sign of Adverse-Effectmethotrexate toxicity and review the literature, emphasizing the risk factors associated with this manifestation.
0.5585 We describe two patients in whom painful Adverse-Effecterosions of their psoriasis developed as the presenting sign of methotrexate toxicity and review the literature, emphasizing the risk factors associated with this manifestation.
Score Text
0.9911 We recommend that a TMA in association with quinine be consistently referred to as quinine - associated Adverse-Effectthrombotic microangiopathy ( quinine - TMA ) to better distinguish this entity from idiopathic TTP.
0.9613 We recommend that a TMA in association with quinine be consistently referred to as Drugquinine - associated thrombotic microangiopathy ( quinine - TMA ) to better distinguish this entity from idiopathic TTP.
Score Text
0.9992 A 77 - year - old woman with no history of epilepsy presented a probable nonconvulsive status epilepticus while receiving continuous intravenous Drugmorphine for back pain relating to vertebral metastasis of a malignant lymphoma.
0.9870 A 77 - year - old woman with no history of epilepsy presented a probable Adverse-Effectnonconvulsive status epilepticus while receiving continuous intravenous morphine for back pain relating to vertebral metastasis of a malignant lymphoma.
Score Text
0.9990 We present a case of the syndrome of inappropriate antidiuretic hormone ( SIADH ) secondary to Drugcisplatin therapy in a patient with advanced - stage large cell neuroendocrine carcinoma of the cervix.
0.9967 We present a case of the syndrome of inappropriate antidiuretic hormone ( Adverse-EffectSIADH ) secondary to cisplatin therapy in a patient with advanced - stage large cell neuroendocrine carcinoma of the cervix.
0.9786 We present a case of the Adverse-Effectsyndrome of inappropriate antidiuretic hormone ( SIADH ) secondary to cisplatin therapy in a patient with advanced - stage large cell neuroendocrine carcinoma of the cervix.
Score Text
0.9992 Prenatal cytomegalovirus ( CMV ) infection associated with severe brain damage was detected in an infant whose mother had been treated with Drugprednisolone and azathioprine for systemic lupus erythematosus ( SLE ).
0.9992 Prenatal cytomegalovirus ( CMV ) infection associated with severe brain damage was detected in an infant whose mother had been treated with prednisolone and Drugazathioprine for systemic lupus erythematosus ( SLE ).
0.9539 Adverse-EffectPrenatal cytomegalovirus ( CMV ) infection associated with severe brain damage was detected in an infant whose mother had been treated with prednisolone and azathioprine for systemic lupus erythematosus ( SLE ).
0.7261 Prenatal cytomegalovirus ( CMV ) infection associated with severe Adverse-Effectbrain damage was detected in an infant whose mother had been treated with prednisolone and azathioprine for systemic lupus erythematosus ( SLE ).
0.9338 Prenatal cytomegalovirus ( CMV ) infection associated with Adverse-Effectsevere brain damage was detected in an infant whose mother had been treated with prednisolone and azathioprine for systemic lupus erythematosus ( SLE ).
Score Text
0.9984 We report a patient with chronic renal failure and ischemic heart disease who developed clinically significant methemoglobinemia after an axillary block with Drugbupivacaine and additional injection of lidocaine in the operative field.
0.9979 We report a patient with chronic renal failure and ischemic heart disease who developed clinically significant Adverse-Effectmethemoglobinemia after an axillary block with bupivacaine and additional injection of lidocaine in the operative field.
0.9977 We report a patient with chronic renal failure and ischemic heart disease who developed clinically significant methemoglobinemia after an axillary block with bupivacaine and additional injection of Druglidocaine in the operative field.
Score Text
0.9633 Review of this and previously reported cases indicates the need for early diagnosis of Drugamiodarone pneumonitis, immediate withdrawal of amiodarone, and prompt but continued steroid therapy to ensure full recovery.
0.9510 Review of this and previously reported cases indicates the need for early diagnosis of amiodarone Adverse-Effectpneumonitis , immediate withdrawal of amiodarone, and prompt but continued steroid therapy to ensure full recovery.
Score Text
0.9961 Two years later, 24 hours following an increase in the dose of disopyramide from 300 to 600 mg / day, AVT with Adverse-Effectsyncope occurred ; isoproterenol abolished the arrhythmia instantly.
0.9955 Two years later, 24 hours following an increase in the dose of Drugdisopyramide from 300 to 600 mg / day, AVT with syncope occurred ; isoproterenol abolished the arrhythmia instantly.
0.9908 Two years later, 24 hours following an increase in the dose of disopyramide from 300 to 600 mg / day, Adverse-EffectAVT with syncope occurred ; isoproterenol abolished the arrhythmia instantly.
Score Text
0.9858 A 74 - year - old patient with idiopathic Parkinson's disease was evaluated for Adverse-Effectunintended sleep episodes that occurred after long - term treatment with 400 mg / day of L - dopa.
0.9734 A 74 - year - old patient with idiopathic Parkinson's disease was evaluated for unintended sleep episodes that occurred after long - term treatment with 400 mg / day of DrugL - dopa .
Score Text
0.9986 Prior to surgery, Druglevodopa induced dyskinesia had improved ( < or = 50 % ) under treatment with amantadine ( 400 mg / day, po ) in all three patients.
0.9985 Prior to surgery, levodopa induced Adverse-Effectdyskinesia had improved ( < or = 50 % ) under treatment with amantadine ( 400 mg / day, po ) in all three patients.
Score Text
0.9981 We report on a patient with acromegaly who developed severe drug - induced Adverse-Effecthepatitis during combined treatment with the long - acting somatostatin - analog octreotide and the GH receptor antagonist pegvisomant.
0.9957 We report on a patient with acromegaly who developed severe drug - induced hepatitis during combined treatment with the long - acting somatostatin - analog Drugoctreotide and the GH receptor antagonist pegvisomant.
0.9957 We report on a patient with acromegaly who developed severe drug - induced hepatitis during combined treatment with the long - acting somatostatin - analog octreotide and the GH receptor antagonist Drugpegvisomant .
Score Text
0.9995 CONCLUSIONS : DrugTopiramate may be associated with ciliochoroidal effusion with forward displacement of the lens - iris diaphragm and anterior chamber shallowing, resulting in acute myopia and angle - closure glaucoma.
0.9925 CONCLUSIONS : Topiramate may be associated with ciliochoroidal effusion with forward displacement of the lens - iris diaphragm and anterior chamber shallowing, resulting in Adverse-Effectacute myopia and angle - closure glaucoma.
0.9817 CONCLUSIONS : Topiramate may be associated with ciliochoroidal effusion with forward displacement of the lens - iris diaphragm and anterior chamber shallowing, resulting in acute myopia and Adverse-Effectangle - closure glaucoma .
0.9489 CONCLUSIONS : Topiramate may be associated with ciliochoroidal effusion with forward Adverse-Effectdisplacement of the lens - iris diaphragm and anterior chamber shallowing, resulting in acute myopia and angle - closure glaucoma.
0.8171 CONCLUSIONS : Topiramate may be associated with ciliochoroidal effusion with forward displacement of the lens - iris diaphragm and Adverse-Effectanterior chamber shallowing , resulting in acute myopia and angle - closure glaucoma.
0.5967 CONCLUSIONS : Topiramate may be associated with Adverse-Effectciliochoroidal effusion with forward displacement of the lens - iris diaphragm and anterior chamber shallowing, resulting in acute myopia and angle - closure glaucoma.
Score Text
0.9994 A case of high - grade endometrial stromal sarcoma, confined into an intrauterine polypoid growth, in a woman with a history of breast cancer who was treated with adjuvant Drugtamoxifen .
0.9696 A case of Adverse-Effecthigh - grade endometrial stromal sarcoma , confined into an intrauterine polypoid growth, in a woman with a history of breast cancer who was treated with adjuvant tamoxifen.
0.9365 A case of high - grade endometrial stromal sarcoma, confined into an Adverse-Effectintrauterine polypoid growth , in a woman with a history of breast cancer who was treated with adjuvant tamoxifen.
Score Text
0.9993 Because of serious side effects of an increase in the QT interval causing torsades de pointes, Drugdofetilide must be initiated with close monitoring of the QT interval in an inpatient setting.
0.9839 Because of serious side effects of an increase in the QT interval causing Adverse-Effecttorsades de pointes , dofetilide must be initiated with close monitoring of the QT interval in an inpatient setting.
0.9439 Because of serious side effects of an Adverse-Effectincrease in the QT interval causing torsades de pointes, dofetilide must be initiated with close monitoring of the QT interval in an inpatient setting.
Score Text
0.9997 The typical Drugfluoxetine - induced symptoms of restlessness, constant pacing, purposeless movements of the feet and legs, and marked anxiety were indistinguishable from those of neuroleptic - induced akathisia.
0.9959 The typical fluoxetine - induced symptoms of Adverse-Effectrestlessness , constant pacing, purposeless movements of the feet and legs, and marked anxiety were indistinguishable from those of neuroleptic - induced akathisia.
0.9941 The typical fluoxetine - induced symptoms of restlessness, Adverse-Effectconstant pacing , purposeless movements of the feet and legs, and marked anxiety were indistinguishable from those of neuroleptic - induced akathisia.
0.9929 The typical fluoxetine - induced symptoms of restlessness, constant pacing, purposeless movements of the feet and legs, and Adverse-Effectmarked anxiety were indistinguishable from those of neuroleptic - induced akathisia.
0.9809 The typical fluoxetine - induced symptoms of restlessness, constant pacing, Adverse-Effectpurposeless movements of the feet and legs , and marked anxiety were indistinguishable from those of neuroleptic - induced akathisia.
0.7438 The typical fluoxetine - induced symptoms of restlessness, constant pacing, purposeless movements of the feet and legs, and marked anxiety were indistinguishable from those of neuroleptic - induced Adverse-Effectakathisia .
Score Text
0.9996 OBJECTIVE : To report a case of Drugphenolphthalein - induced toxic epidermal necrolysis ( TEN ) in a patient maintained on several other medications more commonly known to be associated with TEN.
0.9948 OBJECTIVE : To report a case of phenolphthalein - induced toxic epidermal necrolysis ( Adverse-EffectTEN ) in a patient maintained on several other medications more commonly known to be associated with TEN.
0.9934 OBJECTIVE : To report a case of phenolphthalein - induced toxic epidermal necrolysis ( TEN ) in a patient maintained on several other medications more commonly known to be associated with Adverse-EffectTEN .
0.9872 OBJECTIVE : To report a case of phenolphthalein - induced Adverse-Effecttoxic epidermal necrolysis ( TEN ) in a patient maintained on several other medications more commonly known to be associated with TEN.
Score Text
0.9966 After Druginfliximab treatment, additional sleep studies revealed an increase in the number of apneic events and SaO2 dips suggesting that TNFalpha plays an important role in the pathophysiology of sleep apnea.
0.9904 After infliximab treatment, additional sleep studies revealed an increase in the number of apneic events and Adverse-EffectSaO2 dips suggesting that TNFalpha plays an important role in the pathophysiology of sleep apnea.
0.9787 After infliximab treatment, additional sleep studies revealed an Adverse-Effectincrease in the number of apneic events and SaO2 dips suggesting that TNFalpha plays an important role in the pathophysiology of sleep apnea.
Score Text
0.9994 OBJECTIVE : We report a patient who developed neutropenia on Drugclozapine , but behind the cell count decrease showed to be a diurnal variation of the white blood cells ( WBC ).
0.9768 OBJECTIVE : We report a patient who developed neutropenia on clozapine, but behind the cell count decrease showed to be a Adverse-Effectdiurnal variation of the white blood cells ( WBC ).
Score Text
0.9988 An infant girl with choanal atresia, athelia, minor anomalies, and mild to moderate mental retardation was born to a woman treated for hyperthyroidism throughout pregnancy with methimazole and Drugpropranolol .
0.9987 An infant girl with choanal atresia, athelia, minor anomalies, and mild to moderate mental retardation was born to a woman treated for hyperthyroidism throughout pregnancy with Drugmethimazole and propranolol.
0.9897 An infant girl with choanal atresia, Adverse-Effectathelia , minor anomalies, and mild to moderate mental retardation was born to a woman treated for hyperthyroidism throughout pregnancy with methimazole and propranolol.
0.9710 An infant girl with Adverse-Effectchoanal atresia , athelia, minor anomalies, and mild to moderate mental retardation was born to a woman treated for hyperthyroidism throughout pregnancy with methimazole and propranolol.
An infant girl with choanal atresia, athelia, minor anomalies, and mild to moderate Adverse-Effectmental retardation was born to a woman treated for hyperthyroidism throughout pregnancy with methimazole and propranolol.
Score Text
0.9927 Acute Drugnitrite toxicity results from industrial exposure, accidental ingestion ( e. g., abuse of organic nitrites as an aphrodisiac, especially in the male homosexual population ), and suicidal ingestion.
0.7057 Acute Adverse-Effectnitrite toxicity results from industrial exposure, accidental ingestion ( e. g., abuse of organic nitrites as an aphrodisiac, especially in the male homosexual population ), and suicidal ingestion.
Score Text
0.9995 Severe rash, including the Stevens - Johnson syndrome ( SJS ), is the major toxicity of Drugnevirapine and is described in the package labeling with a prominent, boxed warning.
0.9896 Adverse-EffectSevere rash , including the Stevens - Johnson syndrome ( SJS ), is the major toxicity of nevirapine and is described in the package labeling with a prominent, boxed warning.
0.9818 Severe rash, including the Stevens - Johnson syndrome ( Adverse-EffectSJS ), is the major toxicity of nevirapine and is described in the package labeling with a prominent, boxed warning.
0.9789 Severe rash, including the Adverse-EffectStevens - Johnson syndrome ( SJS ), is the major toxicity of nevirapine and is described in the package labeling with a prominent, boxed warning.
Score Text
0.9971 Presented is a case story of a woman with classical rheumatoid arthritis, who during introduction of Drugsulphasalazine ( SASP ) therapy developed a severe and lasting psoriasis - like skin reaction.
0.9923 Presented is a case story of a woman with classical rheumatoid arthritis, who during introduction of sulphasalazine ( DrugSASP ) therapy developed a severe and lasting psoriasis - like skin reaction.
0.9744 Presented is a case story of a woman with classical rheumatoid arthritis, who during introduction of sulphasalazine ( SASP ) therapy developed a severe and lasting Adverse-Effectpsoriasis - like skin reaction .
Score Text
0.9803 A case is reported in which severe hypocalcemia, with a low plasma parathyroid hormone ( PTH ) concentration, resulted from the therapeutic use of Drugmagnesium sulfate for toxemia of pregnancy.
0.9782 A case is reported in which severe hypocalcemia, with a Adverse-Effectlow plasma parathyroid hormone ( PTH ) concentration, resulted from the therapeutic use of magnesium sulfate for toxemia of pregnancy.
0.9750 A case is reported in which severe hypocalcemia, with a low plasma parathyroid hormone ( Adverse-EffectPTH ) concentration, resulted from the therapeutic use of magnesium sulfate for toxemia of pregnancy.
0.9620 A case is reported in which Adverse-Effectsevere hypocalcemia , with a low plasma parathyroid hormone ( PTH ) concentration, resulted from the therapeutic use of magnesium sulfate for toxemia of pregnancy.
Score Text
0.9819 The electrocardiogram ( ECG ), which was read as normal prior to ritodrine infusion, demonstrated a Adverse-Effecttype I second - degree AV block which disappeared upon discontinuation of ritodrine therapy.
0.9733 The electrocardiogram ( ECG ), which was read as normal prior to Drugritodrine infusion, demonstrated a type I second - degree AV block which disappeared upon discontinuation of ritodrine therapy.
0.9537 The electrocardiogram ( ECG ), which was read as normal prior to ritodrine infusion, demonstrated a type I second - degree AV block which disappeared upon discontinuation of Drugritodrine therapy.
Score Text
0.9947 A case is reported of an elderly woman who developed febrile agranulocytosis several weeks after commencing Drugticlopidine but who had a favorable outcome after cessation of that drug and treatment with filgastrim.
0.9901 A case is reported of an elderly woman who developed Adverse-Effectfebrile agranulocytosis several weeks after commencing ticlopidine but who had a favorable outcome after cessation of that drug and treatment with filgastrim.
Score Text
0.9993 METHODS : Two patients with exudative age - related macular degeneration were treated sequentially with an intravitreal injection of Drugbevacizumab and developed signs of severe but painless infectious endophthalmitis 2 days later.
0.7485 METHODS : Two patients with exudative age - related macular degeneration were treated sequentially with an intravitreal injection of bevacizumab and developed signs of severe but Adverse-Effectpainless infectious endophthalmitis 2 days later.
0.9840 METHODS : Two patients with exudative age - related Adverse-Effectmacular degeneration were treated sequentially with an intravitreal injection of bevacizumab and developed signs of severe but painless infectious endophthalmitis 2 days later.
METHODS : Two patients with exudative Adverse-Effectage - related macular degeneration were treated sequentially with an intravitreal injection of bevacizumab and developed signs of severe but painless infectious endophthalmitis 2 days later.
Score Text
0.9789 3. Thus, the Adverse-Effectdecreased plasma cortisol level during alprazolam treatment of panic disorder was suggested to be caused not by symptom alleviation due to alprazolam but by alprazolam administration itself.
0.9456 3. Thus, the decreased plasma cortisol level during Drugalprazolam treatment of panic disorder was suggested to be caused not by symptom alleviation due to alprazolam but by alprazolam administration itself.
Score Text
0.9995 Although the t - AML developed following oral Drugetoposide therapy, the child had previously received high - dose, multiagent chemotherapy, and rearrangement of the MLL gene was not demonstrated.
0.9842 Although the Adverse-Effectt - AML developed following oral etoposide therapy, the child had previously received high - dose, multiagent chemotherapy, and rearrangement of the MLL gene was not demonstrated.
Score Text
0.9990 A 66 - year - old Japanese woman with severe scleroderma developed Adverse-Effectanemia and thrombocytopenia due to D - penicillamine ( D - Pen ) treatment, although the leukopenia was not markedly severe.
0.9956 A 66 - year - old Japanese woman with severe scleroderma developed anemia and Adverse-Effectthrombocytopenia due to D - penicillamine ( D - Pen ) treatment, although the leukopenia was not markedly severe.
0.9812 A 66 - year - old Japanese woman with severe scleroderma developed anemia and thrombocytopenia due to DrugD - penicillamine ( D - Pen ) treatment, although the leukopenia was not markedly severe.
0.9798 A 66 - year - old Japanese woman with severe scleroderma developed anemia and thrombocytopenia due to D - penicillamine ( DrugD - Pen ) treatment, although the leukopenia was not markedly severe.
Score Text
0.9980 While Drugdoxorubicin was administered, the patient presented thoracic pain and breathing distress due to superior vena cava perforation by the central catheter and subsequent extravasation of the drug into the mediastinum.
0.9945 While doxorubicin was administered, the patient presented Adverse-Effectthoracic pain and breathing distress due to superior vena cava perforation by the central catheter and subsequent extravasation of the drug into the mediastinum.
0.9888 While doxorubicin was administered, the patient presented thoracic pain and Adverse-Effectbreathing distress due to superior vena cava perforation by the central catheter and subsequent extravasation of the drug into the mediastinum.
Score Text
0.9995 A 67 - year - old patient, with primary polymyositis and without previous evidence of liver disease, developed clinical and biochemical features of severe cholestasis 3 months after initiation of Drugazathioprine therapy.
0.9870 A 67 - year - old patient, with primary polymyositis and without previous evidence of liver disease, developed clinical and biochemical features of Adverse-Effectsevere cholestasis 3 months after initiation of azathioprine therapy.
Score Text
0.9990 We describe a life threatening side effect of acute Drugepoprostenol infusion ( pulmonary edema ) in a patient with pulmonary hypertension associated with limited scleroderma and discuss its management and potential etiology.
0.9898 We describe a life threatening side effect of acute epoprostenol infusion ( Adverse-Effectpulmonary edema ) in a patient with pulmonary hypertension associated with limited scleroderma and discuss its management and potential etiology.
Score Text
0.9962 Six patients with no previous signs or symptoms suggestive of coronary artery disease developed acute coronary ischemia / Adverse-Effectinfarction shortly after cis - diamine - dichloroplatinum II ( cisplatin ) - based chemotherapy.
0.9948 Six patients with no previous signs or symptoms suggestive of coronary artery disease developed acute coronary ischemia / infarction shortly after cis - diamine - dichloroplatinum II ( Drugcisplatin ) - based chemotherapy.
0.9916 Six patients with no previous signs or symptoms suggestive of coronary artery disease developed Adverse-Effectacute coronary ischemia / infarction shortly after cis - diamine - dichloroplatinum II ( cisplatin ) - based chemotherapy.
0.9582 Six patients with no previous signs or symptoms suggestive of coronary artery disease developed acute coronary ischemia / infarction shortly after Drugcis - diamine - dichloroplatinum II ( cisplatin ) - based chemotherapy.
0.8872 Six patients with no previous signs or symptoms suggestive of coronary artery disease developed acute coronary ischemia / infarction shortly after Drugcis - diamine - dichloroplatinum II ( cisplatin ) - based chemotherapy.
Score Text
0.9989 In three of these patients the infection was clinically unsuspected ; in the fourth, cutaneous herpes zoster developed after administration of 300 mg of Drugcytarabine daily for the preceding five days.
0.9882 In three of these patients the infection was clinically unsuspected ; in the fourth, Adverse-Effectcutaneous herpes zoster developed after administration of 300 mg of cytarabine daily for the preceding five days.
Score Text
0.9974 INTRODUCTION - The aim of this case report is to present a 15 - year follow - up of a patient with Drugphenytoin ( PHT ) intoxication with unilateral gingival hyperplasia ( GH ).
0.9944 INTRODUCTION - The aim of this case report is to present a 15 - year follow - up of a patient with phenytoin ( DrugPHT ) intoxication with unilateral gingival hyperplasia ( GH ).
0.9761 INTRODUCTION - The aim of this case report is to present a 15 - year follow - up of a patient with phenytoin ( PHT ) intoxication with Adverse-Effectunilateral gingival hyperplasia ( GH ).
Score Text
0.9995 Though physicians treating large populations of patients with HIV are well aware of this complication, only one other report of Drugnevirapine - associated SJS has been documented in the dermatology literature.
0.9977 Though physicians treating large populations of patients with HIV are well aware of this complication, only one other report of nevirapine - associated Adverse-EffectSJS has been documented in the dermatology literature.
Score Text
0.9861 Grade 3 hepatotoxicity ( AST and ALT > 5 to 20 upper limit normal ) or higher has been observed in as many as 1. 4 % of MS patients on DrugIFN beta .
0.9722 Adverse-EffectGrade 3 hepatotoxicity ( AST and ALT > 5 to 20 upper limit normal ) or higher has been observed in as many as 1. 4 % of MS patients on IFN beta.
Score Text
0.9994 OBJECTIVES : To describe the clinicopathologic features of 3 patients with CML who rapidly progressed from chronic phase to blast crisis while taking Drugimatinib and to perform a review of the literature.
0.9927 OBJECTIVES : To describe the clinicopathologic features of 3 patients with CML who rapidly progressed from chronic phase to Adverse-Effectblast crisis while taking imatinib and to perform a review of the literature.
Score Text
0.9930 The purpose of this review is to increase awareness among physicians and other health care professionals that Adverse-EffectDIC may be a rare but potentially severe complication of anti - D IGIV treatment.
0.9769 The purpose of this review is to increase awareness among physicians and other health care professionals that DIC may be a rare but potentially severe complication of Druganti - D IGIV treatment.
Score Text
0.9995 Our patient was a 72 - year - old man with advanced Parkinson's disease ( PD ) who received Druglevodopa and anti - cholinergic drugs and whose head had become almost completely bald.
0.9933 Our patient was a 72 - year - old man with advanced Parkinson's disease ( PD ) who received levodopa and anti - cholinergic drugs and whose head had become almost Adverse-Effectcompletely bald .
Score Text
0.9995 CONCLUSIONS : These results suggest that Drugclozapine may cause TD ; however, the prevalence is low and the severity is relatively mild, with no or mild self - reported discomfort.
0.9985 CONCLUSIONS : These results suggest that clozapine may cause TD ; however, the prevalence is low and the severity is relatively mild, with no or mild self - reported Adverse-Effectdiscomfort .
0.9892 CONCLUSIONS : These results suggest that clozapine may cause Adverse-EffectTD ; however, the prevalence is low and the severity is relatively mild, with no or mild self - reported discomfort.
Score Text
0.9969 CONCLUSIONS : The observation that Adverse-Effectneurotoxicity developed with a delay of 24 to 48 hours after acyclovir peak serum concentrations could explain the wide range of acyclovir levels reported in similar cases.
0.9940 CONCLUSIONS : The observation that neurotoxicity developed with a delay of 24 to 48 hours after Drugacyclovir peak serum concentrations could explain the wide range of acyclovir levels reported in similar cases.
0.9934 CONCLUSIONS : The observation that neurotoxicity developed with a delay of 24 to 48 hours after acyclovir peak serum concentrations could explain the wide range of Drugacyclovir levels reported in similar cases.
Score Text
0.9993 We highlight two instances of systemic allergic reaction, and discuss the potential side effects of local Drugaprotinin injections in the orthopaedic setting as well as the evidence base for its use.
0.9886 We highlight two instances of Adverse-Effectsystemic allergic reaction , and discuss the potential side effects of local aprotinin injections in the orthopaedic setting as well as the evidence base for its use.
Score Text
0.9987 Diarrhoea, T - CD4 + lymphopenia and bilateral patchy pulmonary infiltrates developed in a male 60 yrs of age, who was treated with Drugoxaliplatinum and 5 - fluorouracil for unresectable rectum carcinoma.
0.9984 Adverse-EffectDiarrhoea , T - CD4 + lymphopenia and bilateral patchy pulmonary infiltrates developed in a male 60 yrs of age, who was treated with oxaliplatinum and 5 - fluorouracil for unresectable rectum carcinoma.
0.9977 Diarrhoea, T - CD4 + lymphopenia and bilateral patchy pulmonary infiltrates developed in a male 60 yrs of age, who was treated with oxaliplatinum and Drug5 - fluorouracil for unresectable rectum carcinoma.
0.9817 Diarrhoea, T - CD4 + lymphopenia and Adverse-Effectbilateral patchy pulmonary infiltrates developed in a male 60 yrs of age, who was treated with oxaliplatinum and 5 - fluorouracil for unresectable rectum carcinoma.
0.9729 Diarrhoea, Adverse-EffectT - CD4 + lymphopenia and bilateral patchy pulmonary infiltrates developed in a male 60 yrs of age, who was treated with oxaliplatinum and 5 - fluorouracil for unresectable rectum carcinoma.
Score Text
0.9901 Several cases of Druglithium - induced Creutzfeldt - Jakob syndrome have been reported to date ; all of them were elderly patients and a half had " therapeutic " lithium serum levels.
0.9891 Several cases of lithium - induced Adverse-EffectCreutzfeldt - Jakob syndrome have been reported to date ; all of them were elderly patients and a half had " therapeutic " lithium serum levels.
0.9800 Several cases of lithium - induced Creutzfeldt - Jakob syndrome have been reported to date ; all of them were elderly patients and a half had " therapeutic " Druglithium serum levels.
Score Text
0.9994 We report a case of fulminant hepatic failure associated with Drugdidanosine and masquerading as a surgical abdomen and compare the clinical, biologic, histologic, and ultrastructural findings with reports described previously.
0.9862 We report a case of Adverse-Effectfulminant hepatic failure associated with didanosine and masquerading as a surgical abdomen and compare the clinical, biologic, histologic, and ultrastructural findings with reports described previously.
Score Text
0.9993 We report the case of a 43 - year - old man with ITP refractory to steroids and intravenous immunoglobulin who developed acute respiratory distress syndrome ( ARDS ) after a single infusion of Drugrituximab .
0.9941 We report the case of a 43 - year - old man with ITP refractory to steroids and intravenous immunoglobulin who developed acute respiratory distress syndrome ( Adverse-EffectARDS ) after a single infusion of rituximab.
0.9903 We report the case of a 43 - year - old man with ITP refractory to steroids and intravenous immunoglobulin who developed Adverse-Effectacute respiratory distress syndrome ( ARDS ) after a single infusion of rituximab.
Score Text
0.9993 We report an unusual case of simultaneous transitional cell carcinoma of the renal pelvis and distal ureter without transitional cell carcinoma of the bladder occurring after chronic Drugcyclophosphamide therapy for nonHodgkin's lymphoma.
0.9724 We report an unusual case of simultaneous transitional cell carcinoma of the renal pelvis and Adverse-Effectdistal ureter without transitional cell carcinoma of the bladder occurring after chronic cyclophosphamide therapy for nonHodgkin's lymphoma.
0.9704 We report an unusual case of simultaneous Adverse-Effecttransitional cell carcinoma of the renal pelvis and distal ureter without transitional cell carcinoma of the bladder occurring after chronic cyclophosphamide therapy for nonHodgkin's lymphoma.
Score Text
0.9995 One week after the initial - dose of Drugadalimumab ( 160 mg ), which was initiated due to an acute exacerbation of Crohn's disease, the patient developed a fulminant cardiomyopathy.
0.9925 One week after the initial - dose of adalimumab ( 160 mg ), which was initiated due to an acute exacerbation of Crohn's disease, the patient developed a Adverse-Effectfulminant cardiomyopathy .
Score Text
0.9961 Because there were no other obvious causes of renal failure in either patient, we propose that skeletal muscle ischemia developed during Drugvasopressin infusion, followed by release of myoglobin and renal damage.
0.9856 Because there were no other obvious causes of renal failure in either patient, we propose that Adverse-Effectskeletal muscle ischemia developed during vasopressin infusion, followed by release of myoglobin and renal damage.
0.8323 Because there were no other obvious causes of renal failure in either patient, we propose that skeletal muscle ischemia developed during vasopressin infusion, followed by release of myoglobin and Adverse-Effectrenal damage .
0.6772 Because there were no other obvious causes of Adverse-Effectrenal failure in either patient, we propose that skeletal muscle ischemia developed during vasopressin infusion, followed by release of myoglobin and renal damage.
0.5440 Because there were no other obvious causes of renal failure in either patient, we propose that skeletal muscle ischemia developed during vasopressin infusion, followed by release of Drugmyoglobin and renal damage.
Score Text
0.9992 The authors describe a case of valvular heart disease in a 48 - year - old woman receiving Drugbenfluorex ( 150 mg t. i. d. for 8 years ) and leading to surgical mitral valve replacement.
0.9897 The authors describe a case of Adverse-Effectvalvular heart disease in a 48 - year - old woman receiving benfluorex ( 150 mg t. i. d. for 8 years ) and leading to surgical mitral valve replacement.
Score Text
0.9996 CD20 - negative T - cell - rich B - cell lymphoma as a progression of a nodular lymphocyte - predominant Hodgkin's lymphoma treated with Drugrituximab : a molecular analysis using laser capture microdissection.
0.9352 Adverse-EffectCD20 - negative T - cell - rich B - cell lymphoma as a progression of a nodular lymphocyte - predominant Hodgkin's lymphoma treated with rituximab : a molecular analysis using laser capture microdissection.
Score Text
0.9991 A 65 - year - old man on Drugwarfarin therapy with a sudden spontaneous onset of sub - conjunctival haematoma associated with bloody tears was assessed in the clinic following a referral from an optometrist.
0.9917 A 65 - year - old man on warfarin therapy with a sudden spontaneous onset of sub - conjunctival haematoma associated with Adverse-Effectbloody tears was assessed in the clinic following a referral from an optometrist.
0.9752 A 65 - year - old man on warfarin therapy with a sudden spontaneous onset of Adverse-Effectsub - conjunctival haematoma associated with bloody tears was assessed in the clinic following a referral from an optometrist.
Score Text
0.9929 We describe the clinical response, as determined by increases in total Hb and decreased transfusion needs, in five patients with thalassemia intermedia treated with DrugHU alone or in combination with SPB.
0.9903 We describe the clinical response, as determined by increases in total Hb and decreased transfusion needs, in five patients with thalassemia intermedia treated with HU alone or in combination with DrugSPB .
0.9841 We describe the clinical response, as determined by Adverse-Effectincreases in total Hb and decreased transfusion needs, in five patients with thalassemia intermedia treated with HU alone or in combination with SPB.
0.5968 We describe the clinical response, as determined by increases in total Hb and Adverse-Effectdecreased transfusion needs , in five patients with thalassemia intermedia treated with HU alone or in combination with SPB.
Score Text
0.9996 We report a 31 - year - old women with recurrent Hodgkin's lymphoma and unrecognized HMSN - 1 who developed severe motor neuropathy 3 weeks after the first cycle of treatment including 2 mg of Drugvincristine .
0.9866 We report a 31 - year - old women with recurrent Hodgkin's lymphoma and unrecognized HMSN - 1 who developed Adverse-Effectsevere motor neuropathy 3 weeks after the first cycle of treatment including 2 mg of vincristine.
Score Text
0.9965 This paper reports an autopsy case of a 78 - year - old male with multiple nodules in the liver developed after long - termed administration of phosphate diethylstilbestrol ( DrugPDES ) for prostatic cancer.
0.9776 This paper reports an autopsy case of a 78 - year - old male with multiple nodules in the liver developed after long - termed administration of Drugphosphate diethylstilbestrol ( PDES ) for prostatic cancer.
0.9434 This paper reports an autopsy case of a 78 - year - old male with Adverse-Effectmultiple nodules in the liver developed after long - termed administration of phosphate diethylstilbestrol ( PDES ) for prostatic cancer.
Score Text
0.9997 In this report we described a case of juvenile idiopathic arthritis patient who developed thymic enlargement ( true thymic hyperplasia ), mediastinal lymphadenopathy and pleurisy associated with systemic symptoms under DrugEtanercept treatment.
0.9987 In this report we described a case of juvenile idiopathic arthritis patient who developed thymic enlargement ( true thymic hyperplasia ), mediastinal lymphadenopathy and Adverse-Effectpleurisy associated with systemic symptoms under Etanercept treatment.
0.9914 In this report we described a case of juvenile idiopathic arthritis patient who developed thymic enlargement ( true thymic hyperplasia ), Adverse-Effectmediastinal lymphadenopathy and pleurisy associated with systemic symptoms under Etanercept treatment.
0.9895 In this report we described a case of juvenile idiopathic arthritis patient who developed Adverse-Effectthymic enlargement ( true thymic hyperplasia ), mediastinal lymphadenopathy and pleurisy associated with systemic symptoms under Etanercept treatment.
0.9810 In this report we described a case of juvenile idiopathic arthritis patient who developed thymic enlargement ( true Adverse-Effectthymic hyperplasia ), mediastinal lymphadenopathy and pleurisy associated with systemic symptoms under Etanercept treatment.
Score Text
0.9981 However, the use of Druglithium should be avoided with any patient who is purging, since it may exacerbate the loss of intracellular potassium, thereby increasing the risk of cardiac toxicity.
0.9760 However, the use of lithium should be avoided with any patient who is purging, since it may exacerbate the loss of intracellular potassium, thereby increasing the risk of Adverse-Effectcardiac toxicity .
0.9744 However, the use of lithium should be avoided with any patient who is purging, since it may exacerbate the Adverse-Effectloss of intracellular potassium , thereby increasing the risk of cardiac toxicity.
Score Text
0.9969 CONCLUSIONS : This is the first report of a possible interaction between propafenone and citalopram, which caused propafenone adverse effects ( eg, Adverse-Effectdizziness , falls ) and mimicked coronary artery disease.
0.9924 CONCLUSIONS : This is the first report of a possible interaction between propafenone and Drugcitalopram , which caused propafenone adverse effects ( eg, dizziness, falls ) and mimicked coronary artery disease.
0.9870 CONCLUSIONS : This is the first report of a possible interaction between Drugpropafenone and citalopram, which caused propafenone adverse effects ( eg, dizziness, falls ) and mimicked coronary artery disease.
0.9715 CONCLUSIONS : This is the first report of a possible interaction between propafenone and citalopram, which caused propafenone adverse effects ( eg, dizziness, Adverse-Effectfalls ) and mimicked coronary artery disease.
0.9321 CONCLUSIONS : This is the first report of a possible interaction between propafenone and citalopram, which caused propafenone adverse effects ( eg, dizziness, falls ) and mimicked Adverse-Effectcoronary artery disease .
0.9903 CONCLUSIONS : This is the first report of a possible interaction between propafenone and citalopram, which caused propafenone adverse effects ( Adverse-Effecteg , dizziness, falls ) and mimicked coronary artery disease.
0.9842 CONCLUSIONS : This is the first report of a possible interaction between propafenone and citalopram, which caused Drugpropafenone adverse effects ( eg, dizziness, falls ) and mimicked coronary artery disease.
Score Text
0.9996 A 61 - year - old man developed clinical lupus syndrome with positive antinuclear antibody, positive lupus erythematosus ( LE ) cell preparation, and diffuse proliferative glomerulonephritis following 26 months of Drugprocainamide therapy.
0.9898 A 61 - year - old man developed Adverse-Effectclinical lupus syndrome with positive antinuclear antibody, positive lupus erythematosus ( LE ) cell preparation, and diffuse proliferative glomerulonephritis following 26 months of procainamide therapy.
0.9876 A 61 - year - old man developed clinical lupus syndrome with positive antinuclear antibody, positive lupus erythematosus ( LE ) cell preparation, and Adverse-Effectdiffuse proliferative glomerulonephritis following 26 months of procainamide therapy.
0.9848 A 61 - year - old man developed clinical lupus syndrome with positive antinuclear antibody, Adverse-Effectpositive lupus erythematosus ( LE ) cell preparation, and diffuse proliferative glomerulonephritis following 26 months of procainamide therapy.
0.9777 A 61 - year - old man developed clinical lupus syndrome with Adverse-Effectpositive antinuclear antibody , positive lupus erythematosus ( LE ) cell preparation, and diffuse proliferative glomerulonephritis following 26 months of procainamide therapy.
0.5631 A 61 - year - old man developed clinical lupus syndrome with positive antinuclear antibody, positive lupus erythematosus ( Adverse-EffectLE ) cell preparation , and diffuse proliferative glomerulonephritis following 26 months of procainamide therapy.
A 61 - year - old man developed clinical lupus syndrome with positive antinuclear antibody, positive Adverse-Effectlupus erythematosus ( LE ) cell preparation, and diffuse proliferative glomerulonephritis following 26 months of procainamide therapy.
Score Text
0.9997 This report describes a case of Drugflucytosine - associated ulcerating enteritis in which the small bowel x - ray demonstrated severe luminal narrowing, ulceration, and marked separation of loops of bowel.
0.9949 This report describes a case of flucytosine - associated ulcerating enteritis in which the small bowel x - ray demonstrated severe luminal narrowing, Adverse-Effectulceration , and marked separation of loops of bowel.
0.9912 This report describes a case of flucytosine - associated Adverse-Effectulcerating enteritis in which the small bowel x - ray demonstrated severe luminal narrowing, ulceration, and marked separation of loops of bowel.
0.9825 This report describes a case of flucytosine - associated ulcerating enteritis in which the small bowel x - ray demonstrated Adverse-Effectsevere luminal narrowing , ulceration, and marked separation of loops of bowel.
0.9651 This report describes a case of flucytosine - associated ulcerating enteritis in which the small bowel x - ray demonstrated severe luminal narrowing, ulceration, and Adverse-Effectmarked separation of loops of bowel .
Score Text
0.9994 The pro - arrhythmic effects of Drugprocainamide may be explained on the basis of both its vagolytic action on the atrioventricular node as well as by prolongation of refractoriness in the accessory pathway.
0.9656 The Adverse-Effectpro - arrhythmic effects of procainamide may be explained on the basis of both its vagolytic action on the atrioventricular node as well as by prolongation of refractoriness in the accessory pathway.
0.6640 The pro - arrhythmic effects of procainamide may be explained on the basis of both its vagolytic action on the atrioventricular node as well as by Adverse-Effectprolongation of refractoriness in the accessory pathway .
Score Text
0.9993 When Drugpilsicainide is prescribed in patients with coronary artery disease or renal dysfunction, close attention must be paid to avoid life - threatening arrhythmias due to high plasma concentrations of the drug.
0.9646 When pilsicainide is prescribed in patients with coronary artery disease or renal dysfunction, close attention must be paid to avoid Adverse-Effectlife - threatening arrhythmias due to high plasma concentrations of the drug.
Score Text
0.9961 Sodium valproate and Drugcarbamazepine , antiepileptic drugs that are associated with a relatively low rate of adverse cutaneous reactions, should be added to the growing list of drugs that produce psoriasiform eruptions.
0.9944 Sodium valproate and carbamazepine, antiepileptic drugs that are associated with a relatively low rate of adverse cutaneous reactions, should be added to the growing list of drugs that produce Adverse-Effectpsoriasiform eruptions .
0.9811 DrugSodium valproate and carbamazepine, antiepileptic drugs that are associated with a relatively low rate of adverse cutaneous reactions, should be added to the growing list of drugs that produce psoriasiform eruptions.
Score Text
0.9993 Fatal pulmonary fibrosis associated with DrugBCNU : the relative role of platelet - derived growth factor - B, insulin - like growth factor I, transforming growth factor - beta1 and cyclooxygenase - 2.
0.9870 Adverse-EffectFatal pulmonary fibrosis associated with BCNU : the relative role of platelet - derived growth factor - B, insulin - like growth factor I, transforming growth factor - beta1 and cyclooxygenase - 2.
Score Text
0.9976 We report the development of scrotal ulcer in a patient with acute promyleocytic leukemia ( APL ) within 10 days of treatment with DrugATRA at a dose of 40 mg orally twice daily.
0.9931 We report the development of Adverse-Effectscrotal ulcer in a patient with acute promyleocytic leukemia ( APL ) within 10 days of treatment with ATRA at a dose of 40 mg orally twice daily.
Score Text
0.9989 We report a patient with pulmonary adenocarcinoma complicated by the syndrome of inappropriate secretion of antidiuretic hormone ( SIADH ) following systemic chemotherapy with Drugcisplatin ( CDDP ) and vindesine ( VDS ).
0.9988 We report a patient with pulmonary adenocarcinoma complicated by the syndrome of inappropriate secretion of antidiuretic hormone ( SIADH ) following systemic chemotherapy with cisplatin ( CDDP ) and Drugvindesine ( VDS ).
0.9987 We report a patient with pulmonary adenocarcinoma complicated by the syndrome of inappropriate secretion of antidiuretic hormone ( SIADH ) following systemic chemotherapy with cisplatin ( CDDP ) and vindesine ( DrugVDS ).
0.9985 We report a patient with pulmonary adenocarcinoma complicated by the syndrome of inappropriate secretion of antidiuretic hormone ( SIADH ) following systemic chemotherapy with cisplatin ( DrugCDDP ) and vindesine ( VDS ).
0.9936 We report a patient with pulmonary adenocarcinoma complicated by the syndrome of inappropriate secretion of antidiuretic hormone ( Adverse-EffectSIADH ) following systemic chemotherapy with cisplatin ( CDDP ) and vindesine ( VDS ).
0.9500 We report a patient with pulmonary adenocarcinoma complicated by the Adverse-Effectsyndrome of inappropriate secretion of antidiuretic hormone ( SIADH ) following systemic chemotherapy with cisplatin ( CDDP ) and vindesine ( VDS ).
Score Text
0.9994 A 60 - year - old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on Drugmethazolamide ( Neptazane ) for an ophthalmologic problem.
0.9993 A 60 - year - old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide ( DrugNeptazane ) for an ophthalmologic problem.
0.9922 A 60 - year - old white man with chronic bronchitis was noted to develop acute respiratory failure and Adverse-Effectmetabolic acidosis four days after being started on methazolamide ( Neptazane ) for an ophthalmologic problem.
0.9914 A 60 - year - old white man with chronic bronchitis was noted to develop Adverse-Effectacute respiratory failure and metabolic acidosis four days after being started on methazolamide ( Neptazane ) for an ophthalmologic problem.
Score Text
0.9992 METHODS : A 76 - year - old woman with primary open - angle glaucoma and no history of ocular surgery developed a choroidal detachment 12 hours after initiation of therapy with Drugdorzolamide eye drops.
0.9952 METHODS : A 76 - year - old woman with primary open - angle glaucoma and no history of ocular surgery developed a Adverse-Effectchoroidal detachment 12 hours after initiation of therapy with dorzolamide eye drops.
Score Text
0.9938 This case report describes an adolescent with severe lupus erythematosus who received Drugcyclophosphamide ( CY ) paired with taste ( cod liver oil ) and smell ( rose perfume ) as conditioned stimuli.
0.9708 This case report describes an adolescent with severe lupus erythematosus who received cyclophosphamide ( DrugCY ) paired with taste ( cod liver oil ) and smell ( rose perfume ) as conditioned stimuli.
0.8589 This case report describes an adolescent with Adverse-Effectsevere lupus erythematosus who received cyclophosphamide ( CY ) paired with taste ( cod liver oil ) and smell ( rose perfume ) as conditioned stimuli.
0.6009 This case report describes an adolescent with severe Adverse-Effectlupus erythematosus who received cyclophosphamide ( CY ) paired with taste ( cod liver oil ) and smell ( rose perfume ) as conditioned stimuli.
Score Text
0.9978 Adverse-EffectARDS has been associated with the administration of other monoclonal antibodies, such as infliximab, gemtuzumab ozogamicin, and OKT3 and is believed to be directly mediated by release of proinflammatory cytokines.
0.9958 ARDS has been associated with the administration of other monoclonal antibodies, such as Druginfliximab , gemtuzumab ozogamicin, and OKT3 and is believed to be directly mediated by release of proinflammatory cytokines.
0.9906 ARDS has been associated with the administration of other monoclonal antibodies, such as infliximab, gemtuzumab ozogamicin, and DrugOKT3 and is believed to be directly mediated by release of proinflammatory cytokines.
0.9767 ARDS has been associated with the administration of other monoclonal antibodies, such as infliximab, Druggemtuzumab ozogamicin , and OKT3 and is believed to be directly mediated by release of proinflammatory cytokines.
Score Text
0.9995 Well - differentiated endometrial adenocarcinoma of the secretory type ( FIGO Grade 1 ) with minimal myometrial invasion occurred in a postmenopausal patient on Drugtamoxifen therapy 5 years after mastectomy for breast carcinoma.
0.9743 Well - differentiated Adverse-Effectendometrial adenocarcinoma of the secretory type ( FIGO Grade 1 ) with minimal myometrial invasion occurred in a postmenopausal patient on tamoxifen therapy 5 years after mastectomy for breast carcinoma.
Score Text
0.9810 A case of severe acute hepatitis caused by Drugcyproterone acetate in a 71 year old man with prostatic carcinoma is reported with a review of the literature on hepatic reactions to this drug.
0.9629 A case of Adverse-Effectsevere acute hepatitis caused by cyproterone acetate in a 71 year old man with prostatic carcinoma is reported with a review of the literature on hepatic reactions to this drug.
Score Text
0.9988 We report the case of an 11 - year - old female treated for mediastinal T - cell lymphoma who presented renal failure following the second cycle of high - dose Drugmethotrexate ( HDMTX ).
0.9982 We report the case of an 11 - year - old female treated for mediastinal T - cell lymphoma who presented renal failure following the second cycle of high - dose methotrexate ( DrugHDMTX ).
0.9925 We report the case of an 11 - year - old female treated for mediastinal T - cell lymphoma who presented Adverse-Effectrenal failure following the second cycle of high - dose methotrexate ( HDMTX ).
Score Text
0.9893 Since ethambutol is actively excreted via the renal system, compromise of renal function such as due to renal tuberculosis may lead to serum concentration elevations of ethambutol sufficient to produce Adverse-Effectoptic neuropathy .
0.9822 Since Drugethambutol is actively excreted via the renal system, compromise of renal function such as due to renal tuberculosis may lead to serum concentration elevations of ethambutol sufficient to produce optic neuropathy.
0.9641 Since ethambutol is actively excreted via the renal system, compromise of renal function such as due to renal tuberculosis may lead to serum concentration elevations of Drugethambutol sufficient to produce optic neuropathy.
Score Text
0.9969 Autopsy evidence of herpesvirus infection was found in visceral organs of four leukemic patients who had received large doses of Drugcytarabine ( cytosine arabinoside ; Ara - C ) shortly before their death.
0.9906 Autopsy evidence of Adverse-Effectherpesvirus infection was found in visceral organs of four leukemic patients who had received large doses of cytarabine ( cytosine arabinoside ; Ara - C ) shortly before their death.
0.9793 Autopsy evidence of herpesvirus infection was found in visceral organs of four leukemic patients who had received large doses of cytarabine ( cytosine arabinoside ; DrugAra - C ) shortly before their death.
0.9701 Autopsy evidence of herpesvirus infection was found in visceral organs of four leukemic patients who had received large doses of cytarabine ( Drugcytosine arabinoside ; Ara - C ) shortly before their death.
Score Text
0.9995 We report three patients, all of whom had preexisting diabetic dyslipidemia, who showed a profound reduction in plasma HDL cholesterol and apolipoprotein AI levels soon after the initiation of Drugrosiglitazone therapy.
0.9725 We report three patients, all of whom had preexisting diabetic dyslipidemia, who showed a profound Adverse-Effectreduction in plasma HDL cholesterol and apolipoprotein AI levels soon after the initiation of rosiglitazone therapy.
Score Text
0.9995 We report marked QT prolongation and torsades de pointes in a setting of flash pulmonary edema resulting from acute myocardial ischemia in a patient who was being treated with Drugdofetilide for atrial fibrillation.
0.9860 We report marked QT prolongation and torsades de pointes in a setting of flash pulmonary edema resulting from Adverse-Effectacute myocardial ischemia in a patient who was being treated with dofetilide for atrial fibrillation.
0.9812 We report marked QT prolongation and Adverse-Effecttorsades de pointes in a setting of flash pulmonary edema resulting from acute myocardial ischemia in a patient who was being treated with dofetilide for atrial fibrillation.
0.9776 We report marked Adverse-EffectQT prolongation and torsades de pointes in a setting of flash pulmonary edema resulting from acute myocardial ischemia in a patient who was being treated with dofetilide for atrial fibrillation.
0.9664 We report marked QT prolongation and torsades de pointes in a setting of Adverse-Effectflash pulmonary edema resulting from acute myocardial ischemia in a patient who was being treated with dofetilide for atrial fibrillation.
Score Text
0.9845 CONCLUSIONS : Clinicians should be aware of a risk of Adverse-Effectserotonin syndrome with serious extrapyramidal reactions in patients receiving sertraline or venlafaxine when metoclopramide is coadministered even in a single, conventional dose.
0.9783 CONCLUSIONS : Clinicians should be aware of a risk of serotonin syndrome with serious extrapyramidal reactions in patients receiving sertraline or Drugvenlafaxine when metoclopramide is coadministered even in a single, conventional dose.
0.9721 CONCLUSIONS : Clinicians should be aware of a risk of serotonin syndrome with serious extrapyramidal reactions in patients receiving Drugsertraline or venlafaxine when metoclopramide is coadministered even in a single, conventional dose.
0.9655 CONCLUSIONS : Clinicians should be aware of a risk of serotonin syndrome with serious Adverse-Effectextrapyramidal reactions in patients receiving sertraline or venlafaxine when metoclopramide is coadministered even in a single, conventional dose.
0.9423 CONCLUSIONS : Clinicians should be aware of a risk of serotonin syndrome with serious extrapyramidal reactions in patients receiving sertraline or venlafaxine when Drugmetoclopramide is coadministered even in a single, conventional dose.
Score Text
0.9899 Although both patients recovered from the colitis after the administration of vancomycin, the first case demonstrated a relapse of the Adverse-Effectcolitis after receiving a subsequent course of the same chemotherapy with cisplatin.
0.9043 Although both patients recovered from the colitis after the administration of vancomycin, the first case demonstrated a relapse of the colitis after receiving a subsequent course of the same chemotherapy with Drugcisplatin .
0.9586 Although both patients recovered from the colitis after the administration of Drugvancomycin , the first case demonstrated a relapse of the colitis after receiving a subsequent course of the same chemotherapy with cisplatin.
Score Text
0.9810 Three nephrotic patients who had reduced renal function and active renal disease with progressive deterioration of renal function prior to the use of DrugMP developed transient renal failure following an MP pulse therapy.
0.9800 Three nephrotic patients who had reduced renal function and active renal disease with progressive deterioration of renal function prior to the use of MP developed Adverse-Effecttransient renal failure following an MP pulse therapy.
0.9679 Three nephrotic patients who had reduced renal function and active renal disease with progressive deterioration of renal function prior to the use of MP developed transient renal failure following an DrugMP pulse therapy.
Score Text
0.9997 We discuss a patient who developed severe renal tubular dysfunction secondary to short - term therapy with DrugAmikacin , resulting in refractory hypokalemia, hypocalcemia, hypomagnesemia, metabolic alkalosis, and polyuria.
0.9980 We discuss a patient who developed severe renal tubular dysfunction secondary to short - term therapy with Amikacin, resulting in refractory hypokalemia, hypocalcemia, hypomagnesemia, metabolic alkalosis, and Adverse-Effectpolyuria .
0.9955 We discuss a patient who developed severe renal tubular dysfunction secondary to short - term therapy with Amikacin, resulting in refractory hypokalemia, Adverse-Effecthypocalcemia , hypomagnesemia, metabolic alkalosis, and polyuria.
0.9945 We discuss a patient who developed severe renal tubular dysfunction secondary to short - term therapy with Amikacin, resulting in refractory hypokalemia, hypocalcemia, Adverse-Effecthypomagnesemia , metabolic alkalosis, and polyuria.
0.9859 We discuss a patient who developed severe renal tubular dysfunction secondary to short - term therapy with Amikacin, resulting in refractory hypokalemia, hypocalcemia, hypomagnesemia, Adverse-Effectmetabolic alkalosis , and polyuria.
0.9808 We discuss a patient who developed Adverse-Effectsevere renal tubular dysfunction secondary to short - term therapy with Amikacin, resulting in refractory hypokalemia, hypocalcemia, hypomagnesemia, metabolic alkalosis, and polyuria.
0.9804 We discuss a patient who developed severe renal tubular dysfunction secondary to short - term therapy with Amikacin, resulting in Adverse-Effectrefractory hypokalemia , hypocalcemia, hypomagnesemia, metabolic alkalosis, and polyuria.
Score Text
0.9992 The most serious dental side effect of Drugbisphosphonate treatment ( particularly when it is administered intravenously ) is, paradoxically, osteonecrosis of the mandible or the maxilla represented by exposed nonhealing bone.
0.9829 The most serious dental side effect of bisphosphonate treatment ( particularly when it is administered intravenously ) is, paradoxically, Adverse-Effectosteonecrosis of the mandible or the maxilla represented by exposed nonhealing bone.
Score Text
0.9994 DrugThrombin is highly effective for stopping intractable arterial hemorrhage during stereotactic brain biopsy ; however, it is a vasospastic agent and may have been responsible for the cerebral infarctions in one patient.
0.9851 Thrombin is highly effective for stopping intractable arterial hemorrhage during stereotactic brain biopsy ; however, it is a vasospastic agent and may have been responsible for the Adverse-Effectcerebral infarctions in one patient.
Score Text
0.9970 We suggest that Adverse-Effectsarcoidosis may develop in chronic hepatitis C patients during interferon alpha and / or ribavirin treatment, and diagnostic tests for this adverse effect should be performed during the follow - ups.
0.9961 We suggest that sarcoidosis may develop in chronic hepatitis C patients during interferon alpha and / or Drugribavirin treatment, and diagnostic tests for this adverse effect should be performed during the follow - ups.
0.9885 We suggest that sarcoidosis may develop in chronic hepatitis C patients during Druginterferon alpha and / or ribavirin treatment, and diagnostic tests for this adverse effect should be performed during the follow - ups.
Score Text
0.9921 We postulate that gastritis caused by dexamethasone, Adverse-Effectmucositis caused by doxorubicin, and the unique anatomic nature of a Meckel diverticulum may have contributed to this extremely unlikely and previously unreported event.
0.9747 We postulate that Adverse-Effectgastritis caused by dexamethasone, mucositis caused by doxorubicin, and the unique anatomic nature of a Meckel diverticulum may have contributed to this extremely unlikely and previously unreported event.
0.9420 We postulate that gastritis caused by dexamethasone, mucositis caused by Drugdoxorubicin , and the unique anatomic nature of a Meckel diverticulum may have contributed to this extremely unlikely and previously unreported event.
0.7907 We postulate that gastritis caused by Drugdexamethasone , mucositis caused by doxorubicin, and the unique anatomic nature of a Meckel diverticulum may have contributed to this extremely unlikely and previously unreported event.
Score Text
0.9996 We present two cases of Drugnitrofurantoin - induced pulmonary toxicity in which the initial HRCT showed a widespread reticular pattern and associated distortion of the lung parenchyma, thought to represent established fibrosis.
0.9943 We present two cases of nitrofurantoin - induced pulmonary toxicity in which the initial HRCT showed a widespread reticular pattern and associated distortion of the lung parenchyma, thought to represent established Adverse-Effectfibrosis .
0.9895 We present two cases of nitrofurantoin - induced Adverse-Effectpulmonary toxicity in which the initial HRCT showed a widespread reticular pattern and associated distortion of the lung parenchyma, thought to represent established fibrosis.
0.9767 We present two cases of nitrofurantoin - induced pulmonary toxicity in which the initial HRCT showed a Adverse-Effectwidespread reticular pattern and associated distortion of the lung parenchyma, thought to represent established fibrosis.
0.9753 We present two cases of nitrofurantoin - induced pulmonary toxicity in which the initial HRCT showed a widespread reticular pattern and associated Adverse-Effectdistortion of the lung parenchyma , thought to represent established fibrosis.
Score Text
0.9961 OBJECTIVE : To describe a case of exacerbated mania potentially related to an interaction between lopinavir / ritonavir and valproic acid ( DrugVPA ) and propose a mechanism of action for this interaction.
0.9961 OBJECTIVE : To describe a case of exacerbated mania potentially related to an interaction between Druglopinavir / ritonavir and valproic acid ( VPA ) and propose a mechanism of action for this interaction.
0.9956 OBJECTIVE : To describe a case of exacerbated mania potentially related to an interaction between lopinavir / Drugritonavir and valproic acid ( VPA ) and propose a mechanism of action for this interaction.
0.9877 OBJECTIVE : To describe a case of exacerbated mania potentially related to an interaction between lopinavir / ritonavir and Drugvalproic acid ( VPA ) and propose a mechanism of action for this interaction.
0.9824 OBJECTIVE : To describe a case of exacerbated Adverse-Effectmania potentially related to an interaction between lopinavir / ritonavir and valproic acid ( VPA ) and propose a mechanism of action for this interaction.
Score Text
0.9853 Transtubular potassium gradient ( TTKG ) also decreased and an inverse correlation was found between TTKG and doses of Drugphosphate ( r = - 0. 37 ; p < 0. 02 ; N = 38 ).
0.8880 Adverse-EffectTranstubular potassium gradient ( TTKG ) also decreased and an inverse correlation was found between TTKG and doses of phosphate ( r = - 0. 37 ; p < 0. 02 ; N = 38 ).
Score Text
0.9994 The first known report of Drugquetiapine exacerbating OCS in a 43 - year - old man with obsessive - compulsive disorder ( OCD ), trichotillomania, delusional disorder and bipolar II disorder is presented.
0.9273 The first known report of quetiapine Adverse-Effectexacerbating OCS in a 43 - year - old man with obsessive - compulsive disorder ( OCD ), trichotillomania, delusional disorder and bipolar II disorder is presented.
Score Text
0.9992 METHODS : A 79 - year - old woman being treated with Drugimiquimod 5 days per week for a nodular basal cell developed a verrucous plaque over the treatment area after 7 weeks of therapy.
0.9962 METHODS : A 79 - year - old woman being treated with imiquimod 5 days per week for a nodular basal cell developed a Adverse-Effectverrucous plaque over the treatment area after 7 weeks of therapy.
Score Text
0.9981 CASE SUMMARY : A 57 - year - old female with cardiomyopathy and " sulfa " ( trimethoprim / sulfamethoxazole ) allergy documented as pancreatitis presented with symptoms consistent with pancreatitis after use of Drugfurosemide .
0.9944 CASE SUMMARY : A 57 - year - old female with cardiomyopathy and " sulfa " ( trimethoprim / sulfamethoxazole ) allergy documented as pancreatitis presented with symptoms consistent with Adverse-Effectpancreatitis after use of furosemide.
Score Text
0.9989 We thus concluded that an excessive dose of DrugAZ had probably destroyed the gastric mucosal barrier or thrombocytopenia due to bone marrow disorder and thus eventually led to the development of hemorrhagic gastritis.
0.9934 We thus concluded that an excessive dose of AZ had probably destroyed the gastric mucosal barrier or thrombocytopenia due to bone marrow disorder and thus eventually led to the development of Adverse-Effecthemorrhagic gastritis .
0.9331 We thus concluded that an excessive dose of AZ had probably Adverse-Effectdestroyed the gastric mucosal barrier or thrombocytopenia due to bone marrow disorder and thus eventually led to the development of hemorrhagic gastritis.
0.6110 We thus concluded that an excessive dose of AZ had probably destroyed the gastric mucosal barrier or Adverse-Effectthrombocytopenia due to bone marrow disorder and thus eventually led to the development of hemorrhagic gastritis.
We thus concluded that an excessive dose of AZ had probably destroyed the gastric mucosal barrier or Adverse-Effectthrombocytopenia due to bone marrow disorder and thus eventually led to the development of hemorrhagic gastritis.
Score Text
0.9963 In this article, we present the case of a vitiligo patient who was admitted to our facility with an intense burn after the topical use of Drug8 - methoxypsoralen solution as a suntanning agent.
0.9841 In this article, we present the case of a vitiligo patient who was admitted to our facility with an Adverse-Effectintense burn after the topical use of 8 - methoxypsoralen solution as a suntanning agent.
Score Text
0.9974 A 36 - year - old man being treated with cisplatinum, vinblastine, and Drugbleomycin for testicular carcinoma developed a dense left homonymous hemianopsia, encephalopathy, and a partial nondominant parietal lobe syndrome.
0.9966 A 36 - year - old man being treated with cisplatinum, vinblastine, and bleomycin for testicular carcinoma developed a dense left homonymous hemianopsia, Adverse-Effectencephalopathy , and a partial nondominant parietal lobe syndrome.
0.9964 A 36 - year - old man being treated with cisplatinum, Drugvinblastine , and bleomycin for testicular carcinoma developed a dense left homonymous hemianopsia, encephalopathy, and a partial nondominant parietal lobe syndrome.
0.9957 A 36 - year - old man being treated with Drugcisplatinum , vinblastine, and bleomycin for testicular carcinoma developed a dense left homonymous hemianopsia, encephalopathy, and a partial nondominant parietal lobe syndrome.
0.9721 A 36 - year - old man being treated with cisplatinum, vinblastine, and bleomycin for testicular carcinoma developed a dense Adverse-Effectleft homonymous hemianopsia , encephalopathy, and a partial nondominant parietal lobe syndrome.
0.9400 A 36 - year - old man being treated with cisplatinum, vinblastine, and bleomycin for testicular carcinoma developed a dense left homonymous hemianopsia, encephalopathy, and a Adverse-Effectpartial nondominant parietal lobe syndrome .
Score Text
0.9995 CASE SUMMARIES : In each case, the patients were treated over 5 years with Druglovastatin and developed rhabdomyolysis that coincided with the completion of a prescribed regimen of a newer macrolide antibiotic.
0.9985 CASE SUMMARIES : In each case, the patients were treated over 5 years with lovastatin and developed Adverse-Effectrhabdomyolysis that coincided with the completion of a prescribed regimen of a newer macrolide antibiotic.
Score Text
0.9994 Retinal abnormalities, including retinal hemorrhage and " cotton - wool " spots, often occur within the first 8 weeks in the course of Druginterferon therapy in patients with chronic hepatitis C.
0.9929 Retinal abnormalities, including Adverse-Effectretinal hemorrhage and " cotton - wool " spots, often occur within the first 8 weeks in the course of interferon therapy in patients with chronic hepatitis C.
0.9910 Adverse-EffectRetinal abnormalities , including retinal hemorrhage and " cotton - wool " spots, often occur within the first 8 weeks in the course of interferon therapy in patients with chronic hepatitis C.
0.7523 Retinal abnormalities, including retinal hemorrhage and Adverse-Effect" cotton - wool " spots , often occur within the first 8 weeks in the course of interferon therapy in patients with chronic hepatitis C.
0.8342 Retinal abnormalities, including retinal hemorrhage and " Adverse-Effectcotton - wool " spots , often occur within the first 8 weeks in the course of interferon therapy in patients with chronic hepatitis C.
Score Text
0.9987 To date, only three cases of Adverse-Effectseizures associated with amphotericin B have been reported in the literature, but healthcare providers should be aware of the potential for this rare adverse effect.
0.9851 To date, only three cases of seizures associated with Drugamphotericin B have been reported in the literature, but healthcare providers should be aware of the potential for this rare adverse effect.
Score Text
0.9985 DrugZolpidem ( Ambien ), a relatively new nonbenzodiazepine sedative - hypnotic, was involved in the death of a 39 - year - old obese male who was being treated for depression and insomnia.
0.9971 Zolpidem ( DrugAmbien ), a relatively new nonbenzodiazepine sedative - hypnotic, was involved in the death of a 39 - year - old obese male who was being treated for depression and insomnia.
0.9915 Zolpidem ( Ambien ), a relatively new nonbenzodiazepine sedative - hypnotic, was involved in the Adverse-Effectdeath of a 39 - year - old obese male who was being treated for depression and insomnia.
Score Text
0.9911 A 45 - year - old woman with steroid - dependent Crohn's colitis, successfully managed with maintenance Druginfliximab infusions and methotrexate, developed a lupus - like syndrome eight months after her initial infusion.
0.9905 A 45 - year - old woman with steroid - dependent Crohn's colitis, successfully managed with maintenance infliximab infusions and Drugmethotrexate , developed a lupus - like syndrome eight months after her initial infusion.
0.9890 A 45 - year - old woman with steroid - dependent Crohn's colitis, successfully managed with maintenance infliximab infusions and methotrexate, developed a Adverse-Effectlupus - like syndrome eight months after her initial infusion.
Score Text
0.9996 Although there have been numerous reports of effusions, none have provided complete pleural fluid analysis ; therefore, we report 2 patients with Drugdasatinib - induced pleural effusion with complete pleural fluid analysis.
0.9905 Although there have been numerous reports of effusions, none have provided complete pleural fluid analysis ; therefore, we report 2 patients with dasatinib - induced Adverse-Effectpleural effusion with complete pleural fluid analysis.
Score Text
0.9993 A 53 year old Greenlandic male was admitted twice over a period of 4 years with a new complete right bundle branch block after ingestion of 10 g and 4 g of Drugcarbamazepine respectively.
0.9876 A 53 year old Greenlandic male was admitted twice over a period of 4 years with a new complete Adverse-Effectright bundle branch block after ingestion of 10 g and 4 g of carbamazepine respectively.
Score Text
0.9996 A 65 - year - old female patient presented with jaundice followed 2 days later by severe dyspnea and tachypnea which worsened when patient was lying flat, 1 week after the fourth dose of Drugadalimumab .
0.9983 A 65 - year - old female patient presented with Adverse-Effectjaundice followed 2 days later by severe dyspnea and tachypnea which worsened when patient was lying flat, 1 week after the fourth dose of adalimumab.
0.9981 A 65 - year - old female patient presented with jaundice followed 2 days later by severe dyspnea and Adverse-Effecttachypnea which worsened when patient was lying flat, 1 week after the fourth dose of adalimumab.
0.9934 A 65 - year - old female patient presented with jaundice followed 2 days later by Adverse-Effectsevere dyspnea and tachypnea which worsened when patient was lying flat, 1 week after the fourth dose of adalimumab.
Score Text
0.9990 CASE PRESENTATION : We report a patient with CF who developed recurrent eosinophilia and severe persistent bronchospasm following repeated administration of preservative - free Drugtobramycin by inhalation, beginning at 16 months of age.
0.9820 CASE PRESENTATION : We report a patient with CF who developed recurrent eosinophilia and Adverse-Effectsevere persistent bronchospasm following repeated administration of preservative - free tobramycin by inhalation, beginning at 16 months of age.
0.9650 CASE PRESENTATION : We report a patient with CF who developed Adverse-Effectrecurrent eosinophilia and severe persistent bronchospasm following repeated administration of preservative - free tobramycin by inhalation, beginning at 16 months of age.
Score Text
0.9847 Three patients with niacin - induced visual symptoms had Adverse-Effectcystoid maculopathy without leakage on fluorescein angiography, and a fourth patient with no fundus abnormality experienced cessation of visual symptoms upon discontinuation of niacin.
0.9495 Three patients with Drugniacin - induced visual symptoms had cystoid maculopathy without leakage on fluorescein angiography, and a fourth patient with no fundus abnormality experienced cessation of visual symptoms upon discontinuation of niacin.
0.9452 Three patients with niacin - induced Adverse-Effectvisual symptoms had cystoid maculopathy without leakage on fluorescein angiography, and a fourth patient with no fundus abnormality experienced cessation of visual symptoms upon discontinuation of niacin.
0.9033 Three patients with niacin - induced visual symptoms had cystoid maculopathy without leakage on fluorescein angiography, and a fourth patient with no fundus abnormality experienced cessation of visual symptoms upon discontinuation of Drugniacin .
0.8715 Three patients with niacin - induced visual symptoms had cystoid maculopathy without leakage on fluorescein angiography, and a fourth patient with no fundus abnormality experienced cessation of Adverse-Effectvisual symptoms upon discontinuation of niacin.
0.8169 Three patients with niacin - induced visual symptoms had cystoid maculopathy without leakage on Drugfluorescein angiography, and a fourth patient with no fundus abnormality experienced cessation of visual symptoms upon discontinuation of niacin.
Score Text
0.9888 After an extensive review of the literature, we believe that this is the first communication of the successful use of amiodarone to control hyperthyroidism in a patient with PTU - induced Adverse-Effectfulminant hepatitis .
0.9728 After an extensive review of the literature, we believe that this is the first communication of the successful use of amiodarone to control hyperthyroidism in a patient with DrugPTU - induced fulminant hepatitis.
0.9277 After an extensive review of the literature, we believe that this is the first communication of the successful use of Drugamiodarone to control hyperthyroidism in a patient with PTU - induced fulminant hepatitis.
Score Text
0.9992 The authors present a case study of a mentally healthy man who repeatedly experienced short - lived, obsessional - like suicidal ideas and images after ingestion of the anti - fungal drug Drugketoconazole .
0.9792 The authors present a case study of a mentally healthy man who repeatedly experienced short - lived, Adverse-Effectobsessional - like suicidal ideas and images after ingestion of the anti - fungal drug ketoconazole.
Score Text
0.9955 A 50 - year - old diabetic and hypertensive male patient is reported who had Drugticlopidine - induced marrow aplasia partially responsive to colony - stimulating factors and corticosteroids, but experienced complete recovery with cyclosporine.
0.9943 A 50 - year - old diabetic and hypertensive male patient is reported who had ticlopidine - induced Adverse-Effectmarrow aplasia partially responsive to colony - stimulating factors and corticosteroids, but experienced complete recovery with cyclosporine.
Score Text
0.9963 In this case report, we have described a patient with Crohn's disease who developed subfulminant hepatitis B after the fourth infusion of Druginfliximab due to an unrecognized HBs - antigen carrier state.
0.9894 In this case report, we have described a patient with Crohn's disease who developed Adverse-Effectsubfulminant hepatitis B after the fourth infusion of infliximab due to an unrecognized HBs - antigen carrier state.
Score Text
0.9854 Although Drugretinoic acid is well tolerated by the majority of patients with this disease, a potentially fatal complication of this kind of treatment has been reported : " the retinoic acid syndrome ".
0.9839 Although retinoic acid is well tolerated by the majority of patients with this disease, a potentially fatal complication of this kind of treatment has been reported : " the Adverse-Effectretinoic acid syndrome ".
0.9687 Although retinoic acid is well tolerated by the majority of patients with this disease, a potentially Adverse-Effectfatal complication of this kind of treatment has been reported : " the retinoic acid syndrome ".
Score Text
0.9990 Preliminary results suggest that the higher concentrations of Drugdextrose induce increased histamine release from blood cells, and that this phenomenon is more marked in diabetic, and particularly diabetic - allergic, individuals.
0.9841 Preliminary results suggest that the higher concentrations of dextrose induce Adverse-Effectincreased histamine release from blood cells, and that this phenomenon is more marked in diabetic, and particularly diabetic - allergic, individuals.
Score Text
0.9711 The literature is also reviewed for ARF associated with mannitol infusion in patients who received dialysis and those who did not receive dialysis ; and the possible mechanism ( s ) of mannitol Adverse-Effectnephrotoxicity are discussed.
0.9427 The literature is also reviewed for ARF associated with Drugmannitol infusion in patients who received dialysis and those who did not receive dialysis ; and the possible mechanism ( s ) of mannitol nephrotoxicity are discussed.
0.9339 The literature is also reviewed for ARF associated with mannitol infusion in patients who received dialysis and those who did not receive dialysis ; and the possible mechanism ( s ) of Drugmannitol nephrotoxicity are discussed.
0.8458 The literature is also reviewed for Adverse-EffectARF associated with mannitol infusion in patients who received dialysis and those who did not receive dialysis ; and the possible mechanism ( s ) of mannitol nephrotoxicity are discussed.
0.7561 The literature is also reviewed for ARF associated with mannitol infusion in patients who received dialysis and those who did not receive dialysis ; and the possible mechanism ( s ) of Adverse-Effectmannitol nephrotoxicity are discussed.
Score Text
0.9966 INTRODUCTION : We describe the neurointensive care ( NIC ) management of a patient with severe cerebral swelling and raised intracranial pressure ( ICP ) after severe sodium valproic acid ( DrugVPA ) intoxication.
0.9830 INTRODUCTION : We describe the neurointensive care ( NIC ) management of a patient with severe cerebral swelling and Adverse-Effectraised intracranial pressure ( ICP ) after severe sodium valproic acid ( VPA ) intoxication.
0.9816 INTRODUCTION : We describe the neurointensive care ( NIC ) management of a patient with severe cerebral swelling and raised intracranial pressure ( ICP ) after severe Drugsodium valproic acid ( VPA ) intoxication.
0.9752 INTRODUCTION : We describe the neurointensive care ( NIC ) management of a patient with Adverse-Effectsevere cerebral swelling and raised intracranial pressure ( ICP ) after severe sodium valproic acid ( VPA ) intoxication.
Score Text
0.9836 Four years after the beginning of DrugIFN therapy, he acutely developed moderate hyperglycemia and severe ketonuria with positive islet cell antibody, and then 28 units / day of insulin injection was started.
0.9808 Four years after the beginning of IFN therapy, he acutely developed moderate hyperglycemia and Adverse-Effectsevere ketonuria with positive islet cell antibody, and then 28 units / day of insulin injection was started.
0.9719 Four years after the beginning of IFN therapy, he acutely developed Adverse-Effectmoderate hyperglycemia and severe ketonuria with positive islet cell antibody, and then 28 units / day of insulin injection was started.
0.7638 Four years after the beginning of IFN therapy, he acutely developed moderate hyperglycemia and severe ketonuria with Adverse-Effectpositive islet cell antibody , and then 28 units / day of insulin injection was started.
0.6875 Four years after the beginning of IFN therapy, he acutely developed moderate hyperglycemia and severe ketonuria with positive islet cell antibody, and then 28 units / day of Druginsulin injection was started.
Score Text
0.9969 Adverse-EffectARDS is rarely associated with rituximab infusion for lympho - proliferative disorders, but it should be considered by those administering rituximab, especially when a patient develops severe pulmonary symptoms soon after infusion.
0.9670 ARDS is rarely associated with Drugrituximab infusion for lympho - proliferative disorders, but it should be considered by those administering rituximab, especially when a patient develops severe pulmonary symptoms soon after infusion.
0.9628 ARDS is rarely associated with rituximab infusion for lympho - proliferative disorders, but it should be considered by those administering rituximab, especially when a patient develops Adverse-Effectsevere pulmonary symptoms soon after infusion.
0.9591 ARDS is rarely associated with rituximab infusion for lympho - proliferative disorders, but it should be considered by those administering Drugrituximab , especially when a patient develops severe pulmonary symptoms soon after infusion.
Score Text
0.9994 However, a large case - control study included three cases of either Stevens - Johnson syndrome or toxic epidermal necrolysis associated with Drugofloxacin use, but no details of the cases were given.
0.9872 However, a large case - control study included three cases of either Stevens - Johnson syndrome or Adverse-Effecttoxic epidermal necrolysis associated with ofloxacin use, but no details of the cases were given.
0.9809 However, a large case - control study included three cases of either Adverse-EffectStevens - Johnson syndrome or toxic epidermal necrolysis associated with ofloxacin use, but no details of the cases were given.
Score Text
0.9992 The reported case represents an unusual association between medication with the proton pump inhibitor Druglansoprazole and the development of collagenous colitis suggesting the importance of evaluation of drug use in patients with microscopic colitis.
0.9938 The reported case represents an unusual association between medication with the proton pump inhibitor lansoprazole and the development of Adverse-Effectcollagenous colitis suggesting the importance of evaluation of drug use in patients with microscopic colitis.
Score Text
0.9996 This report details the pulmonary pathologic findings in four patients with rheumatoid arthritis, who developed new onset of pulmonary signs and symptoms with alveolar infiltrates temporally related to the institution of Drugetanercept therapy.
0.9937 This report details the pulmonary pathologic findings in four patients with rheumatoid arthritis, who developed new onset of Adverse-Effectpulmonary signs and symptoms with alveolar infiltrates temporally related to the institution of etanercept therapy.
This report details the pulmonary pathologic findings in four patients with rheumatoid arthritis, who developed new onset of Adverse-Effectpulmonary signs and symptoms with alveolar infiltrates temporally related to the institution of etanercept therapy.
Score Text
0.9497 The former patient had complained once that his visual acuity had decreased after the termination of DrugIFN therapy, and the latter patient complained twice during IFN therapy that his visual acuity had decreased.
0.9263 The former patient had complained once that his Adverse-Effectvisual acuity had decreased after the termination of IFN therapy, and the latter patient complained twice during IFN therapy that his visual acuity had decreased.
0.9261 The former patient had complained once that his visual acuity had decreased after the termination of IFN therapy, and the latter patient complained twice during IFN therapy that his Adverse-Effectvisual acuity had decreased .
0.8416 The former patient had complained once that his visual acuity had decreased after the termination of IFN therapy, and the latter patient complained twice during DrugIFN therapy that his visual acuity had decreased.
Score Text
0.9971 CASE SUMMARY : A 39 - year - old white Jewish schizophrenic man treated with Drugolanzapine developed an elevated serum CK concentration with a peak concentration of 4000 IU / L ( normal < 230 ).
0.9868 CASE SUMMARY : A 39 - year - old white Jewish schizophrenic man treated with olanzapine developed an Adverse-Effectelevated serum CK concentration with a peak concentration of 4000 IU / L ( normal < 230 ).
Score Text
0.9995 We are concerned that the macular lesion was a retinal toxic effect of Druggentamicin because of the recent description of similar lesions occurring after the inadvertent intraocular injection of massive doses of this drug.
0.9919 We are concerned that the Adverse-Effectmacular lesion was a retinal toxic effect of gentamicin because of the recent description of similar lesions occurring after the inadvertent intraocular injection of massive doses of this drug.
0.5271 We are concerned that the macular lesion was a Adverse-Effectretinal toxic effect of gentamicin because of the recent description of similar lesions occurring after the inadvertent intraocular injection of massive doses of this drug.
Score Text
0.9987 Seventy - four per cent of patients with epileptogenic disorders seen at the Emergency Unit at Groote Schuur Hospital were on Drugphenytoin and 11. 6 % of these had blood levels in the toxic range.
0.9649 Seventy - four per cent of patients with epileptogenic disorders seen at the Emergency Unit at Groote Schuur Hospital were on phenytoin and 11. 6 % of these had Adverse-Effectblood levels in the toxic range .
Score Text
0.9802 We describe a case of Adverse-Effectpoisoning with 3, 4 - methylenedioxymet - amphetamine Ecstasy that presented with all the features suggestive of a fatal outcome, including a creatinine phosphokinase level markedly higher than any previously reported.
0.9203 We describe a case of poisoning with Drug3, 4 - methylenedioxymet - amphetamine Ecstasy that presented with all the features suggestive of a fatal outcome, including a creatinine phosphokinase level markedly higher than any previously reported.
Score Text
0.9860 Total blindness with a transient tonic pupillary response, Adverse-Effectdenervation supersensitivity , and abnormal visual - evoked potentials developed in a 54 - year - old man after the use of quinine sulfate for leg cramps.
0.9856 Total blindness with a transient tonic pupillary response, denervation supersensitivity, and abnormal visual - evoked potentials developed in a 54 - year - old man after the use of Drugquinine sulfate for leg cramps.
0.9837 Total blindness with a transient tonic pupillary response, denervation supersensitivity, and Adverse-Effectabnormal visual - evoked potentials developed in a 54 - year - old man after the use of quinine sulfate for leg cramps.
0.9921 Adverse-EffectTotal blindness with a transient tonic pupillary response, denervation supersensitivity, and abnormal visual - evoked potentials developed in a 54 - year - old man after the use of quinine sulfate for leg cramps.
0.9798 Total blindness with a Adverse-Effecttransient tonic pupillary response , denervation supersensitivity, and abnormal visual - evoked potentials developed in a 54 - year - old man after the use of quinine sulfate for leg cramps.
Adverse-EffectTotal blindness with a transient tonic pupillary response , denervation supersensitivity, and abnormal visual - evoked potentials developed in a 54 - year - old man after the use of quinine sulfate for leg cramps.
Score Text
0.9985 We report the case of a patient who developed polyserositis ( pericardial effusion, pleural effusion, and Adverse-Effectpericarditis ) after being started on clozapine, and whose symptoms remitted upon discontinuation of clozapine.
0.9980 We report the case of a patient who developed Adverse-Effectpolyserositis ( pericardial effusion, pleural effusion, and pericarditis ) after being started on clozapine, and whose symptoms remitted upon discontinuation of clozapine.
0.9950 We report the case of a patient who developed polyserositis ( pericardial effusion, pleural effusion, and pericarditis ) after being started on Drugclozapine , and whose symptoms remitted upon discontinuation of clozapine.
0.9932 We report the case of a patient who developed polyserositis ( pericardial effusion, pleural effusion, and pericarditis ) after being started on clozapine, and whose symptoms remitted upon discontinuation of Drugclozapine .
0.9881 We report the case of a patient who developed polyserositis ( Adverse-Effectpericardial effusion , pleural effusion, and pericarditis ) after being started on clozapine, and whose symptoms remitted upon discontinuation of clozapine.
0.9881 We report the case of a patient who developed polyserositis ( pericardial effusion, Adverse-Effectpleural effusion , and pericarditis ) after being started on clozapine, and whose symptoms remitted upon discontinuation of clozapine.
Score Text
0.9983 This article reports the case of an otherwise healthy patient who experienced permanent sensorineural hearing loss after a brief course of Drugnaproxen and reviews the literature on NSAID - related permanent sensorineural hearing loss.
0.9892 This article reports the case of an otherwise healthy patient who experienced permanent Adverse-Effectsensorineural hearing loss after a brief course of naproxen and reviews the literature on NSAID - related permanent sensorineural hearing loss.
0.9817 This article reports the case of an otherwise healthy patient who experienced permanent sensorineural hearing loss after a brief course of naproxen and reviews the literature on NSAID - related permanent Adverse-Effectsensorineural hearing loss .
Score Text
0.9988 Hypo - oestrogenic and anabolic / androgenic side - effects of Drugdanazol are well known by the gynaecologist and some of them are present in > 50 % of patients being treated for endometriosis.
0.9810 Adverse-EffectHypo - oestrogenic and anabolic / androgenic side - effects of danazol are well known by the gynaecologist and some of them are present in > 50 % of patients being treated for endometriosis.
Score Text
0.9994 A 7 - year - old with congenital toxoplasmosis who took Drugpyrimethamine and sulfadiazine for reactivated chorioretinitis developed fever, severe cutaneous involvement, swelling, abdominal pain and transaminitis, persisting weeks after withholding medicines.
0.9993 A 7 - year - old with congenital toxoplasmosis who took pyrimethamine and Drugsulfadiazine for reactivated chorioretinitis developed fever, severe cutaneous involvement, swelling, abdominal pain and transaminitis, persisting weeks after withholding medicines.
0.9990 A 7 - year - old with congenital toxoplasmosis who took pyrimethamine and sulfadiazine for reactivated chorioretinitis developed fever, severe cutaneous involvement, Adverse-Effectswelling , abdominal pain and transaminitis, persisting weeks after withholding medicines.
0.9976 A 7 - year - old with congenital toxoplasmosis who took pyrimethamine and sulfadiazine for reactivated chorioretinitis developed fever, severe cutaneous involvement, swelling, Adverse-Effectabdominal pain and transaminitis, persisting weeks after withholding medicines.
0.9970 A 7 - year - old with congenital toxoplasmosis who took pyrimethamine and sulfadiazine for reactivated chorioretinitis developed fever, severe cutaneous involvement, swelling, abdominal pain and Adverse-Effecttransaminitis , persisting weeks after withholding medicines.
0.9923 A 7 - year - old with congenital toxoplasmosis who took pyrimethamine and sulfadiazine for reactivated chorioretinitis developed Adverse-Effectfever , severe cutaneous involvement, swelling, abdominal pain and transaminitis, persisting weeks after withholding medicines.
0.9885 A 7 - year - old with congenital toxoplasmosis who took pyrimethamine and sulfadiazine for reactivated chorioretinitis developed fever, Adverse-Effectsevere cutaneous involvement , swelling, abdominal pain and transaminitis, persisting weeks after withholding medicines.
Score Text
0.9945 The case reported here is of a child given a large dose of intravenous Drugiron sucrose ( 16 mg / kg ) over 3 hours, who subsequently developed features of systemic iron toxicity.
0.9828 The case reported here is of a child given a large dose of intravenous iron sucrose ( 16 mg / kg ) over 3 hours, who subsequently developed features of Adverse-Effectsystemic iron toxicity .
Score Text
0.9994 The first patient was a 61 - year - old man with a 30 - year history of fistulizing CD in whom B - cell non - Hodgkin's lymphoma was diagnosed 9 months after treatment with Druginfliximab .
0.9731 The first patient was a 61 - year - old man with a 30 - year history of fistulizing CD in whom Adverse-EffectB - cell non - Hodgkin's lymphoma was diagnosed 9 months after treatment with infliximab.
Score Text
0.9994 The authors report a case of focal myocardial necrosis, presenting clinically as an acute myocardial infarction during the administration of the antineoplastic drug, Drugamsacrine , in a patient without coronary artery disease.
0.9880 The authors report a case of Adverse-Effectfocal myocardial necrosis , presenting clinically as an acute myocardial infarction during the administration of the antineoplastic drug, amsacrine, in a patient without coronary artery disease.
0.9722 The authors report a case of focal myocardial necrosis, presenting clinically as an Adverse-Effectacute myocardial infarction during the administration of the antineoplastic drug, amsacrine, in a patient without coronary artery disease.
Score Text
0.9993 OBJECTIVE : The authors described a case of Druginterferon - induced psychosis as a framework to review the literature and discuss the decision to pursue antiviral treatment in psychiatrically ill patients with hepatitis C.
0.9987 OBJECTIVE : The authors described a case of interferon - induced Adverse-Effectpsychosis as a framework to review the literature and discuss the decision to pursue antiviral treatment in psychiatrically ill patients with hepatitis C.
Score Text
0.9949 Although gabapentin withdrawal has been previously reported and usually consists of anxiety, Adverse-Effectdiaphoresis , and palpitations, this is the first reported patient with generalized seizures and status epilepticus secondary to gabapentin withdrawal.
0.9937 Although gabapentin withdrawal has been previously reported and usually consists of Adverse-Effectanxiety , diaphoresis, and palpitations, this is the first reported patient with generalized seizures and status epilepticus secondary to gabapentin withdrawal.
0.9895 Although gabapentin withdrawal has been previously reported and usually consists of anxiety, diaphoresis, and palpitations, this is the first reported patient with Adverse-Effectgeneralized seizures and status epilepticus secondary to gabapentin withdrawal.
0.9756 Although Druggabapentin withdrawal has been previously reported and usually consists of anxiety, diaphoresis, and palpitations, this is the first reported patient with generalized seizures and status epilepticus secondary to gabapentin withdrawal.
0.9624 Although gabapentin withdrawal has been previously reported and usually consists of anxiety, diaphoresis, and palpitations, this is the first reported patient with generalized seizures and status epilepticus secondary to Druggabapentin withdrawal.
0.9586 Although gabapentin withdrawal has been previously reported and usually consists of anxiety, diaphoresis, and Adverse-Effectpalpitations , this is the first reported patient with generalized seizures and status epilepticus secondary to gabapentin withdrawal.
0.8399 Although gabapentin withdrawal has been previously reported and usually consists of anxiety, diaphoresis, and palpitations, this is the first reported patient with generalized seizures and Adverse-Effectstatus epilepticus secondary to gabapentin withdrawal.
Score Text
0.9994 The possibility of deep vein thrombosis caused by the compression of the veins by necrotic tumor should be considered in patients with abdominal or pelvic metastases of GIST, including patients treated with Drugimatinib .
0.9865 The possibility of Adverse-Effectdeep vein thrombosis caused by the compression of the veins by necrotic tumor should be considered in patients with abdominal or pelvic metastases of GIST, including patients treated with imatinib.
0.7946 The possibility of deep vein thrombosis caused by the Adverse-Effectcompression of the veins by necrotic tumor should be considered in patients with abdominal or pelvic metastases of GIST, including patients treated with imatinib.
Score Text
0.9972 Though Adverse-Effectproteinuria and nephrotic syndrome is a rare adverse effect of IFN - beta - 1b therapy, physicians treating MS patients with this agent should pay careful attention to new clinical symptoms and laboratory findings.
0.9940 Though proteinuria and Adverse-Effectnephrotic syndrome is a rare adverse effect of IFN - beta - 1b therapy, physicians treating MS patients with this agent should pay careful attention to new clinical symptoms and laboratory findings.
0.9705 Though proteinuria and nephrotic syndrome is a rare adverse effect of DrugIFN - beta - 1b therapy, physicians treating MS patients with this agent should pay careful attention to new clinical symptoms and laboratory findings.
Score Text
0.9977 Possible mechanisms by which clonidine decreases spasticity are described, probable mechanisms of induced Adverse-Effectbradycardia are reviewed, and specific treatment recommendations for the use of clonidine in spinal cord injured patients are presented.
0.9750 Possible mechanisms by which Drugclonidine decreases spasticity are described, probable mechanisms of induced bradycardia are reviewed, and specific treatment recommendations for the use of clonidine in spinal cord injured patients are presented.
0.9295 Possible mechanisms by which clonidine decreases spasticity are described, probable mechanisms of induced bradycardia are reviewed, and specific treatment recommendations for the use of Drugclonidine in spinal cord injured patients are presented.
Score Text
0.9967 None of them had a history of cardiac disease, and with the possible exception of one case of cardiac arrest, where the patient received Drugdoxorubicin , no predisposing factors could be found.
0.9952 None of them had a history of cardiac disease, and with the possible exception of one case of Adverse-Effectcardiac arrest , where the patient received doxorubicin, no predisposing factors could be found.
Score Text
0.9990 Interestingly, the use of carboplatin ( CBDCA ) and VDS in the subsequent treatment course was well tolerated indicating that the SIADH was most likely to have been induced by administration of DrugCDDP .
0.9972 Interestingly, the use of carboplatin ( CBDCA ) and VDS in the subsequent treatment course was well tolerated indicating that the Adverse-EffectSIADH was most likely to have been induced by administration of CDDP.
Score Text
0.9696 A woman 38 - year - old, suffering for about ten years from multiple sclerosis and treated with repeated therapy cycles of intrathecal DrugDepo - Medrol , developed a spastic paraparesis at the lower limbs.
0.9069 A woman 38 - year - old, suffering for about ten years from multiple sclerosis and treated with repeated therapy cycles of intrathecal Depo - Medrol, developed a Adverse-Effectspastic paraparesis at the lower limbs .
Score Text
0.9949 We describe a patient with acute myeloblastic leukemia ( AML ) who developed Adverse-Effectnephrotic syndrome after receiving several courses of chemotherapy, including macrophage - colony - stimulating factor ( M - CSF ).
0.9580 We describe a patient with acute myeloblastic leukemia ( AML ) who developed nephrotic syndrome after receiving several courses of chemotherapy, including macrophage - colony - stimulating factor ( DrugM - CSF ).
0.9563 We describe a patient with acute myeloblastic leukemia ( AML ) who developed nephrotic syndrome after receiving several courses of chemotherapy, including Drugmacrophage - colony - stimulating factor ( M - CSF ).
Score Text
0.9987 Only after three subsequent episodes of severe, symptomatic thrombocytopenia over the next four weeks did he say, upon repeat questioning, that he had continued to take Drugquinine for night leg cramps.
0.9410 Only after three subsequent episodes of severe, symptomatic Adverse-Effectthrombocytopenia over the next four weeks did he say, upon repeat questioning, that he had continued to take quinine for night leg cramps.
Score Text
0.9993 DrugCaptopril is an angiotensin - converting enzyme ( ACE ) inhibitor and their cutaneous side - effects are documented, but little has been published concerning the usefulness of patch test when they occur.
0.9734 Captopril is an angiotensin - converting enzyme ( ACE ) inhibitor and their Adverse-Effectcutaneous side - effects are documented, but little has been published concerning the usefulness of patch test when they occur.
Score Text
0.9985 Slow acetylators, who comprise roughly 50 % of the South African population, are likely to develop clinical and biochemical features of Drugphenytoin toxicity when this drug is given together with antituberculosis therapy.
0.9449 Slow acetylators, who comprise roughly 50 % of the South African population, are likely to develop clinical and biochemical features of Adverse-Effectphenytoin toxicity when this drug is given together with antituberculosis therapy.
Score Text
0.9995 During intravenous treatment with Drugterlipressin for recurrent gastrointestinal ( GI ) bleeding, a 50 - year - old male with no history of heart disease developed a newly prolonged QT interval and torsade de pointes.
0.9839 During intravenous treatment with terlipressin for recurrent gastrointestinal ( GI ) bleeding, a 50 - year - old male with no history of heart disease developed a newly prolonged QT interval and Adverse-Effecttorsade de pointes .
0.9837 During intravenous treatment with terlipressin for recurrent gastrointestinal ( GI ) bleeding, a 50 - year - old male with no history of heart disease developed a newly Adverse-Effectprolonged QT interval and torsade de pointes.
Score Text
0.9994 OBJECTIVE : To describe what is believed, as of November 4, 2003, to be the first case published in the literature of acute interstitial nephritis ( AIN ) due to Drugpantoprazole .
0.9805 OBJECTIVE : To describe what is believed, as of November 4, 2003, to be the first case published in the literature of Adverse-Effectacute interstitial nephritis ( AIN ) due to pantoprazole.
0.9896 OBJECTIVE : To describe what is believed, as of November 4, 2003, to be the first case published in the literature of acute interstitial nephritis ( Adverse-EffectAIN ) due to pantoprazole.
Score Text
0.9833 A 33 - year - old male presented with Adverse-Effectbrown discolouration of the fingernails following the application of 4 % hydroquinone in sorbolene cream and 0. 1 % tretinoin cream to the face intermittently for 9 months.
0.9158 A 33 - year - old male presented with brown discolouration of the fingernails following the application of Drug4 % hydroquinone in sorbolene cream and 0. 1 % tretinoin cream to the face intermittently for 9 months.
0.7524 A 33 - year - old male presented with brown discolouration of the fingernails following the application of 4 % hydroquinone in sorbolene cream and Drug0. 1 % tretinoin cream to the face intermittently for 9 months.
A 33 - year - old male presented with brown discolouration of the fingernails following the application of 4 % hydroquinone in sorbolene cream and Drug0. 1 % tretinoin cream to the face intermittently for 9 months.
Score Text
0.9944 CONCLUSION : This report describes a case of a probable interaction between topical Drugeconazole lotion 1 % and acenocoumarol that resulted in overanticoagulation and a life - threatening laryngeal hematoma in this elderly patient.
0.9931 CONCLUSION : This report describes a case of a probable interaction between topical econazole lotion 1 % and Drugacenocoumarol that resulted in overanticoagulation and a life - threatening laryngeal hematoma in this elderly patient.
0.9593 CONCLUSION : This report describes a case of a probable interaction between topical econazole lotion 1 % and acenocoumarol that resulted in overanticoagulation and a life - threatening Adverse-Effectlaryngeal hematoma in this elderly patient.
0.9815 CONCLUSION : This report describes a case of a probable interaction between topical econazole lotion 1 % and acenocoumarol that resulted in Adverse-Effectoveranticoagulation and a life - threatening laryngeal hematoma in this elderly patient.
Score Text
0.9986 CASE REPORT : We report a patient who developed a DAT - positive hemolytic episode after a red cell ( RBC ) transfusion was delivered during the infusion of her 17th cycle of Drugoxaliplatin .
0.9819 CASE REPORT : We report a patient who developed a Adverse-EffectDAT - positive hemolytic episode after a red cell ( RBC ) transfusion was delivered during the infusion of her 17th cycle of oxaliplatin.
Score Text
0.9995 We report the case of a patient with the acquired immunodeficiency syndrome treated with Drugrifampicin who had a'normal'screening test for adrenal insufficiency, yet had clinical evidence of adrenal failure.
0.9897 We report the case of a patient with the acquired immunodeficiency syndrome treated with rifampicin who had a'normal'screening test for adrenal insufficiency, yet had clinical evidence of Adverse-Effectadrenal failure .
Score Text
0.9987 Adverse-EffectParaplegia following prophylactic intrathecal cytosine arabinoside ( Ara - C ) is described in a patient with acute myelogenous leukemia in remission who received doses of 100 mg / m2 / d for 5 consecutive days.
0.9844 Paraplegia following prophylactic intrathecal Drugcytosine arabinoside ( Ara - C ) is described in a patient with acute myelogenous leukemia in remission who received doses of 100 mg / m2 / d for 5 consecutive days.
0.9814 Paraplegia following prophylactic intrathecal cytosine arabinoside ( DrugAra - C ) is described in a patient with acute myelogenous leukemia in remission who received doses of 100 mg / m2 / d for 5 consecutive days.
Score Text
0.9985 Infants are particularly susceptible to chronic nitrate - induced Adverse-Effectmethemoglobinemia because of their low stomach acid production, large numbers of nitrite - reducing bacteria, and the relatively easy oxidation of fetal hemoglobin.
0.9895 Infants are particularly susceptible to chronic Drugnitrate - induced methemoglobinemia because of their low stomach acid production, large numbers of nitrite - reducing bacteria, and the relatively easy oxidation of fetal hemoglobin.
0.5902 Infants are particularly susceptible to chronic nitrate - induced methemoglobinemia because of their low stomach acid production, large numbers of Drugnitrite - reducing bacteria, and the relatively easy oxidation of fetal hemoglobin.
Score Text
0.9810 In this study, we report on three individual patients who received BTX - B and who subsequently developed Adverse-Effectparasympathetic dysfunction of the visual system after injections of BTX - B at remote sites.
0.9733 In this study, we report on three individual patients who received DrugBTX - B and who subsequently developed parasympathetic dysfunction of the visual system after injections of BTX - B at remote sites.
0.9658 In this study, we report on three individual patients who received BTX - B and who subsequently developed parasympathetic dysfunction of the visual system after injections of DrugBTX - B at remote sites.
Score Text
0.9978 Reversible valproic acid - induced Adverse-Effectdementia was documented in a 21 - year - old man with epilepsy who had a 3 - year history of insidious progressive decline in global cognitive abilities documented by serial neuropsychological studies.
0.9842 Reversible Drugvalproic acid - induced dementia was documented in a 21 - year - old man with epilepsy who had a 3 - year history of insidious progressive decline in global cognitive abilities documented by serial neuropsychological studies.
Score Text
0.9995 We report on a patient with subarachnoid haemorrhage who developed an acute life - threatening pseudo - obstruction of the colon, a variant of adynamic ileus, while being treated with intravenous Drugnimodipine .
0.9866 We report on a patient with subarachnoid haemorrhage who developed an acute life - threatening pseudo - obstruction of the colon, a variant of Adverse-Effectadynamic ileus , while being treated with intravenous nimodipine.
0.9563 We report on a patient with subarachnoid haemorrhage who developed an acute life - threatening Adverse-Effectpseudo - obstruction of the colon , a variant of adynamic ileus, while being treated with intravenous nimodipine.
Score Text
0.9989 Although high - dose Drugmethotrexate has been shown to be useful in the treatment of primary osteogenic sarcoma, the tumoricidal effects of therapy appear to have caused a fatal rise in intracranial pressure.
0.9825 Although high - dose methotrexate has been shown to be useful in the treatment of primary osteogenic sarcoma, the tumoricidal effects of therapy appear to have caused a Adverse-Effectfatal rise in intracranial pressure .
Score Text
0.9992 Five and one - half years after the diagnosis of myeloma, while in remission on Drugcyclophosphamide therapy, the patient experienced severe abdominal right lower quadrant pain due to a large cecal lymphoma.
0.9652 Five and one - half years after the diagnosis of myeloma, while in remission on cyclophosphamide therapy, the patient experienced severe Adverse-Effectabdominal right lower quadrant pain due to a large cecal lymphoma.
0.9526 Five and one - half years after the diagnosis of myeloma, while in remission on cyclophosphamide therapy, the patient experienced severe abdominal right lower quadrant pain due to a large Adverse-Effectcecal lymphoma .
0.8321 Five and one - half years after the diagnosis of myeloma, while in remission on cyclophosphamide therapy, the patient experienced Adverse-Effectsevere abdominal right lower quadrant pain due to a large cecal lymphoma.
Score Text
0.9996 We describe the exceptional development of AML and lung cancer in a patient with previously diagnosed CLL in minimal residual disease status after Drugfludarabine treatment followed by autologous peripheral blood stem - cell transplantation.
0.9986 We describe the exceptional development of Adverse-EffectAML and lung cancer in a patient with previously diagnosed CLL in minimal residual disease status after fludarabine treatment followed by autologous peripheral blood stem - cell transplantation.
0.9957 We describe the exceptional development of AML and Adverse-Effectlung cancer in a patient with previously diagnosed CLL in minimal residual disease status after fludarabine treatment followed by autologous peripheral blood stem - cell transplantation.
Score Text
0.9930 Three of these patients had convulsions attributed to imipenem / cilastatin ; 3. 6 % of the patients had Adverse-Effectseizure , or 2 % of imipenem / cilastatin administrations was followed by a seizure attack.
0.9735 Three of these patients had Adverse-Effectconvulsions attributed to imipenem / cilastatin ; 3. 6 % of the patients had seizure, or 2 % of imipenem / cilastatin administrations was followed by a seizure attack.
0.9703 Three of these patients had convulsions attributed to imipenem / Drugcilastatin ; 3. 6 % of the patients had seizure, or 2 % of imipenem / cilastatin administrations was followed by a seizure attack.
0.9473 Three of these patients had convulsions attributed to Drugimipenem / cilastatin ; 3. 6 % of the patients had seizure, or 2 % of imipenem / cilastatin administrations was followed by a seizure attack.
0.9295 Three of these patients had convulsions attributed to imipenem / cilastatin ; 3. 6 % of the patients had seizure, or 2 % of imipenem / Drugcilastatin administrations was followed by a seizure attack.
0.9275 Three of these patients had convulsions attributed to imipenem / cilastatin ; 3. 6 % of the patients had seizure, or 2 % of imipenem / cilastatin administrations was followed by a Adverse-Effectseizure attack.
0.8937 Three of these patients had convulsions attributed to imipenem / cilastatin ; 3. 6 % of the patients had seizure, or 2 % of Drugimipenem / cilastatin administrations was followed by a seizure attack.
0.8805 Three of these patients had convulsions attributed to imipenem / cilastatin ; 3. 6 % of the patients had seizure, or 2 % of imipenem / cilastatin administrations was followed by a Adverse-Effectseizure attack .
Score Text
0.9995 Since elevated cortisol levels in Cushing's disease poses a threat for pancreatitis, there is a possibility that patients with Cushing's disease might be more prone to acute pancreatitis following Drugpropofol administration.
0.9314 Since elevated cortisol levels in Cushing's disease poses a threat for pancreatitis, there is a possibility that patients with Cushing's disease might be more prone to Adverse-Effectacute pancreatitis following propofol administration.
0.7611 Since elevated cortisol levels in Cushing's disease poses a threat for Adverse-Effectpancreatitis , there is a possibility that patients with Cushing's disease might be more prone to acute pancreatitis following propofol administration.
Score Text
0.9968 We report a case of torsade de pointes following a single oral dose of Drugamiodarone ( 1400 mg or 30 mg kg - 1 ) administered after short intravenous loading for prevention of paroxysmal atrial flutter.
0.9872 We report a case of Adverse-Effecttorsade de pointes following a single oral dose of amiodarone ( 1400 mg or 30 mg kg - 1 ) administered after short intravenous loading for prevention of paroxysmal atrial flutter.
Score Text
0.9993 Eighty - two patients with various malignancies who received imipenem / Drugcilastatin 143 times for neutropenic fever between March 1994 and October 1999 in Department of Pediatric Oncology, Gazi University, were identified.
0.9993 Eighty - two patients with various malignancies who received Drugimipenem / cilastatin 143 times for neutropenic fever between March 1994 and October 1999 in Department of Pediatric Oncology, Gazi University, were identified.
0.9729 Eighty - two patients with various malignancies who received imipenem / cilastatin 143 times for Adverse-Effectneutropenic fever between March 1994 and October 1999 in Department of Pediatric Oncology, Gazi University, were identified.
Score Text
0.9979 A 36 - y - o patient with schizophrenia, who had consumed gradually increasing quantities of oolong tea that eventually reached 15 L each day, became Adverse-Effectdelirious and was admitted to a psychiatric hospital.
0.9851 A 36 - y - o patient with schizophrenia, who had consumed gradually increasing quantities of Drugoolong tea that eventually reached 15 L each day, became delirious and was admitted to a psychiatric hospital.
Score Text
0.9996 In this report, two cases of ET which evolved into AL without prior exposure to radiation or alkylating agents, and which were treated with long - term Drughydroxyurea therapy, are described.
0.9908 In this report, two cases of ET which evolved into Adverse-EffectAL without prior exposure to radiation or alkylating agents, and which were treated with long - term hydroxyurea therapy, are described.
0.9448 In this report, two cases of Adverse-EffectET which evolved into AL without prior exposure to radiation or alkylating agents, and which were treated with long - term hydroxyurea therapy, are described.
Score Text
0.9980 Animals treated with DrugHAL showed a highly significant 32 % - 46 % loss of tyrosine hydroxylase ( TH ) immunoreactive neurons in the substantia nigra, and 20 % contraction of the TH stained dendritic arbour.
0.8830 Animals treated with HAL showed a highly significant 32 % - 46 % Adverse-Effectloss of tyrosine hydroxylase ( TH ) immunoreactive neurons in the substantia nigra, and 20 % contraction of the TH stained dendritic arbour.
0.7269 Animals treated with HAL showed a highly significant 32 % - 46 Adverse-Effect% loss of tyrosine hydroxylase ( TH ) immunoreactive neurons in the substantia nigra, and 20 % contraction of the TH stained dendritic arbour.
Animals treated with HAL showed a highly Adverse-Effectsignificant 32 % - 46 % loss of tyrosine hydroxylase ( TH ) immunoreactive neurons in the substantia nigra, and 20 % contraction of the TH stained dendritic arbour.
Score Text
0.9984 The patient's clinical presentation, histologic features on liver biopsy and favorable course after stopping the drug suggest that Drugbarbiturates can be added to the list of agents which can cause submassive hepatic necrosis.
0.9875 The patient's clinical presentation, histologic features on liver biopsy and favorable course after stopping the drug suggest that barbiturates can be added to the list of agents which can cause Adverse-Effectsubmassive hepatic necrosis .
Score Text
0.9995 Pneumonitis, bilateral pleural effusions, echocardiographic evidence of cardiac tamponade, and positive autoantibodies developed in a 43 - year - old man, who was receiving long - term Drugsulfasalazine therapy for chronic ulcerative colitis.
0.9984 Adverse-EffectPneumonitis , bilateral pleural effusions, echocardiographic evidence of cardiac tamponade, and positive autoantibodies developed in a 43 - year - old man, who was receiving long - term sulfasalazine therapy for chronic ulcerative colitis.
0.9866 Pneumonitis, Adverse-Effectbilateral pleural effusions , echocardiographic evidence of cardiac tamponade, and positive autoantibodies developed in a 43 - year - old man, who was receiving long - term sulfasalazine therapy for chronic ulcerative colitis.
0.9847 Pneumonitis, bilateral pleural effusions, echocardiographic evidence of Adverse-Effectcardiac tamponade , and positive autoantibodies developed in a 43 - year - old man, who was receiving long - term sulfasalazine therapy for chronic ulcerative colitis.
0.9836 Pneumonitis, bilateral pleural effusions, echocardiographic evidence of cardiac tamponade, and Adverse-Effectpositive autoantibodies developed in a 43 - year - old man, who was receiving long - term sulfasalazine therapy for chronic ulcerative colitis.
Score Text
0.9062 The present report illustrates a rare case of refractory akathisia after Druginterferon - alpha treatment and also that levodopa treatment would be theoretically and practically useful in reducing the neurotoxicity associated with interferon - alpha.
0.8896 The present report illustrates a rare case of refractory akathisia after interferon - alpha treatment and also that levodopa treatment would be theoretically and practically useful in reducing the neurotoxicity associated with Druginterferon - alpha .
0.8640 The present report illustrates a rare case of refractory akathisia after interferon - alpha treatment and also that levodopa treatment would be theoretically and practically useful in reducing the Adverse-Effectneurotoxicity associated with interferon - alpha.
0.8309 The present report illustrates a rare case of refractory Adverse-Effectakathisia after interferon - alpha treatment and also that levodopa treatment would be theoretically and practically useful in reducing the neurotoxicity associated with interferon - alpha.
0.7730 The present report illustrates a rare case of Adverse-Effectrefractory akathisia after interferon - alpha treatment and also that levodopa treatment would be theoretically and practically useful in reducing the neurotoxicity associated with interferon - alpha.
0.5569 The present report illustrates a rare case of refractory akathisia after interferon - alpha treatment and also that Druglevodopa treatment would be theoretically and practically useful in reducing the neurotoxicity associated with interferon - alpha.
Score Text
0.9988 OBJECTIVE : To report the case of a young woman with Graves'disease in whom ototoxicity developed because of Drugpropylthiouracil ( PTU ) - induced antineutrophil cytoplasmic antibody ( ANCA ) - associated vasculitis.
0.9984 OBJECTIVE : To report the case of a young woman with Graves'disease in whom ototoxicity developed because of propylthiouracil ( DrugPTU ) - induced antineutrophil cytoplasmic antibody ( ANCA ) - associated vasculitis.
0.9904 OBJECTIVE : To report the case of a young woman with Graves'disease in whom Adverse-Effectototoxicity developed because of propylthiouracil ( PTU ) - induced antineutrophil cytoplasmic antibody ( ANCA ) - associated vasculitis.
0.9409 OBJECTIVE : To report the case of a young woman with Graves'disease in whom ototoxicity developed because of propylthiouracil ( PTU ) - induced Adverse-Effectantineutrophil cytoplasmic antibody ( ANCA ) - associated vasculitis .
Score Text
0.9986 We report the case of a 20 - year - old woman originally from Cameroon who was infected by the L. loa parasite and developed severe hepatitis, identified 1 month after a single dose of Drugivermectin .
0.9912 We report the case of a 20 - year - old woman originally from Cameroon who was infected by the L. loa parasite and developed Adverse-Effectsevere hepatitis , identified 1 month after a single dose of ivermectin.
Score Text
0.9988 Rapamycin / sirolimus ( SR ), trade named Rapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with myelosuppression, Adverse-Effecthypertension , hyperlipidemia, and infection.
0.9987 DrugRapamycin / sirolimus ( SR ), trade named Rapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with myelosuppression, hypertension, hyperlipidemia, and infection.
0.9986 Rapamycin / sirolimus ( SR ), trade named Rapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with myelosuppression, hypertension, Adverse-Effecthyperlipidemia , and infection.
0.9975 Rapamycin / Drugsirolimus ( SR ), trade named Rapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with myelosuppression, hypertension, hyperlipidemia, and infection.
0.9960 Rapamycin / sirolimus ( SR ), trade named DrugRapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with myelosuppression, hypertension, hyperlipidemia, and infection.
0.9949 Rapamycin / sirolimus ( SR ), trade named Rapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with Adverse-Effectmyelosuppression , hypertension, hyperlipidemia, and infection.
0.9882 Rapamycin / sirolimus ( SR ), trade named Rapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with myelosuppression, hypertension, hyperlipidemia, and Adverse-Effectinfection .
Rapamycin / sirolimus ( DrugSR ), trade named Rapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with myelosuppression, hypertension, hyperlipidemia, and infection.
Score Text
0.9926 The main side - effects of Lp - TAE combined with HT were low - grade fever, localized pain, Adverse-Effectmyelo - suppression and liver dysfunction, but these were transient and eventually disappeared.
0.9869 The main side - effects of Lp - TAE combined with HT were low - grade fever, Adverse-Effectlocalized pain , myelo - suppression and liver dysfunction, but these were transient and eventually disappeared.
0.9865 The main side - effects of Lp - TAE combined with HT were low - grade fever, localized pain, myelo - suppression and Adverse-Effectliver dysfunction , but these were transient and eventually disappeared.
0.9843 The main side - effects of Lp - TAE combined with HT were Adverse-Effectlow - grade fever , localized pain, myelo - suppression and liver dysfunction, but these were transient and eventually disappeared.
0.9744 The main side - effects of DrugLp - TAE combined with HT were low - grade fever, localized pain, myelo - suppression and liver dysfunction, but these were transient and eventually disappeared.
0.9245 The main side - effects of Lp - TAE combined with DrugHT were low - grade fever, localized pain, myelo - suppression and liver dysfunction, but these were transient and eventually disappeared.
Score Text
0.9982 Adverse-EffectHyperkalaemia with renal tubular dysfunction by oral therapy of sulfamethoxazole - trimethoprim ( co - trimoxazole ) is described in 2 elderly Japanese patients with lymphoid malignancy, who developed Pneumocystis carinii pneumonia and improved.
0.9875 Hyperkalaemia with Adverse-Effectrenal tubular dysfunction by oral therapy of sulfamethoxazole - trimethoprim ( co - trimoxazole ) is described in 2 elderly Japanese patients with lymphoid malignancy, who developed Pneumocystis carinii pneumonia and improved.
0.9608 Hyperkalaemia with renal tubular dysfunction by oral therapy of Drugsulfamethoxazole - trimethoprim ( co - trimoxazole ) is described in 2 elderly Japanese patients with lymphoid malignancy, who developed Pneumocystis carinii pneumonia and improved.
0.9591 Hyperkalaemia with renal tubular dysfunction by oral therapy of sulfamethoxazole - trimethoprim ( Drugco - trimoxazole ) is described in 2 elderly Japanese patients with lymphoid malignancy, who developed Pneumocystis carinii pneumonia and improved.
Score Text
0.9900 A young diamond dealer developed Adverse-Effectvisual impairment attributed to bilateral posterior subcapsular cataracts following only four courses of intermittent Decadron used as part of a five - drug antiemetic regimen for cisplatin - associated nausea.
0.9804 A young diamond dealer developed visual impairment attributed to Adverse-Effectbilateral posterior subcapsular cataracts following only four courses of intermittent Decadron used as part of a five - drug antiemetic regimen for cisplatin - associated nausea.
0.9571 A young diamond dealer developed visual impairment attributed to bilateral posterior subcapsular cataracts following only four courses of intermittent DrugDecadron used as part of a five - drug antiemetic regimen for cisplatin - associated nausea.
0.8132 A young diamond dealer developed visual impairment attributed to bilateral posterior subcapsular cataracts following only four courses of intermittent Decadron used as part of a five - drug antiemetic regimen for Drugcisplatin - associated nausea.
A young diamond dealer developed visual impairment attributed to bilateral posterior subcapsular cataracts following only four courses of intermittent Decadron used as part of a five - drug antiemetic regimen for cisplatin - associated Adverse-Effectnausea .
Score Text
0.9997 A 22 - year - old black man developed fever, chills, fatigue, night sweats, tender lymphadenopathy, and a generalized, pruritic, macular eruption 3 weeks after starting Drugminocycline therapy for acne.
0.9990 A 22 - year - old black man developed fever, chills, Adverse-Effectfatigue , night sweats, tender lymphadenopathy, and a generalized, pruritic, macular eruption 3 weeks after starting minocycline therapy for acne.
0.9981 A 22 - year - old black man developed fever, Adverse-Effectchills , fatigue, night sweats, tender lymphadenopathy, and a generalized, pruritic, macular eruption 3 weeks after starting minocycline therapy for acne.
0.9915 A 22 - year - old black man developed Adverse-Effectfever , chills, fatigue, night sweats, tender lymphadenopathy, and a generalized, pruritic, macular eruption 3 weeks after starting minocycline therapy for acne.
0.9887 A 22 - year - old black man developed fever, chills, fatigue, Adverse-Effectnight sweats , tender lymphadenopathy, and a generalized, pruritic, macular eruption 3 weeks after starting minocycline therapy for acne.
0.9528 A 22 - year - old black man developed fever, chills, fatigue, night sweats, tender lymphadenopathy, and a Adverse-Effectgeneralized, pruritic, macular eruption 3 weeks after starting minocycline therapy for acne.
0.9927 A 22 - year - old black man developed fever, chills, fatigue, night sweats, Adverse-Effecttender lymphadenopathy , and a generalized, pruritic, macular eruption 3 weeks after starting minocycline therapy for acne.
Score Text
0.9933 OBJECTIVE : To report a case of chronic, nonproductive cough secondary to the angiotensin - converting enzyme ( ACE ) inhibitor Drugquinapril , with complete resolution after switching to another ACE inhibitor, fosinopril.
0.9732 OBJECTIVE : To report a case of chronic, nonproductive Adverse-Effectcough secondary to the angiotensin - converting enzyme ( ACE ) inhibitor quinapril, with complete resolution after switching to another ACE inhibitor, fosinopril.
0.9727 OBJECTIVE : To report a case of chronic, nonproductive cough secondary to the angiotensin - converting enzyme ( ACE ) inhibitor quinapril, with complete resolution after switching to another ACE inhibitor, Drugfosinopril .
Score Text
0.9972 We have described three patients with hepatitis C for whom IFN - alpha and Drugribavirin were prescribed and who developed two successive phases of silent thyroiditis followed by hyperthryroidism relapse due to Graves'disease.
0.9934 We have described three patients with hepatitis C for whom IFN - alpha and ribavirin were prescribed and who developed two successive phases of silent thyroiditis followed by Adverse-Effecthyperthryroidism relapse due to Graves'disease.
0.9829 We have described three patients with hepatitis C for whom DrugIFN - alpha and ribavirin were prescribed and who developed two successive phases of silent thyroiditis followed by hyperthryroidism relapse due to Graves'disease.
0.9473 We have described three patients with hepatitis C for whom IFN - alpha and ribavirin were prescribed and who developed two successive phases of silent Adverse-Effectthyroiditis followed by hyperthryroidism relapse due to Graves'disease.
0.6484 We have described three patients with hepatitis C for whom IFN - alpha and ribavirin were prescribed and who developed two successive phases of Adverse-Effectsilent thyroiditis followed by hyperthryroidism relapse due to Graves'disease.
Score Text
0.9966 In patients with swallowing dysfunction and pneumonia, a history of mineral oil use should be obtained and a diagnosis of Adverse-EffectELP should be considered in the differential diagnoses if mineral oil use has occurred.
0.9931 In patients with swallowing dysfunction and pneumonia, a history of Drugmineral oil use should be obtained and a diagnosis of ELP should be considered in the differential diagnoses if mineral oil use has occurred.
0.9920 In patients with swallowing dysfunction and pneumonia, a history of mineral oil use should be obtained and a diagnosis of ELP should be considered in the differential diagnoses if Drugmineral oil use has occurred.
0.9604 In patients with swallowing dysfunction and Adverse-Effectpneumonia , a history of mineral oil use should be obtained and a diagnosis of ELP should be considered in the differential diagnoses if mineral oil use has occurred.
0.8637 In patients with Adverse-Effectswallowing dysfunction and pneumonia, a history of mineral oil use should be obtained and a diagnosis of ELP should be considered in the differential diagnoses if mineral oil use has occurred.
Score Text
0.9989 CONCLUSIONS : Life - threatening adrenal suppression, requiring hydrocortisone supplementation and intensive therapy, was observed and successfully treated in a newborn, whose mother had received high - dose Drugmethylprednisolone in late pregnancy.
0.9919 CONCLUSIONS : Life - threatening Adverse-Effectadrenal suppression , requiring hydrocortisone supplementation and intensive therapy, was observed and successfully treated in a newborn, whose mother had received high - dose methylprednisolone in late pregnancy.
Score Text
0.9949 We believe the temporal association of the abnormal liver enzymes in this patient, in the absence of other offending agents, argues strongly in favor of Drug6 - TG as a cause of liver enzyme abnormalities.
0.9863 We believe the temporal association of the Adverse-Effectabnormal liver enzymes in this patient, in the absence of other offending agents, argues strongly in favor of 6 - TG as a cause of liver enzyme abnormalities.
0.9546 We believe the temporal association of the abnormal liver enzymes in this patient, in the absence of other offending agents, argues strongly in favor of 6 - TG as a cause of Adverse-Effectliver enzyme abnormalities .
Score Text
0.9991 Two patients with imminent gangrene of the extremities caused by Drugergot - induced arteriospasm underwent mechanical dilatation of the arteries when conventional measures such as anticoagulation, vasodilation, and sympathetic blockade produced no improvement.
0.9945 Two patients with imminent gangrene of the extremities caused by ergot - induced Adverse-Effectarteriospasm underwent mechanical dilatation of the arteries when conventional measures such as anticoagulation, vasodilation, and sympathetic blockade produced no improvement.
0.9390 Two patients with imminent Adverse-Effectgangrene of the extremities caused by ergot - induced arteriospasm underwent mechanical dilatation of the arteries when conventional measures such as anticoagulation, vasodilation, and sympathetic blockade produced no improvement.
Score Text
0.9995 Patients receiving Drugamifostine who develop only fever should be evaluated for an adverse drug reaction, as well as for sepsis and fevers of neutropenia, and it may be necessary to discontinue the drug.
0.9974 Patients receiving amifostine who develop only fever should be evaluated for an adverse drug reaction, as well as for Adverse-Effectsepsis and fevers of neutropenia, and it may be necessary to discontinue the drug.
0.9918 Patients receiving amifostine who develop only Adverse-Effectfever should be evaluated for an adverse drug reaction, as well as for sepsis and fevers of neutropenia, and it may be necessary to discontinue the drug.
0.9885 Patients receiving amifostine who develop only fever should be evaluated for an adverse drug reaction, as well as for sepsis and Adverse-Effectfevers of neutropenia , and it may be necessary to discontinue the drug.
Score Text
0.9889 Retrospectively, bucillamine was believed to be the cause of the Adverse-Effectgiant hypertrophy because of its structural similarity to D - penicillamine, which was the subject of an abundance of reports of mammary hyperplasia.
0.9656 Retrospectively, bucillamine was believed to be the cause of the giant hypertrophy because of its structural similarity to DrugD - penicillamine , which was the subject of an abundance of reports of mammary hyperplasia.
0.8397 Retrospectively, bucillamine was believed to be the cause of the giant hypertrophy because of its structural similarity to D - penicillamine, which was the subject of an abundance of reports of Adverse-Effectmammary hyperplasia .
0.6269 Retrospectively, Drugbucillamine was believed to be the cause of the giant hypertrophy because of its structural similarity to D - penicillamine, which was the subject of an abundance of reports of mammary hyperplasia.
0.7644 Retrospectively, bucillamine was believed to be the cause of the Adverse-Effectgiant hypertrophy because of its structural similarity to D - penicillamine, which was the subject of an abundance of reports of mammary hyperplasia.
0.7590 Retrospectively, bucillamine was believed to be the cause of the Adverse-Effectgiant hypertrophy because of its structural similarity to D - penicillamine, which was the subject of an abundance of reports of mammary hyperplasia.
0.7498 Retrospectively, bucillamine was believed to be the cause of the Adverse-Effectgiant hypertrophy because of its structural similarity to D - penicillamine, which was the subject of an abundance of reports of mammary hyperplasia.
0.7281 Retrospectively, bucillamine was believed to be the cause of the giant hypertrophy because of its structural similarity to D - penicillamine, which was the subject of an abundance of reports of Drugmammary hyperplasia.
0.6168 Retrospectively, bucillamine was believed to be the cause of the giant hypertrophy because of its structural similarity Drugto D - penicillamine , which was the subject of an abundance of reports of mammary hyperplasia.
0.5533 Retrospectively, bucillamine was believed to be the cause of the Adverse-Effectgiant hypertrophy because of its structural similarity to D - penicillamine, which was the subject of an abundance of reports of mammary hyperplasia.
0.5524 Retrospectively, bucillamine was believed to be the cause of the Adverse-Effectgiant hypertrophy because of its structural similarity to D - penicillamine, which was the subject of an abundance of reports of mammary hyperplasia.
Score Text
0.9954 Both patients were then treated with a carboplatin alternative to cisplatin in the following courses, which resulted in neither a relapse of the Adverse-Effectcolitis nor a recurrence of the malignancies up to this time.
0.9635 Both patients were then treated with a carboplatin alternative to Drugcisplatin in the following courses, which resulted in neither a relapse of the colitis nor a recurrence of the malignancies up to this time.
0.9636 Both patients were then treated with a Drugcarboplatin alternative to cisplatin in the following courses, which resulted in neither a relapse of the colitis nor a recurrence of the malignancies up to this time.
0.9510 Both patients were then treated with a carboplatin alternative to cisplatin in the following courses, which resulted in neither a relapse of the colitis nor a recurrence of the Adverse-Effectmalignancies up to this time.
Score Text
0.9991 PURPOSE / OBJECTIVES : To describe the pharmacogenetic syndrome of dihydropyrimidine dehydrogenase ( DPD ) deficiency, which predisposes patients with cancer to potentially lethal adverse reactions following Drug5 - fluorouracil ( 5 - FU ) - based chemotherapy.
0.9989 PURPOSE / OBJECTIVES : To describe the pharmacogenetic syndrome of dihydropyrimidine dehydrogenase ( DPD ) deficiency, which predisposes patients with cancer to potentially lethal adverse reactions following 5 - fluorouracil ( Drug5 - FU ) - based chemotherapy.
0.9603 PURPOSE / OBJECTIVES : To describe the pharmacogenetic syndrome of dihydropyrimidine dehydrogenase ( DPD ) deficiency, which predisposes patients with cancer to potentially Adverse-Effectlethal adverse reactions following 5 - fluorouracil ( 5 - FU ) - based chemotherapy.
Score Text
0.9995 The aim of this report is to describe the clinical and electroencephalographic findings seen in an elderly woman without previous history of seizures who developed a nonconvulsive generalized status epilepticus following acute withdrawal of Druglorazepam .
0.9855 The aim of this report is to describe the clinical and electroencephalographic findings seen in an elderly woman without previous history of seizures who developed a Adverse-Effectnonconvulsive generalized status epilepticus following acute withdrawal of lorazepam.
Score Text
0.9994 A 71 - year - old man with paroxysmal atrial fibrillation who had a previous anterior myocardial infarction exhibited granulocytopenia 8 days following the administration of oral sustained - release Drugprocainamide ( 750 mg / day ).
0.9974 A 71 - year - old man with paroxysmal atrial fibrillation who had a previous anterior myocardial infarction exhibited Adverse-Effectgranulocytopenia 8 days following the administration of oral sustained - release procainamide ( 750 mg / day ).
Score Text
0.9994 We describe a continuous ambulatory peritoneal dialysis ( CAPD ) patient that developed Drugvancomycin - induced agranulocytosis during treatment for methicillin - resistant Staphylococcus aureus ( MRSA ) - associated external cuff infection and pneumonia.
0.9967 We describe a continuous ambulatory peritoneal dialysis ( CAPD ) patient that developed vancomycin - induced Adverse-Effectagranulocytosis during treatment for methicillin - resistant Staphylococcus aureus ( MRSA ) - associated external cuff infection and pneumonia.
Score Text
0.9993 Although Drugisradipine has been associated with hepatocellular injury, there are no reports of fulminant liver failure with this agent, and our patient had been treated for > 2 years without signs of toxicity.
0.9749 Although isradipine has been associated with Adverse-Effecthepatocellular injury , there are no reports of fulminant liver failure with this agent, and our patient had been treated for > 2 years without signs of toxicity.
0.9888 Although isradipine has been associated with hepatocellular injury, there are no reports of Adverse-Effectfulminant liver failure with this agent, and our patient had been treated for > 2 years without signs of toxicity.
Score Text
0.9996 We describe a patient with CREST syndrome ( calcinosis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly, and telangiectasia ) who paradoxically experienced worsening of Raynaud's phenomenon when using Drugyohimbine for ED.
0.9826 We describe a patient with CREST syndrome ( calcinosis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly, and telangiectasia ) who paradoxically experienced Adverse-Effectworsening of Raynaud's phenomenon when using yohimbine for ED.
Score Text
0.9996 A patient is described with the characteristic features of Drugphenytoin hypersensitivity syndrome ( PHS ) including fever, erythroderma, tibial and facial oedema, pinhead - sized facial pustules and abnormal liver function tests.
0.9975 A patient is described with the characteristic features of phenytoin hypersensitivity syndrome ( PHS ) including fever, Adverse-Effecterythroderma , tibial and facial oedema, pinhead - sized facial pustules and abnormal liver function tests.
0.9906 A patient is described with the characteristic features of phenytoin hypersensitivity syndrome ( PHS ) including Adverse-Effectfever , erythroderma, tibial and facial oedema, pinhead - sized facial pustules and abnormal liver function tests.
0.9893 A patient is described with the characteristic features of phenytoin hypersensitivity syndrome ( PHS ) including fever, erythroderma, tibial and facial oedema, pinhead - sized facial pustules and Adverse-Effectabnormal liver function tests .
0.9836 A patient is described with the characteristic features of phenytoin hypersensitivity syndrome ( PHS ) including fever, erythroderma, tibial and facial oedema, Adverse-Effectpinhead - sized facial pustules and abnormal liver function tests.
0.9707 A patient is described with the characteristic features of phenytoin hypersensitivity syndrome ( PHS ) including fever, erythroderma, Adverse-Effecttibial and facial oedema , pinhead - sized facial pustules and abnormal liver function tests.
A patient is described with the characteristic features of Adverse-Effectphenytoin hypersensitivity syndrome ( PHS ) including fever, erythroderma, tibial and facial oedema, pinhead - sized facial pustules and abnormal liver function tests.
Score Text
0.9991 Although transient increases in ectopy after Drugbretylium therapy have been described, presumably due to catecholamine release, the occurrence of life - threatening ventricular arrhythmia leading to cardiac arrest has not previously been emphasized.
0.9943 Although transient increases in ectopy after bretylium therapy have been described, presumably due to catecholamine release, the occurrence of life - threatening ventricular arrhythmia leading to Adverse-Effectcardiac arrest has not previously been emphasized.
0.9178 Although transient increases in ectopy after bretylium therapy have been described, presumably due to catecholamine release, the occurrence of life - threatening Adverse-Effectventricular arrhythmia leading to cardiac arrest has not previously been emphasized.
Score Text
0.9980 We report a case of Adverse-Effectpancytopenia in a 23 - year - old man with Crohn's disease who was treated with 5 - aminosalicylic acid ( Pentasa ; Nisshin, Tokyo, Japan ) 3. 0 g / day.
0.9923 We report a case of pancytopenia in a 23 - year - old man with Crohn's disease who was treated with 5 - aminosalicylic acid ( DrugPentasa ; Nisshin, Tokyo, Japan ) 3. 0 g / day.
0.9805 We report a case of pancytopenia in a 23 - year - old man with Crohn's disease who was treated with Drug5 - aminosalicylic acid ( Pentasa ; Nisshin, Tokyo, Japan ) 3. 0 g / day.
0.9508 We report a case of pancytopenia in a 23 - year - old man with Crohn's disease who was treated with 5 - aminosalicylic acid ( Pentasa ; DrugNisshin , Tokyo, Japan ) 3. 0 g / day.
Score Text
0.9984 Extrapyramidal side effects induced by some selective serotonin reuptake inhibitors ( SSRIs ), i. e. fluoxetine and Drugsertraline , have been previously reported in patients with depression and obsessive - compulsive disorder ( OCD ).
0.9983 Extrapyramidal side effects induced by some selective serotonin reuptake inhibitors ( SSRIs ), i. e. Drugfluoxetine and sertraline, have been previously reported in patients with depression and obsessive - compulsive disorder ( OCD ).
0.9894 Adverse-EffectExtrapyramidal side effects induced by some selective serotonin reuptake inhibitors ( SSRIs ), i. e. fluoxetine and sertraline, have been previously reported in patients with depression and obsessive - compulsive disorder ( OCD ).
Score Text
0.9995 Because Drugetoposide - induced pulmonary toxicity is an uncommon but serious adverse event, clinicians must be vigilant about the possibility of it, so that the optimal treatment can start as soon as possible.
0.9923 Because etoposide - induced Adverse-Effectpulmonary toxicity is an uncommon but serious adverse event, clinicians must be vigilant about the possibility of it, so that the optimal treatment can start as soon as possible.
Score Text
0.9887 Five cases ( four from the literature and one new case ) are presented in which patients unsuspected of having vitamin B12 deficiency developed subacute combined degeneration of the spinal cord following Drugnitrous oxide anesthesia.
0.9759 Five cases ( four from the literature and one new case ) are presented in which patients unsuspected of having vitamin B12 deficiency developed Adverse-Effectsubacute combined degeneration of the spinal cord following nitrous oxide anesthesia.
Score Text
0.9992 We describe a case of a man treated with an EGFR - inhibitor ( Drugerlotinib ) for a cell lung cancer who developed skin manifestations localized in an uncommon area and with an atypical evolution.
0.9979 We describe a case of a man treated with an EGFR - inhibitor ( erlotinib ) for a cell lung cancer who developed Adverse-Effectskin manifestations localized in an uncommon area and with an atypical evolution.
Score Text
0.9941 Physicians should be cognizant of this potential complication in patients receiving thalidomide or thalidomide - like drugs who present with Adverse-Effectfever and pulmonary infiltrates and fail to improve despite treatment with broad - spectrum antibiotics.
0.9925 Physicians should be cognizant of this potential complication in patients receiving thalidomide or thalidomide - like drugs who present with fever and Adverse-Effectpulmonary infiltrates and fail to improve despite treatment with broad - spectrum antibiotics.
0.9746 Physicians should be cognizant of this potential complication in patients receiving Drugthalidomide or thalidomide - like drugs who present with fever and pulmonary infiltrates and fail to improve despite treatment with broad - spectrum antibiotics.
0.9239 Physicians should be cognizant of this potential complication in patients receiving thalidomide or Drugthalidomide - like drugs who present with fever and pulmonary infiltrates and fail to improve despite treatment with broad - spectrum antibiotics.
Score Text
0.9913 This article describes two cases of Adverse-Effectaplastic anemia , at least one of which was almost certainly induced by the use of methazolamide, and one case of agranulocytosis related to the use of methazolamide.
0.9767 This article describes two cases of aplastic anemia, at least one of which was almost certainly induced by the use of methazolamide, and one case of Adverse-Effectagranulocytosis related to the use of methazolamide.
0.9263 This article describes two cases of aplastic anemia, at least one of which was almost certainly induced by the use of Drugmethazolamide , and one case of agranulocytosis related to the use of methazolamide.
0.8911 This article describes two cases of aplastic anemia, at least one of which was almost certainly induced by the use of methazolamide, and one case of agranulocytosis related to the use of Drugmethazolamide .
Score Text
0.9996 Common adverse events ( frequency 10 % ) of Druglacosamide doses up to 600 mg / day include nonspecific central nervous system effects ( e. g., dizziness, ataxia, diplopia, and somnolence ).
0.9988 Common adverse events ( frequency 10 % ) of lacosamide doses up to 600 mg / day include nonspecific central nervous system effects ( e. g., dizziness, ataxia, Adverse-Effectdiplopia , and somnolence ).
0.9988 Common adverse events ( frequency 10 % ) of lacosamide doses up to 600 mg / day include nonspecific central nervous system effects ( e. g., dizziness, ataxia, diplopia, and Adverse-Effectsomnolence ).
0.9986 Common adverse events ( frequency 10 % ) of lacosamide doses up to 600 mg / day include nonspecific central nervous system effects ( e. g., Adverse-Effectdizziness , ataxia, diplopia, and somnolence ).
0.9984 Common adverse events ( frequency 10 % ) of lacosamide doses up to 600 mg / day include nonspecific central nervous system effects ( e. g., dizziness, Adverse-Effectataxia , diplopia, and somnolence ).
0.7731 Common adverse events ( frequency 10 % ) of lacosamide doses up to 600 mg / day include Adverse-Effectnonspecific central nervous system effects ( e. g., dizziness, ataxia, diplopia, and somnolence ).
0.5843 Common adverse events ( frequency 10 % ) of lacosamide doses up to 600 mg / day include nonspecific Adverse-Effectcentral nervous system effects ( e. g., dizziness, ataxia, diplopia, and somnolence ).
Score Text
0.9995 In this healthy population, the relative risk of developing endometrial carcinoma in the Drugtamoxifen arm was 2. 54, although when stratified by age, in women over 50, the risk grew to 4. 01.
0.9883 In this healthy population, the relative risk of developing Adverse-Effectendometrial carcinoma in the tamoxifen arm was 2. 54, although when stratified by age, in women over 50, the risk grew to 4. 01.
Score Text
0.9994 METHODS : We queried 35 rheumatologists at the Robert Breck Brigham Arthritis Center to determine if weight loss had occurred as an adverse event in patients treated with Drugleflunomide between November 1998 and January 2000.
0.9938 METHODS : We queried 35 rheumatologists at the Robert Breck Brigham Arthritis Center to determine if Adverse-Effectweight loss had occurred as an adverse event in patients treated with leflunomide between November 1998 and January 2000.
Score Text
0.9955 A sixty - year - old woman with advanced breast cancer, previously treated with cisplatin, developed an irreversible lethal renal failure with Adverse-Effectanuria , the day after 5 g / m2 bolus ifosfamide.
0.9898 A sixty - year - old woman with advanced breast cancer, previously treated with cisplatin, developed an irreversible lethal renal failure with anuria, the day after 5 g / m2 bolus Drugifosfamide .
0.8648 A sixty - year - old woman with advanced breast cancer, previously treated with cisplatin, developed an Adverse-Effectirreversible lethal renal failure with anuria, the day after 5 g / m2 bolus ifosfamide.
0.9600 A sixty - year - old woman with advanced breast cancer, previously treated with Drugcisplatin , developed an irreversible lethal renal failure with anuria, the day after 5 g / m2 bolus ifosfamide.
0.6471 A sixty - year - old woman with advanced breast cancer, previously treated with cisplatin, developed an irreversible Adverse-Effectlethal renal failure with anuria, the day after 5 g / m2 bolus ifosfamide.
Score Text
0.9790 Until additional data are available, if intravenous acyclovir is administered concurrently with lithium, we recommend closely monitoring patients for signs of Druglithium toxicity and measuring serum lithium levels every second or third day.
0.9683 Until additional data are available, if intravenous Drugacyclovir is administered concurrently with lithium, we recommend closely monitoring patients for signs of lithium toxicity and measuring serum lithium levels every second or third day.
0.9379 Until additional data are available, if intravenous acyclovir is administered concurrently with lithium, we recommend closely monitoring patients for signs of Adverse-Effectlithium toxicity and measuring serum lithium levels every second or third day.
0.9518 Until additional data are available, if intravenous acyclovir is administered concurrently with Druglithium , we recommend closely monitoring patients for signs of lithium toxicity and measuring serum lithium levels every second or third day.
Score Text
0.9928 Although they had complex medical problems, the high serum concentrations of ampicillin at the time of seizures without their recurrence after discontinuing the antibiotic suggest that the seizures were related to the Drugampicillin therapy.
0.9922 Although they had complex medical problems, the high serum concentrations of ampicillin at the time of seizures without their recurrence after discontinuing the antibiotic suggest that the Adverse-Effectseizures were related to the ampicillin therapy.
0.9806 Although they had complex medical problems, the high serum concentrations of Drugampicillin at the time of seizures without their recurrence after discontinuing the antibiotic suggest that the seizures were related to the ampicillin therapy.
0.8843 Although they had complex medical problems, the high serum concentrations of ampicillin at the time of Adverse-Effectseizures without their recurrence after discontinuing the antibiotic suggest that the seizures were related to the ampicillin therapy.
Score Text
0.9994 We present a case of an elderly woman with a pre - existing history of ischaemic heart disease, who was treated with Drugvenlafaxine , and developed acute myocardial ischaemia within the first week of treatment.
0.9918 We present a case of an elderly woman with a pre - existing history of ischaemic heart disease, who was treated with venlafaxine, and developed Adverse-Effectacute myocardial ischaemia within the first week of treatment.
Score Text
0.9995 We report a patient with recurrent, increasingly severe episodes of PPE, ultimately complicated by a severe bullous eruption, following successive cycles of high - dose Drugcytarabine for the treatment of acute lymphoblastic leukaemia.
0.9820 We report a patient with recurrent, increasingly severe episodes of Adverse-EffectPPE , ultimately complicated by a severe bullous eruption, following successive cycles of high - dose cytarabine for the treatment of acute lymphoblastic leukaemia.
0.9107 We report a patient with recurrent, increasingly severe episodes of PPE, ultimately complicated by a severe Adverse-Effectbullous eruption , following successive cycles of high - dose cytarabine for the treatment of acute lymphoblastic leukaemia.
0.9060 We report a patient with recurrent, increasingly severe episodes of PPE, ultimately complicated by a Adverse-Effectsevere bullous eruption , following successive cycles of high - dose cytarabine for the treatment of acute lymphoblastic leukaemia.
Score Text
0.9852 The evidence of high plasmatic levels of DrugCBZ and the absence of other aetiologic factors lead the authors to conclude that the overdose of CBZ could have represented the precipitating of the episode of acute pancreatitis.
0.9837 The evidence of high plasmatic levels of CBZ and the absence of other aetiologic factors lead the authors to conclude that the overdose of DrugCBZ could have represented the precipitating of the episode of acute pancreatitis.
0.9707 The evidence of high plasmatic levels of CBZ and the absence of other aetiologic factors lead the authors to conclude that the overdose of CBZ could have represented the precipitating of the episode of Adverse-Effectacute pancreatitis .
Score Text
0.9980 Assessment of cortisol response was by insulin - induced Adverse-Effecthypoglycaemia in three cases, by short tetracosactrin test in two, and by low - dose tetracosactrin and 24 - hour urinary cortisol / creatinine ratio in one.
0.9907 Assessment of cortisol response was by Druginsulin - induced hypoglycaemia in three cases, by short tetracosactrin test in two, and by low - dose tetracosactrin and 24 - hour urinary cortisol / creatinine ratio in one.
Score Text
0.9992 A case of anaphylactoid reaction due solely to the use of DrugGelofusine in a patient with non - haemorrhagic hypovolaemia is presented, with a discussion on the management and the use of allergy identification jewellery.
0.9931 A case of Adverse-Effectanaphylactoid reaction due solely to the use of Gelofusine in a patient with non - haemorrhagic hypovolaemia is presented, with a discussion on the management and the use of allergy identification jewellery.
Score Text
0.9896 CONCLUSION : While Adverse-Effectthrombosis has been reported with GnRH - a therapy in men with prostate cancer, its association with treatment in this benign case may have been a consequence of the massive tumor size.
0.9708 CONCLUSION : While thrombosis has been reported with DrugGnRH - a therapy in men with prostate cancer, its association with treatment in this benign case may have been a consequence of the massive tumor size.
0.9480 CONCLUSION : While thrombosis has been reported with GnRH - a therapy in men with prostate cancer, its association with treatment in this benign case may have been a consequence of the Adverse-Effectmassive tumor size .
Score Text
0.9795 Idiosyncratic factors involving vasopressin receptor affinity and distribution, vasopressin - associated vasodilation in some vascular beds, and the effect of vasopressin on the renin - angiotensin system may further contribute to Adverse-Effectimpaired tissue perfusion .
0.9307 Idiosyncratic factors involving vasopressin receptor affinity and distribution, vasopressin - associated Adverse-Effectvasodilation in some vascular beds, and the effect of vasopressin on the renin - angiotensin system may further contribute to impaired tissue perfusion.
0.8983 Idiosyncratic factors involving vasopressin receptor affinity and distribution, Drugvasopressin - associated vasodilation in some vascular beds, and the effect of vasopressin on the renin - angiotensin system may further contribute to impaired tissue perfusion.
0.7965 Idiosyncratic factors involving vasopressin receptor affinity and distribution, vasopressin - associated vasodilation in some vascular beds, and the effect of Drugvasopressin on the renin - angiotensin system may further contribute to impaired tissue perfusion.
Score Text
0.9992 A 35 - year - old woman presented with neurotoxicity correlated to an i. v. regimen of Drug5 - fluorouracil as episodes of acute confusional state and abnormalities of symmetrically restricted diffusion in the periventricular white matter and corpus callosum.
0.9966 A 35 - year - old woman presented with Adverse-Effectneurotoxicity correlated to an i. v. regimen of 5 - fluorouracil as episodes of acute confusional state and abnormalities of symmetrically restricted diffusion in the periventricular white matter and corpus callosum.
0.9662 A 35 - year - old woman presented with neurotoxicity correlated to an i. v. regimen of 5 - fluorouracil as episodes of Adverse-Effectacute confusional state and abnormalities of symmetrically restricted diffusion in the periventricular white matter and corpus callosum.
Score Text
0.9991 Nine eyes from 6 patients, 74 years to 90 years of age, referred by ophthalmologists for repair of cicatricial entropion after at least 2 years of twice - a - day application of Drugdipivefrin .
0.9924 Nine eyes from 6 patients, 74 years to 90 years of age, referred by ophthalmologists for repair of Adverse-Effectcicatricial entropion after at least 2 years of twice - a - day application of dipivefrin.
Score Text
0.9994 DrugMethotrexate - associated nephropathy is a rare complication in pediatric oncology, and a review of the literature suggests that exposure to nephrotoxic agents may be a significant but perhaps underrecognized risk factor for its development.
0.9976 Methotrexate - associated Adverse-Effectnephropathy is a rare complication in pediatric oncology, and a review of the literature suggests that exposure to nephrotoxic agents may be a significant but perhaps underrecognized risk factor for its development.
Score Text
0.9656 In this paper, we report a case of severe hypercalcemia of immobilization in a 40 - year - old hemodialyzed woman treated by Drugcinacalcet HCl for a severe HPTH - II ( PTH > 1, 000 pg / mL ).
0.9524 In this paper, we report a case of Adverse-Effectsevere hypercalcemia of immobilization in a 40 - year - old hemodialyzed woman treated by cinacalcet HCl for a severe HPTH - II ( PTH > 1, 000 pg / mL ).
Score Text
0.9987 Although combinations of belladonna, Drugergotamine , and phenobarbital have been used for medical treatment of menopausal symptoms since the 1960s, this is the first known case report of its association with anticonvulsant hypersensitivity syndrome.
0.9987 Although combinations of Drugbelladonna , ergotamine, and phenobarbital have been used for medical treatment of menopausal symptoms since the 1960s, this is the first known case report of its association with anticonvulsant hypersensitivity syndrome.
0.9984 Although combinations of belladonna, ergotamine, and Drugphenobarbital have been used for medical treatment of menopausal symptoms since the 1960s, this is the first known case report of its association with anticonvulsant hypersensitivity syndrome.
0.9887 Although combinations of belladonna, ergotamine, and phenobarbital have been used for medical treatment of menopausal symptoms since the 1960s, this is the first known case report of its association with Adverse-Effectanticonvulsant hypersensitivity syndrome .
0.7510 Although combinations of belladonna, ergotamine, and phenobarbital have been used for medical treatment of Adverse-Effectmenopausal symptoms since the 1960s, this is the first known case report of its association with anticonvulsant hypersensitivity syndrome.
Score Text
0.9816 OBJECTIVE : To report the occurrence of Adverse-Effectacute cytolytic hepatitis in a patient exposed to pulse itraconazole therapy for 24 weeks and provide a concise review of the literature on cases of itraconazole - induced hepatitis.
0.9615 OBJECTIVE : To report the occurrence of acute cytolytic hepatitis in a patient exposed to pulse itraconazole therapy for 24 weeks and provide a concise review of the literature on cases of itraconazole - induced Adverse-Effecthepatitis .
0.9457 OBJECTIVE : To report the occurrence of acute cytolytic hepatitis in a patient exposed to pulse itraconazole therapy for 24 weeks and provide a concise review of the literature on cases of Drugitraconazole - induced hepatitis.
0.9008 OBJECTIVE : To report the occurrence of acute cytolytic hepatitis in a patient exposed to pulse Drugitraconazole therapy for 24 weeks and provide a concise review of the literature on cases of itraconazole - induced hepatitis.
Score Text
0.9966 INTRODUCTION : In resource limited settings patients on antiretroviral treatment who develop stavudine induced Adverse-Effecthyperlactatemia are often switched to zidovudine on the basis of published studies that demonstrate that this agent can be a safe alternative.
0.9955 INTRODUCTION : In resource limited settings patients on antiretroviral treatment who develop Drugstavudine induced hyperlactatemia are often switched to zidovudine on the basis of published studies that demonstrate that this agent can be a safe alternative.
Score Text
0.9996 CONCLUSIONS : Although Drugmirtazapine offers clinicians a combination of strong efficacy and good safety, we suggest bearing SS in mind when prescribing this drug, especially in frail, elderly patients with underlying chronic conditions.
0.9947 CONCLUSIONS : Although mirtazapine offers clinicians a combination of strong efficacy and good safety, we suggest bearing Adverse-EffectSS in mind when prescribing this drug, especially in frail, elderly patients with underlying chronic conditions.
Score Text
0.9992 The first reported case, in an adult, of Drugcholestyramine induced hyperchloremic metabolic acidosis is a 70 year old female with a two year history of primary biliary cirrhosis confirmed by histologic and immunologic criteria.
0.9874 The first reported case, in an adult, of cholestyramine induced Adverse-Effecthyperchloremic metabolic acidosis is a 70 year old female with a two year history of primary biliary cirrhosis confirmed by histologic and immunologic criteria.
Score Text
0.9855 We have successfully overcome severe neutropenia in an RA patient treated with Druggold salts, using granulocyte colony - stimulating factor ( G - CSF ), reducing the duration of neutropenia and risk of infection.
0.9778 We have successfully overcome Adverse-Effectsevere neutropenia in an RA patient treated with gold salts, using granulocyte colony - stimulating factor ( G - CSF ), reducing the duration of neutropenia and risk of infection.
Score Text
0.9985 We report the case of a lung cancer patient with bronquiloalveolar carcinoma ( BAC ) presenting with BOOP after chemotherapy with Drugdocetaxel and gemcitabine producing severe respiratory insufficiency, and simulating a progression of the tumor.
0.9985 We report the case of a lung cancer patient with bronquiloalveolar carcinoma ( BAC ) presenting with BOOP after chemotherapy with docetaxel and Druggemcitabine producing severe respiratory insufficiency, and simulating a progression of the tumor.
0.9981 We report the case of a lung cancer patient with bronquiloalveolar carcinoma ( BAC ) presenting with Adverse-EffectBOOP after chemotherapy with docetaxel and gemcitabine producing severe respiratory insufficiency, and simulating a progression of the tumor.
0.9711 We report the case of a lung cancer patient with bronquiloalveolar carcinoma ( BAC ) presenting with BOOP after chemotherapy with docetaxel and gemcitabine producing Adverse-Effectsevere respiratory insufficiency , and simulating a progression of the tumor.
0.9681 We report the case of a lung cancer patient with bronquiloalveolar carcinoma ( BAC ) presenting with BOOP after chemotherapy with docetaxel and gemcitabine producing severe respiratory insufficiency, and simulating a Adverse-Effectprogression of the tumor .
Score Text
0.9835 This report details a case of Adverse-Effectbilateral avascular necrosis of the femoral heads in a patient receiving'standard'doses of dexamethasone as part of the antiemetic regimen used in cisplatin - based combination chemotherapy.
0.9750 This report details a case of bilateral avascular necrosis of the femoral heads in a patient receiving'standard'doses of Drugdexamethasone as part of the antiemetic regimen used in cisplatin - based combination chemotherapy.
0.7590 This report details a case of bilateral avascular necrosis of the femoral heads in a patient receiving'standard'doses of dexamethasone as part of the antiemetic regimen used in Drugcisplatin - based combination chemotherapy.
Score Text
0.9985 In the present paper the authors describe 2 female patients who developed Adverse-Effectincontinence secondary to the selective serotonin reuptake inhibitors paroxetine and sertraline, as well as a third who developed this side effect on venlafaxine.
0.9967 In the present paper the authors describe 2 female patients who developed incontinence secondary to the selective serotonin reuptake inhibitors paroxetine and sertraline, as well as a third who developed this side effect on Drugvenlafaxine .
0.9959 In the present paper the authors describe 2 female patients who developed incontinence secondary to the selective serotonin reuptake inhibitors paroxetine and Drugsertraline , as well as a third who developed this side effect on venlafaxine.
0.9941 In the present paper the authors describe 2 female patients who developed incontinence secondary to the selective serotonin reuptake inhibitors Drugparoxetine and sertraline, as well as a third who developed this side effect on venlafaxine.
Score Text
0.9987 Exacerbation of Drug5 - FU dermatologic toxicities in patients with preexisting conditions suggests the importance of aggressive ocular prophylaxis, using frequent ocular lubrication and topical steroid preparations with concurrent medical management of pre - existing dermatologic conditions.
0.9518 Exacerbation of 5 - FU Adverse-Effectdermatologic toxicities in patients with preexisting conditions suggests the importance of aggressive ocular prophylaxis, using frequent ocular lubrication and topical steroid preparations with concurrent medical management of pre - existing dermatologic conditions.
Score Text
0.9904 In this report, two newborns with congenital heart anomalies demonstrated the Adverse-Effectharlequin color change , one whose skin findings showed a course related to the dose of systemic prostaglandin E1, suggesting a possible association.
0.9868 In this report, two newborns with congenital heart anomalies demonstrated the harlequin color change, one whose skin findings showed a course related to the dose of systemic Drugprostaglandin E1 , suggesting a possible association.
Score Text
0.9975 One explanation for the noted increase in the Drugtheophylline level is that metabolism occurs mainly by cytochrome P450 ( CYP 1A2 ), an enzyme that is known to be inhibited with high concentrations of zafirlukast.
0.9972 One explanation for the noted increase in the theophylline level is that metabolism occurs mainly by cytochrome P450 ( CYP 1A2 ), an enzyme that is known to be inhibited with high concentrations of Drugzafirlukast .
0.6536 One explanation for the noted Adverse-Effectincrease in the theophylline level is that metabolism occurs mainly by cytochrome P450 ( CYP 1A2 ), an enzyme that is known to be inhibited with high concentrations of zafirlukast.
Score Text
0.9948 With the use of optical coherence tomography ( OCT ), two patients with IFN - associated retinopathy who had developed Adverse-Effectmacular edema and reduced visual acuity during the clinical course of IFN therapy were observed.
0.9931 With the use of optical coherence tomography ( OCT ), two patients with IFN - associated Adverse-Effectretinopathy who had developed macular edema and reduced visual acuity during the clinical course of IFN therapy were observed.
0.9920 With the use of optical coherence tomography ( OCT ), two patients with IFN - associated retinopathy who had developed macular edema and Adverse-Effectreduced visual acuity during the clinical course of IFN therapy were observed.
0.9810 With the use of optical coherence tomography ( OCT ), two patients with DrugIFN - associated retinopathy who had developed macular edema and reduced visual acuity during the clinical course of IFN therapy were observed.
0.9626 With the use of optical coherence tomography ( OCT ), two patients with IFN - associated retinopathy who had developed macular edema and reduced visual acuity during the clinical course of DrugIFN therapy were observed.
Score Text
0.9983 A case of sideroblastic anemia is presented in a patient with a left ventricular assist device drive - line infection who was receiving Druglinezolid , an antibiotic used for serious infections with gram - positive organisms.
0.9912 A case of Adverse-Effectsideroblastic anemia is presented in a patient with a left ventricular assist device drive - line infection who was receiving linezolid, an antibiotic used for serious infections with gram - positive organisms.
Score Text
0.9989 We introduce a case of a sixty years old woman with several previous episodes of Adverse-Effectrhinitis , conjunctivitis and perspiration immediately after the administration of salmon calcitonin with nasal spray or intramuscular administration ( Calsynar ).
0.9978 We introduce a case of a sixty years old woman with several previous episodes of rhinitis, conjunctivitis and Adverse-Effectperspiration immediately after the administration of salmon calcitonin with nasal spray or intramuscular administration ( Calsynar ).
0.9973 We introduce a case of a sixty years old woman with several previous episodes of rhinitis, Adverse-Effectconjunctivitis and perspiration immediately after the administration of salmon calcitonin with nasal spray or intramuscular administration ( Calsynar ).
0.9971 We introduce a case of a sixty years old woman with several previous episodes of rhinitis, conjunctivitis and perspiration immediately after the administration of salmon calcitonin with nasal spray or intramuscular administration ( DrugCalsynar ).
0.9969 We introduce a case of a sixty years old woman with several previous episodes of rhinitis, conjunctivitis and perspiration immediately after the administration of salmon Drugcalcitonin with nasal spray or intramuscular administration ( Calsynar ).
Score Text
0.9995 Videopolysomnographic and pharmacokinetic studies with monitoring of plasma Druglevodopa levels demonstrated marked motor hyperactivity during augmentation, with anarchic discharges of motor unit potentials, tonic grouped discharges and flexor spasms, associated with painful dysesthesia.
0.9922 Videopolysomnographic and pharmacokinetic studies with monitoring of plasma levodopa levels demonstrated marked motor hyperactivity during augmentation, with anarchic discharges of motor unit potentials, tonic grouped discharges and flexor spasms, associated with Adverse-Effectpainful dysesthesia .
0.9893 Videopolysomnographic and pharmacokinetic studies with monitoring of plasma levodopa levels demonstrated marked motor hyperactivity during augmentation, with anarchic discharges of motor unit potentials, tonic grouped discharges and Adverse-Effectflexor spasms , associated with painful dysesthesia.
0.9863 Videopolysomnographic and pharmacokinetic studies with monitoring of plasma levodopa levels demonstrated Adverse-Effectmarked motor hyperactivity during augmentation, with anarchic discharges of motor unit potentials, tonic grouped discharges and flexor spasms, associated with painful dysesthesia.
0.9809 Videopolysomnographic and pharmacokinetic studies with monitoring of plasma levodopa levels demonstrated marked motor hyperactivity during augmentation, with anarchic discharges of motor unit potentials, Adverse-Effecttonic grouped discharges and flexor spasms, associated with painful dysesthesia.
0.9806 Videopolysomnographic and pharmacokinetic studies with monitoring of plasma levodopa levels demonstrated marked motor hyperactivity during augmentation, with Adverse-Effectanarchic discharges of motor unit potentials , tonic grouped discharges and flexor spasms, associated with painful dysesthesia.
Score Text
0.9989 Currently the use of Drugzidovudine is one of the few specific measures available, and as a potentially teratogenic and fetotoxic agent, any decision for its use requires evaluation of the potential for fetal damage.
0.9924 Currently the use of zidovudine is one of the few specific measures available, and as a potentially Adverse-Effectteratogenic and fetotoxic agent, any decision for its use requires evaluation of the potential for fetal damage.
0.9832 Currently the use of zidovudine is one of the few specific measures available, and as a potentially teratogenic and fetotoxic agent, any decision for its use requires evaluation of the potential for Adverse-Effectfetal damage .
0.8788 Currently the use of zidovudine is one of the few specific measures available, and as a potentially teratogenic and Adverse-Effectfetotoxic agent, any decision for its use requires evaluation of the potential for fetal damage.
Score Text
0.9989 A patient is presented with typical hyperthyroidism, who developed a severe proximal muscle weakness and a raised creatine phosphokinase after treatment for hyperthyroidism with Drugpropylthiouracil ( 100 mg orally, three times a day ).
0.9894 A patient is presented with typical hyperthyroidism, who developed a Adverse-Effectsevere proximal muscle weakness and a raised creatine phosphokinase after treatment for hyperthyroidism with propylthiouracil ( 100 mg orally, three times a day ).
0.9891 A patient is presented with typical hyperthyroidism, who developed a severe proximal muscle weakness and a Adverse-Effectraised creatine phosphokinase after treatment for hyperthyroidism with propylthiouracil ( 100 mg orally, three times a day ).
0.8606 A patient is presented with typical Adverse-Effecthyperthyroidism , who developed a severe proximal muscle weakness and a raised creatine phosphokinase after treatment for hyperthyroidism with propylthiouracil ( 100 mg orally, three times a day ).
Score Text
0.9885 After a six - week course of low - dose Drugcyclosporine A , she developed a severe but reversible loss of glomerular filtration rate and effective renal plasma flow despite of low cyclosporine A plasma levels.
0.9701 After a six - week course of low - dose cyclosporine A, she developed a severe but reversible loss of glomerular filtration rate and Adverse-Effecteffective renal plasma flow despite of low cyclosporine A plasma levels.
0.9527 After a six - week course of low - dose cyclosporine A, she developed a severe but reversible Adverse-Effectloss of glomerular filtration rate and effective renal plasma flow despite of low cyclosporine A plasma levels.
0.8603 After a six - week course of low - dose cyclosporine A, she developed a severe but Adverse-Effectreversible loss of glomerular filtration rate and effective renal plasma flow despite of low cyclosporine A plasma levels.
Score Text
0.9996 We suggest that the previous classification of Drugnitrofurantoin induced lung injury into " acute " and " chronic " injury is an oversimplification in view of the wide variety of pathological entities that have subsequently emerged.
0.9733 We suggest that the previous classification of nitrofurantoin induced Adverse-Effectlung injury into " acute " and " chronic " injury is an oversimplification in view of the wide variety of pathological entities that have subsequently emerged.
We suggest that the previous classification of Adverse-Effectnitrofurantoin induced lung injury into " acute " and " chronic " injury is an oversimplification in view of the wide variety of pathological entities that have subsequently emerged.
Score Text
0.9904 OBJECTIVE : To report the clinical course of a woman with cryptococcal meningitis and no previous cardiac disease who developed a Adverse-Effectfatal cardiac arrhythmia after an acute overdose of amphotericin B and to review its toxicity.
0.9873 OBJECTIVE : To report the clinical course of a woman with cryptococcal meningitis and no previous cardiac disease who developed a fatal cardiac arrhythmia after an acute overdose of Drugamphotericin B and to review its toxicity.
Score Text
0.9989 The following is a case report analysis intended to draw attention to the need for better care coordination by describing the observed relationship of Drugolanzapine to metabolic changes manifested as uncontrolled diabetes mellitus and weight gain.
0.9949 The following is a case report analysis intended to draw attention to the need for better care coordination by describing the observed relationship of olanzapine to metabolic changes manifested as uncontrolled diabetes mellitus and Adverse-Effectweight gain .
0.9765 The following is a case report analysis intended to draw attention to the need for better care coordination by describing the observed relationship of olanzapine to metabolic changes manifested as Adverse-Effectuncontrolled diabetes mellitus and weight gain.
Score Text
0.9969 We consider asterixis to be an easily overlooked sign of Adverse-Effectneurotoxicity , which may occur even at low or moderate dosage levels, if certain drugs as lithium or clozapine are used in combination with CBZ.
0.9964 We consider Adverse-Effectasterixis to be an easily overlooked sign of neurotoxicity, which may occur even at low or moderate dosage levels, if certain drugs as lithium or clozapine are used in combination with CBZ.
0.9940 We consider asterixis to be an easily overlooked sign of neurotoxicity, which may occur even at low or moderate dosage levels, if certain drugs as lithium or Drugclozapine are used in combination with CBZ.
0.9933 We consider asterixis to be an easily overlooked sign of neurotoxicity, which may occur even at low or moderate dosage levels, if certain drugs as lithium or clozapine are used in combination with DrugCBZ .
0.9886 We consider asterixis to be an easily overlooked sign of neurotoxicity, which may occur even at low or moderate dosage levels, if certain drugs as Druglithium or clozapine are used in combination with CBZ.
Score Text
0.9827 It was hypothesized that Drugvalproic acid may interfere with glucuronidation of lamotrigine, leading to increased serum lamotrigine levels, or perhaps alter the drug's metabolism, resulting in accumulation of a toxic intermediate metabolite.
0.9764 It was hypothesized that valproic acid may interfere with glucuronidation of lamotrigine, leading to Adverse-Effectincreased serum lamotrigine levels , or perhaps alter the drug's metabolism, resulting in accumulation of a toxic intermediate metabolite.
0.9634 It was hypothesized that valproic acid may interfere with glucuronidation of lamotrigine, leading to increased serum lamotrigine levels, or perhaps alter the drug's metabolism, resulting in Adverse-Effectaccumulation of a toxic intermediate metabolite .
0.8991 It was hypothesized that valproic acid may interfere with glucuronidation of Druglamotrigine , leading to increased serum lamotrigine levels, or perhaps alter the drug's metabolism, resulting in accumulation of a toxic intermediate metabolite.
Score Text
0.9990 METHODS : A retrospective report of the first case of gemcitabine - related Adverse-EffectHUS , in a patient with metastatic pancreatic adenocarcinoma, treated with a variety of standard therapies in addition to rituximab is presented.
0.9915 METHODS : A retrospective report of the first case of Druggemcitabine - related HUS, in a patient with metastatic pancreatic adenocarcinoma, treated with a variety of standard therapies in addition to rituximab is presented.
Score Text
0.9990 We present a case of HUS in an advanced ovarian cancer patient treated with carboplatin and Druggemcitabine , and described its favorable outcome after chemotherapy interruption and supportive care with a 1 year follow - up.
0.9988 We present a case of Adverse-EffectHUS in an advanced ovarian cancer patient treated with carboplatin and gemcitabine, and described its favorable outcome after chemotherapy interruption and supportive care with a 1 year follow - up.
0.9987 We present a case of HUS in an advanced ovarian cancer patient treated with Drugcarboplatin and gemcitabine, and described its favorable outcome after chemotherapy interruption and supportive care with a 1 year follow - up.
Score Text
0.9979 We describe a patient with transitional cell carcinoma of the renal pelvis who developed respiratory dysfunction and an abnormal chest x - ray with diffuse interstitial opacities while on chemotherapy with Drugpiritrexim , a methotrexate analog.
0.9919 We describe a patient with transitional cell carcinoma of the renal pelvis who developed Adverse-Effectrespiratory dysfunction and an abnormal chest x - ray with diffuse interstitial opacities while on chemotherapy with piritrexim, a methotrexate analog.
0.9764 We describe a patient with transitional cell carcinoma of the renal pelvis who developed respiratory dysfunction and an Adverse-Effectabnormal chest x - ray with diffuse interstitial opacities while on chemotherapy with piritrexim, a methotrexate analog.
0.9954 We describe a patient with transitional cell carcinoma of the renal pelvis who developed respiratory dysfunction and an abnormal chest x - ray with diffuse interstitial opacities while on chemotherapy with piritrexim, a Drugmethotrexate analog.
Score Text
0.9972 CONCLUSIONS : The Adverse-Effectpiloerection observed after the replacement of fluvoxamine with milnacipran in this patient appears to have been due to an increase in the alpha ( 1 ) - adrenoceptor occupancy by endogenous norepinephrine induced by milnacipran.
0.9329 CONCLUSIONS : The piloerection observed after the replacement of fluvoxamine with Drugmilnacipran in this patient appears to have been due to an increase in the alpha ( 1 ) - adrenoceptor occupancy by endogenous norepinephrine induced by milnacipran.
0.9269 CONCLUSIONS : The piloerection observed after the replacement of Drugfluvoxamine with milnacipran in this patient appears to have been due to an increase in the alpha ( 1 ) - adrenoceptor occupancy by endogenous norepinephrine induced by milnacipran.
0.8895 CONCLUSIONS : The piloerection observed after the replacement of fluvoxamine with milnacipran in this patient appears to have been due to an increase in the alpha ( 1 ) - adrenoceptor occupancy by endogenous Drugnorepinephrine induced by milnacipran.
0.8802 CONCLUSIONS : The piloerection observed after the replacement of fluvoxamine with milnacipran in this patient appears to have been due to an increase in the alpha ( 1 ) - adrenoceptor occupancy by endogenous norepinephrine induced by Drugmilnacipran .
Score Text
0.9986 In summary, we report herein the first case of SIADH believed to be an adverse effect of Drugmizoribin , which may therefore needed to be added to the list of drugs which can induce SIADH.
0.9967 In summary, we report herein the first case of SIADH believed to be an adverse effect of mizoribin, which may therefore needed to be added to the list of drugs which can induce Adverse-EffectSIADH .
0.9967 In summary, we report herein the first case of Adverse-EffectSIADH believed to be an adverse effect of mizoribin, which may therefore needed to be added to the list of drugs which can induce SIADH.
Score Text
0.9829 During the first days of Drugarsenic trioxide treatment a rapid decrease in the D - dimers was seen ( normal values reached until day 7 ), together with a slight decrease in peripheral blood leukocytes.
0.9535 During the first days of arsenic trioxide treatment a rapid Adverse-Effectdecrease in the D - dimers was seen ( normal values reached until day 7 ), together with a slight decrease in peripheral blood leukocytes.
0.6664 During the first days of arsenic trioxide treatment a rapid decrease in the D - dimers was seen ( normal values reached until day 7 ), together with a Adverse-Effectslight decrease in peripheral blood leukocytes .
0.8466 During the first days of arsenic trioxide treatment a rapid decrease in the D - dimers was seen ( normal values reached until day 7 ), together with a slight Adverse-Effectdecrease in peripheral blood leukocytes .
Score Text
0.9993 Therefore, although Druggarenoxacin reportedly causes fewer adverse reactions for cardiac rhythms than third - generation quinolone antibiotics, one must be cautious of the interference of other drugs during hypokalemia in order to prevent TdP.
0.9747 Therefore, although garenoxacin reportedly causes fewer adverse reactions for cardiac rhythms than third - generation quinolone antibiotics, one must be cautious of the interference of other drugs during Adverse-Effecthypokalemia in order to prevent TdP.
0.9475 Therefore, although garenoxacin reportedly causes fewer adverse reactions for Adverse-Effectcardiac rhythms than third - generation quinolone antibiotics, one must be cautious of the interference of other drugs during hypokalemia in order to prevent TdP.
Score Text
0.9995 Two children, 1 with idiopathic nephrotic syndrome and 1 with endo - extracapillary glomerulonephritis, presented an episode of seizures and transient blindness at different times after i. v. pulse Drugmethylprednisolone ( IVPMP ) treatment.
0.9986 Two children, 1 with idiopathic nephrotic syndrome and 1 with endo - extracapillary glomerulonephritis, presented an episode of Adverse-Effectseizures and transient blindness at different times after i. v. pulse methylprednisolone ( IVPMP ) treatment.
0.9934 Two children, 1 with idiopathic nephrotic syndrome and 1 with endo - extracapillary glomerulonephritis, presented an episode of seizures and Adverse-Effecttransient blindness at different times after i. v. pulse methylprednisolone ( IVPMP ) treatment.
0.9993 Two children, 1 with idiopathic nephrotic syndrome and 1 with endo - extracapillary glomerulonephritis, presented an episode of seizures and transient blindness at different times after i. v. pulse methylprednisolone ( DrugIVPMP ) treatment.
Score Text
0.9996 A Drugdapsone hypersensitivity syndrome, consisting of fever, headache, nausea, vomiting, lymphadenopathy, hepatitis, hemolysis, leukopenia, and mononucleosis, has been described in patients treated with the drug for leprosy.
0.9983 A dapsone hypersensitivity syndrome, consisting of fever, Adverse-Effectheadache , nausea, vomiting, lymphadenopathy, hepatitis, hemolysis, leukopenia, and mononucleosis, has been described in patients treated with the drug for leprosy.
0.9980 A dapsone hypersensitivity syndrome, consisting of fever, headache, nausea, vomiting, lymphadenopathy, Adverse-Effecthepatitis , hemolysis, leukopenia, and mononucleosis, has been described in patients treated with the drug for leprosy.
0.9979 A dapsone hypersensitivity syndrome, consisting of fever, headache, nausea, vomiting, lymphadenopathy, hepatitis, hemolysis, Adverse-Effectleukopenia , and mononucleosis, has been described in patients treated with the drug for leprosy.
0.9976 A dapsone hypersensitivity syndrome, consisting of fever, headache, nausea, vomiting, lymphadenopathy, hepatitis, Adverse-Effecthemolysis , leukopenia, and mononucleosis, has been described in patients treated with the drug for leprosy.
0.9971 A dapsone hypersensitivity syndrome, consisting of fever, headache, nausea, vomiting, lymphadenopathy, hepatitis, hemolysis, leukopenia, and Adverse-Effectmononucleosis , has been described in patients treated with the drug for leprosy.
0.9970 A dapsone hypersensitivity syndrome, consisting of fever, headache, nausea, Adverse-Effectvomiting , lymphadenopathy, hepatitis, hemolysis, leukopenia, and mononucleosis, has been described in patients treated with the drug for leprosy.
0.9970 A dapsone hypersensitivity syndrome, consisting of fever, headache, Adverse-Effectnausea , vomiting, lymphadenopathy, hepatitis, hemolysis, leukopenia, and mononucleosis, has been described in patients treated with the drug for leprosy.
0.9952 A dapsone hypersensitivity syndrome, consisting of fever, headache, nausea, vomiting, Adverse-Effectlymphadenopathy , hepatitis, hemolysis, leukopenia, and mononucleosis, has been described in patients treated with the drug for leprosy.
0.9884 A dapsone hypersensitivity syndrome, consisting of Adverse-Effectfever , headache, nausea, vomiting, lymphadenopathy, hepatitis, hemolysis, leukopenia, and mononucleosis, has been described in patients treated with the drug for leprosy.
0.9586 A dapsone Adverse-Effecthypersensitivity syndrome , consisting of fever, headache, nausea, vomiting, lymphadenopathy, hepatitis, hemolysis, leukopenia, and mononucleosis, has been described in patients treated with the drug for leprosy.
Score Text
0.9093 Cardiac glycosides are thought to prevent doxorubicin Adverse-Effectcardiomyopathy by competitively inhibiting doxorubicin at its receptor sites, but ouabain has a much shorter half life than doxorubicin and its metabolites and so is less effective than digoxin.
0.8555 Cardiac glycosides are thought to prevent Drugdoxorubicin cardiomyopathy by competitively inhibiting doxorubicin at its receptor sites, but ouabain has a much shorter half life than doxorubicin and its metabolites and so is less effective than digoxin.
Score Text
0.9870 OBJECTIVE : The purpose of this study was to determine whether desensitization to NPH insulin, as well as standard insulin desensitization, could control Adverse-Effectallergic symptoms in a patient allergic to both NPH and regular insulin.
0.9800 OBJECTIVE : The purpose of this study was to determine whether desensitization to NPH insulin, as well as standard Druginsulin desensitization, could control allergic symptoms in a patient allergic to both NPH and regular insulin.
0.9769 OBJECTIVE : The purpose of this study was to determine whether desensitization to DrugNPH insulin , as well as standard insulin desensitization, could control allergic symptoms in a patient allergic to both NPH and regular insulin.
0.9754 OBJECTIVE : The purpose of this study was to determine whether desensitization to NPH insulin, as well as standard insulin desensitization, could control allergic symptoms in a patient allergic to both NPH and regular Druginsulin .
0.9130 OBJECTIVE : The purpose of this study was to determine whether desensitization to NPH insulin, as well as standard insulin desensitization, could control allergic symptoms in a patient allergic to both DrugNPH and regular insulin.
Score Text
0.9996 The authors present an elderly patient with mixed dementia who developed TD at multiple sites, ( including respiratory dyskinesia [ RD ], limb dyskinesia, and orofacial dyskinesia ) following abrupt withdrawal of Drugrisperidone therapy.
0.9942 The authors present an elderly patient with mixed dementia who developed TD at multiple sites, ( including respiratory dyskinesia [ RD ], limb dyskinesia, and Adverse-Effectorofacial dyskinesia ) following abrupt withdrawal of risperidone therapy.
0.9933 The authors present an elderly patient with mixed dementia who developed TD at multiple sites, ( including Adverse-Effectrespiratory dyskinesia [ RD ], limb dyskinesia, and orofacial dyskinesia ) following abrupt withdrawal of risperidone therapy.
0.9929 The authors present an elderly patient with mixed dementia who developed TD at multiple sites, ( including respiratory dyskinesia [ RD ], Adverse-Effectlimb dyskinesia , and orofacial dyskinesia ) following abrupt withdrawal of risperidone therapy.
0.9918 The authors present an elderly patient with mixed dementia who developed Adverse-EffectTD at multiple sites, ( including respiratory dyskinesia [ RD ], limb dyskinesia, and orofacial dyskinesia ) following abrupt withdrawal of risperidone therapy.
0.9883 The authors present an elderly patient with mixed dementia who developed TD at multiple sites, ( including respiratory dyskinesia [ Adverse-EffectRD ], limb dyskinesia, and orofacial dyskinesia ) following abrupt withdrawal of risperidone therapy.
Score Text
0.9982 We conjectured that the side effects of insulin, such as anti - natriuresis and increased vascular permeability, might be pronounced in the presence of the hepatic dysfunction that accompanies insulin insensitivity, hyperinsulinaemia and Adverse-Effecthypoalbuminaemia .
0.9981 We conjectured that the side effects of insulin, such as anti - natriuresis and increased vascular permeability, might be pronounced in the presence of the hepatic dysfunction that accompanies insulin insensitivity, Adverse-Effecthyperinsulinaemia and hypoalbuminaemia.
0.9887 We conjectured that the side effects of Druginsulin , such as anti - natriuresis and increased vascular permeability, might be pronounced in the presence of the hepatic dysfunction that accompanies insulin insensitivity, hyperinsulinaemia and hypoalbuminaemia.
0.9722 We conjectured that the side effects of insulin, such as anti - natriuresis and Adverse-Effectincreased vascular permeability , might be pronounced in the presence of the hepatic dysfunction that accompanies insulin insensitivity, hyperinsulinaemia and hypoalbuminaemia.
0.9636 We conjectured that the side effects of insulin, such as Adverse-Effectanti - natriuresis and increased vascular permeability, might be pronounced in the presence of the hepatic dysfunction that accompanies insulin insensitivity, hyperinsulinaemia and hypoalbuminaemia.
0.7991 We conjectured that the side effects of insulin, such as anti - natriuresis and increased vascular permeability, might be pronounced in the presence of the hepatic dysfunction that accompanies Adverse-Effectinsulin insensitivity , hyperinsulinaemia and hypoalbuminaemia.
Score Text
0.9972 We present two cases in which both patients suffered with Adverse-EffectCLS , which we believe was caused following administration of granulocyte colony - stimulating factor, to our knowledge not described in the intensive care patient previously.
0.9679 We present two cases in which both patients suffered with CLS, which we believe was caused following administration of Druggranulocyte colony - stimulating factor , to our knowledge not described in the intensive care patient previously.
Score Text
0.9931 The principle treatment for DPD - deficient patients with severe acute 5 - FU reactions is supportive care ; however, the administration of thymidine potentially may reverse severe 5 - FU - induced neurologic symptoms such as Adverse-Effectencephalopathy and coma.
0.9809 The principle treatment for DPD - deficient patients with severe acute Drug5 - FU reactions is supportive care ; however, the administration of thymidine potentially may reverse severe 5 - FU - induced neurologic symptoms such as encephalopathy and coma.
0.9795 The principle treatment for DPD - deficient patients with severe acute 5 - FU reactions is supportive care ; however, the administration of thymidine potentially may reverse severe 5 - FU - induced neurologic symptoms such as encephalopathy and Adverse-Effectcoma .
0.9782 The principle treatment for DPD - deficient patients with severe acute 5 - FU reactions is supportive care ; however, the administration of thymidine potentially may reverse severe Drug5 - FU - induced neurologic symptoms such as encephalopathy and coma.
0.9483 The principle treatment for DPD - deficient patients with severe acute 5 - FU reactions is supportive care ; however, the administration of thymidine potentially may reverse severe 5 - FU - induced Adverse-Effectneurologic symptoms such as encephalopathy and coma.
The principle treatment for DPD - deficient patients with Adverse-Effectsevere acute 5 - FU reactions is supportive care ; however, the administration of thymidine potentially may reverse severe 5 - FU - induced neurologic symptoms such as encephalopathy and coma.
Score Text
0.9882 A case report is presented concerning the administration of ketanserin in the treatment of pulmonary vasoconstriction and Adverse-Effectright ventricular failure following the infusion of protamine in a patient undergoing coronary artery bypass surgery and mitral valve replacement.
0.9529 A case report is presented concerning the administration of ketanserin in the treatment of Adverse-Effectpulmonary vasoconstriction and right ventricular failure following the infusion of protamine in a patient undergoing coronary artery bypass surgery and mitral valve replacement.
0.7969 A case report is presented concerning the administration of ketanserin in the treatment of pulmonary vasoconstriction and right ventricular failure following the infusion of Drugprotamine in a patient undergoing coronary artery bypass surgery and mitral valve replacement.
0.9246 A case report is presented concerning the administration of Drugketanserin in the treatment of pulmonary vasoconstriction and right ventricular failure following the infusion of protamine in a patient undergoing coronary artery bypass surgery and mitral valve replacement.
Score Text
0.9979 This patient developed sequential symptoms including alternative hemiparesis, Adverse-Effectdysarthria and altered consciousness 5 days after the second course of HD - MTX ( 8 gm / m2 by 6 h continuous infusion ) with leucovorin rescue.
0.9952 This patient developed sequential symptoms including alternative hemiparesis, dysarthria and Adverse-Effectaltered consciousness 5 days after the second course of HD - MTX ( 8 gm / m2 by 6 h continuous infusion ) with leucovorin rescue.
0.9912 This patient developed sequential symptoms including alternative Adverse-Effecthemiparesis , dysarthria and altered consciousness 5 days after the second course of HD - MTX ( 8 gm / m2 by 6 h continuous infusion ) with leucovorin rescue.
0.9775 This patient developed sequential symptoms including alternative hemiparesis, dysarthria and altered consciousness 5 days after the second course of DrugHD - MTX ( 8 gm / m2 by 6 h continuous infusion ) with leucovorin rescue.
0.5907 This patient developed sequential symptoms including alternative hemiparesis, dysarthria and altered consciousness 5 days after the second course of HD - MTX ( 8 gm / m2 by 6 h continuous infusion ) with Drugleucovorin rescue.
Score Text
0.9988 DrugFK506 , which began to be administered 12 days earlier, rose to a level of 44 ng / mL ( normal range, 10 - 20 ng / mL ) 1 day before neurologic abnormalities began.
0.9872 FK506, which began to be administered 12 days earlier, rose to a level of 44 ng / mL ( normal range, 10 - 20 ng / mL ) 1 day before Adverse-Effectneurologic abnormalities began.
Score Text
0.9873 From 1996 to 2002 several medications were changed due to their adverse effects : indinavir ( renal colic and fever ), nelfinavir ( cutaneous rash ), and efavirenz ( Adverse-Effectnausea and temporary memory loss ).
0.9793 From 1996 to 2002 several medications were changed due to their adverse effects : indinavir ( renal colic and fever ), nelfinavir ( cutaneous rash ), and efavirenz ( nausea and Adverse-Effecttemporary memory loss ).
0.9471 From 1996 to 2002 several medications were changed due to their adverse effects : indinavir ( Adverse-Effectrenal colic and fever ), nelfinavir ( cutaneous rash ), and efavirenz ( nausea and temporary memory loss ).
0.9285 From 1996 to 2002 several medications were changed due to their adverse effects : indinavir ( renal colic and fever ), nelfinavir ( Adverse-Effectcutaneous rash ), and efavirenz ( nausea and temporary memory loss ).
0.5549 From 1996 to 2002 several medications were changed due to their adverse effects : indinavir ( renal colic and Adverse-Effectfever ), nelfinavir ( cutaneous rash ), and efavirenz ( nausea and temporary memory loss ).
0.4701 From 1996 to 2002 several medications were changed due to their adverse effects : Drugindinavir ( renal colic and fever ), nelfinavir ( cutaneous rash ), and efavirenz ( nausea and temporary memory loss ).
0.9925 From 1996 to 2002 several medications were changed due to their adverse effects : indinavir ( renal colic and fever ), nelfinavir ( cutaneous rash ), and Adverse-Effectefavirenz ( nausea and temporary memory loss ).
From 1996 to 2002 several medications were changed due to their adverse effects : indinavir ( renal colic and fever ), Drugnelfinavir ( cutaneous rash ), and efavirenz ( nausea and temporary memory loss ).
From 1996 to 2002 several medications were changed due to their adverse effects : indinavir ( renal colic and fever ), nelfinavir ( cutaneous rash ), and Drugefavirenz ( nausea and temporary memory loss ).
Score Text
0.9995 A 74 - year - old man received oral administration of Drugpilsicainide , a pure sodium channel blocker with slow recovery kinetics, to convert paroxysmal atrial fibrillation to sinus rhythm and developed loss of consciousness two days later.
0.9939 A 74 - year - old man received oral administration of pilsicainide, a pure sodium channel blocker with slow recovery kinetics, to convert paroxysmal atrial fibrillation to sinus rhythm and developed Adverse-Effectloss of consciousness two days later.
Score Text
0.9766 Based on the Naranjo algorithm, the adverse reaction observed was probably related to the hydroxyurea treatment ( score = 6 ) ; however, the Drughydroxyurea chemotherapy could not be discontinued because of the myeloproliferative disorder.
0.9755 Based on the Naranjo algorithm, the adverse reaction observed was probably related to the hydroxyurea treatment ( score = 6 ) ; however, the hydroxyurea chemotherapy could not be discontinued because of the Adverse-Effectmyeloproliferative disorder .
0.9872 Based on the Naranjo algorithm, the adverse reaction observed was probably related to the Drughydroxyurea treatment ( score = 6 ) ; however, the hydroxyurea chemotherapy could not be discontinued because of the myeloproliferative disorder.
Score Text
0.9912 Minor electrocardiographical changes were noted in five out of six patients who were not receiving a cardiac glycoside and four out of six who were receiving Drugouabain , and none of the 16 who were receiving digoxin.
0.9861 Adverse-EffectMinor electrocardiographical changes were noted in five out of six patients who were not receiving a cardiac glycoside and four out of six who were receiving ouabain, and none of the 16 who were receiving digoxin.
0.9850 Minor electrocardiographical changes were noted in five out of six patients who were not receiving a cardiac glycoside and four out of six who were receiving ouabain, and none of the 16 who were receiving Drugdigoxin .
Score Text
0.9966 Phenytoin was discontinued after admission ; however, phenytoin 1 g i. v. was given for a tonic - clonic seizure two days after admission, after which swelling of the face and legs and Adverse-Effectpruritus developed.
0.9770 Phenytoin was discontinued after admission ; however, Drugphenytoin 1 g i. v. was given for a tonic - clonic seizure two days after admission, after which swelling of the face and legs and pruritus developed.
0.9644 Phenytoin was discontinued after admission ; however, phenytoin 1 g i. v. was given for a tonic - clonic seizure two days after admission, after which Adverse-Effectswelling of the face and legs and pruritus developed.
0.9764 DrugPhenytoin was discontinued after admission ; however, phenytoin 1 g i. v. was given for a tonic - clonic seizure two days after admission, after which swelling of the face and legs and pruritus developed.
Score Text
0.9896 It is concluded that ' Adverse-Effectcerebral atrophy ' on CT scans may represent an accumulative effect of ACTH and that ACTH should be given with the utmost discretion, and in as low a dose as possible.
0.9607 It is concluded that'cerebral atrophy'on CT scans may represent an accumulative effect of DrugACTH and that ACTH should be given with the utmost discretion, and in as low a dose as possible.
0.7045 It is concluded that'cerebral atrophy'on CT scans may represent an accumulative effect of ACTH and that DrugACTH should be given with the utmost discretion, and in as low a dose as possible.
Score Text
0.9994 We describe a case of advanced ovarian carcinoma who developed difficulty walking because of marked pain in the lower extremities and loss of proprioception 25 days after treatment with weekly Drugtaxol ( 80 mg / m ( 2 ) x3 ).
0.9954 We describe a case of advanced ovarian carcinoma who developed Adverse-Effectdifficulty walking because of marked pain in the lower extremities and loss of proprioception 25 days after treatment with weekly taxol ( 80 mg / m ( 2 ) x3 ).
0.9886 We describe a case of advanced ovarian carcinoma who developed difficulty walking because of Adverse-Effectmarked pain in the lower extremities and loss of proprioception 25 days after treatment with weekly taxol ( 80 mg / m ( 2 ) x3 ).
0.9857 We describe a case of advanced ovarian carcinoma who developed difficulty walking because of marked pain in the lower extremities and Adverse-Effectloss of proprioception 25 days after treatment with weekly taxol ( 80 mg / m ( 2 ) x3 ).
Score Text
0.9994 We report here a 26 - year - old female with diffuse large B - cell lymphoma who died of severe pulmonary fibrosis 81 days after the administration of high - dose DrugBCNU ( 600 mg / m2 ).
0.9802 We report here a 26 - year - old female with diffuse large B - cell lymphoma who died of Adverse-Effectsevere pulmonary fibrosis 81 days after the administration of high - dose BCNU ( 600 mg / m2 ).
Score Text
0.9918 Symptoms and signs of Adverse-Effectaugmentation were related to low plasma levodopa levels, abating 75 minutes after oral levodopa administration and reappearing after 3 hours, closely mirroring the rapid rise and fall of plasma levodopa concentration.
0.9686 Symptoms and signs of augmentation were related to low plasma levodopa levels, abating 75 minutes after oral Druglevodopa administration and reappearing after 3 hours, closely mirroring the rapid rise and fall of plasma levodopa concentration.
0.9677 Symptoms and signs of augmentation were related to low plasma Druglevodopa levels, abating 75 minutes after oral levodopa administration and reappearing after 3 hours, closely mirroring the rapid rise and fall of plasma levodopa concentration.
0.9323 Symptoms and signs of augmentation were related to low plasma levodopa levels, abating 75 minutes after oral levodopa administration and reappearing after 3 hours, closely mirroring the rapid rise and fall of plasma Druglevodopa concentration.
Score Text
0.9950 METHODS : Double - blind, placebo - controlled titrated oral challenges with pancreatic enzymes resulted in definite vomiting within 1 to 1. 5 hours after challenges with DrugViokase and Pancrease MT 16, but not with placebo.
0.9860 METHODS : Double - blind, placebo - controlled titrated oral challenges with pancreatic enzymes resulted in definite vomiting within 1 to 1. 5 hours after challenges with Viokase and DrugPancrease MT 16 , but not with placebo.
0.9847 METHODS : Double - blind, placebo - controlled titrated oral challenges with pancreatic enzymes resulted in definite Adverse-Effectvomiting within 1 to 1. 5 hours after challenges with Viokase and Pancrease MT 16, but not with placebo.
Score Text
0.9946 After ruling out a hydrotelluric source of fluorine, the patient's Adverse-Effectfluorosis was linked to chronic use of niflumic acid, following the publication in 1978 of the 2 previously reported cases affected by this drug.
0.9834 After ruling out a hydrotelluric source of fluorine, the patient's fluorosis was linked to chronic use of Drugniflumic acid , following the publication in 1978 of the 2 previously reported cases affected by this drug.
Score Text
0.9949 PURPOSE : To investigate the concentration - side effect relationship in a patient with severe acyclovir - induced Adverse-Effectneurotoxicity and to summarize the information available in the literature about central nervous system side effects due to acyclovir.
0.9661 PURPOSE : To investigate the concentration - side effect relationship in a patient with severe Drugacyclovir - induced neurotoxicity and to summarize the information available in the literature about central nervous system side effects due to acyclovir.
0.8867 PURPOSE : To investigate the concentration - side effect relationship in a patient with severe acyclovir - induced neurotoxicity and to summarize the information available in the literature about Adverse-Effectcentral nervous system side effects due to acyclovir.
0.8498 PURPOSE : To investigate the concentration - side effect relationship in a patient with severe acyclovir - induced neurotoxicity and to summarize the information available in the literature about central nervous system side effects due to Drugacyclovir .
Score Text
0.9719 We report a 5 - year - old boy with CF who had a stricture of the hepatic flexure region with associated narrowing due to Adverse-Effectsubmucosal fibrosis of the transverse colon , secondary to high - lipase pancreatin therapy.
0.9688 We report a 5 - year - old boy with CF who had a stricture of the hepatic flexure region with associated narrowing due to submucosal fibrosis of the transverse colon, secondary to Drughigh - lipase pancreatin therapy.
0.9520 We report a 5 - year - old boy with CF who had a stricture of the Adverse-Effecthepatic flexure region with associated narrowing due to submucosal fibrosis of the transverse colon, secondary to high - lipase pancreatin therapy.
0.5492 We report a 5 - year - old boy with CF who had a stricture of Adverse-Effectthe hepatic flexure region with associated narrowing due to submucosal fibrosis of the transverse colon, secondary to high - lipase pancreatin therapy.
0.5194 We report a 5 - year - old boy with CF who had a stricture Adverse-Effectof the hepatic flexure region with associated narrowing due to submucosal fibrosis of the transverse colon, secondary to high - lipase pancreatin therapy.
We report a 5 - year - old boy with CF who had a Adverse-Effectstricture of the hepatic flexure region with associated narrowing due to submucosal fibrosis of the transverse colon, secondary to high - lipase pancreatin therapy.
Score Text
0.9920 The presented patient was treated with 200 mg TCA and developed Adverse-EffectCushing's syndrome 6 weeks later ( cortisol and ACTH concentrations were below limits of detection, TCA concentrations were > 3 micrograms / l ).
0.9809 The presented patient was treated with 200 mg DrugTCA and developed Cushing's syndrome 6 weeks later ( cortisol and ACTH concentrations were below limits of detection, TCA concentrations were > 3 micrograms / l ).
Score Text
0.9993 Such a rapid and relentless progression of Drugmethyldopa - induced liver injury is undoubtedly rare, but it may be prevented by careful supervision of patients who exhibit liver function abnormalities early in the course of therapy.
0.9901 Such a rapid and relentless progression of methyldopa - induced Adverse-Effectliver injury is undoubtedly rare, but it may be prevented by careful supervision of patients who exhibit liver function abnormalities early in the course of therapy.
0.9716 Such a rapid and relentless progression of methyldopa - induced liver injury is undoubtedly rare, but it may be prevented by careful supervision of patients who exhibit Adverse-Effectliver function abnormalities early in the course of therapy.
Score Text
0.9996 We report an HIV - infected woman who developed mild leukopenia as the first sign of a Drugnevirapine - related adverse event, which was followed by skin and hepatic toxicity associated with a more severe leukopenia.
0.9596 We report an HIV - infected woman who developed mild leukopenia as the first sign of a nevirapine - related adverse event, which was followed by skin and hepatic toxicity associated with a more severe Adverse-Effectleukopenia .
0.9490 We report an HIV - infected woman who developed mild leukopenia as the first sign of a nevirapine - related adverse event, which was followed by Adverse-Effectskin and hepatic toxicity associated with a more severe leukopenia.
0.8606 We report an HIV - infected woman who developed mild Adverse-Effectleukopenia as the first sign of a nevirapine - related adverse event, which was followed by skin and hepatic toxicity associated with a more severe leukopenia.
0.6739 We report an HIV - infected woman who developed Adverse-Effectmild leukopenia as the first sign of a nevirapine - related adverse event, which was followed by skin and hepatic toxicity associated with a more severe leukopenia.
Score Text
0.9911 An 11 - year - old boy who was treated with a relatively high dose of methotrimeprazine meleate ( DrugLevemepromazine ) a phenothiazine antipsychotic drug, was admitted to the pediatric intensive care unit suffering from respiratory distress syndrome.
0.9908 An 11 - year - old boy who was treated with a relatively high dose of methotrimeprazine meleate ( Levemepromazine ) a phenothiazine antipsychotic drug, was admitted to the pediatric intensive care unit suffering from Adverse-Effectrespiratory distress syndrome .
0.9854 An 11 - year - old boy who was treated with a relatively high dose of Drugmethotrimeprazine meleate ( Levemepromazine ) a phenothiazine antipsychotic drug, was admitted to the pediatric intensive care unit suffering from respiratory distress syndrome.
Score Text
0.9970 The day after clozapine was stopped, while he was still receiving clomipramine 150 mg / d, he began behaving oddly, started sweating profusely, Adverse-Effectshivering , and became tremulous, agitated, and confused.
0.9966 The day after clozapine was stopped, while he was still receiving clomipramine 150 mg / d, he began behaving oddly, started sweating profusely, shivering, and became Adverse-Effecttremulous , agitated, and confused.
0.9957 The day after Drugclozapine was stopped, while he was still receiving clomipramine 150 mg / d, he began behaving oddly, started sweating profusely, shivering, and became tremulous, agitated, and confused.
0.9935 The day after clozapine was stopped, while he was still receiving clomipramine 150 mg / d, he began behaving oddly, started sweating profusely, shivering, and became tremulous, Adverse-Effectagitated , and confused.
0.9911 The day after clozapine was stopped, while he was still receiving clomipramine 150 mg / d, he began behaving oddly, started Adverse-Effectsweating profusely , shivering, and became tremulous, agitated, and confused.
0.9853 The day after clozapine was stopped, while he was still receiving Drugclomipramine 150 mg / d, he began behaving oddly, started sweating profusely, shivering, and became tremulous, agitated, and confused.
0.9833 The day after clozapine was stopped, while he was still receiving clomipramine 150 mg / d, he began behaving oddly, started sweating profusely, shivering, and became tremulous, agitated, and Adverse-Effectconfused .
0.9829 The day after clozapine was stopped, while he was still receiving clomipramine 150 mg / d, he began Adverse-Effectbehaving oddly , started sweating profusely, shivering, and became tremulous, agitated, and confused.
Score Text
0.9932 PATIENTS : Two patients, ages 40 and 51 years, undergoing treatment with Druginterferon alfa for malignant neoplasms experienced sudden bilateral, sequential visual loss with disc - related field defects and segmental optic disc edema.
0.8637 PATIENTS : Two patients, ages 40 and 51 years, undergoing treatment with interferon alfa for malignant neoplasms experienced Adverse-Effectsudden bilateral, sequential visual loss with disc - related field defects and segmental optic disc edema.
0.6427 PATIENTS : Two patients, ages 40 and 51 years, undergoing treatment with interferon alfa for malignant neoplasms experienced sudden bilateral, Adverse-Effectsequential visual loss with disc - related field defects and segmental optic disc edema.
Score Text
0.9952 We present the case of a patient who had undergone cholecystectomy previously, but in whom morphine given in the Emergency Department precipitated pain consistent with Adverse-Effectbiliary colic ; the pain resolved promptly after administration of naloxone.
0.9838 We present the case of a patient who had undergone cholecystectomy previously, but in whom Drugmorphine given in the Emergency Department precipitated pain consistent with biliary colic ; the pain resolved promptly after administration of naloxone.
0.9823 We present the case of a patient who had undergone cholecystectomy previously, but in whom morphine given in the Emergency Department precipitated Adverse-Effectpain consistent with biliary colic ; the pain resolved promptly after administration of naloxone.
Score Text
0.9990 We describe a 74 - year - old man with rheumatoid arthritis ( RA ) who developed syndrome of inappropriate secretion of antidiuretic hormone ( SIADH ) 1. 5 months after commencement of Drugmizoribin prescription when his arthritis was improved.
0.9978 We describe a 74 - year - old man with rheumatoid arthritis ( RA ) who developed syndrome of inappropriate secretion of antidiuretic hormone ( Adverse-EffectSIADH ) 1. 5 months after commencement of mizoribin prescription when his arthritis was improved.
0.9810 We describe a 74 - year - old man with rheumatoid arthritis ( RA ) who developed Adverse-Effectsyndrome of inappropriate secretion of antidiuretic hormone ( SIADH ) 1. 5 months after commencement of mizoribin prescription when his arthritis was improved.
Score Text
0.9979 DrugRapamycin / sirolimus - induced pneumonitis has been described previously in renal transplant recipients, and this report describes a stable heart - lung transplant recipient who developed a pulmonary infiltrate that reversed after ceasing SR therapy.
0.9978 Rapamycin / sirolimus - induced Adverse-Effectpneumonitis has been described previously in renal transplant recipients, and this report describes a stable heart - lung transplant recipient who developed a pulmonary infiltrate that reversed after ceasing SR therapy.
0.9971 Rapamycin / Drugsirolimus - induced pneumonitis has been described previously in renal transplant recipients, and this report describes a stable heart - lung transplant recipient who developed a pulmonary infiltrate that reversed after ceasing SR therapy.
0.9814 Rapamycin / sirolimus - induced pneumonitis has been described previously in renal transplant recipients, and this report describes a stable heart - lung transplant recipient who developed a Adverse-Effectpulmonary infiltrate that reversed after ceasing SR therapy.
Rapamycin / sirolimus - induced pneumonitis has been described previously in renal transplant recipients, and this report describes a stable heart - lung transplant recipient who developed a pulmonary infiltrate that reversed after ceasing DrugSR therapy.
Score Text
0.9984 We report the case of a 14 - year - old female with acute promyelocytic leukemia who developed symptomatic cardiomyopathy only 4 months into treatment with a combination of Drugdaunomycin and all - trans retinoic acid ( ATRA ).
0.9962 We report the case of a 14 - year - old female with acute promyelocytic leukemia who developed symptomatic cardiomyopathy only 4 months into treatment with a combination of daunomycin and all - trans retinoic acid ( DrugATRA ).
0.9894 We report the case of a 14 - year - old female with acute promyelocytic leukemia who developed Adverse-Effectsymptomatic cardiomyopathy only 4 months into treatment with a combination of daunomycin and all - trans retinoic acid ( ATRA ).
0.9481 We report the case of a 14 - year - old female with acute promyelocytic leukemia who developed symptomatic cardiomyopathy only 4 months into treatment with a combination of daunomycin and Drugall - trans retinoic acid ( ATRA ).
Score Text
0.9715 The authors report a longitudinal case study of a woman with a history of bipolar affective disorder in which DrugL - dopa shortened the manic - depressive cycle length when administered in a double - blind trial.
0.8270 The authors report a longitudinal case study of a woman with a history of bipolar affective disorder in which L - dopa Adverse-Effectshortened the manic - depressive cycle length when administered in a double - blind trial.
0.7032 The authors report a longitudinal case study of a woman with a history of bipolar affective disorder in which L - Adverse-Effectdopa shortened the manic - depressive cycle length when administered in a double - blind trial.
0.6379 The authors report a longitudinal case study of a woman with a history of bipolar affective disorder in which Adverse-EffectL - dopa shortened the manic - depressive cycle length when administered in a double - blind trial.
0.5053 The authors report a longitudinal case study of a woman with a history of bipolar affective disorder in which L Adverse-Effect- dopa shortened the manic - depressive cycle length when administered in a double - blind trial.
Score Text
0.9991 Purple glove syndrome, named for its distinctive purple discoloration and swelling of the hands in the distribution of a glove, is an uncommon complication of intravenous Drugphenytoin administration through small dorsal veins of the hands.
0.9907 Adverse-EffectPurple glove syndrome , named for its distinctive purple discoloration and swelling of the hands in the distribution of a glove, is an uncommon complication of intravenous phenytoin administration through small dorsal veins of the hands.
0.9652 Purple glove syndrome, named for its distinctive purple discoloration and Adverse-Effectswelling of the hands in the distribution of a glove, is an uncommon complication of intravenous phenytoin administration through small dorsal veins of the hands.
0.9569 Purple glove syndrome, named for its distinctive Adverse-Effectpurple discoloration and swelling of the hands in the distribution of a glove, is an uncommon complication of intravenous phenytoin administration through small dorsal veins of the hands.
Score Text
0.9896 In this report, we present a case of Adverse-Effecthypoglycaemic coma associated with SP, an adverse reaction that is likely to be underreported and expected to occur with greater frequency as the use of SP increases.
0.9795 In this report, we present a case of hypoglycaemic coma associated with DrugSP , an adverse reaction that is likely to be underreported and expected to occur with greater frequency as the use of SP increases.
0.9130 In this report, we present a case of hypoglycaemic coma associated with SP, an adverse reaction that is likely to be underreported and expected to occur with greater frequency as the use of DrugSP increases.
Score Text
0.9990 Administration of intravenous Drugnitroglycerin in a patient with idiopathic pulmonary hypertension resulted in an increase in pulmonary artery pressure associated with a decrease in blood flow that is best explained by an increase in pulmonary vascular resistance.
0.9815 Administration of intravenous nitroglycerin in a patient with idiopathic pulmonary hypertension resulted in an increase in pulmonary artery pressure associated with a decrease in blood flow that is best explained by an Adverse-Effectincrease in pulmonary vascular resistance .
0.9783 Administration of intravenous nitroglycerin in a patient with idiopathic pulmonary hypertension resulted in an Adverse-Effectincrease in pulmonary artery pressure associated with a decrease in blood flow that is best explained by an increase in pulmonary vascular resistance.
0.9590 Administration of intravenous nitroglycerin in a patient with idiopathic pulmonary hypertension resulted in an increase in pulmonary artery pressure associated with a Adverse-Effectdecrease in blood flow that is best explained by an increase in pulmonary vascular resistance.
Score Text
0.9986 It was postulated that the allergic reaction was most likely caused by Drugcapecitabine or the intermediate metabolites based on the immediate reappearance of symptoms from the rechallenge, pharmacokinetic data, and well - tolerance of fluorouracil.
0.9889 It was postulated that the Adverse-Effectallergic reaction was most likely caused by capecitabine or the intermediate metabolites based on the immediate reappearance of symptoms from the rechallenge, pharmacokinetic data, and well - tolerance of fluorouracil.
Score Text
0.9978 Prolonged responses were achieved with low doses of DrugHU ( 3 - 10 mg / kg / day ) and higher doses were associated with mild reversible hematologic or hepatic toxicity and no further increases in Hb.
0.9408 Prolonged responses were achieved with low doses of HU ( 3 - 10 mg / kg / day ) and higher doses were associated with mild reversible hematologic or Adverse-Effecthepatic toxicity and no further increases in Hb.
Prolonged responses were achieved with low doses of HU ( 3 - 10 mg / kg / day ) and higher doses were associated with Adverse-Effectmild reversible hematologic or hepatic toxicity and no further increases in Hb.
Score Text
0.9881 This Adverse-Effectpanic anxiety was not relieved by taking etizolam and flunitrazepam again, but subsided rapidly by the re - administration of mianserin 30 mg / day, and because of that the depressive symptom also disappeared.
0.9720 This panic anxiety was not relieved by taking etizolam and flunitrazepam again, but subsided rapidly by the re - administration of Drugmianserin 30 mg / day, and because of that the depressive symptom also disappeared.
0.9914 This panic anxiety was not relieved by taking etizolam and Drugflunitrazepam again, but subsided rapidly by the re - administration of mianserin 30 mg / day, and because of that the depressive symptom also disappeared.
0.9890 This panic anxiety was not relieved by taking Drugetizolam and flunitrazepam again, but subsided rapidly by the re - administration of mianserin 30 mg / day, and because of that the depressive symptom also disappeared.
Score Text
0.9990 Although visual hallucinations have not been reported as an adverse effect of this agent, we describe three patients who experienced complex visual hallucinations and altered mental status after Drugzonisamide treatment was begun or its dosage increased.
0.9900 Although visual hallucinations have not been reported as an adverse effect of this agent, we describe three patients who experienced complex visual hallucinations and Adverse-Effectaltered mental status after zonisamide treatment was begun or its dosage increased.
0.9113 Although visual hallucinations have not been reported as an adverse effect of this agent, we describe three patients who experienced complex Adverse-Effectvisual hallucinations and altered mental status after zonisamide treatment was begun or its dosage increased.
Score Text
0.9996 A child in whom a Drugphenobarbital hypersensitivity drug reaction developed which consisted of fever, a pruritic desquamating erythrodermic rash, alopecia, icterus, protein - losing enteropathy, myositis, and nephritis, is described.
0.9986 A child in whom a phenobarbital hypersensitivity drug reaction developed which consisted of fever, a pruritic desquamating erythrodermic rash, alopecia, icterus, protein - losing enteropathy, myositis, and Adverse-Effectnephritis , is described.
0.9982 A child in whom a phenobarbital hypersensitivity drug reaction developed which consisted of fever, a pruritic desquamating erythrodermic rash, Adverse-Effectalopecia , icterus, protein - losing enteropathy, myositis, and nephritis, is described.
0.9973 A child in whom a phenobarbital hypersensitivity drug reaction developed which consisted of fever, a pruritic desquamating erythrodermic rash, alopecia, Adverse-Effecticterus , protein - losing enteropathy, myositis, and nephritis, is described.
0.9971 A child in whom a phenobarbital hypersensitivity drug reaction developed which consisted of fever, a pruritic desquamating erythrodermic rash, alopecia, icterus, protein - losing enteropathy, Adverse-Effectmyositis , and nephritis, is described.
0.9888 A child in whom a phenobarbital hypersensitivity drug reaction developed which consisted of Adverse-Effectfever , a pruritic desquamating erythrodermic rash, alopecia, icterus, protein - losing enteropathy, myositis, and nephritis, is described.
0.9695 A child in whom a phenobarbital hypersensitivity drug reaction developed which consisted of fever, a pruritic desquamating erythrodermic rash, alopecia, icterus, Adverse-Effectprotein - losing enteropathy , myositis, and nephritis, is described.
0.8898 A child in whom a phenobarbital Adverse-Effecthypersensitivity drug reaction developed which consisted of fever, a pruritic desquamating erythrodermic rash, alopecia, icterus, protein - losing enteropathy, myositis, and nephritis, is described.
0.8131 A child in whom a phenobarbital hypersensitivity drug reaction developed which consisted of fever, Adverse-Effecta pruritic desquamating erythrodermic rash , alopecia, icterus, protein - losing enteropathy, myositis, and nephritis, is described.
0.8421 A child in whom a phenobarbital Adverse-Effecthypersensitivity drug reaction developed which consisted of fever, a pruritic desquamating erythrodermic rash, alopecia, icterus, protein - losing enteropathy, myositis, and nephritis, is described.
0.8150 A child in whom a phenobarbital Adverse-Effecthypersensitivity drug reaction developed which consisted of fever, a pruritic desquamating erythrodermic rash, alopecia, icterus, protein - losing enteropathy, myositis, and nephritis, is described.
0.7748 A child in whom a phenobarbital hypersensitivity drug reaction developed which consisted of fever, a Adverse-Effectpruritic desquamating erythrodermic rash , alopecia, icterus, protein - losing enteropathy, myositis, and nephritis, is described.
Score Text
0.9963 We observed 5 reactions in 3 patients that appear to be related to a high dose - infusion time ratio, indicating that dose and rate of infusion may be important factors in precipitating anaphylactoid reactions with Drugcisplatin .
0.9854 We observed 5 reactions in 3 patients that appear to be related to a high dose - infusion time ratio, indicating that dose and rate of infusion may be important factors in precipitating Adverse-Effectanaphylactoid reactions with cisplatin.
Score Text
0.9994 The present observation suggests, that a batch of different testing doses, including lower testing doses may help to differentiate between an allergic type of contact dermatitis and an irritant type of reaction after treatment with Drugcalcipotriol .
0.9721 The present observation suggests, that a batch of different testing doses, including lower testing doses may help to differentiate between an allergic type of contact dermatitis and an Adverse-Effectirritant type of reaction after treatment with calcipotriol.
Score Text
0.9993 DISCUSSION : Rhabdomyolysis is a clinical syndrome resulting from the destruction of skeletal muscle that may progress to renal failure Several drugs have been associated with rhabdomyolysis, including Druglovastatin , a hydroxymethylglutaryl - coenzyme A reductase inhibitor.
0.9832 DISCUSSION : Rhabdomyolysis is a clinical syndrome resulting from the destruction of skeletal muscle that may progress to renal failure Several drugs have been associated with Adverse-Effectrhabdomyolysis , including lovastatin, a hydroxymethylglutaryl - coenzyme A reductase inhibitor.
0.9945 DISCUSSION : Adverse-EffectRhabdomyolysis is a clinical syndrome resulting from the destruction of skeletal muscle that may progress to renal failure Several drugs have been associated with rhabdomyolysis, including lovastatin, a hydroxymethylglutaryl - coenzyme A reductase inhibitor.
0.8083 DISCUSSION : Rhabdomyolysis is a clinical syndrome resulting from the Adverse-Effectdestruction of skeletal muscle that may progress to renal failure Several drugs have been associated with rhabdomyolysis, including lovastatin, a hydroxymethylglutaryl - coenzyme A reductase inhibitor.
Score Text
0.9942 After initiation of topical Drugvitamin D3 ointment ( 20 micro g / g of tacalcitol ) 10 g / day for the skin lesions, both the serum level of calcium and urinary excretion of calcium increased gradually.
0.9635 After initiation of topical vitamin D3 ointment ( 20 micro g / g of Drugtacalcitol ) 10 g / day for the skin lesions, both the serum level of calcium and urinary excretion of calcium increased gradually.
0.7802 After initiation of topical vitamin D3 ointment ( 20 micro g / g of tacalcitol ) 10 g / day for the skin lesions, both the Adverse-Effectserum level of calcium and urinary excretion of calcium increased gradually.
After initiation of topical vitamin D3 ointment ( 20 micro g / g of tacalcitol ) 10 g / day for the skin lesions, both the Adverse-Effectserum level of calcium and urinary excretion of calcium increased gradually.
Score Text
0.9958 The use of Drugmethotrexate ( MTX ) has been contraindicated for treatment of severe psoriasis in HIV infection on the basis of six previously reported cases in which MTX appeared to potentiate opportunistic infections and accelerate HIV disease.
0.9956 The use of methotrexate ( MTX ) has been contraindicated for treatment of severe psoriasis in HIV infection on the basis of six previously reported cases in which DrugMTX appeared to potentiate opportunistic infections and accelerate HIV disease.
0.9930 The use of methotrexate ( DrugMTX ) has been contraindicated for treatment of severe psoriasis in HIV infection on the basis of six previously reported cases in which MTX appeared to potentiate opportunistic infections and accelerate HIV disease.
0.9685 The use of methotrexate ( MTX ) has been contraindicated for treatment of severe psoriasis in HIV infection on the basis of six previously reported cases in which MTX appeared to potentiate opportunistic infections and Adverse-Effectaccelerate HIV disease .
0.9613 The use of methotrexate ( MTX ) has been contraindicated for treatment of severe psoriasis in HIV infection on the basis of six previously reported cases in which MTX appeared to Adverse-Effectpotentiate opportunistic infections and accelerate HIV disease.
Score Text
0.9987 During clarithromycin coadministration, four out of the seven patients developed moderate - to - severe toxic symptoms of carbamazepine, such as drowsiness, dizziness, and Adverse-Effectataxia , which resolved within 5 days after clarithromycin discontinuation.
0.9986 During clarithromycin coadministration, four out of the seven patients developed moderate - to - severe toxic symptoms of carbamazepine, such as drowsiness, Adverse-Effectdizziness , and ataxia, which resolved within 5 days after clarithromycin discontinuation.
0.9983 During clarithromycin coadministration, four out of the seven patients developed moderate - to - severe toxic symptoms of carbamazepine, such as Adverse-Effectdrowsiness , dizziness, and ataxia, which resolved within 5 days after clarithromycin discontinuation.
0.9972 During clarithromycin coadministration, four out of the seven patients developed moderate - to - severe toxic symptoms of carbamazepine, such as drowsiness, dizziness, and ataxia, which resolved within 5 days after Drugclarithromycin discontinuation.
0.9970 During Drugclarithromycin coadministration, four out of the seven patients developed moderate - to - severe toxic symptoms of carbamazepine, such as drowsiness, dizziness, and ataxia, which resolved within 5 days after clarithromycin discontinuation.
0.9955 During clarithromycin coadministration, four out of the seven patients developed moderate - to - severe toxic symptoms of Drugcarbamazepine , such as drowsiness, dizziness, and ataxia, which resolved within 5 days after clarithromycin discontinuation.
0.8147 During clarithromycin coadministration, four out of the seven patients developed moderate - to - severe Adverse-Effecttoxic symptoms of carbamazepine, such as drowsiness, dizziness, and ataxia, which resolved within 5 days after clarithromycin discontinuation.
Score Text
0.9996 CASE SUMMARY : We report the case of a 31 - year - old patient hospitalized due to behavioral alterations and treated with oral Drugzuclopenthixol , an antipsychotic from the thioxanthene family, who developed an acute, painful erection.
0.8751 CASE SUMMARY : We report the case of a 31 - year - old patient hospitalized due to behavioral alterations and treated with oral zuclopenthixol, an antipsychotic from the thioxanthene family, who developed an acute, Adverse-Effectpainful erection .
Score Text
0.9997 DIAGNOSIS : Severe Drugtemozolomide - induced immunosuppression, exacerbated by corticosteroids, with profound T - cell lymphocytopenia and simultaneous opportunistic infections with Pneumocystis jiroveci pneumonia, brain abscess with Listeria monocytogenes, and cutaneous Kaposi's sarcoma.
0.9935 DIAGNOSIS : Severe temozolomide - induced Adverse-Effectimmunosuppression , exacerbated by corticosteroids, with profound T - cell lymphocytopenia and simultaneous opportunistic infections with Pneumocystis jiroveci pneumonia, brain abscess with Listeria monocytogenes, and cutaneous Kaposi's sarcoma.
0.9721 DIAGNOSIS : Severe temozolomide - induced immunosuppression, exacerbated by corticosteroids, with profound T - cell lymphocytopenia and simultaneous opportunistic infections with Pneumocystis jiroveci pneumonia, brain abscess with Listeria monocytogenes, and Adverse-Effectcutaneous Kaposi's sarcoma .
0.9697 DIAGNOSIS : Severe temozolomide - induced immunosuppression, exacerbated by corticosteroids, with profound T - cell lymphocytopenia and simultaneous opportunistic infections with Pneumocystis jiroveci pneumonia, Adverse-Effectbrain abscess with Listeria monocytogenes , and cutaneous Kaposi's sarcoma.
0.9233 DIAGNOSIS : Severe temozolomide - induced immunosuppression, exacerbated by corticosteroids, with profound T - cell lymphocytopenia and simultaneous opportunistic Adverse-Effectinfections with Pneumocystis jiroveci pneumonia , brain abscess with Listeria monocytogenes, and cutaneous Kaposi's sarcoma.
0.9170 DIAGNOSIS : Severe temozolomide - induced immunosuppression, exacerbated by corticosteroids, with profound Adverse-EffectT - cell lymphocytopenia and simultaneous opportunistic infections with Pneumocystis jiroveci pneumonia, brain abscess with Listeria monocytogenes, and cutaneous Kaposi's sarcoma.
0.9311 DIAGNOSIS : Severe temozolomide - induced immunosuppression, exacerbated by corticosteroids, with profound T - cell lymphocytopenia and simultaneous Adverse-Effectopportunistic infections with Pneumocystis jiroveci pneumonia , brain abscess with Listeria monocytogenes, and cutaneous Kaposi's sarcoma.
0.8217 DIAGNOSIS : Severe temozolomide - induced immunosuppression, exacerbated by corticosteroids, with profound T - cell lymphocytopenia and Adverse-Effectsimultaneous opportunistic infections with Pneumocystis jiroveci pneumonia , brain abscess with Listeria monocytogenes, and cutaneous Kaposi's sarcoma.
0.6133 DIAGNOSIS : Severe temozolomide - induced immunosuppression, Adverse-Effectexacerbated by corticosteroids , with profound T - cell lymphocytopenia and simultaneous opportunistic infections with Pneumocystis jiroveci pneumonia, brain abscess with Listeria monocytogenes, and cutaneous Kaposi's sarcoma.
Score Text
0.9974 Many clinicians appear to be concerned about the potential hepatotoxicity of the opiate antagonist Drugnaltrexone ( NTX ) and this may be one reason why it is not used more widely in treating both heroin and alcohol abusers.
0.9966 Many clinicians appear to be concerned about the potential hepatotoxicity of the opiate antagonist naltrexone ( DrugNTX ) and this may be one reason why it is not used more widely in treating both heroin and alcohol abusers.
0.9958 Many clinicians appear to be concerned about the potential Adverse-Effecthepatotoxicity of the opiate antagonist naltrexone ( NTX ) and this may be one reason why it is not used more widely in treating both heroin and alcohol abusers.
Score Text
0.9988 Our review of 194 RA patients and 38 PsA patients receiving MTX has identified four RA patients and one PsA patient with MTX - induced Adverse-Effectpneumonitis , giving a prevalence of 2. 1 % and 0. 03 %, respectively.
0.9842 Our review of 194 RA patients and 38 PsA patients receiving MTX has identified four RA patients and one PsA patient with DrugMTX - induced pneumonitis, giving a prevalence of 2. 1 % and 0. 03 %, respectively.
0.9841 Our review of 194 RA patients and 38 PsA patients receiving DrugMTX has identified four RA patients and one PsA patient with MTX - induced pneumonitis, giving a prevalence of 2. 1 % and 0. 03 %, respectively.
Score Text
0.9911 A 7 - year - old boy developed a severe unilateral grand mal seizure at the age of 5 years ( Drugphenobarbitone therapy ) ; 1. 5 years later valproate ( 2 - propylpentanoic acid, VPA ) was added to the therapy.
0.9897 A 7 - year - old boy developed a severe unilateral grand mal seizure at the age of 5 years ( phenobarbitone therapy ) ; 1. 5 years later Drugvalproate ( 2 - propylpentanoic acid, VPA ) was added to the therapy.
0.9881 A 7 - year - old boy developed a severe unilateral grand mal seizure at the age of 5 years ( phenobarbitone therapy ) ; 1. 5 years later valproate ( 2 - propylpentanoic acid, DrugVPA ) was added to the therapy.
0.9852 A 7 - year - old boy developed a Adverse-Effectsevere unilateral grand mal seizure at the age of 5 years ( phenobarbitone therapy ) ; 1. 5 years later valproate ( 2 - propylpentanoic acid, VPA ) was added to the therapy.
0.9728 A 7 - year - old boy developed a severe unilateral grand mal seizure at the age of 5 years ( phenobarbitone therapy ) ; 1. 5 years later valproate ( Drug2 - propylpentanoic acid , VPA ) was added to the therapy.
Score Text
0.9705 The authors suggest that fluoxetine - induced akathisia may be caused by serotonergically mediated inhibition of dopaminergic neurotransmission and that the pathophysiology of fluoxetine - induced Adverse-Effectakathisia and tricyclic antidepressant - induced " jitteriness " may be identical.
0.9557 The authors suggest that fluoxetine - induced akathisia may be caused by serotonergically mediated inhibition of dopaminergic neurotransmission and that the pathophysiology of Drugfluoxetine - induced akathisia and tricyclic antidepressant - induced " jitteriness " may be identical.
0.9474 The authors suggest that fluoxetine - induced Adverse-Effectakathisia may be caused by serotonergically mediated inhibition of dopaminergic neurotransmission and that the pathophysiology of fluoxetine - induced akathisia and tricyclic antidepressant - induced " jitteriness " may be identical.
0.9402 The authors suggest that Drugfluoxetine - induced akathisia may be caused by serotonergically mediated inhibition of dopaminergic neurotransmission and that the pathophysiology of fluoxetine - induced akathisia and tricyclic antidepressant - induced " jitteriness " may be identical.
0.9625 The authors suggest that fluoxetine - induced akathisia may be caused by serotonergically mediated inhibition of dopaminergic neurotransmission and that the pathophysiology of fluoxetine - induced akathisia and tricyclic antidepressant - induced " Adverse-Effectjitteriness " may be identical.
0.5098 The authors suggest that fluoxetine - induced akathisia may be caused by Adverse-Effectserotonergically mediated inhibition of dopaminergic neurotransmission and that the pathophysiology of fluoxetine - induced akathisia and tricyclic antidepressant - induced " jitteriness " may be identical.
Score Text
0.9776 Given that discontinuation of nitrofurantoin and introduction of methylprednisolon therapy significantly lowered liver enzyme levels, restoring most of them to normal, we concluded that this was probably the case of toxic liver damage caused by Drugnitrofurantoin .
0.9738 Given that discontinuation of nitrofurantoin and introduction of methylprednisolon therapy significantly lowered liver enzyme levels, restoring most of them to normal, we concluded that this was probably the case of Adverse-Effecttoxic liver damage caused by nitrofurantoin.
0.9672 Given that discontinuation of nitrofurantoin and introduction of Drugmethylprednisolon therapy significantly lowered liver enzyme levels, restoring most of them to normal, we concluded that this was probably the case of toxic liver damage caused by nitrofurantoin.
0.9579 Given that discontinuation of Drugnitrofurantoin and introduction of methylprednisolon therapy significantly lowered liver enzyme levels, restoring most of them to normal, we concluded that this was probably the case of toxic liver damage caused by nitrofurantoin.
Score Text
0.9994 In this report we present four patients treated with a combination of different psychotropic drugs, in whom asterixis was triggered either by adding Drugcarbamazepine ( CBZ ) to a treatment regimen, or by increasing its dosage.
0.9992 In this report we present four patients treated with a combination of different psychotropic drugs, in whom asterixis was triggered either by adding carbamazepine ( DrugCBZ ) to a treatment regimen, or by increasing its dosage.
0.9982 In this report we present four patients treated with a combination of different psychotropic drugs, in whom Adverse-Effectasterixis was triggered either by adding carbamazepine ( CBZ ) to a treatment regimen, or by increasing its dosage.
Score Text
0.9945 Approximately 15 min after the first administration of nebulised Drugmorphine the patient became markedly bradypneic ( respiratory rate : 4 - 5 bpm ), hypotensive ( BP 70 / 40 mmHg ), and responded only partially to command.
0.9924 Approximately 15 min after the first administration of nebulised morphine the patient became markedly bradypneic ( respiratory rate : 4 - 5 bpm ), Adverse-Effecthypotensive ( BP 70 / 40 mmHg ), and responded only partially to command.
0.9894 Approximately 15 min after the first administration of nebulised morphine the patient became markedly Adverse-Effectbradypneic ( respiratory rate : 4 - 5 bpm ), hypotensive ( BP 70 / 40 mmHg ), and responded only partially to command.
Score Text
0.9985 Replicate brain magnetic resonance imaging examinations after six weeks and 11 months of Drugpenicillamine therapy documented the development of new brain lesions during this period, while liver biopsy specimen data disclosed that excellent hepatic decoppering had occurred.
0.9913 Replicate brain magnetic resonance imaging examinations after six weeks and 11 months of penicillamine therapy documented the development of new Adverse-Effectbrain lesions during this period, while liver biopsy specimen data disclosed that excellent hepatic decoppering had occurred.
Score Text
0.9986 This case emphasizes the importance of the evaluation of Druglithium - associated polyuria with a direct measurement of plasma vasopressin, interpreted with simultaneous plasma and urine osmolality to secure the correct diagnosis and ensure appropriate therapeutic management.
0.9985 This case emphasizes the importance of the evaluation of lithium - associated Adverse-Effectpolyuria with a direct measurement of plasma vasopressin, interpreted with simultaneous plasma and urine osmolality to secure the correct diagnosis and ensure appropriate therapeutic management.
Score Text
0.9874 We report a 50 - year - old male patient with a 15 - year history of psoriasis including mutilating psoriatic arthritis, in whom the withdrawal of cyclosporin A induced a Adverse-Effectgeneralised pustular exacerbation and a aggravation of the joint condition.
0.9859 We report a 50 - year - old male patient with a 15 - year history of psoriasis including mutilating psoriatic arthritis, in whom the withdrawal of Drugcyclosporin A induced a generalised pustular exacerbation and a aggravation of the joint condition.
0.9844 We report a 50 - year - old male patient with a 15 - year history of psoriasis including mutilating psoriatic arthritis, in whom the withdrawal of cyclosporin A induced a generalised pustular exacerbation and a Adverse-Effectaggravation of the joint condition .
Score Text
0.9844 An objective causality assessment indicated a probable relationship between Adverse-Effectclotting abnormality and warfarin administration, although the degree of elevation of the INR was unusual in the light of the daily warfarin dose and duration of its exposure.
0.9641 An objective causality assessment indicated a probable relationship between clotting abnormality and Drugwarfarin administration, although the degree of elevation of the INR was unusual in the light of the daily warfarin dose and duration of its exposure.
0.5896 An objective causality assessment indicated a probable relationship between clotting abnormality and warfarin administration, although the degree of elevation of the INR was unusual in the light of the daily Drugwarfarin dose and duration of its exposure.
Score Text
0.9995 Even though only a few cases of this adverse event have been reported in the literature, severe Drugdocetaxel - induced pulmonary toxicity needs to be considered in the differential diagnosis when such patients present with respiratory symptoms.
0.9887 Even though only a few cases of this adverse event have been reported in the literature, severe docetaxel - induced Adverse-Effectpulmonary toxicity needs to be considered in the differential diagnosis when such patients present with respiratory symptoms.
0.9657 Even though only a few cases of this adverse event have been reported in the literature, severe docetaxel - induced pulmonary toxicity needs to be considered in the differential diagnosis when such patients present with Adverse-Effectrespiratory symptoms .
Score Text
0.9970 METHODS : A 68 - year - old man developed intense conjunctival hyperemia and cystoid macula edema after switching from Druglatanoprost to bimatoprost 9 months after cataract surgery in an eye at low - risk for this cystoid macular edema.
0.9966 METHODS : A 68 - year - old man developed intense conjunctival hyperemia and cystoid macula edema after switching from latanoprost to Drugbimatoprost 9 months after cataract surgery in an eye at low - risk for this cystoid macular edema.
0.9870 METHODS : A 68 - year - old man developed intense conjunctival hyperemia and Adverse-Effectcystoid macula edema after switching from latanoprost to bimatoprost 9 months after cataract surgery in an eye at low - risk for this cystoid macular edema.
0.9826 METHODS : A 68 - year - old man developed Adverse-Effectintense conjunctival hyperemia and cystoid macula edema after switching from latanoprost to bimatoprost 9 months after cataract surgery in an eye at low - risk for this cystoid macular edema.
0.9742 METHODS : A 68 - year - old man developed intense conjunctival hyperemia and cystoid macula edema after switching from latanoprost to bimatoprost 9 months after cataract surgery in an eye at low - risk for this Adverse-Effectcystoid macular edema .
Score Text
0.9993 CASE REPORT : A woman of 80 years, on long - term Drugwarfarin therapy presented with an acute dissecting thoracic aortic aneurysm ; on investigation the only precipitating factor found was an international normalised ratio of 4. 8.
0.9842 CASE REPORT : A woman of 80 years, on long - term warfarin therapy presented with an Adverse-Effectacute dissecting thoracic aortic aneurysm ; on investigation the only precipitating factor found was an international normalised ratio of 4. 8.
Score Text
0.9987 We describe a 57 - year - old man with acral erythrocyanosis progressing to acute digital ischemia and gangrene that developed after combined chemotherapy ( Drugbleomycin and methotrexate ) used to treat a metastatic squamous cell carcinoma of the hypopharynx.
0.9987 We describe a 57 - year - old man with acral erythrocyanosis progressing to acute digital ischemia and gangrene that developed after combined chemotherapy ( bleomycin and Drugmethotrexate ) used to treat a metastatic squamous cell carcinoma of the hypopharynx.
0.9978 We describe a 57 - year - old man with acral erythrocyanosis progressing to acute digital ischemia and Adverse-Effectgangrene that developed after combined chemotherapy ( bleomycin and methotrexate ) used to treat a metastatic squamous cell carcinoma of the hypopharynx.
0.9871 We describe a 57 - year - old man with acral erythrocyanosis progressing to Adverse-Effectacute digital ischemia and gangrene that developed after combined chemotherapy ( bleomycin and methotrexate ) used to treat a metastatic squamous cell carcinoma of the hypopharynx.
Score Text
0.9867 One patient required nursing home placement and a Adverse-Effectfeeding gastrostomy as a result of the worsening parkinsonism during risperidone treatment, but was able to return home and have the gastrostomy removed after switching from risperidone to clozapine.
0.9850 One patient required nursing home placement and a feeding gastrostomy as a result of the Adverse-Effectworsening parkinsonism during risperidone treatment, but was able to return home and have the gastrostomy removed after switching from risperidone to clozapine.
0.9736 One patient required nursing home placement and a feeding gastrostomy as a result of the worsening parkinsonism during Drugrisperidone treatment, but was able to return home and have the gastrostomy removed after switching from risperidone to clozapine.
0.8691 One patient required nursing home placement and a feeding gastrostomy as a result of the worsening parkinsonism during risperidone treatment, but was able to return home and have the gastrostomy removed after switching from Drugrisperidone to clozapine.
0.9060 One patient required nursing home placement and a feeding gastrostomy as a result of the worsening parkinsonism during risperidone treatment, but was able to return home and have the gastrostomy removed after switching from risperidone to Drugclozapine .
Score Text
0.9993 We report the case of an 87 - year - old white woman with myasthenia gravis who presented with nausea, shortness of breath, azotemia, and Adverse-Effecthyperkalemia shortly after completing a course of intravenous immunoglobulin ( IVIG ).
0.9991 We report the case of an 87 - year - old white woman with myasthenia gravis who presented with nausea, shortness of breath, Adverse-Effectazotemia , and hyperkalemia shortly after completing a course of intravenous immunoglobulin ( IVIG ).
0.9987 We report the case of an 87 - year - old white woman with myasthenia gravis who presented with nausea, shortness of breath, azotemia, and hyperkalemia shortly after completing a course of intravenous Drugimmunoglobulin ( IVIG ).
0.9985 We report the case of an 87 - year - old white woman with myasthenia gravis who presented with Adverse-Effectnausea , shortness of breath, azotemia, and hyperkalemia shortly after completing a course of intravenous immunoglobulin ( IVIG ).
0.9980 We report the case of an 87 - year - old white woman with myasthenia gravis who presented with nausea, shortness of breath, azotemia, and hyperkalemia shortly after completing a course of intravenous immunoglobulin ( DrugIVIG ).
0.9839 We report the case of an 87 - year - old white woman with myasthenia gravis who presented with nausea, Adverse-Effectshortness of breath , azotemia, and hyperkalemia shortly after completing a course of intravenous immunoglobulin ( IVIG ).
Score Text
0.9977 After therapy for diabetic coma with insulin ( containing the preservative Drugcresol ) and electrolyte solutions was started, the patient complained of increasing myalgia, developed a high fever and respiratory and metabolic acidosis and lost consciousness.
0.9968 After therapy for diabetic coma with insulin ( containing the preservative cresol ) and electrolyte solutions was started, the patient complained of Adverse-Effectincreasing myalgia , developed a high fever and respiratory and metabolic acidosis and lost consciousness.
0.9959 After therapy for diabetic coma with Druginsulin ( containing the preservative cresol ) and electrolyte solutions was started, the patient complained of increasing myalgia, developed a high fever and respiratory and metabolic acidosis and lost consciousness.
0.9936 After therapy for diabetic coma with insulin ( containing the preservative cresol ) and electrolyte solutions was started, the patient complained of increasing myalgia, developed a high fever and respiratory and metabolic acidosis and Adverse-Effectlost consciousness .
0.9802 After therapy for diabetic coma with insulin ( containing the preservative cresol ) and electrolyte solutions was started, the patient complained of increasing myalgia, developed a high fever and Adverse-Effectrespiratory and metabolic acidosis and lost consciousness.
0.9795 After therapy for diabetic coma with insulin ( containing the preservative cresol ) and electrolyte solutions was started, the patient complained of increasing myalgia, developed a Adverse-Effecthigh fever and respiratory and metabolic acidosis and lost consciousness.
Score Text
0.9988 A study of in vitro reactivity to L - T4, as assessed by peripheral blood lymphocyte transformation, was carried out in a patient with Hashimoto's disease who developed Adverse-Effectleukopenia during treatment with L - T4.
0.9727 A study of in vitro reactivity to L - T4, as assessed by peripheral blood lymphocyte transformation, was carried out in a patient with Hashimoto's disease who developed leukopenia during treatment with DrugL - T4 .
0.9632 A study of in vitro reactivity to DrugL - T4 , as assessed by peripheral blood lymphocyte transformation, was carried out in a patient with Hashimoto's disease who developed leukopenia during treatment with L - T4.
Score Text
0.9994 The clinical course suggests that Drugcaffeine , which is present in oolong tea, was mainly responsible for the rhabdomyolysis as well as the delirium, although severe hyponatremia has been reported to cause rhabdomyolysis on rare occasions.
0.9967 The clinical course suggests that caffeine, which is present in oolong tea, was mainly responsible for the rhabdomyolysis as well as the delirium, although severe hyponatremia has been reported to cause Adverse-Effectrhabdomyolysis on rare occasions.
0.9963 The clinical course suggests that caffeine, which is present in oolong tea, was mainly responsible for the Adverse-Effectrhabdomyolysis as well as the delirium, although severe hyponatremia has been reported to cause rhabdomyolysis on rare occasions.
0.9941 The clinical course suggests that caffeine, which is present in oolong tea, was mainly responsible for the rhabdomyolysis as well as the Adverse-Effectdelirium , although severe hyponatremia has been reported to cause rhabdomyolysis on rare occasions.
0.8331 The clinical course suggests that caffeine, which is present in oolong tea, was mainly responsible for the rhabdomyolysis as well as the delirium, although severe Adverse-Effecthyponatremia has been reported to cause rhabdomyolysis on rare occasions.
0.8092 The clinical course suggests that caffeine, which is present in oolong tea, was mainly responsible for the rhabdomyolysis as well as the delirium, although Adverse-Effectsevere hyponatremia has been reported to cause rhabdomyolysis on rare occasions.
Score Text
0.9974 A toxic encephalopathy characterized by depressed level of consciousness, marked irritability, and Adverse-Effectataxia developed in seven children, 5 years of age and younger, following administration of an antiemetic combination of pentobarbital and pyrilamine maleate.
0.9954 A toxic encephalopathy characterized by depressed level of consciousness, marked irritability, and ataxia developed in seven children, 5 years of age and younger, following administration of an antiemetic combination of Drugpentobarbital and pyrilamine maleate.
0.9904 A Adverse-Effecttoxic encephalopathy characterized by depressed level of consciousness, marked irritability, and ataxia developed in seven children, 5 years of age and younger, following administration of an antiemetic combination of pentobarbital and pyrilamine maleate.
0.9865 A toxic encephalopathy characterized by Adverse-Effectdepressed level of consciousness , marked irritability, and ataxia developed in seven children, 5 years of age and younger, following administration of an antiemetic combination of pentobarbital and pyrilamine maleate.
0.9854 A toxic encephalopathy characterized by depressed level of consciousness, Adverse-Effectmarked irritability , and ataxia developed in seven children, 5 years of age and younger, following administration of an antiemetic combination of pentobarbital and pyrilamine maleate.
0.9739 A toxic encephalopathy characterized by depressed level of consciousness, marked irritability, and ataxia developed in seven children, 5 years of age and younger, following administration of an antiemetic combination of pentobarbital and Drugpyrilamine maleate .
Score Text
0.9889 Careful follow - up of so - called " self - limited " Druginsulin edema is encouraged, and the early institution of diuretic therapy is advocated in elderly patients to prevent the development of overt cardiac failure.
0.6581 Careful follow - up of so - called " self - limited " insulin Adverse-Effectedema is encouraged, and the early institution of diuretic therapy is advocated in elderly patients to prevent the development of overt cardiac failure.
0.6294 Careful follow - up of so - called " self - limited " Adverse-Effectinsulin edema is encouraged, and the early institution of diuretic therapy is advocated in elderly patients to prevent the development of overt cardiac failure.
Score Text
0.9984 We present a 46 - year - old African - American man with AIDS who was admitted on two different occasions within three weeks for signs and symptoms of meningitis after using trimethoprim / Drugsulfamethoxazole ( TMP / SMX ).
0.9983 We present a 46 - year - old African - American man with AIDS who was admitted on two different occasions within three weeks for signs and symptoms of meningitis after using Drugtrimethoprim / sulfamethoxazole ( TMP / SMX ).
0.9978 We present a 46 - year - old African - American man with AIDS who was admitted on two different occasions within three weeks for signs and symptoms of meningitis after using trimethoprim / sulfamethoxazole ( TMP / DrugSMX ).
0.9974 We present a 46 - year - old African - American man with AIDS who was admitted on two different occasions within three weeks for signs and symptoms of meningitis after using trimethoprim / sulfamethoxazole ( DrugTMP / SMX ).
0.9969 We present a 46 - year - old African - American man with AIDS who was admitted on two different occasions within three weeks for signs and symptoms of Adverse-Effectmeningitis after using trimethoprim / sulfamethoxazole ( TMP / SMX ).
Score Text
0.9994 We report ( to our knowledge, for the first time in a child ) the emergence of psychosis in a 12 - year old white girl with an increased Drugefavirenz concentration and heterozygous gene polymorphism of the CYP2B6 - G516 T.
0.9984 We report ( to our knowledge, for the first time in a child ) the emergence of Adverse-Effectpsychosis in a 12 - year old white girl with an increased efavirenz concentration and heterozygous gene polymorphism of the CYP2B6 - G516 T.
Score Text
0.9994 We report the first case of a human immunodeficiency virus type 1 ( HIV - 1 ) - infected individual receiving combination antiretroviral therapy, which included ritonavir, who developed Cushing syndrome with profound complications after epidural Drugtriamcinolone injections.
0.9934 We report the first case of a human immunodeficiency virus type 1 ( HIV - 1 ) - infected individual receiving combination antiretroviral therapy, which included ritonavir, who developed Adverse-EffectCushing syndrome with profound complications after epidural triamcinolone injections.
Score Text
0.9990 After seven months'continuous treatment for suspected tuberculosis with rifampicin and ethambutol a nine - year - old boy developed Adverse-Effectpolyarthritis , rash and hepatitis in association with anti - native DNA antibodies and positive antinuclear factor.
0.9989 After seven months'continuous treatment for suspected tuberculosis with rifampicin and ethambutol a nine - year - old boy developed polyarthritis, rash and Adverse-Effecthepatitis in association with anti - native DNA antibodies and positive antinuclear factor.
0.9981 After seven months'continuous treatment for suspected tuberculosis with rifampicin and Drugethambutol a nine - year - old boy developed polyarthritis, rash and hepatitis in association with anti - native DNA antibodies and positive antinuclear factor.
0.9967 After seven months'continuous treatment for suspected tuberculosis with rifampicin and ethambutol a nine - year - old boy developed polyarthritis, Adverse-Effectrash and hepatitis in association with anti - native DNA antibodies and positive antinuclear factor.
0.9836 After seven months'continuous treatment for suspected tuberculosis with rifampicin and ethambutol a nine - year - old boy developed polyarthritis, rash and hepatitis in association with Adverse-Effectanti - native DNA antibodies and positive antinuclear factor.
0.9985 After seven months'continuous treatment for suspected tuberculosis with Drugrifampicin and ethambutol a nine - year - old boy developed polyarthritis, rash and hepatitis in association with anti - native DNA antibodies and positive antinuclear factor.
0.9863 After seven months'continuous treatment for suspected tuberculosis with rifampicin and ethambutol a nine - year - old boy developed polyarthritis, rash and hepatitis in association with anti - native DNA antibodies and Adverse-Effectpositive antinuclear factor .
Score Text
0.9984 We report a 43 - year - old woman who developed sore throat, swelling of the lips and oral cavity and dysphagia, 2 weeks after the use of Drugbudesonide spray ( Budefat ) for treatment of bronchial asthma.
0.9967 We report a 43 - year - old woman who developed sore throat, swelling of the lips and oral cavity and dysphagia, 2 weeks after the use of budesonide spray ( DrugBudefat ) for treatment of bronchial asthma.
0.9952 We report a 43 - year - old woman who developed sore throat, swelling of the lips and oral cavity and Adverse-Effectdysphagia , 2 weeks after the use of budesonide spray ( Budefat ) for treatment of bronchial asthma.
0.9925 We report a 43 - year - old woman who developed Adverse-Effectsore throat , swelling of the lips and oral cavity and dysphagia, 2 weeks after the use of budesonide spray ( Budefat ) for treatment of bronchial asthma.
0.9803 We report a 43 - year - old woman who developed sore throat, Adverse-Effectswelling of the lips and oral cavity and dysphagia, 2 weeks after the use of budesonide spray ( Budefat ) for treatment of bronchial asthma.
Score Text
0.9994 However, in the mid - to - late 1980s, a series of letters to the editor and case reports announced an association between Drugtamoxifen therapy in women with breast cancer and the development of endometrial carcinoma.
0.9922 However, in the mid - to - late 1980s, a series of letters to the editor and case reports announced an association between tamoxifen therapy in women with breast cancer and the development of Adverse-Effectendometrial carcinoma .
Score Text
0.9579 We report a cae of Adverse-Effectparanoid psychosis following use of a decongestant containing PPA and summarize the case report literature of psychiatric adverse effects to PPA in which doses were known and stated to be within recommended guidelines.
0.9461 We report a cae of paranoid psychosis following use of a decongestant containing DrugPPA and summarize the case report literature of psychiatric adverse effects to PPA in which doses were known and stated to be within recommended guidelines.
0.9443 We report a cae of paranoid psychosis following use of a decongestant containing PPA and summarize the case report literature of psychiatric adverse effects to DrugPPA in which doses were known and stated to be within recommended guidelines.
We report a cae of paranoid psychosis following use of a decongestant containing PPA and summarize the case report literature of Adverse-Effectpsychiatric adverse effects to PPA in which doses were known and stated to be within recommended guidelines.
Score Text
0.9995 OBJECTIVE : To our knowledge, this is the first published case report of an adolescent girl with a mitochondrial disorder and depression who displayed both new - onset psychotic and increased mood symptoms during treatment with Drugrisperidone .
0.6814 OBJECTIVE : To our knowledge, this is the first published case report of an adolescent girl with a mitochondrial disorder and depression who displayed both new - onset psychotic and Adverse-Effectincreased mood symptoms during treatment with risperidone.
0.6389 OBJECTIVE : To our knowledge, this is the first published case report of an adolescent girl with a mitochondrial disorder and depression who displayed both new - onset Adverse-Effectpsychotic and increased mood symptoms during treatment with risperidone.
Score Text
0.9995 Ten days after Drugitraconazole was started, he developed paralytic ileus, neurogenic bladder, mild left ptosis, and absence of deep reflexes, with severe paralysis of the lower extremities and mild weakness of the upper extremities.
0.9943 Ten days after itraconazole was started, he developed Adverse-Effectparalytic ileus , neurogenic bladder, mild left ptosis, and absence of deep reflexes, with severe paralysis of the lower extremities and mild weakness of the upper extremities.
0.9924 Ten days after itraconazole was started, he developed paralytic ileus, Adverse-Effectneurogenic bladder , mild left ptosis, and absence of deep reflexes, with severe paralysis of the lower extremities and mild weakness of the upper extremities.
0.9874 Ten days after itraconazole was started, he developed paralytic ileus, neurogenic bladder, Adverse-Effectmild left ptosis , and absence of deep reflexes, with severe paralysis of the lower extremities and mild weakness of the upper extremities.
0.9768 Ten days after itraconazole was started, he developed paralytic ileus, neurogenic bladder, mild left ptosis, and absence of deep reflexes, with severe paralysis of the lower extremities and Adverse-Effectmild weakness of the upper extremities .
0.9768 Ten days after itraconazole was started, he developed paralytic ileus, neurogenic bladder, mild left ptosis, and absence of deep reflexes, with Adverse-Effectsevere paralysis of the lower extremities and mild weakness of the upper extremities.
0.9610 Ten days after itraconazole was started, he developed paralytic ileus, neurogenic bladder, mild left ptosis, and Adverse-Effectabsence of deep reflexes , with severe paralysis of the lower extremities and mild weakness of the upper extremities.
Score Text
0.9784 Administration of intrathecal DrugAra - C in the same dose over longer intervals within 3 - 5 days between consecutive doses resulted in mild, transient neurological symptoms ( paresthesias ) in only one of 30 patients so treated.
0.9619 Administration of intrathecal Ara - C in the same dose over longer intervals within 3 - 5 days between consecutive doses resulted in mild, transient neurological symptoms ( Adverse-Effectparesthesias ) in only one of 30 patients so treated.
0.5662 Administration of intrathecal Ara - C in the same dose over longer intervals within 3 - 5 days between consecutive doses resulted in Adverse-Effectmild, transient neurological symptoms ( paresthesias ) in only one of 30 patients so treated.
Score Text
0.9992 PATIENT AND METHOD : A 34 - year - old woman with chronic hepatitis C, genotype 3, receiving pegylated interferon alpha - 2a and ribavirin for 6 months, developed progressive malaise and Adverse-Effectanemia 6 months after the end of treatment.
0.9974 PATIENT AND METHOD : A 34 - year - old woman with chronic hepatitis C, genotype 3, receiving pegylated interferon alpha - 2a and Drugribavirin for 6 months, developed progressive malaise and anemia 6 months after the end of treatment.
0.9962 PATIENT AND METHOD : A 34 - year - old woman with chronic hepatitis C, genotype 3, receiving pegylated interferon alpha - 2a and ribavirin for 6 months, developed Adverse-Effectprogressive malaise and anemia 6 months after the end of treatment.
0.9746 PATIENT AND METHOD : A 34 - year - old woman with chronic hepatitis C, genotype 3, receiving Drugpegylated interferon alpha - 2a and ribavirin for 6 months, developed progressive malaise and anemia 6 months after the end of treatment.
Score Text
0.9842 CASE SUMMARY : A 46 - year - old African - American man experienced recurrent grand mal seizures during intravenous infusion of Drugamphotericin B , then petit mal seizures as the infusion was stopped and the drug concentrations decreased with time.
0.9319 CASE SUMMARY : A 46 - year - old African - American man experienced recurrent Adverse-Effectgrand mal seizures during intravenous infusion of amphotericin B, then petit mal seizures as the infusion was stopped and the drug concentrations decreased with time.
0.9157 CASE SUMMARY : A 46 - year - old African - American man experienced recurrent grand mal seizures during intravenous infusion of amphotericin B, then Adverse-Effectpetit mal seizures as the infusion was stopped and the drug concentrations decreased with time.
0.7613 CASE SUMMARY : A 46 - year - old African - American man experienced Adverse-Effectrecurrent grand mal seizures during intravenous infusion of amphotericin B, then petit mal seizures as the infusion was stopped and the drug concentrations decreased with time.
Score Text
0.9997 We report the case of a young man, affected by rheumatoid arthritis who developed a rapid - onset short - of - breath, hemoptysis, and severe weakness, about 2 weeks after the administration of Drugleflunomide .
0.9990 We report the case of a young man, affected by rheumatoid arthritis who developed a rapid - onset short - of - breath, Adverse-Effecthemoptysis , and severe weakness, about 2 weeks after the administration of leflunomide.
0.9970 We report the case of a young man, affected by rheumatoid arthritis who developed a rapid - onset short - of - breath, hemoptysis, and Adverse-Effectsevere weakness , about 2 weeks after the administration of leflunomide.
0.9780 We report the case of a young man, affected by rheumatoid arthritis who developed a rapid - onset Adverse-Effectshort - of - breath , hemoptysis, and severe weakness, about 2 weeks after the administration of leflunomide.
Score Text
0.9965 It is thought that the clinico - pathological features and chronology of this case bore the hallmarks of the so - called " 3 - week sulphasalazine syndrome ", a rare, but often fatal, immunoallergic reaction to Drugsulphasalazine .
0.9690 It is thought that the clinico - pathological features and chronology of this case bore the hallmarks of the so - called " 3 - week Drugsulphasalazine syndrome ", a rare, but often fatal, immunoallergic reaction to sulphasalazine.
0.9331 It is thought that the clinico - pathological features and chronology of this case bore the hallmarks of the so - called " 3 - week sulphasalazine syndrome ", a rare, but often Adverse-Effectfatal , immunoallergic reaction to sulphasalazine.
0.9288 It is thought that the clinico - pathological features and chronology of this case bore the hallmarks of the so - called " 3 - week Adverse-Effectsulphasalazine syndrome ", a rare, but often fatal, immunoallergic reaction to sulphasalazine.
0.9157 It is thought that the clinico - pathological features and chronology of this case bore the hallmarks of the so - called " 3 - week sulphasalazine syndrome ", a rare, but often fatal, Adverse-Effectimmunoallergic reaction to sulphasalazine.
Score Text
0.9342 After several unrevealing medical work - ups, he was found to have a high blood Druglead level ( 122 microg / dL ) ; he has a history of scraping and sanding lead paint without adequate protective measures.
0.8937 After several unrevealing medical work - ups, he was found to have a Adverse-Effecthigh blood lead level ( 122 microg / dL ) ; he has a history of scraping and sanding lead paint without adequate protective measures.
0.6641 After several unrevealing medical work - ups, he was found to have a high blood lead level ( 122 microg / dL ) ; he has a history of scraping and sanding Druglead paint without adequate protective measures.
Score Text
0.9815 OBJECTIVES : The authors described a case of Adverse-EffectHashimoto's disease during interferon - alpha ( IFN - alpha ) treatment for chronic viral C hepatitis in a patient with the specific genetic susceptibility associated with the thyroid disease.
0.9746 OBJECTIVES : The authors described a case of Hashimoto's disease during Druginterferon - alpha ( IFN - alpha ) treatment for chronic viral C hepatitis in a patient with the specific genetic susceptibility associated with the thyroid disease.
0.9712 OBJECTIVES : The authors described a case of Hashimoto's disease during interferon - alpha ( DrugIFN - alpha ) treatment for chronic viral C hepatitis in a patient with the specific genetic susceptibility associated with the thyroid disease.
Score Text
0.9996 A high dose of Drugcotrimoxazole induced hyperkalaemia with the elevation of serum creatinine and blood urea, and increased urinary N - acetyl glucosaminase after several days of the drug administration in these patients ; one patient became unconscious.
0.9980 A high dose of cotrimoxazole induced Adverse-Effecthyperkalaemia with the elevation of serum creatinine and blood urea, and increased urinary N - acetyl glucosaminase after several days of the drug administration in these patients ; one patient became unconscious.
0.9820 A high dose of cotrimoxazole induced hyperkalaemia with the elevation of serum creatinine and blood urea, and Adverse-Effectincreased urinary N - acetyl glucosaminase after several days of the drug administration in these patients ; one patient became unconscious.
0.9766 A high dose of cotrimoxazole induced hyperkalaemia with the Adverse-Effectelevation of serum creatinine and blood urea , and increased urinary N - acetyl glucosaminase after several days of the drug administration in these patients ; one patient became unconscious.
0.8553 A high dose of cotrimoxazole induced hyperkalaemia with the elevation of serum creatinine and blood urea, and increased urinary N - acetyl glucosaminase after several days of the drug administration in these patients ; Adverse-Effectone patient became unconscious .
0.9823 A high dose of cotrimoxazole induced hyperkalaemia with the elevation of serum creatinine and blood urea, and increased urinary N - acetyl glucosaminase after several days of the drug administration in these patients ; one patient became Adverse-Effectunconscious .
0.9818 A high dose of cotrimoxazole induced hyperkalaemia with the elevation of serum creatinine and blood urea, and increased urinary N - acetyl glucosaminase after several days of the drug administration in these patients ; one patient Adverse-Effectbecame unconscious .
0.9028 A high dose of cotrimoxazole induced hyperkalaemia with the elevation of serum creatinine and blood urea, and increased urinary N - acetyl glucosaminase after several days of the drug administration in these patients ; one Adverse-Effectpatient became unconscious .
Score Text
0.9991 We report on 7 patients ( 2 women, 5 men ) with chronic renal failure, who developed under a high dosage of the new diuretic Drugmuzolimine ( range 240 to 1440 mg per day ) fatal neuromyeloencephalopathy.
0.9821 We report on 7 patients ( 2 women, 5 men ) with chronic renal failure, who developed under a high dosage of the new diuretic muzolimine ( range 240 to 1440 mg per day ) Adverse-Effectfatal neuromyeloencephalopathy .
Score Text
0.9962 We report the first case of fulminant adult respiratory distress syndrome ( ARDS ) associated with pegylated interferon alpha - 2a ( pegIFNalpha - 2a ) and Drugribavirin use for hepatitis C, complicated by subsequent and ultimately fatal sepsis and multiorgan failure.
0.9929 We report the first case of fulminant adult respiratory distress syndrome ( Adverse-EffectARDS ) associated with pegylated interferon alpha - 2a ( pegIFNalpha - 2a ) and ribavirin use for hepatitis C, complicated by subsequent and ultimately fatal sepsis and multiorgan failure.
0.9806 We report the first case of fulminant adult respiratory distress syndrome ( ARDS ) associated with Drugpegylated interferon alpha - 2a ( pegIFNalpha - 2a ) and ribavirin use for hepatitis C, complicated by subsequent and ultimately fatal sepsis and multiorgan failure.
0.9805 We report the first case of fulminant adult respiratory distress syndrome ( ARDS ) associated with pegylated interferon alpha - 2a ( DrugpegIFNalpha - 2a ) and ribavirin use for hepatitis C, complicated by subsequent and ultimately fatal sepsis and multiorgan failure.
0.9157 We report the first case of fulminant Adverse-Effectadult respiratory distress syndrome ( ARDS ) associated with pegylated interferon alpha - 2a ( pegIFNalpha - 2a ) and ribavirin use for hepatitis C, complicated by subsequent and ultimately fatal sepsis and multiorgan failure.
0.9590 We report the first case of Adverse-Effectfulminant adult respiratory distress syndrome ( ARDS ) associated with pegylated interferon alpha - 2a ( pegIFNalpha - 2a ) and ribavirin use for hepatitis C, complicated by subsequent and ultimately fatal sepsis and multiorgan failure.
Score Text
0.9977 Here we describe a patient with Crohn's disease who developed a severe Druginfliximab infusion reaction ( IIR ), complicated 1 day later by severe swelling of the forearm and hand ipsilateral to the site of infliximab infusion.
0.9966 Here we describe a patient with Crohn's disease who developed a severe infliximab infusion reaction ( IIR ), complicated 1 day later by severe swelling of the forearm and hand ipsilateral to the site of Druginfliximab infusion.
0.9921 Here we describe a patient with Crohn's disease who developed a severe infliximab infusion reaction ( Adverse-EffectIIR ), complicated 1 day later by severe swelling of the forearm and hand ipsilateral to the site of infliximab infusion.
0.9704 Here we describe a patient with Crohn's disease who developed a severe infliximab infusion reaction ( IIR ), complicated 1 day later by Adverse-Effectsevere swelling of the forearm and hand ipsilateral to the site of infliximab infusion.
Here we describe a patient with Crohn's disease who developed a Adverse-Effectsevere infliximab infusion reaction ( IIR ), complicated 1 day later by severe swelling of the forearm and hand ipsilateral to the site of infliximab infusion.
Score Text
0.9993 However, there remain questions concerning whether these drugs, especially Drugmethimazole ( MMI ), may be associated with aplasia cutis congenita ( ACC ) and how best to avoid impairment of fetal thyroid function during their use.
0.9858 However, there remain questions concerning whether these drugs, especially methimazole ( MMI ), may be associated with Adverse-Effectaplasia cutis congenita ( ACC ) and how best to avoid impairment of fetal thyroid function during their use.
0.9736 However, there remain questions concerning whether these drugs, especially methimazole ( MMI ), may be associated with aplasia cutis congenita ( Adverse-EffectACC ) and how best to avoid impairment of fetal thyroid function during their use.
0.9585 However, there remain questions concerning whether these drugs, especially methimazole ( DrugMMI ), may be associated with aplasia cutis congenita ( ACC ) and how best to avoid impairment of fetal thyroid function during their use.
0.9516 However, there remain questions concerning whether these drugs, especially methimazole ( MMI ), may be associated with aplasia cutis congenita ( ACC ) and how best to avoid Adverse-Effectimpairment of fetal thyroid function during their use.
Score Text
0.9927 Case 2, a 29 - year - old woman, developed Adverse-Effectbilateral optic neuritis combined with numbness of the lower extremities as well as bowel and bladder dysfunction after a 22 - month use of recombinant interferon alpha - 2b for chronic myelogenous leukemia.
0.9902 Case 2, a 29 - year - old woman, developed bilateral optic neuritis combined with numbness of the lower extremities as well as Adverse-Effectbowel and bladder dysfunction after a 22 - month use of recombinant interferon alpha - 2b for chronic myelogenous leukemia.
0.9861 Case 2, a 29 - year - old woman, developed bilateral optic neuritis combined with Adverse-Effectnumbness of the lower extremities as well as bowel and bladder dysfunction after a 22 - month use of recombinant interferon alpha - 2b for chronic myelogenous leukemia.
0.9627 Case 2, a 29 - year - old woman, developed bilateral optic neuritis combined with numbness of the lower extremities as well as bowel and bladder dysfunction after a 22 - month use of Drugrecombinant interferon alpha - 2b for chronic myelogenous leukemia.
Score Text
0.9940 We report a case of a patient with mild chronic renal insufficiency who had been taking simvastatin for over a year and developed Adverse-Effectacute weakness within 3 weeks after the start of treatment with colchicine for acute gouty bursitis.
0.9677 We report a case of a patient with mild chronic renal insufficiency who had been taking Drugsimvastatin for over a year and developed acute weakness within 3 weeks after the start of treatment with colchicine for acute gouty bursitis.
0.9392 We report a case of a patient with mild chronic renal insufficiency who had been taking simvastatin for over a year and developed acute weakness within 3 weeks after the start of treatment with Drugcolchicine for acute gouty bursitis.
We report a case of a patient with Adverse-Effectmild chronic renal insufficiency who had been taking simvastatin for over a year and developed acute weakness within 3 weeks after the start of treatment with colchicine for acute gouty bursitis.
Score Text
0.9996 We report a case of a patient with pulmonary hypertension and undifferentiated connective tissue disease who, after 2 months of treatment with Drugepoprostenol , presented with rapidly progressive erythema, scaling, nausea and vomiting, and fever.
0.9979 We report a case of a patient with pulmonary hypertension and undifferentiated connective tissue disease who, after 2 months of treatment with epoprostenol, presented with rapidly progressive erythema, scaling, nausea and Adverse-Effectvomiting , and fever.
0.9975 We report a case of a patient with pulmonary hypertension and undifferentiated connective tissue disease who, after 2 months of treatment with epoprostenol, presented with rapidly progressive erythema, Adverse-Effectscaling , nausea and vomiting, and fever.
0.9962 We report a case of a patient with pulmonary hypertension and undifferentiated connective tissue disease who, after 2 months of treatment with epoprostenol, presented with rapidly progressive erythema, scaling, Adverse-Effectnausea and vomiting, and fever.
0.9917 We report a case of a patient with pulmonary hypertension and undifferentiated connective tissue disease who, after 2 months of treatment with epoprostenol, presented with Adverse-Effectrapidly progressive erythema , scaling, nausea and vomiting, and fever.
0.9895 We report a case of a patient with pulmonary hypertension and undifferentiated connective tissue disease who, after 2 months of treatment with epoprostenol, presented with rapidly progressive erythema, scaling, nausea and vomiting, and Adverse-Effectfever .
Score Text
0.9863 CONCLUSIONS : This case report showed that the clinical appearance of Adverse-EffectHashimoto's disease after IFN - alpha therapy for chronic C hepatitis in our patient was associated with a specific genetic predisposition ( DR5 ) for this pathology.
0.9779 CONCLUSIONS : This case report showed that the clinical appearance of Hashimoto's disease after DrugIFN - alpha therapy for chronic C hepatitis in our patient was associated with a specific genetic predisposition ( DR5 ) for this pathology.
Score Text
0.9995 We report a case of a patient with rheumatoid arthritis treated with low - dose Drugmethotrexate ( 15 mg / week ) who developed infection with both M. tuberculosis and M. chelonae after the revision of a prosthetic hip.
0.9391 We report a case of a patient with rheumatoid arthritis treated with low - dose methotrexate ( 15 mg / week ) who developed Adverse-Effectinfection with both M. tuberculosis and M. chelonae after the revision of a prosthetic hip.
Score Text
0.9996 The case histories are presented of two patients who developed lung disease associated with the use of Drugnitrofurantoin with histological features of bronchiolitis obliterans organising pneumonia ( BOOP ), a rare but recognised form of drug induced injury.
0.9925 The case histories are presented of two patients who developed Adverse-Effectlung disease associated with the use of nitrofurantoin with histological features of bronchiolitis obliterans organising pneumonia ( BOOP ), a rare but recognised form of drug induced injury.
0.9907 The case histories are presented of two patients who developed lung disease associated with the use of nitrofurantoin with histological features of bronchiolitis obliterans organising pneumonia ( Adverse-EffectBOOP ), a rare but recognised form of drug induced injury.
0.9764 The case histories are presented of two patients who developed lung disease associated with the use of nitrofurantoin with histological features of Adverse-Effectbronchiolitis obliterans organising pneumonia ( BOOP ), a rare but recognised form of drug induced injury.
Score Text
0.9994 A selective association between Drugfluoxetine and extensive, prominent eye movements in nonrapid eye movement ( NREM ) sleep was detected, utilizing Fisher's exact one - tailed statistic ( p less than 0. 00001 for each comparison ).
0.9590 A selective association between fluoxetine and extensive, prominent Adverse-Effecteye movements in nonrapid eye movement ( NREM ) sleep was detected, utilizing Fisher's exact one - tailed statistic ( p less than 0. 00001 for each comparison ).
Score Text
0.9980 Our findings suggest that Adverse-Effecthyperkalemia can develop with the use of low - dose heparin, within seven days of initiating heparin therapy, and that patients with diabetes mellitus or chronic renal insufficiency are especially predisposed to this complication.
0.9920 Our findings suggest that hyperkalemia can develop with the use of low - dose heparin, within seven days of initiating Drugheparin therapy, and that patients with diabetes mellitus or chronic renal insufficiency are especially predisposed to this complication.
0.9914 Our findings suggest that hyperkalemia can develop with the use of low - dose Drugheparin , within seven days of initiating heparin therapy, and that patients with diabetes mellitus or chronic renal insufficiency are especially predisposed to this complication.
Score Text
0.9998 We describe a case of disseminated muscular cysticercosis followed by myositis ( fever, diffuse myalgia, weakness of the lower limbs, and inflammatory reaction around dying cysticerci ) induced by Drugpraziquantel therapy, an event not described previously.
0.9990 We describe a case of disseminated muscular cysticercosis followed by Adverse-Effectmyositis ( fever, diffuse myalgia, weakness of the lower limbs, and inflammatory reaction around dying cysticerci ) induced by praziquantel therapy, an event not described previously.
0.9923 We describe a case of disseminated muscular cysticercosis followed by myositis ( fever, Adverse-Effectdiffuse myalgia , weakness of the lower limbs, and inflammatory reaction around dying cysticerci ) induced by praziquantel therapy, an event not described previously.
0.9909 We describe a case of disseminated muscular cysticercosis followed by myositis ( Adverse-Effectfever , diffuse myalgia, weakness of the lower limbs, and inflammatory reaction around dying cysticerci ) induced by praziquantel therapy, an event not described previously.
0.9835 We describe a case of disseminated muscular cysticercosis followed by myositis ( fever, diffuse myalgia, Adverse-Effectweakness of the lower limbs , and inflammatory reaction around dying cysticerci ) induced by praziquantel therapy, an event not described previously.
0.9784 We describe a case of disseminated muscular cysticercosis followed by myositis ( fever, diffuse myalgia, weakness of the lower limbs, and Adverse-Effectinflammatory reaction around dying cysticerci ) induced by praziquantel therapy, an event not described previously.
0.9708 We describe a case of Adverse-Effectdisseminated muscular cysticercosis followed by myositis ( fever, diffuse myalgia, weakness of the lower limbs, and inflammatory reaction around dying cysticerci ) induced by praziquantel therapy, an event not described previously.
Score Text
0.9887 A 51 - yr - old nonsmoking male patient without any history of previous allergies, asthma, hay fever, or urticaria developed attacks of asthma when captopril was added to the nadolol and Drugdyazide treatment for his high blood pressure.
0.9853 A 51 - yr - old nonsmoking male patient without any history of previous allergies, asthma, hay fever, or urticaria developed attacks of asthma when captopril was added to the Drugnadolol and dyazide treatment for his high blood pressure.
0.9797 A 51 - yr - old nonsmoking male patient without any history of previous allergies, asthma, hay fever, or urticaria developed Adverse-Effectattacks of asthma when captopril was added to the nadolol and dyazide treatment for his high blood pressure.
0.9542 A 51 - yr - old nonsmoking male patient without any history of previous allergies, asthma, hay fever, or urticaria developed attacks of asthma when Drugcaptopril was added to the nadolol and dyazide treatment for his high blood pressure.
Score Text
0.9924 Despite a response of the meningeal tumor the patient developed in the third week of DrugMTX treatment a progressive visual loss and loss of consciousness which worsened during subsequent Ara - C treatment and led to death within 3 weeks.
0.9873 Despite a response of the meningeal tumor the patient developed in the third week of MTX treatment a progressive visual loss and Adverse-Effectloss of consciousness which worsened during subsequent Ara - C treatment and led to death within 3 weeks.
0.9860 Despite a response of the meningeal tumor the patient developed in the third week of MTX treatment a progressive visual loss and loss of consciousness which worsened during subsequent DrugAra - C treatment and led to death within 3 weeks.
0.9828 Despite a response of the meningeal tumor the patient developed in the third week of MTX treatment a Adverse-Effectprogressive visual loss and loss of consciousness which worsened during subsequent Ara - C treatment and led to death within 3 weeks.
0.8956 Despite a response of the meningeal tumor the patient developed in the third week of MTX treatment a progressive visual loss and loss of consciousness which worsened during subsequent Ara - C treatment and led to Adverse-Effectdeath within 3 weeks.
Score Text
0.9961 A 32 - year - old man with a family history of type 2 diabetes mellitus presented with Adverse-Effectcirculatory collapse and deep coma after 9 days of treatment with perospirone hydrochloride, a recently developed atypical antipsychotic agent available only in Japan.
0.9948 A 32 - year - old man with a family history of type 2 diabetes mellitus presented with circulatory collapse and Adverse-Effectdeep coma after 9 days of treatment with perospirone hydrochloride, a recently developed atypical antipsychotic agent available only in Japan.
0.9825 A 32 - year - old man with a family history of type 2 diabetes mellitus presented with circulatory collapse and deep coma after 9 days of treatment with Drugperospirone hydrochloride , a recently developed atypical antipsychotic agent available only in Japan.
Score Text
0.9995 A woman with a 20 - year history of acral pustular psoriasis of Hallopeau and recurrent pustular lesions of the forearms and lower legs, developed a B - cell lymphoma of the lip following 4 1 / 2 years of treatment with Drugrazoxane .
0.9775 A woman with a 20 - year history of acral pustular psoriasis of Hallopeau and recurrent pustular lesions of the forearms and lower legs, developed a Adverse-EffectB - cell lymphoma of the lip following 4 1 / 2 years of treatment with razoxane.
Score Text
0.9981 Fatal lung fibrosis caused by Drugpaclitaxel toxicity has not been reported In this report, we describe the case of a 62 - year - old woman who received six cycles of paclitaxel and carboplatin as combination chemotherapy for advanced ovarian cancer.
0.9967 Fatal lung fibrosis caused by paclitaxel toxicity has not been reported In this report, we describe the case of a 62 - year - old woman who received six cycles of Drugpaclitaxel and carboplatin as combination chemotherapy for advanced ovarian cancer.
0.9966 Fatal lung fibrosis caused by paclitaxel toxicity has not been reported In this report, we describe the case of a 62 - year - old woman who received six cycles of paclitaxel and Drugcarboplatin as combination chemotherapy for advanced ovarian cancer.
0.9882 Adverse-EffectFatal lung fibrosis caused by paclitaxel toxicity has not been reported In this report, we describe the case of a 62 - year - old woman who received six cycles of paclitaxel and carboplatin as combination chemotherapy for advanced ovarian cancer.
Score Text
0.9994 Since Drugimiquimod induces large amounts of type I interferon production from TLR7 - expressing plasmacytoid dendritic cell precursors ( PDCs ), the natural interferon - producing cells of the peripheral blood, we asked whether PDCs are present in psoriatic skin.
0.9749 Since imiquimod induces Adverse-Effectlarge amounts of type I interferon production from TLR7 - expressing plasmacytoid dendritic cell precursors ( PDCs ), the natural interferon - producing cells of the peripheral blood, we asked whether PDCs are present in psoriatic skin.
Score Text
0.9891 As this relapse coincided with development of a strong delayed - type hypersensitivity response to Drugtuberculin and improved after treatment with the anti - inflammatory agent oxpentifylline, it was probably caused by restoration of pathogen - specific cellular immunity.
0.9561 As this relapse coincided with development of a strong delayed - type Adverse-Effecthypersensitivity response to tuberculin and improved after treatment with the anti - inflammatory agent oxpentifylline, it was probably caused by restoration of pathogen - specific cellular immunity.
Score Text
0.9993 In view of our experience in the present case, it should be stressed that close monitoring of coagulation capacity is necessary in critically ill patients in order to avoid fatal haemorrhage after initiating Drugwarfarin therapy regardless of the dosage.
0.9926 In view of our experience in the present case, it should be stressed that close monitoring of coagulation capacity is necessary in critically ill patients in order to avoid Adverse-Effectfatal haemorrhage after initiating warfarin therapy regardless of the dosage.
Score Text
0.9993 On day 4, following 3 doses of Drugdalteparin , the patient developed acute respiratory distress attributable to a massive right hemothorax confirmed by computed tomography pulmonary angiography ( CTPA ) and intercostal drainage of 1500 mL of frank blood.
0.9902 On day 4, following 3 doses of dalteparin, the patient developed Adverse-Effectacute respiratory distress attributable to a massive right hemothorax confirmed by computed tomography pulmonary angiography ( CTPA ) and intercostal drainage of 1500 mL of frank blood.
Score Text
0.9993 We report an 82 - year - old man who developed ventricular tachycardia and Torsades de Pointes ( TdP ) after oral administration of Druggarenoxacin , a novel quinolone antibiotic agent that differs from the third - generation quinolones, for pneumonia.
0.9974 We report an 82 - year - old man who developed ventricular tachycardia and Torsades de Pointes ( Adverse-EffectTdP ) after oral administration of garenoxacin, a novel quinolone antibiotic agent that differs from the third - generation quinolones, for pneumonia.
0.9913 We report an 82 - year - old man who developed Adverse-Effectventricular tachycardia and Torsades de Pointes ( TdP ) after oral administration of garenoxacin, a novel quinolone antibiotic agent that differs from the third - generation quinolones, for pneumonia.
0.9838 We report an 82 - year - old man who developed ventricular tachycardia and Adverse-EffectTorsades de Pointes ( TdP ) after oral administration of garenoxacin, a novel quinolone antibiotic agent that differs from the third - generation quinolones, for pneumonia.
Score Text
0.9983 After the dose of Drugmethylprednisolone was reduced from 40 mg to 20 mg i. v. q6h and shifted to other anti - asthma treatment by procaterol metered dose inhaler via spacer, the psychotic reaction disappeared a few hours later.
0.9915 After the dose of methylprednisolone was reduced from 40 mg to 20 mg i. v. q6h and shifted to other anti - asthma treatment by procaterol metered dose inhaler via spacer, the Adverse-Effectpsychotic reaction disappeared a few hours later.
Score Text
0.9987 The cases are important in documenting that drug - induced dystonias do occur in patients with dementia, that Drugrisperidone appears to have contributed to dystonia among elderly patients, and that the categorization of dystonic reactions needs further clarification.
0.9970 The cases are important in documenting that drug - induced dystonias do occur in patients with dementia, that risperidone appears to have contributed to Adverse-Effectdystonia among elderly patients, and that the categorization of dystonic reactions needs further clarification.
0.9968 The cases are important in documenting that drug - induced Adverse-Effectdystonias do occur in patients with dementia, that risperidone appears to have contributed to dystonia among elderly patients, and that the categorization of dystonic reactions needs further clarification.
Score Text
0.9994 He was started on oral Druglansoprazole 60 mg twice daily and, on hospital day 2, his platelet count decreased to 102 x 10 ( 3 ) / mm ( 3 ) ; on hospital day 3, the platelet count was 36 x 10 ( 3 ) / mm ( 3 ).
0.9585 He was started on oral lansoprazole 60 mg twice daily and, on hospital day 2, his Adverse-Effectplatelet count decreased to 102 x 10 ( 3 ) / mm ( 3 ) ; on hospital day 3, the platelet count was 36 x 10 ( 3 ) / mm ( 3 ).
Score Text
0.9995 Here we present the case of a woman who received high doses of Drugmethylprednisolone ( 1 g iv daily ) for active Graves'ophthalmopathy, and developed severe hypertension followed by myocardial infarction on the fifth day of treatment.
0.9934 Here we present the case of a woman who received high doses of methylprednisolone ( 1 g iv daily ) for active Graves'ophthalmopathy, and developed severe hypertension followed by Adverse-Effectmyocardial infarction on the fifth day of treatment.
0.9921 Here we present the case of a woman who received high doses of methylprednisolone ( 1 g iv daily ) for active Graves'ophthalmopathy, and developed Adverse-Effectsevere hypertension followed by myocardial infarction on the fifth day of treatment.
Score Text
0.9778 We report on three cases wherein treatment of dexmedetomidine - induced bradycardia with i. v. glycopyrrolate ( 5. 0 microg / kg ) not only resulting in resolution of bradycardia but also resulting in an Adverse-Effectexaggerated increase of arterial blood pressure .
0.9760 We report on three cases wherein treatment of Drugdexmedetomidine - induced bradycardia with i. v. glycopyrrolate ( 5. 0 microg / kg ) not only resulting in resolution of bradycardia but also resulting in an exaggerated increase of arterial blood pressure.
0.9292 We report on three cases wherein treatment of dexmedetomidine - induced Adverse-Effectbradycardia with i. v. glycopyrrolate ( 5. 0 microg / kg ) not only resulting in resolution of bradycardia but also resulting in an exaggerated increase of arterial blood pressure.
0.6511 We report on three cases wherein treatment of dexmedetomidine - induced bradycardia with i. v. Drugglycopyrrolate ( 5. 0 microg / kg ) not only resulting in resolution of bradycardia but also resulting in an exaggerated increase of arterial blood pressure.
Score Text
0.9951 While the introduction of carmustine wafers ( Gliadel wafers ) into the tumor resection cavity has been shown to be a beneficial therapy for malignant glioma, it is recognized that clinically significant Adverse-Effectcerebral edema is a potential adverse effect.
0.9917 While the introduction of Drugcarmustine wafers ( Gliadel wafers ) into the tumor resection cavity has been shown to be a beneficial therapy for malignant glioma, it is recognized that clinically significant cerebral edema is a potential adverse effect.
0.9846 While the introduction of carmustine wafers ( DrugGliadel wafers ) into the tumor resection cavity has been shown to be a beneficial therapy for malignant glioma, it is recognized that clinically significant cerebral edema is a potential adverse effect.
Score Text
0.9924 CASE REPORT : We present a case of a 28 - yr - old male who developed a severe case of Adverse-Effectnephrotic syndrome while being treated for relapsing / remitting Multiple Sclerosis ( RRMS ) with weekly injections of interferon beta 1a.
0.9792 CASE REPORT : We present a case of a 28 - yr - old male who developed a severe case of nephrotic syndrome while being treated for relapsing / remitting Multiple Sclerosis ( RRMS ) with weekly injections of Druginterferon beta 1a .
Score Text
0.9788 We report a case of ST elevation in right precordial leads compatible with Adverse-Effecttype 1 Brugada syndrome following administration of propafenone in a patient with Wolff - Parkinson - White syndrome who was receiving lithium at concentrations within therapeutic levels.
0.9671 We report a case of ST elevation in right precordial leads compatible with type 1 Brugada syndrome following administration of Drugpropafenone in a patient with Wolff - Parkinson - White syndrome who was receiving lithium at concentrations within therapeutic levels.
0.9350 We report a case of Adverse-EffectST elevation in right precordial leads compatible with type 1 Brugada syndrome following administration of propafenone in a patient with Wolff - Parkinson - White syndrome who was receiving lithium at concentrations within therapeutic levels.
0.8434 We report a case of ST elevation in right precordial leads compatible with type 1 Brugada syndrome following administration of propafenone in a patient with Wolff - Parkinson - White syndrome who was receiving Druglithium at concentrations within therapeutic levels.
Score Text
0.9991 The authors report a case of acute pancreatitis ( AP ) occurring in a patient under treatment with Drugcarbamazepine ( CBZ ) for post - traumatic petit mal epilepsy, and review the current literature of drug - induced AP.
0.9986 The authors report a case of acute pancreatitis ( AP ) occurring in a patient under treatment with carbamazepine ( DrugCBZ ) for post - traumatic petit mal epilepsy, and review the current literature of drug - induced AP.
0.9867 The authors report a case of Adverse-Effectacute pancreatitis ( AP ) occurring in a patient under treatment with carbamazepine ( CBZ ) for post - traumatic petit mal epilepsy, and review the current literature of drug - induced AP.
0.6259 The authors report a case of acute pancreatitis ( Adverse-EffectAP ) occurring in a patient under treatment with carbamazepine ( CBZ ) for post - traumatic petit mal epilepsy, and review the current literature of drug - induced AP.
The authors report a case of acute Adverse-Effectpancreatitis ( AP ) occurring in a patient under treatment with carbamazepine ( CBZ ) for post - traumatic petit mal epilepsy, and review the current literature of drug - induced AP.
Score Text
0.9995 These cases were considered unusual in light of the short delay of their onset after initiation of immunosuppressive therapy and their fulminant course : 3 of these patients died of PCP occurring during the first month of treatment with Drugprednisone .
0.9547 These cases were considered unusual in light of the short delay of their onset after initiation of immunosuppressive therapy and their fulminant course : 3 of these patients Adverse-Effectdied of PCP occurring during the first month of treatment with prednisone.
0.9821 These cases were considered unusual in light of the short delay of their onset after initiation of immunosuppressive therapy and their fulminant course : 3 of these patients died of Adverse-EffectPCP occurring during the first month of treatment with prednisone.
Score Text
0.9741 A small initial dose of Drugprazosin ranging from 0. 5 to 1 mg has been recommended to avoid the first - dose phenomenon characterized by a sudden and severe drop in blood pressure after the administration of the first dose of prazosin.
0.9274 A small initial dose of prazosin ranging from 0. 5 to 1 mg has been recommended to avoid the first - dose phenomenon characterized by a sudden and severe drop in blood pressure after the administration of the first dose of Drugprazosin .
0.8738 A small initial dose of prazosin ranging from 0. 5 to 1 mg has been recommended to avoid the first - dose phenomenon characterized by a sudden and Adverse-Effectsevere drop in blood pressure after the administration of the first dose of prazosin.
0.9458 A small initial dose of prazosin ranging from 0. 5 to 1 mg has been recommended to avoid the first - dose phenomenon characterized by a sudden and severe Adverse-Effectdrop in blood pressure after the administration of the first dose of prazosin.
Score Text
0.9980 In a postural challenge test after administration of isosorbide dinitrate ( 5 mg ), blood pressure decreased from 120 / 67 to 65 / 35 mmHg, followed by Adverse-Effectsyncope with a sudden decrease in pulse rate from 85 to 60 beats / min.
0.9807 In a postural challenge test after administration of isosorbide dinitrate ( 5 mg ), blood pressure decreased from 120 / 67 to 65 / 35 mmHg, followed by syncope with a Adverse-Effectsudden decrease in pulse rate from 85 to 60 beats / min.
0.9806 In a postural challenge test after administration of Drugisosorbide dinitrate ( 5 mg ), blood pressure decreased from 120 / 67 to 65 / 35 mmHg, followed by syncope with a sudden decrease in pulse rate from 85 to 60 beats / min.
0.9667 In a postural challenge test after administration of isosorbide dinitrate ( 5 mg ), Adverse-Effectblood pressure decreased from 120 / 67 to 65 / 35 mmHg, followed by syncope with a sudden decrease in pulse rate from 85 to 60 beats / min.
Score Text
0.9976 CONCLUSIONS : This report indicates clindamycin phosphate vaginal cream as the most probable cause of CDIC due to the temporal relationship between the occurrence of Adverse-Effectdiarrhea and clindamycin administration, lack of concomitant medications, and documentation of C. difficile toxin.
0.9912 CONCLUSIONS : This report indicates clindamycin phosphate vaginal cream as the most probable cause of CDIC due to the temporal relationship between the occurrence of diarrhea and Drugclindamycin administration, lack of concomitant medications, and documentation of C. difficile toxin.
0.9861 CONCLUSIONS : This report indicates clindamycin phosphate vaginal cream as the most probable cause of Adverse-EffectCDIC due to the temporal relationship between the occurrence of diarrhea and clindamycin administration, lack of concomitant medications, and documentation of C. difficile toxin.
0.9839 CONCLUSIONS : This report indicates clindamycin phosphate vaginal cream as the most probable cause of CDIC due to the temporal relationship between the occurrence of diarrhea and clindamycin administration, lack of concomitant medications, and documentation of Adverse-EffectC. difficile toxin .
0.9818 CONCLUSIONS : This report indicates Drugclindamycin phosphate vaginal cream as the most probable cause of CDIC due to the temporal relationship between the occurrence of diarrhea and clindamycin administration, lack of concomitant medications, and documentation of C. difficile toxin.
Score Text
0.9978 DISCUSSION : Amphotericin B deoxycholate has been reported to produce significant cardiac toxicity, with ventricular arrhythmias and Adverse-Effectbradycardia reported in overdoses in children and in adults with preexisting cardiac disease, even when administered in conventional dosages and infusion rates.
0.9934 DISCUSSION : Amphotericin B deoxycholate has been reported to produce significant Adverse-Effectcardiac toxicity , with ventricular arrhythmias and bradycardia reported in overdoses in children and in adults with preexisting cardiac disease, even when administered in conventional dosages and infusion rates.
0.9928 DISCUSSION : Amphotericin B deoxycholate has been reported to produce significant cardiac toxicity, with Adverse-Effectventricular arrhythmias and bradycardia reported in overdoses in children and in adults with preexisting cardiac disease, even when administered in conventional dosages and infusion rates.
0.9762 DISCUSSION : DrugAmphotericin B deoxycholate has been reported to produce significant cardiac toxicity, with ventricular arrhythmias and bradycardia reported in overdoses in children and in adults with preexisting cardiac disease, even when administered in conventional dosages and infusion rates.
Score Text
0.9987 This report suggests that Adverse-Effectanemia can occur due to MMF, in particular when it is given with prednisone, a side effect well documented in the transplantation literature when the triple combination of MMF, cyclosporine and prednisone is used.
0.9768 This report suggests that anemia can occur due to MMF, in particular when it is given with prednisone, a side effect well documented in the transplantation literature when the triple combination of MMF, Drugcyclosporine and prednisone is used.
0.9743 This report suggests that anemia can occur due to MMF, in particular when it is given with prednisone, a side effect well documented in the transplantation literature when the triple combination of MMF, cyclosporine and Drugprednisone is used.
0.9704 This report suggests that anemia can occur due to DrugMMF , in particular when it is given with prednisone, a side effect well documented in the transplantation literature when the triple combination of MMF, cyclosporine and prednisone is used.
0.9683 This report suggests that anemia can occur due to MMF, in particular when it is given with prednisone, a side effect well documented in the transplantation literature when the triple combination of DrugMMF , cyclosporine and prednisone is used.
0.9602 This report suggests that anemia can occur due to MMF, in particular when it is given with Drugprednisone , a side effect well documented in the transplantation literature when the triple combination of MMF, cyclosporine and prednisone is used.
Score Text
0.9996 A 79 - year - old man with ischemic heart disease, chronic atrial fibrillation, chronic renal failure, hypothyroidism, and gout arthritis was hospitalized because of fatigue, myalgia, and leg weakness, shortly after starting treatment with Drugcolchicine .
0.9991 A 79 - year - old man with ischemic heart disease, chronic atrial fibrillation, chronic renal failure, hypothyroidism, and gout arthritis was hospitalized because of Adverse-Effectfatigue , myalgia, and leg weakness, shortly after starting treatment with colchicine.
0.9991 A 79 - year - old man with ischemic heart disease, chronic atrial fibrillation, chronic renal failure, hypothyroidism, and gout arthritis was hospitalized because of fatigue, Adverse-Effectmyalgia , and leg weakness, shortly after starting treatment with colchicine.
0.9963 A 79 - year - old man with ischemic heart disease, chronic atrial fibrillation, chronic renal failure, hypothyroidism, and gout arthritis was hospitalized because of fatigue, myalgia, and Adverse-Effectleg weakness , shortly after starting treatment with colchicine.
Score Text
0.9998 RESULTS : In a 22 - year - old Thai woman with Graves'disease, tinnitus, hearing impairment in the left ear ( with progression to the right ear ), and vertigo developed after 3 years of therapy with DrugPTU .
0.9991 RESULTS : In a 22 - year - old Thai woman with Graves'disease, Adverse-Effecttinnitus , hearing impairment in the left ear ( with progression to the right ear ), and vertigo developed after 3 years of therapy with PTU.
0.9989 RESULTS : In a 22 - year - old Thai woman with Graves'disease, tinnitus, hearing impairment in the left ear ( with progression to the right ear ), and Adverse-Effectvertigo developed after 3 years of therapy with PTU.
0.9095 RESULTS : In a 22 - year - old Thai woman with Graves'disease, tinnitus, Adverse-Effecthearing impairment in the left ear ( with progression to the right ear ), and vertigo developed after 3 years of therapy with PTU.
0.8594 RESULTS : In a 22 - year - old Thai woman with Graves'disease, tinnitus, hearing impairment in the left ear ( with Adverse-Effectprogression to the right ear ), and vertigo developed after 3 years of therapy with PTU.
RESULTS : In a 22 - year - old Thai woman with Graves'disease, tinnitus, Adverse-Effecthearing impairment in the left ear ( with progression to the right ear ) , and vertigo developed after 3 years of therapy with PTU.
Score Text
0.9921 This case is remarkable since 1 ) ECM developed after subcutaneous and not after intramuscular injection, 2 ) the injection was given by the patient himself, and 3 ) glatiramer acetate can induce Adverse-Effectskin necrosis as a side effect.
0.9758 This case is remarkable since 1 ) ECM developed after subcutaneous and not after intramuscular injection, 2 ) the injection was given by the patient himself, and 3 ) Drugglatiramer acetate can induce skin necrosis as a side effect.
0.9928 This case is remarkable since 1 ) Adverse-EffectECM developed after subcutaneous and not after intramuscular injection, 2 ) the injection was given by the patient himself, and 3 ) glatiramer acetate can induce skin necrosis as a side effect.
Score Text
0.9961 Subsequent in vivo / vitro studies clearly demonstrated that the neurological effects were due to a synergistic action of desferrioxamine and Drugprochlorperazine , probably resulting in exceptional fluxes of intra / extra cellular iron / copper disturbing noradrenergic and serotonergic systems.
0.9949 Subsequent in vivo / vitro studies clearly demonstrated that the neurological effects were due to a synergistic action of Drugdesferrioxamine and prochlorperazine, probably resulting in exceptional fluxes of intra / extra cellular iron / copper disturbing noradrenergic and serotonergic systems.
0.9885 Subsequent in vivo / vitro studies clearly demonstrated that the Adverse-Effectneurological effects were due to a synergistic action of desferrioxamine and prochlorperazine, probably resulting in exceptional fluxes of intra / extra cellular iron / copper disturbing noradrenergic and serotonergic systems.
Score Text
0.9996 We describe 2 patients with severe erosive rheumatoid arthritis and rheumatoid vasculitis, respectively, in whom Druginfliximab therapy was associated with peripheral neuropathy due to necrotizing vasculitis in one patient and to progression of preexisting mononeuritis multiplex in the other.
0.9838 We describe 2 patients with severe erosive rheumatoid arthritis and rheumatoid vasculitis, respectively, in whom infliximab therapy was associated with peripheral neuropathy due to Adverse-Effectnecrotizing vasculitis in one patient and to progression of preexisting mononeuritis multiplex in the other.
0.9826 We describe 2 patients with severe erosive rheumatoid arthritis and rheumatoid vasculitis, respectively, in whom infliximab therapy was associated with peripheral neuropathy due to necrotizing vasculitis in one patient and to Adverse-Effectprogression of preexisting mononeuritis multiplex in the other.
0.9810 We describe 2 patients with severe erosive rheumatoid arthritis and rheumatoid vasculitis, respectively, in whom infliximab therapy was associated with Adverse-Effectperipheral neuropathy due to necrotizing vasculitis in one patient and to progression of preexisting mononeuritis multiplex in the other.
Score Text
0.9930 Adverse-EffectMI related to the use of activated and non - activated PCCs predominantly affects young patients who often have no preceding history of, or risk factors for, MI and tends to be associated with large cumulative doses of concentrate.
0.9841 MI related to the use of activated and non - activated DrugPCCs predominantly affects young patients who often have no preceding history of, or risk factors for, MI and tends to be associated with large cumulative doses of concentrate.
Score Text
0.9993 We report on a 56 - year - old female who exhibited drug refractory paroxysmal atrial fibrillation, in which marked prolongation of the QT interval and T wave inversion on electrocardiogram was demonstrated reproducibly shortly after the administration of oral Drugpirmenol therapy.
0.9846 We report on a 56 - year - old female who exhibited drug refractory paroxysmal atrial fibrillation, in which marked prolongation of the QT interval and Adverse-EffectT wave inversion on electrocardiogram was demonstrated reproducibly shortly after the administration of oral pirmenol therapy.
0.9759 We report on a 56 - year - old female who exhibited drug refractory paroxysmal atrial fibrillation, in which marked Adverse-Effectprolongation of the QT interval and T wave inversion on electrocardiogram was demonstrated reproducibly shortly after the administration of oral pirmenol therapy.
0.9441 We report on a 56 - year - old female who exhibited Adverse-Effectdrug refractory paroxysmal atrial fibrillation , in which marked prolongation of the QT interval and T wave inversion on electrocardiogram was demonstrated reproducibly shortly after the administration of oral pirmenol therapy.
Score Text
0.9942 This case of Druglinezolid - associated acute interstitial nephritis within the context of a drug rash with eosinophilia and systemic symptoms ( DRESS ) syndrome in a patient treated with linezolid raises concerns about the presumed renal safety of this drug.
0.9907 This case of linezolid - associated acute interstitial nephritis within the context of a drug rash with eosinophilia and systemic symptoms ( Adverse-EffectDRESS ) syndrome in a patient treated with linezolid raises concerns about the presumed renal safety of this drug.
0.9892 This case of linezolid - associated Adverse-Effectacute interstitial nephritis within the context of a drug rash with eosinophilia and systemic symptoms ( DRESS ) syndrome in a patient treated with linezolid raises concerns about the presumed renal safety of this drug.
0.9770 This case of linezolid - associated acute interstitial nephritis within the context of a drug rash with eosinophilia and systemic symptoms ( DRESS ) syndrome in a patient treated with Druglinezolid raises concerns about the presumed renal safety of this drug.
0.9585 This case of linezolid - associated acute interstitial nephritis within the context of a Adverse-Effectdrug rash with eosinophilia and systemic symptoms ( DRESS ) syndrome in a patient treated with linezolid raises concerns about the presumed renal safety of this drug.
Score Text
0.9937 INTRODUCTION : Although gefitinib used for the treatment of non - small - cell lung cancer is a well - known cause of interstitial lung disease ( Adverse-EffectILD ), few case reports on erlotinib - induced ILD have been issued.
0.9496 INTRODUCTION : Although gefitinib used for the treatment of non - small - cell lung cancer is a well - known cause of Adverse-Effectinterstitial lung disease ( ILD ), few case reports on erlotinib - induced ILD have been issued.
0.9470 INTRODUCTION : Although gefitinib used for the treatment of non - small - cell lung cancer is a well - known cause of interstitial lung disease ( ILD ), few case reports on Drugerlotinib - induced ILD have been issued.
0.9456 INTRODUCTION : Although Druggefitinib used for the treatment of non - small - cell lung cancer is a well - known cause of interstitial lung disease ( ILD ), few case reports on erlotinib - induced ILD have been issued.
0.6495 INTRODUCTION : Although gefitinib used for the treatment of non - small - cell lung cancer is a well - known cause of interstitial lung disease ( ILD ), few case reports on erlotinib - induced Adverse-EffectILD have been issued.
Score Text
0.9987 RESULTS : A 44 - year - old man taking Drugnaproxen for chronic low back pain and a 20 - year - old woman on oxaprozin for rheumatoid arthritis presented with tense bullae and cutaneous fragility on the face and the back of the hands.
0.9982 RESULTS : A 44 - year - old man taking naproxen for chronic low back pain and a 20 - year - old woman on Drugoxaprozin for rheumatoid arthritis presented with tense bullae and cutaneous fragility on the face and the back of the hands.
0.9930 RESULTS : A 44 - year - old man taking naproxen for chronic low back pain and a 20 - year - old woman on oxaprozin for rheumatoid arthritis presented with Adverse-Effecttense bullae and cutaneous fragility on the face and the back of the hands.
0.9890 RESULTS : A 44 - year - old man taking naproxen for chronic low back pain and a 20 - year - old woman on oxaprozin for rheumatoid arthritis presented with tense bullae and Adverse-Effectcutaneous fragility on the face and the back of the hands.
Score Text
0.9983 The patient's previous rash and the temporal relation of this event and the ingestion of phenolphthalein, as well as the similarity of this case to other reports, point to phenolphthalein as the cause of Adverse-EffectTEN in this patient.
0.9529 The patient's previous Adverse-Effectrash and the temporal relation of this event and the ingestion of phenolphthalein, as well as the similarity of this case to other reports, point to phenolphthalein as the cause of TEN in this patient.
0.9477 The patient's previous rash and the temporal relation of this event and the ingestion of Drugphenolphthalein , as well as the similarity of this case to other reports, point to phenolphthalein as the cause of TEN in this patient.
0.8471 The patient's previous rash and the temporal relation of this event and the ingestion of phenolphthalein, as well as the similarity of this case to other reports, point to Drugphenolphthalein as the cause of TEN in this patient.
Score Text
0.9972 The case history confirms that Druggold treatment, even in the same patient, can give rise to a wide range of skin disturbances, which in many cases do not break out until long after the drug has been withdrawn.
0.9880 The case history confirms that gold treatment, even in the same patient, can give rise to a wide range of Adverse-Effectskin disturbances , which in many cases do not break out until long after the drug has been withdrawn.
Score Text
0.9996 A patient receiving Drugvancomycin for a serious staphylococcal infection had a lupus - like syndrome characterized by a malar rash, pain and erythema of the cartilage of both ears, and tender erythematous and hemorrhagic lesions of the finger tips.
0.9929 A patient receiving vancomycin for a serious staphylococcal infection had a lupus - like syndrome characterized by a Adverse-Effectmalar rash , pain and erythema of the cartilage of both ears, and tender erythematous and hemorrhagic lesions of the finger tips.
0.9896 A patient receiving vancomycin for a serious staphylococcal infection had a lupus - like syndrome characterized by a malar rash, pain and erythema of the cartilage of both ears, and Adverse-Effecttender erythematous and hemorrhagic lesions of the finger tips.
0.9854 A patient receiving vancomycin for a serious staphylococcal infection had a Adverse-Effectlupus - like syndrome characterized by a malar rash, pain and erythema of the cartilage of both ears, and tender erythematous and hemorrhagic lesions of the finger tips.
0.9825 A patient receiving vancomycin for a serious staphylococcal infection had a lupus - like syndrome characterized by a malar rash, pain and erythema of the cartilage of both ears, and tender erythematous and Adverse-Effecthemorrhagic lesions of the finger tips .
0.9744 A patient receiving vancomycin for a serious staphylococcal infection had a lupus - like syndrome characterized by a malar rash, pain and Adverse-Effecterythema of the cartilage of both ears , and tender erythematous and hemorrhagic lesions of the finger tips.
0.9693 A patient receiving vancomycin for a serious staphylococcal infection had a lupus - like syndrome characterized by a malar rash, Adverse-Effectpain and erythema of the cartilage of both ears, and tender erythematous and hemorrhagic lesions of the finger tips.
Score Text
0.9994 Because the combination of Drugbleomycin and vinca alkaloids is commonly used for the treatment of AIDS - related Kaposi's sarcoma, clinicians should be aware of the risk of provoking acral necrosis in patients who develop Raynaud's phenomenon under chemotherapy.
0.9795 Because the combination of bleomycin and vinca alkaloids is commonly used for the treatment of AIDS - related Kaposi's sarcoma, clinicians should be aware of the risk of provoking Adverse-Effectacral necrosis in patients who develop Raynaud's phenomenon under chemotherapy.
0.9789 Because the combination of bleomycin and vinca alkaloids is commonly used for the treatment of AIDS - related Kaposi's sarcoma, clinicians should be aware of the risk of provoking acral necrosis in patients who develop Adverse-EffectRaynaud's phenomenon under chemotherapy.
0.8321 Because the combination of bleomycin and vinca alkaloids is commonly used for the treatment of AIDS - related Adverse-EffectKaposi's sarcoma , clinicians should be aware of the risk of provoking acral necrosis in patients who develop Raynaud's phenomenon under chemotherapy.
Score Text
0.9957 DrugMethotrexate ( MTX ) is a commonly used second line agent for RA, and there have been several recent reports of Epstein - Barr virus ( EBV ) - associated polyclonal B cell lymphoproliferative disorder in MTX - treated RA patients.
0.9953 Methotrexate ( DrugMTX ) is a commonly used second line agent for RA, and there have been several recent reports of Epstein - Barr virus ( EBV ) - associated polyclonal B cell lymphoproliferative disorder in MTX - treated RA patients.
0.9933 Methotrexate ( MTX ) is a commonly used second line agent for RA, and there have been several recent reports of Epstein - Barr virus ( EBV ) - associated polyclonal B cell lymphoproliferative disorder in DrugMTX - treated RA patients.
Methotrexate ( MTX ) is a commonly used second line agent for RA, and there have been several recent reports of Adverse-EffectEpstein - Barr virus ( EBV ) - associated polyclonal B cell lymphoproliferative disorder in MTX - treated RA patients.
Score Text
0.9377 We present a case of acute Drugepinephrine toxicity resulting in acute myocardial ischemia in a young boy with combined variable immunodeficiency syndrome who developed severe allergic reaction to intravenous immunoglobulin, and was subsequently given epinephrine by mistake intravenously rather than subcutaneously.
0.8940 We present a case of acute epinephrine toxicity resulting in acute myocardial ischemia in a young boy with combined variable immunodeficiency syndrome who developed Adverse-Effectsevere allergic reaction to intravenous immunoglobulin, and was subsequently given epinephrine by mistake intravenously rather than subcutaneously.
0.7045 We present a case of acute epinephrine toxicity resulting in acute myocardial ischemia in a young boy with combined variable immunodeficiency syndrome who developed severe allergic reaction to intravenous immunoglobulin, and was subsequently given Drugepinephrine by mistake intravenously rather than subcutaneously.
0.5201 We present a case of acute epinephrine toxicity resulting in Adverse-Effectacute myocardial ischemia in a young boy with combined variable immunodeficiency syndrome who developed severe allergic reaction to intravenous immunoglobulin, and was subsequently given epinephrine by mistake intravenously rather than subcutaneously.
0.5517 We present a case of acute Adverse-Effectepinephrine toxicity resulting in acute myocardial ischemia in a young boy with combined variable immunodeficiency syndrome who developed severe allergic reaction to intravenous immunoglobulin, and was subsequently given epinephrine by mistake intravenously rather than subcutaneously.
Score Text
0.9996 We report a myeloma patient who developed severe paralytic ileus during Drugbortezomib therapy, which presented in the context of progressive constipation without other known causes and which regressed promptly with medical management after drug cessation, suggesting a direct causal relationship.
0.9801 We report a myeloma patient who developed Adverse-Effectsevere paralytic ileus during bortezomib therapy, which presented in the context of progressive constipation without other known causes and which regressed promptly with medical management after drug cessation, suggesting a direct causal relationship.
Score Text
0.9898 These in vitro findings and clinical course suggest that TRAb / TBII without thyroid - stimulating activity may develop in patients with Drugamiodarone - induced destructive thyroiditis, as reported in patients with destructive thyroiditis, such as subacute and silent thyroiditis.
0.9669 These in vitro findings and clinical course suggest that TRAb / TBII without thyroid - stimulating activity may develop in patients with amiodarone - induced Adverse-Effectdestructive thyroiditis , as reported in patients with destructive thyroiditis, such as subacute and silent thyroiditis.
0.9589 These in vitro findings and clinical course suggest that TRAb / TBII without thyroid - stimulating activity may develop in patients with amiodarone - induced destructive thyroiditis, as reported in patients with Adverse-Effectdestructive thyroiditis , such as subacute and silent thyroiditis.
0.7556 These in vitro findings and clinical course suggest that TRAb / TBII without thyroid - stimulating activity may develop in patients with amiodarone - induced destructive thyroiditis, as reported in patients with destructive thyroiditis, such as subacute and silent Adverse-Effectthyroiditis .
0.6746 These in vitro findings and clinical course suggest that DrugTRAb / TBII without thyroid - stimulating activity may develop in patients with amiodarone - induced destructive thyroiditis, as reported in patients with destructive thyroiditis, such as subacute and silent thyroiditis.
0.5879 These in vitro findings and clinical course suggest that TRAb / TBII without thyroid - stimulating activity may develop in patients with amiodarone - induced destructive thyroiditis, as reported in patients with destructive Adverse-Effectthyroiditis , such as subacute and silent thyroiditis.
These in vitro findings and clinical course suggest that Adverse-EffectTRAb / TBII without thyroid - stimulating activity may develop in patients with amiodarone - induced destructive thyroiditis, as reported in patients with destructive thyroiditis, such as subacute and silent thyroiditis.
Score Text
0.9974 When SASP was changed to 5 - aminosalicylic acid ( 5 - ASA ), his skin eruptions were resolved, however, he developed weakness and Adverse-Effectatrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and gait disturbance.
0.9970 When SASP was changed to 5 - aminosalicylic acid ( 5 - ASA ), his skin eruptions were resolved, however, he developed Adverse-Effectweakness and atrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and gait disturbance.
0.9888 When SASP was changed to 5 - aminosalicylic acid ( Drug5 - ASA ), his skin eruptions were resolved, however, he developed weakness and atrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and gait disturbance.
0.9886 When SASP was changed to 5 - aminosalicylic acid ( 5 - ASA ), his skin eruptions were resolved, however, he developed weakness and atrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and Adverse-Effectgait disturbance .
0.9783 When SASP was changed to Drug5 - aminosalicylic acid ( 5 - ASA ), his skin eruptions were resolved, however, he developed weakness and atrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and gait disturbance.
0.9765 When SASP was changed to 5 - aminosalicylic acid ( 5 - ASA ), his skin eruptions were resolved, however, he developed weakness and atrophy in his right arm as well as progressive Adverse-Effectworsening of the dysesthesia in his legs and gait disturbance.
0.9423 When DrugSASP was changed to 5 - aminosalicylic acid ( 5 - ASA ), his skin eruptions were resolved, however, he developed weakness and atrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and gait disturbance.
0.9215 When SASP was changed to 5 - aminosalicylic acid ( 5 - ASA ), his Adverse-Effectskin eruptions were resolved, however, he developed weakness and atrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and gait disturbance.
Score Text
0.9981 CASE REPORT : Soon after initiation of amiodarone HCl ( 200 mg / day ), a 76 - year - old man came to us with symptoms of visual " shining, " Adverse-Effectglare , color vision anomalies, and gradually decreased vision.
0.9943 CASE REPORT : Soon after initiation of amiodarone HCl ( 200 mg / day ), a 76 - year - old man came to us with symptoms of visual " shining, " glare, color vision anomalies, and gradually Adverse-Effectdecreased vision .
0.9893 CASE REPORT : Soon after initiation of Drugamiodarone HCl ( 200 mg / day ), a 76 - year - old man came to us with symptoms of visual " shining, " glare, color vision anomalies, and gradually decreased vision.
0.9874 CASE REPORT : Soon after initiation of amiodarone HCl ( 200 mg / day ), a 76 - year - old man came to us with symptoms of visual " shining, " glare, Adverse-Effectcolor vision anomalies , and gradually decreased vision.
0.9863 CASE REPORT : Soon after initiation of amiodarone HCl ( 200 mg / day ), a 76 - year - old man came to us with symptoms of Adverse-Effectvisual " shining , " glare, color vision anomalies, and gradually decreased vision.
Score Text
0.9940 The mechanism of the decrease in plasma potassium induced by Drugphosphate treatment was investigated in a 24 - year - old hypertensive patient with hypophosphatemic osteomalacia, who was the youngest of four patients, belonging to a 23 number kindred of five generations.
0.9791 The mechanism of the Adverse-Effectdecrease in plasma potassium induced by phosphate treatment was investigated in a 24 - year - old hypertensive patient with hypophosphatemic osteomalacia, who was the youngest of four patients, belonging to a 23 number kindred of five generations.
Score Text
0.9976 A 16 - year - old white male with acute biphenotypic leukemia developed evidence of the eosinophilia myalgia syndrome associated with total parenteral nutritional support with solutions containing Drugtryptophan , which were given during his initial induction chemotherapy and also after autologous marrow transplantation.
0.9902 A 16 - year - old white male with acute biphenotypic leukemia developed evidence of the Adverse-Effecteosinophilia myalgia syndrome associated with total parenteral nutritional support with solutions containing tryptophan, which were given during his initial induction chemotherapy and also after autologous marrow transplantation.
Score Text
0.9984 Subsequently, he developed Adverse-Effecthyperglycemia ( fasting blood glucose 138 mg / dL ) that resolved when olanzapine was stopped and recurred ( fasting blood glucose 150 mg / dL ) after 2 days of rechallenge with olanzapine 2. 5 mg twice daily.
0.9851 Subsequently, he developed hyperglycemia ( fasting blood glucose 138 mg / dL ) that resolved when Drugolanzapine was stopped and recurred ( fasting blood glucose 150 mg / dL ) after 2 days of rechallenge with olanzapine 2. 5 mg twice daily.
0.9757 Subsequently, he developed hyperglycemia ( fasting blood glucose 138 mg / dL ) that resolved when olanzapine was stopped and recurred ( fasting blood glucose 150 mg / dL ) after 2 days of rechallenge with Drugolanzapine 2. 5 mg twice daily.
Score Text
0.9985 The potential development of SJS / Adverse-EffectTEN , a severe life - threatening illness, emphasizes the need for judicious use of TMP - Sx and close monitoring and follow - up for patients who were given TMP - Sx for SSTIs.
0.9979 The potential development of Adverse-EffectSJS / TEN, a severe life - threatening illness, emphasizes the need for judicious use of TMP - Sx and close monitoring and follow - up for patients who were given TMP - Sx for SSTIs.
0.9772 The potential development of SJS / TEN, a severe life - threatening illness, emphasizes the need for judicious use of DrugTMP - Sx and close monitoring and follow - up for patients who were given TMP - Sx for SSTIs.
0.9793 The potential development of SJS / TEN, a severe life - threatening illness, emphasizes the need for judicious use of TMP - Sx and close monitoring and follow - up for patients who were given DrugTMP - Sx for SSTIs.
Score Text
0.9976 We report a patient with type 2 diabetes mellitus who, while treated with the antitumor necrosis factor - alpha blocking agent Drugetanercept for severe plaque psoriasis, experienced persistent hypoglycemia requiring the lowering and eventual elimination of his previous insulin regimen.
0.9771 We report a patient with type 2 diabetes mellitus who, while treated with the antitumor necrosis factor - alpha blocking agent etanercept for severe plaque psoriasis, experienced Adverse-Effectpersistent hypoglycemia requiring the lowering and eventual elimination of his previous insulin regimen.
Score Text
0.9915 Case 1, a 62 - year - old woman, developed Adverse-Effectbilateral optic neuritis with decreased sensation of vibration and increased deep tendon reflex in the lower extremities after a seven - month use of recombinant interferon alpha - 2a for chronic active hepatitis C.
0.9862 Case 1, a 62 - year - old woman, developed bilateral optic neuritis with decreased sensation of vibration and Adverse-Effectincreased deep tendon reflex in the lower extremities after a seven - month use of recombinant interferon alpha - 2a for chronic active hepatitis C.
0.9844 Case 1, a 62 - year - old woman, developed bilateral optic neuritis with Adverse-Effectdecreased sensation of vibration and increased deep tendon reflex in the lower extremities after a seven - month use of recombinant interferon alpha - 2a for chronic active hepatitis C.
0.9653 Case 1, a 62 - year - old woman, developed bilateral optic neuritis with decreased sensation of vibration and increased deep tendon reflex in the lower extremities after a seven - month use of Drugrecombinant interferon alpha - 2a for chronic active hepatitis C.
Score Text
0.9925 In all cases, drugs in addition to quetiapine were detected, but in cases # 1 and # 2, the cause of Adverse-Effectdeath was considered to be a quetiapine overdose and the other drugs were not considered to be contributory.
0.9814 In all cases, drugs in addition to quetiapine were detected, but in cases # 1 and # 2, the cause of death was considered to be a Drugquetiapine overdose and the other drugs were not considered to be contributory.
0.9714 In all cases, drugs in addition to Drugquetiapine were detected, but in cases # 1 and # 2, the cause of death was considered to be a quetiapine overdose and the other drugs were not considered to be contributory.
Score Text
0.9992 Of particular interest in this patient is the fluctuation of the QT interval at a stable dose of Drugmethadone , suggesting that a single normal electrocardiogram ( ECG ) does not guarantee that the patient is not at risk of ventricular arrhythmias.
0.9889 Of particular interest in this patient is the Adverse-Effectfluctuation of the QT interval at a stable dose of methadone, suggesting that a single normal electrocardiogram ( ECG ) does not guarantee that the patient is not at risk of ventricular arrhythmias.
Score Text
0.9880 Ethambutol is frequently used in the treatment of tuberculosis, and, although Adverse-Effectoptic neuropathies have been reported with the use of ethambutol, this adverse side effect has been considered to be rare and generally reversible with discontinuation of the medication.
0.9794 DrugEthambutol is frequently used in the treatment of tuberculosis, and, although optic neuropathies have been reported with the use of ethambutol, this adverse side effect has been considered to be rare and generally reversible with discontinuation of the medication.
Score Text
0.9967 The authors suggest that in the absence of any proven benefit of Drugitraconazole prophylaxis, and given the interaction of this drug with vincristine leading to severe and even potentially fatal toxicities, the combination use of these drugs should be avoided.
0.9953 The authors suggest that in the absence of any proven benefit of itraconazole prophylaxis, and given the interaction of this drug with Drugvincristine leading to severe and even potentially fatal toxicities, the combination use of these drugs should be avoided.
0.8764 The authors suggest that in the absence of any proven benefit of itraconazole prophylaxis, and given the interaction of this drug with vincristine leading to severe and even potentially Adverse-Effectfatal toxicities , the combination use of these drugs should be avoided.
Score Text
0.9686 Two 65 - year - old white men with coronary heart disease, given Drugniacin therapy for dyslipidemia for 5 months, developed intense dental and gingival pain that was associated with increases in dose and that was relieved with discontinuance of niacin treatment.
0.9530 Two 65 - year - old white men with coronary heart disease, given niacin therapy for dyslipidemia for 5 months, developed intense dental and gingival pain that was associated with increases in dose and that was relieved with discontinuance of Drugniacin treatment.
0.9488 Two 65 - year - old white men with coronary heart disease, given niacin therapy for dyslipidemia for 5 months, developed Adverse-Effectintense dental and gingival pain that was associated with increases in dose and that was relieved with discontinuance of niacin treatment.
0.6884 Two 65 - year - old white men with coronary heart disease, given niacin therapy for dyslipidemia for 5 months, developed intense Adverse-Effectdental and gingival pain that was associated with increases in dose and that was relieved with discontinuance of niacin treatment.
Score Text
0.9990 A 62 - year - old woman who was being treated for squamous cell carcinoma of the head and neck developed a chemotherapy - related hemolytic - uremic syndrome during the second cycle of neoadjuvant chemotherapy consisting of cisplatin, Drugbleomycin , and methotrexate.
0.9990 A 62 - year - old woman who was being treated for squamous cell carcinoma of the head and neck developed a chemotherapy - related hemolytic - uremic syndrome during the second cycle of neoadjuvant chemotherapy consisting of cisplatin, bleomycin, and Drugmethotrexate .
0.9990 A 62 - year - old woman who was being treated for squamous cell carcinoma of the head and neck developed a chemotherapy - related hemolytic - uremic syndrome during the second cycle of neoadjuvant chemotherapy consisting of Drugcisplatin , bleomycin, and methotrexate.
0.9893 A 62 - year - old woman who was being treated for squamous cell carcinoma of the head and neck developed a chemotherapy - related Adverse-Effecthemolytic - uremic syndrome during the second cycle of neoadjuvant chemotherapy consisting of cisplatin, bleomycin, and methotrexate.
Score Text
0.9882 A case of Adverse-Effectskeletal fluorosis induced by prolonged treatment with niflumic acid, a fast - acting non - steroid antiinflammatory agent, is reported in a 35 - year - old woman suffering from rheumatoid arthritis and treated, in addition, with corticosteroids.
0.9791 A case of skeletal fluorosis induced by prolonged treatment with Drugniflumic acid , a fast - acting non - steroid antiinflammatory agent, is reported in a 35 - year - old woman suffering from rheumatoid arthritis and treated, in addition, with corticosteroids.
Score Text
0.9996 The reported cases of in utero exposure to Drugcyclosposphamide shared the following manifestations with our patient : growth deficiency, developmental delay, craniosynostosis, blepharophimosis, flat nasal bridge, abnormal ears, and distal limb defects including hypoplastic thumbs and oligodactyly.
0.9969 The reported cases of in utero exposure to cyclosposphamide shared the following manifestations with our patient : growth deficiency, developmental delay, craniosynostosis, Adverse-Effectblepharophimosis , flat nasal bridge, abnormal ears, and distal limb defects including hypoplastic thumbs and oligodactyly.
0.9965 The reported cases of in utero exposure to cyclosposphamide shared the following manifestations with our patient : growth deficiency, developmental delay, Adverse-Effectcraniosynostosis , blepharophimosis, flat nasal bridge, abnormal ears, and distal limb defects including hypoplastic thumbs and oligodactyly.
0.9961 The reported cases of in utero exposure to cyclosposphamide shared the following manifestations with our patient : growth deficiency, developmental delay, craniosynostosis, blepharophimosis, flat nasal bridge, abnormal ears, and distal limb defects including hypoplastic thumbs and Adverse-Effectoligodactyly .
0.9931 The reported cases of in utero exposure to cyclosposphamide shared the following manifestations with our patient : growth deficiency, developmental delay, craniosynostosis, blepharophimosis, flat nasal bridge, abnormal ears, and distal limb defects including Adverse-Effecthypoplastic thumbs and oligodactyly.
0.9921 The reported cases of in utero exposure to cyclosposphamide shared the following manifestations with our patient : growth deficiency, Adverse-Effectdevelopmental delay , craniosynostosis, blepharophimosis, flat nasal bridge, abnormal ears, and distal limb defects including hypoplastic thumbs and oligodactyly.
0.9907 The reported cases of in utero exposure to cyclosposphamide shared the following manifestations with our patient : growth deficiency, developmental delay, craniosynostosis, blepharophimosis, flat nasal bridge, abnormal ears, and Adverse-Effectdistal limb defects including hypoplastic thumbs and oligodactyly.
0.9901 The reported cases of in utero exposure to cyclosposphamide shared the following manifestations with our patient : growth deficiency, developmental delay, craniosynostosis, blepharophimosis, Adverse-Effectflat nasal bridge , abnormal ears, and distal limb defects including hypoplastic thumbs and oligodactyly.
0.9924 The reported cases of in utero exposure to cyclosposphamide shared the following manifestations with our patient : growth deficiency, developmental delay, craniosynostosis, blepharophimosis, flat nasal bridge, Adverse-Effectabnormal ears , and distal limb defects including hypoplastic thumbs and oligodactyly.
0.9907 The reported cases of in utero exposure to cyclosposphamide shared the following manifestations with our patient : Adverse-Effectgrowth deficiency , developmental delay, craniosynostosis, blepharophimosis, flat nasal bridge, abnormal ears, and distal limb defects including hypoplastic thumbs and oligodactyly.
Score Text
0.9996 Seven of the eight cases of acute leukemia occurred in a series of 553 patients treated with DrugTreosulfan for ovarian cancer in the period from 1970 to 1977 and followed closely for a total of 1159 patient - years up to February 1978.
0.9921 Seven of the eight cases of Adverse-Effectacute leukemia occurred in a series of 553 patients treated with Treosulfan for ovarian cancer in the period from 1970 to 1977 and followed closely for a total of 1159 patient - years up to February 1978.
Score Text
0.9967 In addition, while cases of loop diuretic - induced Adverse-Effectpancreatitis , including furosemide, have been published, the allergic manifestations with both sulfonamide antibiotics and non - antibiotics in our patient suggest possible cross - reactivity between these 2 drug classes.
0.9911 In addition, while cases of loop diuretic - induced pancreatitis, including Drugfurosemide , have been published, the allergic manifestations with both sulfonamide antibiotics and non - antibiotics in our patient suggest possible cross - reactivity between these 2 drug classes.
0.9625 In addition, while cases of loop diuretic - induced pancreatitis, including furosemide, have been published, the allergic manifestations with both Drugsulfonamide antibiotics and non - antibiotics in our patient suggest possible cross - reactivity between these 2 drug classes.
0.8826 In addition, while cases of loop diuretic - induced pancreatitis, including furosemide, have been published, the Adverse-Effectallergic manifestations with both sulfonamide antibiotics and non - antibiotics in our patient suggest possible cross - reactivity between these 2 drug classes.
Score Text
0.9995 The cause of these previously unreported side effects of Drugniacin therapy is uncertain but may be related to prostaglandin - mediated vasodilatation, hyperalgesia of sensory nerve receptors, and potentiation of inflammation in the gingiva with referral of pain to the teeth.
0.9878 The cause of these previously unreported side effects of niacin therapy is uncertain but may be related to prostaglandin - mediated vasodilatation, Adverse-Effecthyperalgesia of sensory nerve receptors , and potentiation of inflammation in the gingiva with referral of pain to the teeth.
0.9878 The cause of these previously unreported side effects of niacin therapy is uncertain but may be related to Adverse-Effectprostaglandin - mediated vasodilatation , hyperalgesia of sensory nerve receptors, and potentiation of inflammation in the gingiva with referral of pain to the teeth.
0.9858 The cause of these previously unreported side effects of niacin therapy is uncertain but may be related to prostaglandin - mediated vasodilatation, hyperalgesia of sensory nerve receptors, and Adverse-Effectpotentiation of inflammation in the gingiva with referral of pain to the teeth.
0.9166 The cause of these previously unreported side effects of niacin therapy is uncertain but may be related to prostaglandin - mediated vasodilatation, hyperalgesia of sensory nerve receptors, and potentiation of inflammation in the gingiva with referral of Adverse-Effectpain to the teeth .
Score Text
0.9996 OBJECTIVE : To document a case of serotonin syndrome ( SS ) associated with Drugmirtazapine monotherapy, review the previously reported cases of SS associated with this tetracyclic antidepressant, and discuss the possible pathogenic mechanisms leading to this serious adverse drug reaction.
0.9944 OBJECTIVE : To document a case of Adverse-Effectserotonin syndrome ( SS ) associated with mirtazapine monotherapy, review the previously reported cases of SS associated with this tetracyclic antidepressant, and discuss the possible pathogenic mechanisms leading to this serious adverse drug reaction.
0.9084 OBJECTIVE : To document a case of serotonin syndrome ( Adverse-EffectSS ) associated with mirtazapine monotherapy, review the previously reported cases of SS associated with this tetracyclic antidepressant, and discuss the possible pathogenic mechanisms leading to this serious adverse drug reaction.
0.5599 OBJECTIVE : To document a case of serotonin syndrome ( SS ) associated with mirtazapine monotherapy, review the previously reported cases of Adverse-EffectSS associated with this tetracyclic antidepressant, and discuss the possible pathogenic mechanisms leading to this serious adverse drug reaction.
Score Text
0.9995 A variety of movement disorders are known to occur in association with Drugcarbamazepine ( CBZ ) therapy in adults and children, but development of tics has been described infrequently and only in patients with underlying Tourette's syndrome or other movement disorders.
0.9993 A variety of movement disorders are known to occur in association with carbamazepine ( DrugCBZ ) therapy in adults and children, but development of tics has been described infrequently and only in patients with underlying Tourette's syndrome or other movement disorders.
0.9971 A variety of movement disorders are known to occur in association with carbamazepine ( CBZ ) therapy in adults and children, but development of Adverse-Effecttics has been described infrequently and only in patients with underlying Tourette's syndrome or other movement disorders.
0.9918 A variety of Adverse-Effectmovement disorders are known to occur in association with carbamazepine ( CBZ ) therapy in adults and children, but development of tics has been described infrequently and only in patients with underlying Tourette's syndrome or other movement disorders.
Score Text
0.9975 Although the two local anesthetics usually do not cause methemoglobinemia, we suspect that the displacement of lidocaine from protein binding by bupivacaine, in combination with metabolic acidosis and treatment with other oxidants, was the reason for the development of Adverse-Effectmethemoglobinemia .
0.9947 Although the two local anesthetics usually do not cause methemoglobinemia, we suspect that the displacement of Druglidocaine from protein binding by bupivacaine, in combination with metabolic acidosis and treatment with other oxidants, was the reason for the development of methemoglobinemia.
0.9086 Although the two local anesthetics usually do not cause Adverse-Effectmethemoglobinemia , we suspect that the displacement of lidocaine from protein binding by bupivacaine, in combination with metabolic acidosis and treatment with other oxidants, was the reason for the development of methemoglobinemia.
Score Text
0.9976 Herein, we describe a patient with AIDS who presented to medical attention with pancytopenia 48 months postchemotherapy with etoposide, prednisone, Drugvincristine , cyclophosphamide, doxorubicin, and rituximab ( R - EPOCH ) for diffuse large B - cell lymphoma.
0.9976 Herein, we describe a patient with AIDS who presented to medical attention with pancytopenia 48 months postchemotherapy with etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and Drugrituximab ( R - EPOCH ) for diffuse large B - cell lymphoma.
0.9975 Herein, we describe a patient with AIDS who presented to medical attention with pancytopenia 48 months postchemotherapy with etoposide, Drugprednisone , vincristine, cyclophosphamide, doxorubicin, and rituximab ( R - EPOCH ) for diffuse large B - cell lymphoma.
0.9975 Herein, we describe a patient with AIDS who presented to medical attention with pancytopenia 48 months postchemotherapy with etoposide, prednisone, vincristine, Drugcyclophosphamide , doxorubicin, and rituximab ( R - EPOCH ) for diffuse large B - cell lymphoma.
0.9974 Herein, we describe a patient with AIDS who presented to medical attention with Adverse-Effectpancytopenia 48 months postchemotherapy with etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab ( R - EPOCH ) for diffuse large B - cell lymphoma.
0.9974 Herein, we describe a patient with AIDS who presented to medical attention with pancytopenia 48 months postchemotherapy with etoposide, prednisone, vincristine, cyclophosphamide, Drugdoxorubicin , and rituximab ( R - EPOCH ) for diffuse large B - cell lymphoma.
0.9974 Herein, we describe a patient with AIDS who presented to medical attention with pancytopenia 48 months postchemotherapy with Drugetoposide , prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab ( R - EPOCH ) for diffuse large B - cell lymphoma.
0.5104 Herein, we describe a patient with AIDS who presented to medical attention with pancytopenia 48 months postchemotherapy with etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab ( DrugR - EPOCH ) for diffuse large B - cell lymphoma.
Score Text
0.9864 We report five cases of Drugcarboplatin ( CBDCA ) hypersensitivity after weekly low - dose paclitaxel ( 60 mg / m2 ) / CBDCA ( area under the concentration curve = 2 ) therapy in patients with recurrent ovarian cancer receiving multiple platinum - based chemotherapy.
0.9829 We report five cases of carboplatin ( CBDCA ) hypersensitivity after weekly low - dose Drugpaclitaxel ( 60 mg / m2 ) / CBDCA ( area under the concentration curve = 2 ) therapy in patients with recurrent ovarian cancer receiving multiple platinum - based chemotherapy.
0.9803 We report five cases of carboplatin ( DrugCBDCA ) hypersensitivity after weekly low - dose paclitaxel ( 60 mg / m2 ) / CBDCA ( area under the concentration curve = 2 ) therapy in patients with recurrent ovarian cancer receiving multiple platinum - based chemotherapy.
0.9605 We report five cases of carboplatin ( CBDCA ) Adverse-Effecthypersensitivity after weekly low - dose paclitaxel ( 60 mg / m2 ) / CBDCA ( area under the concentration curve = 2 ) therapy in patients with recurrent ovarian cancer receiving multiple platinum - based chemotherapy.
Score Text
0.9988 However, we recently saw two patients with renal tuberculosis treated with Drugethambutol in whom visual loss from toxic optic neuropathies was severe and irreversible despite careful ophthalmological monitoring and prompt discontinuation of the agent at the first sign of impaired visual function.
0.9868 However, we recently saw two patients with renal tuberculosis treated with ethambutol in whom Adverse-Effectvisual loss from toxic optic neuropathies was severe and irreversible despite careful ophthalmological monitoring and prompt discontinuation of the agent at the first sign of impaired visual function.
0.9653 However, we recently saw two patients with renal tuberculosis treated with ethambutol in whom visual loss from Adverse-Effecttoxic optic neuropathies was severe and irreversible despite careful ophthalmological monitoring and prompt discontinuation of the agent at the first sign of impaired visual function.
Score Text
0.9995 The aim of this paper is to report the case of rosaceiform eruption induced by Drugerlotinib in an 81 - year - old - man and to discuss the pathogenetic role of Demodex folliculorum mites, found in the present patient, using skin scraping.
0.9911 The aim of this paper is to report the case of Adverse-Effectrosaceiform eruption induced by erlotinib in an 81 - year - old - man and to discuss the pathogenetic role of Demodex folliculorum mites, found in the present patient, using skin scraping.
Score Text
0.9930 Recently, her serum Drugtheophylline levels had increased to the toxic range ( 133. 2 micromol / L [ 24 microg / mL ] ) shortly after the addition of zafirlukast ( Accolate, Zeneca Pharmaceuticals, Wilmington, Del ) to her regimen.
0.9923 Recently, her serum theophylline levels had increased to the toxic range ( 133. 2 micromol / L [ 24 microg / mL ] ) shortly after the addition of Drugzafirlukast ( Accolate, Zeneca Pharmaceuticals, Wilmington, Del ) to her regimen.
0.9891 Recently, her serum theophylline levels had increased to the toxic range ( 133. 2 micromol / L [ 24 microg / mL ] ) shortly after the addition of zafirlukast ( DrugAccolate , Zeneca Pharmaceuticals, Wilmington, Del ) to her regimen.
0.6396 Recently, her serum Adverse-Effecttheophylline levels had increased to the toxic range ( 133. 2 micromol / L [ 24 microg / mL ] ) shortly after the addition of zafirlukast ( Accolate, Zeneca Pharmaceuticals, Wilmington, Del ) to her regimen.
0.9195 Recently, her serum theophylline Adverse-Effectlevels had increased to the toxic range ( 133. 2 micromol / L [ 24 microg / mL ] ) shortly after the addition of zafirlukast ( Accolate, Zeneca Pharmaceuticals, Wilmington, Del ) to her regimen.
0.8657 Recently, her serum theophylline levels Adverse-Effecthad increased to the toxic range ( 133. 2 micromol / L [ 24 microg / mL ] ) shortly after the addition of zafirlukast ( Accolate, Zeneca Pharmaceuticals, Wilmington, Del ) to her regimen.
0.8644 Recently, her serum theophylline levels had Adverse-Effectincreased to the toxic range ( 133. 2 micromol / L [ 24 microg / mL ] ) shortly after the addition of zafirlukast ( Accolate, Zeneca Pharmaceuticals, Wilmington, Del ) to her regimen.
Score Text
0.9996 The current report describes a man who was prescribed Drugzonisamide for epilepsy and subsequently developed widespread skin rash, acute kidney injury, high - grade fever, eosinophilia, liver dysfunction, lymphadenopathy and an increase in antihuman herpesvirus - 6 immunoglobulin G titer.
0.9978 The current report describes a man who was prescribed zonisamide for epilepsy and subsequently developed widespread skin rash, acute kidney injury, high - grade fever, Adverse-Effecteosinophilia , liver dysfunction, lymphadenopathy and an increase in antihuman herpesvirus - 6 immunoglobulin G titer.
0.9965 The current report describes a man who was prescribed zonisamide for epilepsy and subsequently developed widespread skin rash, acute kidney injury, high - grade fever, eosinophilia, liver dysfunction, Adverse-Effectlymphadenopathy and an increase in antihuman herpesvirus - 6 immunoglobulin G titer.
0.9953 The current report describes a man who was prescribed zonisamide for epilepsy and subsequently developed widespread Adverse-Effectskin rash , acute kidney injury, high - grade fever, eosinophilia, liver dysfunction, lymphadenopathy and an increase in antihuman herpesvirus - 6 immunoglobulin G titer.
0.9907 The current report describes a man who was prescribed zonisamide for epilepsy and subsequently developed widespread skin rash, acute kidney injury, high - grade fever, eosinophilia, Adverse-Effectliver dysfunction , lymphadenopathy and an increase in antihuman herpesvirus - 6 immunoglobulin G titer.
0.9898 The current report describes a man who was prescribed zonisamide for epilepsy and subsequently developed widespread skin rash, Adverse-Effectacute kidney injury , high - grade fever, eosinophilia, liver dysfunction, lymphadenopathy and an increase in antihuman herpesvirus - 6 immunoglobulin G titer.
0.9859 The current report describes a man who was prescribed zonisamide for epilepsy and subsequently developed widespread skin rash, acute kidney injury, Adverse-Effecthigh - grade fever , eosinophilia, liver dysfunction, lymphadenopathy and an increase in antihuman herpesvirus - 6 immunoglobulin G titer.
0.8632 The current report describes a man who was prescribed zonisamide for epilepsy and subsequently developed widespread skin rash, acute kidney injury, high - grade fever, eosinophilia, liver dysfunction, lymphadenopathy and an increase in antihuman herpesvirus - 6 Adverse-Effectimmunoglobulin G titer .
The current report describes a man who was prescribed zonisamide for epilepsy and subsequently developed widespread skin rash, acute kidney injury, high - grade fever, eosinophilia, liver dysfunction, lymphadenopathy and Adverse-Effectan increase in antihuman herpesvirus - 6 immunoglobulin G titer .
Score Text
0.9995 DrugOxcarbazepine - associated angioedema manifested by swelling of the face, eyes, lips, or tongue or difficulty swallowing or breathing ( or both ) is a rare but potentially life - threatening reaction for which early recognition and management are vital.
0.9983 Oxcarbazepine - associated Adverse-Effectangioedema manifested by swelling of the face, eyes, lips, or tongue or difficulty swallowing or breathing ( or both ) is a rare but potentially life - threatening reaction for which early recognition and management are vital.
Score Text
0.9911 CASE REPORT : We describe here a case of a 60 year old female that experienced a relapse of Adverse-Effectsymptomatic hyperlactatemia after being switched from stavudine to zidovudine and how the case was managed at the Infectious Diseases Institute, Kampala, Uganda.
0.9823 CASE REPORT : We describe here a case of a 60 year old female that experienced a relapse of symptomatic hyperlactatemia after being switched from stavudine to Drugzidovudine and how the case was managed at the Infectious Diseases Institute, Kampala, Uganda.
0.9787 CASE REPORT : We describe here a case of a 60 year old female that experienced a relapse of symptomatic hyperlactatemia after being switched from Drugstavudine to zidovudine and how the case was managed at the Infectious Diseases Institute, Kampala, Uganda.
Score Text
0.9995 CONCLUSIONS : SD - OCT and AO detected abnormalities that correlate topographically with visual field loss from Drughydroxychloroquine toxicity as demonstrated by HVF 10 - 2 and may be useful in the detection of subclinical abnormalities that precede symptoms or objective visual field loss.
0.9823 CONCLUSIONS : SD - OCT and AO detected abnormalities that correlate topographically with Adverse-Effectvisual field loss from hydroxychloroquine toxicity as demonstrated by HVF 10 - 2 and may be useful in the detection of subclinical abnormalities that precede symptoms or objective visual field loss.
0.9797 CONCLUSIONS : SD - OCT and AO detected abnormalities that correlate topographically with visual field loss from hydroxychloroquine toxicity as demonstrated by HVF 10 - 2 and may be useful in the detection of subclinical abnormalities that precede symptoms or Adverse-Effectobjective visual field loss .
0.6693 CONCLUSIONS : SD - OCT and AO detected Adverse-Effectabnormalities that correlate topographically with visual field loss from hydroxychloroquine toxicity as demonstrated by HVF 10 - 2 and may be useful in the detection of subclinical abnormalities that precede symptoms or objective visual field loss.
Score Text
0.9993 A 64 year old man with recurrent metastatic squamous cell carcinoma of the head and neck developed severe skin rash and bone marrow aplasia 4 and 7 days, respectively, following a single dose of 40 mg / m2 Drugmethotrexate ( MTX ).
0.9991 A 64 year old man with recurrent metastatic squamous cell carcinoma of the head and neck developed severe skin rash and bone marrow aplasia 4 and 7 days, respectively, following a single dose of 40 mg / m2 methotrexate ( DrugMTX ).
0.9943 A 64 year old man with recurrent metastatic squamous cell carcinoma of the head and neck developed Adverse-Effectsevere skin rash and bone marrow aplasia 4 and 7 days, respectively, following a single dose of 40 mg / m2 methotrexate ( MTX ).
0.9921 A 64 year old man with recurrent metastatic squamous cell carcinoma of the head and neck developed severe skin rash and Adverse-Effectbone marrow aplasia 4 and 7 days, respectively, following a single dose of 40 mg / m2 methotrexate ( MTX ).
Score Text
0.9836 The clinical course suggested that recombinant alpha - 2b peginterferon plus ribavirin provoked Adverse-Effecttype 1 diabetes mellitus , therefore, in patients who are candidates for interferon therapy the presence of pancreatic autoantibodies and the fasting plasma glucose level should be investigated before and during treatment.
0.9827 The clinical course suggested that recombinant alpha - 2b peginterferon plus Drugribavirin provoked type 1 diabetes mellitus, therefore, in patients who are candidates for interferon therapy the presence of pancreatic autoantibodies and the fasting plasma glucose level should be investigated before and during treatment.
0.9108 The clinical course suggested that Drugrecombinant alpha - 2b peginterferon plus ribavirin provoked type 1 diabetes mellitus, therefore, in patients who are candidates for interferon therapy the presence of pancreatic autoantibodies and the fasting plasma glucose level should be investigated before and during treatment.
0.5594 The clinical course suggested that recombinant Drugalpha - 2b peginterferon plus ribavirin provoked type 1 diabetes mellitus, therefore, in patients who are candidates for interferon therapy the presence of pancreatic autoantibodies and the fasting plasma glucose level should be investigated before and during treatment.
Score Text
0.9971 An episode of leukoencephalopathy is reported in a 13 - year - old girl who, after standard radiotherapy for a posterior fossa medulloblastoma, received 8 treatments with a protocol containing a 4 - hour infusion of 500 mg / m2 Drugmethotrexate and 12 mg intrathecal methotrexate.
0.9971 An episode of leukoencephalopathy is reported in a 13 - year - old girl who, after standard radiotherapy for a posterior fossa medulloblastoma, received 8 treatments with a protocol containing a 4 - hour infusion of 500 mg / m2 methotrexate and 12 mg intrathecal Drugmethotrexate .
0.9965 An episode of Adverse-Effectleukoencephalopathy is reported in a 13 - year - old girl who, after standard radiotherapy for a posterior fossa medulloblastoma, received 8 treatments with a protocol containing a 4 - hour infusion of 500 mg / m2 methotrexate and 12 mg intrathecal methotrexate.
Score Text
0.9987 In this report, one patient who developed gangrene after Drugbleomycin and vincristine / vinblastine chemotherapy for AIDS - related Kaposi's sarcoma and another HIV - infected patient who exhibited symptoms of severe Raynaud's phenomenon related to the same regimen are presented.
0.9981 In this report, one patient who developed gangrene after bleomycin and Drugvincristine / vinblastine chemotherapy for AIDS - related Kaposi's sarcoma and another HIV - infected patient who exhibited symptoms of severe Raynaud's phenomenon related to the same regimen are presented.
0.9981 In this report, one patient who developed Adverse-Effectgangrene after bleomycin and vincristine / vinblastine chemotherapy for AIDS - related Kaposi's sarcoma and another HIV - infected patient who exhibited symptoms of severe Raynaud's phenomenon related to the same regimen are presented.
0.9977 In this report, one patient who developed gangrene after bleomycin and vincristine / Drugvinblastine chemotherapy for AIDS - related Kaposi's sarcoma and another HIV - infected patient who exhibited symptoms of severe Raynaud's phenomenon related to the same regimen are presented.
0.9677 In this report, one patient who developed gangrene after bleomycin and vincristine / vinblastine chemotherapy for AIDS - related Kaposi's sarcoma and another HIV - infected patient who exhibited symptoms of Adverse-Effectsevere Raynaud's phenomenon related to the same regimen are presented.
Score Text
0.9989 The polycystic changes disappeared from the ovaries in 2 of the women after valproate therapy was discontinued, and the 2 women who had gained weight and developed Adverse-Effectamenorrhea while being treated with valproate lost weight and resumed menstruating after the change in medication.
0.9695 The polycystic changes disappeared from the ovaries in 2 of the women after Drugvalproate therapy was discontinued, and the 2 women who had gained weight and developed amenorrhea while being treated with valproate lost weight and resumed menstruating after the change in medication.
0.9484 The polycystic changes disappeared from the ovaries in 2 of the women after valproate therapy was discontinued, and the 2 women who had gained weight and developed amenorrhea while being treated with Drugvalproate lost weight and resumed menstruating after the change in medication.
0.9431 The Adverse-Effectpolycystic changes disappeared from the ovaries in 2 of the women after valproate therapy was discontinued, and the 2 women who had gained weight and developed amenorrhea while being treated with valproate lost weight and resumed menstruating after the change in medication.
The polycystic changes disappeared from the ovaries in 2 of the women after valproate therapy was discontinued, and the 2 women who had Adverse-Effectgained weight and developed amenorrhea while being treated with valproate lost weight and resumed menstruating after the change in medication.
Score Text
0.9993 Six of 13 outpatients with schizophrenia who participated in a ten - week open trial of Drugrisperidone had an initial good response to the medication followed by development of intolerable affect, including feelings of agitation and depression and periods of crying and insomnia.
0.9992 Six of 13 outpatients with schizophrenia who participated in a ten - week open trial of risperidone had an initial good response to the medication followed by development of intolerable affect, including feelings of agitation and depression and periods of crying and Adverse-Effectinsomnia .
0.9937 Six of 13 outpatients with schizophrenia who participated in a ten - week open trial of risperidone had an initial good response to the medication followed by development of Adverse-Effectintolerable affect , including feelings of agitation and depression and periods of crying and insomnia.
0.9884 Six of 13 outpatients with schizophrenia who participated in a ten - week open trial of risperidone had an initial good response to the medication followed by development of intolerable affect, including feelings of agitation and Adverse-Effectdepression and periods of crying and insomnia.
0.9871 Six of 13 outpatients with schizophrenia who participated in a ten - week open trial of risperidone had an initial good response to the medication followed by development of intolerable affect, including Adverse-Effectfeelings of agitation and depression and periods of crying and insomnia.
0.9855 Six of 13 outpatients with schizophrenia who participated in a ten - week open trial of risperidone had an initial good response to the medication followed by development of intolerable affect, including feelings of agitation and depression and Adverse-Effectperiods of crying and insomnia.
Score Text
0.9979 We report a case of drug - induced Kaposi's sarcoma ( KS ) on the sole of the right foot in a 71 - year - old man, treated for 6 months with corticosteroid therapy ( Drugprednisolone 25 mg / day ) for pericardial effusion.
0.9875 We report a case of drug - induced Adverse-EffectKaposi's sarcoma ( KS ) on the sole of the right foot in a 71 - year - old man, treated for 6 months with corticosteroid therapy ( prednisolone 25 mg / day ) for pericardial effusion.
0.8086 We report a case of drug - induced Kaposi's sarcoma ( Adverse-EffectKS ) on the sole of the right foot in a 71 - year - old man, treated for 6 months with corticosteroid therapy ( prednisolone 25 mg / day ) for pericardial effusion.
Score Text
0.9992 In this report, a patient who had undergone a renal transplantation as a result of malignant hypertension, and who was on immunosuppressive therapy consisting of Drugcyclosporin , prednisone and azathioprine, developed thrombosis of the central retinal vein 5 years following the transplantation.
0.9990 In this report, a patient who had undergone a renal transplantation as a result of malignant hypertension, and who was on immunosuppressive therapy consisting of cyclosporin, Drugprednisone and azathioprine, developed thrombosis of the central retinal vein 5 years following the transplantation.
0.9990 In this report, a patient who had undergone a renal transplantation as a result of malignant hypertension, and who was on immunosuppressive therapy consisting of cyclosporin, prednisone and Drugazathioprine , developed thrombosis of the central retinal vein 5 years following the transplantation.
0.9191 In this report, a patient who had undergone a renal transplantation as a result of malignant hypertension, and who was on immunosuppressive therapy consisting of cyclosporin, prednisone and azathioprine, developed Adverse-Effectthrombosis of the central retinal vein 5 years following the transplantation.
0.8910 In this report, a patient who had undergone a renal transplantation as a result of malignant hypertension, and who was on immunosuppressive therapy consisting of cyclosporin, prednisone and azathioprine, developed Adverse-Effectthrombosis of the central retinal vein 5 years following the transplantation.
Score Text
0.9854 Based upon the observed fall of the filtration fraction, the rise in the relative clearance of 99Tc - dimercaptosuccinic acid and the increase in proteinuria, we suggest that in this case the tubules and / or interstitium are the main targets for Drugcyclosporine A nephrotoxicity.
0.9368 Based upon the observed fall of the filtration fraction, the rise in the relative clearance of 99Tc - dimercaptosuccinic acid and the Adverse-Effectincrease in proteinuria , we suggest that in this case the tubules and / or interstitium are the main targets for cyclosporine A nephrotoxicity.
0.9236 Based upon the observed Adverse-Effectfall of the filtration fraction , the rise in the relative clearance of 99Tc - dimercaptosuccinic acid and the increase in proteinuria, we suggest that in this case the tubules and / or interstitium are the main targets for cyclosporine A nephrotoxicity.
0.8919 Based upon the observed fall of the filtration fraction, the rise in the relative clearance of 99Tc - dimercaptosuccinic acid and the increase in proteinuria, we suggest that in this case the tubules and / or interstitium are the main targets for cyclosporine A Adverse-Effectnephrotoxicity .
0.6234 Based upon the observed fall of the filtration fraction, the Adverse-Effectrise in the relative clearance of 99Tc - dimercaptosuccinic acid and the increase in proteinuria, we suggest that in this case the tubules and / or interstitium are the main targets for cyclosporine A nephrotoxicity.
0.9291 Based upon the observed fall of the filtration fraction, the rise in the relative clearance of Drug99Tc - dimercaptosuccinic acid and the increase in proteinuria, we suggest that in this case the tubules and / or interstitium are the main targets for cyclosporine A nephrotoxicity.
0.8073 Based upon the observed fall of the filtration fraction, the Adverse-Effectrise in the relative clearance of 99Tc - dimercaptosuccinic acid and the increase in proteinuria, we suggest that in this case the tubules and / or interstitium are the main targets for cyclosporine A nephrotoxicity.
0.7881 Based upon the observed fall of the filtration fraction, the Adverse-Effectrise in the relative clearance of 99Tc - dimercaptosuccinic acid and the increase in proteinuria, we suggest that in this case the tubules and / or interstitium are the main targets for cyclosporine A nephrotoxicity.
Score Text
0.9720 Although there is one case report of Adverse-Effectcholesterol crystal embolization following t - PA therapy with only extrarenal manifestations ( N Engl J Med 321 : 1270, 1989 ), this is the first reported case of atheroembolic acute renal failure following t - PA therapy.
0.9646 Although there is one case report of cholesterol crystal embolization following t - PA therapy with only extrarenal manifestations ( N Engl J Med 321 : 1270, 1989 ), this is the first reported case of Adverse-Effectatheroembolic acute renal failure following t - PA therapy.
0.9172 Although there is one case report of cholesterol crystal embolization following t - PA therapy with only extrarenal manifestations ( N Engl J Med 321 : 1270, 1989 ), this is the first reported case of atheroembolic acute renal failure following Drugt - PA therapy.
0.9064 Although there is one case report of cholesterol crystal embolization following Drugt - PA therapy with only extrarenal manifestations ( N Engl J Med 321 : 1270, 1989 ), this is the first reported case of atheroembolic acute renal failure following t - PA therapy.
0.7432 Although there is one case report of cholesterol crystal embolization following t - PA therapy with only Adverse-Effectextrarenal manifestations ( N Engl J Med 321 : 1270, 1989 ), this is the first reported case of atheroembolic acute renal failure following t - PA therapy.
0.5435 Although there is one case report of cholesterol crystal embolization following t Drug- PA therapy with only extrarenal manifestations ( N Engl J Med 321 : 1270, 1989 ), this is the first reported case of atheroembolic acute renal failure following t - PA therapy.
Score Text
0.9600 Rebound hyperglycemia was observed with both intermediate ( neutral protamine hagedorn ) and long - acting ( Drugprotamine zinc iletin ) insulins, and the range of insulin doses at which the disorder developed overlapped previously determined therapeutic doses for these insulins in the cat.
0.9530 Rebound hyperglycemia was observed with both intermediate ( neutral Drugprotamine hagedorn ) and long - acting ( protamine zinc iletin ) insulins, and the range of insulin doses at which the disorder developed overlapped previously determined therapeutic doses for these insulins in the cat.
0.8618 Rebound hyperglycemia was observed with both intermediate ( Drugneutral protamine hagedorn ) and long - acting ( protamine zinc iletin ) insulins, and the range of insulin doses at which the disorder developed overlapped previously determined therapeutic doses for these insulins in the cat.
0.8416 Rebound Adverse-Effecthyperglycemia was observed with both intermediate ( neutral protamine hagedorn ) and long - acting ( protamine zinc iletin ) insulins, and the range of insulin doses at which the disorder developed overlapped previously determined therapeutic doses for these insulins in the cat.
Adverse-EffectRebound hyperglycemia was observed with both intermediate ( neutral protamine hagedorn ) and long - acting ( protamine zinc iletin ) insulins, and the range of insulin doses at which the disorder developed overlapped previously determined therapeutic doses for these insulins in the cat.
Score Text
0.9982 The goal of this study is to describe three patients diagnosed with migraine and epilepsy ( both under control ) who evolved into status migrainosus after the introduction of Drugoxcarbazepine ( OXC ), as part of a switch off from carbamazepine ( CBZ ).
0.9981 The goal of this study is to describe three patients diagnosed with migraine and epilepsy ( both under control ) who evolved into status migrainosus after the introduction of oxcarbazepine ( OXC ), as part of a switch off from Drugcarbamazepine ( CBZ ).
0.9979 The goal of this study is to describe three patients diagnosed with migraine and epilepsy ( both under control ) who evolved into status migrainosus after the introduction of oxcarbazepine ( OXC ), as part of a switch off from carbamazepine ( DrugCBZ ).
0.9978 The goal of this study is to describe three patients diagnosed with migraine and epilepsy ( both under control ) who evolved into status migrainosus after the introduction of oxcarbazepine ( DrugOXC ), as part of a switch off from carbamazepine ( CBZ ).
0.9941 The goal of this study is to describe three patients diagnosed with migraine and epilepsy ( both under control ) who evolved into Adverse-Effectstatus migrainosus after the introduction of oxcarbazepine ( OXC ), as part of a switch off from carbamazepine ( CBZ ).
Score Text
0.9886 Physicians should be aware of the risk of severe Adverse-EffectAIHA in CLL patients with a history of AIHA or positivation of the DAT during previous fludarabine administration, or in case of secondary fixation of complement to the red cell membrane occurring during fludarabine treatment.
0.9861 Physicians should be aware of the risk of severe AIHA in CLL patients with a history of AIHA or positivation of the DAT during previous fludarabine administration, or in case of secondary fixation of complement to the red cell membrane occurring during Drugfludarabine treatment.
0.9794 Physicians should be aware of the risk of severe AIHA in CLL patients with a history of AIHA or positivation of the DAT during previous Drugfludarabine administration, or in case of secondary fixation of complement to the red cell membrane occurring during fludarabine treatment.
0.9770 Physicians should be aware of the risk of severe AIHA in CLL patients with a history of Adverse-EffectAIHA or positivation of the DAT during previous fludarabine administration, or in case of secondary fixation of complement to the red cell membrane occurring during fludarabine treatment.
0.9758 Physicians should be aware of the risk of severe AIHA in CLL patients with a history of AIHA or Adverse-Effectpositivation of the DAT during previous fludarabine administration, or in case of secondary fixation of complement to the red cell membrane occurring during fludarabine treatment.
Score Text
0.9923 We report a case of Stevens - Johnson syndrome / toxic epidermal necrolysis ( SJS / Adverse-EffectTEN ) secondary to trimethoprim - sulfamethoxazole ( TMP - Sx ) therapy for presumed community - associated methicillin - resistant Staphylococcus aureus ( CA - MRSA ) infection.
0.9868 We report a case of Stevens - Johnson syndrome / Adverse-Effecttoxic epidermal necrolysis ( SJS / TEN ) secondary to trimethoprim - sulfamethoxazole ( TMP - Sx ) therapy for presumed community - associated methicillin - resistant Staphylococcus aureus ( CA - MRSA ) infection.
0.9853 We report a case of Adverse-EffectStevens - Johnson syndrome / toxic epidermal necrolysis ( SJS / TEN ) secondary to trimethoprim - sulfamethoxazole ( TMP - Sx ) therapy for presumed community - associated methicillin - resistant Staphylococcus aureus ( CA - MRSA ) infection.
0.9645 We report a case of Stevens - Johnson syndrome / toxic epidermal necrolysis ( SJS / TEN ) secondary to trimethoprim - sulfamethoxazole ( DrugTMP - Sx ) therapy for presumed community - associated methicillin - resistant Staphylococcus aureus ( CA - MRSA ) infection.
0.9631 We report a case of Stevens - Johnson syndrome / toxic epidermal necrolysis ( Adverse-EffectSJS / TEN ) secondary to trimethoprim - sulfamethoxazole ( TMP - Sx ) therapy for presumed community - associated methicillin - resistant Staphylococcus aureus ( CA - MRSA ) infection.
0.8906 We report a case of Stevens - Johnson syndrome / toxic epidermal necrolysis ( SJS / TEN ) secondary to Drugtrimethoprim - sulfamethoxazole ( TMP - Sx ) therapy for presumed community - associated methicillin - resistant Staphylococcus aureus ( CA - MRSA ) infection.
Score Text
0.9883 CONCLUSIONS : Sustained - release verapamil is thought to be the cause of the Adverse-Effectasthma attack in this patient because she was not taking any other preparations ; the symptoms started with the administration of sustained - release verapamil and were relieved after its discontinuation.
0.9817 CONCLUSIONS : Sustained - release Drugverapamil is thought to be the cause of the asthma attack in this patient because she was not taking any other preparations ; the symptoms started with the administration of sustained - release verapamil and were relieved after its discontinuation.
0.9765 CONCLUSIONS : Sustained - release verapamil is thought to be the cause of the asthma attack in this patient because she was not taking any other preparations ; the symptoms started with the administration of sustained - release Drugverapamil and were relieved after its discontinuation.
Score Text
0.9888 Further studies are necessary to evaluate whether the study of HLA antigens may be a very useful tool to detect the patients with a predisposition to develop autoimmune thyroiditis, in order to make a early diagnosis of Adverse-Effectthyroid disorders during the IFN - alpha treatment.
0.9874 Further studies are necessary to evaluate whether the study of HLA antigens may be a very useful tool to detect the patients with a predisposition to develop Adverse-Effectautoimmune thyroiditis , in order to make a early diagnosis of thyroid disorders during the IFN - alpha treatment.
0.9760 Further studies are necessary to evaluate whether the study of HLA antigens may be a very useful tool to detect the patients with a predisposition to develop autoimmune thyroiditis, in order to make a early diagnosis of thyroid disorders during the DrugIFN - alpha treatment.
Score Text
0.9994 A patient with psoriasis is described who had an abnormal response to the glucose tolerance test without other evidence of diabetes and then developed postprandial hyperglycemia and glycosuria during a period of topical administration of a corticosteroid cream, Drughalcinonide cream 0. 1 %, under occlusion.
0.9989 A patient with psoriasis is described who had an abnormal response to the glucose tolerance test without other evidence of diabetes and then developed postprandial hyperglycemia and Adverse-Effectglycosuria during a period of topical administration of a corticosteroid cream, halcinonide cream 0. 1 %, under occlusion.
0.9918 A patient with psoriasis is described who had an abnormal response to the glucose tolerance test without other evidence of diabetes and then developed Adverse-Effectpostprandial hyperglycemia and glycosuria during a period of topical administration of a corticosteroid cream, halcinonide cream 0. 1 %, under occlusion.
Score Text
0.9992 A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, rash, fever, leukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of Drugcarbamazepine ( CBZ ; Tegretol ) used against benign Rolandic epilepsy.
0.9990 A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, rash, fever, leukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( DrugCBZ ; Tegretol ) used against benign Rolandic epilepsy.
0.9990 A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, rash, fever, leukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( CBZ ; DrugTegretol ) used against benign Rolandic epilepsy.
0.9988 A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, rash, fever, Adverse-Effectleukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( CBZ ; Tegretol ) used against benign Rolandic epilepsy.
0.9980 A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, Adverse-Effectrash , fever, leukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( CBZ ; Tegretol ) used against benign Rolandic epilepsy.
0.9903 A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, rash, Adverse-Effectfever , leukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( CBZ ; Tegretol ) used against benign Rolandic epilepsy.
0.9831 A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, rash, fever, leukopenia and Adverse-Effectpositive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( CBZ ; Tegretol ) used against benign Rolandic epilepsy.
0.6825 A 14 - year - old female developed Adverse-Effectsystemic lupus erythematosus ( SLE ) - like symptoms , rash, fever, leukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( CBZ ; Tegretol ) used against benign Rolandic epilepsy.
0.9772 A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, rash, fever, leukopenia and positive anti - nuclear antibody ( Adverse-EffectANA ) two weeks after administration of carbamazepine ( CBZ ; Tegretol ) used against benign Rolandic epilepsy.
0.6003 A 14 - year - old female developed systemic lupus erythematosus ( Adverse-EffectSLE ) - like symptoms , rash, fever, leukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( CBZ ; Tegretol ) used against benign Rolandic epilepsy.
Score Text
0.9982 Since the thrombocyte count started to increase immediately after initiation and dropped immediately after discontinuation of ciprofloxacin and Drugtazobactam / piperacillin and all other drugs were discontinued already before or were started after the nadir of the thrombocyte count, these two antibiotics were regarded causative.
0.9982 Since the thrombocyte count started to increase immediately after initiation and dropped immediately after discontinuation of ciprofloxacin and tazobactam / Drugpiperacillin and all other drugs were discontinued already before or were started after the nadir of the thrombocyte count, these two antibiotics were regarded causative.
0.9981 Since the thrombocyte count started to increase immediately after initiation and dropped immediately after discontinuation of Drugciprofloxacin and tazobactam / piperacillin and all other drugs were discontinued already before or were started after the nadir of the thrombocyte count, these two antibiotics were regarded causative.
0.9587 Since the Adverse-Effectthrombocyte count started to increase immediately after initiation and dropped immediately after discontinuation of ciprofloxacin and tazobactam / piperacillin and all other drugs were discontinued already before or were started after the nadir of the thrombocyte count, these two antibiotics were regarded causative.
Score Text
0.9837 Our findings suggest that significant Adverse-Effectprogression of marrow reticulin fibrosis during imatinib therapy can be an indicator for a return or progression of CML and, in some patients with CML, imatinib may promote cytogenetic clonal evolution, resulting in a poor response to treatment.
0.9745 Our findings suggest that significant progression of marrow reticulin fibrosis during Drugimatinib therapy can be an indicator for a return or progression of CML and, in some patients with CML, imatinib may promote cytogenetic clonal evolution, resulting in a poor response to treatment.
0.8985 Our findings suggest that significant progression of marrow reticulin fibrosis during imatinib therapy can be an indicator for a return or progression of CML and, in some patients with CML, Drugimatinib may promote cytogenetic clonal evolution, resulting in a poor response to treatment.
Score Text
0.9932 Ciprofloxacin is among the standard treatments for infected ischemic ulcers ; in the rare case of ciprofloxacin - induced Adverse-Effecthemorrhagic vasculitis , it might be interpreted as progression of infection, instead of a complication of the treatment, thus leading to faulty diagnosis and treatment.
0.9852 Ciprofloxacin is among the standard treatments for infected ischemic ulcers ; in the rare case of Drugciprofloxacin - induced hemorrhagic vasculitis, it might be interpreted as progression of infection, instead of a complication of the treatment, thus leading to faulty diagnosis and treatment.
0.9555 Ciprofloxacin is among the standard treatments for infected ischemic ulcers ; in the rare case of ciprofloxacin - induced hemorrhagic vasculitis, it might be interpreted as Adverse-Effectprogression of infection , instead of a complication of the treatment, thus leading to faulty diagnosis and treatment.
0.8797 DrugCiprofloxacin is among the standard treatments for infected ischemic ulcers ; in the rare case of ciprofloxacin - induced hemorrhagic vasculitis, it might be interpreted as progression of infection, instead of a complication of the treatment, thus leading to faulty diagnosis and treatment.
Score Text
0.9992 CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, grepafloxacin, trovafloxacin, gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including Adverse-Effectheadache , dizziness and insomnia.
0.9991 CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, grepafloxacin, trovafloxacin, gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, dizziness and Adverse-Effectinsomnia .
0.9989 CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, grepafloxacin, trovafloxacin, gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, Adverse-Effectdizziness and insomnia.
0.9989 CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, grepafloxacin, Drugtrovafloxacin , gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, dizziness and insomnia.
0.9988 CONCLUSION : The new quinolone derivatives ( Druglevofloxacin , sparfloxacin, grepafloxacin, trovafloxacin, gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, dizziness and insomnia.
0.9988 CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, Druggrepafloxacin , trovafloxacin, gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, dizziness and insomnia.
0.9988 CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, grepafloxacin, trovafloxacin, Druggatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, dizziness and insomnia.
0.9987 CONCLUSION : The new quinolone derivatives ( levofloxacin, Drugsparfloxacin , grepafloxacin, trovafloxacin, gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, dizziness and insomnia.
0.9986 CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, grepafloxacin, trovafloxacin, gatifloxacin and Drugmoxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, dizziness and insomnia.
0.7192 CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, grepafloxacin, trovafloxacin, gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause Adverse-Effectcentral nervous system - related adverse effects , including headache, dizziness and insomnia.
Score Text
0.9851 CONCLUSIONS : In our reported case, a local hyperproduction of TNF - alpha from macrophages that was induced by the injected Druginsulin could explain the dedifferentiation of the adipocytes of the subcutaneous tissue and the reversion that was induced by the local injection of dexamethasone.
0.9248 CONCLUSIONS : In our reported case, a local hyperproduction of TNF - alpha from macrophages that was induced by the injected insulin could explain the Adverse-Effectdedifferentiation of the adipocytes of the subcutaneous tissue and the reversion that was induced by the local injection of dexamethasone.
0.9757 CONCLUSIONS : In our reported case, a local hyperproduction of TNF - alpha from macrophages that was induced by the injected insulin could explain the dedifferentiation of the adipocytes of the subcutaneous tissue and the reversion that was induced by the local injection of Drugdexamethasone .
0.6449 CONCLUSIONS : In our reported case, a local hyperproduction of TNF - alpha from macrophages that was induced by the injected insulin could explain the dedifferentiation of the adipocytes of the subcutaneous tissue and the Adverse-Effectreversion that was induced by the local injection of dexamethasone.
0.6189 CONCLUSIONS : In our reported case, a local hyperproduction of TNF - alpha from macrophages that was induced by the injected insulin could explain the Adverse-Effectdedifferentiation of the adipocytes of the subcutaneous tissue and the reversion that was induced by the local injection of dexamethasone.
CONCLUSIONS : In our reported case, a local Adverse-Effecthyperproduction of TNF - alpha from macrophages that was induced by the injected insulin could explain the dedifferentiation of the adipocytes of the subcutaneous tissue and the reversion that was induced by the local injection of dexamethasone.
Score Text
0.9687 Factors that suggested an association between the severe angioedematous reaction and DrugBP topical application include the strong reaction to BP in the patch - test, the temporal relationship, the complete resolution of symptoms after the drug was withdrawn and the absence of other identified explanations.
0.9656 Factors that suggested an association between the Adverse-Effectsevere angioedematous reaction and BP topical application include the strong reaction to BP in the patch - test, the temporal relationship, the complete resolution of symptoms after the drug was withdrawn and the absence of other identified explanations.
Score Text
0.9328 To develop information on the relative rarity or frequency of Adverse-Effectneurologic worsening with the initiation of penicillamine therapy, we conducted a retrospective survey of 25 additional patients with Wilson's disease who met the criteria of presenting with neurologic disease and having been treated with penicillamine.
0.9303 To develop information on the relative rarity or frequency of neurologic worsening with the initiation of Drugpenicillamine therapy, we conducted a retrospective survey of 25 additional patients with Wilson's disease who met the criteria of presenting with neurologic disease and having been treated with penicillamine.
0.8400 To develop information on the relative rarity or frequency of neurologic worsening with the initiation of penicillamine therapy, we conducted a retrospective survey of 25 additional patients with Wilson's disease who met the criteria of presenting with neurologic disease and having been treated with Drugpenicillamine .
0.8649 To develop information on the Adverse-Effectrelative rarity or frequency of neurologic worsening with the initiation of penicillamine therapy, we conducted a retrospective survey of 25 additional patients with Wilson's disease who met the criteria of presenting with neurologic disease and having been treated with penicillamine.
To develop information on the relative rarity or frequency of neurologic worsening with the initiation of penicillamine therapy, we conducted a retrospective survey of 25 additional patients with Wilson's disease who met the criteria of presenting with Adverse-Effectneurologic disease and having been treated with penicillamine.
Score Text
0.9987 The risk of developing Adverse-EffectsAML is estimated to be between 1 % and 5 %, 2 - 20 years after exposure to etoposide but may also be related to cumulative drug doses, treatment schedules, host factors and co - administration of other antineoplastic agents.
0.9967 The risk of developing sAML is estimated to be between 1 % and 5 %, 2 - 20 years after exposure to Drugetoposide but may also be related to cumulative drug doses, treatment schedules, host factors and co - administration of other antineoplastic agents.
Score Text
0.9994 The presence of a lymphocyte alveolitis with a predominance of CD4 + T cells in 3 RA patients and CD8 + T cells with a concomitant increase in neutrophils in another case suggests that immunologically mediated reactions may be one damage mechanism in DrugMTX - induced pneumonitis.
0.9988 The presence of a lymphocyte alveolitis with a predominance of CD4 + T cells in 3 RA patients and CD8 + T cells with a concomitant increase in neutrophils in another case suggests that immunologically mediated reactions may be one damage mechanism in MTX - induced Adverse-Effectpneumonitis .
Score Text
0.9996 Renal failure appeared 8 to 17 days after beginning Druggentamicin therapy and was characterized by creatinine clearances 4 to 10 ml / min, urine to plasma creatinine ratios less than 20, urinary sodium concentrations 16 to 60 mEq / liter, proteinuria, and cylindruria.
0.9953 Adverse-EffectRenal failure appeared 8 to 17 days after beginning gentamicin therapy and was characterized by creatinine clearances 4 to 10 ml / min, urine to plasma creatinine ratios less than 20, urinary sodium concentrations 16 to 60 mEq / liter, proteinuria, and cylindruria.
Score Text
0.9986 He had been taking trimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of Adverse-Effectheadaches , dizziness, difficulty with speech, weakness, and itching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9981 He had been taking trimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, Adverse-Effectdizziness , difficulty with speech, weakness, and itching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9942 He had been taking trimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and itching on the trunk of his body and legs, where a Adverse-Effectmaculopapular rash was noted.
0.9936 He had been taking trimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, Adverse-Effectweakness , and itching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9855 He had been taking trimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, Adverse-Effectdifficulty with speech , weakness, and itching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9141 He had been taking Drugtrimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and itching on the trunk of his body and legs, where a maculopapular rash was noted.
0.6019 He had been taking trimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and Adverse-Effectitching on the trunk of his body and legs, where a maculopapular rash was noted.
0.5630 He had been taking trimethoprim - Drugsulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and itching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9767 He had been taking trimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and Adverse-Effectitching on the trunk of his body and legs , where a maculopapular rash was noted.
0.5527 He had been taking trimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and Adverse-Effectitching on the trunk of his body and legs, where a maculopapular rash was noted.
0.5433 He had been taking trimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and Adverse-Effectitching on the trunk of his body and legs, where a maculopapular rash was noted.
0.5404 He had been taking trimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and Adverse-Effectitching on the trunk of his body and legs, where a maculopapular rash was noted.
0.5174 He had been taking trimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and Adverse-Effectitching on the trunk of his body and legs, where a maculopapular rash was noted.
Score Text
0.9892 A clinically atypical, neuropathologically verified case of Adverse-EffectCreutzfeldt - Jakob disease is described in a 32 - year - old New Zealand woman with idiopathic hypopituitarism who had been treated in late adolescence ( 1970 to 1973 ) with human growth hormone processed from pooled cadaveric pituitary glands.
0.9819 A clinically atypical, neuropathologically verified case of Creutzfeldt - Jakob disease is described in a 32 - year - old New Zealand woman with idiopathic hypopituitarism who had been treated in late adolescence ( 1970 to 1973 ) with Drughuman growth hormone processed from pooled cadaveric pituitary glands.
Score Text
0.9994 In a series of 104 cases of intentional or inadvertent use of Drugzidovudine at differing gestations in pregnancy, there were eight spontaneous first trimester abortions, eight therapeutic terminations, and eight cases of fetal abnormality occurring among a total of 88 cases where the pregnancy progressed.
0.9945 In a series of 104 cases of intentional or inadvertent use of zidovudine at differing gestations in pregnancy, there were eight spontaneous first trimester abortions, eight therapeutic terminations, and eight cases of Adverse-Effectfetal abnormality occurring among a total of 88 cases where the pregnancy progressed.
0.8856 In a series of 104 cases of intentional or inadvertent use of zidovudine at differing gestations in pregnancy, there were eight spontaneous Adverse-Effectfirst trimester abortions , eight therapeutic terminations, and eight cases of fetal abnormality occurring among a total of 88 cases where the pregnancy progressed.
0.5700 In a series of 104 cases of intentional or inadvertent use of zidovudine at differing gestations in pregnancy, there were eight Adverse-Effectspontaneous first trimester abortions , eight therapeutic terminations, and eight cases of fetal abnormality occurring among a total of 88 cases where the pregnancy progressed.
Score Text
0.9963 This is the first reported case of Adverse-EffectBOOP associated with single - agent rituximab, and along with two other patients we describe, as well as two prior reports of BOOP in NHL patients receiving rituximab - based combinations, strengthens the possibility of a causal relationship.
0.9960 This is the first reported case of BOOP associated with single - agent rituximab, and along with two other patients we describe, as well as two prior reports of Adverse-EffectBOOP in NHL patients receiving rituximab - based combinations, strengthens the possibility of a causal relationship.
0.9610 This is the first reported case of BOOP associated with single - agent Drugrituximab , and along with two other patients we describe, as well as two prior reports of BOOP in NHL patients receiving rituximab - based combinations, strengthens the possibility of a causal relationship.
0.9025 This is the first reported case of BOOP associated with single - agent rituximab, and along with two other patients we describe, as well as two prior reports of BOOP in NHL patients receiving Drugrituximab - based combinations, strengthens the possibility of a causal relationship.
Score Text
0.9995 The patient completed a 10 - month follow - up, maintaining a complete resolution of the treated skin lesions ; however, the development of a painful hand ulcer, possibly associated with the Drughydroxyurea , and new skin cancers were observed at the last follow - up visit.
0.9921 The patient completed a 10 - month follow - up, maintaining a complete resolution of the treated skin lesions ; however, the development of a painful hand ulcer, possibly associated with the hydroxyurea, and new Adverse-Effectskin cancers were observed at the last follow - up visit.
0.9703 The patient completed a 10 - month follow - up, maintaining a complete resolution of the treated skin lesions ; however, the development of a Adverse-Effectpainful hand ulcer , possibly associated with the hydroxyurea, and new skin cancers were observed at the last follow - up visit.
Score Text
0.9987 The case is presented of a 72 - year - old man with hormone - refractory prostate cancer and weekly administration of 30 mg / m2 Drugdocetaxel who developed subacute interstitial pneumonitis - related pulmonary fibrosis after seven doses and died despite mechanical ventilation and high - dose corticosteroid treatment.
0.9792 The case is presented of a 72 - year - old man with hormone - refractory prostate cancer and weekly administration of 30 mg / m2 docetaxel who developed Adverse-Effectsubacute interstitial pneumonitis - related pulmonary fibrosis after seven doses and died despite mechanical ventilation and high - dose corticosteroid treatment.
Score Text
0.9878 Therefore, it is reasonable to conclude that : 1 ) 2 - CdA can induce durable complete remission in MCD patients but unfortunately it can not cure the disease ; 2 ) the possibility that Drug2 - CdA may accelerate the transformation of MCD to NHL can not be ruled out.
0.6904 Therefore, it is reasonable to conclude that : 1 ) 2 - CdA can induce durable complete remission in MCD patients but unfortunately it can not cure the disease ; 2 ) the possibility that 2 - CdA may accelerate the Adverse-Effecttransformation of MCD to NHL can not be ruled out.
0.9923 Therefore, it is reasonable to conclude that : 1 ) Drug2 - CdA can induce durable complete remission in MCD patients but unfortunately it can not cure the disease ; 2 ) the possibility that 2 - CdA may accelerate the transformation of MCD to NHL can not be ruled out.
Score Text
0.9994 A 26 - year - old Japanese man, who had been receiving medical attention for ulcerative colitis for one year, presented with diffuse erythema and pustules on his face and trunk, malaise, and fever up to 39 degrees C one day after the administration of Drugsalazosulfapyridine .
0.9982 A 26 - year - old Japanese man, who had been receiving medical attention for ulcerative colitis for one year, presented with diffuse erythema and pustules on his face and trunk, Adverse-Effectmalaise , and fever up to 39 degrees C one day after the administration of salazosulfapyridine.
0.9943 A 26 - year - old Japanese man, who had been receiving medical attention for ulcerative colitis for one year, presented with diffuse erythema and Adverse-Effectpustules on his face and trunk, malaise, and fever up to 39 degrees C one day after the administration of salazosulfapyridine.
0.9941 A 26 - year - old Japanese man, who had been receiving medical attention for ulcerative colitis for one year, presented with Adverse-Effectdiffuse erythema and pustules on his face and trunk, malaise, and fever up to 39 degrees C one day after the administration of salazosulfapyridine.
0.9780 A 26 - year - old Japanese man, who had been receiving medical attention for ulcerative colitis for one year, presented with diffuse erythema and pustules on his face and trunk, malaise, and Adverse-Effectfever up to 39 degrees C one day after the administration of salazosulfapyridine.
Score Text
0.9995 We present a case report of a patient with alveolar hydatid disease, whose treatment with Drugmebendazole was brief due to side effects of alopecia and granulocytopenia ; and review the features of this disease which, with increasing international migration, may be encountered more frequently in Australia.
0.9987 We present a case report of a patient with alveolar hydatid disease, whose treatment with mebendazole was brief due to side effects of alopecia and Adverse-Effectgranulocytopenia ; and review the features of this disease which, with increasing international migration, may be encountered more frequently in Australia.
0.9987 We present a case report of a patient with alveolar hydatid disease, whose treatment with mebendazole was brief due to side effects of Adverse-Effectalopecia and granulocytopenia ; and review the features of this disease which, with increasing international migration, may be encountered more frequently in Australia.
Score Text
0.9987 We describe 2 male patients, a 49 - year - old with psoriatic arthritis and impaired renal function and a 43 - year - old renal transplant recipient, who both sustained a marked decline in glomerular filtration rate in conjunction with a selective inhibitor of cyclooxygenase - 2 ( COX - 2 ), Drugrofecoxib .
0.9776 We describe 2 male patients, a 49 - year - old with psoriatic arthritis and impaired renal function and a 43 - year - old renal transplant recipient, who both sustained a marked Adverse-Effectdecline in glomerular filtration rate in conjunction with a selective inhibitor of cyclooxygenase - 2 ( COX - 2 ), rofecoxib.
Score Text
0.9996 The main clinical features of this 58 - year - old female patient were laboratory evidence of leucopenia and cholestasis, and biopsy features of fatty liver parenchyma degeneration with granulocytic portal infiltration and bile stasis, demonstrated 20 days after the initiation of antithyroid therapy with 20 mg Drugmethimazole daily.
0.9975 The main clinical features of this 58 - year - old female patient were laboratory evidence of Adverse-Effectleucopenia and cholestasis, and biopsy features of fatty liver parenchyma degeneration with granulocytic portal infiltration and bile stasis, demonstrated 20 days after the initiation of antithyroid therapy with 20 mg methimazole daily.
0.9958 The main clinical features of this 58 - year - old female patient were laboratory evidence of leucopenia and Adverse-Effectcholestasis , and biopsy features of fatty liver parenchyma degeneration with granulocytic portal infiltration and bile stasis, demonstrated 20 days after the initiation of antithyroid therapy with 20 mg methimazole daily.
0.9890 The main clinical features of this 58 - year - old female patient were laboratory evidence of leucopenia and cholestasis, and biopsy features of fatty liver parenchyma degeneration with granulocytic portal infiltration and Adverse-Effectbile stasis , demonstrated 20 days after the initiation of antithyroid therapy with 20 mg methimazole daily.
0.9884 The main clinical features of this 58 - year - old female patient were laboratory evidence of leucopenia and cholestasis, and biopsy features of fatty liver parenchyma degeneration with Adverse-Effectgranulocytic portal infiltration and bile stasis, demonstrated 20 days after the initiation of antithyroid therapy with 20 mg methimazole daily.
0.9881 The main clinical features of this 58 - year - old female patient were laboratory evidence of leucopenia and cholestasis, and biopsy features of Adverse-Effectfatty liver parenchyma degeneration with granulocytic portal infiltration and bile stasis, demonstrated 20 days after the initiation of antithyroid therapy with 20 mg methimazole daily.
Score Text
0.9955 On the fifth day after administration of a high dose of ARA - C ( 2 g / m2 intravenously every 12 hours ), she developed bullous lesions on the hands and soles that disseminated, evolving to necrosis, Adverse-Effectsepsis , and death on the 22nd day.
0.9897 On the fifth day after administration of a high dose of ARA - C ( 2 g / m2 intravenously every 12 hours ), she developed bullous lesions on the hands and soles that disseminated, evolving to necrosis, sepsis, and Adverse-Effectdeath on the 22nd day.
0.9823 On the fifth day after administration of a high dose of DrugARA - C ( 2 g / m2 intravenously every 12 hours ), she developed bullous lesions on the hands and soles that disseminated, evolving to necrosis, sepsis, and death on the 22nd day.
0.9461 On the fifth day after administration of a high dose of ARA - C ( 2 g / m2 intravenously every 12 hours ), she developed Adverse-Effectbullous lesions on the hands and soles that disseminated, evolving to necrosis, sepsis, and death on the 22nd day.
0.9248 On the fifth day after administration of a high dose of ARA - C ( 2 g / m2 intravenously every 12 hours ), she developed bullous lesions on the hands and soles that disseminated, evolving to Adverse-Effectnecrosis , sepsis, and death on the 22nd day.
On the fifth day after administration of a high dose of ARA - C ( 2 g / m2 intravenously every 12 hours ), she developed Adverse-Effectbullous lesions on the hands and soles that disseminated, evolving to necrosis , sepsis, and death on the 22nd day.
Score Text
0.9891 It is presumed that her hyperchloremic metabolic acidosis was secondary to Drugcholestyramine because of the similarity to pediatric reports ; the rapid and lasting response to intravenous sodium bicarbonate ; the absence of another etiology ; normal serum potassium, chloride and bicarbonate despite continued spironolactone therapy after recovery.
0.9850 It is presumed that her Adverse-Effecthyperchloremic metabolic acidosis was secondary to cholestyramine because of the similarity to pediatric reports ; the rapid and lasting response to intravenous sodium bicarbonate ; the absence of another etiology ; normal serum potassium, chloride and bicarbonate despite continued spironolactone therapy after recovery.
Score Text
0.9995 Previous studies have demonstrated the interaction of DrugMTX and a variety of non - steroidal, anti - inflammatory drugs ( NSAIDs ) with various clinical manifestations including acute renal failure, pancytopenia, vomiting, diarrhea, elevated liver transaminases, jaundice, mucosal ulcerations, and pyrexia.
0.9989 Previous studies have demonstrated the interaction of MTX and a variety of non - steroidal, anti - inflammatory drugs ( NSAIDs ) with various clinical manifestations including acute renal failure, pancytopenia, vomiting, diarrhea, elevated liver transaminases, jaundice, mucosal ulcerations, and Adverse-Effectpyrexia .
0.9987 Previous studies have demonstrated the interaction of MTX and a variety of non - steroidal, anti - inflammatory drugs ( NSAIDs ) with various clinical manifestations including acute renal failure, pancytopenia, vomiting, Adverse-Effectdiarrhea , elevated liver transaminases, jaundice, mucosal ulcerations, and pyrexia.
0.9985 Previous studies have demonstrated the interaction of MTX and a variety of non - steroidal, anti - inflammatory drugs ( NSAIDs ) with various clinical manifestations including acute renal failure, pancytopenia, vomiting, diarrhea, elevated liver transaminases, Adverse-Effectjaundice , mucosal ulcerations, and pyrexia.
0.9983 Previous studies have demonstrated the interaction of MTX and a variety of non - steroidal, anti - inflammatory drugs ( NSAIDs ) with various clinical manifestations including acute renal failure, pancytopenia, Adverse-Effectvomiting , diarrhea, elevated liver transaminases, jaundice, mucosal ulcerations, and pyrexia.
0.9982 Previous studies have demonstrated the interaction of MTX and a variety of non - steroidal, anti - inflammatory drugs ( NSAIDs ) with various clinical manifestations including acute renal failure, Adverse-Effectpancytopenia , vomiting, diarrhea, elevated liver transaminases, jaundice, mucosal ulcerations, and pyrexia.
0.9919 Previous studies have demonstrated the interaction of MTX and a variety of non - steroidal, anti - inflammatory drugs ( NSAIDs ) with various clinical manifestations including acute renal failure, pancytopenia, vomiting, diarrhea, elevated liver transaminases, jaundice, Adverse-Effectmucosal ulcerations , and pyrexia.
0.9884 Previous studies have demonstrated the interaction of MTX and a variety of non - steroidal, anti - inflammatory drugs ( NSAIDs ) with various clinical manifestations including Adverse-Effectacute renal failure , pancytopenia, vomiting, diarrhea, elevated liver transaminases, jaundice, mucosal ulcerations, and pyrexia.
0.9884 Previous studies have demonstrated the interaction of MTX and a variety of non - steroidal, anti - inflammatory drugs ( NSAIDs ) with various clinical manifestations including acute renal failure, pancytopenia, vomiting, diarrhea, Adverse-Effectelevated liver transaminases , jaundice, mucosal ulcerations, and pyrexia.
Score Text
0.9984 METHOD : Case analysis of a poly - drug overdose ( Drugvenlafaxine , topiramate, divalproex sodium, risperidone, and carbamazepine ) presenting with mixed SS / NMS features and whose clinical management suggests a practical algorithm for treatment of undifferentiated SS / NMS in critical care settings.
0.9979 METHOD : Case analysis of a poly - drug overdose ( venlafaxine, topiramate, divalproex sodium, Drugrisperidone , and carbamazepine ) presenting with mixed SS / NMS features and whose clinical management suggests a practical algorithm for treatment of undifferentiated SS / NMS in critical care settings.
0.9977 METHOD : Case analysis of a poly - drug overdose ( venlafaxine, Drugtopiramate , divalproex sodium, risperidone, and carbamazepine ) presenting with mixed SS / NMS features and whose clinical management suggests a practical algorithm for treatment of undifferentiated SS / NMS in critical care settings.
0.9977 METHOD : Case analysis of a poly - drug overdose ( venlafaxine, topiramate, divalproex sodium, risperidone, and Drugcarbamazepine ) presenting with mixed SS / NMS features and whose clinical management suggests a practical algorithm for treatment of undifferentiated SS / NMS in critical care settings.
0.9933 METHOD : Case analysis of a poly - drug overdose ( venlafaxine, topiramate, Drugdivalproex sodium , risperidone, and carbamazepine ) presenting with mixed SS / NMS features and whose clinical management suggests a practical algorithm for treatment of undifferentiated SS / NMS in critical care settings.
0.8617 METHOD : Case analysis of a poly - drug overdose ( venlafaxine, topiramate, divalproex sodium, risperidone, and carbamazepine ) presenting with mixed Adverse-EffectSS / NMS features and whose clinical management suggests a practical algorithm for treatment of undifferentiated SS / NMS in critical care settings.
0.8041 METHOD : Case analysis of a poly - drug overdose ( venlafaxine, topiramate, divalproex sodium, risperidone, and carbamazepine ) presenting with mixed SS / Adverse-EffectNMS features and whose clinical management suggests a practical algorithm for treatment of undifferentiated SS / NMS in critical care settings.
Score Text
0.9983 After rechallenge with monotherapy pegvisomant, however, the hepatic enzyme disturbances reappeared within a few weeks, indicating that most likely pegvisomant alone and not the long - acting somatostatin analog or the combination of these two drugs was responsible for this case of drug - induced Adverse-Effecthepatitis .
0.9818 After rechallenge with monotherapy pegvisomant, however, the Adverse-Effecthepatic enzyme disturbances reappeared within a few weeks, indicating that most likely pegvisomant alone and not the long - acting somatostatin analog or the combination of these two drugs was responsible for this case of drug - induced hepatitis.
0.9616 After rechallenge with monotherapy pegvisomant, however, the hepatic enzyme disturbances reappeared within a few weeks, indicating that most likely Drugpegvisomant alone and not the long - acting somatostatin analog or the combination of these two drugs was responsible for this case of drug - induced hepatitis.
0.9667 After rechallenge with monotherapy pegvisomant, however, the hepatic enzyme disturbances reappeared within a few weeks, indicating that most likely pegvisomant alone and not the long - acting Drugsomatostatin analog or the combination of these two drugs was responsible for this case of drug - induced hepatitis.
After rechallenge with monotherapy Drugpegvisomant , however, the hepatic enzyme disturbances reappeared within a few weeks, indicating that most likely pegvisomant alone and not the long - acting somatostatin analog or the combination of these two drugs was responsible for this case of drug - induced hepatitis.
Score Text
0.9983 Possible pathophysiological mechanisms which may have been operative in this case include : a direct central nervous system ( CNS ) toxic effect of valproic acid ; a paradoxical epileptogenic effect secondary to the drug ; and an indirect CNS toxic effect mediated through valproic acid - induced Adverse-Effecthyperammonemia .
0.9852 Possible pathophysiological mechanisms which may have been operative in this case include : a direct central nervous system ( CNS ) toxic effect of valproic acid ; a paradoxical epileptogenic effect secondary to the drug ; and an indirect CNS toxic effect mediated through Drugvalproic acid - induced hyperammonemia.
0.8988 Possible pathophysiological mechanisms which may have been operative in this case include : a direct central nervous system ( CNS ) toxic effect of Drugvalproic acid ; a paradoxical epileptogenic effect secondary to the drug ; and an indirect CNS toxic effect mediated through valproic acid - induced hyperammonemia.
Score Text
0.9995 The authors also determined that their case of myositis developing in the rectus abdominus muscle of a patient with pancreatic adenocarcinoma was the manifestation of radiation recall, thereby bringing the number of patients who developed radiation recall to Druggemcitabine and were discussed in the current study to 13.
0.9941 The authors also determined that their case of myositis developing in the rectus abdominus muscle of a patient with pancreatic adenocarcinoma was the manifestation of radiation recall, thereby bringing the number of patients who developed Adverse-Effectradiation recall to gemcitabine and were discussed in the current study to 13.
0.9935 The authors also determined that their case of myositis developing in the rectus abdominus muscle of a patient with pancreatic adenocarcinoma was the manifestation of Adverse-Effectradiation recall , thereby bringing the number of patients who developed radiation recall to gemcitabine and were discussed in the current study to 13.
0.9821 The authors also determined that their case of Adverse-Effectmyositis developing in the rectus abdominus muscle of a patient with pancreatic adenocarcinoma was the manifestation of radiation recall, thereby bringing the number of patients who developed radiation recall to gemcitabine and were discussed in the current study to 13.
Score Text
0.9995 These findings suggest that Drugclozapine - induced seizures can be successfully treated, that gradual dose titration can reduce the likelihood of further episodes of seizures and that concomitant use of a suitable mood stabilizer / anti - epileptic medication can improve the outcome of treatment - resistant schizophrenia.
0.9980 These findings suggest that clozapine - induced Adverse-Effectseizures can be successfully treated, that gradual dose titration can reduce the likelihood of further episodes of seizures and that concomitant use of a suitable mood stabilizer / anti - epileptic medication can improve the outcome of treatment - resistant schizophrenia.
0.9946 These findings suggest that clozapine - induced seizures can be successfully treated, that gradual dose titration can reduce the likelihood of further episodes of Adverse-Effectseizures and that concomitant use of a suitable mood stabilizer / anti - epileptic medication can improve the outcome of treatment - resistant schizophrenia.
Score Text
0.9883 We report the case histories of two patients with histologically confirmed adenocarcinoma of the prostate, both of whom had been treated with steroidal anti - androgen therapy in the form of cyproterone acetate prior to radical or palliative pelvic irradiation, and who subsequently developed Adverse-Effectfemoral head avascular necrosis .
0.9827 We report the case histories of two patients with histologically confirmed adenocarcinoma of the prostate, both of whom had been treated with steroidal anti - androgen therapy in the form of Drugcyproterone acetate prior to radical or palliative pelvic irradiation, and who subsequently developed femoral head avascular necrosis.
0.9094 We report the case histories of two patients with histologically confirmed Adverse-Effectadenocarcinoma of the prostate , both of whom had been treated with steroidal anti - androgen therapy in the form of cyproterone acetate prior to radical or palliative pelvic irradiation, and who subsequently developed femoral head avascular necrosis.
Score Text
0.9995 Postoperatively, the first two patients treated with 1 to 2 cc of Drugthrombin were slow to awaken ; one had evidence of vasospasm by transcranial Doppler ultrasound studies and multiple infarcts on cranial computerized tomography, while the other had a moderate - sized frontal hematoma with intracranial hypertension.
0.9963 Postoperatively, the first two patients treated with 1 to 2 cc of thrombin were slow to awaken ; one had evidence of Adverse-Effectvasospasm by transcranial Doppler ultrasound studies and multiple infarcts on cranial computerized tomography, while the other had a moderate - sized frontal hematoma with intracranial hypertension.
0.9842 Postoperatively, the first two patients treated with 1 to 2 cc of thrombin were slow to awaken ; one had evidence of vasospasm by transcranial Doppler ultrasound studies and Adverse-Effectmultiple infarcts on cranial computerized tomography, while the other had a moderate - sized frontal hematoma with intracranial hypertension.
0.8962 Postoperatively, the first two patients treated with 1 to 2 cc of thrombin were Adverse-Effectslow to awaken ; one had evidence of vasospasm by transcranial Doppler ultrasound studies and multiple infarcts on cranial computerized tomography, while the other had a moderate - sized frontal hematoma with intracranial hypertension.
0.7154 Postoperatively, the first two patients treated with 1 to 2 cc of thrombin were slow to awaken ; one had evidence of vasospasm by transcranial Doppler ultrasound studies and multiple infarcts on cranial computerized tomography, while the other had a moderate - sized frontal hematoma with Adverse-Effectintracranial hypertension .
0.7072 Postoperatively, the first two patients treated with 1 to 2 cc of thrombin were slow to awaken ; one had evidence of vasospasm by transcranial Doppler ultrasound studies and multiple infarcts on cranial computerized tomography, while the other had a moderate - sized Adverse-Effectfrontal hematoma with intracranial hypertension.
Score Text
0.9979 RESULTS : The estimated number of Accutane prescriptions for reproductive - aged women has more than doubled in the past 10 years ; it is the most widely used Adverse-Effectteratogenic drug in the United States, with approximately 2. 5 per 1, 000 reproductive - aged women exposed to Accutane in 1999.
0.9942 RESULTS : The estimated number of DrugAccutane prescriptions for reproductive - aged women has more than doubled in the past 10 years ; it is the most widely used teratogenic drug in the United States, with approximately 2. 5 per 1, 000 reproductive - aged women exposed to Accutane in 1999.
Score Text
0.9984 A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and Adverse-Effecteosinophilia two weeks after receiving trimethoprim ( TMP ) - sulfamethoxazole ( SMX ) treatment.
0.9974 A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim ( TMP ) - sulfamethoxazole ( DrugSMX ) treatment.
0.9966 A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, Adverse-Effectskin eruptions , cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim ( TMP ) - sulfamethoxazole ( SMX ) treatment.
0.9955 A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, Adverse-Effecthepatosplenomegaly , atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim ( TMP ) - sulfamethoxazole ( SMX ) treatment.
0.9948 A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, Adverse-Effectcervical lymphadenopathy , hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim ( TMP ) - sulfamethoxazole ( SMX ) treatment.
0.9935 A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with Adverse-Effectfever , skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim ( TMP ) - sulfamethoxazole ( SMX ) treatment.
0.9923 A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim ( TMP ) - Drugsulfamethoxazole ( SMX ) treatment.
0.9889 A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, Adverse-Effectatypical lymphocytosis , and eosinophilia two weeks after receiving trimethoprim ( TMP ) - sulfamethoxazole ( SMX ) treatment.
0.9466 A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving Drugtrimethoprim ( TMP ) - sulfamethoxazole ( SMX ) treatment.
0.8080 A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim ( DrugTMP ) - sulfamethoxazole ( SMX ) treatment.
Score Text
0.9972 Although it is difficult to be certain of the direct link of amiodarone on the basis of a single case, it is reasonable to presume that this histopathology is associated with amiodarone - induced Adverse-Effecthypothyroidism and that involution changes represent the hypofunctional status of this drug - induced disorder.
0.9558 Although it is difficult to be certain of the direct link of amiodarone on the basis of a single case, it is reasonable to presume that this histopathology is associated with Drugamiodarone - induced hypothyroidism and that involution changes represent the hypofunctional status of this drug - induced disorder.
0.8922 Although it is difficult to be certain of the direct link of Drugamiodarone on the basis of a single case, it is reasonable to presume that this histopathology is associated with amiodarone - induced hypothyroidism and that involution changes represent the hypofunctional status of this drug - induced disorder.
0.5120 Although it is difficult to be certain of the direct link of amiodarone on the basis of a single case, it is reasonable to presume that this histopathology is associated with amiodarone - induced hypothyroidism and that involution changes represent the Adverse-Effecthypofunctional status of this drug - induced disorder.
Score Text
0.9973 It also highlights a current major etiologic question, that is, whether and to what degree lead exposure contributes to the development of Adverse-Effecthypertension , and raises the issue of whether lead - induced hypertension constitutes a subset of hypertension that is especially amenable to therapy with dietary calcium.
0.9359 It also highlights a current major etiologic question, that is, whether and to what degree Druglead exposure contributes to the development of hypertension, and raises the issue of whether lead - induced hypertension constitutes a subset of hypertension that is especially amenable to therapy with dietary calcium.
0.9083 It also highlights a current major etiologic question, that is, whether and to what degree lead exposure contributes to the development of hypertension, and raises the issue of whether Druglead - induced hypertension constitutes a subset of hypertension that is especially amenable to therapy with dietary calcium.
0.9609 It also highlights a current major etiologic question, that is, whether and to what degree lead exposure contributes to the development of hypertension, and raises the issue of whether lead - induced hypertension constitutes a subset of Adverse-Effecthypertension that is especially amenable to therapy with dietary calcium.
0.9577 It also highlights a current major etiologic question, that is, whether and to what degree lead exposure contributes to the development of hypertension, and raises the issue of whether lead - induced Adverse-Effecthypertension constitutes a subset of hypertension that is especially amenable to therapy with dietary calcium.
It also highlights a current major etiologic question, that is, whether and to what degree lead exposure contributes to the development of hypertension, and raises the issue of whether Adverse-Effectlead - induced hypertension constitutes a subset of hypertension that is especially amenable to therapy with dietary calcium.
Score Text
0.9994 DrugRisperidone is a frequently used member of a new class of atypical antipsychotics - the serotonin - dopamine antagonists ( SDAs ) - due to its comparatively high efficacy and low D2 / 5HT2 binding ratio, which results in a low incidence of extrapyramidal side effects including tardive dyskinesia ( TD ).
0.9920 Risperidone is a frequently used member of a new class of atypical antipsychotics - the serotonin - dopamine antagonists ( SDAs ) - due to its comparatively high efficacy and low D2 / 5HT2 binding ratio, which results in a low incidence of extrapyramidal side effects including Adverse-Effecttardive dyskinesia ( TD ).
0.9844 Risperidone is a frequently used member of a new class of atypical antipsychotics - the serotonin - dopamine antagonists ( SDAs ) - due to its comparatively high efficacy and low D2 / 5HT2 binding ratio, which results in a low incidence of extrapyramidal side effects including tardive dyskinesia ( Adverse-EffectTD ).
0.9011 Risperidone is a frequently used member of a new class of atypical antipsychotics - the serotonin - dopamine antagonists ( SDAs ) - due to its comparatively high efficacy and low D2 / 5HT2 binding ratio, which results in a low incidence of Adverse-Effectextrapyramidal side effects including tardive dyskinesia ( TD ).
Score Text
0.9996 DrugVancomycin is widely used against methicillin - resistant Staphylococcus aureus infections, but it is associated with many adverse effects such as nephrotoxicity, ototoxicity, gastrointestinal disturbances, blood disorders, and two types of hypersensitivity reactions - an anaphylactoid reaction known as " red man syndrome " and anaphylaxis.
0.9988 Vancomycin is widely used against methicillin - resistant Staphylococcus aureus infections, but it is associated with many adverse effects such as nephrotoxicity, ototoxicity, gastrointestinal disturbances, blood disorders, and two types of hypersensitivity reactions - an anaphylactoid reaction known as " red man syndrome " and Adverse-Effectanaphylaxis .
0.9984 Vancomycin is widely used against methicillin - resistant Staphylococcus aureus infections, but it is associated with many adverse effects such as Adverse-Effectnephrotoxicity , ototoxicity, gastrointestinal disturbances, blood disorders, and two types of hypersensitivity reactions - an anaphylactoid reaction known as " red man syndrome " and anaphylaxis.
0.9983 Vancomycin is widely used against methicillin - resistant Staphylococcus aureus infections, but it is associated with many adverse effects such as nephrotoxicity, Adverse-Effectototoxicity , gastrointestinal disturbances, blood disorders, and two types of hypersensitivity reactions - an anaphylactoid reaction known as " red man syndrome " and anaphylaxis.
0.9958 Vancomycin is widely used against methicillin - resistant Staphylococcus aureus infections, but it is associated with many adverse effects such as nephrotoxicity, ototoxicity, gastrointestinal disturbances, Adverse-Effectblood disorders , and two types of hypersensitivity reactions - an anaphylactoid reaction known as " red man syndrome " and anaphylaxis.
0.9923 Vancomycin is widely used against methicillin - resistant Staphylococcus aureus infections, but it is associated with many adverse effects such as nephrotoxicity, ototoxicity, gastrointestinal disturbances, blood disorders, and two types of hypersensitivity reactions - an anaphylactoid reaction known as " Adverse-Effectred man syndrome " and anaphylaxis.
0.9920 Vancomycin is widely used against methicillin - resistant Staphylococcus aureus infections, but it is associated with many adverse effects such as nephrotoxicity, ototoxicity, Adverse-Effectgastrointestinal disturbances , blood disorders, and two types of hypersensitivity reactions - an anaphylactoid reaction known as " red man syndrome " and anaphylaxis.
0.9797 Vancomycin is widely used against methicillin - resistant Staphylococcus aureus infections, but it is associated with many adverse effects such as nephrotoxicity, ototoxicity, gastrointestinal disturbances, blood disorders, and two types of Adverse-Effecthypersensitivity reactions - an anaphylactoid reaction known as " red man syndrome " and anaphylaxis.
0.5081 Vancomycin is widely used against methicillin - resistant Staphylococcus aureus infections, but it is associated with many adverse effects such as nephrotoxicity, ototoxicity, gastrointestinal disturbances, blood disorders, and two types of hypersensitivity reactions - an Adverse-Effectanaphylactoid reaction known as " red man syndrome " and anaphylaxis.
0.9930 Vancomycin is widely used against methicillin - resistant Staphylococcus aureus infections, but it is associated with many adverse effects such as nephrotoxicity, ototoxicity, gastrointestinal disturbances, blood disorders, and two types of hypersensitivity reactions - an Adverse-Effectanaphylactoid reaction known as " red man syndrome " and anaphylaxis.
Score Text
0.9996 Among 12 thyrotoxic patients, a patient with arrhythmogenic right ventricular dysplasia, who had been taking Drugamiodarone for 4 years, developed thyrotoxicosis with subacute onset, accompanied by transiently positive thyrotropin ( TSH ) receptor antibody ( TRAb ), or thyrotropin - binding inhibiting immunoglobulin ( TBII ).
0.9983 Among 12 thyrotoxic patients, a patient with arrhythmogenic right ventricular dysplasia, who had been taking amiodarone for 4 years, developed Adverse-Effectthyrotoxicosis with subacute onset, accompanied by transiently positive thyrotropin ( TSH ) receptor antibody ( TRAb ), or thyrotropin - binding inhibiting immunoglobulin ( TBII ).
0.9772 Among 12 thyrotoxic patients, a patient with arrhythmogenic right ventricular dysplasia, who had been taking amiodarone for 4 years, developed thyrotoxicosis with subacute onset, accompanied by Adverse-Effecttransiently positive thyrotropin ( TSH ) receptor antibody ( TRAb ), or thyrotropin - binding inhibiting immunoglobulin ( TBII ).
0.9609 Among 12 thyrotoxic patients, a patient with arrhythmogenic right ventricular dysplasia, who had been taking amiodarone for 4 years, developed thyrotoxicosis with subacute onset, accompanied by transiently positive thyrotropin ( TSH ) receptor antibody ( TRAb ), or Adverse-Effectthyrotropin - binding inhibiting immunoglobulin ( TBII ).
0.9695 Among 12 thyrotoxic patients, a patient with arrhythmogenic right ventricular dysplasia, who had been taking amiodarone for 4 years, developed thyrotoxicosis with Adverse-Effectsubacute onset , accompanied by transiently positive thyrotropin ( TSH ) receptor antibody ( TRAb ), or thyrotropin - binding inhibiting immunoglobulin ( TBII ).
0.9327 Among 12 thyrotoxic patients, a patient with arrhythmogenic right ventricular dysplasia, who had been taking amiodarone for 4 years, developed thyrotoxicosis with subacute onset, accompanied by transiently positive thyrotropin ( TSH ) receptor antibody ( TRAb ), or Adverse-Effectthyrotropin - binding inhibiting immunoglobulin ( TBII ).
0.9130 Among 12 thyrotoxic patients, a patient with arrhythmogenic right ventricular dysplasia, who had been taking amiodarone for 4 years, developed thyrotoxicosis with subacute onset, accompanied by transiently positive thyrotropin ( TSH ) receptor antibody ( TRAb ), or Adverse-Effectthyrotropin - binding inhibiting immunoglobulin ( TBII ).
0.9045 Among 12 thyrotoxic patients, a patient with arrhythmogenic right ventricular dysplasia, who had been taking amiodarone for 4 years, developed thyrotoxicosis with subacute onset, accompanied by transiently positive thyrotropin ( TSH ) receptor antibody ( TRAb ), or Adverse-Effectthyrotropin - binding inhibiting immunoglobulin ( TBII ).
0.7653 Among 12 thyrotoxic patients, a patient with arrhythmogenic right ventricular dysplasia, who had been taking amiodarone for 4 years, developed thyrotoxicosis with subacute onset, accompanied by transiently positive thyrotropin ( TSH ) receptor antibody ( Adverse-EffectTRAb ), or thyrotropin - binding inhibiting immunoglobulin ( TBII ).
Score Text
0.9916 Adverse-EffectThrombocytopenia with or without microangiopathy following quinine is often referred to as quinine " hypersensitivity. " When schistocytes are present it is frequently termed " quinine - associated TTP / HUS. " A severe deficiency of the vWF - cleaving protease, ADAMTS13, is associated with idiopathic TTP.
0.9582 Thrombocytopenia with or without microangiopathy following Drugquinine is often referred to as quinine " hypersensitivity. " When schistocytes are present it is frequently termed " quinine - associated TTP / HUS. " A severe deficiency of the vWF - cleaving protease, ADAMTS13, is associated with idiopathic TTP.
0.8918 Thrombocytopenia with or without microangiopathy following quinine is often referred to as quinine " hypersensitivity. " When schistocytes are present it is frequently termed " Drugquinine - associated TTP / HUS. " A severe deficiency of the vWF - cleaving protease, ADAMTS13, is associated with idiopathic TTP.
0.9728 Thrombocytopenia with or without microangiopathy following quinine is often referred to as quinine " hypersensitivity. " When schistocytes are present it is frequently termed " quinine - associated TTP / Adverse-EffectHUS . " A severe deficiency of the vWF - cleaving protease, ADAMTS13, is associated with idiopathic TTP.
0.9492 Thrombocytopenia with or without microangiopathy following quinine is often referred to as Drugquinine " hypersensitivity. " When schistocytes are present it is frequently termed " quinine - associated TTP / HUS. " A severe deficiency of the vWF - cleaving protease, ADAMTS13, is associated with idiopathic TTP.
0.8587 Thrombocytopenia with or without microangiopathy following quinine is often referred to as quinine " Adverse-Effecthypersensitivity . " When schistocytes are present it is frequently termed " quinine - associated TTP / HUS. " A severe deficiency of the vWF - cleaving protease, ADAMTS13, is associated with idiopathic TTP.
0.6475 Thrombocytopenia with or without microangiopathy following quinine is often referred to as quinine " hypersensitivity. " When schistocytes are present it is frequently termed " quinine - associated TTP / HUS. " A Adverse-Effectsevere deficiency of the vWF - cleaving protease , ADAMTS13, is associated with idiopathic TTP.
Thrombocytopenia with or without microangiopathy following quinine is often referred to as quinine " hypersensitivity. " When schistocytes are present it is frequently termed " quinine - associated Adverse-EffectTTP / HUS . " A severe deficiency of the vWF - cleaving protease, ADAMTS13, is associated with idiopathic TTP.
Score Text
0.9958 Intravenous verapamil therapy in babies may cause Adverse-Effectapnea , hypotension, and bradycardia ; continued episodes of atrial flutter in a child may cause sudden death ; quinidine may be related to the death ; children with " familial seizure disorders " may in fact have the long QT interval syndrome.
0.9928 Intravenous verapamil therapy in babies may cause apnea, hypotension, and bradycardia ; continued episodes of atrial flutter in a child may cause Adverse-Effectsudden death ; quinidine may be related to the death ; children with " familial seizure disorders " may in fact have the long QT interval syndrome.
0.9912 Intravenous Drugverapamil therapy in babies may cause apnea, hypotension, and bradycardia ; continued episodes of atrial flutter in a child may cause sudden death ; quinidine may be related to the death ; children with " familial seizure disorders " may in fact have the long QT interval syndrome.
0.9908 Intravenous verapamil therapy in babies may cause apnea, hypotension, and bradycardia ; continued episodes of atrial flutter in a child may cause sudden death ; quinidine may be related to the death ; children with " familial seizure disorders " may in fact have the Adverse-Effectlong QT interval syndrome .
0.9867 Intravenous verapamil therapy in babies may cause apnea, Adverse-Effecthypotension , and bradycardia ; continued episodes of atrial flutter in a child may cause sudden death ; quinidine may be related to the death ; children with " familial seizure disorders " may in fact have the long QT interval syndrome.
0.9540 Intravenous verapamil therapy in babies may cause apnea, hypotension, and Adverse-Effectbradycardia ; continued episodes of atrial flutter in a child may cause sudden death ; quinidine may be related to the death ; children with " familial seizure disorders " may in fact have the long QT interval syndrome.
0.9319 Intravenous verapamil therapy in babies may cause apnea, hypotension, and bradycardia ; continued episodes of atrial flutter in a child may cause sudden death ; Drugquinidine may be related to the death ; children with " familial seizure disorders " may in fact have the long QT interval syndrome.
0.5350 Intravenous verapamil therapy in babies may cause apnea, hypotension, and bradycardia ; continued episodes of Adverse-Effectatrial flutter in a child may cause sudden death ; quinidine may be related to the death ; children with " familial seizure disorders " may in fact have the long QT interval syndrome.
Intravenous verapamil therapy in babies may cause apnea, hypotension, and bradycardia ; continued episodes of atrial flutter in a child may cause sudden death ; quinidine may be related to the Adverse-Effectdeath ; children with " familial seizure disorders " may in fact have the long QT interval syndrome.
Score Text
0.9908 The pharmaceutical company producing Halfan has reported 8 Adverse-Effectcardiac arrests , leading to 6 deaths, when a higher dose than recommended was used, there was recent or concomitant treatment with mefloquine, there was pre - existing prolongation of the QT interval or the patient had a thiamine deficiency.
0.9890 The pharmaceutical company producing DrugHalfan has reported 8 cardiac arrests, leading to 6 deaths, when a higher dose than recommended was used, there was recent or concomitant treatment with mefloquine, there was pre - existing prolongation of the QT interval or the patient had a thiamine deficiency.
0.9826 The pharmaceutical company producing Halfan has reported 8 cardiac arrests, leading to 6 Adverse-Effectdeaths , when a higher dose than recommended was used, there was recent or concomitant treatment with mefloquine, there was pre - existing prolongation of the QT interval or the patient had a thiamine deficiency.
0.8201 The pharmaceutical company producing Halfan has reported 8 cardiac arrests, leading to 6 deaths, when a higher dose than recommended was used, there was recent or concomitant treatment with Drugmefloquine , there was pre - existing prolongation of the QT interval or the patient had a thiamine deficiency.
0.5427 The pharmaceutical company producing Halfan has reported 8 cardiac arrests, leading to 6 deaths, when a higher dose than recommended was used, there was recent or concomitant treatment with mefloquine, there was pre - existing Adverse-Effectprolongation of the QT interval or the patient had a thiamine deficiency.
Score Text
0.9919 The administration of " sweet spirits of nitre " ( 4 % ethyl nitrite CH3CH2ONO in 70 % ethyl alcohol ) was followed by acute methemoglobinemia and Adverse-Effectsevere anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin died from the consequences of hypoxemia.
0.9908 The administration of " sweet spirits of nitre " ( 4 % ethyl nitrite CH3CH2ONO in 70 % ethyl alcohol ) was followed by Adverse-Effectacute methemoglobinemia and severe anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin died from the consequences of hypoxemia.
0.9884 The administration of " sweet spirits of nitre " ( 4 % ethyl nitrite CH3CH2ONO in 70 % ethyl alcohol ) was followed by acute methemoglobinemia and severe anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin died from the consequences of Adverse-Effecthypoxemia .
0.9482 The administration of " Drugsweet spirits of nitre " ( 4 % ethyl nitrite CH3CH2ONO in 70 % ethyl alcohol ) was followed by acute methemoglobinemia and severe anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin died from the consequences of hypoxemia.
0.7210 The administration of " sweet spirits of nitre " ( Drug4 % ethyl nitrite CH3CH2ONO in 70 % ethyl alcohol ) was followed by acute methemoglobinemia and severe anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin died from the consequences of hypoxemia.
0.6386 The administration of " sweet spirits of nitre " ( 4 % ethyl nitrite CH3CH2ONO in 70 % ethyl alcohol ) was followed by acute methemoglobinemia and severe anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin Adverse-Effectdied from the consequences of hypoxemia.
0.6638 The administration of " sweet Drugspirits of nitre " ( 4 % ethyl nitrite CH3CH2ONO in 70 % ethyl alcohol ) was followed by acute methemoglobinemia and severe anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin died from the consequences of hypoxemia.
Score Text
0.9968 Although the literature on the use of Drugrisperidone in elderly patients with dementia consists largely of uncontrolled trials, case reports, and chart reviews, it appears that this agent is effective for managing agitation in this population and does so with a low frequency of extrapyramidal symptoms ( EPS ).
0.9906 Although the literature on the use of risperidone in elderly patients with dementia consists largely of uncontrolled trials, case reports, and chart reviews, it appears that this agent is effective for managing agitation in this population and does so with a low frequency of Adverse-Effectextrapyramidal symptoms ( EPS ).
0.9854 Although the literature on the use of risperidone in elderly patients with dementia consists largely of uncontrolled trials, case reports, and chart reviews, it appears that this agent is effective for managing agitation in this population and does so with a low frequency of extrapyramidal symptoms ( Adverse-EffectEPS ).
Score Text
0.9984 Two patients with ovarian cancer who had received multiple courses of cisplatin without complications experienced hypersensitivity reactions to cisplatin : one, involving intrahepatic artery infusion, manifested general erythema, dyspnea, and Adverse-Effecthypotension ; the other, involving intravenous infusion, manifested abdominal pain, general erythema, and fever.
0.9968 Two patients with ovarian cancer who had received multiple courses of cisplatin without complications experienced hypersensitivity reactions to cisplatin : one, involving intrahepatic artery infusion, manifested general erythema, Adverse-Effectdyspnea , and hypotension ; the other, involving intravenous infusion, manifested abdominal pain, general erythema, and fever.
0.9965 Two patients with ovarian cancer who had received multiple courses of cisplatin without complications experienced hypersensitivity reactions to cisplatin : one, involving intrahepatic artery infusion, manifested general erythema, dyspnea, and hypotension ; the other, involving intravenous infusion, manifested Adverse-Effectabdominal pain , general erythema, and fever.
0.9958 Two patients with ovarian cancer who had received multiple courses of cisplatin without complications experienced hypersensitivity reactions to cisplatin : one, involving intrahepatic artery infusion, manifested general erythema, dyspnea, and hypotension ; the other, involving intravenous infusion, manifested abdominal pain, Adverse-Effectgeneral erythema , and fever.
0.9953 Two patients with ovarian cancer who had received multiple courses of cisplatin without complications experienced hypersensitivity reactions to cisplatin : one, involving intrahepatic artery infusion, manifested Adverse-Effectgeneral erythema , dyspnea, and hypotension ; the other, involving intravenous infusion, manifested abdominal pain, general erythema, and fever.
0.9826 Two patients with ovarian cancer who had received multiple courses of cisplatin without complications experienced hypersensitivity reactions to cisplatin : one, involving intrahepatic artery infusion, manifested general erythema, dyspnea, and hypotension ; the other, involving intravenous infusion, manifested abdominal pain, general erythema, and Adverse-Effectfever .
0.9727 Two patients with ovarian cancer who had received multiple courses of Drugcisplatin without complications experienced hypersensitivity reactions to cisplatin : one, involving intrahepatic artery infusion, manifested general erythema, dyspnea, and hypotension ; the other, involving intravenous infusion, manifested abdominal pain, general erythema, and fever.
0.9673 Two patients with ovarian cancer who had received multiple courses of cisplatin without complications experienced hypersensitivity reactions to Drugcisplatin : one, involving intrahepatic artery infusion, manifested general erythema, dyspnea, and hypotension ; the other, involving intravenous infusion, manifested abdominal pain, general erythema, and fever.
0.9596 Two patients with ovarian cancer who had received multiple courses of cisplatin without complications experienced Adverse-Effecthypersensitivity reactions to cisplatin : one, involving intrahepatic artery infusion, manifested general erythema, dyspnea, and hypotension ; the other, involving intravenous infusion, manifested abdominal pain, general erythema, and fever.
Score Text
0.9901 We report 5 patients ( 3 patients with chronic hepatitis C treated with pegylated interferon alfa - 2b in association with oral ribavirin and two patients with chronic myelocytic leukemia ) who developed Adverse-Effectlocal cutaneous reactions at sites of injection after the administration of weekly subcutaneous injections of pegylated interferon alfa - 2b at different doses.
0.9777 We report 5 patients ( 3 patients with chronic hepatitis C treated with pegylated interferon alfa - 2b in association with oral ribavirin and two patients with chronic myelocytic leukemia ) who developed local cutaneous reactions at sites of injection after the administration of weekly subcutaneous injections of Drugpegylated interferon alfa - 2b at different doses.
0.9759 We report 5 patients ( 3 patients with chronic hepatitis C treated with Drugpegylated interferon alfa - 2b in association with oral ribavirin and two patients with chronic myelocytic leukemia ) who developed local cutaneous reactions at sites of injection after the administration of weekly subcutaneous injections of pegylated interferon alfa - 2b at different doses.
0.9034 We report 5 patients ( 3 patients with chronic hepatitis C treated with pegylated interferon alfa - 2b in association with oral Drugribavirin and two patients with chronic myelocytic leukemia ) who developed local cutaneous reactions at sites of injection after the administration of weekly subcutaneous injections of pegylated interferon alfa - 2b at different doses.
Score Text
0.9884 Although this type of hyperpigmentation has been previously seen in patients with cancer who are receiving bleomycin, this is, to our knowledge, the first reported case of bleomycin - induced Adverse-Effecthyperpigmentation in an AIDS patient and should be added to the growing list of cutaneous eruptions seen in these patients.
0.9612 Although this type of hyperpigmentation has been previously seen in patients with cancer who are receiving bleomycin, this is, to our knowledge, the first reported case of Drugbleomycin - induced hyperpigmentation in an AIDS patient and should be added to the growing list of cutaneous eruptions seen in these patients.
0.9543 Although this type of Adverse-Effecthyperpigmentation has been previously seen in patients with cancer who are receiving bleomycin, this is, to our knowledge, the first reported case of bleomycin - induced hyperpigmentation in an AIDS patient and should be added to the growing list of cutaneous eruptions seen in these patients.
0.9294 Although this type of hyperpigmentation has been previously seen in patients with cancer who are receiving Drugbleomycin , this is, to our knowledge, the first reported case of bleomycin - induced hyperpigmentation in an AIDS patient and should be added to the growing list of cutaneous eruptions seen in these patients.
0.9833 Although this type of hyperpigmentation has been previously seen in patients with cancer who are receiving bleomycin, this is, to our knowledge, the first reported case of bleomycin - induced hyperpigmentation in an AIDS patient and should be added to the growing list of Adverse-Effectcutaneous eruptions seen in these patients.
Score Text
0.9711 Our report suggested that CBDCA hypersensitivity was correlated with the total dose of previously administered platinum agents and that CBDCA should be excluded in patients who have received multiple platinum - based chemotherapy, even in platinum - sensitive cases, because DrugCBDCA hypersensitivity can occur even with low - dose CBDCA administration.
0.9682 Our report suggested that DrugCBDCA hypersensitivity was correlated with the total dose of previously administered platinum agents and that CBDCA should be excluded in patients who have received multiple platinum - based chemotherapy, even in platinum - sensitive cases, because CBDCA hypersensitivity can occur even with low - dose CBDCA administration.
0.9528 Our report suggested that CBDCA hypersensitivity was correlated with the total dose of previously administered platinum agents and that CBDCA should be excluded in patients who have received multiple platinum - based chemotherapy, even in platinum - sensitive cases, because CBDCA hypersensitivity can occur even with low - dose DrugCBDCA administration.
0.9021 Our report suggested that CBDCA hypersensitivity was correlated with the total dose of previously administered platinum agents and that CBDCA should be excluded in patients who have received multiple platinum - based chemotherapy, even in platinum - sensitive cases, because CBDCA Adverse-Effecthypersensitivity can occur even with low - dose CBDCA administration.
0.8476 Our report suggested that CBDCA Adverse-Effecthypersensitivity was correlated with the total dose of previously administered platinum agents and that CBDCA should be excluded in patients who have received multiple platinum - based chemotherapy, even in platinum - sensitive cases, because CBDCA hypersensitivity can occur even with low - dose CBDCA administration.
0.7224 Our report suggested that CBDCA hypersensitivity was correlated with the total dose of previously administered platinum agents and that DrugCBDCA should be excluded in patients who have received multiple platinum - based chemotherapy, even in platinum - sensitive cases, because CBDCA hypersensitivity can occur even with low - dose CBDCA administration.
Score Text
0.9943 This paper reports on a 6. 9 - year - old autistic male who developed repeated episodes of Adverse-Effectacute dystonic reactions associated with pimozide administration at the doses of 0. 096 mg / kg / day and 0. 032 mg / kg / day and 32 hours following pimozide withdrawal, as well as during subsequent thioridazine administration.
0.9592 This paper reports on a 6. 9 - year - old autistic male who developed repeated episodes of acute dystonic reactions associated with Drugpimozide administration at the doses of 0. 096 mg / kg / day and 0. 032 mg / kg / day and 32 hours following pimozide withdrawal, as well as during subsequent thioridazine administration.
0.9512 This paper reports on a 6. 9 - year - old autistic male who developed repeated episodes of acute dystonic reactions associated with pimozide administration at the doses of 0. 096 mg / kg / day and 0. 032 mg / kg / day and 32 hours following pimozide withdrawal, as well as during subsequent Drugthioridazine administration.
0.9301 This paper reports on a 6. 9 - year - old autistic male who developed repeated episodes of acute dystonic reactions associated with pimozide administration at the doses of 0. 096 mg / kg / day and 0. 032 mg / kg / day and 32 hours following Drugpimozide withdrawal, as well as during subsequent thioridazine administration.
Score Text
0.9759 We have seen a case of terminal malignant melanoma in which clinical manifestations, indicative of Adverse-Effectanterior spinal artery syndrome , developed following the injection of 0. 3 ml of 10 % phenol - glycerine into the cervical subarachnoid space at the C4 - - C5 level for the control of severe right arm pain.
0.7603 We have seen a case of terminal malignant melanoma in which clinical manifestations, indicative of anterior spinal artery syndrome, developed following the injection of 0. 3 ml of 10 % Drugphenol - glycerine into the cervical subarachnoid space at the C4 - - C5 level for the control of severe right arm pain.
0.9850 We have seen a case of Adverse-Effectterminal malignant melanoma in which clinical manifestations, indicative of anterior spinal artery syndrome, developed following the injection of 0. 3 ml of 10 % phenol - glycerine into the cervical subarachnoid space at the C4 - - C5 level for the control of severe right arm pain.
Score Text
0.9992 Contrary to previous recommendations, our experience cautions against the further use of high - dose Drugcytarabine in patients who develop PPE, and is a timely reminder of the potential toxicity of this agent, which is now increasingly being used as first - line treatment in the management of haematologic malignancies.
0.9974 Contrary to previous recommendations, our experience cautions against the further use of high - dose cytarabine in patients who develop Adverse-EffectPPE , and is a timely reminder of the potential toxicity of this agent, which is now increasingly being used as first - line treatment in the management of haematologic malignancies.
Score Text
0.9819 Attempts were made to stop and then restart the Drugtheophylline therapy at progressively lower doses ; however, with each attempt, the patient's reaction to the drug became more toxic, with serum theophylline levels ranging between 99. 9 and 149. 9 micromol / L ( 18 and 27 microg / mL ).
0.9633 Attempts were made to stop and then restart the theophylline therapy at progressively lower doses ; however, with each attempt, the patient's reaction to the drug became more toxic, with serum Drugtheophylline levels ranging between 99. 9 and 149. 9 micromol / L ( 18 and 27 microg / mL ).
Attempts were made to stop and then restart the theophylline therapy at progressively lower doses ; however, with each attempt, the patient's Adverse-Effectreaction to the drug became more toxic , with serum theophylline levels ranging between 99. 9 and 149. 9 micromol / L ( 18 and 27 microg / mL ).
Score Text
0.9954 Since recent studies have reported no negative interactions with concurrent use, we here report three cases ( one case of a prolonged seizure, a serotonin syndrome and a focal seizure ) of severe Druglithium - induced side effects while patients underwent ECT without complications and lithium serum levels were still subtherapeutic.
0.9915 Since recent studies have reported no negative interactions with concurrent use, we here report three cases ( one case of a prolonged seizure, a Adverse-Effectserotonin syndrome and a focal seizure ) of severe lithium - induced side effects while patients underwent ECT without complications and lithium serum levels were still subtherapeutic.
0.9880 Since recent studies have reported no negative interactions with concurrent use, we here report three cases ( one case of a prolonged seizure, a serotonin syndrome and a Adverse-Effectfocal seizure ) of severe lithium - induced side effects while patients underwent ECT without complications and lithium serum levels were still subtherapeutic.
0.9877 Since recent studies have reported no negative interactions with concurrent use, we here report three cases ( one case of a Adverse-Effectprolonged seizure , a serotonin syndrome and a focal seizure ) of severe lithium - induced side effects while patients underwent ECT without complications and lithium serum levels were still subtherapeutic.
Score Text
0.9996 Eleven patients developed infection requiring hospitalization while taking Drugleflunomide including : lower respiratory tract infections ( 3 ), cellulitis ( 2 ), disseminated herpes zoster ( 2 ), probable TB liver ( 1 ), abdominal sepsis ( 1 ), mycotic aneurysm ( 1 ) and gastroenteritis ( 1 ).
0.9939 Eleven patients developed Adverse-Effectinfection requiring hospitalization while taking leflunomide including : lower respiratory tract infections ( 3 ), cellulitis ( 2 ), disseminated herpes zoster ( 2 ), probable TB liver ( 1 ), abdominal sepsis ( 1 ), mycotic aneurysm ( 1 ) and gastroenteritis ( 1 ).
0.9937 Eleven patients developed infection requiring hospitalization while taking leflunomide including : lower respiratory tract infections ( 3 ), cellulitis ( 2 ), disseminated herpes zoster ( 2 ), probable TB liver ( 1 ), abdominal sepsis ( 1 ), mycotic aneurysm ( 1 ) and Adverse-Effectgastroenteritis ( 1 ).
0.9933 Eleven patients developed infection requiring hospitalization while taking leflunomide including : lower respiratory tract infections ( 3 ), cellulitis ( 2 ), disseminated herpes zoster ( 2 ), probable Adverse-EffectTB liver ( 1 ), abdominal sepsis ( 1 ), mycotic aneurysm ( 1 ) and gastroenteritis ( 1 ).
0.9920 Eleven patients developed infection requiring hospitalization while taking leflunomide including : lower respiratory tract infections ( 3 ), cellulitis ( 2 ), disseminated herpes zoster ( 2 ), probable TB liver ( 1 ), Adverse-Effectabdominal sepsis ( 1 ), mycotic aneurysm ( 1 ) and gastroenteritis ( 1 ).
0.9899 Eleven patients developed infection requiring hospitalization while taking leflunomide including : lower respiratory tract infections ( 3 ), Adverse-Effectcellulitis ( 2 ), disseminated herpes zoster ( 2 ), probable TB liver ( 1 ), abdominal sepsis ( 1 ), mycotic aneurysm ( 1 ) and gastroenteritis ( 1 ).
0.9875 Eleven patients developed infection requiring hospitalization while taking leflunomide including : lower respiratory tract infections ( 3 ), cellulitis ( 2 ), Adverse-Effectdisseminated herpes zoster ( 2 ), probable TB liver ( 1 ), abdominal sepsis ( 1 ), mycotic aneurysm ( 1 ) and gastroenteritis ( 1 ).
0.9847 Eleven patients developed infection requiring hospitalization while taking leflunomide including : Adverse-Effectlower respiratory tract infections ( 3 ), cellulitis ( 2 ), disseminated herpes zoster ( 2 ), probable TB liver ( 1 ), abdominal sepsis ( 1 ), mycotic aneurysm ( 1 ) and gastroenteritis ( 1 ).
0.9797 Eleven patients developed infection requiring hospitalization while taking leflunomide including : lower respiratory tract infections ( 3 ), cellulitis ( 2 ), disseminated herpes zoster ( 2 ), probable TB liver ( 1 ), abdominal sepsis ( 1 ), Adverse-Effectmycotic aneurysm ( 1 ) and gastroenteritis ( 1 ).
Score Text
0.9950 During dose - finding studies for intravenous proton pump inhibitors omeprazole and pantoprazole, three of six young female volunteers receiving omeprazole and two young female volunteers receiving pantoprazole developed Adverse-Effectperipheral edema within 8 hr when high doses of the proton pump inhibitors were applied by continuous infusion together with large volumes of fluid.
0.9765 During dose - finding studies for intravenous proton pump inhibitors omeprazole and pantoprazole, three of six young female volunteers receiving Drugomeprazole and two young female volunteers receiving pantoprazole developed peripheral edema within 8 hr when high doses of the proton pump inhibitors were applied by continuous infusion together with large volumes of fluid.
0.9666 During dose - finding studies for intravenous proton pump inhibitors omeprazole and pantoprazole, three of six young female volunteers receiving omeprazole and two young female volunteers receiving Drugpantoprazole developed peripheral edema within 8 hr when high doses of the proton pump inhibitors were applied by continuous infusion together with large volumes of fluid.
0.9809 During dose - finding studies for intravenous proton pump inhibitors omeprazole and Drugpantoprazole , three of six young female volunteers receiving omeprazole and two young female volunteers receiving pantoprazole developed peripheral edema within 8 hr when high doses of the proton pump inhibitors were applied by continuous infusion together with large volumes of fluid.
0.9749 During dose - finding studies for intravenous proton pump inhibitors Drugomeprazole and pantoprazole, three of six young female volunteers receiving omeprazole and two young female volunteers receiving pantoprazole developed peripheral edema within 8 hr when high doses of the proton pump inhibitors were applied by continuous infusion together with large volumes of fluid.
Score Text
0.9980 Only two case reports of adults with allergic contact dermatitis to this chemical exist in the literature, and we describe three more cases of children with recalcitrant atopic dermatitis found to have potential allergic contact dermatitis to Drugbisabolol - a component of the Aquaphor emollient they were using to treat their atopic dermatitis.
0.9779 Only two case reports of adults with allergic contact dermatitis to this chemical exist in the literature, and we describe three more cases of children with recalcitrant atopic dermatitis found to have potential Adverse-Effectallergic contact dermatitis to bisabolol - a component of the Aquaphor emollient they were using to treat their atopic dermatitis.
Score Text
0.9764 We describe the Adverse-Effectinfectious toxicities experienced by the first two patients in our institution treated with dexamethasone ( 10 mg / m ( 2 ) / day for 4 weeks with gradual tapering ) during induction according to the dexamethasone arm of BFM 2000 and review the relevant literature that suggests an increased risk of infectious complications with dexamethasone.
0.9185 We describe the infectious toxicities experienced by the first two patients in our institution treated with Drugdexamethasone ( 10 mg / m ( 2 ) / day for 4 weeks with gradual tapering ) during induction according to the dexamethasone arm of BFM 2000 and review the relevant literature that suggests an increased risk of infectious complications with dexamethasone.
0.8319 We describe the infectious toxicities experienced by the first two patients in our institution treated with dexamethasone ( 10 mg / m ( 2 ) / day for 4 weeks with gradual tapering ) during induction according to the dexamethasone arm of BFM 2000 and review the relevant literature that suggests an increased risk of infectious complications with Drugdexamethasone .
0.5027 We describe the infectious toxicities experienced by the first two patients in our institution treated with dexamethasone ( 10 mg / m ( 2 ) / day for 4 weeks with gradual tapering ) during induction according to the dexamethasone arm of BFM 2000 and review the relevant literature that suggests an increased risk of Adverse-Effectinfectious complications with dexamethasone.
0.8606 We describe the infectious toxicities experienced by the first two patients in our institution treated with dexamethasone ( 10 mg / m ( 2 ) / day for 4 weeks with gradual tapering ) during induction according to the Drugdexamethasone arm of BFM 2000 and review the relevant literature that suggests an increased risk of infectious complications with dexamethasone.
Score Text
0.9994 We report the case histories of identical twin brothers who developed concordant acute lymphoblastic leukemia at the age of 4 years and who later developed leukoencephalopathy and hydrocephalus related to central nervous system prophylaxis by, in the first case intrathecally administered Drugmethotrexate and, in the second by intrathecally administered methotrexate and cranial irradiation.
0.9994 We report the case histories of identical twin brothers who developed concordant acute lymphoblastic leukemia at the age of 4 years and who later developed leukoencephalopathy and hydrocephalus related to central nervous system prophylaxis by, in the first case intrathecally administered methotrexate and, in the second by intrathecally administered Drugmethotrexate and cranial irradiation.
0.9982 We report the case histories of identical twin brothers who developed concordant acute lymphoblastic leukemia at the age of 4 years and who later developed leukoencephalopathy and Adverse-Effecthydrocephalus related to central nervous system prophylaxis by, in the first case intrathecally administered methotrexate and, in the second by intrathecally administered methotrexate and cranial irradiation.
0.9977 We report the case histories of identical twin brothers who developed concordant acute lymphoblastic leukemia at the age of 4 years and who later developed Adverse-Effectleukoencephalopathy and hydrocephalus related to central nervous system prophylaxis by, in the first case intrathecally administered methotrexate and, in the second by intrathecally administered methotrexate and cranial irradiation.
0.9098 We report the case histories of identical twin brothers who developed Adverse-Effectconcordant acute lymphoblastic leukemia at the age of 4 years and who later developed leukoencephalopathy and hydrocephalus related to central nervous system prophylaxis by, in the first case intrathecally administered methotrexate and, in the second by intrathecally administered methotrexate and cranial irradiation.
0.8080 We report the case histories of identical twin brothers who developed concordant acute lymphoblastic leukemia at the age of 4 years and who later developed leukoencephalopathy and hydrocephalus related to Adverse-Effectcentral nervous system prophylaxis by, in the first case intrathecally administered methotrexate and, in the second by intrathecally administered methotrexate and cranial irradiation.
Score Text
0.9954 CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, agitation, tachycardia, Adverse-Effecttremors , myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of fentanyl.
0.9951 CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, agitation, tachycardia, tremors, myoclonic jerks and unsteady gait, consistent with Adverse-Effectserotonin syndrome , following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of fentanyl.
0.9948 CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) Drugcitalopram developed confusion, agitation, tachycardia, tremors, myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of fentanyl.
0.9944 CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, agitation, Adverse-Effecttachycardia , tremors, myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of fentanyl.
0.9943 CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, Adverse-Effectagitation , tachycardia, tremors, myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of fentanyl.
0.9929 CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, agitation, tachycardia, tremors, Adverse-Effectmyoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of fentanyl.
0.9922 CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, agitation, tachycardia, tremors, myoclonic jerks and Adverse-Effectunsteady gait , consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of fentanyl.
0.9850 CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed Adverse-Effectconfusion , agitation, tachycardia, tremors, myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of fentanyl.
0.9763 CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, agitation, tachycardia, tremors, myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of Drugfentanyl .
0.9750 CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, agitation, tachycardia, tremors, myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of Drugfentanyl , and all symptoms and signs resolved following discontinuation of fentanyl.
Score Text
0.9996 We describe longitudinal diffusion - weighted MRI findings of sub - acute leukoencephalopathy following Drugmethotrexate therapy in a 24 - year - old man diagnosed with pre - B - cell acute lymphoblastic leukemia ( ALL ), presenting with right - sided paralysis and aphasia after second consolidation with intrathecal triple - drug therapy given intrathecally.
0.9653 We describe longitudinal diffusion - weighted MRI findings of Adverse-Effectsub - acute leukoencephalopathy following methotrexate therapy in a 24 - year - old man diagnosed with pre - B - cell acute lymphoblastic leukemia ( ALL ), presenting with right - sided paralysis and aphasia after second consolidation with intrathecal triple - drug therapy given intrathecally.
0.6072 We describe longitudinal diffusion - weighted MRI findings of sub - acute leukoencephalopathy following methotrexate therapy in a 24 - year - old man diagnosed with pre - B - cell acute lymphoblastic leukemia ( ALL ), presenting with right - sided paralysis and Adverse-Effectaphasia after second consolidation with intrathecal triple - drug therapy given intrathecally.
Score Text
0.9996 This report describes an individual with mental retardation who experienced behavioral exacerbation associated with Drugclonazepam prescribed at 2 mg / day ( 0. 02 mg / kg / day ) to treat aggression, self - injurious behavior, property destruction, and screaming, which was measured with a 15 - minute partial interval recording measurement method.
0.9934 This report describes an individual with mental retardation who experienced Adverse-Effectbehavioral exacerbation associated with clonazepam prescribed at 2 mg / day ( 0. 02 mg / kg / day ) to treat aggression, self - injurious behavior, property destruction, and screaming, which was measured with a 15 - minute partial interval recording measurement method.
Score Text
0.9978 In this article lithium is not discussed, although there are a number of concerns about lithium's potential Adverse-Effectteratogenicity , and it has been implicated in Epstein's anomaly, a congenital heart defect among infants born to women taking lithium ; as with other medications, however, the data have specific limitations.
0.9891 In this article lithium is not discussed, although there are a number of concerns about Druglithium ' s potential teratogenicity, and it has been implicated in Epstein's anomaly, a congenital heart defect among infants born to women taking lithium ; as with other medications, however, the data have specific limitations.
0.9780 In this article lithium is not discussed, although there are a number of concerns about lithium's potential teratogenicity, and it has been implicated in Epstein's anomaly, a congenital heart defect among infants born to women taking Druglithium ; as with other medications, however, the data have specific limitations.
0.9744 In this article lithium is not discussed, although there are a number of concerns about lithium's potential teratogenicity, and it has been implicated in Adverse-EffectEpstein's anomaly , a congenital heart defect among infants born to women taking lithium ; as with other medications, however, the data have specific limitations.
0.9843 In this article Druglithium is not discussed, although there are a number of concerns about lithium's potential teratogenicity, and it has been implicated in Epstein's anomaly, a congenital heart defect among infants born to women taking lithium ; as with other medications, however, the data have specific limitations.
0.9689 In this article lithium is not discussed, although there are a number of concerns about lithium's potential teratogenicity, and it has been implicated in Epstein's anomaly, a Adverse-Effectcongenital heart defect among infants born to women taking lithium ; as with other medications, however, the data have specific limitations.
Score Text
0.9995 CASE SUMMARY : A 61 - year - old woman with no apparent risk factors for liver injury developed acute hepatitis one week after the final dose of a long - term course of pulse Drugitraconazole therapy ( 200 mg orally twice daily, 1 wk on, 3 wk off, for 24 wk ) for onychomycosis.
0.9920 CASE SUMMARY : A 61 - year - old woman with no apparent risk factors for liver injury developed Adverse-Effectacute hepatitis one week after the final dose of a long - term course of pulse itraconazole therapy ( 200 mg orally twice daily, 1 wk on, 3 wk off, for 24 wk ) for onychomycosis.
Score Text
0.9957 Thirty - six patients with AL received, in a three - month period, 51 cycles of combined chemotherapy which included, in all of them, cytosine arabinoside ( ARA - C ) ; among them, along with myelosuppression, five experienced fever, infectious complications, gastrointestinal tract symptoms and Adverse-Effectsevere myalgias .
0.9946 Thirty - six patients with AL received, in a three - month period, 51 cycles of combined chemotherapy which included, in all of them, cytosine arabinoside ( ARA - C ) ; among them, along with myelosuppression, five experienced Adverse-Effectfever , infectious complications, gastrointestinal tract symptoms and severe myalgias.
0.9934 Thirty - six patients with AL received, in a three - month period, 51 cycles of combined chemotherapy which included, in all of them, cytosine arabinoside ( ARA - C ) ; among them, along with myelosuppression, five experienced fever, infectious complications, Adverse-Effectgastrointestinal tract symptoms and severe myalgias.
0.9874 Thirty - six patients with AL received, in a three - month period, 51 cycles of combined chemotherapy which included, in all of them, cytosine arabinoside ( ARA - C ) ; among them, along with myelosuppression, five experienced fever, Adverse-Effectinfectious complications , gastrointestinal tract symptoms and severe myalgias.
0.9834 Thirty - six patients with AL received, in a three - month period, 51 cycles of combined chemotherapy which included, in all of them, Drugcytosine arabinoside ( ARA - C ) ; among them, along with myelosuppression, five experienced fever, infectious complications, gastrointestinal tract symptoms and severe myalgias.
0.9826 Thirty - six patients with AL received, in a three - month period, 51 cycles of combined chemotherapy which included, in all of them, cytosine arabinoside ( DrugARA - C ) ; among them, along with myelosuppression, five experienced fever, infectious complications, gastrointestinal tract symptoms and severe myalgias.
Score Text
0.9993 1. Changes in the plasma cortisol level were reported in a male patient with panic disorder during the period of low - dose Drugalprazolam treatment ( mean 0. 62 + / - 0. 15 mg / day ) compared with during the period of high - dose period ( mean 1. 08 + / - 0. 28 mg / day ).
0.9762 1. Adverse-EffectChanges in the plasma cortisol level were reported in a male patient with panic disorder during the period of low - dose alprazolam treatment ( mean 0. 62 + / - 0. 15 mg / day ) compared with during the period of high - dose period ( mean 1. 08 + / - 0. 28 mg / day ).
Score Text
0.9813 DISCUSSION : After exclusion of other causes, the onset of Adverse-Effectthrombocytopenia after administration of lansoprazole, the resolution of the adverse reaction after discontinuation of the drug, and the fact that no other medicines were introduced during this time frame lead us to believe that this was most likely an idiosyncratic thrombocytopenic response to lansoprazole.
0.9269 DISCUSSION : After exclusion of other causes, the onset of thrombocytopenia after administration of Druglansoprazole , the resolution of the adverse reaction after discontinuation of the drug, and the fact that no other medicines were introduced during this time frame lead us to believe that this was most likely an idiosyncratic thrombocytopenic response to lansoprazole.
0.9200 DISCUSSION : After exclusion of other causes, the onset of thrombocytopenia after administration of lansoprazole, the resolution of the adverse reaction after discontinuation of the drug, and the fact that no other medicines were introduced during this time frame lead us to believe that this was most likely an idiosyncratic thrombocytopenic response to Druglansoprazole .
0.5404 DISCUSSION : After exclusion of other causes, the onset of thrombocytopenia after administration of lansoprazole, the resolution of the adverse reaction after discontinuation of the drug, and the fact that no other medicines were introduced during this time frame lead us to believe that this was most likely an Adverse-Effectidiosyncratic thrombocytopenic response to lansoprazole.
DISCUSSION : After exclusion of other causes, the onset of thrombocytopenia after administration of lansoprazole, the resolution of the adverse reaction after discontinuation of the drug, and the fact that no other medicines were introduced during this time frame lead us to believe that this was most likely an idiosyncratic Adverse-Effectthrombocytopenic response to lansoprazole.
Score Text
0.9916 In a single practice during the 21 years 1971 - 1991, the incidence of Adverse-Effectgestational diabetes in pregnancies in which norethisterone was prescribed was 32. 4 % ( 22 of 69 ) in comparison with 7. 1 % in pregnancies in which the women did not take norethisterone ( 137 of 1, 684 ) ( p < 0. 001 ).
0.9434 In a single practice during the 21 years 1971 - 1991, the incidence of gestational diabetes in pregnancies in which Drugnorethisterone was prescribed was 32. 4 % ( 22 of 69 ) in comparison with 7. 1 % in pregnancies in which the women did not take norethisterone ( 137 of 1, 684 ) ( p < 0. 001 ).
0.8606 In a single practice during the 21 years 1971 - 1991, the incidence of gestational diabetes in pregnancies in which norethisterone was prescribed was 32. 4 % ( 22 of 69 ) in comparison with 7. 1 % in pregnancies in which the women did not take Drugnorethisterone ( 137 of 1, 684 ) ( p < 0. 001 ).
Score Text
0.9931 These findings are consistent with an immune - complex form of glomerulopathy in which gold is neither the antigen nor a hapten in the glomerular deposits, and they suggest the hypothesis that antibodies to tubular epithelial antigens induced by gold therapy may be a causative factor in the Adverse-Effectrenal disease associated with gold therapy in rheumatoid arthritis.
0.9874 These findings are consistent with an immune - complex form of glomerulopathy in which gold is neither the antigen nor a hapten in the glomerular deposits, and they suggest the hypothesis that antibodies to tubular epithelial antigens induced by gold therapy may be a causative factor in the renal disease associated with Druggold therapy in rheumatoid arthritis.
0.9836 These findings are consistent with an immune - complex form of glomerulopathy in which gold is neither the antigen nor a hapten in the glomerular deposits, and they suggest the hypothesis that antibodies to tubular epithelial antigens induced by Druggold therapy may be a causative factor in the renal disease associated with gold therapy in rheumatoid arthritis.
0.9817 These findings are consistent with an immune - complex form of glomerulopathy in which Druggold is neither the antigen nor a hapten in the glomerular deposits, and they suggest the hypothesis that antibodies to tubular epithelial antigens induced by gold therapy may be a causative factor in the renal disease associated with gold therapy in rheumatoid arthritis.
Score Text
0.9991 The latter form ( DrugMacrodantin ) is reported to engender less gastrointestinal intolerance but it can produce the same adverse effects as the conventional form - - liver damage, acute and chronic pulmonary reactions, peripheral neuropathy, blood dyscrasias and allergic reactions - - and does so just as rapidly and floridly ; one such case is reported here.
0.9962 The latter form ( Macrodantin ) is reported to engender less gastrointestinal intolerance but it can produce the same adverse effects as the conventional form - - liver damage, acute and chronic pulmonary reactions, peripheral neuropathy, blood dyscrasias and Adverse-Effectallergic reactions - - and does so just as rapidly and floridly ; one such case is reported here.
0.9958 The latter form ( Macrodantin ) is reported to engender less gastrointestinal intolerance but it can produce the same adverse effects as the conventional form - - liver damage, acute and chronic pulmonary reactions, Adverse-Effectperipheral neuropathy , blood dyscrasias and allergic reactions - - and does so just as rapidly and floridly ; one such case is reported here.
0.9946 The latter form ( Macrodantin ) is reported to engender less gastrointestinal intolerance but it can produce the same adverse effects as the conventional form - - Adverse-Effectliver damage , acute and chronic pulmonary reactions, peripheral neuropathy, blood dyscrasias and allergic reactions - - and does so just as rapidly and floridly ; one such case is reported here.
0.9931 The latter form ( Macrodantin ) is reported to engender less gastrointestinal intolerance but it can produce the same adverse effects as the conventional form - - liver damage, acute and chronic pulmonary reactions, peripheral neuropathy, Adverse-Effectblood dyscrasias and allergic reactions - - and does so just as rapidly and floridly ; one such case is reported here.
0.9726 The latter form ( Macrodantin ) is reported to engender less gastrointestinal intolerance but it can produce the same adverse effects as the conventional form - - liver damage, Adverse-Effectacute and chronic pulmonary reactions , peripheral neuropathy, blood dyscrasias and allergic reactions - - and does so just as rapidly and floridly ; one such case is reported here.
Score Text
0.9949 RESULTS : After 4 - to 14 - month period of therapy with the combination of indapamide ( 2. 5 mg / day ) and Drugfosinopril ( 10 mg / day ) in three patients and 6 - month period of monotherapy with indapamide ( 2. 5 mg / day ) in one patient, glucose levels of all patients increased and achieve criteria of diabetes diagnoses.
0.9934 RESULTS : After 4 - to 14 - month period of therapy with the combination of Drugindapamide ( 2. 5 mg / day ) and fosinopril ( 10 mg / day ) in three patients and 6 - month period of monotherapy with indapamide ( 2. 5 mg / day ) in one patient, glucose levels of all patients increased and achieve criteria of diabetes diagnoses.
0.9918 RESULTS : After 4 - to 14 - month period of therapy with the combination of indapamide ( 2. 5 mg / day ) and fosinopril ( 10 mg / day ) in three patients and 6 - month period of monotherapy with Drugindapamide ( 2. 5 mg / day ) in one patient, glucose levels of all patients increased and achieve criteria of diabetes diagnoses.
0.9822 RESULTS : After 4 - to 14 - month period of therapy with the combination of indapamide ( 2. 5 mg / day ) and fosinopril ( 10 mg / day ) in three patients and 6 - month period of monotherapy with indapamide ( 2. 5 mg / day ) in one patient, glucose levels of all patients increased and achieve criteria of Adverse-Effectdiabetes diagnoses.
Score Text
0.9860 This case demonstrates an occupational activity ( construction ) that has now become the dominant source of lead exposure for U. S. adults, the importance of a good occupational history to suspecting and making a diagnosis, the possible outcomes of chronic Druglead toxicity, and the importance of preventing further exposure and using proper methods to treat acute toxicity.
0.9780 This case demonstrates an occupational activity ( construction ) that has now become the dominant source of lead exposure for U. S. adults, the importance of a good occupational history to suspecting and making a diagnosis, the possible outcomes of chronic Adverse-Effectlead toxicity , and the importance of preventing further exposure and using proper methods to treat acute toxicity.
0.9537 This case demonstrates an occupational activity ( construction ) that has now become the dominant source of Druglead exposure for U. S. adults, the importance of a good occupational history to suspecting and making a diagnosis, the possible outcomes of chronic lead toxicity, and the importance of preventing further exposure and using proper methods to treat acute toxicity.
0.5236 This case demonstrates an occupational activity ( construction ) that has now become the dominant source of lead exposure for U. S. adults, the importance of a good occupational history to suspecting and making a diagnosis, the possible outcomes of chronic lead toxicity, and the importance of preventing further exposure and using proper methods to treat Adverse-Effectacute toxicity .
Score Text
0.9898 By means of the in vitro heparin - induced platelet activation ( HIPA ) assay it was shown that standard heparin and the LMW heparins Fragmin and Fraxiparin ( Sanofi Labaz, Munich, FRG ), as well as the enoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced Adverse-Effectplatelet activation with the patient's serum.
0.9890 By means of the in vitro heparin - induced platelet activation ( HIPA ) assay it was shown that standard heparin and the LMW heparins Fragmin and DrugFraxiparin ( Sanofi Labaz, Munich, FRG ), as well as the enoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced platelet activation with the patient's serum.
0.9758 By means of the in vitro heparin - induced platelet activation ( HIPA ) assay it was shown that standard heparin and the LMW heparins DrugFragmin and Fraxiparin ( Sanofi Labaz, Munich, FRG ), as well as the enoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced platelet activation with the patient's serum.
0.9658 By means of the in vitro heparin - induced platelet activation ( HIPA ) assay it was shown that standard Drugheparin and the LMW heparins Fragmin and Fraxiparin ( Sanofi Labaz, Munich, FRG ), as well as the enoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced platelet activation with the patient's serum.
0.9428 By means of the in vitro Drugheparin - induced platelet activation ( HIPA ) assay it was shown that standard heparin and the LMW heparins Fragmin and Fraxiparin ( Sanofi Labaz, Munich, FRG ), as well as the enoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced platelet activation with the patient's serum.
0.9423 By means of the in vitro heparin - induced Adverse-Effectplatelet activation ( HIPA ) assay it was shown that standard heparin and the LMW heparins Fragmin and Fraxiparin ( Sanofi Labaz, Munich, FRG ), as well as the enoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced platelet activation with the patient's serum.
0.7525 By means of the in vitro heparin - induced platelet activation ( HIPA ) assay it was shown that standard heparin and the LMW heparins Fragmin and Fraxiparin ( DrugSanofi Labaz , Munich, FRG ), as well as the enoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced platelet activation with the patient's serum.
0.7161 By means of the in vitro heparin - induced platelet activation ( HIPA ) assay it was shown that standard heparin and the LMW heparins Fragmin and Fraxiparin ( Sanofi Labaz, Munich, FRG ), as well as the Drugenoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced platelet activation with the patient's serum.
By means of the in vitro heparin - induced platelet activation ( HIPA ) assay it was shown that standard heparin and the LMW heparins Fragmin and Fraxiparin ( Sanofi Labaz, Munich, FRG ), as well as the enoxaparine DrugClexane ( Nattermann, Cologne, FRG ), all induced platelet activation with the patient's serum.
Score Text
0.9006 CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with DrugCS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving CS.
0.9002 CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in Drugcorticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving CS.
0.8458 CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving DrugCS .
0.9730 CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with Adverse-Effectcutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving CS.
0.8650 CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a Adverse-Effectvisceral involvement after cutaneous leishmaniasis in a man receiving CS.
0.8481 CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( DrugCS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving CS.
0.6728 CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous Drugleishmaniasis in a man receiving CS.
0.5387 CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral Drugleishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving CS.
0.4986 CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual Drugleishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving CS.
CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated Adverse-Effectlingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving CS.
CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after Adverse-Effectcutaneous leishmaniasis in a man receiving CS.
CASE PRESENTATION : Three cases of Adverse-EffectLeishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving CS.
Score Text
0.9996 Although the existence of an acute pericarditis or an acute myocarditis as possible causes of the ST elevation can not be fully ruled out, the sudden onset, prominent magnitude, and brief duration of the ST elevation are perhaps more indicative of an acute ischemic event, possibly related to a transient coronary vasoconstriction induced by the Drugdopamine infusion.
0.9299 Although the existence of an acute pericarditis or an acute myocarditis as possible causes of the ST elevation can not be fully ruled out, the sudden onset, prominent magnitude, and brief duration of the ST elevation are perhaps more indicative of an acute ischemic event, possibly related to a Adverse-Effecttransient coronary vasoconstriction induced by the dopamine infusion.
0.6154 Although the existence of an acute pericarditis or an acute myocarditis as possible causes of the ST elevation can not be fully ruled out, the sudden onset, prominent magnitude, and brief duration of the ST elevation are perhaps more indicative of an Adverse-Effectacute ischemic event , possibly related to a transient coronary vasoconstriction induced by the dopamine infusion.
Although the existence of an acute pericarditis or an acute myocarditis as possible causes of the ST elevation can not be fully ruled out, the sudden onset, prominent magnitude, and brief duration of the ST elevation are perhaps more indicative of an acute ischemic event, possibly related to a transient Adverse-Effectcoronary vasoconstriction induced by the dopamine infusion.
Score Text
0.9091 Its overall toxicity is considerably less compared to standard induction chemotherapy ; however, it is associated with a high incidence of a potentially fatal symptom complex referred to as " Drugretinoic acid syndrome. " This report describes a patient with APL who developed the syndrome a few weeks after initiating induction therapy with ATRA despite being treated for hyperleukocytosis.
0.8186 Its overall toxicity is considerably less compared to standard induction chemotherapy ; however, it is associated with a high incidence of a potentially fatal symptom complex referred to as " Adverse-Effectretinoic acid syndrome . " This report describes a patient with APL who developed the syndrome a few weeks after initiating induction therapy with ATRA despite being treated for hyperleukocytosis.
0.8001 Its overall toxicity is considerably less compared to standard induction chemotherapy ; however, it is associated with a high incidence of a Adverse-Effectpotentially fatal symptom complex referred to as " retinoic acid syndrome. " This report describes a patient with APL who developed the syndrome a few weeks after initiating induction therapy with ATRA despite being treated for hyperleukocytosis.
0.7016 Its overall Adverse-Effecttoxicity is considerably less compared to standard induction chemotherapy ; however, it is associated with a high incidence of a potentially fatal symptom complex referred to as " retinoic acid syndrome. " This report describes a patient with APL who developed the syndrome a few weeks after initiating induction therapy with ATRA despite being treated for hyperleukocytosis.
0.9689 Its overall toxicity is considerably less compared to standard induction chemotherapy ; however, it is associated with a high incidence of a potentially Adverse-Effectfatal symptom complex referred to as " retinoic acid syndrome. " This report describes a patient with APL who developed the syndrome a few weeks after initiating induction therapy with ATRA despite being treated for hyperleukocytosis.
Score Text
0.9990 We further used immunohistochemistry ( IHC ) to examine the relative role of platelet - derived growth factor - B ( PDGF - B ), insulin - like growth factor I ( IGF - I ), transforming growth factor - beta1 ( TGF - beta1 ) and cyclooxygenase - 2 ( COX - 2 ) in the pathogenesis of DrugBCNU - related pulmonary fibrosis.
0.9848 We further used immunohistochemistry ( IHC ) to examine the relative role of platelet - derived growth factor - B ( PDGF - B ), insulin - like growth factor I ( IGF - I ), transforming growth factor - beta1 ( TGF - beta1 ) and cyclooxygenase - 2 ( COX - 2 ) in the pathogenesis of BCNU - related Adverse-Effectpulmonary fibrosis .
Score Text
0.9751 CONCLUSION : The present findings suggest that : ( i ) amantadine probably exerts its anti - dyskinetic effect by acting on the " indirect " pathway ; ( ii ) the pathophysiological mechanisms of subthalamotomy induced dyskinesias may differ from those involved in DrugL - dopa induced dyskinesias ; ( iii ) dyskinesias induced by STN surgery resolve spontaneously as compensatory mechanisms develop.
0.9147 CONCLUSION : The present findings suggest that : ( i ) amantadine probably exerts its anti - dyskinetic effect by acting on the " indirect " pathway ; ( ii ) the pathophysiological mechanisms of subthalamotomy induced dyskinesias may differ from those involved in L - dopa induced Adverse-Effectdyskinesias ; ( iii ) dyskinesias induced by STN surgery resolve spontaneously as compensatory mechanisms develop.
0.9344 CONCLUSION : The present findings suggest that : ( i ) Drugamantadine probably exerts its anti - dyskinetic effect by acting on the " indirect " pathway ; ( ii ) the pathophysiological mechanisms of subthalamotomy induced dyskinesias may differ from those involved in L - dopa induced dyskinesias ; ( iii ) dyskinesias induced by STN surgery resolve spontaneously as compensatory mechanisms develop.
0.8067 CONCLUSION : The present findings suggest that : ( i ) amantadine probably exerts its anti - dyskinetic effect by acting on the " indirect " pathway ; ( ii ) the pathophysiological mechanisms of subthalamotomy induced Adverse-Effectdyskinesias may differ from those involved in L - dopa induced dyskinesias ; ( iii ) dyskinesias induced by STN surgery resolve spontaneously as compensatory mechanisms develop.
Score Text
0.9990 A 10 - year - old boy with osteosarcoma and normal renal function manifested laboratory evidence of impending renal toxicity and extreme elevation of aspartate aminotrasferase and alanine aminotransferase within 2 hours after the completion of a 4 - hour infusion of high - dose Drugmethotrexate ( MTX ) ( 12 g / m2 ), and went on to develop acute renal failure with life - threatening hyperkalemia 29 hours later.
0.9988 A 10 - year - old boy with osteosarcoma and normal renal function manifested laboratory evidence of impending renal toxicity and extreme elevation of aspartate aminotrasferase and alanine aminotransferase within 2 hours after the completion of a 4 - hour infusion of high - dose methotrexate ( DrugMTX ) ( 12 g / m2 ), and went on to develop acute renal failure with life - threatening hyperkalemia 29 hours later.
0.9763 A 10 - year - old boy with osteosarcoma and normal renal function manifested laboratory evidence of impending renal toxicity and extreme elevation of aspartate aminotrasferase and alanine aminotransferase within 2 hours after the completion of a 4 - hour infusion of high - dose methotrexate ( MTX ) ( 12 g / m2 ), and went on to develop Adverse-Effectacute renal failure with life - threatening hyperkalemia 29 hours later.
0.9260 A 10 - year - old boy with osteosarcoma and normal renal function manifested laboratory evidence of impending Adverse-Effectrenal toxicity and extreme elevation of aspartate aminotrasferase and alanine aminotransferase within 2 hours after the completion of a 4 - hour infusion of high - dose methotrexate ( MTX ) ( 12 g / m2 ), and went on to develop acute renal failure with life - threatening hyperkalemia 29 hours later.
0.8893 A 10 - year - old boy with osteosarcoma and normal renal function manifested laboratory evidence of impending renal toxicity and extreme Adverse-Effectelevation of aspartate aminotrasferase and alanine aminotransferase within 2 hours after the completion of a 4 - hour infusion of high - dose methotrexate ( MTX ) ( 12 g / m2 ), and went on to develop acute renal failure with life - threatening hyperkalemia 29 hours later.
0.7199 A 10 - year - old boy with osteosarcoma and normal renal function manifested laboratory evidence of Adverse-Effectimpending renal toxicity and extreme elevation of aspartate aminotrasferase and alanine aminotransferase within 2 hours after the completion of a 4 - hour infusion of high - dose methotrexate ( MTX ) ( 12 g / m2 ), and went on to develop acute renal failure with life - threatening hyperkalemia 29 hours later.
Score Text
0.9911 Although risk factors for DrugMTX - induced pulmonary toxicity are poorly understood, the presence in 3 out of 5 of our patients of pre - existing lung disease, represented by diffuse interstitial changes on chest X - ray, and mild bronchial asthma in two RA patients and by pulmonary silicosis in the patient with PsA may account for a predisposition to the development of MTX pneumonitis.
0.9848 Although risk factors for MTX - induced Adverse-Effectpulmonary toxicity are poorly understood, the presence in 3 out of 5 of our patients of pre - existing lung disease, represented by diffuse interstitial changes on chest X - ray, and mild bronchial asthma in two RA patients and by pulmonary silicosis in the patient with PsA may account for a predisposition to the development of MTX pneumonitis.
0.9533 Although risk factors for MTX - induced pulmonary toxicity are poorly understood, the presence in 3 out of 5 of our patients of pre - existing lung disease, represented by diffuse interstitial changes on chest X - ray, and mild bronchial asthma in two RA patients and by pulmonary silicosis in the patient with PsA may account for a predisposition to the development of MTX Adverse-Effectpneumonitis .
0.9282 Although risk factors for MTX - induced pulmonary toxicity are poorly understood, the presence in 3 out of 5 of our patients of pre - existing lung disease, represented by diffuse interstitial changes on chest X - ray, and Adverse-Effectmild bronchial asthma in two RA patients and by pulmonary silicosis in the patient with PsA may account for a predisposition to the development of MTX pneumonitis.
0.7543 Although risk factors for MTX - induced pulmonary toxicity are poorly understood, the presence in 3 out of 5 of our patients of pre - existing lung disease, represented by diffuse interstitial changes on chest X - ray, and mild bronchial asthma in two RA patients and by pulmonary silicosis in the patient with PsA may account for a predisposition to the development of Adverse-EffectMTX pneumonitis .
0.6013 Although risk factors for MTX - induced pulmonary toxicity are poorly understood, the presence in 3 out of 5 of our patients of pre - existing lung disease, represented by diffuse interstitial changes on chest X - ray, and mild bronchial asthma in two RA patients and by Adverse-Effectpulmonary silicosis in the patient with PsA may account for a predisposition to the development of MTX pneumonitis.
Although risk factors for MTX - induced pulmonary toxicity are poorly understood, the presence in 3 out of 5 of our patients of pre - existing lung disease, represented by diffuse interstitial changes on chest X - ray, and mild bronchial asthma in two RA patients and by pulmonary silicosis in the patient with PsA may account for a predisposition to the development of DrugMTX pneumonitis.
Score Text
0.9905 A retrospective epidemiological study of deaths from hepatic angiosarcoma ( HAS ) in the U. S. showed that during 1964 - - 74 there were 168 such cases, of which 37 ( 22 % ) were associated with previously known causes ( Drugvinyl chloride ,'Thorotrast ', and inorganic arsenic ) and 4 ( 3. 1 % ) of the remaining 131 cases with the use of androgenic - anabolic steroids.
0.9893 A retrospective epidemiological study of deaths from hepatic angiosarcoma ( HAS ) in the U. S. showed that during 1964 - - 74 there were 168 such cases, of which 37 ( 22 % ) were associated with previously known causes ( vinyl chloride, ' DrugThorotrast ', and inorganic arsenic ) and 4 ( 3. 1 % ) of the remaining 131 cases with the use of androgenic - anabolic steroids.
0.9891 A retrospective epidemiological study of deaths from hepatic angiosarcoma ( HAS ) in the U. S. showed that during 1964 - - 74 there were 168 such cases, of which 37 ( 22 % ) were associated with previously known causes ( vinyl chloride,'Thorotrast ', and Druginorganic arsenic ) and 4 ( 3. 1 % ) of the remaining 131 cases with the use of androgenic - anabolic steroids.
0.8729 A retrospective epidemiological study of deaths from Adverse-Effecthepatic angiosarcoma ( HAS ) in the U. S. showed that during 1964 - - 74 there were 168 such cases, of which 37 ( 22 % ) were associated with previously known causes ( vinyl chloride,'Thorotrast ', and inorganic arsenic ) and 4 ( 3. 1 % ) of the remaining 131 cases with the use of androgenic - anabolic steroids.
0.9826 A retrospective epidemiological study of Adverse-Effectdeaths from hepatic angiosarcoma ( HAS ) in the U. S. showed that during 1964 - - 74 there were 168 such cases, of which 37 ( 22 % ) were associated with previously known causes ( vinyl chloride,'Thorotrast ', and inorganic arsenic ) and 4 ( 3. 1 % ) of the remaining 131 cases with the use of androgenic - anabolic steroids.
0.8285 A retrospective epidemiological study of deaths from hepatic angiosarcoma ( HAS ) in the U. S. showed that during 1964 - - 74 there were 168 such cases, of which 37 ( 22 % ) were associated with previously known causes ( vinyl chloride,'Thorotrast ', and inorganic arsenic ) and 4 ( 3. 1 % ) of the remaining 131 cases with the use of Drugandrogenic - anabolic steroids .
Score Text
0.9874 Although his renal function recovered completely with high - dose leucovorin, hemodialysis, charcoal hemoperfusion, and carboxypeptidase G2, we present this case to emphasize that signs of Adverse-Effectrenal toxicity may be present as early as 2 hours after the completion of a 4 - hour MTX infusion, and to suggest that monitoring for MTX toxicity should perhaps begin within a few hours after the completion of 4 - hour MTX infusion.
0.8931 Although his renal function recovered completely with high - dose leucovorin, hemodialysis, charcoal hemoperfusion, and carboxypeptidase G2, we present this case to emphasize that signs of renal toxicity may be present as early as 2 hours after the completion of a 4 - hour DrugMTX infusion, and to suggest that monitoring for MTX toxicity should perhaps begin within a few hours after the completion of 4 - hour MTX infusion.
0.8830 Although his renal function recovered completely with high - dose leucovorin, hemodialysis, charcoal hemoperfusion, and carboxypeptidase G2, we present this case to emphasize that signs of renal toxicity may be present as early as 2 hours after the completion of a 4 - hour MTX infusion, and to suggest that monitoring for DrugMTX toxicity should perhaps begin within a few hours after the completion of 4 - hour MTX infusion.
0.8661 Although his renal function recovered completely with high - dose leucovorin, hemodialysis, charcoal hemoperfusion, and carboxypeptidase G2, we present this case to emphasize that signs of renal toxicity may be present as early as 2 hours after the completion of a 4 - hour MTX infusion, and to suggest that monitoring for MTX toxicity should perhaps begin within a few hours after the completion of 4 - hour DrugMTX infusion.
0.7612 Although his renal function recovered completely with high - dose leucovorin, hemodialysis, charcoal hemoperfusion, and Drugcarboxypeptidase G2 , we present this case to emphasize that signs of renal toxicity may be present as early as 2 hours after the completion of a 4 - hour MTX infusion, and to suggest that monitoring for MTX toxicity should perhaps begin within a few hours after the completion of 4 - hour MTX infusion.
Score Text
0.9929 We suggest that nicotinic acid was the cause of his liver disease, that this case is of particular note because of the rather short period of therapy before the onset of liver injury and the severity of the hepatic failure, and that the probable increased use of nicotinic acid for serum cholesterol control makes it especially important for physicians and their patients to be alert to the signs of Adverse-Effecthepatotoxicity .
0.9837 We suggest that nicotinic acid was the cause of his liver disease, that this case is of particular note because of the rather short period of therapy before the onset of liver injury and the severity of the hepatic failure, and that the probable increased use of Drugnicotinic acid for serum cholesterol control makes it especially important for physicians and their patients to be alert to the signs of hepatotoxicity.
0.9821 We suggest that Drugnicotinic acid was the cause of his liver disease, that this case is of particular note because of the rather short period of therapy before the onset of liver injury and the severity of the hepatic failure, and that the probable increased use of nicotinic acid for serum cholesterol control makes it especially important for physicians and their patients to be alert to the signs of hepatotoxicity.
0.9121 We suggest that nicotinic acid was the cause of his Adverse-Effectliver disease , that this case is of particular note because of the rather short period of therapy before the onset of liver injury and the severity of the hepatic failure, and that the probable increased use of nicotinic acid for serum cholesterol control makes it especially important for physicians and their patients to be alert to the signs of hepatotoxicity.
0.9897 We suggest that nicotinic acid was the cause of his liver disease, that this case is of particular note because of the rather short period of therapy before the onset of liver injury and the severity of the Adverse-Effecthepatic failure , and that the probable increased use of nicotinic acid for serum cholesterol control makes it especially important for physicians and their patients to be alert to the signs of hepatotoxicity.
0.9664 We suggest that nicotinic acid was the cause of his liver disease, that this case is of particular note because of the rather short period of therapy before the onset of Adverse-Effectliver injury and the severity of the hepatic failure, and that the probable increased use of nicotinic acid for serum cholesterol control makes it especially important for physicians and their patients to be alert to the signs of hepatotoxicity.
Score Text
0.9878 In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken Drugmequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross - reaction to promethazine, decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.9766 In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross - reaction to promethazine, decreased MED to both UVA and UVB, and Adverse-Effectpersistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.9727 In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross - reaction to Drugpromethazine , decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.9557 In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross - reaction to promethazine, Adverse-Effectdecreased MED to both UVA and UVB , and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.9315 In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross - reaction to promethazine, decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the Drugmequitazine .
0.9098 In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate Adverse-Effecterythema reaction, cross - reaction to promethazine, decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.9955 In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate Adverse-Effecterythema reaction , cross - reaction to promethazine, decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.7930 In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross - reaction to promethazine, Adverse-Effectdecreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.6799 In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, Adverse-Effectcross - reaction to promethazine, decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.5977 In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross - reaction to promethazine, Adverse-Effectdecreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, Adverse-Effectcross - reaction to promethazine , decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
Score Text
0.9979 Major points illustrated are, ( 1 ) occurrence of Adverse-EffectHIT with any dose or form of heparin ; ( 2 ) misperceptions on the diagnostic criteria ; ( 3 ) correct ( thrombin inhibitors ) and incorrect ( platelet transfusions and warfarin ) management ; ( 4 ) influence of management strategy on clinical outcomes ; ( 5 ) severity of the syndrome ; and ( 6 ) potential for both anamnestic response to heparin and disappearance of HIT antibodies over time.
0.9862 Major points illustrated are, ( 1 ) occurrence of HIT with any dose or form of Drugheparin ; ( 2 ) misperceptions on the diagnostic criteria ; ( 3 ) correct ( thrombin inhibitors ) and incorrect ( platelet transfusions and warfarin ) management ; ( 4 ) influence of management strategy on clinical outcomes ; ( 5 ) severity of the syndrome ; and ( 6 ) potential for both anamnestic response to heparin and disappearance of HIT antibodies over time.
0.7708 Major points illustrated are, ( 1 ) occurrence of HIT with any dose or form of heparin ; ( 2 ) misperceptions on the diagnostic criteria ; ( 3 ) correct ( thrombin inhibitors ) and incorrect ( platelet transfusions and warfarin ) management ; ( 4 ) influence of management strategy on clinical outcomes ; ( 5 ) severity of the syndrome ; and ( 6 ) potential for both anamnestic response to Drugheparin and disappearance of HIT antibodies over time.
0.5895 Major points illustrated are, ( 1 ) occurrence of HIT with any dose or form of heparin ; ( 2 ) misperceptions on the diagnostic criteria ; ( 3 ) correct ( thrombin inhibitors ) and incorrect ( platelet transfusions and Drugwarfarin ) management ; ( 4 ) influence of management strategy on clinical outcomes ; ( 5 ) severity of the syndrome ; and ( 6 ) potential for both anamnestic response to heparin and disappearance of HIT antibodies over time.
Score Text
0.9835 These findings mean that the effect of the MP pulse therapy on renal function depends on the clinical state of the patient and that renal deterioration after the pulse therapy may be more marked in patients who are more nephrotic and more impaired in renal function and suggest that increasing sodium and water retention during an MP therapy and the associated renal interstitial edema, proposed as one of the mechanisms of acute renal failure occurring in patients with minimal - change nephrotic syndrome, may be responsible for the DrugMP - induced transient renal failure.
0.9801 These findings mean that the effect of the MP pulse therapy on renal function depends on the clinical state of the patient and that renal deterioration after the pulse therapy may be more marked in patients who are more nephrotic and more impaired in renal function and suggest that increasing sodium and water retention during an MP therapy and the associated renal interstitial edema, proposed as one of the mechanisms of acute renal failure occurring in patients with minimal - change nephrotic syndrome, may be responsible for the MP - induced Adverse-Effecttransient renal failure .
0.9742 These findings mean that the effect of the DrugMP pulse therapy on renal function depends on the clinical state of the patient and that renal deterioration after the pulse therapy may be more marked in patients who are more nephrotic and more impaired in renal function and suggest that increasing sodium and water retention during an MP therapy and the associated renal interstitial edema, proposed as one of the mechanisms of acute renal failure occurring in patients with minimal - change nephrotic syndrome, may be responsible for the MP - induced transient renal failure.
0.8577 These findings mean that the effect of the MP pulse therapy on renal function depends on the clinical state of the patient and that renal deterioration after the pulse therapy may be more marked in patients who are more nephrotic and more impaired in renal function and suggest that increasing sodium and water retention during an DrugMP therapy and the associated renal interstitial edema, proposed as one of the mechanisms of acute renal failure occurring in patients with minimal - change nephrotic syndrome, may be responsible for the MP - induced transient renal failure.
0.8011 These findings mean that the effect of the MP pulse therapy on renal function depends on the clinical state of the patient and that renal deterioration after the pulse therapy may be more marked in patients who are more nephrotic and more impaired in renal function and suggest that increasing sodium and water retention during an MP therapy and the associated Adverse-Effectrenal interstitial edema , proposed as one of the mechanisms of acute renal failure occurring in patients with minimal - change nephrotic syndrome, may be responsible for the MP - induced transient renal failure.